data_6pqm_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6pqm _Structure_validation_residue.Date_analyzed 2019-09-13 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 53.8 t . . . . . 0 N--CA 1.471 0.591 0 CA-C-O 121.49 0.662 . . . . 75.11 110.395 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 44.8 mtm -102.64 -175.54 2.85 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.183 1.793 . . . . 65.14 110.132 -166.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 8.3 p -94.25 87.7 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.115 0 CA-C-O 123.196 1.474 . . . . 74.01 108.037 159.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.28 -5.09 7.81 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 113.737 -1.574 . . . . 73.3 110.308 -177.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.51 ' HA ' ' HB3' ' A' ' 233' ' ' LEU . 69.9 m -37.54 -63.48 0.45 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.972 2.109 . . . . 35.41 114.488 -170.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 62.0 t80 . . . . . 0 N--CA 1.477 0.889 0 CA-C-O 121.116 0.484 . . . . 73.12 111.234 -172.517 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 . . . . . 0 N--CA 1.475 0.789 0 N-CA-C 108.071 -1.085 . . . . 74.24 108.071 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -74.39 170.06 16.41 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 114.587 -1.188 . . . . 72.3 110.086 175.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 35.6 tp -152.71 139.08 18.5 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 115.904 -0.589 . . . . 75.33 109.5 176.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -112.5 139.94 47.66 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.53 -0.915 . . . . 74.44 108.53 169.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -147.76 156.35 42.65 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.464 -0.939 . . . . 73.1 108.464 166.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 20.4 p -84.28 150.94 25.08 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 122.446 1.117 . . . . 64.14 112.248 169.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.549 HD11 ' HB3' ' A' ' 212' ' ' ALA . 36.7 tp -126.03 133.66 51.67 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 113.063 -1.881 . . . . 71.34 106.774 170.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . 0.441 ' HB2' HG23 ' A' ' 256' ' ' THR . 12.7 p-10 -94.69 111.55 23.32 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 108.535 -0.913 . . . . 74.13 108.535 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.579 HG22 HG23 ' A' ' 210' ' ' VAL . 58.1 t -115.94 129.48 25.15 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-N 114.783 -1.099 . . . . 73.21 108.884 -179.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -65.73 146.41 83.73 Favored 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 122.398 2.066 . . . . 75.53 111.513 169.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.431 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.62 -45.7 98.56 Favored Pre-proline 0 CA--C 1.565 1.527 0 C-N-CA 123.612 0.765 . . . . 75.24 111.918 174.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 27.6 Cg_endo -61.06 -31.03 90.52 Favored 'Trans proline' 0 C--N 1.404 3.462 0 C-N-CA 122.293 1.996 . . . . 74.32 112.618 176.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -86.25 -24.17 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 N-CA-C 108.962 -0.755 . . . . 70.21 108.962 -177.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -74.25 -37.03 63.88 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 123.079 0.552 . . . . 71.13 110.764 178.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 28.4 t -87.45 -38.71 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 O-C-N 124.68 1.238 . . . . 74.21 112.711 -178.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 54.9 t -98.4 -42.26 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 O-C-N 121.953 -0.467 . . . . 72.35 111.149 -175.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 123.06 155.56 9.34 Favored Glycine 0 C--N 1.339 0.732 0 N-CA-C 111.021 -0.832 . . . . 70.24 111.021 -175.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 161.38 156.09 8.16 Favored Glycine 0 C--O 1.245 0.819 0 N-CA-C 111.29 -0.724 . . . . 74.4 111.29 177.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.615 ' HD3' ' HB3' ' A' ' 220' ' ' GLU . 37.3 ttmt -84.28 136.66 33.83 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 109.437 -0.579 . . . . 75.22 109.437 175.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.579 HG23 HG22 ' A' ' 199' ' ' VAL . 11.4 m -135.16 151.48 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.363 1.065 . . . . 73.4 108.776 175.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . 0.4 ' HD2' ' N ' ' A' ' 212' ' ' ALA . 2.2 tmm_? -96.34 141.79 29.25 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.419 0.688 . . . . 71.23 109.734 -171.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.549 ' HB3' HD11 ' A' ' 197' ' ' LEU . . . -131.1 123.88 29.57 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.536 0.734 . . . . 63.51 109.03 -177.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 37.8 tpp -80.36 109.78 15.18 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 107.837 -1.172 . . . . 71.23 107.837 172.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 73.4 p -113.0 -172.64 2.09 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.418 0.687 . . . . 63.3 110.536 -176.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . 0.587 HD23 ' HD3' ' A' ' 241' ' ' PRO . 66.6 tp -46.18 -50.82 15.23 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.439 1.095 . . . . 72.33 111.598 170.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -72.09 -30.05 64.71 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.055 -0.975 . . . . 75.32 111.753 -174.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 132.45 -164.45 23.91 Favored Glycine 0 C--N 1.342 0.871 0 CA-C-O 119.344 -0.698 . . . . 75.52 111.676 -170.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -66.68 129.02 20.1 Favored 'Trans proline' 0 C--N 1.374 1.89 0 C-N-CA 122.437 2.091 . . . . 75.31 111.346 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.424 HG22 ' O ' ' A' ' 212' ' ' ALA . 28.4 m -134.26 164.17 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 123.472 0.709 . . . . 74.22 110.975 -175.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.615 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 41.9 mt-10 -109.07 114.61 28.49 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.257 1.023 . . . . 64.05 108.689 -171.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 34.9 t -125.6 100.81 7.4 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 123.471 0.709 . . . . 74.13 109.665 -174.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.568 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -79.21 117.6 20.38 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 122.556 0.342 . . . . 74.04 110.243 174.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 30.2 m -88.09 152.12 50.18 Favored Pre-proline 0 N--CA 1.49 1.569 0 C-N-CA 123.253 0.621 . . . . 72.11 111.877 -175.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . 0.542 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 33.5 Cg_endo -63.62 163.71 23.46 Favored 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 122.651 2.234 . . . . 72.31 113.432 176.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -84.16 33.73 0.51 Allowed 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 123.237 2.625 . . . . 74.2 113.263 175.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . 0.409 ' HD2' ' HA ' ' A' ' 226' ' ' ARG . 10.0 tpt180 -150.07 -1.61 0.41 Allowed 'General case' 0 N--CA 1.477 0.897 0 O-C-N 121.805 -0.559 . . . . 73.32 112.217 175.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.587 HG21 HG13 ' A' ' 253' ' ' VAL . 0.6 OUTLIER -59.6 152.45 22.18 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 123.683 0.615 . . . . 71.34 109.639 -164.457 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . 0.482 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 5.2 pt20 -132.46 161.42 33.74 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.081 0.553 . . . . 75.25 110.29 -169.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -60.47 112.11 1.84 Allowed 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 109.818 -0.438 . . . . 50.32 109.818 174.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.25 -3.31 22.23 Favored Glycine 0 C--O 1.244 0.774 0 CA-C-N 115.269 -0.878 . . . . 71.42 111.895 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.482 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -67.79 126.85 30.71 Favored 'General case' 0 C--N 1.361 1.078 0 N-CA-C 109.016 -0.735 . . . . 75.22 109.016 -172.114 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -97.27 98.73 10.24 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 108.944 -0.761 . . . . 74.12 108.944 -173.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.51 ' HB3' ' HA ' ' A' ' 172' ' ' SER . 31.5 mt -79.16 100.78 7.59 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.059 -1.46 . . . . 72.31 107.059 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -79.69 124.97 29.06 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 124.381 1.05 . . . . 75.04 110.164 -175.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.565 ' HB3' ' HB2' ' A' ' 238' ' ' LYS . 7.1 mp -111.41 123.94 51.24 Favored 'General case' 0 C--O 1.219 -0.504 0 N-CA-C 104.769 -2.308 . . . . 70.45 104.769 170.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.468 ' HA ' ' HB3' ' A' ' 248' ' ' ASP . 44.2 tptt -103.07 117.34 34.35 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 118.92 0.782 . . . . 72.43 110.58 -171.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 79.03 27.03 57.05 Favored Glycine 0 C--N 1.345 1.045 0 O-C-N 123.429 0.455 . . . . 73.44 112.012 -175.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.565 ' HB2' ' HB3' ' A' ' 235' ' ' LEU . 29.4 mmmt -128.82 24.0 5.72 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.219 1.008 . . . . 74.14 111.68 -176.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . 0.445 ' HA2' ' HB2' ' A' ' 249' ' ' LEU . . . -95.73 -129.47 5.92 Favored Glycine 0 N--CA 1.469 0.876 0 N-CA-C 110.857 -0.897 . . . . 64.33 110.857 178.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . 0.457 ' O ' ' HA ' ' A' ' 246' ' ' ARG . 4.8 m-30 -68.58 153.13 96.16 Favored Pre-proline 0 CA--C 1.548 0.894 0 CA-C-N 117.374 0.587 . . . . 64.15 111.45 177.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.593 ' HB2' ' HD2' ' A' ' 243' ' ' PRO . 89.3 Cg_endo -69.95 172.64 12.45 Favored 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 123.346 2.697 . . . . 73.43 112.74 -174.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -66.33 -38.19 93.46 Favored Glycine 0 CA--C 1.545 1.943 0 CA-C-O 118.353 -1.248 . . . . 75.02 113.733 -178.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . 0.593 ' HD2' ' HB2' ' A' ' 241' ' ' PRO . 79.3 Cg_exo -52.75 -39.05 78.05 Favored 'Trans proline' 0 C--N 1.392 2.859 0 CA-C-N 120.918 2.359 . . . . 74.21 113.619 167.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -78.73 -23.5 45.43 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.583 0.753 . . . . 71.33 110.635 175.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 102.83 113.3 3.77 Favored Glycine 0 C--N 1.342 0.864 0 N-CA-C 108.4 -1.88 . . . . 72.13 108.4 -168.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.457 ' HA ' ' O ' ' A' ' 240' ' ' PHE . 15.9 ttp180 -70.81 131.22 43.47 Favored 'General case' 0 C--N 1.348 0.526 0 CA-C-N 117.473 0.636 . . . . 72.54 110.033 -172.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -136.23 -157.15 7.7 Favored Glycine 0 CA--C 1.502 -0.775 0 N-CA-C 110.879 -0.888 . . . . 63.42 110.879 176.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . 0.468 ' HB3' ' HA ' ' A' ' 236' ' ' LYS . 0.4 OUTLIER -124.24 159.03 31.08 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.698 0.799 . . . . 71.12 111.081 -175.945 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.445 ' HB2' ' HA2' ' A' ' 239' ' ' GLY . 8.0 tp -130.12 135.35 48.12 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.222 1.009 . . . . 73.33 108.512 -167.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -118.86 146.35 44.94 Favored 'General case' 0 C--O 1.247 0.922 0 N-CA-C 107.137 -1.431 . . . . 75.13 107.137 -174.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.463 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 71.1 mt -123.04 114.21 20.08 Favored 'General case' 0 C--O 1.223 -0.329 0 N-CA-C 108.078 -1.082 . . . . 75.22 108.078 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -88.59 111.71 22.2 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 107.712 -1.218 . . . . 72.25 107.712 -175.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.587 HG13 HG21 ' A' ' 227' ' ' THR . 56.0 t -62.06 127.35 21.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 114.871 -1.058 . . . . 74.04 110.176 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 14.5 mmt85 -117.1 122.24 43.58 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 106.89 -1.522 . . . . 73.43 106.89 173.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 46.3 mm -82.65 118.55 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 115.491 -0.777 . . . . 75.05 110.411 -174.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' THR . . . . . 0.441 HG23 ' HB2' ' A' ' 198' ' ' ASP . 1.4 t . . . . . 0 CA--C 1.556 1.188 0 C-N-CA 124.928 1.291 . . . . 74.14 107.697 -175.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.436 HG13 HG22 ' A' ' 221' ' ' VAL . 56.1 t . . . . . 0 N--CA 1.476 0.872 0 CA-C-O 121.761 0.791 . . . . 72.43 111.715 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 46.2 mtm -99.38 -176.72 3.37 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.794 1.638 . . . . 74.32 109.898 -169.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 8.7 p -94.5 87.11 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.027 0 CA-C-O 122.986 1.375 . . . . 75.41 108.324 163.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' MET . . . . . 0.437 ' HE3' HD13 ' A' ' 235' ' ' LEU . 0.0 OUTLIER -124.57 -4.84 7.68 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 125.552 1.541 . . . . 62.32 110.024 -178.673 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 68.4 m -41.85 -64.81 0.52 Allowed 'General case' 0 C--O 1.246 0.909 0 C-N-CA 126.369 1.868 . . . . 74.25 113.042 -168.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . 0.637 ' HB2' ' HB3' ' A' ' 224' ' ' PRO . 63.1 t80 . . . . . 0 C--N 1.352 0.696 0 N-CA-C 108.764 -0.828 . . . . 73.4 108.764 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.406 ' HG2' ' HA3' ' A' ' 245' ' ' GLY . 26.5 mt-30 . . . . . 0 N--CA 1.477 0.915 0 CA-C-O 121.079 0.466 . . . . 73.53 111.076 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.58 171.03 15.32 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-N 115.187 -0.915 . . . . 71.45 109.299 -176.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.412 ' O ' ' HA ' ' A' ' 249' ' ' LEU . 37.1 tp -152.3 131.53 12.78 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.44 -0.948 . . . . 62.34 108.44 174.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.483 ' HD2' ' HZ2' ' A' ' 232' ' ' LYS . 36.0 m-85 -117.26 138.29 51.83 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 123.41 0.684 . . . . 74.55 109.158 171.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -148.14 165.79 29.81 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.49 1.116 . . . . 73.52 108.165 176.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' THR . . . . . 0.436 HG23 ' HE ' ' A' ' 254' ' ' ARG . 39.8 p -93.67 154.74 17.65 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 122.395 1.093 . . . . 71.22 112.275 168.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.573 HD12 ' HB3' ' A' ' 212' ' ' ALA . 35.4 tp -125.6 132.16 52.57 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 112.767 -2.015 . . . . 75.34 106.421 165.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -95.27 117.42 30.24 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 107.879 -1.156 . . . . 73.04 107.879 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.572 HG23 HG23 ' A' ' 210' ' ' VAL . 58.0 t -119.57 131.55 24.34 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 124.353 1.061 . . . . 72.34 110.019 -178.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -65.1 144.23 81.03 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.326 2.017 . . . . 61.15 111.418 168.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.448 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.47 -44.94 98.62 Favored Pre-proline 0 CA--C 1.564 1.517 0 C-N-CA 123.799 0.84 . . . . 73.33 112.167 174.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.453 ' O ' ' HB ' ' A' ' 206' ' ' VAL . 17.8 Cg_endo -58.72 -33.45 98.35 Favored 'Trans proline' 0 C--N 1.404 3.499 0 C-N-CA 121.784 1.656 . . . . 74.13 112.361 175.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -86.06 -23.61 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 N-CA-C 109.357 -0.609 . . . . 75.12 109.357 -177.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -74.12 -39.33 63.41 Favored 'General case' 0 C--O 1.243 0.729 0 C-N-CA 123.046 0.538 . . . . 72.32 110.897 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 38.6 t -89.42 -36.05 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.818 1.247 . . . . 74.32 112.962 -178.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.453 ' HB ' ' O ' ' A' ' 202' ' ' PRO . 47.6 t -95.98 -41.47 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 O-C-N 121.538 -0.726 . . . . 72.11 110.184 -177.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 121.57 152.12 8.66 Favored Glycine 0 C--N 1.344 0.98 0 N-CA-C 110.57 -1.012 . . . . 71.24 110.57 -178.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.89 155.99 8.77 Favored Glycine 0 C--O 1.242 0.606 0 N-CA-C 112.289 -0.324 . . . . 65.23 112.289 176.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.621 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 38.3 ttmt -84.25 132.47 34.64 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.049 0.54 . . . . 73.34 109.781 175.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.572 HG23 HG23 ' A' ' 199' ' ' VAL . 8.3 m -131.07 150.62 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.674 1.19 . . . . 73.51 108.225 174.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -95.73 143.62 26.83 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 109.226 -0.657 . . . . 73.55 109.226 -174.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.573 ' HB3' HD12 ' A' ' 197' ' ' LEU . . . -130.76 128.02 39.92 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.976 0.91 . . . . 51.34 109.035 -177.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 31.7 tpp -79.39 116.37 19.59 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.642 -0.873 . . . . 64.2 108.642 171.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 68.8 p -121.06 -176.59 3.3 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.787 0.835 . . . . 74.03 110.001 -177.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . 0.509 HD21 ' HD3' ' A' ' 241' ' ' PRO . 66.6 tp -46.72 -51.38 16.27 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.497 1.119 . . . . 72.42 111.894 172.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -72.1 -27.19 62.49 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 114.044 -1.434 . . . . 74.32 111.269 -172.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 131.98 -164.39 23.71 Favored Glycine 0 C--N 1.338 0.677 0 N-CA-C 111.508 -0.637 . . . . 75.43 111.508 -174.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -66.45 129.83 22.29 Favored 'Trans proline' 0 C--N 1.361 1.21 0 C-N-CA 122.407 2.071 . . . . 74.43 111.35 178.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 31.8 m -133.18 161.33 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 123.738 0.815 . . . . 62.42 110.816 -177.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.616 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 53.1 mt-10 -110.32 110.77 21.7 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.559 1.144 . . . . 74.41 109.842 -173.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.436 HG22 HG13 ' A' ' 168' ' ' VAL . 48.8 t -121.15 102.39 12.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 C-N-CA 124.352 1.061 . . . . 75.21 109.228 -172.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.621 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -79.2 117.08 19.89 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 122.796 0.439 . . . . 54.33 110.532 174.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 34.8 m -86.52 153.59 55.93 Favored Pre-proline 0 N--CA 1.487 1.392 0 C-N-CA 123.737 0.815 . . . . 74.51 111.457 -176.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . 0.637 ' HB3' ' HB2' ' A' ' 173' ' ' TYR . 32.7 Cg_endo -63.02 164.94 17.86 Favored 'Trans proline' 0 C--N 1.379 2.155 0 C-N-CA 122.737 2.291 . . . . 74.43 113.189 175.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -84.0 29.53 0.54 Allowed 'Trans proline' 0 C--N 1.369 1.606 0 C-N-CA 123.258 2.639 . . . . 74.22 113.178 172.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -145.9 0.1 0.83 Allowed 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 118.618 -0.706 . . . . 75.12 112.499 177.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.589 HG21 HG13 ' A' ' 253' ' ' VAL . 0.6 OUTLIER -60.95 154.66 21.85 Favored 'General case' 0 CA--C 1.573 1.84 0 O-C-N 123.375 0.422 . . . . 74.34 109.906 -167.117 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . 0.485 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 4.8 pt20 -135.26 161.94 33.98 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.563 0.745 . . . . 71.41 110.948 -169.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -62.75 110.86 1.88 Allowed 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.244 -0.65 . . . . 73.34 109.244 176.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.09 -0.55 22.65 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-N 115.187 -0.915 . . . . 61.33 111.903 178.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.485 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -67.92 123.85 21.75 Favored 'General case' 0 C--N 1.362 1.128 0 N-CA-C 108.824 -0.806 . . . . 75.31 108.824 -171.041 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.731 ' HZ1' ' HB2' ' A' ' 252' ' ' GLU . 29.6 mmmt -100.08 96.72 7.7 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.222 -0.658 . . . . 75.54 109.222 -170.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.474 ' O ' ' HA ' ' A' ' 250' ' ' TYR . 24.4 mt -80.21 98.57 7.41 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 106.378 -1.712 . . . . 74.2 106.378 -177.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . 0.649 ' HD3' ' HE2' ' A' ' 236' ' ' LYS . 0.0 OUTLIER -82.19 125.61 31.11 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.476 0.71 . . . . 71.11 111.501 178.631 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.552 ' HB3' ' HB2' ' A' ' 238' ' ' LYS . 7.2 mp -111.17 128.52 55.93 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 106.627 -1.619 . . . . 74.52 106.627 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.649 ' HE2' ' HD3' ' A' ' 234' ' ' ARG . 5.6 mptp? -97.07 116.84 30.0 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.253 0.621 . . . . 74.21 110.986 -173.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 76.46 29.27 58.31 Favored Glycine 0 C--N 1.35 1.307 0 O-C-N 124.06 0.85 . . . . 50.32 112.047 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.552 ' HB2' ' HB3' ' A' ' 235' ' ' LEU . 29.3 mmmt -127.27 20.38 6.82 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.113 0.965 . . . . 75.45 111.124 -175.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -94.95 -127.84 5.22 Favored Glycine 0 C--N 1.343 0.942 0 N-CA-C 110.059 -1.217 . . . . 71.12 110.059 178.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . 0.429 ' O ' ' HA ' ' A' ' 246' ' ' ARG . 7.3 m-30 -71.53 152.07 93.83 Favored Pre-proline 0 CA--C 1.554 1.098 0 CA-C-N 117.121 0.46 . . . . 72.41 111.767 177.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.509 ' HD3' HD21 ' A' ' 215' ' ' LEU . 59.2 Cg_endo -65.67 172.08 8.67 Favored 'Trans proline' 0 C--N 1.384 2.426 0 C-N-CA 123.468 2.779 . . . . 74.43 112.332 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.421 ' N ' ' HD2' ' A' ' 243' ' ' PRO . . . -66.31 -42.24 94.16 Favored Glycine 0 CA--C 1.541 1.672 0 CA-C-O 118.241 -1.311 . . . . 61.5 114.185 -176.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . 0.421 ' HD2' ' N ' ' A' ' 242' ' ' GLY . 10.2 Cg_endo -51.77 -38.78 67.72 Favored 'Trans proline' 0 C--N 1.392 2.825 0 C-N-CA 122.697 2.265 . . . . 72.21 113.223 168.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -79.19 -23.68 43.7 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.168 0.587 . . . . 32.22 110.839 176.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . 0.406 ' HA3' ' HG2' ' A' ' 191' ' ' GLN . . . 105.79 111.33 3.58 Favored Glycine 0 C--N 1.343 0.919 0 N-CA-C 108.757 -1.737 . . . . 74.11 108.757 -170.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.429 ' HA ' ' O ' ' A' ' 240' ' ' PHE . 74.3 mtt180 -63.6 124.54 21.64 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.46 0.704 . . . . 73.53 110.965 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -136.81 -158.15 7.9 Favored Glycine 0 C--O 1.24 0.517 0 CA-C-N 115.582 -0.736 . . . . 52.21 112.253 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -117.32 164.74 14.38 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.839 0.856 . . . . 73.02 109.517 -176.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.412 ' HA ' ' O ' ' A' ' 193' ' ' LEU . 12.3 tp -133.78 132.53 40.61 Favored 'General case' 0 C--O 1.217 -0.654 0 N-CA-C 108.541 -0.911 . . . . 73.22 108.541 -176.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.474 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 0.4 OUTLIER -113.27 145.55 40.84 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 123.48 0.712 . . . . 73.45 109.433 177.803 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 73.5 mt -124.28 112.5 17.08 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.361 -1.348 . . . . 72.21 107.361 176.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . 0.731 ' HB2' ' HZ1' ' A' ' 232' ' ' LYS . 33.3 tt0 -92.19 106.57 18.55 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 107.526 -1.287 . . . . 71.55 107.526 -172.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.589 HG13 HG21 ' A' ' 227' ' ' THR . 56.0 t -61.88 125.86 18.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 115.005 -0.998 . . . . 73.35 110.623 -177.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . 0.436 ' HE ' HG23 ' A' ' 196' ' ' THR . 26.4 mtm180 -113.6 123.77 50.75 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 106.644 -1.613 . . . . 75.2 106.644 171.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 46.5 mm -84.78 130.77 35.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 C-N-CA 123.181 0.592 . . . . 75.14 109.851 -175.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.4 t . . . . . 0 CA--C 1.563 1.471 0 C-N-CA 124.24 1.016 . . . . 72.4 108.355 -172.109 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.428 HG13 HG22 ' A' ' 221' ' ' VAL . 51.1 t . . . . . 0 N--CA 1.476 0.847 0 CA-C-O 121.441 0.639 . . . . 74.5 110.54 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 43.3 mtm -98.35 -177.78 3.82 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 125.544 1.538 . . . . 75.4 109.656 -169.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 9.0 p -100.52 90.4 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 N-CA-C 107.42 -1.326 . . . . 73.43 107.42 162.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' MET . . . . . 0.411 ' HG3' ' HA ' ' A' ' 235' ' ' LEU . 0.0 OUTLIER -125.3 -6.14 7.13 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 114.096 -1.411 . . . . 75.31 110.297 -175.863 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.428 ' HA ' ' HB3' ' A' ' 233' ' ' LEU . 67.2 m -40.77 -65.29 0.43 Allowed 'General case' 0 C--N 1.353 0.728 0 C-N-CA 126.461 1.904 . . . . 75.24 113.682 -165.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 72.8 t80 . . . . . 0 C--O 1.238 0.486 0 O-C-N 123.504 0.502 . . . . 74.41 110.187 -177.636 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 . . . . . 0 N--CA 1.472 0.653 0 N-CA-C 108.563 -0.903 . . . . 74.25 108.563 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.428 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 38.5 p-10 -74.72 165.15 25.7 Favored 'General case' 0 C--O 1.247 0.948 0 CA-C-N 115.343 -0.844 . . . . 73.51 109.984 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.4 HD12 ' CE1' ' A' ' 240' ' ' PHE . 53.1 tp -149.94 143.34 25.18 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.902 -0.59 . . . . 65.2 109.548 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -115.52 138.47 51.0 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.969 0.908 . . . . 73.32 108.636 173.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -149.09 158.32 44.09 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.73 -0.841 . . . . 60.33 108.73 170.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 26.5 p -81.3 153.08 27.26 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 122.187 0.994 . . . . 64.23 111.851 166.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.632 HD12 ' HB3' ' A' ' 212' ' ' ALA . 33.5 tp -122.62 134.5 54.51 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 113.053 -1.885 . . . . 74.43 106.911 162.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -94.7 117.47 30.18 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 108.142 -1.058 . . . . 75.02 108.142 177.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.586 HG22 HG23 ' A' ' 210' ' ' VAL . 45.1 t -122.51 132.21 24.29 Favored Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 124.049 0.94 . . . . 72.21 109.153 178.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . 0.401 ' HD2' ' HB ' ' A' ' 203' ' ' ILE . 14.9 Cg_exo -69.57 145.55 58.6 Favored 'Trans proline' 0 C--N 1.365 1.433 0 C-N-CA 122.352 2.035 . . . . 63.11 110.52 169.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.45 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -52.91 -43.56 94.36 Favored Pre-proline 0 N--CA 1.486 1.332 0 N-CA-C 112.567 0.58 . . . . 64.34 112.567 173.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.45 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 10.6 Cg_endo -55.21 -37.72 94.1 Favored 'Trans proline' 0 C--N 1.399 3.217 0 C-N-CA 122.006 1.804 . . . . 73.53 112.736 174.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.401 ' HB ' ' HD2' ' A' ' 200' ' ' PRO . 1.8 mp -86.55 -23.66 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 N-CA-C 109.841 -0.429 . . . . 74.22 109.841 -175.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -73.48 -38.0 65.56 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 123.146 0.578 . . . . 72.55 111.029 178.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 39.8 t -89.01 -35.43 7.71 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 C-N-CA 125.022 1.329 . . . . 74.51 112.648 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.437 ' HB ' ' O ' ' A' ' 202' ' ' PRO . 51.5 t -97.92 -42.93 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 O-C-N 121.547 -0.721 . . . . 75.2 111.129 -176.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 121.82 152.45 8.7 Favored Glycine 0 C--N 1.339 0.743 0 N-CA-C 110.707 -0.957 . . . . 74.35 110.707 -176.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 161.81 155.55 7.98 Favored Glycine 0 C--O 1.245 0.839 0 N-CA-C 111.307 -0.717 . . . . 74.42 111.307 177.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.615 ' HD3' ' HB3' ' A' ' 220' ' ' GLU . 36.3 ttmt -84.85 133.66 34.31 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 122.998 0.519 . . . . 75.24 110.026 174.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.586 HG23 HG22 ' A' ' 199' ' ' VAL . 15.5 m -131.24 153.4 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.417 1.087 . . . . 75.41 109.665 177.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . 0.585 ' HE ' ' HB3' ' A' ' 218' ' ' PRO . 0.0 OUTLIER -95.14 142.69 27.3 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.266 1.026 . . . . 74.04 109.352 -171.79 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.632 ' HB3' HD12 ' A' ' 197' ' ' LEU . . . -132.85 122.35 24.28 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.561 0.745 . . . . 73.41 109.459 -177.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 34.2 tpp -78.9 109.91 13.62 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 108.958 -0.756 . . . . 74.15 108.958 172.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 67.5 p -120.36 -175.08 2.93 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.928 0.891 . . . . 64.11 110.387 -175.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . 0.513 HD22 ' HD3' ' A' ' 241' ' ' PRO . 64.0 tp -44.19 -53.32 6.64 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.298 1.039 . . . . 72.32 112.754 174.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -73.32 -27.89 61.77 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 114.821 -1.081 . . . . 74.34 111.392 -172.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 135.05 -164.45 24.78 Favored Glycine 0 C--N 1.341 0.855 0 N-CA-C 111.687 -0.565 . . . . 74.02 111.687 -171.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . 0.585 ' HB3' ' HE ' ' A' ' 211' ' ' ARG . 41.3 Cg_endo -63.93 130.73 28.45 Favored 'Trans proline' 0 C--N 1.369 1.639 0 C-N-CA 122.848 2.365 . . . . 73.4 111.335 176.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 23.2 m -131.84 161.82 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.707 0.803 . . . . 74.53 110.723 -177.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.615 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 43.9 mt-10 -112.0 112.68 24.49 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.445 1.098 . . . . 65.53 109.899 -171.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.428 HG22 HG13 ' A' ' 168' ' ' VAL . 50.5 t -126.39 102.61 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 124.221 1.008 . . . . 74.21 110.174 -171.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.615 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -78.06 118.19 20.09 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.948 0.499 . . . . 73.43 110.391 174.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 36.0 m -90.71 152.33 44.74 Favored Pre-proline 0 N--CA 1.482 1.159 0 C-N-CA 123.445 0.698 . . . . 73.43 111.296 -176.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . 0.522 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 36.1 Cg_endo -63.91 165.4 18.96 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.839 2.359 . . . . 65.25 113.054 175.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -84.78 28.98 0.55 Allowed 'Trans proline' 0 C--N 1.378 2.091 0 C-N-CA 123.222 2.614 . . . . 74.52 113.032 175.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 35.4 mmt180 -145.07 -2.8 0.78 Allowed 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.335 0.654 . . . . 74.2 112.259 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.569 HG21 HG13 ' A' ' 253' ' ' VAL . 0.6 OUTLIER -60.81 149.47 35.77 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.433 -0.58 . . . . 74.44 109.433 -165.864 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . 0.464 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 13.2 pt20 -133.81 162.3 32.38 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.123 0.569 . . . . 74.01 110.417 -173.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -59.73 110.97 1.27 Allowed 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.145 0.498 . . . . 74.42 110.05 178.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.63 -0.66 21.79 Favored Glycine 0 C--N 1.335 0.49 0 CA-C-N 114.675 -1.148 . . . . 74.24 112.095 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.464 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -68.18 125.24 25.75 Favored 'General case' 0 C--N 1.359 0.992 0 N-CA-C 108.901 -0.777 . . . . 74.21 108.901 -175.002 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -98.9 97.58 8.75 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.283 0.633 . . . . 72.54 109.571 -168.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.487 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 22.2 mt -82.68 100.01 9.96 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 107.839 -1.171 . . . . 72.51 107.839 -176.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . 0.507 ' H ' ' HD3' ' A' ' 234' ' ' ARG . 0.0 OUTLIER -82.95 113.76 20.77 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.154 -0.93 . . . . 64.41 111.185 -176.964 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.475 ' O ' ' HB2' ' A' ' 248' ' ' ASP . 7.3 mp -100.66 127.25 47.12 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 106.772 -1.566 . . . . 75.14 106.772 173.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -101.74 117.12 34.21 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.342 0.657 . . . . 73.02 110.636 -175.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 79.08 32.35 39.83 Favored Glycine 0 C--N 1.348 1.227 0 O-C-N 124.268 0.98 . . . . 73.23 112.309 -177.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.448 ' HB2' ' HB3' ' A' ' 235' ' ' LEU . 29.3 mmmt -128.7 19.59 6.14 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.607 0.763 . . . . 74.21 111.66 -178.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -98.04 -134.03 8.18 Favored Glycine 0 C--N 1.343 0.953 0 N-CA-C 111.039 -0.824 . . . . 74.3 111.039 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . 0.462 ' O ' ' HA ' ' A' ' 246' ' ' ARG . 5.9 m-30 -66.18 154.91 89.04 Favored Pre-proline 0 CA--C 1.547 0.854 0 N-CA-C 112.699 0.629 . . . . 63.24 112.699 -177.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.513 ' HD3' HD22 ' A' ' 215' ' ' LEU . 86.2 Cg_endo -71.99 171.54 16.47 Favored 'Trans proline' 0 C--N 1.383 2.348 0 C-N-CA 123.285 2.657 . . . . 74.32 112.797 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.463 ' N ' ' HD2' ' A' ' 243' ' ' PRO . . . -67.17 -38.33 91.99 Favored Glycine 0 CA--C 1.545 1.962 0 CA-C-O 118.364 -1.242 . . . . 75.12 114.713 -177.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 242' ' ' GLY . 10.0 Cg_endo -53.72 -37.18 83.94 Favored 'Trans proline' 0 C--N 1.39 2.74 0 CA-C-N 120.974 2.387 . . . . 74.25 112.511 169.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -80.16 -24.6 40.28 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.513 0.725 . . . . 72.21 110.834 175.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 105.95 111.35 3.58 Favored Glycine 0 C--N 1.341 0.819 0 N-CA-C 107.802 -2.119 . . . . 73.2 107.802 -167.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.462 ' HA ' ' O ' ' A' ' 240' ' ' PHE . 1.5 tmm_? -73.12 128.52 35.73 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 109.738 -0.468 . . . . 73.0 109.738 -170.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -137.09 -156.79 7.43 Favored Glycine 0 C--N 1.342 0.911 0 CA-C-N 115.982 -0.554 . . . . 64.15 112.951 -175.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . 0.475 ' HB2' ' O ' ' A' ' 235' ' ' LEU . 32.4 p-10 -123.78 165.23 17.65 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.327 1.051 . . . . 63.21 110.526 -174.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 10.8 tp -135.56 135.37 40.28 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.191 -0.67 . . . . 72.42 109.191 -170.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -115.66 145.81 42.39 Favored 'General case' 0 C--O 1.246 0.88 0 N-CA-C 107.637 -1.246 . . . . 64.52 107.637 -178.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.487 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 82.2 mt -123.82 113.79 19.01 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 108.558 -0.904 . . . . 75.53 108.558 -179.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -89.78 110.49 21.4 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.83 -1.174 . . . . 73.23 107.83 -176.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.569 HG13 HG21 ' A' ' 227' ' ' THR . 51.2 t -61.81 134.16 27.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 115.162 -0.927 . . . . 62.45 110.527 -178.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 18.1 mtp85 -120.73 125.22 47.08 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.337 -1.357 . . . . 71.44 107.337 172.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 48.0 mm -84.92 112.83 22.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 108.948 -0.76 . . . . 74.22 108.948 -179.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 CA--C 1.557 1.248 0 CA-C-O 117.415 -1.279 . . . . 73.34 108.912 -171.734 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 54.6 t . . . . . 0 N--CA 1.475 0.823 0 CA-C-O 121.731 0.777 . . . . 65.1 111.415 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 43.4 mtm -101.42 -176.05 3.03 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.619 1.968 . . . . 74.53 109.462 -170.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 10.3 p -101.77 88.84 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.079 0 CA-C-O 122.973 1.368 . . . . 72.24 107.791 163.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.72 -5.66 8.61 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 114.05 -1.432 . . . . 72.44 110.587 -174.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.448 ' HA ' ' HB3' ' A' ' 233' ' ' LEU . 69.3 m -36.25 -64.96 0.29 Allowed 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 127.014 2.126 . . . . 72.25 115.617 -167.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . 0.434 ' HB2' ' HG3' ' A' ' 224' ' ' PRO . 66.9 t80 . . . . . 0 N--CA 1.479 1.005 0 C-N-CA 123.165 0.586 . . . . 74.32 111.517 -170.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 . . . . . 0 N--CA 1.478 0.949 0 CA-C-O 121.246 0.546 . . . . 75.23 110.169 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -76.28 164.29 26.2 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-N 115.394 -0.821 . . . . 64.44 110.458 -177.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 40.9 tp -151.1 140.14 21.07 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.344 -0.844 . . . . 73.41 109.846 176.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -114.77 140.04 49.22 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.649 0.78 . . . . 74.12 109.421 168.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -145.16 157.03 44.19 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 108.353 -0.98 . . . . 64.33 108.353 167.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 30.0 p -81.46 154.38 26.37 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 122.139 0.971 . . . . 75.11 111.516 167.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.583 HD12 ' HB3' ' A' ' 212' ' ' ALA . 42.3 tp -121.17 133.32 55.18 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 113.286 -1.779 . . . . 73.22 107.026 168.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -92.55 112.35 24.26 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 106.95 -1.5 . . . . 72.55 106.95 -177.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.534 HG22 HG23 ' A' ' 210' ' ' VAL . 43.3 t -124.55 130.41 24.3 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 123.333 0.653 . . . . 74.45 109.275 -177.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -66.81 144.13 69.95 Favored 'Trans proline' 0 C--N 1.368 1.6 0 C-N-CA 121.984 1.789 . . . . 75.55 110.974 166.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.439 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.16 -45.19 98.41 Favored Pre-proline 0 CA--C 1.562 1.421 0 CA-C-O 118.309 -0.853 . . . . 61.14 112.322 174.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.479 ' O ' ' HB ' ' A' ' 206' ' ' VAL . 22.9 Cg_endo -59.35 -30.98 94.17 Favored 'Trans proline' 0 C--N 1.4 3.252 0 C-N-CA 121.909 1.739 . . . . 72.15 112.537 175.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.7 mp -85.88 -25.97 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 O-C-N 121.645 -0.659 . . . . 74.1 109.68 -178.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -74.25 -38.81 63.37 Favored 'General case' 0 C--O 1.246 0.913 0 CA-C-O 121.13 0.49 . . . . 62.41 111.078 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 41.2 t -88.96 -37.21 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 C-N-CA 124.809 1.244 . . . . 74.31 112.653 -177.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.479 ' HB ' ' O ' ' A' ' 202' ' ' PRO . 53.1 t -96.85 -42.4 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 O-C-N 121.648 -0.658 . . . . 73.23 109.71 -176.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 124.31 148.66 7.48 Favored Glycine 0 C--N 1.349 1.287 0 N-CA-C 111.306 -0.718 . . . . 64.55 111.306 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 165.48 156.07 9.0 Favored Glycine 0 C--N 1.342 0.876 0 N-CA-C 112.259 -0.336 . . . . 74.41 112.259 177.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.607 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 38.1 ttmt -85.01 131.93 34.4 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.284 0.634 . . . . 72.21 110.16 176.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.534 HG23 HG22 ' A' ' 199' ' ' VAL . 13.8 m -131.07 153.22 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 124.023 0.929 . . . . 75.22 110.106 178.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -94.5 142.73 27.1 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.159 0.984 . . . . 72.1 109.468 -171.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.583 ' HB3' HD12 ' A' ' 197' ' ' LEU . . . -132.74 119.51 20.43 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.388 0.675 . . . . 74.2 109.774 -176.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 35.5 tpp -78.68 110.13 13.54 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 108.759 -0.83 . . . . 73.1 108.759 171.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 67.1 p -119.17 -175.26 2.89 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.085 0.954 . . . . 73.24 110.706 -174.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . 0.519 HD23 ' HD3' ' A' ' 241' ' ' PRO . 65.5 tp -49.77 -50.66 43.77 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.984 0.914 . . . . 74.13 111.439 169.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -71.86 -26.7 62.46 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 114.567 -1.197 . . . . 74.33 111.84 -173.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 133.09 -165.17 24.08 Favored Glycine 0 C--N 1.344 1.004 0 N-CA-C 111.488 -0.645 . . . . 52.54 111.488 -178.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -67.56 128.08 17.52 Favored 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 121.709 1.606 . . . . 75.15 110.566 174.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 25.1 m -132.98 162.3 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 123.329 0.652 . . . . 72.23 110.397 -174.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.593 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 45.1 mt-10 -111.78 111.64 22.75 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.647 0.779 . . . . 74.33 109.446 -173.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 57.4 t -122.65 103.81 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 124.812 1.245 . . . . 71.13 109.646 -172.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.607 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -75.34 117.57 17.29 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 110.061 -0.348 . . . . 71.12 110.061 174.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 28.3 m -85.47 153.5 58.8 Favored Pre-proline 0 N--CA 1.489 1.495 0 C-N-CA 122.889 0.475 . . . . 74.5 110.796 -176.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . 0.434 ' HG3' ' HB2' ' A' ' 173' ' ' TYR . 34.2 Cg_exo -59.7 162.36 15.74 Favored 'Trans proline' 0 C--N 1.383 2.373 0 C-N-CA 122.43 2.087 . . . . 73.3 112.757 177.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -91.02 30.12 0.36 Allowed 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 123.219 2.613 . . . . 72.52 112.039 177.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 -145.12 -9.12 0.59 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.061 0.945 . . . . 75.2 111.403 178.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.605 HG21 HG13 ' A' ' 253' ' ' VAL . 0.8 OUTLIER -59.39 156.39 12.96 Favored 'General case' 0 CA--C 1.567 1.633 0 O-C-N 123.885 0.741 . . . . 73.22 111.603 -158.906 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . 0.404 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 19.7 pt20 -130.22 162.55 28.67 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.341 0.657 . . . . 73.12 110.851 -171.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . 0.441 ' HB1' HH21 ' A' ' 254' ' ' ARG . . . -61.4 112.64 2.26 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.903 -0.59 . . . . 62.31 109.438 174.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.44 -3.86 21.74 Favored Glycine 0 N--CA 1.466 0.68 0 CA-C-N 115.642 -0.708 . . . . 72.55 112.067 178.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.404 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -68.69 126.24 29.08 Favored 'General case' 0 C--N 1.358 0.948 0 N-CA-C 109.268 -0.641 . . . . 74.13 109.268 -173.065 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -98.39 98.47 9.69 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.373 -0.603 . . . . 74.45 109.373 -171.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.448 ' HB3' ' HA ' ' A' ' 172' ' ' SER . 25.0 mt -79.64 99.77 7.52 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 106.917 -1.512 . . . . 73.4 106.917 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -81.34 115.68 20.81 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-O 121.546 0.689 . . . . 72.22 110.871 -176.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.421 ' HB3' ' HB2' ' A' ' 238' ' ' LYS . 7.3 mp -99.52 124.82 45.04 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 105.458 -2.053 . . . . 71.44 105.458 170.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 41.0 tptt -102.14 117.93 35.83 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 117.909 0.322 . . . . 70.34 110.156 -171.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 77.65 22.02 70.69 Favored Glycine 0 C--N 1.342 0.913 0 O-C-N 123.542 0.526 . . . . 73.14 112.86 -178.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.425 ' HB3' ' HZ3' ' A' ' 238' ' ' LYS . 1.5 mmmp? -120.65 20.74 11.7 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.012 0.925 . . . . 73.11 110.035 -177.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -96.75 -135.09 8.38 Favored Glycine 0 C--N 1.349 1.285 0 N-CA-C 111.258 -0.737 . . . . 72.24 111.258 178.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 6.3 m-30 -65.1 150.59 95.21 Favored Pre-proline 0 N--CA 1.48 1.035 0 N-CA-C 112.339 0.496 . . . . 71.44 112.339 -177.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.519 ' HD3' HD23 ' A' ' 215' ' ' LEU . 60.0 Cg_endo -67.37 170.38 13.59 Favored 'Trans proline' 0 C--N 1.383 2.376 0 C-N-CA 123.13 2.553 . . . . 73.41 113.075 -177.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -68.37 -39.58 87.44 Favored Glycine 0 CA--C 1.538 1.509 0 CA-C-O 118.613 -1.104 . . . . 63.32 114.361 -177.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -48.38 -40.27 36.08 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 122.515 2.144 . . . . 75.14 113.871 164.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -77.9 -24.64 48.32 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.51 0.724 . . . . 74.24 110.705 175.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 106.65 111.45 3.58 Favored Glycine 0 C--N 1.336 0.546 0 N-CA-C 108.095 -2.002 . . . . 71.24 108.095 -167.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -71.84 125.23 26.64 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-N 117.458 0.629 . . . . 75.24 110.198 -172.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -138.81 -157.73 7.45 Favored Glycine 0 C--N 1.337 0.599 0 CA-C-N 116.085 -0.507 . . . . 72.24 112.727 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -119.78 165.22 14.84 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.945 0.898 . . . . 74.34 110.085 -173.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 10.5 tp -134.39 133.24 40.35 Favored 'General case' 0 C--O 1.219 -0.523 0 N-CA-C 107.683 -1.228 . . . . 75.52 107.683 -173.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 7.7 m-30 -116.13 147.89 40.88 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 108.063 -1.088 . . . . 73.41 108.063 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 78.2 mt -122.8 114.27 20.29 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 107.89 -1.152 . . . . 74.35 107.89 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -88.05 111.75 21.88 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 107.816 -1.179 . . . . 74.51 107.816 -178.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.605 HG13 HG21 ' A' ' 227' ' ' THR . 53.2 t -60.92 125.74 17.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 O-C-N 123.976 0.797 . . . . 74.13 109.891 178.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . 0.441 HH21 ' HB1' ' A' ' 229' ' ' ALA . 0.2 OUTLIER -112.01 124.28 52.07 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 106.658 -1.608 . . . . 75.25 106.658 174.667 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 51.3 mm -88.51 126.7 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 O-C-N 123.931 0.77 . . . . 73.15 109.527 -177.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 CA--C 1.558 1.278 0 N-CA-C 107.605 -1.257 . . . . 74.3 107.605 -177.07 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 78.9 t . . . . . 0 N--CA 1.481 1.09 0 CA-C-O 121.342 0.591 . . . . 73.15 111.52 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 44.5 mtm -101.97 -174.92 2.7 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.936 1.694 . . . . 73.53 110.059 -168.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 10.9 p -95.3 87.85 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.188 0 CA-C-O 123.195 1.474 . . . . 65.54 108.126 162.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' MET . . . . . 0.47 ' HE3' HD12 ' A' ' 235' ' ' LEU . 0.0 OUTLIER -123.15 -3.76 8.5 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 114.053 -1.431 . . . . 75.03 110.106 -177.08 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.494 ' HA ' ' HB3' ' A' ' 233' ' ' LEU . 68.1 m -41.51 -66.52 0.33 Allowed 'General case' 0 C--N 1.353 0.741 0 C-N-CA 126.348 1.859 . . . . 64.52 113.454 -170.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . 0.42 ' HB2' ' HG3' ' A' ' 224' ' ' PRO . 54.1 t80 . . . . . 0 C--O 1.242 0.702 0 N-CA-C 108.422 -0.955 . . . . 73.24 108.422 178.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 . . . . . 0 N--CA 1.481 1.104 0 N-CA-C 109.147 -0.686 . . . . 72.21 109.147 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -75.23 154.78 37.36 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-N 114.717 -1.129 . . . . 72.03 108.849 -177.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 57.6 tp -148.88 132.41 16.73 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.305 -0.628 . . . . 72.45 109.305 -174.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -117.04 140.14 49.85 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.386 0.674 . . . . 73.54 109.213 174.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -147.8 158.19 43.91 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.69 0.796 . . . . 72.2 108.985 174.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 24.0 p -83.86 152.12 24.75 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 122.339 1.066 . . . . 74.45 112.292 167.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.584 HD13 ' HB3' ' A' ' 212' ' ' ALA . 33.3 tp -124.46 134.11 53.16 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 112.695 -2.048 . . . . 75.43 107.008 167.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -93.35 116.77 29.32 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.216 -1.031 . . . . 75.35 108.216 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.565 HG22 HG23 ' A' ' 210' ' ' VAL . 61.7 t -123.14 130.55 24.53 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 124.141 0.976 . . . . 75.12 109.174 178.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -66.09 143.63 72.55 Favored 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 122.161 1.907 . . . . 72.43 111.015 167.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.421 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.47 -43.75 96.22 Favored Pre-proline 0 CA--C 1.566 1.568 0 CA-C-O 118.141 -0.933 . . . . 72.45 112.572 175.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.421 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 19.1 Cg_endo -57.65 -31.28 91.48 Favored 'Trans proline' 0 C--N 1.403 3.445 0 C-N-CA 121.876 1.717 . . . . 73.24 112.634 173.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -87.14 -25.64 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 N-CA-C 109.487 -0.56 . . . . 74.31 109.487 -178.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -73.43 -37.95 65.7 Favored 'General case' 0 C--O 1.244 0.794 0 C-N-CA 122.983 0.513 . . . . 72.14 110.987 178.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 25.4 t -88.29 -38.65 11.93 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 125.368 1.467 . . . . 74.43 112.875 -177.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 79.5 t -98.5 -41.46 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 O-C-N 121.664 -0.647 . . . . 74.23 110.45 -176.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 126.98 152.73 8.09 Favored Glycine 0 N--CA 1.468 0.815 0 N-CA-C 111.287 -0.725 . . . . 71.22 111.287 -178.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.98 154.16 7.84 Favored Glycine 0 C--O 1.244 0.74 0 CA-C-N 116.978 0.389 . . . . 63.31 112.675 175.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.572 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 36.7 ttmt -85.95 131.29 34.32 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.572 0.749 . . . . 75.33 109.215 175.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.565 HG23 HG22 ' A' ' 199' ' ' VAL . 15.8 m -130.0 154.45 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 123.734 0.814 . . . . 62.34 109.633 -177.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.11 135.91 33.86 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.732 0.813 . . . . 74.25 109.274 -171.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.584 ' HB3' HD13 ' A' ' 197' ' ' LEU . . . -132.73 116.49 16.66 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.813 -0.81 . . . . 43.12 108.813 -176.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 36.7 tpp -80.78 109.87 15.75 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 107.819 -1.178 . . . . 72.3 107.819 173.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 64.8 p -113.22 -175.42 2.66 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.125 0.57 . . . . 74.42 110.533 -174.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . 0.427 HD22 ' HD3' ' A' ' 241' ' ' PRO . 60.5 tp -47.67 -51.17 22.61 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 124.323 1.014 . . . . 74.31 110.888 169.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -72.31 -27.03 62.19 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 113.884 -1.507 . . . . 73.31 110.944 -174.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 129.73 -166.14 22.0 Favored Glycine 0 C--N 1.341 0.81 0 CA-C-N 116.133 -0.485 . . . . 74.14 112.007 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -62.67 130.76 30.76 Favored 'Trans proline' 0 CA--C 1.552 1.419 0 C-N-CA 122.649 2.233 . . . . 74.43 111.84 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 212' ' ' ALA . 20.6 m -139.61 160.3 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 123.061 0.544 . . . . 73.24 110.408 -172.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.564 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 40.2 mt-10 -110.88 111.82 23.23 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.738 0.815 . . . . 53.25 109.311 -175.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 60.4 t -120.56 102.96 13.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 124.25 1.02 . . . . 74.01 108.937 -173.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.572 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -76.72 117.2 18.1 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 109.98 -0.378 . . . . 74.33 109.98 175.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 35.5 m -87.85 152.02 50.64 Favored Pre-proline 0 N--CA 1.487 1.399 0 C-N-CA 122.996 0.518 . . . . 61.33 110.562 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . 0.546 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 35.5 Cg_endo -63.48 163.48 23.77 Favored 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 122.213 1.942 . . . . 74.3 113.034 176.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -80.63 29.8 0.52 Allowed 'Trans proline' 0 C--N 1.373 1.864 0 C-N-CA 123.354 2.702 . . . . 71.41 113.416 174.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 -150.7 0.69 0.42 Allowed 'General case' 0 N--CA 1.474 0.738 0 O-C-N 122.113 -0.367 . . . . 73.03 111.839 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.652 HG21 HG13 ' A' ' 253' ' ' VAL . 0.7 OUTLIER -60.82 153.23 25.05 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.497 -0.557 . . . . 72.34 109.497 -169.058 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . 0.439 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 19.6 pt20 -132.73 162.11 32.28 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.403 0.681 . . . . 73.52 110.44 -171.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -61.13 111.46 1.72 Allowed 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 108.946 -0.761 . . . . 72.04 108.946 172.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.69 -1.62 21.68 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-N 115.087 -0.961 . . . . 72.23 112.501 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.439 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -68.79 127.08 31.82 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.445 0.698 . . . . 72.33 109.494 -173.971 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -98.21 97.1 8.56 Favored 'General case' 0 C--O 1.244 0.767 0 C-N-CA 123.413 0.685 . . . . 74.32 109.309 -170.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.494 ' HB3' ' HA ' ' A' ' 172' ' ' SER . 24.3 mt -80.23 99.24 7.73 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 107.504 -1.295 . . . . 73.25 107.504 -178.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 2.3 ppt_? -81.51 117.39 21.88 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.761 0.825 . . . . 74.55 112.579 -174.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.47 HD12 ' HE3' ' A' ' 171' ' ' MET . 7.6 mp -110.18 126.98 54.67 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 107.035 -1.468 . . . . 75.33 107.035 174.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -103.44 118.06 35.87 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.715 0.806 . . . . 75.21 111.024 -173.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 78.97 22.4 66.05 Favored Glycine 0 C--N 1.347 1.192 0 O-C-N 123.882 0.739 . . . . 64.51 112.304 -178.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -120.5 19.33 12.01 Favored 'General case' 0 C--N 1.347 0.486 0 C-N-CA 123.462 0.705 . . . . 72.13 109.984 -178.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -95.69 -136.61 8.77 Favored Glycine 0 C--N 1.35 1.361 0 N-CA-C 111.06 -0.816 . . . . 72.02 111.06 177.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 6.3 m-30 -68.28 148.27 98.24 Favored Pre-proline 0 CA--C 1.551 0.988 0 CA-C-N 117.559 0.68 . . . . 65.54 111.429 -178.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.427 ' HD3' HD22 ' A' ' 215' ' ' LEU . 65.7 Cg_endo -67.01 172.33 9.96 Favored 'Trans proline' 0 C--N 1.38 2.19 0 C-N-CA 123.399 2.733 . . . . 75.42 112.416 -177.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.447 ' N ' ' HD2' ' A' ' 243' ' ' PRO . . . -66.34 -38.29 93.52 Favored Glycine 0 CA--C 1.545 1.941 0 CA-C-O 117.92 -1.489 . . . . 64.51 114.163 -176.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 242' ' ' GLY . 9.7 Cg_endo -53.19 -35.28 72.83 Favored 'Trans proline' 0 C--N 1.392 2.867 0 CA-C-N 120.892 2.346 . . . . 74.44 113.351 167.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -85.45 -25.11 27.13 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.079 0.552 . . . . 73.13 110.464 176.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 112.52 114.19 3.29 Favored Glycine 0 C--N 1.343 0.962 0 N-CA-C 109.866 -1.294 . . . . 71.22 109.866 -169.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 32.2 ttm180 -66.22 128.44 36.13 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 117.389 0.594 . . . . 74.33 110.591 -176.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -148.1 -156.48 7.08 Favored Glycine 0 C--N 1.336 0.534 0 CA-C-N 115.657 -0.702 . . . . 72.32 112.48 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -118.58 165.86 13.43 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.214 0.605 . . . . 73.53 109.373 -171.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.441 ' O ' ' HB2' ' A' ' 235' ' ' LEU . 11.3 tp -133.83 132.07 39.97 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 107.31 -1.367 . . . . 71.12 107.31 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 9.8 m-30 -122.73 147.22 46.74 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.127 -1.064 . . . . 72.1 108.127 -178.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.416 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 86.0 mt -123.08 115.92 22.63 Favored 'General case' 0 C--O 1.222 -0.364 0 N-CA-C 108.327 -0.99 . . . . 74.25 108.327 -176.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -88.39 111.62 21.96 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 107.574 -1.269 . . . . 73.42 107.574 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.652 HG13 HG21 ' A' ' 227' ' ' THR . 55.6 t -61.35 128.35 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 CA-C-N 115.126 -0.943 . . . . 75.21 110.088 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 8.1 mmt180 -119.89 123.44 43.6 Favored 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 107.809 -1.182 . . . . 74.33 107.809 177.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 47.9 mm -82.76 122.11 36.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 114.718 -1.128 . . . . 73.13 109.945 -174.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.7 t . . . . . 0 CA--C 1.557 1.233 0 N-CA-C 107.229 -1.397 . . . . 72.53 107.229 -179.182 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.526 HG13 HG23 ' A' ' 221' ' ' VAL . 53.2 t . . . . . 0 N--CA 1.475 0.811 0 CA-C-O 121.21 0.528 . . . . 73.51 110.863 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 50.2 mtm -99.43 -176.47 3.3 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 125.8 1.64 . . . . 73.3 110.019 -169.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 8.8 p -99.97 86.48 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 CA-C-O 123.149 1.452 . . . . 74.52 107.94 163.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' MET . . . . . 0.472 ' HG3' ' HA ' ' A' ' 235' ' ' LEU . 0.0 OUTLIER -122.63 -5.36 8.67 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 113.675 -1.602 . . . . 74.15 110.041 -176.96 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.522 ' HA ' ' HB3' ' A' ' 233' ' ' LEU . 69.4 m -40.93 -63.33 0.68 Allowed 'General case' 0 C--N 1.35 0.608 0 C-N-CA 126.818 2.047 . . . . 65.21 114.553 -168.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . 0.61 ' HB2' ' HB3' ' A' ' 224' ' ' PRO . 67.3 t80 . . . . . 0 N--CA 1.474 0.761 0 CA-C-O 121.224 0.535 . . . . 72.11 110.9 -176.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 . . . . . 0 N--CA 1.479 1.008 0 N-CA-C 107.213 -1.403 . . . . 75.12 107.213 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 24.5 p-10 -74.21 172.67 11.36 Favored 'General case' 0 C--O 1.245 0.843 0 CA-C-N 113.425 -1.716 . . . . 73.11 109.724 167.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 33.0 tp -152.06 140.39 20.48 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.847 0.356 . . . . 74.04 110.324 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -115.46 139.69 49.81 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.269 1.028 . . . . 72.45 108.632 168.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.418 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -147.92 158.13 43.89 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.097 -1.075 . . . . 71.24 108.097 168.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 32.3 p -82.89 153.78 24.94 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 122.146 0.974 . . . . 63.01 112.585 167.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.544 HD12 ' HB3' ' A' ' 212' ' ' ALA . 25.8 tp -124.23 132.01 53.57 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 112.88 -1.964 . . . . 75.54 107.09 164.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -94.45 116.78 29.19 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.827 -0.805 . . . . 70.14 108.827 177.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.552 HG22 HG23 ' A' ' 210' ' ' VAL . 57.4 t -117.93 134.62 23.27 Favored Pre-proline 0 CA--C 1.549 0.923 0 CA-C-N 114.573 -1.194 . . . . 72.24 109.214 -177.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -67.5 146.7 75.17 Favored 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 122.185 1.923 . . . . 75.43 111.121 169.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.436 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.66 -45.76 98.58 Favored Pre-proline 0 CA--C 1.567 1.612 0 C-N-CA 123.65 0.78 . . . . 75.4 112.568 174.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 28.0 Cg_endo -60.73 -31.41 91.9 Favored 'Trans proline' 0 C--N 1.393 2.887 0 C-N-CA 122.202 1.934 . . . . 72.35 112.98 176.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -86.19 -24.47 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 109.441 -0.577 . . . . 73.11 109.441 -177.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -73.31 -37.7 66.09 Favored 'General case' 0 C--O 1.244 0.78 0 C-N-CA 123.053 0.541 . . . . 45.11 111.417 178.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 24.9 t -88.99 -36.66 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 CA-C-N 114.348 -1.296 . . . . 74.44 113.506 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 55.7 t -96.92 -42.3 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 O-C-N 121.486 -0.759 . . . . 74.11 111.007 -177.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 123.36 152.87 8.59 Favored Glycine 0 C--N 1.341 0.861 0 N-CA-C 110.727 -0.949 . . . . 55.03 110.727 -175.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.68 151.83 6.74 Favored Glycine 0 C--O 1.246 0.849 0 N-CA-C 111.578 -0.609 . . . . 75.2 111.578 177.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.614 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 4.2 ttmp? -84.2 130.2 34.84 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 108.667 -0.864 . . . . 73.21 108.667 174.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.552 HG23 HG22 ' A' ' 199' ' ' VAL . 15.8 m -129.9 152.24 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.383 1.073 . . . . 71.14 108.301 178.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . 0.405 ' HD2' ' N ' ' A' ' 212' ' ' ALA . 4.8 tmm_? -95.37 141.93 28.35 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 108.466 -0.939 . . . . 75.44 108.466 -172.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.544 ' HB3' HD12 ' A' ' 197' ' ' LEU . . . -132.14 124.92 30.06 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.959 0.903 . . . . 73.11 109.065 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 39.8 tpp -79.86 109.98 14.79 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 108.243 -1.021 . . . . 75.11 108.243 171.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 71.0 p -117.96 -175.59 2.87 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.838 0.855 . . . . 75.21 110.684 -177.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 63.0 tp -42.1 -50.65 4.72 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.809 1.244 . . . . 70.33 112.345 174.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -71.57 -27.08 62.91 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 114.552 -1.203 . . . . 74.55 111.595 -173.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 127.9 -163.35 21.58 Favored Glycine 0 C--N 1.34 0.791 0 N-CA-C 110.849 -0.9 . . . . 73.22 110.849 -170.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -65.49 129.84 23.57 Favored 'Trans proline' 0 C--N 1.371 1.741 0 C-N-CA 122.301 2.001 . . . . 75.11 111.594 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.414 HG22 ' O ' ' A' ' 212' ' ' ALA . 27.6 m -134.83 162.04 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 123.456 0.703 . . . . 73.31 111.041 -176.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.61 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 46.6 mt-10 -110.93 113.04 25.31 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.124 0.97 . . . . 75.05 109.77 -173.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.526 HG23 HG13 ' A' ' 168' ' ' VAL . 48.3 t -123.42 102.92 12.18 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 124.429 1.091 . . . . 74.33 109.815 -172.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.614 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -78.96 116.94 19.58 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 122.604 0.361 . . . . 71.11 110.505 175.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 35.3 m -88.79 152.44 48.87 Favored Pre-proline 0 N--CA 1.488 1.446 0 C-N-CA 123.252 0.621 . . . . 72.31 111.478 -175.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . 0.61 ' HB3' ' HB2' ' A' ' 173' ' ' TYR . 36.9 Cg_endo -63.13 166.36 14.77 Favored 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 122.838 2.359 . . . . 72.13 113.147 178.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -84.72 30.19 0.52 Allowed 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 122.838 2.359 . . . . 74.53 112.609 174.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -147.92 -0.72 0.6 Allowed 'General case' 0 N--CA 1.475 0.823 0 O-C-N 121.635 -0.666 . . . . 74.5 111.955 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.619 HG21 HG13 ' A' ' 253' ' ' VAL . 0.6 OUTLIER -61.18 152.53 28.44 Favored 'General case' 0 CA--C 1.567 1.633 0 N-CA-C 109.74 -0.467 . . . . 63.32 109.74 -167.482 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . 0.446 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 20.2 pt20 -135.05 161.47 35.21 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.456 0.703 . . . . 73.44 109.665 -173.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -61.33 111.23 1.68 Allowed 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 109.066 -0.716 . . . . 74.14 109.066 175.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 116.3 -0.47 20.68 Favored Glycine 0 N--CA 1.468 0.806 0 CA-C-N 114.783 -1.099 . . . . 74.34 112.787 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -70.92 127.36 32.32 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.83 0.852 . . . . 73.13 109.7 -175.671 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -97.62 99.22 10.6 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 109.324 -0.621 . . . . 74.14 109.324 -173.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.522 ' HB3' ' HA ' ' A' ' 172' ' ' SER . 22.8 mt -79.32 98.49 6.71 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.051 -1.463 . . . . 72.31 107.051 179.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 6.3 ppt_? -81.94 114.13 20.33 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-O 121.456 0.646 . . . . 75.35 111.972 -176.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.472 ' HA ' ' HG3' ' A' ' 171' ' ' MET . 7.2 mp -99.39 129.11 45.56 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 106.63 -1.619 . . . . 75.33 106.63 173.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 27.8 tptt -101.7 115.88 31.51 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 117.892 0.315 . . . . 75.03 110.721 -171.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.428 ' H ' ' HB3' ' A' ' 248' ' ' ASP . . . 78.12 29.38 53.98 Favored Glycine 0 C--N 1.344 1.019 0 O-C-N 123.832 0.708 . . . . 62.12 112.872 -178.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -119.31 20.05 12.64 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.841 0.856 . . . . 73.44 110.959 -177.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -95.95 -141.28 11.75 Favored Glycine 0 C--N 1.349 1.28 0 N-CA-C 110.453 -1.059 . . . . 54.2 110.453 178.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 7.2 m-30 -68.63 148.85 98.09 Favored Pre-proline 0 CA--C 1.548 0.881 0 CA-C-N 117.221 0.511 . . . . 75.2 111.592 -175.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -65.59 170.91 10.34 Favored 'Trans proline' 0 C--N 1.384 2.409 0 C-N-CA 123.209 2.606 . . . . 73.04 112.179 177.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -67.28 -39.65 92.07 Favored Glycine 0 CA--C 1.546 1.98 0 CA-C-O 118.719 -1.045 . . . . 53.31 114.186 -175.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_exo -50.39 -39.33 53.96 Favored 'Trans proline' 0 C--N 1.384 2.406 0 C-N-CA 122.601 2.201 . . . . 74.51 113.789 166.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -81.93 -24.22 35.72 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.045 0.538 . . . . 74.53 110.55 177.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 111.36 112.62 3.32 Favored Glycine 0 C--N 1.34 0.781 0 N-CA-C 109.112 -1.595 . . . . 74.45 109.112 -170.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -70.51 129.01 38.11 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 109.091 -0.707 . . . . 75.22 109.091 -172.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -148.9 -161.54 9.74 Favored Glycine 0 C--N 1.341 0.848 0 O-C-N 123.451 0.469 . . . . 72.21 112.751 173.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . 0.428 ' HB3' ' H ' ' A' ' 237' ' ' GLY . 15.8 p-10 -123.9 164.24 19.66 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.562 1.145 . . . . 72.13 110.782 -176.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 8.9 tp -132.0 136.28 47.16 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 109.27 -0.641 . . . . 64.02 109.27 -166.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -121.64 148.11 44.98 Favored 'General case' 0 C--O 1.247 0.939 0 N-CA-C 108.164 -1.05 . . . . 74.24 108.164 -176.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.418 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 71.5 mt -123.59 113.96 19.39 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 108.891 -0.781 . . . . 74.41 108.891 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -88.45 111.79 22.2 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.223 -1.028 . . . . 74.14 108.223 -177.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.619 HG13 HG21 ' A' ' 227' ' ' THR . 55.4 t -61.36 130.18 25.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 114.862 -1.063 . . . . 65.35 110.404 178.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 37.3 mtm180 -116.84 125.47 51.61 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 106.578 -1.638 . . . . 75.41 106.578 169.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 49.8 mm -84.27 127.5 39.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 108.727 -0.842 . . . . 70.42 108.727 -178.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.2 t . . . . . 0 CA--C 1.552 1.049 0 N-CA-C 108.369 -0.975 . . . . 70.3 108.369 -177.165 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 53.0 t . . . . . 0 N--CA 1.479 1.01 0 CA-C-O 121.529 0.681 . . . . 74.14 111.403 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 46.6 mtm -100.66 -176.83 3.3 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.282 1.833 . . . . 73.32 109.271 -173.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 11.2 p -98.97 88.74 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.321 0 CA-C-O 123.092 1.425 . . . . 72.41 107.758 163.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.92 -4.46 8.05 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 113.767 -1.56 . . . . 75.01 110.593 -172.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.516 ' HB3' HD22 ' A' ' 233' ' ' LEU . 70.3 m -40.7 -64.38 0.54 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.421 1.889 . . . . 75.5 114.187 -173.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . 0.61 ' HB2' ' HG3' ' A' ' 224' ' ' PRO . 45.2 t80 . . . . . 0 C--O 1.242 0.692 0 N-CA-C 108.321 -0.992 . . . . 72.13 108.321 -178.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.409 ' HG2' ' HA3' ' A' ' 245' ' ' GLY . 73.4 mt-30 . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 121.934 0.873 . . . . 75.42 109.625 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -74.33 169.59 17.34 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 114.209 -1.359 . . . . 62.42 110.645 172.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 57.7 tp -150.63 141.12 22.48 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.995 0.518 . . . . 74.52 109.803 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -116.6 138.68 51.24 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 123.996 0.918 . . . . 74.44 109.231 172.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -149.32 159.23 44.45 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 108.703 -0.851 . . . . 72.52 108.703 169.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 31.1 p -85.88 153.07 22.48 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.931 0.872 . . . . 74.33 112.322 166.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.573 HD13 ' HB3' ' A' ' 212' ' ' ALA . 31.6 tp -124.58 132.76 53.43 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 113.086 -1.87 . . . . 75.13 107.245 166.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -95.1 113.26 24.93 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.953 0.882 . . . . 73.51 109.467 -176.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.56 HG22 HG21 ' A' ' 210' ' ' VAL . 60.9 t -118.62 132.09 24.0 Favored Pre-proline 0 CA--C 1.55 0.966 0 CA-C-N 114.711 -1.131 . . . . 65.35 109.967 -177.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -66.66 144.64 72.91 Favored 'Trans proline' 0 C--N 1.37 1.691 0 C-N-CA 122.281 1.987 . . . . 74.22 111.298 166.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.432 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.08 -43.75 95.45 Favored Pre-proline 0 CA--C 1.561 1.379 0 C-N-CA 124.245 1.018 . . . . 72.41 112.586 173.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 18.8 Cg_endo -57.89 -33.01 96.5 Favored 'Trans proline' 0 C--N 1.397 3.127 0 C-N-CA 121.681 1.588 . . . . 72.42 112.702 173.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -86.42 -23.69 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 N-CA-C 109.303 -0.628 . . . . 74.33 109.303 -177.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -76.0 -36.87 59.0 Favored 'General case' 0 C--O 1.248 0.982 0 C-N-CA 123.094 0.558 . . . . 70.51 111.691 178.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 31.9 t -88.89 -36.51 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 125.161 1.384 . . . . 72.45 112.555 -179.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.427 ' HB ' ' O ' ' A' ' 202' ' ' PRO . 60.3 t -98.21 -42.14 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 O-C-N 121.659 -0.651 . . . . 63.22 109.981 -176.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 122.85 153.86 8.91 Favored Glycine 0 C--N 1.342 0.901 0 N-CA-C 110.666 -0.974 . . . . 61.14 110.666 -175.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.81 149.32 5.77 Favored Glycine 0 C--O 1.241 0.567 0 N-CA-C 112.058 -0.417 . . . . 70.45 112.058 175.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.638 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 36.8 ttmt -85.24 128.46 34.69 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.491 -0.559 . . . . 74.5 109.491 176.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.56 HG21 HG22 ' A' ' 199' ' ' VAL . 15.4 m -129.81 149.51 33.7 Favored 'Isoleucine or valine' 0 C--O 1.245 0.847 0 N-CA-C 108.036 -1.098 . . . . 75.11 108.036 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 7.0 tmm_? -96.78 143.87 27.3 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.169 0.587 . . . . 75.35 109.716 -170.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.573 ' HB3' HD13 ' A' ' 197' ' ' LEU . . . -132.28 124.58 29.15 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.551 0.74 . . . . 55.04 109.163 -177.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 36.1 tpp -79.84 109.49 14.31 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.155 -1.054 . . . . 74.31 108.155 174.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 53.2 p -111.24 -177.59 3.24 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 123.324 0.65 . . . . 74.33 109.924 -176.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . 0.539 HD21 ' HD3' ' A' ' 241' ' ' PRO . 62.1 tp -46.56 -52.82 12.65 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.292 1.037 . . . . 73.31 111.433 174.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -73.46 -27.69 61.54 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 113.674 -1.603 . . . . 72.31 111.554 -173.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 138.5 -166.99 25.16 Favored Glycine 0 C--N 1.35 1.308 0 CA-C-O 119.693 -0.504 . . . . 63.34 112.437 -176.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -65.47 130.1 24.27 Favored 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 122.454 2.103 . . . . 73.03 111.56 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 22.8 m -129.16 158.24 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 123.222 0.609 . . . . 74.24 110.055 -179.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.507 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 46.6 mt-10 -112.8 111.95 23.09 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.708 -0.849 . . . . 71.41 108.708 -174.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 99.3 t -124.84 104.13 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.207 1.003 . . . . 73.15 110.542 -169.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.638 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -77.31 117.61 18.98 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 122.658 0.383 . . . . 75.52 110.373 175.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.421 HG13 HG23 ' A' ' 199' ' ' VAL . 27.7 m -85.81 154.4 58.43 Favored Pre-proline 0 N--CA 1.479 1.012 0 C-N-CA 123.433 0.693 . . . . 75.32 111.329 -175.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . 0.61 ' HG3' ' HB2' ' A' ' 173' ' ' TYR . 36.7 Cg_exo -59.17 161.98 15.08 Favored 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 122.669 2.246 . . . . 74.13 113.231 178.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -89.28 25.99 0.57 Allowed 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 123.231 2.62 . . . . 74.2 112.632 173.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 14.4 mmt180 -146.04 0.76 0.84 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.74 0.816 . . . . 73.44 111.384 176.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.582 HG21 HG13 ' A' ' 253' ' ' VAL . 0.7 OUTLIER -62.05 153.38 29.9 Favored 'General case' 0 CA--C 1.568 1.647 0 O-C-N 123.382 0.426 . . . . 72.1 110.207 -167.56 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -133.8 162.03 33.1 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.634 0.774 . . . . 72.45 110.237 -176.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -60.23 110.63 1.28 Allowed 'General case' 0 C--N 1.351 0.672 0 O-C-N 123.446 0.466 . . . . 62.51 109.909 177.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 116.1 1.14 20.76 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-N 115.158 -0.928 . . . . 72.11 111.984 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.83 125.39 26.61 Favored 'General case' 0 C--N 1.359 1.004 0 N-CA-C 108.683 -0.858 . . . . 75.32 108.683 -177.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.55 ' HZ2' ' HB2' ' A' ' 252' ' ' GLU . 28.0 mmmt -97.39 97.56 9.22 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.35 -0.981 . . . . 74.01 108.35 -171.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.516 HD22 ' HB3' ' A' ' 172' ' ' SER . 25.0 mt -78.33 97.63 5.66 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 106.429 -1.693 . . . . 74.32 106.429 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 7.8 ppt_? -81.81 125.07 30.23 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 122.909 0.483 . . . . 74.43 110.862 -177.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 8.9 mp -108.78 130.05 55.38 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 106.697 -1.594 . . . . 75.44 106.697 175.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.51 113.62 25.21 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 122.734 0.413 . . . . 75.21 109.905 -170.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 76.71 24.69 66.71 Favored Glycine 0 C--N 1.343 0.954 0 O-C-N 123.596 0.56 . . . . 53.14 113.644 177.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -117.86 23.79 11.45 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.24 0.616 . . . . 74.4 110.547 -176.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -96.43 -131.21 6.74 Favored Glycine 0 C--N 1.346 1.089 0 CA-C-O 119.62 -0.545 . . . . 74.0 111.882 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 6.7 m-30 -72.15 154.68 92.19 Favored Pre-proline 0 CA--C 1.55 0.953 0 N-CA-C 112.746 0.647 . . . . 75.51 112.746 -176.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.539 ' HD3' HD21 ' A' ' 215' ' ' LEU . 73.7 Cg_endo -69.7 172.43 12.59 Favored 'Trans proline' 0 C--N 1.389 2.706 0 C-N-CA 123.428 2.752 . . . . 72.5 112.265 -179.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.407 ' N ' ' HD2' ' A' ' 243' ' ' PRO . . . -68.07 -39.33 88.81 Favored Glycine 0 CA--C 1.544 1.877 0 CA-C-O 118.257 -1.302 . . . . 50.15 114.395 -175.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . 0.407 ' HD2' ' N ' ' A' ' 242' ' ' GLY . 9.7 Cg_endo -55.14 -36.39 92.96 Favored 'Trans proline' 0 C--N 1.385 2.448 0 CA-C-N 120.725 2.263 . . . . 74.35 113.677 167.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -79.01 -24.04 43.97 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.053 0.541 . . . . 65.54 110.39 174.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . 0.409 ' HA3' ' HG2' ' A' ' 191' ' ' GLN . . . 107.69 112.38 3.62 Favored Glycine 0 C--N 1.344 1.023 0 N-CA-C 108.752 -1.739 . . . . 72.23 108.752 -169.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -69.7 122.18 18.64 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.614 -0.884 . . . . 75.24 108.614 -173.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -137.5 -159.51 8.24 Favored Glycine 0 C--N 1.342 0.878 0 O-C-N 123.551 0.532 . . . . 32.11 112.907 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -121.44 163.95 17.93 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.099 1.36 . . . . 72.14 110.549 -173.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 9.8 tp -134.89 134.21 40.45 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 109.628 -0.508 . . . . 71.05 109.628 -169.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -115.09 146.74 41.01 Favored 'General case' 0 C--O 1.244 0.766 0 N-CA-C 108.931 -0.766 . . . . 75.33 108.931 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 82.5 mt -123.86 113.81 19.02 Favored 'General case' 0 C--O 1.224 -0.241 0 N-CA-C 107.557 -1.275 . . . . 74.32 107.557 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . 0.55 ' HB2' ' HZ2' ' A' ' 232' ' ' LYS . 34.4 tt0 -91.03 111.86 23.51 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.251 -1.018 . . . . 74.3 108.251 -173.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.582 HG13 HG21 ' A' ' 227' ' ' THR . 53.8 t -60.04 126.75 18.34 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.423 0 O-C-N 124.238 0.961 . . . . 74.14 109.811 179.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 16.2 mtt180 -116.24 125.24 51.94 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.012 -1.477 . . . . 75.34 107.012 172.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 49.6 mm -86.33 123.06 39.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 108.718 -0.845 . . . . 75.03 108.718 -178.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.3 t . . . . . 0 CA--C 1.555 1.144 0 N-CA-C 109.271 -0.64 . . . . 73.03 109.271 -173.558 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.416 HG13 HG23 ' A' ' 221' ' ' VAL . 53.0 t . . . . . 0 CA--C 1.544 0.72 0 CA-C-O 121.213 0.53 . . . . 74.23 110.858 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 42.1 mtm -99.32 -176.91 3.43 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.825 1.65 . . . . 74.53 109.032 -171.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 14.5 p -95.57 86.5 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 CA-C-O 123.457 1.599 . . . . 63.32 107.585 163.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' MET . . . . . 0.482 ' HG3' ' HA ' ' A' ' 235' ' ' LEU . 0.0 OUTLIER -122.62 -4.2 8.74 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 113.348 -1.751 . . . . 75.15 109.728 -175.912 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.471 ' HA ' ' HB3' ' A' ' 233' ' ' LEU . 66.3 m -41.95 -66.52 0.34 Allowed 'General case' 0 C--N 1.353 0.729 0 C-N-CA 126.202 1.801 . . . . 65.21 112.933 -169.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . 0.404 ' HB2' ' HG3' ' A' ' 224' ' ' PRO . 43.0 t80 . . . . . 0 CA--C 1.541 0.63 0 N-CA-C 108.925 -0.769 . . . . 73.25 108.925 -176.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 . . . . . 0 N--CA 1.479 1.014 0 N-CA-C 108.579 -0.897 . . . . 75.11 108.579 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 30.2 p-10 -75.26 175.74 8.04 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-N 113.869 -1.514 . . . . 74.31 110.443 170.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 32.2 tp -152.31 138.64 18.46 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.597 -0.729 . . . . 53.21 109.246 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.415 ' HD2' ' HZ3' ' A' ' 232' ' ' LYS . 32.4 m-85 -116.01 139.29 50.41 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.581 0.753 . . . . 74.41 109.51 173.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -147.91 157.3 43.45 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.426 -0.953 . . . . 74.22 108.426 169.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 26.6 p -81.44 153.45 26.89 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 121.887 0.851 . . . . 75.52 111.272 164.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.583 HD13 ' HB3' ' A' ' 212' ' ' ALA . 37.3 tp -125.31 131.54 53.03 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 113.345 -1.752 . . . . 74.44 106.755 167.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . 0.425 ' HB2' HG23 ' A' ' 256' ' ' THR . 5.7 p-10 -93.43 114.65 27.1 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 107.554 -1.276 . . . . 65.42 107.554 -178.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.548 HG23 HG23 ' A' ' 210' ' ' VAL . 55.0 t -121.05 131.04 24.59 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 114.85 -1.068 . . . . 63.42 109.198 -177.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . 0.406 ' HD2' ' HB ' ' A' ' 203' ' ' ILE . 20.8 Cg_exo -66.97 148.25 81.57 Favored 'Trans proline' 0 C--N 1.369 1.63 0 C-N-CA 122.321 2.014 . . . . 72.54 110.951 169.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.436 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.62 -45.88 98.48 Favored Pre-proline 0 CA--C 1.562 1.423 0 CA-C-O 118.38 -0.819 . . . . 73.3 112.205 172.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 20.6 Cg_endo -59.6 -31.14 93.93 Favored 'Trans proline' 0 C--N 1.396 3.053 0 C-N-CA 122.096 1.864 . . . . 74.0 112.814 176.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.406 ' HB ' ' HD2' ' A' ' 200' ' ' PRO . 1.8 mp -87.71 -24.55 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 109.52 -0.548 . . . . 74.21 109.52 -177.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -76.14 -37.3 58.15 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-O 121.064 0.459 . . . . 74.35 110.806 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 23.6 t -88.52 -38.52 11.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 CA-C-N 114.156 -1.384 . . . . 73.11 112.124 -177.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.423 ' HB ' ' O ' ' A' ' 202' ' ' PRO . 72.3 t -98.76 -40.44 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 O-C-N 121.959 -0.463 . . . . 75.25 110.89 -178.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 121.33 150.41 8.32 Favored Glycine 0 N--CA 1.472 1.072 0 N-CA-C 111.311 -0.715 . . . . 71.32 111.311 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 165.65 155.6 8.77 Favored Glycine 0 C--O 1.244 0.773 0 CA-C-N 116.869 0.334 . . . . 62.54 112.473 177.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.613 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 34.6 ttmt -86.33 129.76 34.74 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.106 0.562 . . . . 75.01 109.878 179.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.548 HG23 HG23 ' A' ' 199' ' ' VAL . 10.8 m -131.96 151.94 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 124.467 1.107 . . . . 74.33 108.863 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -93.96 144.14 25.72 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.409 -0.589 . . . . 75.3 109.409 -171.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.583 ' HB3' HD13 ' A' ' 197' ' ' LEU . . . -133.05 125.27 29.26 Favored 'General case' 0 C--N 1.349 0.56 0 N-CA-C 108.907 -0.775 . . . . 75.04 108.907 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 36.5 tpp -78.68 112.74 16.09 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 108.706 -0.85 . . . . 75.4 108.706 171.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 64.1 p -119.59 -175.01 2.86 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 123.71 0.804 . . . . 72.14 110.222 -176.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . 0.524 HD23 ' HD3' ' A' ' 241' ' ' PRO . 67.2 tp -47.08 -52.93 13.93 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.239 1.016 . . . . 75.23 112.456 175.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -72.51 -27.85 62.51 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.178 -0.919 . . . . 74.52 110.977 -172.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 138.22 -165.26 25.48 Favored Glycine 0 C--N 1.34 0.794 0 N-CA-C 111.581 -0.608 . . . . 74.5 111.581 -172.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -66.18 131.15 25.96 Favored 'Trans proline' 0 C--N 1.37 1.707 0 C-N-CA 122.347 2.031 . . . . 73.23 110.779 177.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 29.4 m -130.93 161.12 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.642 0.777 . . . . 75.14 110.148 -178.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.504 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 43.7 mt-10 -111.65 111.94 23.29 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.742 0.817 . . . . 71.25 108.906 -175.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.416 HG23 HG13 ' A' ' 168' ' ' VAL . 57.4 t -121.75 103.76 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 124.164 0.986 . . . . 74.1 110.11 -171.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.613 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -78.32 118.29 20.37 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.437 0.695 . . . . 74.23 110.666 176.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 35.7 m -89.09 151.29 46.65 Favored Pre-proline 0 N--CA 1.481 1.093 0 C-N-CA 122.869 0.468 . . . . 72.21 110.975 -176.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . 0.666 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 28.6 Cg_endo -61.38 164.54 14.95 Favored 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 122.724 2.283 . . . . 73.32 113.102 176.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -91.75 37.65 0.28 Allowed 'Trans proline' 0 C--N 1.373 1.85 0 C-N-CA 123.427 2.751 . . . . 75.3 112.066 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 -148.37 -9.58 0.37 Allowed 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 116.579 -0.282 . . . . 74.45 111.356 176.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.666 ' HB ' ' HG2' ' A' ' 224' ' ' PRO . 0.7 OUTLIER -59.62 154.15 18.34 Favored 'General case' 0 CA--C 1.559 1.318 0 O-C-N 124.102 0.876 . . . . 74.44 110.633 -161.665 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . 0.46 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 4.5 pt20 -134.53 162.28 32.7 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.317 0.647 . . . . 74.23 110.371 -172.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -58.6 112.81 1.74 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 122.985 0.514 . . . . 73.4 110.841 177.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.52 1.6 21.53 Favored Glycine 0 CA--C 1.522 0.492 0 CA-C-N 115.135 -0.938 . . . . 65.32 111.877 178.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.46 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -69.82 125.52 26.97 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.121 0.569 . . . . 73.42 109.698 -175.769 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.461 ' HZ2' ' HB2' ' A' ' 252' ' ' GLU . 71.6 mmtt -97.09 100.6 12.09 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 109.241 -0.652 . . . . 72.42 109.241 -176.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.471 ' HB3' ' HA ' ' A' ' 172' ' ' SER . 39.7 mt -78.4 102.22 7.66 Favored 'General case' 0 C--N 1.341 0.236 0 N-CA-C 108.208 -1.034 . . . . 75.13 108.208 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . 0.62 ' HD2' ' H ' ' A' ' 234' ' ' ARG . 0.0 OUTLIER -79.98 117.73 21.09 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 124.733 1.271 . . . . 75.13 111.836 -174.773 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.609 ' HB3' ' HB2' ' A' ' 238' ' ' LYS . 8.2 mp -107.68 128.08 54.24 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 106.907 -1.516 . . . . 74.31 106.907 173.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -101.52 116.81 33.61 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.753 0.821 . . . . 72.23 111.441 -174.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 74.63 27.72 64.66 Favored Glycine 0 C--N 1.351 1.401 0 O-C-N 123.895 0.747 . . . . 62.31 111.857 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.609 ' HB2' ' HB3' ' A' ' 235' ' ' LEU . 28.7 mmmt -126.29 22.11 7.2 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.365 1.066 . . . . 73.23 111.134 -175.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -93.93 -128.31 5.04 Favored Glycine 0 C--N 1.341 0.815 0 N-CA-C 110.22 -1.152 . . . . 64.52 110.22 176.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . 0.452 ' O ' ' HA ' ' A' ' 246' ' ' ARG . 6.6 m-30 -70.08 153.81 95.06 Favored Pre-proline 0 CA--C 1.551 0.992 0 CA-C-N 117.65 0.725 . . . . 74.51 111.714 176.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.524 ' HD3' HD23 ' A' ' 215' ' ' LEU . 60.4 Cg_endo -68.35 171.73 12.38 Favored 'Trans proline' 0 C--N 1.381 2.239 0 C-N-CA 123.38 2.72 . . . . 71.11 112.078 178.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.432 ' N ' ' HD2' ' A' ' 243' ' ' PRO . . . -67.59 -39.55 90.75 Favored Glycine 0 CA--C 1.543 1.834 0 CA-C-O 118.4 -1.222 . . . . 73.43 114.634 -176.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 242' ' ' GLY . 9.1 Cg_endo -51.88 -38.81 68.94 Favored 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 122.698 2.265 . . . . 75.32 113.225 167.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -78.68 -25.29 44.81 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.449 0.699 . . . . 74.23 110.66 175.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 106.1 112.77 3.73 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 109.084 -1.606 . . . . 74.05 109.084 -168.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.452 ' HA ' ' O ' ' A' ' 240' ' ' PHE . 52.7 ttp180 -72.22 127.06 31.37 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 117.266 0.533 . . . . 74.33 110.977 -175.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -136.56 -157.18 7.65 Favored Glycine 0 C--O 1.239 0.452 0 CA-C-N 115.575 -0.739 . . . . 63.22 111.718 178.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -116.29 166.14 12.38 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.872 0.869 . . . . 72.41 109.028 -174.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 10.6 tp -134.78 134.14 40.6 Favored 'General case' 0 C--O 1.213 -0.827 0 N-CA-C 108.333 -0.988 . . . . 75.11 108.333 -176.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.445 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 8.1 m-85 -121.97 146.23 47.35 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 108.943 -0.762 . . . . 72.34 108.943 -177.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.426 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 77.6 mt -124.64 115.52 20.93 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.917 -0.772 . . . . 74.23 108.917 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . 0.461 ' HB2' ' HZ2' ' A' ' 232' ' ' LYS . 35.4 tt0 -88.94 106.71 18.59 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 107.873 -1.158 . . . . 72.4 107.873 -173.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.631 HG13 HG21 ' A' ' 227' ' ' THR . 52.7 t -59.93 125.26 15.74 Favored 'Isoleucine or valine' 0 C--N 1.34 0.184 0 O-C-N 124.09 0.869 . . . . 75.1 109.439 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -120.78 124.35 44.87 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.212 -1.403 . . . . 74.34 107.212 176.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 51.1 mm -85.75 118.45 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 O-C-N 124.124 0.89 . . . . 74.21 109.414 -173.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' THR . . . . . 0.425 HG23 ' HB2' ' A' ' 198' ' ' ASP . 1.0 OUTLIER . . . . . 0 CA--C 1.554 1.107 0 N-CA-C 108.582 -0.896 . . . . 73.53 108.582 -171.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.467 HG13 HG22 ' A' ' 221' ' ' VAL . 54.9 t . . . . . 0 N--CA 1.475 0.787 0 CA-C-O 121.323 0.582 . . . . 72.45 111.765 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 44.1 mtm -98.75 -176.75 3.44 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.651 1.581 . . . . 72.13 109.651 -174.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 8.3 p -99.98 89.04 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 CA-C-O 122.964 1.364 . . . . 74.42 108.592 163.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' MET . . . . . 0.421 ' HG3' ' HA ' ' A' ' 235' ' ' LEU . 0.0 OUTLIER -123.76 -6.09 8.01 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 113.946 -1.479 . . . . 72.25 110.789 -174.478 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.47 ' HB3' HD23 ' A' ' 233' ' ' LEU . 66.1 m -39.64 -66.45 0.3 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.545 1.938 . . . . 75.02 114.638 -167.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 57.5 t80 . . . . . 0 N--CA 1.472 0.625 0 C-N-CA 122.603 0.361 . . . . 74.24 110.068 -175.386 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.519 ' HG2' ' HA3' ' A' ' 245' ' ' GLY . 45.2 mt-30 . . . . . 0 N--CA 1.477 0.916 0 CA-C-O 121.338 0.59 . . . . 71.01 110.47 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -75.4 162.08 28.68 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 114.806 -1.088 . . . . 73.23 109.182 176.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.423 HD21 HD11 ' A' ' 249' ' ' LEU . 52.7 tp -149.96 136.52 19.14 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.128 -0.693 . . . . 71.53 109.128 171.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -113.17 139.58 48.64 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.011 -0.737 . . . . 74.54 109.011 170.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.469 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -148.38 155.05 40.76 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.491 0.716 . . . . 73.1 109.338 173.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 25.2 p -82.0 153.62 26.11 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 122.085 0.945 . . . . 75.45 112.774 171.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.589 HD13 ' HB3' ' A' ' 212' ' ' ALA . 39.3 tp -126.97 132.26 50.86 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 113.108 -1.86 . . . . 74.32 106.642 169.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -95.13 111.59 23.39 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.068 -1.086 . . . . 73.24 108.068 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.508 HG22 HG21 ' A' ' 210' ' ' VAL . 46.8 t -114.84 131.91 23.22 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-N 114.663 -1.153 . . . . 74.42 109.299 -178.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -68.59 145.3 63.61 Favored 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 122.229 1.953 . . . . 73.12 110.934 168.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.431 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.86 -45.56 98.82 Favored Pre-proline 0 CA--C 1.564 1.493 0 O-C-N 123.961 0.788 . . . . 71.12 111.845 174.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 19.6 Cg_endo -58.97 -32.9 98.38 Favored 'Trans proline' 0 C--N 1.403 3.442 0 C-N-CA 122.155 1.903 . . . . 71.52 112.777 175.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.7 mp -86.0 -24.85 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 109.509 -0.552 . . . . 75.42 109.509 -176.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -73.22 -37.71 66.32 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 122.942 0.497 . . . . 64.44 110.943 178.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 21.0 t -87.78 -37.28 10.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-N 114.426 -1.261 . . . . 74.34 112.981 -178.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 53.4 t -96.62 -42.2 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 O-C-N 122.203 -0.311 . . . . 71.32 110.484 -175.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 121.2 145.46 7.22 Favored Glycine 0 C--N 1.339 0.743 0 N-CA-C 110.76 -0.936 . . . . 73.11 110.76 -176.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 166.13 155.72 8.98 Favored Glycine 0 C--O 1.246 0.906 0 CA-C-O 121.29 0.383 . . . . 63.03 112.538 178.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.612 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 36.8 ttmt -86.32 131.73 34.14 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.564 0.745 . . . . 73.45 109.685 178.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.508 HG21 HG22 ' A' ' 199' ' ' VAL . 14.2 m -129.2 149.23 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 124.165 0.986 . . . . 71.22 109.197 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . 0.405 ' HD2' ' N ' ' A' ' 212' ' ' ALA . 4.4 tmm_? -95.98 141.55 29.26 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 108.918 -0.771 . . . . 72.31 108.918 -170.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.589 ' HB3' HD13 ' A' ' 197' ' ' LEU . . . -132.64 116.17 16.32 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.501 1.12 . . . . 61.35 109.223 -175.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 38.1 tpp -78.85 108.7 12.49 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 107.612 -1.255 . . . . 75.4 107.612 172.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 71.3 p -114.48 -175.17 2.62 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.811 0.844 . . . . 75.42 110.611 -175.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . 0.567 HD21 ' HD3' ' A' ' 241' ' ' PRO . 61.8 tp -45.01 -52.4 8.9 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.757 1.223 . . . . 70.0 112.091 173.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -72.11 -28.08 63.06 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 114.189 -1.369 . . . . 65.02 111.031 -171.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 135.02 -166.23 24.43 Favored Glycine 0 C--O 1.243 0.717 0 CA-C-N 115.509 -0.769 . . . . 74.25 111.304 -173.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.0 131.43 23.83 Favored 'Trans proline' 0 C--N 1.363 1.3 0 C-N-CA 122.352 2.035 . . . . 73.15 111.672 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 28.9 m -134.26 157.76 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.749 0.82 . . . . 72.14 109.981 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.484 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 38.7 mt-10 -114.28 115.56 27.61 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.641 0.776 . . . . 73.51 110.568 -176.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.467 HG22 HG13 ' A' ' 168' ' ' VAL . 98.3 t -121.74 105.29 16.22 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 125.366 1.466 . . . . 75.21 110.245 -168.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.612 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -76.3 118.47 19.05 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 122.425 0.29 . . . . 72.42 110.621 176.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 35.0 m -87.25 151.72 51.67 Favored Pre-proline 0 N--CA 1.489 1.496 0 C-N-CA 123.178 0.591 . . . . 75.34 110.673 -178.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . 0.671 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 26.1 Cg_endo -61.06 163.59 16.31 Favored 'Trans proline' 0 C--N 1.38 2.215 0 C-N-CA 122.706 2.271 . . . . 64.4 113.193 177.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -87.27 34.02 0.43 Allowed 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 122.951 2.434 . . . . 74.12 112.572 178.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -149.73 -3.35 0.4 Allowed 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 112.321 0.489 . . . . 73.05 112.321 177.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.671 ' HB ' ' HG2' ' A' ' 224' ' ' PRO . 0.7 OUTLIER -61.97 154.34 26.75 Favored 'General case' 0 CA--C 1.563 1.461 0 O-C-N 123.304 0.377 . . . . 74.55 111.788 -165.099 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -136.82 161.04 37.08 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.472 0.709 . . . . 73.54 110.193 -178.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -58.56 113.12 1.85 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.45 0.7 . . . . 75.15 111.175 -177.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 116.69 0.31 19.96 Favored Glycine 0 CA--C 1.524 0.616 0 CA-C-N 115.064 -0.971 . . . . 73.44 112.395 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.417 ' HE ' HD22 ' A' ' 233' ' ' LEU . 0.0 OUTLIER -68.97 130.76 43.69 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 109.076 -0.713 . . . . 72.24 109.076 -176.396 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -97.76 96.18 8.06 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 109.018 -0.734 . . . . 74.11 109.018 -168.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.47 HD23 ' HB3' ' A' ' 172' ' ' SER . 24.4 mt -82.6 97.62 8.58 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 106.694 -1.595 . . . . 72.2 106.694 -178.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 3.5 ppt_? -83.23 125.29 31.42 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 123.97 0.794 . . . . 73.53 110.988 -179.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.421 ' HA ' ' HG3' ' A' ' 171' ' ' MET . 7.3 mp -110.02 126.65 54.2 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 106.286 -1.746 . . . . 74.24 106.286 177.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 11.3 tptp -98.6 115.28 28.29 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 110.048 -0.353 . . . . 75.4 110.048 -170.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.612 ' HA2' HH11 ' A' ' 246' ' ' ARG . . . 79.66 23.35 62.48 Favored Glycine 0 C--N 1.343 0.951 0 O-C-N 123.836 0.71 . . . . 40.14 113.65 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? -122.72 23.93 9.31 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.296 0.638 . . . . 75.33 111.292 -177.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . 0.43 ' HA2' ' HB2' ' A' ' 249' ' ' LEU . . . -93.79 -130.96 5.86 Favored Glycine 0 C--N 1.349 1.261 0 CA-C-O 119.296 -0.725 . . . . 74.23 111.919 -178.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -69.29 149.21 97.44 Favored Pre-proline 0 CA--C 1.553 1.093 0 CA-C-N 117.366 0.583 . . . . 74.15 111.53 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.567 ' HD3' HD21 ' A' ' 215' ' ' LEU . 44.1 Cg_endo -63.62 171.78 6.51 Favored 'Trans proline' 0 C--N 1.391 2.764 0 C-N-CA 123.574 2.849 . . . . 74.22 112.565 -178.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -66.02 -42.95 94.38 Favored Glycine 0 CA--C 1.544 1.849 0 CA-C-O 118.223 -1.321 . . . . 74.11 114.098 -173.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -58.92 -34.75 99.24 Favored 'Trans proline' 0 C--N 1.388 2.644 0 CA-C-N 120.812 2.306 . . . . 74.22 113.785 170.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -77.14 -24.54 51.61 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.18 0.592 . . . . 72.31 110.37 173.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . 0.519 ' HA3' ' HG2' ' A' ' 191' ' ' GLN . . . 110.51 117.74 3.84 Favored Glycine 0 C--N 1.344 0.973 0 N-CA-C 110.532 -1.027 . . . . 74.34 110.532 -172.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.612 HH11 ' HA2' ' A' ' 237' ' ' GLY . 2.3 tmm_? -68.6 124.74 24.43 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.18 -0.674 . . . . 74.42 109.18 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -143.12 -156.2 6.7 Favored Glycine 0 N--CA 1.47 0.943 0 O-C-N 123.517 0.511 . . . . 74.31 112.109 176.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -115.53 167.05 11.23 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 109.112 -0.699 . . . . 62.32 109.112 -176.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.43 ' HB2' ' HA2' ' A' ' 239' ' ' GLY . 17.9 tp -134.48 133.07 39.99 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 108.499 -0.926 . . . . 74.24 108.499 -175.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -114.06 147.6 38.45 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 123.598 0.759 . . . . 73.22 110.245 178.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.469 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 88.9 mt -125.65 113.85 17.91 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 114.017 -1.447 . . . . 64.24 107.511 174.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -89.73 112.64 23.98 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 107.671 -1.233 . . . . 75.42 107.671 -176.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.558 HG13 HG21 ' A' ' 227' ' ' THR . 54.6 t -59.65 127.31 18.79 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.117 0 O-C-N 124.46 1.1 . . . . 70.31 109.75 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 8.3 mmt180 -123.96 123.45 40.41 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.251 -1.018 . . . . 75.12 108.251 175.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 46.2 mm -87.15 118.73 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 123.258 0.623 . . . . 75.41 110.033 -174.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.4 t . . . . . 0 CA--C 1.56 1.357 0 C-N-CA 123.546 0.738 . . . . 62.41 109.251 -171.555 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 47.5 t . . . . . 0 CA--C 1.545 0.76 0 CA-C-O 121.12 0.486 . . . . 73.03 111.596 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 47.9 mtm -99.11 -175.62 3.08 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 126.183 1.793 . . . . 75.42 109.703 -171.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 14.3 p -95.63 87.81 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.351 0 N-CA-C 107.107 -1.442 . . . . 74.42 107.107 161.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' MET . . . . . 0.403 ' SD ' ' HG ' ' A' ' 235' ' ' LEU . 0.0 OUTLIER -129.96 -4.79 4.52 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 114.211 -1.359 . . . . 74.41 110.9 -174.203 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.451 ' HA ' ' HB3' ' A' ' 233' ' ' LEU . 70.9 m -40.17 -65.13 0.43 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.666 1.986 . . . . 64.42 113.049 -171.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 55.4 t80 . . . . . 0 CA--C 1.543 0.677 0 N-CA-C 107.518 -1.29 . . . . 72.33 107.518 179.542 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.41 ' HG2' ' HA3' ' A' ' 245' ' ' GLY . 21.9 mt-30 . . . . . 0 C--O 1.245 0.819 0 N-CA-C 108.252 -1.018 . . . . 75.31 108.252 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 29.2 p-10 -74.17 167.64 21.17 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 114.722 -1.126 . . . . 52.34 110.548 174.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 52.8 tp -150.65 139.64 21.0 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.449 -0.796 . . . . 75.22 109.821 177.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -110.03 138.77 45.94 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 123.869 0.867 . . . . 74.34 109.509 171.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -148.05 157.78 43.7 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 108.185 -1.043 . . . . 63.12 108.185 168.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' THR . . . . . 0.435 HG22 ' HB3' ' A' ' 252' ' ' GLU . 27.8 p -92.87 152.58 19.32 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.957 0.884 . . . . 74.43 112.242 168.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.619 HD12 ' HB3' ' A' ' 212' ' ' ALA . 41.1 tp -123.86 130.79 53.17 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 113.073 -1.876 . . . . 74.34 106.826 167.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . 0.417 ' HB2' HG22 ' A' ' 256' ' ' THR . 10.0 p-10 -94.63 112.39 24.14 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 121.951 0.881 . . . . 72.34 109.047 -178.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.574 HG22 HG23 ' A' ' 210' ' ' VAL . 61.0 t -119.35 132.81 23.85 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 124.119 0.968 . . . . 61.21 109.903 -175.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -68.46 144.35 60.96 Favored 'Trans proline' 0 C--N 1.369 1.608 0 C-N-CA 121.999 1.799 . . . . 70.1 111.337 167.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.432 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.0 -43.62 94.97 Favored Pre-proline 0 CA--C 1.559 1.301 0 CA-C-O 118.104 -0.95 . . . . 73.44 112.601 173.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 19.3 Cg_endo -56.86 -33.61 95.1 Favored 'Trans proline' 0 C--N 1.399 3.237 0 C-N-CA 121.728 1.618 . . . . 73.22 112.631 173.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -86.71 -24.25 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 N-CA-C 109.623 -0.51 . . . . 61.5 109.623 -177.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -73.5 -37.59 65.63 Favored 'General case' 0 C--O 1.246 0.89 0 C-N-CA 123.335 0.654 . . . . 62.32 110.866 178.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 41.4 t -90.04 -34.67 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.224 0 CA-C-N 113.498 -1.683 . . . . 74.32 113.414 -177.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 54.6 t -101.39 -42.39 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 O-C-N 121.479 -0.763 . . . . 73.41 111.096 -178.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 126.12 155.24 8.89 Favored Glycine 0 C--N 1.34 0.773 0 N-CA-C 110.941 -0.863 . . . . 34.4 110.941 -176.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.64 149.1 5.68 Favored Glycine 0 C--O 1.246 0.894 0 N-CA-C 111.48 -0.648 . . . . 74.5 111.48 176.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.579 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 34.3 ttpt -84.71 129.83 34.78 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 109.267 -0.642 . . . . 75.52 109.267 174.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.574 HG23 HG22 ' A' ' 199' ' ' VAL . 9.7 m -133.37 147.93 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 124.013 0.925 . . . . 71.43 108.77 -178.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . 0.42 ' HD2' ' N ' ' A' ' 212' ' ' ALA . 6.4 tmm_? -94.77 141.79 28.21 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.218 0.607 . . . . 73.01 109.429 -170.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.619 ' HB3' HD12 ' A' ' 197' ' ' LEU . . . -131.18 126.22 35.04 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.495 1.118 . . . . 73.52 108.498 -176.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 37.3 tpp -80.05 108.5 13.69 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 108.083 -1.08 . . . . 75.13 108.083 173.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 71.4 p -117.23 178.8 4.23 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.692 0.797 . . . . 75.02 110.741 -176.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 69.0 tp -45.33 -50.71 11.86 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.17 1.388 . . . . 72.24 112.276 176.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -71.96 -26.69 62.37 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 114.551 -1.204 . . . . 72.13 111.288 -173.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 138.6 -166.53 25.29 Favored Glycine 0 C--N 1.341 0.861 0 N-CA-C 111.389 -0.684 . . . . 74.35 111.389 -177.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -65.33 130.27 24.92 Favored 'Trans proline' 0 C--N 1.368 1.555 0 C-N-CA 121.9 1.733 . . . . 73.12 110.771 174.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 30.2 m -134.74 159.72 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 123.312 0.645 . . . . 74.22 110.532 -174.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.545 ' HB3' ' HD2' ' A' ' 209' ' ' LYS . 44.6 mt-10 -113.42 114.7 26.95 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.344 0.658 . . . . 72.2 109.764 -174.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 54.9 t -122.01 103.74 13.87 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 C-N-CA 125.009 1.324 . . . . 73.34 109.667 -169.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.579 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -77.48 117.88 19.37 Favored 'General case' 0 N--CA 1.478 0.943 0 O-C-N 122.167 -0.333 . . . . 52.12 110.478 175.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 27.5 m -85.23 152.8 58.85 Favored Pre-proline 0 N--CA 1.492 1.66 0 C-N-CA 123.202 0.601 . . . . 73.2 111.157 -176.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . 0.55 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 33.6 Cg_endo -65.99 163.03 32.71 Favored 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 121.75 1.633 . . . . 73.45 112.541 177.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -85.34 27.42 0.6 Allowed 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 122.854 2.369 . . . . 74.52 112.94 178.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 41.5 mmt-85 -144.93 0.11 0.93 Allowed 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.382 0.673 . . . . 70.32 111.447 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.615 HG21 HG13 ' A' ' 253' ' ' VAL . 0.7 OUTLIER -61.65 155.71 21.84 Favored 'General case' 0 CA--C 1.573 1.859 0 O-C-N 123.88 0.738 . . . . 65.25 109.529 -169.191 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . 0.421 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 4.8 pt20 -133.07 162.86 30.59 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.541 0.736 . . . . 73.4 110.844 -174.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -59.38 110.75 1.16 Allowed 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 109.444 -0.576 . . . . 75.34 109.444 171.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 114.35 0.36 23.6 Favored Glycine 0 CA--C 1.524 0.61 0 CA-C-N 115.379 -0.828 . . . . 75.12 111.686 178.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.421 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -72.04 125.5 27.4 Favored 'General case' 0 C--N 1.359 0.99 0 N-CA-C 109.022 -0.733 . . . . 75.4 109.022 -174.141 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -98.98 97.7 8.83 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 123.508 0.723 . . . . 75.21 109.457 -169.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.451 ' HB3' ' HA ' ' A' ' 172' ' ' SER . 30.7 mt -80.38 98.0 7.29 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 107.008 -1.479 . . . . 72.54 107.008 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 2.0 ppt_? -83.61 117.37 23.12 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 121.493 0.663 . . . . 74.11 111.417 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.403 ' HG ' ' SD ' ' A' ' 171' ' ' MET . 6.3 mp -99.17 125.8 44.82 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 105.479 -2.045 . . . . 74.11 105.479 174.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.402 ' HD2' ' HA ' ' A' ' 236' ' ' LYS . 18.3 tptt -101.79 117.43 34.84 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 118.657 0.662 . . . . 73.14 111.234 -168.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.459 ' H ' ' HB3' ' A' ' 248' ' ' ASP . . . 78.03 24.6 63.75 Favored Glycine 0 C--N 1.354 1.583 0 O-C-N 123.837 0.711 . . . . 74.34 112.549 -174.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -119.1 20.67 12.61 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.571 0.748 . . . . 75.42 110.943 -175.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -96.83 -139.56 10.69 Favored Glycine 0 C--N 1.346 1.097 0 N-CA-C 111.124 -0.79 . . . . 71.42 111.124 177.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 7.1 m-30 -68.89 149.53 97.85 Favored Pre-proline 0 N--CA 1.478 0.955 0 N-CA-C 112.372 0.508 . . . . 74.23 112.372 -174.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -63.12 170.87 7.02 Favored 'Trans proline' 0 C--N 1.386 2.549 0 C-N-CA 123.488 2.792 . . . . 64.11 112.65 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.426 ' N ' ' HD2' ' A' ' 243' ' ' PRO . . . -66.55 -40.03 94.1 Favored Glycine 0 CA--C 1.551 2.306 0 CA-C-O 118.244 -1.309 . . . . 64.44 114.695 -174.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' A' ' 242' ' ' GLY . 13.1 Cg_endo -56.64 -36.61 98.24 Favored 'Trans proline' 0 C--N 1.391 2.763 0 CA-C-N 120.792 2.296 . . . . 64.03 113.219 169.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -78.28 -25.36 46.67 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.148 0.579 . . . . 72.45 110.414 175.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . 0.41 ' HA3' ' HG2' ' A' ' 191' ' ' GLN . . . 113.18 117.08 3.39 Favored Glycine 0 C--N 1.344 1.007 0 N-CA-C 109.543 -1.423 . . . . 75.54 109.543 -169.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 45.9 ttm105 -72.11 125.98 28.64 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 117.283 0.541 . . . . 75.33 110.4 -178.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -148.54 -158.18 7.89 Favored Glycine 0 C--N 1.331 0.287 0 CA-C-N 116.008 -0.542 . . . . 74.2 112.094 175.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . 0.459 ' HB3' ' H ' ' A' ' 237' ' ' GLY . 0.1 OUTLIER -126.72 166.26 17.71 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.261 1.024 . . . . 73.15 110.526 -174.465 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 7.2 tp -132.86 134.66 44.91 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.667 -0.864 . . . . 72.24 108.667 -167.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -115.18 146.95 40.89 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 108.352 -0.981 . . . . 71.12 108.352 -175.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.416 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 84.6 mt -124.22 113.87 18.86 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 107.94 -1.133 . . . . 73.05 107.94 179.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . 0.435 ' HB3' HG22 ' A' ' 196' ' ' THR . 24.1 tt0 -88.74 110.39 20.96 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 107.698 -1.223 . . . . 72.24 107.698 -176.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.615 HG13 HG21 ' A' ' 227' ' ' THR . 55.5 t -60.77 125.63 17.26 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.263 0 O-C-N 124.116 0.885 . . . . 64.3 109.186 176.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 24.4 mtp85 -122.29 122.97 40.34 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 107.919 -1.141 . . . . 74.24 107.919 178.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.433 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 47.2 mm -85.84 118.67 32.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 O-C-N 123.635 0.584 . . . . 73.42 109.89 -171.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' THR . . . . . 0.417 HG22 ' HB2' ' A' ' 198' ' ' ASP . 1.7 t . . . . . 0 CA--C 1.551 1.008 0 C-N-CA 124.329 1.052 . . . . 74.44 109.357 -171.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 53.7 t . . . . . 0 N--CA 1.478 0.925 0 CA-C-O 121.885 0.85 . . . . 74.54 111.908 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 43.3 mtm -101.62 -176.06 3.03 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 126.625 1.97 . . . . 75.42 109.862 -168.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 10.2 p -99.23 87.14 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 CA-C-O 123.066 1.413 . . . . 73.52 107.534 162.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' MET . . . . . 0.473 ' HE2' HD12 ' A' ' 235' ' ' LEU . 0.0 OUTLIER -122.43 -4.45 8.83 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 113.883 -1.508 . . . . 74.11 110.285 -174.855 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.442 ' HB3' HD21 ' A' ' 233' ' ' LEU . 69.6 m -39.0 -68.3 0.17 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.775 2.03 . . . . 63.34 113.839 -166.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . 0.496 ' HB2' ' HG3' ' A' ' 224' ' ' PRO . 67.2 t80 . . . . . 0 CA--C 1.538 0.494 0 N-CA-C 109.372 -0.603 . . . . 75.22 109.372 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 . . . . . 0 N--CA 1.468 0.428 0 CA-C-O 121.369 0.604 . . . . 74.31 109.439 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -82.95 167.62 17.8 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 114.844 -1.071 . . . . 72.24 109.925 175.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 50.3 tp -150.55 138.73 20.24 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.161 -0.472 . . . . 74.41 109.766 -177.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -117.33 139.45 50.83 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.035 0.934 . . . . 72.43 109.207 172.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -148.39 158.65 44.24 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.737 -0.838 . . . . 72.24 108.737 171.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 33.2 p -80.95 153.63 27.4 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 122.13 0.967 . . . . 74.43 111.802 168.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.611 HD11 ' HB3' ' A' ' 212' ' ' ALA . 38.8 tp -124.09 133.42 53.62 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 112.961 -1.927 . . . . 73.42 106.402 166.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -93.05 114.76 27.39 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.785 -1.191 . . . . 73.53 107.785 178.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.578 HG22 HG23 ' A' ' 210' ' ' VAL . 61.0 t -122.93 130.51 24.58 Favored Pre-proline 0 CA--C 1.542 0.673 0 C-N-CA 124.202 1.001 . . . . 52.33 108.832 179.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -68.48 146.72 69.04 Favored 'Trans proline' 0 C--N 1.363 1.29 0 C-N-CA 122.402 2.068 . . . . 75.2 111.76 168.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.444 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.23 -44.79 98.08 Favored Pre-proline 0 CA--C 1.564 1.507 0 C-N-CA 124.178 0.991 . . . . 63.34 112.25 172.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 19.8 Cg_endo -58.11 -34.68 98.74 Favored 'Trans proline' 0 C--N 1.401 3.294 0 C-N-CA 122.127 1.885 . . . . 72.1 112.58 174.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -85.43 -23.37 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 N-CA-C 109.138 -0.69 . . . . 74.33 109.138 -177.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -74.25 -37.98 63.62 Favored 'General case' 0 C--O 1.247 0.95 0 C-N-CA 123.108 0.563 . . . . 73.22 111.589 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 35.0 t -88.89 -37.88 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 CA-C-N 114.443 -1.253 . . . . 65.15 112.798 -179.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.413 ' HB ' ' O ' ' A' ' 202' ' ' PRO . 54.5 t -95.82 -41.63 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 O-C-N 121.834 -0.541 . . . . 70.13 110.463 -175.234 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 121.59 151.1 8.43 Favored Glycine 0 C--N 1.344 1.012 0 N-CA-C 111.044 -0.822 . . . . 61.44 111.044 -177.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.77 154.48 7.96 Favored Glycine 0 C--O 1.246 0.862 0 N-CA-C 112.253 -0.339 . . . . 71.21 112.253 176.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.592 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 39.1 ttmt -85.32 132.68 34.21 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 123.472 0.709 . . . . 73.32 109.901 175.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.578 HG23 HG22 ' A' ' 199' ' ' VAL . 12.9 m -130.79 153.5 39.24 Favored 'Isoleucine or valine' 0 C--O 1.244 0.807 0 C-N-CA 124.713 1.205 . . . . 73.24 108.607 176.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -93.4 145.05 24.76 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.544 0.737 . . . . 74.32 110.239 -176.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.611 ' HB3' HD11 ' A' ' 197' ' ' LEU . . . -131.06 117.96 19.87 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 107.726 -1.213 . . . . 73.13 107.726 177.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 34.3 tpp -79.66 109.1 13.73 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 107.399 -1.334 . . . . 62.31 107.399 177.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 62.3 p -113.46 -172.38 2.06 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.253 0.621 . . . . 74.21 110.858 -172.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . 0.595 HD21 ' HD3' ' A' ' 241' ' ' PRO . 63.1 tp -46.63 -52.1 14.4 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.561 1.144 . . . . 65.33 111.223 171.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -74.08 -28.96 61.63 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 114.294 -1.321 . . . . 73.31 112.3 -174.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 134.43 -166.72 24.1 Favored Glycine 0 C--N 1.346 1.102 0 CA-C-O 119.33 -0.706 . . . . 73.2 111.589 -173.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -62.32 136.06 57.57 Favored 'Trans proline' 0 C--N 1.372 1.766 0 C-N-CA 122.869 2.379 . . . . 74.3 111.301 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 212' ' ' ALA . 24.3 m -135.34 157.91 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 109.922 -0.399 . . . . 71.32 109.922 -176.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.563 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 44.6 mt-10 -110.01 105.44 14.58 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.773 0.829 . . . . 65.13 109.147 -167.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 58.7 t -122.11 101.98 10.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 115.198 -0.91 . . . . 75.2 109.335 -172.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.592 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -79.21 118.35 21.07 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 109.361 -0.607 . . . . 64.13 109.361 172.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 34.1 m -85.23 152.09 57.75 Favored Pre-proline 0 N--CA 1.482 1.164 0 C-N-CA 123.124 0.57 . . . . 73.32 110.363 -176.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . 0.496 ' HG3' ' HB2' ' A' ' 173' ' ' TYR . 36.2 Cg_endo -62.82 163.37 22.13 Favored 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 122.227 1.951 . . . . 74.14 112.362 176.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -85.37 32.96 0.47 Allowed 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 122.899 2.4 . . . . 74.12 112.729 175.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 13.2 tpt180 -149.41 4.32 0.6 Allowed 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 116.095 -0.502 . . . . 75.42 110.731 175.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.545 HG21 HG13 ' A' ' 253' ' ' VAL . 0.6 OUTLIER -59.94 154.35 19.05 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.896 -0.779 . . . . 74.43 108.896 -169.855 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -131.7 161.39 32.9 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.291 0.636 . . . . 75.03 110.384 -168.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -62.33 109.37 1.32 Allowed 'General case' 0 C--O 1.241 0.62 0 N-CA-C 107.922 -1.14 . . . . 53.45 107.922 167.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 113.85 2.76 23.74 Favored Glycine 0 C--N 1.337 0.589 0 CA-C-N 115.309 -0.859 . . . . 72.41 112.428 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.14 127.08 31.58 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.046 -0.724 . . . . 74.01 109.046 -175.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -99.73 98.19 9.04 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 123.466 0.706 . . . . 73.43 109.353 -171.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.469 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 20.3 mt -82.63 98.62 9.11 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 106.928 -1.508 . . . . 75.42 106.928 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 7.1 ppt_? -83.06 114.0 20.99 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-O 121.349 0.595 . . . . 74.15 111.374 -179.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.473 HD12 ' HE2' ' A' ' 171' ' ' MET . 8.0 mp -104.11 126.67 51.41 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 106.52 -1.659 . . . . 74.51 106.52 174.278 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -102.92 119.05 38.16 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.476 0.71 . . . . 72.34 111.35 -174.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 79.0 31.42 43.33 Favored Glycine 0 C--N 1.354 1.564 0 O-C-N 123.969 0.793 . . . . 63.54 112.309 -175.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -127.98 20.33 6.45 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.389 0.676 . . . . 74.23 111.053 -178.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -98.01 -131.27 7.08 Favored Glycine 0 C--N 1.349 1.267 0 CA-C-O 119.576 -0.569 . . . . 53.22 112.407 -177.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -71.16 155.18 93.45 Favored Pre-proline 0 CA--C 1.55 0.98 0 CA-C-N 117.453 0.627 . . . . 74.34 112.453 -178.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.595 ' HD3' HD21 ' A' ' 215' ' ' LEU . 88.8 Cg_endo -72.99 171.67 17.05 Favored 'Trans proline' 0 C--N 1.387 2.603 0 C-N-CA 123.502 2.801 . . . . 75.51 112.67 -174.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -66.41 -38.72 93.79 Favored Glycine 0 CA--C 1.545 1.958 0 CA-C-O 118.382 -1.232 . . . . 75.43 113.575 -179.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . 0.461 ' HD2' ' HB2' ' A' ' 241' ' ' PRO . 53.5 Cg_exo -46.3 -44.47 20.11 Favored 'Trans proline' 0 C--N 1.385 2.464 0 C-N-CA 123.047 2.498 . . . . 73.54 114.041 163.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -78.73 -23.81 45.22 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.675 0.79 . . . . 74.31 110.765 177.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 105.27 114.49 3.96 Favored Glycine 0 C--N 1.341 0.861 0 N-CA-C 108.458 -1.857 . . . . 74.55 108.458 -165.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.61 124.0 23.74 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.163 0.585 . . . . 72.33 109.53 -172.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -137.8 -156.69 7.28 Favored Glycine 0 N--CA 1.477 1.432 0 CA-C-O 119.886 -0.397 . . . . 34.22 112.305 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 235' ' ' LEU . 6.5 p30 -123.0 167.54 13.47 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.178 0.591 . . . . 71.44 111.706 -175.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 11.7 tp -134.67 134.41 41.09 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.634 0.774 . . . . 65.12 109.265 -170.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 4.2 m-30 -118.94 148.94 42.41 Favored 'General case' 0 C--O 1.25 1.114 0 N-CA-C 108.708 -0.849 . . . . 74.35 108.708 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.469 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 88.4 mt -120.72 124.42 45.12 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.446 -0.576 . . . . 61.43 109.446 -177.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -91.51 100.82 13.51 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 107.197 -1.408 . . . . 75.53 107.197 -177.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.545 HG13 HG21 ' A' ' 227' ' ' THR . 55.7 t -63.15 123.58 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-O 121.488 0.661 . . . . 74.44 110.7 -178.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -114.66 123.5 49.46 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 107.606 -1.257 . . . . 70.51 107.606 177.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 47.0 mm -88.21 111.57 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 O-C-N 123.981 0.801 . . . . 74.22 110.181 -175.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.6 t . . . . . 0 C--O 1.255 1.376 0 C-N-CA 124.143 0.977 . . . . 43.35 110.196 -173.526 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 45.7 t . . . . . 0 N--CA 1.478 0.946 0 CA-C-O 121.196 0.522 . . . . 73.45 110.61 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 50.6 mtm -98.8 -177.69 3.73 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 125.226 1.41 . . . . 71.51 110.212 -169.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 7.7 p -99.05 87.79 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.065 0 CA-C-O 122.989 1.376 . . . . 75.32 107.49 162.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.1 -4.97 8.97 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 125.495 1.518 . . . . 73.23 109.979 -176.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 69.9 m -36.36 -66.15 0.23 Allowed 'General case' 0 C--N 1.35 0.612 0 C-N-CA 126.906 2.082 . . . . 75.32 114.559 -167.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . 0.424 ' HB2' ' HG3' ' A' ' 224' ' ' PRO . 77.2 t80 . . . . . 0 CA--C 1.54 0.579 0 N-CA-C 110.1 -0.333 . . . . 73.52 110.1 -177.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.437 ' HG2' ' HA3' ' A' ' 245' ' ' GLY . 70.9 mt-30 . . . . . 0 N--CA 1.477 0.907 0 CA-C-O 121.301 0.572 . . . . 73.42 109.675 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -77.0 165.09 25.11 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-N 115.051 -0.977 . . . . 61.4 109.625 177.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 35.2 tp -151.47 139.14 19.71 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.933 -0.576 . . . . 73.22 109.841 178.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -116.55 140.21 49.64 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.411 1.084 . . . . 74.33 109.555 174.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -149.59 160.87 43.13 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 123.908 0.883 . . . . 72.21 108.781 168.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 34.7 p -83.91 154.4 23.43 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 121.757 0.789 . . . . 75.33 111.458 163.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.562 HD12 ' HB3' ' A' ' 212' ' ' ALA . 37.4 tp -121.11 132.05 54.63 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 113.768 -1.56 . . . . 72.41 107.152 162.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -93.18 111.36 22.97 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 108.248 -1.019 . . . . 74.0 108.248 -178.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.567 HG22 HG23 ' A' ' 210' ' ' VAL . 56.4 t -120.36 131.73 24.34 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 123.87 0.868 . . . . 74.13 108.892 -178.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -66.49 148.19 83.45 Favored 'Trans proline' 0 C--N 1.369 1.631 0 C-N-CA 121.957 1.771 . . . . 72.11 111.253 168.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.45 ' HB2' ' HD3' ' A' ' 202' ' ' PRO . . . -53.77 -46.78 98.27 Favored Pre-proline 0 CA--C 1.56 1.336 0 CA-C-O 118.609 -0.71 . . . . 75.44 111.523 174.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.45 ' HD3' ' HB2' ' A' ' 201' ' ' ALA . 73.0 Cg_exo -51.37 -39.62 63.14 Favored 'Trans proline' 0 C--N 1.396 3.061 0 C-N-CA 122.744 2.296 . . . . 73.24 114.08 172.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -84.99 -24.73 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 N-CA-C 109.525 -0.546 . . . . 73.44 109.525 -174.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -74.21 -37.95 63.73 Favored 'General case' 0 C--O 1.247 0.955 0 CA-C-O 121.548 0.69 . . . . 73.42 111.552 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 14.1 t -88.14 -38.49 11.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 113.798 -1.547 . . . . 70.43 112.008 -177.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 90.3 t -97.15 -41.73 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 122.931 0.493 . . . . 71.51 110.37 -174.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 120.85 145.97 7.42 Favored Glycine 0 C--N 1.35 1.311 0 N-CA-C 110.803 -0.919 . . . . 73.14 110.803 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 166.96 154.66 8.55 Favored Glycine 0 C--O 1.247 0.959 0 CA-C-N 117.202 0.501 . . . . 63.21 112.715 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.636 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 38.8 ttmt -85.65 129.84 34.72 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.627 0.771 . . . . 72.51 110.09 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.567 HG23 HG22 ' A' ' 199' ' ' VAL . 14.0 m -131.05 151.46 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 123.917 0.887 . . . . 72.31 109.753 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -95.02 141.51 28.59 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 109.034 -0.728 . . . . 75.11 109.034 -172.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.562 ' HB3' HD12 ' A' ' 197' ' ' LEU . . . -132.37 120.96 22.74 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.841 0.856 . . . . 74.04 108.831 -176.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 34.6 tpp -77.79 110.16 12.42 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 108.625 -0.88 . . . . 73.03 108.625 173.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 61.0 p -116.92 -179.55 3.72 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.827 0.851 . . . . 75.41 110.068 -177.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . 0.514 HD21 ' HD3' ' A' ' 241' ' ' PRO . 65.7 tp -46.03 -52.05 12.57 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.544 1.138 . . . . 72.51 112.159 175.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -72.97 -26.81 61.5 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.533 1.133 . . . . 62.41 111.738 -174.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 139.19 -166.61 25.42 Favored Glycine 0 C--N 1.343 0.941 0 CA-C-O 119.437 -0.646 . . . . 63.51 111.981 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.28 129.73 23.56 Favored 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 122.026 1.817 . . . . 74.25 111.021 175.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 24.7 m -130.37 160.84 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 123.363 0.665 . . . . 73.25 110.227 -177.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.612 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 45.2 mt-10 -112.81 111.42 22.18 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.393 0.677 . . . . 72.1 109.684 -173.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 62.7 t -121.63 103.18 13.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 124.887 1.275 . . . . 74.12 109.43 -173.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.636 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -78.95 118.12 20.67 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 110.004 -0.369 . . . . 72.32 110.004 175.173 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 33.7 m -86.18 150.08 51.39 Favored Pre-proline 0 N--CA 1.485 1.298 0 C-N-CA 122.936 0.494 . . . . 72.21 110.516 -177.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . 0.47 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 24.1 Cg_endo -62.66 163.1 22.46 Favored 'Trans proline' 0 C--N 1.384 2.411 0 C-N-CA 122.431 2.088 . . . . 73.15 112.912 178.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -83.85 35.58 0.56 Allowed 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 123.225 2.617 . . . . 74.35 112.945 177.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -150.6 -4.93 0.32 Allowed 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.06 0.544 . . . . 73.34 111.549 176.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.609 HG21 HG13 ' A' ' 253' ' ' VAL . 0.6 OUTLIER -60.59 151.14 29.61 Favored 'General case' 0 CA--C 1.57 1.735 0 N-CA-C 109.266 -0.642 . . . . 74.4 109.266 -165.529 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . 0.434 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 20.6 pt20 -134.2 162.43 32.16 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.025 0.53 . . . . 74.15 110.368 -170.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -56.53 111.33 0.97 Allowed 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 109.824 -0.436 . . . . 74.13 109.824 175.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 114.82 -0.29 23.01 Favored Glycine 0 C--N 1.337 0.615 0 CA-C-N 115.564 -0.744 . . . . 65.32 112.094 178.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.434 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -72.45 122.72 21.73 Favored 'General case' 0 C--N 1.354 0.782 0 N-CA-C 108.661 -0.866 . . . . 73.22 108.661 -173.808 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 10.8 mmmm -98.35 97.57 8.92 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 109.307 -0.627 . . . . 75.33 109.307 -168.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 22.2 mt -80.5 97.06 6.97 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.14 -1.43 . . . . 74.42 107.14 -177.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.07 117.26 23.31 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.772 -0.649 . . . . 75.24 111.328 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 7.5 mp -97.69 127.55 43.73 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 105.807 -1.923 . . . . 70.35 105.807 171.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 15.3 tptt -101.23 115.45 30.53 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.525 0.33 . . . . 72.23 110.478 -167.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 77.84 32.49 45.11 Favored Glycine 0 C--N 1.349 1.281 0 O-C-N 123.922 0.764 . . . . 64.31 112.144 -175.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -125.98 23.41 7.19 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.796 0.838 . . . . 73.04 111.611 -174.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -93.8 -129.44 5.37 Favored Glycine 0 C--N 1.342 0.891 0 N-CA-C 110.916 -0.874 . . . . 71.55 110.916 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 6.9 m-30 -70.89 151.19 95.15 Favored Pre-proline 0 CA--C 1.551 1.011 0 CA-C-N 117.72 0.76 . . . . 72.11 111.678 177.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.514 ' HD3' HD21 ' A' ' 215' ' ' LEU . 60.3 Cg_endo -66.27 172.69 8.5 Favored 'Trans proline' 0 C--N 1.385 2.469 0 C-N-CA 123.561 2.841 . . . . 63.2 112.157 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.419 ' N ' ' HD2' ' A' ' 243' ' ' PRO . . . -66.35 -42.18 94.12 Favored Glycine 0 CA--C 1.545 1.964 0 CA-C-O 118.311 -1.272 . . . . 73.33 114.067 -174.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . 0.419 ' HD2' ' N ' ' A' ' 242' ' ' GLY . 9.3 Cg_endo -53.76 -36.44 82.2 Favored 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 122.74 2.293 . . . . 74.45 113.441 169.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -78.98 -24.07 44.03 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.318 0.647 . . . . 73.44 110.692 174.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . 0.437 ' HA3' ' HG2' ' A' ' 191' ' ' GLN . . . 109.33 116.05 3.84 Favored Glycine 0 C--N 1.344 1.018 0 N-CA-C 109.599 -1.4 . . . . 73.22 109.599 -170.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -72.36 124.48 25.21 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 117.355 0.577 . . . . 72.32 110.402 -178.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -140.07 -157.46 7.25 Favored Glycine 0 N--CA 1.466 0.639 0 N-CA-C 111.044 -0.823 . . . . 72.13 111.044 174.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 8.4 p30 -119.86 167.56 11.99 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 117.515 0.657 . . . . 71.42 110.708 -177.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 9.8 tp -133.53 133.92 42.76 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 108.923 -0.769 . . . . 74.04 108.923 -172.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -115.46 146.05 42.01 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 109.105 -0.702 . . . . 74.5 109.105 -177.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 81.2 mt -125.79 113.09 16.82 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 107.896 -1.15 . . . . 74.34 107.896 178.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -89.6 113.36 24.79 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.846 -0.798 . . . . 74.23 108.846 -177.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.609 HG13 HG21 ' A' ' 227' ' ' THR . 55.8 t -59.36 124.28 13.3 Favored 'Isoleucine or valine' 0 C--N 1.344 0.365 0 O-C-N 124.089 0.868 . . . . 74.14 109.479 178.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 8.4 mmt180 -122.9 122.79 39.47 Favored 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 107.376 -1.342 . . . . 72.13 107.376 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 48.9 mm -84.17 120.67 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 O-C-N 124.216 0.948 . . . . 63.23 110.603 -170.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.4 t . . . . . 0 CA--C 1.558 1.267 0 CA-C-O 118.038 -0.982 . . . . 72.01 109.691 -169.794 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.452 HG13 HG22 ' A' ' 221' ' ' VAL . 52.9 t . . . . . 0 N--CA 1.471 0.62 0 CA-C-O 121.806 0.812 . . . . 75.21 111.25 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 43.2 mtm -100.48 -175.49 2.93 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 126.362 1.865 . . . . 73.32 109.433 -166.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 9.1 p -99.28 87.97 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.147 0 CA-C-O 123.022 1.391 . . . . 65.43 107.856 163.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' MET . . . . . 0.441 ' HE2' HD12 ' A' ' 235' ' ' LEU . 0.0 OUTLIER -123.51 -6.46 8.13 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 113.851 -1.522 . . . . 73.15 110.637 -175.562 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.553 ' HA ' ' HB3' ' A' ' 233' ' ' LEU . 68.5 m -44.36 -65.25 0.54 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.272 1.829 . . . . 75.35 113.586 -172.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . 0.445 ' HB2' ' HB3' ' A' ' 224' ' ' PRO . 42.6 t80 . . . . . 0 CA--C 1.536 0.44 0 C-N-CA 123.776 0.83 . . . . 73.0 109.588 -177.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 121.1 0.476 . . . . 74.43 109.931 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -75.37 153.9 37.51 Favored 'General case' 0 C--O 1.244 0.791 0 CA-C-N 114.489 -1.232 . . . . 72.42 107.923 174.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 46.7 tp -147.54 141.42 25.82 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 122.802 0.441 . . . . 71.23 110.123 -170.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -116.69 139.44 50.55 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.322 0.649 . . . . 75.2 109.849 172.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -141.17 156.84 45.88 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 108.078 -1.082 . . . . 64.35 108.078 167.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 35.3 p -86.51 152.63 22.48 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-O 121.95 0.881 . . . . 64.55 111.656 168.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.613 HD12 ' HB3' ' A' ' 212' ' ' ALA . 42.4 tp -121.62 131.08 53.91 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 113.264 -1.789 . . . . 75.21 107.3 167.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -94.43 111.77 23.53 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 122.023 0.916 . . . . 71.1 108.982 -177.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.583 HG22 HG23 ' A' ' 210' ' ' VAL . 53.4 t -120.09 132.32 24.13 Favored Pre-proline 0 CA--C 1.546 0.789 0 CA-C-N 114.707 -1.133 . . . . 65.13 109.964 -176.195 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -68.96 147.28 67.65 Favored 'Trans proline' 0 C--N 1.372 1.807 0 C-N-CA 122.326 2.018 . . . . 72.22 111.269 167.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.422 ' HB2' ' HD3' ' A' ' 202' ' ' PRO . . . -53.2 -46.67 97.71 Favored Pre-proline 0 CA--C 1.569 1.686 0 C-N-CA 123.447 0.699 . . . . 75.2 111.945 174.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.422 ' HD3' ' HB2' ' A' ' 201' ' ' ALA . 78.2 Cg_exo -51.13 -39.97 60.49 Favored 'Trans proline' 0 C--N 1.396 3.033 0 C-N-CA 122.638 2.225 . . . . 63.4 113.817 172.092 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.7 mp -84.68 -23.13 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 N-CA-C 109.327 -0.62 . . . . 73.12 109.327 -174.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -73.32 -39.28 65.4 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 123.143 0.577 . . . . 75.24 111.897 178.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 39.7 t -88.93 -34.32 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 CA-C-N 114.787 -1.097 . . . . 75.34 113.201 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.419 ' HB ' ' O ' ' A' ' 202' ' ' PRO . 54.5 t -97.96 -42.17 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 O-C-N 121.514 -0.741 . . . . 75.32 110.636 -175.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 123.52 152.36 8.45 Favored Glycine 0 C--N 1.341 0.836 0 N-CA-C 111.05 -0.82 . . . . 72.44 111.05 -176.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.45 149.21 5.71 Favored Glycine 0 C--O 1.242 0.647 0 N-CA-C 111.476 -0.65 . . . . 74.32 111.476 176.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.646 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 36.0 ttmt -85.62 130.0 34.68 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 109.444 -0.576 . . . . 73.12 109.444 174.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.583 HG23 HG22 ' A' ' 199' ' ' VAL . 8.7 m -130.64 151.4 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.46 1.104 . . . . 74.41 108.693 -178.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 47.7 ttt180 -94.68 140.38 29.96 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.188 -0.914 . . . . 75.54 109.558 -167.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.613 ' HB3' HD12 ' A' ' 197' ' ' LEU . . . -132.23 115.35 15.56 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.028 0.931 . . . . 73.43 109.097 -171.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 32.5 tpp -78.78 110.9 14.38 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 108.167 -1.049 . . . . 75.24 108.167 175.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 69.6 p -115.28 -176.25 2.87 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.56 0.744 . . . . 74.23 110.456 -176.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . 0.57 HD23 ' HD3' ' A' ' 241' ' ' PRO . 66.3 tp -47.57 -51.68 20.22 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.624 1.169 . . . . 71.11 111.998 177.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -72.17 -27.95 62.91 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 114.507 -1.224 . . . . 71.51 111.078 -174.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 136.64 -165.91 24.93 Favored Glycine 0 C--N 1.34 0.79 0 N-CA-C 111.464 -0.654 . . . . 74.33 111.464 -175.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -65.9 132.62 30.9 Favored 'Trans proline' 0 C--N 1.368 1.59 0 C-N-CA 122.565 2.176 . . . . 73.33 112.024 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 31.5 m -132.6 160.82 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.432 1.093 . . . . 72.5 109.333 177.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -113.16 115.73 28.71 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 122.959 0.504 . . . . 71.41 110.035 -176.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.452 HG22 HG13 ' A' ' 168' ' ' VAL . 59.0 t -121.77 105.73 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.16 1.384 . . . . 73.25 110.705 -168.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.646 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -73.82 118.52 16.88 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.889 0.476 . . . . 74.45 110.946 176.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 27.1 m -88.66 150.59 46.4 Favored Pre-proline 0 N--CA 1.483 1.184 0 C-N-CA 122.566 0.346 . . . . 73.3 110.776 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . 0.474 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 33.1 Cg_endo -64.97 165.57 21.1 Favored 'Trans proline' 0 C--N 1.373 1.829 0 C-N-CA 122.625 2.217 . . . . 75.21 113.653 176.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -83.68 29.1 0.55 Allowed 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 123.167 2.578 . . . . 74.13 113.664 172.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 35.4 mmt180 -143.97 -1.44 0.97 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.099 0.56 . . . . 73.52 111.505 177.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.582 HG21 HG13 ' A' ' 253' ' ' VAL . 0.6 OUTLIER -61.17 152.12 29.5 Favored 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 108.919 -0.771 . . . . 73.52 108.919 -166.27 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . 0.505 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 4.5 pt20 -135.31 163.03 30.91 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.314 0.645 . . . . 73.41 110.407 -174.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -61.1 110.76 1.46 Allowed 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 109.288 -0.634 . . . . 73.31 109.288 175.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.74 -0.25 21.57 Favored Glycine 0 CA--C 1.525 0.683 0 CA-C-N 115.369 -0.832 . . . . 75.44 112.308 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.505 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -68.26 125.45 26.45 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.737 0.815 . . . . 72.12 109.605 -174.189 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 49.2 mmtm -99.4 98.23 9.18 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.232 0.613 . . . . 75.31 109.504 -172.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.553 ' HB3' ' HA ' ' A' ' 172' ' ' SER . 22.5 mt -82.25 99.96 9.61 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 107.048 -1.464 . . . . 72.33 107.048 178.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -79.77 125.89 30.26 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 121.169 0.509 . . . . 75.25 110.99 -177.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.441 HD12 ' HE2' ' A' ' 171' ' ' MET . 7.7 mp -111.13 127.91 55.72 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 105.999 -1.852 . . . . 74.35 105.999 172.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 41.4 tptt -101.75 117.89 35.81 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 118.054 0.388 . . . . 73.31 110.84 -173.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 79.22 30.69 45.08 Favored Glycine 0 C--N 1.347 1.159 0 O-C-N 123.481 0.488 . . . . 75.32 111.98 -178.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -127.43 20.51 6.72 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.007 0.923 . . . . 62.11 110.424 -176.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -96.92 -130.5 6.6 Favored Glycine 0 C--N 1.347 1.155 0 N-CA-C 111.19 -0.764 . . . . 45.34 111.19 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . 0.47 ' O ' ' HA ' ' A' ' 246' ' ' ARG . 4.8 m-30 -71.16 155.53 93.0 Favored Pre-proline 0 N--CA 1.478 0.931 0 N-CA-C 112.479 0.548 . . . . 71.21 112.479 -178.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.57 ' HD3' HD23 ' A' ' 215' ' ' LEU . 73.2 Cg_endo -69.35 171.81 13.35 Favored 'Trans proline' 0 C--N 1.388 2.633 0 C-N-CA 123.297 2.665 . . . . 74.25 112.396 -174.067 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.441 ' N ' ' HD2' ' A' ' 243' ' ' PRO . . . -66.81 -38.05 92.73 Favored Glycine 0 CA--C 1.544 1.851 0 CA-C-O 118.204 -1.331 . . . . 75.43 114.424 -176.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' A' ' 242' ' ' GLY . 10.2 Cg_endo -52.27 -42.1 62.18 Favored 'Trans proline' 0 C--N 1.383 2.391 0 CA-C-N 120.696 2.248 . . . . 71.31 113.237 166.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -77.32 -23.04 51.06 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.546 0.738 . . . . 51.54 110.256 174.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 104.37 115.46 4.08 Favored Glycine 0 C--N 1.342 0.888 0 N-CA-C 109.33 -1.508 . . . . 74.33 109.33 -169.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 240' ' ' PHE . 38.4 ttp180 -69.04 124.08 22.79 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 117.663 0.731 . . . . 73.55 110.681 -178.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -133.93 -157.05 8.12 Favored Glycine 0 C--N 1.337 0.615 0 CA-C-N 115.193 -0.912 . . . . 73.21 111.003 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -121.04 160.62 23.22 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.412 0.685 . . . . 73.12 110.764 -171.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 11.6 tp -135.32 133.79 39.18 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.729 0.811 . . . . 74.35 108.994 -172.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -114.7 150.38 35.33 Favored 'General case' 0 C--O 1.245 0.867 0 N-CA-C 108.527 -0.916 . . . . 72.02 108.527 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 64.6 mt -121.13 113.4 19.96 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.548 -1.278 . . . . 71.4 107.548 178.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -88.61 112.16 22.74 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 107.556 -1.276 . . . . 72.12 107.556 -179.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.582 HG13 HG21 ' A' ' 227' ' ' THR . 55.7 t -62.28 128.69 24.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 115.085 -0.961 . . . . 71.4 110.509 177.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 42.5 mtp180 -115.08 125.27 53.32 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 106.805 -1.554 . . . . 75.2 106.805 171.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 48.3 mm -87.3 127.03 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 N-CA-C 109.576 -0.527 . . . . 73.35 109.576 -176.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.7 t . . . . . 0 CA--C 1.56 1.355 0 N-CA-C 108.275 -1.009 . . . . 64.3 108.275 -174.078 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.416 ' HB ' ' HB ' ' A' ' 219' ' ' VAL . 55.5 t . . . . . 0 N--CA 1.482 1.135 0 CA-C-O 121.822 0.82 . . . . 74.5 112.22 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 39.4 mtm -100.97 -176.18 3.09 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.526 1.931 . . . . 75.4 110.17 -165.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 9.4 p -96.88 88.13 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 CA-C-O 122.939 1.352 . . . . 73.43 108.238 163.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' MET . . . . . 0.434 ' HE3' HG11 ' A' ' 221' ' ' VAL . 0.0 OUTLIER -123.71 -4.8 8.14 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 114.418 -1.265 . . . . 75.31 110.64 -176.25 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.504 ' HA ' ' HB3' ' A' ' 233' ' ' LEU . 69.9 m -41.29 -66.12 0.37 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.493 1.917 . . . . 75.24 114.508 -169.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 70.9 t80 . . . . . 0 CA--C 1.536 0.404 0 CA-C-O 121.031 0.443 . . . . 74.41 110.829 -173.115 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.412 ' HA ' ' O ' ' A' ' 245' ' ' GLY . 23.1 mt-30 . . . . . 0 N--CA 1.479 0.997 0 CA-C-O 121.83 0.824 . . . . 74.25 109.085 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 29.3 p-10 -74.27 160.97 30.39 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 114.016 -1.447 . . . . 73.51 110.8 -177.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 48.5 tp -150.63 135.05 17.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.159 -0.928 . . . . 65.2 108.628 173.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -116.27 138.84 50.96 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.663 -0.866 . . . . 73.32 108.663 176.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -149.15 158.58 44.29 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.399 0.679 . . . . 60.33 109.406 171.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 37.0 p -81.33 154.37 26.54 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.924 0.869 . . . . 64.23 111.842 165.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.616 HD12 ' HB3' ' A' ' 212' ' ' ALA . 34.9 tp -125.74 133.48 52.07 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 113.52 -1.673 . . . . 74.43 106.924 170.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -94.68 111.7 23.47 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.79 -0.818 . . . . 75.02 108.79 -175.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.586 HG22 HG22 ' A' ' 210' ' ' VAL . 46.4 t -123.18 129.78 24.81 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 124.328 1.051 . . . . 72.21 109.813 -177.196 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -67.52 149.03 79.78 Favored 'Trans proline' 0 C--N 1.365 1.429 0 C-N-CA 122.586 2.191 . . . . 63.11 112.079 169.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.419 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.3 -46.96 97.67 Favored Pre-proline 0 CA--C 1.562 1.432 0 CA-C-O 118.353 -0.832 . . . . 64.34 112.446 173.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.479 ' O ' ' HB ' ' A' ' 206' ' ' VAL . 24.2 Cg_endo -60.43 -31.77 93.0 Favored 'Trans proline' 0 C--N 1.395 3.017 0 C-N-CA 121.719 1.613 . . . . 73.53 112.461 177.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.7 mp -86.2 -22.96 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 N-CA-C 109.475 -0.565 . . . . 74.22 109.475 -178.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -73.31 -37.96 65.99 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 122.989 0.516 . . . . 72.55 111.098 176.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 19.5 t -89.2 -33.18 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.977 1.311 . . . . 74.51 113.011 -178.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.479 ' HB ' ' O ' ' A' ' 202' ' ' PRO . 51.2 t -100.49 -43.18 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 O-C-N 121.611 -0.68 . . . . 75.2 110.726 -176.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 121.22 152.18 8.73 Favored Glycine 0 N--CA 1.466 0.699 0 N-CA-C 110.811 -0.916 . . . . 74.35 110.811 -176.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.71 152.98 7.25 Favored Glycine 0 C--O 1.243 0.658 0 N-CA-C 111.671 -0.572 . . . . 74.42 111.671 177.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.582 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 30.2 tttt -85.62 130.41 34.58 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.747 -0.834 . . . . 75.24 108.747 176.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.586 HG22 HG22 ' A' ' 199' ' ' VAL . 13.1 m -129.1 151.83 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 N-CA-C 108.632 -0.877 . . . . 75.41 108.632 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . 0.416 ' HD2' ' N ' ' A' ' 212' ' ' ALA . 6.2 tmm_? -94.09 142.14 27.73 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 109.322 -0.622 . . . . 74.04 109.322 -169.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.616 ' HB3' HD12 ' A' ' 197' ' ' LEU . . . -132.73 119.24 20.08 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.083 0.953 . . . . 73.41 108.612 -177.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 37.4 tpp -79.68 107.66 12.63 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 107.756 -1.201 . . . . 74.15 107.756 173.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 63.9 p -117.03 -174.8 2.66 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.24 0.616 . . . . 64.11 110.77 -172.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . 0.497 HD22 ' HD3' ' A' ' 241' ' ' PRO . 64.9 tp -48.73 -51.94 26.19 Favored 'General case' 0 C--N 1.358 0.963 0 C-N-CA 123.896 0.879 . . . . 72.32 111.872 175.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -72.46 -28.31 62.84 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.234 -0.894 . . . . 74.34 110.701 -173.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 138.4 -166.58 25.23 Favored Glycine 0 C--N 1.341 0.829 0 CA-C-O 119.648 -0.529 . . . . 74.02 112.186 -174.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -64.92 129.56 23.56 Favored 'Trans proline' 0 C--N 1.369 1.609 0 C-N-CA 122.454 2.103 . . . . 73.4 111.286 176.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.423 HG21 ' O ' ' A' ' 212' ' ' ALA . 21.0 m -133.28 160.66 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 123.445 0.698 . . . . 74.53 110.558 -176.264 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -113.12 115.43 28.28 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.893 0.877 . . . . 65.53 109.746 -176.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.434 HG11 ' HE3' ' A' ' 171' ' ' MET . 58.5 t -121.96 103.55 13.62 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.887 0 C-N-CA 124.866 1.266 . . . . 74.21 110.103 -170.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.582 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -77.88 118.22 19.99 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.605 0.362 . . . . 73.43 110.673 177.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 34.0 m -89.01 152.33 48.17 Favored Pre-proline 0 N--CA 1.48 1.064 0 C-N-CA 123.27 0.628 . . . . 73.43 111.225 -177.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . 0.604 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 32.0 Cg_endo -63.73 164.08 22.55 Favored 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 122.593 2.195 . . . . 65.25 113.094 175.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -86.74 28.73 0.53 Allowed 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 123.137 2.558 . . . . 74.52 113.393 177.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 60.1 mmt-85 -145.64 1.21 0.9 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.335 0.654 . . . . 74.2 111.705 176.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.659 HG21 HG13 ' A' ' 253' ' ' VAL . 0.7 OUTLIER -61.26 154.97 22.19 Favored 'General case' 0 CA--C 1.57 1.747 0 O-C-N 123.383 0.427 . . . . 74.44 110.116 -168.986 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . 0.456 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 13.8 pt20 -140.7 162.62 34.98 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.318 0.647 . . . . 74.01 110.63 -174.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -59.27 111.56 1.4 Allowed 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 121.14 0.495 . . . . 74.42 110.527 -178.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.44 0.56 21.94 Favored Glycine 0 CA--C 1.519 0.324 0 CA-C-N 114.882 -1.053 . . . . 74.24 111.823 179.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.456 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -69.12 125.12 25.69 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 109.051 -0.722 . . . . 74.21 109.051 -175.065 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -98.55 98.44 9.62 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.146 0.578 . . . . 72.54 109.7 -169.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.504 ' HB3' ' HA ' ' A' ' 172' ' ' SER . 21.5 mt -81.87 100.31 9.54 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.253 -1.388 . . . . 72.51 107.253 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.61 126.11 30.84 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.245 0.545 . . . . 64.41 111.205 -178.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.534 ' HB3' ' HB2' ' A' ' 238' ' ' LYS . 7.3 mp -110.07 124.93 52.38 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 105.948 -1.871 . . . . 75.14 105.948 173.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.32 115.34 30.36 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.079 0.552 . . . . 73.02 111.652 -172.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 76.99 31.82 51.7 Favored Glycine 0 C--N 1.351 1.375 0 CA-C-N 115.05 -0.977 . . . . 73.23 111.92 -175.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.534 ' HB2' ' HB3' ' A' ' 235' ' ' LEU . 30.5 mmmt -128.91 19.96 5.99 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.833 0.853 . . . . 74.21 111.204 -176.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -96.93 -134.56 8.21 Favored Glycine 0 C--N 1.343 0.943 0 N-CA-C 111.633 -0.587 . . . . 74.3 111.633 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 4.6 m-30 -70.09 151.78 95.95 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 122.676 0.39 . . . . 63.24 111.754 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.497 ' HD3' HD22 ' A' ' 215' ' ' LEU . 60.8 Cg_endo -66.97 172.14 10.19 Favored 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 123.532 2.821 . . . . 74.32 112.373 -177.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -66.36 -38.68 93.82 Favored Glycine 0 CA--C 1.539 1.56 0 CA-C-O 118.158 -1.356 . . . . 75.12 114.012 -177.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . 0.48 ' HD2' ' HB2' ' A' ' 241' ' ' PRO . 73.8 Cg_exo -45.73 -45.99 15.87 Favored 'Trans proline' 0 C--N 1.385 2.475 0 C-N-CA 122.771 2.314 . . . . 74.25 114.033 165.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -80.34 -24.45 39.86 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.535 0.734 . . . . 72.21 111.05 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 191' ' ' GLN . . . 113.34 112.29 3.07 Favored Glycine 0 C--N 1.337 0.63 0 N-CA-C 109.617 -1.393 . . . . 73.2 109.617 -169.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.93 123.09 17.63 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.7 0.8 . . . . 73.0 110.457 -179.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -147.67 -155.63 6.68 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-N 116.236 -0.438 . . . . 64.15 113.319 -175.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -119.91 164.17 16.46 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.745 0.818 . . . . 63.21 110.197 -170.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 10.3 tp -134.02 133.53 41.36 Favored 'General case' 0 C--O 1.214 -0.815 0 N-CA-C 107.634 -1.247 . . . . 72.42 107.634 -178.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -122.11 146.18 47.45 Favored 'General case' 0 C--O 1.246 0.908 0 N-CA-C 108.389 -0.967 . . . . 64.52 108.389 -177.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 88.1 mt -124.82 115.91 21.42 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.807 0.843 . . . . 75.53 108.857 -176.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -89.09 110.16 20.92 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.815 -1.18 . . . . 73.23 107.815 -176.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.659 HG13 HG21 ' A' ' 227' ' ' THR . 45.4 t -60.04 128.54 21.21 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.365 0 O-C-N 123.872 0.733 . . . . 62.45 109.73 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.84 123.35 45.69 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 105.981 -1.859 . . . . 71.44 105.981 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 48.8 mm -86.38 117.95 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 109.006 -0.739 . . . . 74.22 109.006 -177.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.2 t . . . . . 0 CA--C 1.557 1.245 0 N-CA-C 107.687 -1.227 . . . . 73.34 107.687 -174.0 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.461 HG13 HG22 ' A' ' 221' ' ' VAL . 53.6 t . . . . . 0 N--CA 1.475 0.799 0 CA-C-O 121.906 0.86 . . . . 73.43 112.139 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 40.6 mtm -99.69 -175.68 3.05 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 126.051 1.74 . . . . 63.32 109.263 -169.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 10.3 p -97.28 88.12 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.184 0 CA-C-O 122.858 1.313 . . . . 74.41 108.275 164.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.27 -5.16 8.34 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 113.771 -1.559 . . . . 73.42 109.945 -178.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.425 ' HA ' ' HB3' ' A' ' 233' ' ' LEU . 67.0 m -39.22 -64.93 0.42 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 127.029 2.132 . . . . 74.0 114.578 -169.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . 0.426 ' HB2' ' HB3' ' A' ' 224' ' ' PRO . 72.6 t80 . . . . . 0 N--CA 1.471 0.6 0 C-N-CA 123.462 0.705 . . . . 75.32 110.901 -176.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 . . . . . 0 N--CA 1.473 0.698 0 N-CA-C 107.482 -1.303 . . . . 74.04 107.482 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.438 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 17.9 p-10 -74.3 160.7 30.74 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 113.08 -1.873 . . . . 75.31 110.411 170.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.438 HD21 HD12 ' A' ' 249' ' ' LEU . 57.6 tp -149.22 143.74 26.11 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.779 -0.646 . . . . 72.4 109.749 -174.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.52 ' HD2' ' HZ1' ' A' ' 232' ' ' LYS . 64.3 m-85 -116.25 139.13 50.69 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.911 0.885 . . . . 74.02 110.169 174.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -148.59 157.39 43.43 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.257 1.023 . . . . 54.21 108.979 173.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 24.9 p -83.75 153.43 24.14 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 122.091 0.948 . . . . 72.52 112.663 168.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.623 HD13 ' HB3' ' A' ' 212' ' ' ALA . 31.6 tp -126.29 133.67 51.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 112.909 -1.951 . . . . 74.12 106.971 167.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -94.3 114.03 26.04 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.206 -1.035 . . . . 75.21 108.206 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.606 HG22 HG23 ' A' ' 210' ' ' VAL . 48.9 t -121.56 132.0 24.32 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 124.186 0.994 . . . . 72.05 109.688 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -69.24 144.21 56.0 Favored 'Trans proline' 0 C--N 1.37 1.703 0 C-N-CA 122.289 1.993 . . . . 74.43 111.014 166.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.434 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -54.48 -42.21 93.31 Favored Pre-proline 0 CA--C 1.565 1.54 0 CA-C-O 118.059 -0.972 . . . . 73.34 112.544 173.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.434 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 11.5 Cg_endo -55.22 -36.63 93.79 Favored 'Trans proline' 0 C--N 1.404 3.465 0 C-N-CA 121.885 1.723 . . . . 74.55 112.83 172.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -85.46 -23.89 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 N-CA-C 109.14 -0.689 . . . . 71.41 109.14 -177.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . 0.41 ' HA ' HG22 ' A' ' 227' ' ' THR . . . -73.83 -37.33 64.88 Favored 'General case' 0 C--O 1.247 0.934 0 CA-C-O 121.44 0.638 . . . . 75.21 111.299 179.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 25.2 t -88.71 -38.0 10.93 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-N 113.72 -1.582 . . . . 70.53 112.435 -177.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 76.1 t -97.51 -42.59 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 O-C-N 122.13 -0.356 . . . . 73.43 110.341 -176.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 121.1 148.95 8.06 Favored Glycine 0 C--N 1.341 0.855 0 N-CA-C 110.612 -0.995 . . . . 74.53 110.612 -176.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 165.73 155.39 8.66 Favored Glycine 0 C--O 1.246 0.876 0 N-CA-C 111.856 -0.497 . . . . 74.41 111.856 178.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.634 ' HD3' ' HB3' ' A' ' 220' ' ' GLU . 3.5 ttmp? -84.94 131.22 34.52 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.373 0.669 . . . . 75.43 109.701 178.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.606 HG23 HG22 ' A' ' 199' ' ' VAL . 9.5 m -130.04 151.76 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.444 1.098 . . . . 75.14 108.642 177.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? -95.5 140.84 29.78 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 108.976 -0.75 . . . . 74.31 108.976 -172.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.623 ' HB3' HD13 ' A' ' 197' ' ' LEU . . . -131.25 119.8 22.32 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.719 -0.845 . . . . 74.14 108.719 -177.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 37.3 tpp -79.35 107.35 12.05 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 107.592 -1.262 . . . . 74.53 107.592 172.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' THR . . . . . 0.416 HG22 HD23 ' A' ' 251' ' ' LEU . 71.5 p -112.43 -173.55 2.27 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.836 0.854 . . . . 71.54 110.878 -174.301 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 61.7 tp -44.98 -52.63 8.59 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.314 1.046 . . . . 75.52 112.063 167.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -71.81 -26.53 62.44 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 114.263 -1.335 . . . . 72.41 111.46 -169.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 131.09 -165.77 22.95 Favored Glycine 0 C--N 1.34 0.777 0 N-CA-C 110.661 -0.976 . . . . 65.41 110.661 -171.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -65.78 131.02 26.17 Favored 'Trans proline' 0 C--N 1.37 1.67 0 C-N-CA 121.89 1.727 . . . . 70.45 110.715 175.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.403 HG22 ' O ' ' A' ' 212' ' ' ALA . 26.6 m -133.36 162.82 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 123.754 0.821 . . . . 75.3 110.495 -178.283 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.634 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 38.3 mt-10 -112.02 116.07 29.96 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.395 1.078 . . . . 72.23 109.307 -175.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.461 HG22 HG13 ' A' ' 168' ' ' VAL . 44.5 t -124.32 103.28 12.31 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 C-N-CA 124.233 1.013 . . . . 75.33 109.635 -173.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.55 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -78.1 118.4 20.32 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.552 -0.536 . . . . 74.1 109.552 173.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 34.7 m -89.03 151.43 46.95 Favored Pre-proline 0 N--CA 1.483 1.182 0 C-N-CA 123.031 0.532 . . . . 71.14 110.54 -178.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . 0.451 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 41.4 Cg_endo -65.22 165.83 20.88 Favored 'Trans proline' 0 C--N 1.38 2.189 0 C-N-CA 122.939 2.426 . . . . 63.43 113.412 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -80.27 31.97 0.5 Allowed 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 123.163 2.575 . . . . 75.22 113.1 172.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -150.17 -2.32 0.39 Allowed 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 112.275 0.472 . . . . 74.4 112.275 178.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.59 HG21 HG13 ' A' ' 253' ' ' VAL . 0.6 OUTLIER -59.95 150.48 28.75 Favored 'General case' 0 CA--C 1.566 1.596 0 N-CA-C 108.901 -0.778 . . . . 74.34 108.901 -168.423 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . 0.436 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 4.5 pt20 -133.36 162.2 32.47 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.039 0.535 . . . . 74.21 109.876 -171.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . 0.572 ' HB1' HH21 ' A' ' 254' ' ' ARG . . . -59.18 111.52 1.37 Allowed 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 109.318 -0.623 . . . . 71.01 109.318 174.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 114.89 1.16 22.71 Favored Glycine 0 C--N 1.338 0.641 0 CA-C-N 115.696 -0.684 . . . . 71.04 112.013 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.436 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -69.66 123.76 22.21 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 108.967 -0.753 . . . . 73.45 108.967 -174.098 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.576 ' HZ3' ' HB2' ' A' ' 252' ' ' GLU . 30.7 mmmt -100.15 97.21 8.05 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 108.767 -0.827 . . . . 73.34 108.767 -172.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.495 ' O ' ' HA ' ' A' ' 250' ' ' TYR . 20.3 mt -81.51 99.07 8.58 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 106.406 -1.701 . . . . 72.01 106.406 -176.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . 0.688 ' HD3' ' HE2' ' A' ' 236' ' ' LYS . 0.5 OUTLIER -83.02 126.16 32.24 Favored 'General case' 0 CA--C 1.561 1.401 0 C-N-CA 123.854 0.862 . . . . 73.04 112.262 179.803 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.444 ' HB3' ' HB2' ' A' ' 238' ' ' LYS . 7.6 mp -113.72 124.44 52.3 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.964 1.306 . . . . 74.51 108.697 -176.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.688 ' HE2' ' HD3' ' A' ' 234' ' ' ARG . 5.2 mptp? -94.31 115.11 27.29 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 118.537 0.608 . . . . 73.41 110.942 -169.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 77.48 20.48 74.48 Favored Glycine 0 C--N 1.349 1.283 0 O-C-N 124.236 0.96 . . . . 72.44 112.305 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 235' ' ' LEU . 1.0 OUTLIER -117.45 19.46 14.0 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.814 0.846 . . . . 73.23 110.037 -178.575 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -95.85 -139.98 10.72 Favored Glycine 0 C--N 1.35 1.338 0 N-CA-C 110.951 -0.86 . . . . 75.43 110.951 176.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . 0.436 ' O ' ' HA ' ' A' ' 246' ' ' ARG . 6.1 m-30 -61.11 146.94 87.32 Favored Pre-proline 0 N--CA 1.477 0.878 0 N-CA-C 112.645 0.609 . . . . 72.4 112.645 -175.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -59.71 171.08 2.96 Favored 'Trans proline' 0 C--N 1.385 2.497 0 C-N-CA 123.486 2.791 . . . . 75.24 112.524 -178.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.416 ' N ' ' HD2' ' A' ' 243' ' ' PRO . . . -67.64 -41.34 89.74 Favored Glycine 0 CA--C 1.552 2.392 0 CA-C-O 118.284 -1.287 . . . . 73.11 114.237 -174.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' A' ' 242' ' ' GLY . 10.8 Cg_endo -55.57 -36.5 94.63 Favored 'Trans proline' 0 C--N 1.392 2.843 0 C-N-CA 122.749 2.299 . . . . 70.54 112.914 168.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -77.47 -24.67 50.17 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.24 0.616 . . . . 72.03 110.688 174.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 106.68 115.59 4.03 Favored Glycine 0 C--N 1.341 0.821 0 N-CA-C 109.34 -1.504 . . . . 72.22 109.34 -172.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.436 ' HA ' ' O ' ' A' ' 240' ' ' PHE . 29.0 ttm180 -72.87 123.9 24.32 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 117.603 0.702 . . . . 75.24 111.274 -177.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -139.65 -152.74 5.92 Favored Glycine 0 C--N 1.341 0.83 0 CA-C-N 114.808 -1.087 . . . . 74.12 112.304 -177.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . 0.438 ' O ' ' HA ' ' A' ' 192' ' ' ASP . 11.0 t70 -114.69 163.01 16.06 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.403 1.081 . . . . 72.12 108.705 -168.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.438 HD12 HD21 ' A' ' 193' ' ' LEU . 18.8 tp -134.84 132.77 39.01 Favored 'General case' 0 C--O 1.214 -0.804 0 N-CA-C 109.209 -0.663 . . . . 74.25 109.209 -177.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.495 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 0.4 OUTLIER -112.04 145.27 39.99 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-O 121.688 0.756 . . . . 73.21 109.691 178.856 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.416 HD23 HG22 ' A' ' 214' ' ' THR . 72.5 mt -125.65 113.85 17.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 113.909 -1.496 . . . . 74.51 107.602 174.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . 0.576 ' HB2' ' HZ3' ' A' ' 232' ' ' LYS . 35.1 tt0 -91.54 109.55 20.86 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 107.774 -1.195 . . . . 63.23 107.774 -173.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.59 HG13 HG21 ' A' ' 227' ' ' THR . 52.1 t -61.53 122.77 12.94 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 O-C-N 124.301 1.0 . . . . 74.01 109.988 -179.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . 0.572 HH21 ' HB1' ' A' ' 229' ' ' ALA . 0.3 OUTLIER -115.2 122.89 47.41 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 106.872 -1.529 . . . . 74.45 106.872 176.878 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 44.9 mm -87.62 114.97 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 O-C-N 123.918 0.761 . . . . 74.3 110.108 -174.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 CA--C 1.56 1.362 0 C-N-CA 124.09 0.956 . . . . 75.35 109.516 -172.057 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 54.4 t . . . . . 0 N--CA 1.472 0.67 0 CA-C-O 121.68 0.752 . . . . 72.24 110.119 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 42.9 mtm -99.17 -176.91 3.45 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 125.552 1.541 . . . . 74.43 109.515 -167.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 12.6 p -100.53 86.32 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 CA-C-O 123.428 1.585 . . . . 73.53 107.453 165.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' MET . . . . . 0.451 ' HG3' ' HA ' ' A' ' 235' ' ' LEU . 0.0 OUTLIER -124.07 -3.86 8.03 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 113.394 -1.73 . . . . 54.32 110.263 -173.554 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.532 ' HB3' HD22 ' A' ' 233' ' ' LEU . 66.7 m -44.74 -69.84 0.12 Allowed 'General case' 0 C--N 1.351 0.65 0 C-N-CA 125.856 1.662 . . . . 74.41 113.542 -166.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . 0.534 ' HB2' ' HG3' ' A' ' 224' ' ' PRO . 50.8 t80 . . . . . 0 CA--C 1.541 0.614 0 N-CA-C 108.215 -1.031 . . . . 74.42 108.215 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.439 ' HG2' ' HA3' ' A' ' 245' ' ' GLY . 75.0 mt-30 . . . . . 0 N--CA 1.475 0.816 0 CA-C-O 121.599 0.714 . . . . 72.34 110.752 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -85.35 158.8 20.17 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 114.908 -1.042 . . . . 72.41 110.081 -174.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 53.6 tp -150.31 142.48 24.1 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.04 0.536 . . . . 75.32 110.042 -176.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -114.1 142.07 46.68 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.677 0.791 . . . . 74.32 109.286 173.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -148.62 162.4 39.77 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.936 0.894 . . . . 73.21 108.916 173.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 34.6 p -85.95 154.6 21.36 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 122.015 0.912 . . . . 74.31 111.984 166.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.622 HD11 ' HB3' ' A' ' 212' ' ' ALA . 29.2 tp -124.55 133.63 53.24 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 113.404 -1.725 . . . . 73.41 107.172 160.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -93.33 114.03 26.37 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 108.205 -1.035 . . . . 74.42 108.205 178.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.577 HG22 HG23 ' A' ' 210' ' ' VAL . 46.1 t -121.56 131.15 24.51 Favored Pre-proline 0 CA--C 1.546 0.803 0 CA-C-N 115.049 -0.978 . . . . 74.52 109.018 -178.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -68.59 148.27 72.07 Favored 'Trans proline' 0 C--N 1.364 1.391 0 C-N-CA 122.522 2.148 . . . . 74.34 111.379 169.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.404 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.28 -45.75 98.24 Favored Pre-proline 0 CA--C 1.558 1.262 0 CA-C-O 118.597 -0.716 . . . . 62.43 112.887 174.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.45 ' O ' ' HB ' ' A' ' 206' ' ' VAL . 30.1 Cg_endo -61.16 -30.15 88.22 Favored 'Trans proline' 0 C--N 1.395 2.998 0 C-N-CA 121.685 1.59 . . . . 74.43 112.193 178.003 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -86.47 -25.37 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 N-CA-C 109.482 -0.562 . . . . 74.42 109.482 -177.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -73.4 -37.67 65.87 Favored 'General case' 0 C--O 1.247 0.936 0 C-N-CA 122.89 0.476 . . . . 74.04 111.18 178.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 25.6 t -88.36 -38.0 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 C-N-CA 124.884 1.274 . . . . 73.41 112.869 -178.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.45 ' HB ' ' O ' ' A' ' 202' ' ' PRO . 54.5 t -97.26 -41.47 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 O-C-N 121.841 -0.537 . . . . 74.24 110.545 -175.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 121.61 148.15 7.79 Favored Glycine 0 C--N 1.341 0.847 0 N-CA-C 110.789 -0.925 . . . . 73.41 110.789 -177.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 166.51 151.41 6.8 Favored Glycine 0 C--O 1.245 0.792 0 N-CA-C 112.098 -0.401 . . . . 62.11 112.098 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.639 ' HD3' ' HB3' ' A' ' 220' ' ' GLU . 37.5 ttmt -85.06 132.39 34.33 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.781 0.832 . . . . 73.13 109.615 175.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.577 HG23 HG22 ' A' ' 199' ' ' VAL . 11.2 m -136.11 152.18 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.365 1.066 . . . . 75.54 109.407 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 8.8 tmm_? -94.59 142.83 26.99 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.581 0.752 . . . . 72.41 110.711 -170.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.622 ' HB3' HD11 ' A' ' 197' ' ' LEU . . . -131.17 123.12 27.83 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.912 0.885 . . . . 74.11 109.366 -176.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 33.8 tpp -78.6 109.05 12.45 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 108.52 -0.918 . . . . 73.04 108.52 175.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 51.6 p -113.73 -178.35 3.36 Favored 'General case' 0 C--O 1.244 0.8 0 C-N-CA 123.242 0.617 . . . . 74.01 111.132 -174.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . 0.507 HD22 ' HD3' ' A' ' 241' ' ' PRO . 65.5 tp -45.83 -51.66 12.55 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 124.278 0.986 . . . . 73.35 111.33 170.14 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -73.56 -29.4 62.4 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 114.05 -1.432 . . . . 74.54 111.442 -174.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 136.68 -167.18 24.64 Favored Glycine 0 C--N 1.348 1.211 0 CA-C-O 119.558 -0.579 . . . . 61.42 112.407 -177.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.91 129.47 24.71 Favored 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 122.329 2.019 . . . . 73.43 111.046 176.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 28.1 m -132.8 161.55 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 123.573 0.749 . . . . 74.45 110.138 -176.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.639 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 51.8 mt-10 -111.54 115.56 29.38 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.711 0.804 . . . . 75.22 109.416 -173.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 59.8 t -126.63 104.66 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 124.451 1.1 . . . . 72.33 110.102 -169.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.594 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -76.89 117.99 19.04 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 110.066 -0.346 . . . . 62.32 110.066 176.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 34.0 m -88.07 152.36 50.55 Favored Pre-proline 0 N--CA 1.48 1.034 0 C-N-CA 123.002 0.521 . . . . 74.24 110.765 -178.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . 0.543 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 34.6 Cg_endo -62.55 163.69 20.39 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.242 1.961 . . . . 73.42 112.231 174.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -86.76 32.94 0.44 Allowed 'Trans proline' 0 C--N 1.371 1.75 0 C-N-CA 123.249 2.633 . . . . 75.52 112.074 176.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 5.2 tpt180 -148.99 -0.71 0.5 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 122.764 0.426 . . . . 75.21 111.324 178.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.607 HG21 HG13 ' A' ' 253' ' ' VAL . 0.6 OUTLIER -61.12 153.01 26.84 Favored 'General case' 0 CA--C 1.563 1.476 0 N-CA-C 109.519 -0.549 . . . . 63.11 109.519 -167.242 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . 0.455 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 19.5 pt20 -132.77 161.56 33.75 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.182 0.593 . . . . 70.25 110.41 -170.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . 0.454 ' HB1' ' NH2' ' A' ' 254' ' ' ARG . . . -61.27 110.84 1.52 Allowed 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 109.509 -0.552 . . . . 73.15 109.509 174.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 113.92 0.46 24.21 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 111.28 -0.728 . . . . 64.11 111.28 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.455 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -68.84 126.93 31.31 Favored 'General case' 0 C--N 1.362 1.152 0 N-CA-C 109.187 -0.671 . . . . 74.25 109.187 -173.513 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -97.71 97.7 9.24 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 108.947 -0.76 . . . . 74.41 108.947 -169.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.532 HD22 ' HB3' ' A' ' 172' ' ' SER . 25.8 mt -81.11 99.56 8.57 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.696 -1.224 . . . . 73.53 107.696 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.44 113.32 17.49 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.733 -0.667 . . . . 73.34 110.363 -178.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.545 ' HB3' ' HB2' ' A' ' 238' ' ' LYS . 7.5 mp -99.55 124.73 45.01 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 105.943 -1.873 . . . . 73.44 105.943 169.268 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -102.68 118.05 36.0 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.563 0.745 . . . . 75.12 109.777 -176.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 78.42 31.2 46.96 Favored Glycine 0 C--N 1.349 1.264 0 O-C-N 124.103 0.877 . . . . 72.32 112.735 -177.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.545 ' HB2' ' HB3' ' A' ' 235' ' ' LEU . 29.9 mmmt -129.94 21.25 5.4 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.028 0.931 . . . . 74.32 111.042 -179.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -96.81 -131.1 6.8 Favored Glycine 0 C--N 1.346 1.089 0 N-CA-C 111.468 -0.653 . . . . 75.35 111.468 -179.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 7.1 m-30 -70.8 151.77 95.19 Favored Pre-proline 0 CA--C 1.553 1.093 0 C-N-CA 123.458 0.703 . . . . 73.24 112.321 -178.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.507 ' HD3' HD22 ' A' ' 215' ' ' LEU . 58.8 Cg_endo -66.3 171.36 10.51 Favored 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 124.142 3.228 . . . . 73.32 112.977 179.08 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -66.35 -40.5 94.6 Favored Glycine 0 CA--C 1.543 1.84 0 CA-C-O 118.233 -1.315 . . . . 74.01 115.604 -175.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -53.9 -36.86 84.77 Favored 'Trans proline' 0 C--N 1.379 2.18 0 CA-C-N 120.827 2.313 . . . . 64.24 113.029 168.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -79.56 -26.61 41.34 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 122.987 0.515 . . . . 72.44 110.398 174.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . 0.439 ' HA3' ' HG2' ' A' ' 191' ' ' GLN . . . 110.65 115.67 3.63 Favored Glycine 0 C--N 1.345 1.083 0 N-CA-C 109.413 -1.475 . . . . 74.32 109.413 -170.157 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 11.1 mmm-85 -67.91 121.98 17.2 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.02 0.528 . . . . 74.51 110.292 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -143.73 -156.15 6.69 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-N 115.823 -0.626 . . . . 72.14 112.131 -177.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -120.64 165.53 14.92 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 123.675 0.79 . . . . 62.23 110.749 -172.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 16.1 tp -135.46 134.49 39.64 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 107.828 -1.175 . . . . 75.43 107.828 -173.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 8.9 m-30 -114.39 148.48 37.62 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 109.144 -0.687 . . . . 74.33 109.144 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.451 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 69.9 mt -122.93 113.94 19.78 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.24 -1.393 . . . . 74.22 107.24 178.093 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -89.65 111.68 22.71 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 106.986 -1.487 . . . . 72.31 106.986 -176.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.607 HG13 HG21 ' A' ' 227' ' ' THR . 54.7 t -62.21 125.82 19.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 O-C-N 123.977 0.798 . . . . 73.05 110.278 -178.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . 0.454 ' NH2' ' HB1' ' A' ' 229' ' ' ALA . 3.8 mmp_? -117.0 122.53 44.49 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.036 -1.468 . . . . 74.22 107.036 176.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 48.7 mm -88.37 115.42 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 O-C-N 123.799 0.687 . . . . 71.23 110.273 -172.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.0 t . . . . . 0 CA--C 1.562 1.413 0 C-N-CA 124.389 1.076 . . . . 61.13 109.23 -169.377 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.498 HG13 HG23 ' A' ' 221' ' ' VAL . 60.7 t . . . . . 0 N--CA 1.473 0.722 0 CA-C-O 121.62 0.724 . . . . 75.52 112.301 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 42.6 mtm -99.51 -176.05 3.17 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.618 1.967 . . . . 64.2 108.813 -171.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 9.9 p -101.57 86.58 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.179 0 CA-C-O 123.067 1.413 . . . . 72.22 108.642 166.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.7 -4.76 9.2 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 113.933 -1.485 . . . . 75.1 110.232 -174.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 68.9 m -39.92 -67.31 0.24 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.778 2.031 . . . . 61.32 114.661 -164.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 51.1 t80 . . . . . 0 N--CA 1.469 0.498 0 C-N-CA 122.482 0.313 . . . . 73.31 110.537 -169.271 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 . . . . . 0 N--CA 1.478 0.952 0 CA-C-O 120.952 0.406 . . . . 71.22 110.724 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -76.04 154.93 35.31 Favored 'General case' 0 N--CA 1.481 1.125 0 CA-C-N 115.342 -0.845 . . . . 72.24 109.547 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 56.9 tp -148.23 140.39 24.14 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.028 0.531 . . . . 74.24 110.34 175.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -114.55 138.76 50.24 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.089 0.955 . . . . 73.02 110.097 173.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.414 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -147.8 156.59 42.89 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.792 -0.818 . . . . 74.51 108.792 167.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 30.0 p -81.85 151.46 27.32 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 122.113 0.959 . . . . 75.03 112.14 168.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.602 HD13 ' HB3' ' A' ' 212' ' ' ALA . 27.2 tp -120.74 132.38 55.02 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 112.977 -1.92 . . . . 72.13 107.155 164.054 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -94.93 114.53 26.38 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 107.973 -1.121 . . . . 72.12 107.973 178.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.577 HG22 HG22 ' A' ' 210' ' ' VAL . 46.4 t -113.52 130.23 23.91 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 114.866 -1.061 . . . . 74.22 108.649 178.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -66.01 146.22 81.78 Favored 'Trans proline' 0 C--N 1.373 1.83 0 C-N-CA 122.287 1.992 . . . . 74.14 110.924 169.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.418 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.64 -46.21 98.36 Favored Pre-proline 0 CA--C 1.568 1.672 0 CA-C-O 118.334 -0.841 . . . . 54.11 112.304 175.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.418 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 26.0 Cg_endo -60.82 -31.48 91.77 Favored 'Trans proline' 0 C--N 1.403 3.446 0 C-N-CA 121.697 1.598 . . . . 62.43 112.549 176.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -86.44 -23.69 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 N-CA-C 109.153 -0.684 . . . . 74.31 109.153 -177.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -74.17 -38.53 63.65 Favored 'General case' 0 C--O 1.247 0.931 0 C-N-CA 122.938 0.495 . . . . 73.24 110.933 179.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 22.1 t -88.64 -36.45 9.05 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 CA-C-N 113.532 -1.667 . . . . 73.2 112.504 -177.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.412 ' HB ' ' O ' ' A' ' 202' ' ' PRO . 55.5 t -98.61 -42.81 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 O-C-N 122.163 -0.335 . . . . 74.31 110.782 -177.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 122.26 152.14 8.57 Favored Glycine 0 N--CA 1.466 0.651 0 N-CA-C 110.919 -0.873 . . . . 72.1 110.919 -176.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.72 155.68 8.57 Favored Glycine 0 C--O 1.241 0.538 0 N-CA-C 111.444 -0.662 . . . . 72.01 111.444 178.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.583 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 35.4 ttmt -84.45 129.67 34.84 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 109.128 -0.693 . . . . 72.24 109.128 177.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.577 HG22 HG22 ' A' ' 199' ' ' VAL . 15.9 m -132.08 147.84 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.425 0.69 . . . . 71.33 109.594 179.062 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 14.4 ttp-105 -96.84 139.98 32.08 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.901 -1.045 . . . . 74.23 110.258 -167.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.602 ' HB3' HD13 ' A' ' 197' ' ' LEU . . . -132.24 120.59 22.39 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.001 0.92 . . . . 60.32 108.87 -174.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 33.5 tpp -78.04 110.02 12.62 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 108.826 -0.805 . . . . 75.55 108.826 174.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 56.4 p -112.33 -176.11 2.84 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 123.865 0.866 . . . . 72.3 109.971 -176.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . 0.559 HD23 ' HD3' ' A' ' 241' ' ' PRO . 65.1 tp -47.9 -52.1 20.66 Favored 'General case' 0 C--N 1.354 0.782 0 C-N-CA 124.003 0.921 . . . . 74.22 111.55 173.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -72.84 -26.95 61.66 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 114.661 -1.154 . . . . 73.31 111.811 -171.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 137.85 -165.56 25.32 Favored Glycine 0 C--N 1.34 0.78 0 N-CA-C 111.299 -0.72 . . . . 60.33 111.299 -173.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.36 131.69 23.9 Favored 'Trans proline' 0 C--N 1.37 1.699 0 C-N-CA 122.081 1.854 . . . . 71.4 110.741 178.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 19.3 m -126.56 157.31 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 108.778 -0.823 . . . . 73.54 108.778 177.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.512 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 43.1 mt-10 -114.56 114.45 25.76 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 123.105 0.562 . . . . 73.33 109.511 -178.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.498 HG23 HG13 ' A' ' 168' ' ' VAL . 89.2 t -120.26 104.79 16.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 C-N-CA 125.474 1.51 . . . . 75.52 109.16 -169.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.583 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -76.11 117.63 18.01 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 122.836 0.454 . . . . 74.4 110.167 177.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 35.3 m -90.35 152.63 45.81 Favored Pre-proline 0 N--CA 1.478 0.927 0 C-N-CA 123.43 0.692 . . . . 74.3 111.289 -175.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . 0.525 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 45.2 Cg_endo -63.4 166.74 14.42 Favored 'Trans proline' 0 C--N 1.376 2.001 0 C-N-CA 123.507 2.805 . . . . 75.25 113.425 176.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -84.51 32.13 0.5 Allowed 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 122.83 2.353 . . . . 74.5 112.503 173.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 -150.51 -1.19 0.39 Allowed 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 112.561 0.578 . . . . 75.14 112.561 -179.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.546 HG21 HG13 ' A' ' 253' ' ' VAL . 0.6 OUTLIER -60.05 153.13 22.34 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 109.762 -0.458 . . . . 75.33 109.762 -167.101 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . 0.455 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 4.1 pt20 -133.08 161.51 34.21 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.55 0.74 . . . . 64.21 110.028 -174.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -63.46 110.66 2.02 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 109.024 -0.732 . . . . 70.42 109.024 174.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 114.72 3.74 21.87 Favored Glycine 0 C--O 1.241 0.545 0 CA-C-N 115.031 -0.986 . . . . 72.41 112.148 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.455 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -68.46 127.93 34.78 Favored 'General case' 0 CA--C 1.553 1.094 0 N-CA-C 109.288 -0.634 . . . . 75.22 109.288 -179.806 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -97.24 96.99 8.79 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.113 0.565 . . . . 74.02 109.776 -173.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.499 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 19.3 mt -81.83 99.21 8.88 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 106.558 -1.645 . . . . 75.32 106.558 179.092 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 5.0 ppt_? -82.56 116.2 21.87 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.832 -0.622 . . . . 74.43 111.396 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 7.3 mp -105.1 126.99 52.68 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 106.56 -1.645 . . . . 75.24 106.56 173.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 15.9 tptm -101.61 117.1 34.21 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 122.612 0.365 . . . . 72.31 110.668 -171.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 78.89 24.18 62.56 Favored Glycine 0 C--N 1.342 0.863 0 O-C-N 124.004 0.815 . . . . 64.34 112.907 -177.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 1.9 mmmp? -117.21 21.24 13.28 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 122.836 0.454 . . . . 72.22 111.144 -177.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -96.95 -129.95 6.4 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-O 119.406 -0.663 . . . . 64.54 112.095 -178.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 6.0 m-30 -71.04 152.76 94.82 Favored Pre-proline 0 CA--C 1.557 1.229 0 C-N-CA 123.264 0.626 . . . . 75.52 112.427 -177.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.559 ' HD3' HD23 ' A' ' 215' ' ' LEU . 74.3 Cg_endo -69.29 172.83 11.48 Favored 'Trans proline' 0 C--N 1.392 2.825 0 C-N-CA 123.837 3.025 . . . . 73.13 112.72 -179.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.405 ' N ' ' HD2' ' A' ' 243' ' ' PRO . . . -67.52 -39.73 91.04 Favored Glycine 0 CA--C 1.542 1.753 0 CA-C-O 118.058 -1.412 . . . . 72.14 114.671 -174.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . 0.405 ' HD2' ' N ' ' A' ' 242' ' ' GLY . 8.7 Cg_endo -52.28 -41.14 67.99 Favored 'Trans proline' 0 C--N 1.386 2.547 0 CA-C-N 121.071 2.435 . . . . 74.15 112.72 167.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -76.72 -25.21 53.28 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.16 0.584 . . . . 73.32 110.679 176.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 109.02 115.73 3.84 Favored Glycine 0 C--N 1.342 0.869 0 N-CA-C 109.354 -1.498 . . . . 73.22 109.354 -168.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -70.1 122.4 19.34 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 108.732 -0.84 . . . . 74.22 108.732 -178.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -142.82 -156.16 6.68 Favored Glycine 0 N--CA 1.465 0.596 0 N-CA-C 111.445 -0.662 . . . . 64.52 111.445 177.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 12.2 p30 -120.13 168.48 11.16 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-O 121.753 0.787 . . . . 71.54 111.357 -171.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 14.7 tp -135.5 133.46 38.49 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 107.84 -1.171 . . . . 74.43 107.84 -171.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -118.53 148.49 42.58 Favored 'General case' 0 C--O 1.253 1.28 0 N-CA-C 108.63 -0.878 . . . . 74.22 108.63 -178.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.499 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 91.6 mt -121.25 119.62 32.8 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.514 0.725 . . . . 72.21 109.162 -178.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -89.25 104.6 17.13 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 107.287 -1.375 . . . . 74.23 107.287 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.546 HG13 HG21 ' A' ' 227' ' ' THR . 55.4 t -62.89 128.43 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 121.271 0.558 . . . . 72.13 110.294 178.301 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 21.5 mtm105 -117.16 126.08 52.24 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.135 -1.432 . . . . 73.24 107.135 172.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 40.9 mm -88.5 127.28 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 109.751 -0.463 . . . . 72.2 109.751 -178.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.7 t . . . . . 0 CA--C 1.559 1.318 0 N-CA-C 107.775 -1.195 . . . . 74.24 107.775 -177.856 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.46 HG13 HG22 ' A' ' 221' ' ' VAL . 55.9 t . . . . . 0 N--CA 1.473 0.676 0 CA-C-O 121.36 0.6 . . . . 64.52 110.075 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 46.5 mtm -99.28 -178.78 4.02 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.099 1.36 . . . . 73.1 109.212 -169.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 10.0 p -97.71 85.73 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 CA-C-O 123.429 1.585 . . . . 71.32 107.318 164.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' MET . . . . . 0.45 ' HE3' HG11 ' A' ' 221' ' ' VAL . 0.0 OUTLIER -121.65 -4.7 9.23 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 113.608 -1.633 . . . . 72.32 109.846 -174.66 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.541 ' HA ' ' HB3' ' A' ' 233' ' ' LEU . 67.5 m -43.1 -64.11 0.69 Allowed 'General case' 0 C--O 1.241 0.608 0 C-N-CA 126.681 1.992 . . . . 73.44 113.425 -176.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . 0.442 ' HB2' ' HB3' ' A' ' 224' ' ' PRO . 45.5 t80 . . . . . 0 CA--C 1.536 0.427 0 C-N-CA 123.535 0.734 . . . . 75.52 109.355 -178.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . 0.557 ' HB3' ' HA3' ' A' ' 247' ' ' GLY . 91.4 mt-30 . . . . . 0 C--O 1.247 0.932 0 CA-C-O 121.279 0.561 . . . . 71.22 110.721 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -73.53 153.8 40.13 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 114.407 -1.269 . . . . 70.2 108.978 -177.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 60.5 tp -148.89 138.91 22.18 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 123.841 0.856 . . . . 72.54 108.994 174.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -111.56 142.14 44.23 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.861 0.864 . . . . 74.24 108.74 171.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -147.67 156.37 42.71 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 108.734 -0.839 . . . . 72.23 108.734 167.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 33.0 p -84.69 153.01 23.36 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-O 122.368 1.08 . . . . 65.53 112.127 168.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.555 HD12 ' HB3' ' A' ' 212' ' ' ALA . 20.5 tp -125.52 132.86 52.53 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 112.507 -2.133 . . . . 73.23 106.361 167.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -95.26 112.24 23.98 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.875 0.845 . . . . 75.42 108.772 -179.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.626 HG23 HG23 ' A' ' 210' ' ' VAL . 41.1 t -117.18 132.13 23.65 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 124.589 1.156 . . . . 73.22 108.882 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -68.79 147.55 69.33 Favored 'Trans proline' 0 C--N 1.369 1.647 0 C-N-CA 122.108 1.872 . . . . 74.41 111.159 167.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -54.43 -45.69 99.28 Favored Pre-proline 0 N--CA 1.487 1.38 0 CA-C-O 118.3 -0.857 . . . . 62.12 111.784 174.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -50.85 -40.43 57.48 Favored 'Trans proline' 0 C--N 1.405 3.536 0 C-N-CA 122.172 1.915 . . . . 71.05 113.169 172.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -84.64 -23.25 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 109.398 -0.593 . . . . 75.12 109.398 -175.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . 0.459 ' HA ' HG22 ' A' ' 227' ' ' THR . . . -74.2 -39.57 63.07 Favored 'General case' 0 C--O 1.246 0.902 0 C-N-CA 123.06 0.544 . . . . 63.34 111.515 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 25.1 t -88.73 -36.92 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-N 114.558 -1.201 . . . . 75.2 112.598 -178.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 73.4 t -98.72 -41.02 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 O-C-N 122.136 -0.352 . . . . 73.3 110.807 -176.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 123.13 150.38 8.04 Favored Glycine 0 N--CA 1.475 1.236 0 CA-C-N 118.248 0.476 . . . . 75.03 112.068 177.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.91 153.6 7.57 Favored Glycine 0 C--N 1.343 0.946 0 N-CA-C 112.356 -0.297 . . . . 62.31 112.356 177.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.592 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 37.1 ttmt -84.63 131.95 34.54 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 122.945 0.498 . . . . 72.21 110.026 175.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.626 HG23 HG23 ' A' ' 199' ' ' VAL . 12.6 m -135.44 150.56 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.78 1.232 . . . . 75.32 108.639 -177.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -95.81 142.52 27.98 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.032 0.533 . . . . 74.32 110.563 -169.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.555 ' HB3' HD12 ' A' ' 197' ' ' LEU . . . -130.74 123.62 29.63 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.728 0.811 . . . . 64.2 109.301 -176.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 35.7 tpp -78.78 111.01 14.48 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 115.621 -0.718 . . . . 73.41 109.502 174.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 46.0 p -119.59 -177.05 3.29 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.955 0.902 . . . . 75.3 110.998 -174.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . 0.533 HD23 ' HD3' ' A' ' 241' ' ' PRO . 59.6 tp -49.4 -51.16 36.93 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.465 1.106 . . . . 73.53 111.114 167.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -71.84 -25.75 62.1 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 113.444 -1.707 . . . . 74.43 111.002 -171.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 135.14 -166.6 24.37 Favored Glycine 0 C--N 1.342 0.897 0 N-CA-C 111.136 -0.786 . . . . 72.04 111.136 178.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -66.79 128.79 19.57 Favored 'Trans proline' 0 C--N 1.364 1.357 0 C-N-CA 121.44 1.427 . . . . 71.24 109.852 171.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 27.3 m -130.19 160.2 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.159 0.584 . . . . 75.01 110.143 -176.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.536 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 44.2 mt-10 -111.72 115.8 29.68 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.868 0.867 . . . . 65.52 109.016 -174.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.46 HG22 HG13 ' A' ' 168' ' ' VAL . 60.2 t -125.34 104.14 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 124.633 1.173 . . . . 61.24 110.414 -168.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.592 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -74.59 117.26 16.21 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.846 -0.427 . . . . 63.04 109.846 175.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 32.9 m -90.93 151.74 43.69 Favored Pre-proline 0 N--CA 1.482 1.168 0 C-N-CA 122.803 0.441 . . . . 75.31 109.96 179.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . 0.509 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 39.3 Cg_endo -65.17 166.03 20.19 Favored 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 122.535 2.157 . . . . 63.31 113.284 178.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -79.2 35.5 0.56 Allowed 'Trans proline' 0 C--N 1.37 1.673 0 C-N-CA 122.803 2.336 . . . . 72.22 112.626 167.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 19.3 tpt180 -147.88 -10.65 0.39 Allowed 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.339 0.496 . . . . 71.01 112.339 -178.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.573 HG21 HG13 ' A' ' 253' ' ' VAL . 0.6 OUTLIER -61.16 150.15 35.18 Favored 'General case' 0 CA--C 1.565 1.547 0 N-CA-C 109.226 -0.657 . . . . 75.21 109.226 -164.66 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . 0.495 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 10.7 pt20 -132.52 162.5 31.07 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 122.991 0.517 . . . . 63.12 109.917 -174.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . 0.651 ' HB1' HH21 ' A' ' 254' ' ' ARG . . . -56.91 111.47 1.04 Allowed 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 109.601 -0.518 . . . . 63.21 109.601 174.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.14 -0.83 22.59 Favored Glycine 0 C--N 1.336 0.553 0 CA-C-N 115.268 -0.878 . . . . 72.31 112.418 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.495 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -70.37 124.65 24.7 Favored 'General case' 0 C--N 1.358 0.939 0 N-CA-C 109.262 -0.644 . . . . 72.44 109.262 -171.129 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -98.87 96.62 7.98 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 109.599 -0.519 . . . . 74.34 109.599 -168.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.541 ' HB3' ' HA ' ' A' ' 172' ' ' SER . 19.7 mt -81.88 99.52 9.09 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 106.822 -1.547 . . . . 74.2 106.822 -175.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . 0.455 ' HD2' ' O ' ' A' ' 234' ' ' ARG . 5.1 ppt_? -79.84 121.52 25.5 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 123.645 0.591 . . . . 73.13 110.899 -176.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 8.1 mp -108.55 125.74 52.16 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 105.861 -1.903 . . . . 73.41 105.861 172.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 17.5 tptt -101.87 116.3 32.4 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 118.138 0.426 . . . . 73.44 109.929 -171.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 79.35 21.71 66.6 Favored Glycine 0 C--N 1.349 1.278 0 O-C-N 123.763 0.664 . . . . 60.53 113.834 -178.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.485 ' HZ1' ' HB3' ' A' ' 238' ' ' LYS . 0.8 OUTLIER -117.54 20.81 13.37 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.736 0.814 . . . . 73.34 109.884 -178.976 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -98.94 -132.61 7.75 Favored Glycine 0 C--N 1.349 1.303 0 CA-C-O 119.097 -0.835 . . . . 73.44 111.82 -178.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -70.29 152.1 95.67 Favored Pre-proline 0 N--CA 1.481 1.079 0 N-CA-C 112.943 0.72 . . . . 71.31 112.943 -172.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.533 ' HD3' HD23 ' A' ' 215' ' ' LEU . 61.0 Cg_endo -67.2 170.56 13.01 Favored 'Trans proline' 0 C--N 1.392 2.859 0 C-N-CA 122.928 2.419 . . . . 74.02 112.526 -178.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.437 ' N ' ' HD2' ' A' ' 243' ' ' PRO . . . -67.71 -38.58 89.95 Favored Glycine 0 CA--C 1.544 1.874 0 CA-C-O 117.973 -1.459 . . . . 75.23 114.357 -175.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 242' ' ' GLY . 10.1 Cg_endo -54.02 -36.28 83.87 Favored 'Trans proline' 0 C--N 1.388 2.644 0 CA-C-N 120.998 2.399 . . . . 55.54 113.438 167.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -81.33 -25.06 36.71 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-O 121.136 0.493 . . . . 74.53 110.125 174.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 112.22 114.8 3.37 Favored Glycine 0 C--N 1.341 0.82 0 N-CA-C 109.66 -1.376 . . . . 74.5 109.66 -168.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -72.38 122.64 21.53 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 117.825 0.812 . . . . 72.52 109.639 -177.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . 0.557 ' HA3' ' HB3' ' A' ' 191' ' ' GLN . . . -148.34 -154.61 6.35 Favored Glycine 0 CA--C 1.503 -0.713 0 CA-C-N 116.003 -0.544 . . . . 71.04 112.315 -176.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 38.5 p-10 -121.46 163.54 18.61 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.507 0.723 . . . . 74.31 111.125 -167.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 9.5 tp -134.71 134.5 41.12 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.365 -0.976 . . . . 73.44 108.365 -171.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -115.81 148.46 39.87 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.471 -0.937 . . . . 73.13 108.471 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.402 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 67.7 mt -123.17 115.15 21.3 Favored 'General case' 0 C--O 1.22 -0.474 0 N-CA-C 108.29 -1.004 . . . . 73.32 108.29 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -89.38 113.54 24.87 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.618 -0.882 . . . . 73.03 108.618 -177.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.573 HG13 HG21 ' A' ' 227' ' ' THR . 50.3 t -60.75 124.79 15.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 O-C-N 124.019 0.824 . . . . 71.45 110.335 176.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . 0.651 HH21 ' HB1' ' A' ' 229' ' ' ALA . 0.5 OUTLIER -120.08 122.31 40.79 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 107.356 -1.35 . . . . 71.43 107.356 176.195 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.438 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 49.1 mm -83.8 122.36 37.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 O-C-N 123.984 0.803 . . . . 73.44 109.835 -173.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.2 t . . . . . 0 CA--C 1.565 1.549 0 C-N-CA 124.23 1.012 . . . . 70.05 108.822 -172.622 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 52.4 t . . . . . 0 N--CA 1.48 1.053 0 CA-C-O 121.385 0.612 . . . . 72.22 110.992 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 53.4 mtm -99.4 -176.68 3.36 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 125.915 1.686 . . . . 75.45 110.894 -164.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 8.5 p -101.88 86.17 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.073 0 N-CA-C 107.195 -1.409 . . . . 72.41 107.195 160.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.17 -4.25 7.95 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 114.148 -1.387 . . . . 75.01 110.76 -173.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.465 ' HA ' ' HB3' ' A' ' 233' ' ' LEU . 67.2 m -44.1 -65.82 0.46 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.995 1.718 . . . . 65.34 114.046 -168.23 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 55.3 t80 . . . . . 0 C--O 1.243 0.754 0 N-CA-C 108.601 -0.889 . . . . 73.4 108.601 -176.614 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 . . . . . 0 N--CA 1.477 0.895 0 N-CA-C 108.908 -0.775 . . . . 72.33 108.908 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -76.57 168.57 19.84 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-N 114.638 -1.165 . . . . 75.15 109.958 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 39.1 tp -152.44 142.97 22.72 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.269 -0.423 . . . . 74.41 110.104 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -116.13 138.14 51.51 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.797 0.839 . . . . 73.12 109.107 171.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -148.77 160.14 43.48 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.628 0.771 . . . . 73.51 109.42 174.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 37.9 p -84.42 154.54 22.74 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 122.276 1.036 . . . . 72.13 112.195 167.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.581 HD13 ' HB3' ' A' ' 212' ' ' ALA . 30.8 tp -120.47 134.4 55.28 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 112.844 -1.98 . . . . 73.44 106.789 165.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -97.52 111.72 23.87 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 109.107 -0.701 . . . . 74.34 109.107 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.626 HG22 HG23 ' A' ' 210' ' ' VAL . 28.1 t -123.01 130.98 24.39 Favored Pre-proline 0 N--CA 1.479 0.979 0 C-N-CA 124.549 1.139 . . . . 75.44 109.579 -177.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -69.95 144.93 54.55 Favored 'Trans proline' 0 C--N 1.366 1.489 0 C-N-CA 122.22 1.947 . . . . 73.33 111.232 165.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -53.13 -44.63 97.61 Favored Pre-proline 0 N--CA 1.487 1.413 0 CA-C-O 118.348 -0.834 . . . . 74.11 111.953 174.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -47.55 -41.49 29.87 Favored 'Trans proline' 0 C--N 1.401 3.317 0 C-N-CA 122.556 2.171 . . . . 75.15 113.416 171.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -85.91 -23.29 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 109.716 -0.476 . . . . 70.11 109.716 -175.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -72.45 -37.76 68.45 Favored 'General case' 0 C--O 1.249 1.051 0 CA-C-O 121.05 0.452 . . . . 74.42 111.535 178.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 20.3 t -89.73 -36.05 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.987 0 C-N-CA 125.444 1.497 . . . . 51.12 113.168 -178.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 54.4 t -97.12 -43.14 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 O-C-N 121.998 -0.438 . . . . 72.43 110.268 -176.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 120.95 151.51 8.62 Favored Glycine 0 C--N 1.339 0.744 0 N-CA-C 110.89 -0.884 . . . . 70.35 110.89 -176.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.6 155.89 8.65 Favored Glycine 0 C--O 1.246 0.886 0 N-CA-C 112.048 -0.421 . . . . 74.01 112.048 177.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.579 ' HD3' ' HB3' ' A' ' 220' ' ' GLU . 38.5 ttmt -84.54 131.6 34.62 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.319 0.648 . . . . 75.33 109.519 174.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.626 HG23 HG22 ' A' ' 199' ' ' VAL . 6.7 m -134.42 154.4 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.4 1.08 . . . . 72.41 110.581 -175.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 2.5 tmm_? -93.32 139.92 30.13 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.569 1.147 . . . . 75.01 109.751 -171.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.581 ' HB3' HD13 ' A' ' 197' ' ' LEU . . . -132.42 122.6 25.23 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.145 0.978 . . . . 73.01 108.734 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 31.3 tpp -77.68 110.2 12.32 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.679 -0.86 . . . . 64.43 108.679 173.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 62.2 p -121.25 -179.28 4.0 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.998 0.919 . . . . 75.23 110.221 -176.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . 0.483 HD22 ' HD3' ' A' ' 241' ' ' PRO . 61.2 tp -45.09 -52.9 8.59 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.686 1.195 . . . . 75.22 112.485 176.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -72.39 -27.48 62.39 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 114.218 -1.355 . . . . 74.31 111.385 -173.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 138.02 -165.11 25.47 Favored Glycine 0 C--N 1.345 1.055 0 N-CA-C 111.561 -0.616 . . . . 64.44 111.561 -176.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -67.01 129.25 20.27 Favored 'Trans proline' 0 C--N 1.369 1.62 0 C-N-CA 122.147 1.898 . . . . 73.25 111.011 175.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 30.2 m -129.72 160.23 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 123.528 0.731 . . . . 74.44 110.659 -175.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.579 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 44.4 mt-10 -113.01 114.53 27.02 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.835 0.854 . . . . 72.22 109.655 -168.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 61.9 t -127.34 103.43 10.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 124.87 1.268 . . . . 74.03 109.39 -166.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.534 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -77.82 116.79 18.61 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.892 -0.41 . . . . 73.4 109.892 175.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 29.8 m -89.35 152.04 47.12 Favored Pre-proline 0 N--CA 1.492 1.626 0 C-N-CA 123.222 0.609 . . . . 72.13 111.116 -176.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . 0.582 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 29.7 Cg_endo -62.21 162.47 23.16 Favored 'Trans proline' 0 C--N 1.382 2.307 0 C-N-CA 122.197 1.931 . . . . 73.24 112.517 175.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -85.4 30.97 0.49 Allowed 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 123.115 2.543 . . . . 74.13 112.519 176.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -149.06 3.17 0.6 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 122.747 0.419 . . . . 75.11 111.447 176.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.582 ' HB ' ' HG2' ' A' ' 224' ' ' PRO . 0.7 OUTLIER -61.85 155.64 22.74 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 109.829 -0.434 . . . . 64.25 109.829 -171.776 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -136.55 162.41 33.19 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.078 0.551 . . . . 74.3 110.097 -176.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . 0.558 ' HB1' HH21 ' A' ' 254' ' ' ARG . . . -56.15 112.25 1.17 Allowed 'General case' 0 CA--C 1.538 0.505 0 O-C-N 123.471 0.482 . . . . 44.22 109.915 174.017 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.29 -1.07 22.37 Favored Glycine 0 C--O 1.239 0.418 0 CA-C-N 114.968 -1.014 . . . . 74.53 111.982 176.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.62 129.72 40.75 Favored 'General case' 0 C--N 1.361 1.108 0 N-CA-C 109.179 -0.674 . . . . 74.22 109.179 -174.071 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm -98.67 97.69 8.92 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.977 0.911 . . . . 75.32 110.065 -170.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.465 ' HB3' ' HA ' ' A' ' 172' ' ' SER . 17.3 mt -88.09 101.04 13.41 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 107.65 -1.241 . . . . 74.32 107.65 -178.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.48 125.53 29.69 Favored 'General case' 0 CA--C 1.551 1.009 0 CA-C-O 121.164 0.507 . . . . 74.44 110.213 178.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 6.9 mp -106.04 126.77 52.6 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 105.879 -1.897 . . . . 74.1 105.879 171.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 8.1 tptp -101.32 115.75 31.23 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 109.994 -0.373 . . . . 73.24 109.994 -168.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 77.5 29.25 56.03 Favored Glycine 0 C--N 1.354 1.574 0 O-C-N 123.676 0.61 . . . . 70.14 112.676 -178.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -124.53 23.85 8.04 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.807 0.843 . . . . 73.54 110.715 -177.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -94.41 -132.04 6.47 Favored Glycine 0 C--N 1.353 1.523 0 N-CA-C 111.167 -0.773 . . . . 74.32 111.167 178.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 6.2 m-30 -69.48 154.36 94.93 Favored Pre-proline 0 N--CA 1.481 1.08 0 CA-C-N 117.47 0.635 . . . . 64.01 112.043 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.483 ' HD3' HD22 ' A' ' 215' ' ' LEU . 72.8 Cg_endo -70.13 171.26 15.2 Favored 'Trans proline' 0 C--N 1.387 2.565 0 C-N-CA 122.826 2.351 . . . . 75.21 111.909 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -67.68 -38.96 90.43 Favored Glycine 0 CA--C 1.542 1.774 0 CA-C-O 118.479 -1.178 . . . . 75.23 114.078 -178.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . 0.429 ' HD2' ' HB2' ' A' ' 241' ' ' PRO . 87.8 Cg_exo -48.72 -35.19 29.56 Favored 'Trans proline' 0 C--N 1.383 2.36 0 C-N-CA 123.054 2.503 . . . . 75.13 114.09 165.267 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -88.3 -24.62 23.13 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.457 0.703 . . . . 73.34 110.998 174.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 105.76 115.23 4.03 Favored Glycine 0 C--N 1.345 1.06 0 N-CA-C 109.192 -1.563 . . . . 73.42 109.192 -169.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 35.3 mtt180 -73.1 134.07 44.38 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 122.988 0.515 . . . . 75.44 112.145 -178.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -145.75 -155.91 6.67 Favored Glycine 0 C--O 1.242 0.606 0 CA-C-N 114.654 -1.157 . . . . 74.44 110.304 174.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 12.6 p30 -118.01 168.03 10.91 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 122.949 0.5 . . . . 63.31 110.083 -175.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 9.7 tp -134.42 133.3 40.37 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 107.862 -1.162 . . . . 74.41 107.862 -172.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 10.0 m-30 -114.26 149.46 35.86 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.761 -0.829 . . . . 71.43 108.761 -177.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.413 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 92.1 mt -123.76 121.94 36.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.546 -0.752 . . . . 74.34 109.038 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -88.76 112.55 23.31 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 107.289 -1.375 . . . . 71.11 107.289 174.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.53 HG13 HG21 ' A' ' 227' ' ' THR . 54.1 t -60.8 123.47 13.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 108.868 -0.789 . . . . 75.13 108.868 173.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . 0.558 HH21 ' HB1' ' A' ' 229' ' ' ALA . 0.4 OUTLIER -114.65 123.29 48.92 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 106.71 -1.589 . . . . 73.24 106.71 176.411 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 38.1 mm -86.78 119.99 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 O-C-N 123.783 0.677 . . . . 74.51 109.721 -176.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.3 t . . . . . 0 CA--C 1.562 1.413 0 C-N-CA 125.292 1.437 . . . . 74.14 107.669 -170.533 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.411 HG13 HG22 ' A' ' 221' ' ' VAL . 55.4 t . . . . . 0 N--CA 1.473 0.686 0 CA-C-O 121.474 0.654 . . . . 72.52 110.39 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 48.8 mtm -98.29 -176.2 3.33 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.88 1.672 . . . . 71.51 110.074 -168.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 8.7 p -101.71 88.47 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.026 0 CA-C-O 123.125 1.441 . . . . 72.23 108.079 161.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.81 -6.03 7.99 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 113.717 -1.583 . . . . 73.42 110.021 -177.129 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.452 ' HA ' ' HB3' ' A' ' 233' ' ' LEU . 68.5 m -37.64 -64.63 0.37 Allowed 'General case' 0 C--N 1.351 0.643 0 C-N-CA 126.97 2.108 . . . . 72.55 114.379 -168.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . 0.454 ' HB2' ' HB3' ' A' ' 224' ' ' PRO . 53.3 t80 . . . . . 0 CA--C 1.538 0.488 0 O-C-N 123.661 0.6 . . . . 74.23 109.639 -174.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 . . . . . 0 N--CA 1.478 0.971 0 CA-C-O 120.938 0.399 . . . . 65.31 110.636 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 35.1 p-10 -75.54 172.83 11.88 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-N 115.7 -0.682 . . . . 65.3 110.578 178.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 33.9 tp -152.96 140.7 20.0 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.878 -0.601 . . . . 73.42 110.545 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.569 ' HD2' ' HZ1' ' A' ' 232' ' ' LYS . 59.6 m-85 -112.36 137.95 49.78 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.508 -0.769 . . . . 72.54 108.927 169.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.428 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -148.13 158.01 43.83 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 107.919 -1.141 . . . . 73.32 107.919 170.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 25.1 p -89.87 154.11 20.13 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 122.188 0.994 . . . . 75.22 112.511 169.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.624 HD12 ' HB3' ' A' ' 212' ' ' ALA . 22.2 tp -124.28 132.84 53.59 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 112.997 -1.911 . . . . 74.13 107.352 164.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -94.72 113.7 25.51 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 108.372 -0.973 . . . . 73.53 108.372 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.616 HG22 HG21 ' A' ' 210' ' ' VAL . 24.8 t -118.0 130.9 24.43 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 114.95 -1.023 . . . . 74.04 108.578 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . 0.495 ' HG2' ' HB ' ' A' ' 203' ' ' ILE . 59.3 Cg_endo -73.76 149.76 43.5 Favored 'Trans proline' 0 C--N 1.366 1.475 0 C-N-CA 121.47 1.447 . . . . 73.24 110.833 168.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -53.45 -44.71 98.14 Favored Pre-proline 0 N--CA 1.483 1.202 0 CA-C-O 118.193 -0.908 . . . . 65.32 112.186 177.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.463 ' HD2' ' HB2' ' A' ' 200' ' ' PRO . 86.0 Cg_exo -50.56 -41.22 53.67 Favored 'Trans proline' 0 C--N 1.399 3.223 0 C-N-CA 122.46 2.107 . . . . 71.52 113.525 173.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.495 ' HB ' ' HG2' ' A' ' 200' ' ' PRO . 1.8 mp -86.42 -23.07 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 N-CA-C 109.718 -0.475 . . . . 74.31 109.718 -176.403 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -72.57 -36.71 68.25 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 122.934 0.494 . . . . 73.11 111.044 177.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 25.4 t -89.56 -36.37 8.57 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 125.663 1.585 . . . . 72.23 112.873 -178.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 50.2 t -98.23 -42.58 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 O-C-N 121.663 -0.648 . . . . 64.3 110.91 -176.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 120.82 153.95 9.19 Favored Glycine 0 C--N 1.341 0.855 0 N-CA-C 110.704 -0.958 . . . . 64.33 110.704 -176.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 161.03 154.94 7.61 Favored Glycine 0 C--O 1.245 0.786 0 N-CA-C 111.57 -0.612 . . . . 75.13 111.57 177.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.62 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 39.3 ttmt -86.54 128.95 35.02 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.905 0.352 . . . . 74.23 110.655 176.041 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.616 HG21 HG22 ' A' ' 199' ' ' VAL . 13.5 m -130.74 144.51 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.958 1.303 . . . . 74.34 108.533 -179.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 24.2 ttt180 -97.08 141.62 30.0 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.059 0.943 . . . . 73.52 110.437 -167.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.624 ' HB3' HD12 ' A' ' 197' ' ' LEU . . . -133.18 124.75 28.02 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.429 1.491 . . . . 72.31 110.187 -168.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 33.6 tpp -77.48 114.95 16.83 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 109.024 -0.732 . . . . 73.13 109.024 174.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 63.0 p -124.16 -176.3 3.46 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.193 0.997 . . . . 74.2 110.292 -177.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . 0.514 HD23 ' HD3' ' A' ' 241' ' ' PRO . 66.9 tp -47.24 -51.58 18.38 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.623 1.169 . . . . 74.53 112.657 176.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -72.01 -27.22 62.58 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 114.75 -1.114 . . . . 74.21 111.085 -172.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 137.14 -165.2 25.22 Favored Glycine 0 C--O 1.244 0.774 0 N-CA-C 110.702 -0.959 . . . . 63.44 110.702 -173.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.79 131.54 24.44 Favored 'Trans proline' 0 CA--C 1.549 1.226 0 C-N-CA 121.979 1.786 . . . . 73.33 111.187 175.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 25.7 m -129.65 157.25 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 124.087 0.955 . . . . 74.45 108.742 -179.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.512 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 47.0 mt-10 -115.24 117.23 29.91 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-O 121.145 0.498 . . . . 71.12 111.358 -176.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.411 HG22 HG13 ' A' ' 168' ' ' VAL . 100.0 t -121.86 107.15 19.31 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 125.65 1.58 . . . . 62.43 110.893 -165.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.62 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -75.19 118.19 17.84 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.583 0.353 . . . . 71.42 111.122 176.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 26.8 m -89.6 154.4 48.32 Favored Pre-proline 0 N--CA 1.489 1.48 0 C-N-CA 123.71 0.804 . . . . 74.2 111.693 -176.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . 0.576 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 34.2 Cg_endo -63.02 164.04 20.63 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 122.658 2.239 . . . . 74.12 113.057 174.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -87.08 32.13 0.44 Allowed 'Trans proline' 0 C--N 1.37 1.66 0 C-N-CA 122.779 2.319 . . . . 74.22 113.19 174.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -147.97 1.46 0.66 Allowed 'General case' 0 N--CA 1.485 1.29 0 CA-C-O 118.903 -0.57 . . . . 74.53 112.333 175.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.576 ' HB ' ' HG2' ' A' ' 224' ' ' PRO . 0.7 OUTLIER -60.57 154.64 20.57 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 123.466 0.479 . . . . 72.24 110.406 -168.144 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . 0.475 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 4.9 pt20 -134.38 161.19 35.68 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.27 0.628 . . . . 71.03 110.698 -174.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -60.29 112.15 1.82 Allowed 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.906 -0.405 . . . . 71.53 109.906 176.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.41 0.75 21.96 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-N 115.083 -0.962 . . . . 75.3 112.122 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -72.81 126.05 28.99 Favored 'General case' 0 C--N 1.359 0.98 0 N-CA-C 108.835 -0.802 . . . . 71.24 108.835 -174.735 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.656 ' HZ3' ' HB2' ' A' ' 252' ' ' GLU . 30.1 mmmt -97.17 98.15 9.78 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 108.255 -1.016 . . . . 73.02 108.255 -173.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.452 ' HB3' ' HA ' ' A' ' 172' ' ' SER . 30.9 mt -77.96 99.94 6.24 Favored 'General case' 0 C--N 1.343 0.297 0 N-CA-C 106.803 -1.555 . . . . 72.42 106.803 -179.271 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . 0.538 ' HB2' ' HE2' ' A' ' 236' ' ' LYS . 0.0 OUTLIER -81.4 111.42 17.74 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 114.282 -1.326 . . . . 64.42 111.642 -173.952 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.512 ' O ' ' HB2' ' A' ' 248' ' ' ASP . 7.3 mp -100.28 127.85 46.48 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 106.193 -1.78 . . . . 73.42 106.193 173.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.538 ' HE2' ' HB2' ' A' ' 234' ' ' ARG . 5.3 mptp? -101.48 119.49 38.85 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.46 0.704 . . . . 73.31 110.868 -175.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 78.19 23.58 65.62 Favored Glycine 0 C--N 1.354 1.546 0 O-C-N 123.89 0.744 . . . . 60.41 112.662 -179.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.483 ' HB2' ' HB3' ' A' ' 235' ' ' LEU . 26.8 mmmt -119.06 21.28 12.42 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.297 1.039 . . . . 74.33 111.052 -175.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -94.12 -128.6 5.19 Favored Glycine 0 C--N 1.345 1.043 0 N-CA-C 110.243 -1.143 . . . . 74.11 110.243 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . 0.435 ' O ' ' HA ' ' A' ' 246' ' ' ARG . 7.3 m-30 -70.98 152.41 94.95 Favored Pre-proline 0 CA--C 1.551 0.985 0 CA-C-N 117.479 0.64 . . . . 71.45 111.668 178.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.514 ' HD3' HD23 ' A' ' 215' ' ' LEU . 48.2 Cg_endo -64.92 171.8 8.15 Favored 'Trans proline' 0 C--N 1.387 2.6 0 C-N-CA 123.182 2.588 . . . . 74.33 112.166 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -66.19 -41.87 94.62 Favored Glycine 0 CA--C 1.541 1.706 0 CA-C-O 118.489 -1.173 . . . . 72.1 113.445 -177.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . 0.45 ' HD2' ' HB2' ' A' ' 241' ' ' PRO . 81.4 Cg_exo -54.67 -39.9 86.84 Favored 'Trans proline' 0 C--N 1.388 2.632 0 C-N-CA 122.556 2.171 . . . . 72.44 114.095 168.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -76.68 -22.43 54.0 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.479 0.712 . . . . 71.23 110.646 177.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 106.93 111.78 3.61 Favored Glycine 0 C--N 1.343 0.953 0 N-CA-C 108.679 -1.768 . . . . 62.51 108.679 -172.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.435 ' HA ' ' O ' ' A' ' 240' ' ' PHE . 54.1 ttp180 -73.4 124.66 26.21 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 117.086 0.443 . . . . 72.44 110.76 -174.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -135.84 -158.8 8.3 Favored Glycine 0 CA--C 1.505 -0.552 0 N-CA-C 110.488 -1.045 . . . . 73.34 110.488 174.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . 0.512 ' HB2' ' O ' ' A' ' 235' ' ' LEU . 34.2 p-10 -123.14 161.96 23.42 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.137 0.575 . . . . 72.22 110.125 -174.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 8.4 tp -132.0 134.89 46.09 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 108.375 -0.972 . . . . 72.1 108.375 -168.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -115.67 148.96 39.1 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 108.53 -0.915 . . . . 74.33 108.53 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.428 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 75.0 mt -122.38 112.49 18.15 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 108.594 -0.891 . . . . 72.33 108.594 179.045 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . 0.656 ' HB2' ' HZ3' ' A' ' 232' ' ' LYS . 34.1 tt0 -89.76 112.28 23.53 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.285 -1.006 . . . . 72.11 108.285 -173.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.557 HG11 HG21 ' A' ' 227' ' ' THR . 53.8 t -61.6 125.9 18.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 114.969 -1.014 . . . . 74.13 110.222 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 41.8 mtp180 -115.54 122.51 45.9 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 106.571 -1.64 . . . . 74.4 106.571 171.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.468 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 46.8 mm -83.76 123.57 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 122.665 0.386 . . . . 71.31 110.123 -175.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.2 t . . . . . 0 CA--C 1.561 1.4 0 C-N-CA 124.273 1.029 . . . . 75.43 109.056 -172.275 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 12.5 tmm? . . . . . 0 N--CA 1.478 0.969 0 N-CA-C 108.894 -0.78 . . . . 70.23 108.894 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.486 ' HB2' ' HB2' ' A' ' 167' ' ' ALA . 0.0 OUTLIER -126.61 85.43 2.38 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.2 1.0 . . . . 73.32 110.442 -174.863 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -71.7 -33.49 68.82 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.898 0.879 . . . . 54.23 111.538 -178.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -96.26 37.45 3.43 Favored Glycine 0 N--CA 1.472 1.039 0 N-CA-C 111.894 -0.482 . . . . 62.4 111.894 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.486 ' HB2' ' HB2' ' A' ' 164' ' ' LYS . . . -153.39 172.91 16.34 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.491 1.117 . . . . 62.35 109.133 178.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 53.8 t -108.9 147.06 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 123.572 0.749 . . . . 75.11 110.395 -173.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 44.8 mtm -102.64 -175.54 2.85 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.183 1.793 . . . . 65.14 110.132 -166.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 8.3 p -94.25 87.7 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.115 0 CA-C-O 123.196 1.474 . . . . 74.01 108.037 159.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.28 -5.09 7.81 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 113.737 -1.574 . . . . 73.3 110.308 -177.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.51 ' HA ' ' HB3' ' A' ' 233' ' ' LEU . 69.9 m -37.54 -63.48 0.45 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.972 2.109 . . . . 35.41 114.488 -170.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -58.7 -34.02 70.84 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 121.116 0.484 . . . . 73.12 111.234 -172.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 92.55 75.97 1.32 Allowed Glycine 0 C--N 1.341 0.818 0 N-CA-C 108.429 -1.868 . . . . 73.44 108.429 -172.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -60.0 88.71 0.01 OUTLIER 'General case' 0 C--N 1.354 0.774 0 C-N-CA 124.242 1.017 . . . . 71.43 110.09 -177.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 47.1 m -120.69 124.76 45.97 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 113.828 -1.533 . . . . 74.24 108.605 -176.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -57.66 -21.91 42.69 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.525 0.73 . . . . 75.04 111.398 173.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -67.66 171.61 6.16 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 124.871 1.268 . . . . 75.52 111.903 170.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -61.81 -40.96 97.08 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.843 0.857 . . . . 74.32 110.887 176.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -170.73 115.06 0.57 Allowed Glycine 0 C--N 1.328 0.121 0 CA-C-N 115.033 -0.985 . . . . 53.22 110.989 178.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 50.5 m -147.36 169.99 18.28 Favored 'General case' 0 C--O 1.244 0.784 0 C-N-CA 123.366 0.666 . . . . 75.33 110.524 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -148.1 -42.97 0.03 OUTLIER Glycine 0 C--N 1.341 0.83 0 CA-C-N 115.737 -0.665 . . . . 54.33 111.787 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 69.12 66.41 2.27 Favored Glycine 0 C--N 1.346 1.11 0 N-CA-C 111.945 -0.462 . . . . 74.13 111.945 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 71.4 p -71.89 147.06 47.44 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 123.132 0.573 . . . . 73.31 110.596 177.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -160.37 175.38 37.13 Favored Glycine 0 C--N 1.341 0.849 0 N-CA-C 111.942 -0.463 . . . . 75.13 111.942 -177.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 72.91 14.15 78.64 Favored Glycine 0 C--N 1.35 1.316 0 C-N-CA 122.591 0.139 . . . . 74.53 112.979 -175.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 63.2 p -73.9 145.96 44.39 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.085 0.954 . . . . 72.42 111.342 -176.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.71 -57.88 2.97 Favored Glycine 0 C--N 1.345 1.079 0 CA-C-N 116.255 -0.429 . . . . 65.15 112.082 177.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -82.34 6.64 67.34 Favored Glycine 0 C--N 1.348 1.248 0 CA-C-O 119.5 -0.611 . . . . 62.24 114.157 -177.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 38.9 t 62.9 52.29 2.7 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.912 0.885 . . . . 75.13 111.253 175.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -105.88 -31.9 8.6 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 114.768 -1.105 . . . . 74.24 108.071 170.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -74.39 170.06 16.41 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 114.587 -1.188 . . . . 72.3 110.086 175.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 35.6 tp -152.71 139.08 18.5 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 115.904 -0.589 . . . . 75.33 109.5 176.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -112.5 139.94 47.66 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.53 -0.915 . . . . 74.44 108.53 169.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -147.76 156.35 42.65 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.464 -0.939 . . . . 73.1 108.464 166.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 20.4 p -84.28 150.94 25.08 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 122.446 1.117 . . . . 64.14 112.248 169.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.549 HD11 ' HB3' ' A' ' 212' ' ' ALA . 36.7 tp -126.03 133.66 51.67 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 113.063 -1.881 . . . . 71.34 106.774 170.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.441 ' HB2' HG23 ' A' ' 256' ' ' THR . 12.7 p-10 -94.69 111.55 23.32 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 108.535 -0.913 . . . . 74.13 108.535 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.579 HG22 HG23 ' A' ' 210' ' ' VAL . 58.1 t -115.94 129.48 25.15 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-N 114.783 -1.099 . . . . 73.21 108.884 -179.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -65.73 146.41 83.73 Favored 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 122.398 2.066 . . . . 75.53 111.513 169.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.431 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.62 -45.7 98.56 Favored Pre-proline 0 CA--C 1.565 1.527 0 C-N-CA 123.612 0.765 . . . . 75.24 111.918 174.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 27.6 Cg_endo -61.06 -31.03 90.52 Favored 'Trans proline' 0 C--N 1.404 3.462 0 C-N-CA 122.293 1.996 . . . . 74.32 112.618 176.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -86.25 -24.17 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 N-CA-C 108.962 -0.755 . . . . 70.21 108.962 -177.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -74.25 -37.03 63.88 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 123.079 0.552 . . . . 71.13 110.764 178.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 28.4 t -87.45 -38.71 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 O-C-N 124.68 1.238 . . . . 74.21 112.711 -178.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 54.9 t -98.4 -42.26 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 O-C-N 121.953 -0.467 . . . . 72.35 111.149 -175.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 123.06 155.56 9.34 Favored Glycine 0 C--N 1.339 0.732 0 N-CA-C 111.021 -0.832 . . . . 70.24 111.021 -175.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 161.38 156.09 8.16 Favored Glycine 0 C--O 1.245 0.819 0 N-CA-C 111.29 -0.724 . . . . 74.4 111.29 177.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.615 ' HD3' ' HB3' ' A' ' 220' ' ' GLU . 37.3 ttmt -84.28 136.66 33.83 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 109.437 -0.579 . . . . 75.22 109.437 175.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.579 HG23 HG22 ' A' ' 199' ' ' VAL . 11.4 m -135.16 151.48 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.363 1.065 . . . . 73.4 108.776 175.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . 0.4 ' HD2' ' N ' ' A' ' 212' ' ' ALA . 2.2 tmm_? -96.34 141.79 29.25 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.419 0.688 . . . . 71.23 109.734 -171.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.549 ' HB3' HD11 ' A' ' 197' ' ' LEU . . . -131.1 123.88 29.57 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.536 0.734 . . . . 63.51 109.03 -177.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 37.8 tpp -80.36 109.78 15.18 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 107.837 -1.172 . . . . 71.23 107.837 172.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 73.4 p -113.0 -172.64 2.09 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.418 0.687 . . . . 63.3 110.536 -176.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.587 HD23 ' HD3' ' A' ' 241' ' ' PRO . 66.6 tp -46.18 -50.82 15.23 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.439 1.095 . . . . 72.33 111.598 170.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -72.09 -30.05 64.71 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.055 -0.975 . . . . 75.32 111.753 -174.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 132.45 -164.45 23.91 Favored Glycine 0 C--N 1.342 0.871 0 CA-C-O 119.344 -0.698 . . . . 75.52 111.676 -170.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -66.68 129.02 20.1 Favored 'Trans proline' 0 C--N 1.374 1.89 0 C-N-CA 122.437 2.091 . . . . 75.31 111.346 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.424 HG22 ' O ' ' A' ' 212' ' ' ALA . 28.4 m -134.26 164.17 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 123.472 0.709 . . . . 74.22 110.975 -175.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.615 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 41.9 mt-10 -109.07 114.61 28.49 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.257 1.023 . . . . 64.05 108.689 -171.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 34.9 t -125.6 100.81 7.4 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 123.471 0.709 . . . . 74.13 109.665 -174.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.568 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -79.21 117.6 20.38 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 122.556 0.342 . . . . 74.04 110.243 174.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 30.2 m -88.09 152.12 50.18 Favored Pre-proline 0 N--CA 1.49 1.569 0 C-N-CA 123.253 0.621 . . . . 72.11 111.877 -175.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . 0.542 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 33.5 Cg_endo -63.62 163.71 23.46 Favored 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 122.651 2.234 . . . . 72.31 113.432 176.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -84.16 33.73 0.51 Allowed 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 123.237 2.625 . . . . 74.2 113.263 175.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . 0.409 ' HD2' ' HA ' ' A' ' 226' ' ' ARG . 10.0 tpt180 -150.07 -1.61 0.41 Allowed 'General case' 0 N--CA 1.477 0.897 0 O-C-N 121.805 -0.559 . . . . 73.32 112.217 175.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.587 HG21 HG13 ' A' ' 253' ' ' VAL . 0.6 OUTLIER -59.6 152.45 22.18 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 123.683 0.615 . . . . 71.34 109.639 -164.457 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . 0.482 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 5.2 pt20 -132.46 161.42 33.74 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.081 0.553 . . . . 75.25 110.29 -169.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -60.47 112.11 1.84 Allowed 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 109.818 -0.438 . . . . 50.32 109.818 174.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.25 -3.31 22.23 Favored Glycine 0 C--O 1.244 0.774 0 CA-C-N 115.269 -0.878 . . . . 71.42 111.895 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.482 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -67.79 126.85 30.71 Favored 'General case' 0 C--N 1.361 1.078 0 N-CA-C 109.016 -0.735 . . . . 75.22 109.016 -172.114 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -97.27 98.73 10.24 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 108.944 -0.761 . . . . 74.12 108.944 -173.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.51 ' HB3' ' HA ' ' A' ' 172' ' ' SER . 31.5 mt -79.16 100.78 7.59 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.059 -1.46 . . . . 72.31 107.059 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -79.69 124.97 29.06 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 124.381 1.05 . . . . 75.04 110.164 -175.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.565 ' HB3' ' HB2' ' A' ' 238' ' ' LYS . 7.1 mp -111.41 123.94 51.24 Favored 'General case' 0 C--O 1.219 -0.504 0 N-CA-C 104.769 -2.308 . . . . 70.45 104.769 170.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.468 ' HA ' ' HB3' ' A' ' 248' ' ' ASP . 44.2 tptt -103.07 117.34 34.35 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 118.92 0.782 . . . . 72.43 110.58 -171.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 79.03 27.03 57.05 Favored Glycine 0 C--N 1.345 1.045 0 O-C-N 123.429 0.455 . . . . 73.44 112.012 -175.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.565 ' HB2' ' HB3' ' A' ' 235' ' ' LEU . 29.4 mmmt -128.82 24.0 5.72 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.219 1.008 . . . . 74.14 111.68 -176.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . 0.445 ' HA2' ' HB2' ' A' ' 249' ' ' LEU . . . -95.73 -129.47 5.92 Favored Glycine 0 N--CA 1.469 0.876 0 N-CA-C 110.857 -0.897 . . . . 64.33 110.857 178.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . 0.457 ' O ' ' HA ' ' A' ' 246' ' ' ARG . 4.8 m-30 -68.58 153.13 96.16 Favored Pre-proline 0 CA--C 1.548 0.894 0 CA-C-N 117.374 0.587 . . . . 64.15 111.45 177.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.593 ' HB2' ' HD2' ' A' ' 243' ' ' PRO . 89.3 Cg_endo -69.95 172.64 12.45 Favored 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 123.346 2.697 . . . . 73.43 112.74 -174.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -66.33 -38.19 93.46 Favored Glycine 0 CA--C 1.545 1.943 0 CA-C-O 118.353 -1.248 . . . . 75.02 113.733 -178.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . 0.593 ' HD2' ' HB2' ' A' ' 241' ' ' PRO . 79.3 Cg_exo -52.75 -39.05 78.05 Favored 'Trans proline' 0 C--N 1.392 2.859 0 CA-C-N 120.918 2.359 . . . . 74.21 113.619 167.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -78.73 -23.5 45.43 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.583 0.753 . . . . 71.33 110.635 175.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 102.83 113.3 3.77 Favored Glycine 0 C--N 1.342 0.864 0 N-CA-C 108.4 -1.88 . . . . 72.13 108.4 -168.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.457 ' HA ' ' O ' ' A' ' 240' ' ' PHE . 15.9 ttp180 -70.81 131.22 43.47 Favored 'General case' 0 C--N 1.348 0.526 0 CA-C-N 117.473 0.636 . . . . 72.54 110.033 -172.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -136.23 -157.15 7.7 Favored Glycine 0 CA--C 1.502 -0.775 0 N-CA-C 110.879 -0.888 . . . . 63.42 110.879 176.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . 0.468 ' HB3' ' HA ' ' A' ' 236' ' ' LYS . 0.4 OUTLIER -124.24 159.03 31.08 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.698 0.799 . . . . 71.12 111.081 -175.945 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.445 ' HB2' ' HA2' ' A' ' 239' ' ' GLY . 8.0 tp -130.12 135.35 48.12 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.222 1.009 . . . . 73.33 108.512 -167.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -118.86 146.35 44.94 Favored 'General case' 0 C--O 1.247 0.922 0 N-CA-C 107.137 -1.431 . . . . 75.13 107.137 -174.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.463 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 71.1 mt -123.04 114.21 20.08 Favored 'General case' 0 C--O 1.223 -0.329 0 N-CA-C 108.078 -1.082 . . . . 75.22 108.078 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -88.59 111.71 22.2 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 107.712 -1.218 . . . . 72.25 107.712 -175.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.587 HG13 HG21 ' A' ' 227' ' ' THR . 56.0 t -62.06 127.35 21.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 114.871 -1.058 . . . . 74.04 110.176 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 14.5 mmt85 -117.1 122.24 43.58 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 106.89 -1.522 . . . . 73.43 106.89 173.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 46.3 mm -82.65 118.55 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 115.491 -0.777 . . . . 75.05 110.411 -174.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' THR . . . . . 0.441 HG23 ' HB2' ' A' ' 198' ' ' ASP . 1.4 t . . . . . 0 CA--C 1.556 1.188 0 C-N-CA 124.928 1.291 . . . . 74.14 107.697 -175.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 19.7 mmt . . . . . 0 N--CA 1.482 1.14 0 CA-C-O 120.72 0.295 . . . . 71.22 110.501 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 22.8 pttm -79.83 87.84 5.28 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.411 -0.813 . . . . 73.53 109.118 171.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -81.19 -14.47 57.53 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-N 115.716 -0.675 . . . . 73.1 112.129 -174.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -101.41 9.11 57.31 Favored Glycine 0 N--CA 1.472 1.096 0 O-C-N 123.433 0.458 . . . . 72.3 112.945 174.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -142.29 168.92 18.59 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.027 0.931 . . . . 71.03 109.798 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.436 HG13 HG22 ' A' ' 221' ' ' VAL . 56.1 t -110.33 151.08 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-O 121.761 0.791 . . . . 72.43 111.715 -168.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 46.2 mtm -99.38 -176.72 3.37 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.794 1.638 . . . . 74.32 109.898 -169.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 8.7 p -94.5 87.11 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.027 0 CA-C-O 122.986 1.375 . . . . 75.41 108.324 163.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' MET . . . . . 0.437 ' HE3' HD13 ' A' ' 235' ' ' LEU . 0.0 OUTLIER -124.57 -4.84 7.68 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 125.552 1.541 . . . . 62.32 110.024 -178.673 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 68.4 m -41.85 -64.81 0.52 Allowed 'General case' 0 C--O 1.246 0.909 0 C-N-CA 126.369 1.868 . . . . 74.25 113.042 -168.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . 0.637 ' HB2' ' HB3' ' A' ' 224' ' ' PRO . 63.1 t80 -67.36 -49.94 61.9 Favored 'General case' 0 C--N 1.352 0.696 0 N-CA-C 108.764 -0.828 . . . . 73.4 108.764 178.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 56.87 90.84 0.01 OUTLIER Glycine 0 C--N 1.363 2.045 0 O-C-N 125.09 1.494 . . . . 73.32 111.028 -173.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -52.44 85.7 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.936 1.294 . . . . 65.25 112.233 -172.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 31.5 m -78.07 121.46 24.3 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.06 -0.973 . . . . 64.55 108.737 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -64.1 -25.22 68.0 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 116.186 -0.461 . . . . 75.3 110.328 171.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -64.49 157.78 25.74 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.987 0.915 . . . . 74.14 110.599 168.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -71.39 -24.02 61.99 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.114 0.566 . . . . 72.44 110.561 176.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -118.7 173.34 14.87 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-N 115.385 -0.825 . . . . 62.43 112.331 177.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 46.6 m -83.17 135.25 34.86 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.581 0.752 . . . . 74.02 110.224 178.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -58.14 96.22 0.06 OUTLIER Glycine 0 C--N 1.347 1.164 0 O-C-N 123.935 0.772 . . . . 62.41 112.201 176.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -78.23 77.51 1.68 Allowed Glycine 0 C--N 1.349 1.3 0 C-N-CA 123.292 0.472 . . . . 70.54 111.929 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 23.0 t -160.5 136.07 8.14 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 107.897 -1.149 . . . . 52.32 107.897 -177.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -169.84 140.1 5.9 Favored Glycine 0 C--N 1.342 0.863 0 C-N-CA 121.359 -0.448 . . . . 75.41 113.599 -176.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 65.46 -87.49 0.09 OUTLIER Glycine 0 C--N 1.351 1.363 0 O-C-N 124.521 0.777 . . . . 64.34 114.26 173.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 33.5 t -175.33 -40.32 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.403 1.081 . . . . 73.23 109.92 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 118.46 -18.17 11.05 Favored Glycine 0 C--N 1.354 1.536 0 N-CA-C 114.678 0.631 . . . . 73.23 114.678 176.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -78.19 -71.43 1.23 Allowed Glycine 0 N--CA 1.471 1.01 0 CA-C-N 117.557 0.678 . . . . 72.13 113.362 -172.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 58.1 m -150.21 20.75 0.86 Allowed 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.43 0.692 . . . . 65.12 110.602 -177.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.406 ' HG2' ' HA3' ' A' ' 245' ' ' GLY . 26.5 mt-30 -106.95 -31.54 8.28 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.702 0.801 . . . . 73.53 111.076 -170.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.58 171.03 15.32 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-N 115.187 -0.915 . . . . 71.45 109.299 -176.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.412 ' O ' ' HA ' ' A' ' 249' ' ' LEU . 37.1 tp -152.3 131.53 12.78 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.44 -0.948 . . . . 62.34 108.44 174.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.483 ' HD2' ' HZ2' ' A' ' 232' ' ' LYS . 36.0 m-85 -117.26 138.29 51.83 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 123.41 0.684 . . . . 74.55 109.158 171.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -148.14 165.79 29.81 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.49 1.116 . . . . 73.52 108.165 176.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' THR . . . . . 0.436 HG23 ' HE ' ' A' ' 254' ' ' ARG . 39.8 p -93.67 154.74 17.65 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 122.395 1.093 . . . . 71.22 112.275 168.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.573 HD12 ' HB3' ' A' ' 212' ' ' ALA . 35.4 tp -125.6 132.16 52.57 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 112.767 -2.015 . . . . 75.34 106.421 165.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -95.27 117.42 30.24 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 107.879 -1.156 . . . . 73.04 107.879 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.572 HG23 HG23 ' A' ' 210' ' ' VAL . 58.0 t -119.57 131.55 24.34 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 124.353 1.061 . . . . 72.34 110.019 -178.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -65.1 144.23 81.03 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.326 2.017 . . . . 61.15 111.418 168.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.448 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.47 -44.94 98.62 Favored Pre-proline 0 CA--C 1.564 1.517 0 C-N-CA 123.799 0.84 . . . . 73.33 112.167 174.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.453 ' O ' ' HB ' ' A' ' 206' ' ' VAL . 17.8 Cg_endo -58.72 -33.45 98.35 Favored 'Trans proline' 0 C--N 1.404 3.499 0 C-N-CA 121.784 1.656 . . . . 74.13 112.361 175.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -86.06 -23.61 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 N-CA-C 109.357 -0.609 . . . . 75.12 109.357 -177.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -74.12 -39.33 63.41 Favored 'General case' 0 C--O 1.243 0.729 0 C-N-CA 123.046 0.538 . . . . 72.32 110.897 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 38.6 t -89.42 -36.05 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.818 1.247 . . . . 74.32 112.962 -178.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.453 ' HB ' ' O ' ' A' ' 202' ' ' PRO . 47.6 t -95.98 -41.47 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 O-C-N 121.538 -0.726 . . . . 72.11 110.184 -177.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 121.57 152.12 8.66 Favored Glycine 0 C--N 1.344 0.98 0 N-CA-C 110.57 -1.012 . . . . 71.24 110.57 -178.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.89 155.99 8.77 Favored Glycine 0 C--O 1.242 0.606 0 N-CA-C 112.289 -0.324 . . . . 65.23 112.289 176.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.621 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 38.3 ttmt -84.25 132.47 34.64 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.049 0.54 . . . . 73.34 109.781 175.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.572 HG23 HG23 ' A' ' 199' ' ' VAL . 8.3 m -131.07 150.62 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.674 1.19 . . . . 73.51 108.225 174.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -95.73 143.62 26.83 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 109.226 -0.657 . . . . 73.55 109.226 -174.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.573 ' HB3' HD12 ' A' ' 197' ' ' LEU . . . -130.76 128.02 39.92 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.976 0.91 . . . . 51.34 109.035 -177.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 31.7 tpp -79.39 116.37 19.59 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.642 -0.873 . . . . 64.2 108.642 171.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 68.8 p -121.06 -176.59 3.3 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.787 0.835 . . . . 74.03 110.001 -177.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.509 HD21 ' HD3' ' A' ' 241' ' ' PRO . 66.6 tp -46.72 -51.38 16.27 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.497 1.119 . . . . 72.42 111.894 172.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -72.1 -27.19 62.49 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 114.044 -1.434 . . . . 74.32 111.269 -172.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 131.98 -164.39 23.71 Favored Glycine 0 C--N 1.338 0.677 0 N-CA-C 111.508 -0.637 . . . . 75.43 111.508 -174.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -66.45 129.83 22.29 Favored 'Trans proline' 0 C--N 1.361 1.21 0 C-N-CA 122.407 2.071 . . . . 74.43 111.35 178.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 31.8 m -133.18 161.33 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 123.738 0.815 . . . . 62.42 110.816 -177.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.616 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 53.1 mt-10 -110.32 110.77 21.7 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.559 1.144 . . . . 74.41 109.842 -173.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.436 HG22 HG13 ' A' ' 168' ' ' VAL . 48.8 t -121.15 102.39 12.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 C-N-CA 124.352 1.061 . . . . 75.21 109.228 -172.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.621 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -79.2 117.08 19.89 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 122.796 0.439 . . . . 54.33 110.532 174.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 34.8 m -86.52 153.59 55.93 Favored Pre-proline 0 N--CA 1.487 1.392 0 C-N-CA 123.737 0.815 . . . . 74.51 111.457 -176.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . 0.637 ' HB3' ' HB2' ' A' ' 173' ' ' TYR . 32.7 Cg_endo -63.02 164.94 17.86 Favored 'Trans proline' 0 C--N 1.379 2.155 0 C-N-CA 122.737 2.291 . . . . 74.43 113.189 175.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -84.0 29.53 0.54 Allowed 'Trans proline' 0 C--N 1.369 1.606 0 C-N-CA 123.258 2.639 . . . . 74.22 113.178 172.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -145.9 0.1 0.83 Allowed 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 118.618 -0.706 . . . . 75.12 112.499 177.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.589 HG21 HG13 ' A' ' 253' ' ' VAL . 0.6 OUTLIER -60.95 154.66 21.85 Favored 'General case' 0 CA--C 1.573 1.84 0 O-C-N 123.375 0.422 . . . . 74.34 109.906 -167.117 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . 0.485 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 4.8 pt20 -135.26 161.94 33.98 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.563 0.745 . . . . 71.41 110.948 -169.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -62.75 110.86 1.88 Allowed 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.244 -0.65 . . . . 73.34 109.244 176.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.09 -0.55 22.65 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-N 115.187 -0.915 . . . . 61.33 111.903 178.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.485 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -67.92 123.85 21.75 Favored 'General case' 0 C--N 1.362 1.128 0 N-CA-C 108.824 -0.806 . . . . 75.31 108.824 -171.041 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.731 ' HZ1' ' HB2' ' A' ' 252' ' ' GLU . 29.6 mmmt -100.08 96.72 7.7 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.222 -0.658 . . . . 75.54 109.222 -170.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.474 ' O ' ' HA ' ' A' ' 250' ' ' TYR . 24.4 mt -80.21 98.57 7.41 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 106.378 -1.712 . . . . 74.2 106.378 -177.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . 0.649 ' HD3' ' HE2' ' A' ' 236' ' ' LYS . 0.0 OUTLIER -82.19 125.61 31.11 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.476 0.71 . . . . 71.11 111.501 178.631 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.552 ' HB3' ' HB2' ' A' ' 238' ' ' LYS . 7.2 mp -111.17 128.52 55.93 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 106.627 -1.619 . . . . 74.52 106.627 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.649 ' HE2' ' HD3' ' A' ' 234' ' ' ARG . 5.6 mptp? -97.07 116.84 30.0 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.253 0.621 . . . . 74.21 110.986 -173.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 76.46 29.27 58.31 Favored Glycine 0 C--N 1.35 1.307 0 O-C-N 124.06 0.85 . . . . 50.32 112.047 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.552 ' HB2' ' HB3' ' A' ' 235' ' ' LEU . 29.3 mmmt -127.27 20.38 6.82 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.113 0.965 . . . . 75.45 111.124 -175.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -94.95 -127.84 5.22 Favored Glycine 0 C--N 1.343 0.942 0 N-CA-C 110.059 -1.217 . . . . 71.12 110.059 178.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . 0.429 ' O ' ' HA ' ' A' ' 246' ' ' ARG . 7.3 m-30 -71.53 152.07 93.83 Favored Pre-proline 0 CA--C 1.554 1.098 0 CA-C-N 117.121 0.46 . . . . 72.41 111.767 177.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.509 ' HD3' HD21 ' A' ' 215' ' ' LEU . 59.2 Cg_endo -65.67 172.08 8.67 Favored 'Trans proline' 0 C--N 1.384 2.426 0 C-N-CA 123.468 2.779 . . . . 74.43 112.332 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.421 ' N ' ' HD2' ' A' ' 243' ' ' PRO . . . -66.31 -42.24 94.16 Favored Glycine 0 CA--C 1.541 1.672 0 CA-C-O 118.241 -1.311 . . . . 61.5 114.185 -176.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . 0.421 ' HD2' ' N ' ' A' ' 242' ' ' GLY . 10.2 Cg_endo -51.77 -38.78 67.72 Favored 'Trans proline' 0 C--N 1.392 2.825 0 C-N-CA 122.697 2.265 . . . . 72.21 113.223 168.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -79.19 -23.68 43.7 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.168 0.587 . . . . 32.22 110.839 176.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . 0.406 ' HA3' ' HG2' ' A' ' 191' ' ' GLN . . . 105.79 111.33 3.58 Favored Glycine 0 C--N 1.343 0.919 0 N-CA-C 108.757 -1.737 . . . . 74.11 108.757 -170.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.429 ' HA ' ' O ' ' A' ' 240' ' ' PHE . 74.3 mtt180 -63.6 124.54 21.64 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.46 0.704 . . . . 73.53 110.965 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -136.81 -158.15 7.9 Favored Glycine 0 C--O 1.24 0.517 0 CA-C-N 115.582 -0.736 . . . . 52.21 112.253 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -117.32 164.74 14.38 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.839 0.856 . . . . 73.02 109.517 -176.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.412 ' HA ' ' O ' ' A' ' 193' ' ' LEU . 12.3 tp -133.78 132.53 40.61 Favored 'General case' 0 C--O 1.217 -0.654 0 N-CA-C 108.541 -0.911 . . . . 73.22 108.541 -176.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.474 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 0.4 OUTLIER -113.27 145.55 40.84 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 123.48 0.712 . . . . 73.45 109.433 177.803 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 73.5 mt -124.28 112.5 17.08 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.361 -1.348 . . . . 72.21 107.361 176.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . 0.731 ' HB2' ' HZ1' ' A' ' 232' ' ' LYS . 33.3 tt0 -92.19 106.57 18.55 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 107.526 -1.287 . . . . 71.55 107.526 -172.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.589 HG13 HG21 ' A' ' 227' ' ' THR . 56.0 t -61.88 125.86 18.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 115.005 -0.998 . . . . 73.35 110.623 -177.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . 0.436 ' HE ' HG23 ' A' ' 196' ' ' THR . 26.4 mtm180 -113.6 123.77 50.75 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 106.644 -1.613 . . . . 75.2 106.644 171.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 46.5 mm -84.78 130.77 35.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 C-N-CA 123.181 0.592 . . . . 75.14 109.851 -175.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.4 t . . . . . 0 CA--C 1.563 1.471 0 C-N-CA 124.24 1.016 . . . . 72.4 108.355 -172.109 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' MET . . . . . 0.484 ' HA ' ' SD ' ' A' ' 169' ' ' MET . 1.0 OUTLIER . . . . . 0 N--CA 1.482 1.158 0 N-CA-C 109.31 -0.626 . . . . 72.15 109.31 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 32.6 mtmm -84.69 131.43 34.58 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 122.944 0.498 . . . . 74.31 109.809 173.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -86.62 -52.76 5.35 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.855 0.862 . . . . 71.44 111.477 -173.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -98.19 17.35 58.75 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-N 115.878 -0.601 . . . . 63.54 112.954 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -151.95 172.14 16.7 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.226 1.01 . . . . 65.32 109.405 176.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.428 HG13 HG22 ' A' ' 221' ' ' VAL . 51.1 t -111.05 149.96 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.999 0.919 . . . . 74.5 110.54 -178.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' MET . . . . . 0.484 ' SD ' ' HA ' ' A' ' 163' ' ' MET . 43.3 mtm -98.35 -177.78 3.82 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 125.544 1.538 . . . . 75.4 109.656 -169.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 9.0 p -100.52 90.4 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 N-CA-C 107.42 -1.326 . . . . 73.43 107.42 162.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' MET . . . . . 0.411 ' HG3' ' HA ' ' A' ' 235' ' ' LEU . 0.0 OUTLIER -125.3 -6.14 7.13 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 114.096 -1.411 . . . . 75.31 110.297 -175.863 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.428 ' HA ' ' HB3' ' A' ' 233' ' ' LEU . 67.2 m -40.77 -65.29 0.43 Allowed 'General case' 0 C--N 1.353 0.728 0 C-N-CA 126.461 1.904 . . . . 75.24 113.682 -165.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -63.54 -48.53 77.14 Favored 'General case' 0 C--O 1.238 0.486 0 O-C-N 123.504 0.502 . . . . 74.41 110.187 -177.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 60.91 93.03 0.01 OUTLIER Glycine 0 C--N 1.346 1.11 0 N-CA-C 109.715 -1.354 . . . . 70.32 109.715 -167.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -55.82 95.34 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.86 0.864 . . . . 70.42 110.215 -177.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 51.1 m -82.52 120.71 25.85 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-N 114.688 -1.142 . . . . 74.41 109.869 -174.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -70.43 -20.9 62.87 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 115.52 -0.764 . . . . 73.42 109.763 170.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -72.3 161.8 30.35 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.459 1.104 . . . . 60.31 110.933 173.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -81.9 2.96 28.07 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.185 0.594 . . . . 61.32 111.576 176.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -143.16 139.71 9.14 Favored Glycine 0 C--N 1.346 1.118 0 N-CA-C 111.069 -0.812 . . . . 64.11 111.069 173.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 23.0 t -106.4 106.3 16.75 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.746 0.818 . . . . 72.12 109.459 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -99.02 -123.35 4.91 Favored Glycine 0 C--N 1.347 1.166 0 O-C-N 123.16 0.288 . . . . 63.51 112.555 -178.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 146.02 82.9 0.05 OUTLIER Glycine 0 C--N 1.347 1.15 0 CA-C-N 116.606 0.203 . . . . 74.22 112.874 175.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 62.0 p -131.13 162.42 29.92 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.865 0.866 . . . . 72.03 109.673 177.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -172.42 -84.91 0.06 OUTLIER Glycine 0 C--N 1.346 1.12 0 C-N-CA 121.665 -0.302 . . . . 52.33 113.253 175.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.411 ' O ' ' HB2' ' A' ' 191' ' ' GLN . . . -87.01 50.23 4.12 Favored Glycine 0 C--N 1.347 1.192 0 C-N-CA 123.118 0.39 . . . . 61.13 113.289 -172.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 9.6 t -97.27 93.56 6.59 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.516 0.726 . . . . 75.51 109.936 -173.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -136.28 -83.1 0.14 Allowed Glycine 0 C--N 1.346 1.108 0 CA-C-N 116.232 -0.44 . . . . 72.31 112.473 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -106.27 -72.41 0.82 Allowed Glycine 0 C--N 1.351 1.399 0 N-CA-C 110.358 -1.097 . . . . 62.24 110.358 178.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 67.1 m -154.57 76.54 1.02 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.778 0.831 . . . . 64.45 109.38 174.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.411 ' HB2' ' O ' ' A' ' 186' ' ' GLY . 27.5 mt-30 -117.39 -48.21 2.62 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 114.575 -1.193 . . . . 74.25 108.563 172.018 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.428 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 38.5 p-10 -74.72 165.15 25.7 Favored 'General case' 0 C--O 1.247 0.948 0 CA-C-N 115.343 -0.844 . . . . 73.51 109.984 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.4 HD12 ' CE1' ' A' ' 240' ' ' PHE . 53.1 tp -149.94 143.34 25.18 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.902 -0.59 . . . . 65.2 109.548 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -115.52 138.47 51.0 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.969 0.908 . . . . 73.32 108.636 173.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -149.09 158.32 44.09 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.73 -0.841 . . . . 60.33 108.73 170.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 26.5 p -81.3 153.08 27.26 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 122.187 0.994 . . . . 64.23 111.851 166.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.632 HD12 ' HB3' ' A' ' 212' ' ' ALA . 33.5 tp -122.62 134.5 54.51 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 113.053 -1.885 . . . . 74.43 106.911 162.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -94.7 117.47 30.18 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 108.142 -1.058 . . . . 75.02 108.142 177.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.586 HG22 HG23 ' A' ' 210' ' ' VAL . 45.1 t -122.51 132.21 24.29 Favored Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 124.049 0.94 . . . . 72.21 109.153 178.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . 0.401 ' HD2' ' HB ' ' A' ' 203' ' ' ILE . 14.9 Cg_exo -69.57 145.55 58.6 Favored 'Trans proline' 0 C--N 1.365 1.433 0 C-N-CA 122.352 2.035 . . . . 63.11 110.52 169.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.45 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -52.91 -43.56 94.36 Favored Pre-proline 0 N--CA 1.486 1.332 0 N-CA-C 112.567 0.58 . . . . 64.34 112.567 173.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.45 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 10.6 Cg_endo -55.21 -37.72 94.1 Favored 'Trans proline' 0 C--N 1.399 3.217 0 C-N-CA 122.006 1.804 . . . . 73.53 112.736 174.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.401 ' HB ' ' HD2' ' A' ' 200' ' ' PRO . 1.8 mp -86.55 -23.66 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 N-CA-C 109.841 -0.429 . . . . 74.22 109.841 -175.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -73.48 -38.0 65.56 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 123.146 0.578 . . . . 72.55 111.029 178.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 39.8 t -89.01 -35.43 7.71 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 C-N-CA 125.022 1.329 . . . . 74.51 112.648 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.437 ' HB ' ' O ' ' A' ' 202' ' ' PRO . 51.5 t -97.92 -42.93 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 O-C-N 121.547 -0.721 . . . . 75.2 111.129 -176.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 121.82 152.45 8.7 Favored Glycine 0 C--N 1.339 0.743 0 N-CA-C 110.707 -0.957 . . . . 74.35 110.707 -176.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 161.81 155.55 7.98 Favored Glycine 0 C--O 1.245 0.839 0 N-CA-C 111.307 -0.717 . . . . 74.42 111.307 177.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.615 ' HD3' ' HB3' ' A' ' 220' ' ' GLU . 36.3 ttmt -84.85 133.66 34.31 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 122.998 0.519 . . . . 75.24 110.026 174.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.586 HG23 HG22 ' A' ' 199' ' ' VAL . 15.5 m -131.24 153.4 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.417 1.087 . . . . 75.41 109.665 177.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . 0.585 ' HE ' ' HB3' ' A' ' 218' ' ' PRO . 0.0 OUTLIER -95.14 142.69 27.3 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.266 1.026 . . . . 74.04 109.352 -171.79 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.632 ' HB3' HD12 ' A' ' 197' ' ' LEU . . . -132.85 122.35 24.28 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.561 0.745 . . . . 73.41 109.459 -177.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 34.2 tpp -78.9 109.91 13.62 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 108.958 -0.756 . . . . 74.15 108.958 172.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 67.5 p -120.36 -175.08 2.93 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.928 0.891 . . . . 64.11 110.387 -175.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.513 HD22 ' HD3' ' A' ' 241' ' ' PRO . 64.0 tp -44.19 -53.32 6.64 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.298 1.039 . . . . 72.32 112.754 174.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -73.32 -27.89 61.77 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 114.821 -1.081 . . . . 74.34 111.392 -172.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 135.05 -164.45 24.78 Favored Glycine 0 C--N 1.341 0.855 0 N-CA-C 111.687 -0.565 . . . . 74.02 111.687 -171.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . 0.585 ' HB3' ' HE ' ' A' ' 211' ' ' ARG . 41.3 Cg_endo -63.93 130.73 28.45 Favored 'Trans proline' 0 C--N 1.369 1.639 0 C-N-CA 122.848 2.365 . . . . 73.4 111.335 176.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 23.2 m -131.84 161.82 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.707 0.803 . . . . 74.53 110.723 -177.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.615 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 43.9 mt-10 -112.0 112.68 24.49 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.445 1.098 . . . . 65.53 109.899 -171.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.428 HG22 HG13 ' A' ' 168' ' ' VAL . 50.5 t -126.39 102.61 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 124.221 1.008 . . . . 74.21 110.174 -171.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.615 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -78.06 118.19 20.09 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.948 0.499 . . . . 73.43 110.391 174.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 36.0 m -90.71 152.33 44.74 Favored Pre-proline 0 N--CA 1.482 1.159 0 C-N-CA 123.445 0.698 . . . . 73.43 111.296 -176.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . 0.522 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 36.1 Cg_endo -63.91 165.4 18.96 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.839 2.359 . . . . 65.25 113.054 175.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -84.78 28.98 0.55 Allowed 'Trans proline' 0 C--N 1.378 2.091 0 C-N-CA 123.222 2.614 . . . . 74.52 113.032 175.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 35.4 mmt180 -145.07 -2.8 0.78 Allowed 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.335 0.654 . . . . 74.2 112.259 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.569 HG21 HG13 ' A' ' 253' ' ' VAL . 0.6 OUTLIER -60.81 149.47 35.77 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.433 -0.58 . . . . 74.44 109.433 -165.864 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . 0.464 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 13.2 pt20 -133.81 162.3 32.38 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.123 0.569 . . . . 74.01 110.417 -173.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -59.73 110.97 1.27 Allowed 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.145 0.498 . . . . 74.42 110.05 178.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.63 -0.66 21.79 Favored Glycine 0 C--N 1.335 0.49 0 CA-C-N 114.675 -1.148 . . . . 74.24 112.095 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.464 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -68.18 125.24 25.75 Favored 'General case' 0 C--N 1.359 0.992 0 N-CA-C 108.901 -0.777 . . . . 74.21 108.901 -175.002 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -98.9 97.58 8.75 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.283 0.633 . . . . 72.54 109.571 -168.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.487 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 22.2 mt -82.68 100.01 9.96 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 107.839 -1.171 . . . . 72.51 107.839 -176.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . 0.507 ' H ' ' HD3' ' A' ' 234' ' ' ARG . 0.0 OUTLIER -82.95 113.76 20.77 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.154 -0.93 . . . . 64.41 111.185 -176.964 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.475 ' O ' ' HB2' ' A' ' 248' ' ' ASP . 7.3 mp -100.66 127.25 47.12 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 106.772 -1.566 . . . . 75.14 106.772 173.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -101.74 117.12 34.21 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.342 0.657 . . . . 73.02 110.636 -175.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 79.08 32.35 39.83 Favored Glycine 0 C--N 1.348 1.227 0 O-C-N 124.268 0.98 . . . . 73.23 112.309 -177.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.448 ' HB2' ' HB3' ' A' ' 235' ' ' LEU . 29.3 mmmt -128.7 19.59 6.14 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.607 0.763 . . . . 74.21 111.66 -178.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -98.04 -134.03 8.18 Favored Glycine 0 C--N 1.343 0.953 0 N-CA-C 111.039 -0.824 . . . . 74.3 111.039 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . 0.462 ' O ' ' HA ' ' A' ' 246' ' ' ARG . 5.9 m-30 -66.18 154.91 89.04 Favored Pre-proline 0 CA--C 1.547 0.854 0 N-CA-C 112.699 0.629 . . . . 63.24 112.699 -177.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.513 ' HD3' HD22 ' A' ' 215' ' ' LEU . 86.2 Cg_endo -71.99 171.54 16.47 Favored 'Trans proline' 0 C--N 1.383 2.348 0 C-N-CA 123.285 2.657 . . . . 74.32 112.797 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.463 ' N ' ' HD2' ' A' ' 243' ' ' PRO . . . -67.17 -38.33 91.99 Favored Glycine 0 CA--C 1.545 1.962 0 CA-C-O 118.364 -1.242 . . . . 75.12 114.713 -177.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 242' ' ' GLY . 10.0 Cg_endo -53.72 -37.18 83.94 Favored 'Trans proline' 0 C--N 1.39 2.74 0 CA-C-N 120.974 2.387 . . . . 74.25 112.511 169.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -80.16 -24.6 40.28 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.513 0.725 . . . . 72.21 110.834 175.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 105.95 111.35 3.58 Favored Glycine 0 C--N 1.341 0.819 0 N-CA-C 107.802 -2.119 . . . . 73.2 107.802 -167.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.462 ' HA ' ' O ' ' A' ' 240' ' ' PHE . 1.5 tmm_? -73.12 128.52 35.73 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 109.738 -0.468 . . . . 73.0 109.738 -170.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -137.09 -156.79 7.43 Favored Glycine 0 C--N 1.342 0.911 0 CA-C-N 115.982 -0.554 . . . . 64.15 112.951 -175.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . 0.475 ' HB2' ' O ' ' A' ' 235' ' ' LEU . 32.4 p-10 -123.78 165.23 17.65 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.327 1.051 . . . . 63.21 110.526 -174.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 10.8 tp -135.56 135.37 40.28 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.191 -0.67 . . . . 72.42 109.191 -170.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -115.66 145.81 42.39 Favored 'General case' 0 C--O 1.246 0.88 0 N-CA-C 107.637 -1.246 . . . . 64.52 107.637 -178.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.487 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 82.2 mt -123.82 113.79 19.01 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 108.558 -0.904 . . . . 75.53 108.558 -179.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -89.78 110.49 21.4 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.83 -1.174 . . . . 73.23 107.83 -176.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.569 HG13 HG21 ' A' ' 227' ' ' THR . 51.2 t -61.81 134.16 27.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 115.162 -0.927 . . . . 62.45 110.527 -178.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 18.1 mtp85 -120.73 125.22 47.08 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.337 -1.357 . . . . 71.44 107.337 172.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 48.0 mm -84.92 112.83 22.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 108.948 -0.76 . . . . 74.22 108.948 -179.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 CA--C 1.557 1.248 0 CA-C-O 117.415 -1.279 . . . . 73.34 108.912 -171.734 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 50.6 ttm . . . . . 0 N--CA 1.473 0.704 0 N-CA-C 109.576 -0.528 . . . . 75.3 109.576 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.461 ' HB2' ' HB2' ' A' ' 167' ' ' ALA . 0.0 OUTLIER -77.69 93.05 4.2 Favored 'General case' 0 CA--C 1.555 1.168 0 CA-C-O 121.823 0.82 . . . . 74.24 111.711 -179.734 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -78.18 -21.4 50.22 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.554 0.741 . . . . 72.43 111.457 176.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -97.48 17.07 59.61 Favored Glycine 0 C--N 1.345 1.059 0 O-C-N 123.555 0.534 . . . . 74.24 112.625 178.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.461 ' HB2' ' HB2' ' A' ' 164' ' ' LYS . . . -148.08 172.84 13.62 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.58 1.152 . . . . 74.21 108.837 176.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 54.6 t -110.22 152.3 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-O 121.731 0.777 . . . . 65.1 111.415 -170.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 43.4 mtm -101.42 -176.05 3.03 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.619 1.968 . . . . 74.53 109.462 -170.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 10.3 p -101.77 88.84 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.079 0 CA-C-O 122.973 1.368 . . . . 72.24 107.791 163.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.72 -5.66 8.61 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 114.05 -1.432 . . . . 72.44 110.587 -174.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.448 ' HA ' ' HB3' ' A' ' 233' ' ' LEU . 69.3 m -36.25 -64.96 0.29 Allowed 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 127.014 2.126 . . . . 72.25 115.617 -167.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . 0.434 ' HB2' ' HG3' ' A' ' 224' ' ' PRO . 66.9 t80 -61.4 -33.42 73.65 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.165 0.586 . . . . 74.32 111.517 -170.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 79.39 39.85 17.5 Favored Glycine 0 C--N 1.343 0.919 0 N-CA-C 110.191 -1.164 . . . . 75.41 110.191 -173.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -70.07 102.15 1.98 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.353 1.061 . . . . 54.24 110.494 -173.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 58.3 p -110.12 124.94 52.43 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.937 1.295 . . . . 54.55 108.995 176.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -65.52 -13.09 58.15 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.922 0.489 . . . . 72.33 112.315 176.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -90.51 161.7 15.38 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.539 1.136 . . . . 61.23 109.071 168.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -59.81 -36.52 76.93 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 112.168 0.433 . . . . 73.34 112.168 -175.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -159.7 -176.53 31.87 Favored Glycine 0 CA--C 1.522 0.527 0 CA-C-N 115.302 -0.863 . . . . 72.24 111.999 177.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 36.2 m -110.92 7.38 21.71 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.559 0.744 . . . . 74.13 111.169 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 84.63 -57.75 5.01 Favored Glycine 0 C--N 1.354 1.565 0 N-CA-C 112.03 -0.428 . . . . 74.3 112.03 -178.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -169.3 -128.83 1.04 Allowed Glycine 0 C--N 1.34 0.77 0 N-CA-C 111.035 -0.826 . . . . 71.13 111.035 177.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 46.6 t -143.28 125.15 15.13 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 123.601 0.76 . . . . 54.22 109.931 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -78.41 68.17 2.98 Favored Glycine 0 C--N 1.35 1.352 0 N-CA-C 111.347 -0.701 . . . . 73.44 111.347 169.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -157.58 -97.14 0.12 Allowed Glycine 0 C--O 1.241 0.541 0 N-CA-C 109.304 -1.518 . . . . 73.22 109.304 -178.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 23.7 m 57.72 26.28 12.84 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 124.76 1.224 . . . . 72.14 112.53 171.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -102.33 147.03 17.07 Favored Glycine 0 C--N 1.343 0.954 0 CA-C-N 115.599 -0.728 . . . . 64.0 112.549 -176.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -64.82 -62.32 5.1 Favored Glycine 0 C--N 1.346 1.119 0 N-CA-C 111.696 -0.562 . . . . 74.33 111.696 178.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 67.8 p -89.47 22.31 3.01 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.705 0.802 . . . . 62.31 111.439 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -117.59 -56.11 2.24 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.19 0.596 . . . . 75.23 110.169 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -76.28 164.29 26.2 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-N 115.394 -0.821 . . . . 64.44 110.458 -177.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 40.9 tp -151.1 140.14 21.07 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.344 -0.844 . . . . 73.41 109.846 176.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -114.77 140.04 49.22 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.649 0.78 . . . . 74.12 109.421 168.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -145.16 157.03 44.19 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 108.353 -0.98 . . . . 64.33 108.353 167.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 30.0 p -81.46 154.38 26.37 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 122.139 0.971 . . . . 75.11 111.516 167.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.583 HD12 ' HB3' ' A' ' 212' ' ' ALA . 42.3 tp -121.17 133.32 55.18 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 113.286 -1.779 . . . . 73.22 107.026 168.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -92.55 112.35 24.26 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 106.95 -1.5 . . . . 72.55 106.95 -177.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.534 HG22 HG23 ' A' ' 210' ' ' VAL . 43.3 t -124.55 130.41 24.3 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 123.333 0.653 . . . . 74.45 109.275 -177.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -66.81 144.13 69.95 Favored 'Trans proline' 0 C--N 1.368 1.6 0 C-N-CA 121.984 1.789 . . . . 75.55 110.974 166.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.439 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.16 -45.19 98.41 Favored Pre-proline 0 CA--C 1.562 1.421 0 CA-C-O 118.309 -0.853 . . . . 61.14 112.322 174.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.479 ' O ' ' HB ' ' A' ' 206' ' ' VAL . 22.9 Cg_endo -59.35 -30.98 94.17 Favored 'Trans proline' 0 C--N 1.4 3.252 0 C-N-CA 121.909 1.739 . . . . 72.15 112.537 175.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.7 mp -85.88 -25.97 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 O-C-N 121.645 -0.659 . . . . 74.1 109.68 -178.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -74.25 -38.81 63.37 Favored 'General case' 0 C--O 1.246 0.913 0 CA-C-O 121.13 0.49 . . . . 62.41 111.078 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 41.2 t -88.96 -37.21 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 C-N-CA 124.809 1.244 . . . . 74.31 112.653 -177.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.479 ' HB ' ' O ' ' A' ' 202' ' ' PRO . 53.1 t -96.85 -42.4 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 O-C-N 121.648 -0.658 . . . . 73.23 109.71 -176.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 124.31 148.66 7.48 Favored Glycine 0 C--N 1.349 1.287 0 N-CA-C 111.306 -0.718 . . . . 64.55 111.306 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 165.48 156.07 9.0 Favored Glycine 0 C--N 1.342 0.876 0 N-CA-C 112.259 -0.336 . . . . 74.41 112.259 177.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.607 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 38.1 ttmt -85.01 131.93 34.4 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.284 0.634 . . . . 72.21 110.16 176.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.534 HG23 HG22 ' A' ' 199' ' ' VAL . 13.8 m -131.07 153.22 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 124.023 0.929 . . . . 75.22 110.106 178.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -94.5 142.73 27.1 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.159 0.984 . . . . 72.1 109.468 -171.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.583 ' HB3' HD12 ' A' ' 197' ' ' LEU . . . -132.74 119.51 20.43 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.388 0.675 . . . . 74.2 109.774 -176.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 35.5 tpp -78.68 110.13 13.54 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 108.759 -0.83 . . . . 73.1 108.759 171.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 67.1 p -119.17 -175.26 2.89 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.085 0.954 . . . . 73.24 110.706 -174.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.519 HD23 ' HD3' ' A' ' 241' ' ' PRO . 65.5 tp -49.77 -50.66 43.77 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.984 0.914 . . . . 74.13 111.439 169.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -71.86 -26.7 62.46 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 114.567 -1.197 . . . . 74.33 111.84 -173.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 133.09 -165.17 24.08 Favored Glycine 0 C--N 1.344 1.004 0 N-CA-C 111.488 -0.645 . . . . 52.54 111.488 -178.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -67.56 128.08 17.52 Favored 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 121.709 1.606 . . . . 75.15 110.566 174.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 25.1 m -132.98 162.3 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 123.329 0.652 . . . . 72.23 110.397 -174.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.593 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 45.1 mt-10 -111.78 111.64 22.75 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.647 0.779 . . . . 74.33 109.446 -173.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 57.4 t -122.65 103.81 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 124.812 1.245 . . . . 71.13 109.646 -172.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.607 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -75.34 117.57 17.29 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 110.061 -0.348 . . . . 71.12 110.061 174.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 28.3 m -85.47 153.5 58.8 Favored Pre-proline 0 N--CA 1.489 1.495 0 C-N-CA 122.889 0.475 . . . . 74.5 110.796 -176.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . 0.434 ' HG3' ' HB2' ' A' ' 173' ' ' TYR . 34.2 Cg_exo -59.7 162.36 15.74 Favored 'Trans proline' 0 C--N 1.383 2.373 0 C-N-CA 122.43 2.087 . . . . 73.3 112.757 177.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -91.02 30.12 0.36 Allowed 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 123.219 2.613 . . . . 72.52 112.039 177.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 -145.12 -9.12 0.59 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.061 0.945 . . . . 75.2 111.403 178.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.605 HG21 HG13 ' A' ' 253' ' ' VAL . 0.8 OUTLIER -59.39 156.39 12.96 Favored 'General case' 0 CA--C 1.567 1.633 0 O-C-N 123.885 0.741 . . . . 73.22 111.603 -158.906 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . 0.404 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 19.7 pt20 -130.22 162.55 28.67 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.341 0.657 . . . . 73.12 110.851 -171.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . 0.441 ' HB1' HH21 ' A' ' 254' ' ' ARG . . . -61.4 112.64 2.26 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.903 -0.59 . . . . 62.31 109.438 174.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.44 -3.86 21.74 Favored Glycine 0 N--CA 1.466 0.68 0 CA-C-N 115.642 -0.708 . . . . 72.55 112.067 178.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.404 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -68.69 126.24 29.08 Favored 'General case' 0 C--N 1.358 0.948 0 N-CA-C 109.268 -0.641 . . . . 74.13 109.268 -173.065 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -98.39 98.47 9.69 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.373 -0.603 . . . . 74.45 109.373 -171.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.448 ' HB3' ' HA ' ' A' ' 172' ' ' SER . 25.0 mt -79.64 99.77 7.52 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 106.917 -1.512 . . . . 73.4 106.917 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -81.34 115.68 20.81 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-O 121.546 0.689 . . . . 72.22 110.871 -176.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.421 ' HB3' ' HB2' ' A' ' 238' ' ' LYS . 7.3 mp -99.52 124.82 45.04 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 105.458 -2.053 . . . . 71.44 105.458 170.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 41.0 tptt -102.14 117.93 35.83 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 117.909 0.322 . . . . 70.34 110.156 -171.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 77.65 22.02 70.69 Favored Glycine 0 C--N 1.342 0.913 0 O-C-N 123.542 0.526 . . . . 73.14 112.86 -178.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.425 ' HB3' ' HZ3' ' A' ' 238' ' ' LYS . 1.5 mmmp? -120.65 20.74 11.7 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.012 0.925 . . . . 73.11 110.035 -177.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -96.75 -135.09 8.38 Favored Glycine 0 C--N 1.349 1.285 0 N-CA-C 111.258 -0.737 . . . . 72.24 111.258 178.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 6.3 m-30 -65.1 150.59 95.21 Favored Pre-proline 0 N--CA 1.48 1.035 0 N-CA-C 112.339 0.496 . . . . 71.44 112.339 -177.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.519 ' HD3' HD23 ' A' ' 215' ' ' LEU . 60.0 Cg_endo -67.37 170.38 13.59 Favored 'Trans proline' 0 C--N 1.383 2.376 0 C-N-CA 123.13 2.553 . . . . 73.41 113.075 -177.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -68.37 -39.58 87.44 Favored Glycine 0 CA--C 1.538 1.509 0 CA-C-O 118.613 -1.104 . . . . 63.32 114.361 -177.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -48.38 -40.27 36.08 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 122.515 2.144 . . . . 75.14 113.871 164.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -77.9 -24.64 48.32 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.51 0.724 . . . . 74.24 110.705 175.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 106.65 111.45 3.58 Favored Glycine 0 C--N 1.336 0.546 0 N-CA-C 108.095 -2.002 . . . . 71.24 108.095 -167.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -71.84 125.23 26.64 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-N 117.458 0.629 . . . . 75.24 110.198 -172.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -138.81 -157.73 7.45 Favored Glycine 0 C--N 1.337 0.599 0 CA-C-N 116.085 -0.507 . . . . 72.24 112.727 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -119.78 165.22 14.84 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.945 0.898 . . . . 74.34 110.085 -173.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 10.5 tp -134.39 133.24 40.35 Favored 'General case' 0 C--O 1.219 -0.523 0 N-CA-C 107.683 -1.228 . . . . 75.52 107.683 -173.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 7.7 m-30 -116.13 147.89 40.88 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 108.063 -1.088 . . . . 73.41 108.063 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 78.2 mt -122.8 114.27 20.29 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 107.89 -1.152 . . . . 74.35 107.89 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -88.05 111.75 21.88 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 107.816 -1.179 . . . . 74.51 107.816 -178.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.605 HG13 HG21 ' A' ' 227' ' ' THR . 53.2 t -60.92 125.74 17.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 O-C-N 123.976 0.797 . . . . 74.13 109.891 178.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . 0.441 HH21 ' HB1' ' A' ' 229' ' ' ALA . 0.2 OUTLIER -112.01 124.28 52.07 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 106.658 -1.608 . . . . 75.25 106.658 174.667 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 51.3 mm -88.51 126.7 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 O-C-N 123.931 0.77 . . . . 73.15 109.527 -177.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 CA--C 1.558 1.278 0 N-CA-C 107.605 -1.257 . . . . 74.3 107.605 -177.07 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 57.9 ttp . . . . . 0 N--CA 1.484 1.24 0 N-CA-C 109.675 -0.491 . . . . 73.45 109.675 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.52 153.05 35.82 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.084 0.554 . . . . 73.21 110.416 172.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -105.17 -36.42 7.26 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.885 0.874 . . . . 74.35 111.165 -172.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -98.72 24.55 31.67 Favored Glycine 0 C--N 1.343 0.918 0 CA-C-N 115.972 -0.558 . . . . 70.03 113.07 -177.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -147.87 165.83 29.43 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.681 0.793 . . . . 64.33 109.978 178.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 78.9 t -109.19 146.07 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 123.598 0.759 . . . . 73.15 111.52 -169.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 44.5 mtm -101.97 -174.92 2.7 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.936 1.694 . . . . 73.53 110.059 -168.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 10.9 p -95.3 87.85 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.188 0 CA-C-O 123.195 1.474 . . . . 65.54 108.126 162.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' MET . . . . . 0.47 ' HE3' HD12 ' A' ' 235' ' ' LEU . 0.0 OUTLIER -123.15 -3.76 8.5 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 114.053 -1.431 . . . . 75.03 110.106 -177.08 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.494 ' HA ' ' HB3' ' A' ' 233' ' ' LEU . 68.1 m -41.51 -66.52 0.33 Allowed 'General case' 0 C--N 1.353 0.741 0 C-N-CA 126.348 1.859 . . . . 64.52 113.454 -170.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . 0.42 ' HB2' ' HG3' ' A' ' 224' ' ' PRO . 54.1 t80 -71.62 -43.26 66.48 Favored 'General case' 0 C--O 1.242 0.702 0 N-CA-C 108.422 -0.955 . . . . 73.24 108.422 178.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 57.12 67.1 2.39 Favored Glycine 0 C--N 1.359 1.824 0 O-C-N 124.683 1.239 . . . . 73.22 110.192 -176.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -62.29 88.14 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.007 0 CA-C-O 122.13 0.967 . . . . 74.34 112.725 -169.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 17.1 p -87.91 117.86 27.05 Favored 'General case' 0 C--O 1.245 0.821 0 N-CA-C 106.876 -1.527 . . . . 63.34 106.876 166.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -59.85 -29.77 68.51 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.531 0.732 . . . . 75.12 111.564 -173.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -97.49 129.65 44.65 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 107.758 -1.201 . . . . 70.45 107.758 163.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -68.66 -37.31 79.54 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.761 0.824 . . . . 74.53 111.255 -171.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -73.8 -8.37 77.25 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-N 115.053 -0.976 . . . . 71.01 113.688 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 34.8 m -82.84 146.7 28.77 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.357 0.663 . . . . 74.23 110.443 176.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 82.0 29.24 38.69 Favored Glycine 0 C--N 1.347 1.173 0 O-C-N 123.503 0.502 . . . . 63.41 112.601 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -86.92 9.72 70.98 Favored Glycine 0 C--N 1.349 1.299 0 C-N-CA 123.101 0.381 . . . . 62.43 113.195 177.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 39.8 p -66.7 157.98 31.29 Favored 'General case' 0 C--O 1.246 0.872 0 C-N-CA 123.862 0.865 . . . . 73.13 111.014 174.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -179.0 141.13 4.73 Favored Glycine 0 C--N 1.336 0.538 0 CA-C-N 116.062 -0.517 . . . . 75.33 112.462 -178.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -90.51 59.37 3.36 Favored Glycine 0 C--N 1.347 1.186 0 N-CA-C 111.948 -0.461 . . . . 64.43 111.948 178.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 49.3 m -63.08 109.19 1.42 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.142 0.577 . . . . 74.25 111.04 -177.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -154.79 157.86 27.89 Favored Glycine 0 C--O 1.243 0.68 0 N-CA-C 110.651 -0.979 . . . . 72.44 110.651 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -57.29 -36.41 75.76 Favored Glycine 0 C--N 1.349 1.251 0 O-C-N 124.284 0.638 . . . . 52.43 113.873 -174.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 43.5 m -135.61 42.84 2.65 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.279 0.632 . . . . 64.53 110.374 173.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -118.64 -66.8 1.04 Allowed 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 109.147 -0.686 . . . . 72.21 109.147 172.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -75.23 154.78 37.36 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-N 114.717 -1.129 . . . . 72.03 108.849 -177.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 57.6 tp -148.88 132.41 16.73 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.305 -0.628 . . . . 72.45 109.305 -174.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -117.04 140.14 49.85 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.386 0.674 . . . . 73.54 109.213 174.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -147.8 158.19 43.91 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.69 0.796 . . . . 72.2 108.985 174.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 24.0 p -83.86 152.12 24.75 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 122.339 1.066 . . . . 74.45 112.292 167.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.584 HD13 ' HB3' ' A' ' 212' ' ' ALA . 33.3 tp -124.46 134.11 53.16 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 112.695 -2.048 . . . . 75.43 107.008 167.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -93.35 116.77 29.32 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.216 -1.031 . . . . 75.35 108.216 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.565 HG22 HG23 ' A' ' 210' ' ' VAL . 61.7 t -123.14 130.55 24.53 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 124.141 0.976 . . . . 75.12 109.174 178.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -66.09 143.63 72.55 Favored 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 122.161 1.907 . . . . 72.43 111.015 167.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.421 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.47 -43.75 96.22 Favored Pre-proline 0 CA--C 1.566 1.568 0 CA-C-O 118.141 -0.933 . . . . 72.45 112.572 175.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.421 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 19.1 Cg_endo -57.65 -31.28 91.48 Favored 'Trans proline' 0 C--N 1.403 3.445 0 C-N-CA 121.876 1.717 . . . . 73.24 112.634 173.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -87.14 -25.64 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 N-CA-C 109.487 -0.56 . . . . 74.31 109.487 -178.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -73.43 -37.95 65.7 Favored 'General case' 0 C--O 1.244 0.794 0 C-N-CA 122.983 0.513 . . . . 72.14 110.987 178.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 25.4 t -88.29 -38.65 11.93 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 125.368 1.467 . . . . 74.43 112.875 -177.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 79.5 t -98.5 -41.46 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 O-C-N 121.664 -0.647 . . . . 74.23 110.45 -176.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 126.98 152.73 8.09 Favored Glycine 0 N--CA 1.468 0.815 0 N-CA-C 111.287 -0.725 . . . . 71.22 111.287 -178.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.98 154.16 7.84 Favored Glycine 0 C--O 1.244 0.74 0 CA-C-N 116.978 0.389 . . . . 63.31 112.675 175.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.572 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 36.7 ttmt -85.95 131.29 34.32 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.572 0.749 . . . . 75.33 109.215 175.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.565 HG23 HG22 ' A' ' 199' ' ' VAL . 15.8 m -130.0 154.45 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 123.734 0.814 . . . . 62.34 109.633 -177.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.11 135.91 33.86 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.732 0.813 . . . . 74.25 109.274 -171.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.584 ' HB3' HD13 ' A' ' 197' ' ' LEU . . . -132.73 116.49 16.66 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.813 -0.81 . . . . 43.12 108.813 -176.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 36.7 tpp -80.78 109.87 15.75 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 107.819 -1.178 . . . . 72.3 107.819 173.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 64.8 p -113.22 -175.42 2.66 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.125 0.57 . . . . 74.42 110.533 -174.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.427 HD22 ' HD3' ' A' ' 241' ' ' PRO . 60.5 tp -47.67 -51.17 22.61 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 124.323 1.014 . . . . 74.31 110.888 169.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -72.31 -27.03 62.19 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 113.884 -1.507 . . . . 73.31 110.944 -174.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 129.73 -166.14 22.0 Favored Glycine 0 C--N 1.341 0.81 0 CA-C-N 116.133 -0.485 . . . . 74.14 112.007 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -62.67 130.76 30.76 Favored 'Trans proline' 0 CA--C 1.552 1.419 0 C-N-CA 122.649 2.233 . . . . 74.43 111.84 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 212' ' ' ALA . 20.6 m -139.61 160.3 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 123.061 0.544 . . . . 73.24 110.408 -172.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.564 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 40.2 mt-10 -110.88 111.82 23.23 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.738 0.815 . . . . 53.25 109.311 -175.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 60.4 t -120.56 102.96 13.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 124.25 1.02 . . . . 74.01 108.937 -173.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.572 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -76.72 117.2 18.1 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 109.98 -0.378 . . . . 74.33 109.98 175.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 35.5 m -87.85 152.02 50.64 Favored Pre-proline 0 N--CA 1.487 1.399 0 C-N-CA 122.996 0.518 . . . . 61.33 110.562 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . 0.546 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 35.5 Cg_endo -63.48 163.48 23.77 Favored 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 122.213 1.942 . . . . 74.3 113.034 176.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -80.63 29.8 0.52 Allowed 'Trans proline' 0 C--N 1.373 1.864 0 C-N-CA 123.354 2.702 . . . . 71.41 113.416 174.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 -150.7 0.69 0.42 Allowed 'General case' 0 N--CA 1.474 0.738 0 O-C-N 122.113 -0.367 . . . . 73.03 111.839 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.652 HG21 HG13 ' A' ' 253' ' ' VAL . 0.7 OUTLIER -60.82 153.23 25.05 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.497 -0.557 . . . . 72.34 109.497 -169.058 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . 0.439 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 19.6 pt20 -132.73 162.11 32.28 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.403 0.681 . . . . 73.52 110.44 -171.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -61.13 111.46 1.72 Allowed 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 108.946 -0.761 . . . . 72.04 108.946 172.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.69 -1.62 21.68 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-N 115.087 -0.961 . . . . 72.23 112.501 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.439 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -68.79 127.08 31.82 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.445 0.698 . . . . 72.33 109.494 -173.971 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -98.21 97.1 8.56 Favored 'General case' 0 C--O 1.244 0.767 0 C-N-CA 123.413 0.685 . . . . 74.32 109.309 -170.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.494 ' HB3' ' HA ' ' A' ' 172' ' ' SER . 24.3 mt -80.23 99.24 7.73 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 107.504 -1.295 . . . . 73.25 107.504 -178.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 2.3 ppt_? -81.51 117.39 21.88 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.761 0.825 . . . . 74.55 112.579 -174.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.47 HD12 ' HE3' ' A' ' 171' ' ' MET . 7.6 mp -110.18 126.98 54.67 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 107.035 -1.468 . . . . 75.33 107.035 174.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -103.44 118.06 35.87 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.715 0.806 . . . . 75.21 111.024 -173.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 78.97 22.4 66.05 Favored Glycine 0 C--N 1.347 1.192 0 O-C-N 123.882 0.739 . . . . 64.51 112.304 -178.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -120.5 19.33 12.01 Favored 'General case' 0 C--N 1.347 0.486 0 C-N-CA 123.462 0.705 . . . . 72.13 109.984 -178.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -95.69 -136.61 8.77 Favored Glycine 0 C--N 1.35 1.361 0 N-CA-C 111.06 -0.816 . . . . 72.02 111.06 177.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 6.3 m-30 -68.28 148.27 98.24 Favored Pre-proline 0 CA--C 1.551 0.988 0 CA-C-N 117.559 0.68 . . . . 65.54 111.429 -178.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.427 ' HD3' HD22 ' A' ' 215' ' ' LEU . 65.7 Cg_endo -67.01 172.33 9.96 Favored 'Trans proline' 0 C--N 1.38 2.19 0 C-N-CA 123.399 2.733 . . . . 75.42 112.416 -177.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.447 ' N ' ' HD2' ' A' ' 243' ' ' PRO . . . -66.34 -38.29 93.52 Favored Glycine 0 CA--C 1.545 1.941 0 CA-C-O 117.92 -1.489 . . . . 64.51 114.163 -176.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 242' ' ' GLY . 9.7 Cg_endo -53.19 -35.28 72.83 Favored 'Trans proline' 0 C--N 1.392 2.867 0 CA-C-N 120.892 2.346 . . . . 74.44 113.351 167.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -85.45 -25.11 27.13 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.079 0.552 . . . . 73.13 110.464 176.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 112.52 114.19 3.29 Favored Glycine 0 C--N 1.343 0.962 0 N-CA-C 109.866 -1.294 . . . . 71.22 109.866 -169.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 32.2 ttm180 -66.22 128.44 36.13 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 117.389 0.594 . . . . 74.33 110.591 -176.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -148.1 -156.48 7.08 Favored Glycine 0 C--N 1.336 0.534 0 CA-C-N 115.657 -0.702 . . . . 72.32 112.48 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -118.58 165.86 13.43 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.214 0.605 . . . . 73.53 109.373 -171.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.441 ' O ' ' HB2' ' A' ' 235' ' ' LEU . 11.3 tp -133.83 132.07 39.97 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 107.31 -1.367 . . . . 71.12 107.31 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 9.8 m-30 -122.73 147.22 46.74 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.127 -1.064 . . . . 72.1 108.127 -178.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.416 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 86.0 mt -123.08 115.92 22.63 Favored 'General case' 0 C--O 1.222 -0.364 0 N-CA-C 108.327 -0.99 . . . . 74.25 108.327 -176.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -88.39 111.62 21.96 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 107.574 -1.269 . . . . 73.42 107.574 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.652 HG13 HG21 ' A' ' 227' ' ' THR . 55.6 t -61.35 128.35 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 CA-C-N 115.126 -0.943 . . . . 75.21 110.088 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 8.1 mmt180 -119.89 123.44 43.6 Favored 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 107.809 -1.182 . . . . 74.33 107.809 177.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 47.9 mm -82.76 122.11 36.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 114.718 -1.128 . . . . 73.13 109.945 -174.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.7 t . . . . . 0 CA--C 1.557 1.233 0 N-CA-C 107.229 -1.397 . . . . 72.53 107.229 -179.182 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 27.3 ttt . . . . . 0 N--CA 1.479 0.997 0 N-CA-C 109.039 -0.726 . . . . 75.51 109.039 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.485 ' HB2' ' HB2' ' A' ' 167' ' ' ALA . 0.0 OUTLIER -65.8 93.81 0.19 Allowed 'General case' 0 CA--C 1.557 1.25 0 C-N-CA 123.53 0.732 . . . . 74.15 111.559 -179.925 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -72.71 -24.93 61.06 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.444 0.698 . . . . 72.32 110.987 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -98.69 25.59 27.39 Favored Glycine 0 C--N 1.349 1.279 0 CA-C-N 116.158 -0.474 . . . . 64.1 112.63 176.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.485 ' HB2' ' HB2' ' A' ' 164' ' ' LYS . . . -152.66 173.2 15.53 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.939 0.896 . . . . 73.11 108.876 173.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.526 HG13 HG23 ' A' ' 221' ' ' VAL . 53.2 t -109.41 151.07 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.107 0.563 . . . . 73.51 110.863 -172.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 50.2 mtm -99.43 -176.47 3.3 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 125.8 1.64 . . . . 73.3 110.019 -169.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 8.8 p -99.97 86.48 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 CA-C-O 123.149 1.452 . . . . 74.52 107.94 163.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' MET . . . . . 0.472 ' HG3' ' HA ' ' A' ' 235' ' ' LEU . 0.0 OUTLIER -122.63 -5.36 8.67 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 113.675 -1.602 . . . . 74.15 110.041 -176.96 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.522 ' HA ' ' HB3' ' A' ' 233' ' ' LEU . 69.4 m -40.93 -63.33 0.68 Allowed 'General case' 0 C--N 1.35 0.608 0 C-N-CA 126.818 2.047 . . . . 65.21 114.553 -168.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . 0.61 ' HB2' ' HB3' ' A' ' 224' ' ' PRO . 67.3 t80 -59.03 -35.76 73.83 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.224 0.535 . . . . 72.11 110.9 -176.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 106.94 63.82 0.59 Allowed Glycine 0 N--CA 1.439 -1.114 0 N-CA-C 108.032 -2.027 . . . . 71.12 108.032 -167.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -60.62 98.22 0.06 Allowed 'General case' 0 C--O 1.241 0.62 0 C-N-CA 124.493 1.117 . . . . 71.34 110.023 -176.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 48.5 m -120.87 120.79 36.55 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.843 0.857 . . . . 61.32 111.01 -175.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -78.18 -8.77 58.72 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 109.259 -0.645 . . . . 74.34 109.259 160.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -75.4 174.07 10.09 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.525 1.53 . . . . 74.13 110.777 165.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -56.11 -37.99 70.16 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.464 0.706 . . . . 75.21 111.449 172.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 160.63 54.6 0.01 OUTLIER Glycine 0 C--N 1.338 0.677 0 CA-C-N 115.256 -0.884 . . . . 72.33 111.401 176.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 14.6 m -93.83 117.32 29.93 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.281 0.632 . . . . 61.51 110.845 -173.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -121.52 -72.69 0.3 Allowed Glycine 0 C--N 1.349 1.285 0 N-CA-C 111.633 -0.587 . . . . 71.3 111.633 177.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 72.09 174.0 21.67 Favored Glycine 0 C--N 1.351 1.372 0 CA-C-O 121.375 0.431 . . . . 75.33 114.055 175.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' SER . . . . . 0.569 ' HB3' ' HB2' ' A' ' 187' ' ' SER . 73.2 m -113.38 126.96 55.93 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.97 0.908 . . . . 71.13 109.838 177.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -85.1 -75.66 1.22 Allowed Glycine 0 C--N 1.344 0.999 0 O-C-N 123.631 0.582 . . . . 74.34 111.87 -176.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 191' ' ' GLN . . . -94.32 52.95 2.12 Favored Glycine 0 C--N 1.342 0.877 0 N-CA-C 111.728 -0.549 . . . . 71.5 111.728 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.569 ' HB2' ' HB3' ' A' ' 184' ' ' SER . 23.1 t -77.23 119.3 20.7 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 122.424 0.29 . . . . 71.31 110.409 -177.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -167.65 -131.22 1.25 Allowed Glycine 0 C--N 1.342 0.872 0 N-CA-C 111.865 -0.494 . . . . 73.1 111.865 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -83.33 -56.96 2.57 Favored Glycine 0 C--N 1.347 1.167 0 N-CA-C 112.14 -0.384 . . . . 42.24 112.14 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 17.7 m -152.93 60.69 0.79 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.144 0.978 . . . . 73.4 109.182 -175.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.464 ' HB2' ' O ' ' A' ' 186' ' ' GLY . 20.8 mt-30 -119.17 -52.47 2.29 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 107.213 -1.403 . . . . 75.12 107.213 172.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 24.5 p-10 -74.21 172.67 11.36 Favored 'General case' 0 C--O 1.245 0.843 0 CA-C-N 113.425 -1.716 . . . . 73.11 109.724 167.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 33.0 tp -152.06 140.39 20.48 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.847 0.356 . . . . 74.04 110.324 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -115.46 139.69 49.81 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.269 1.028 . . . . 72.45 108.632 168.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.418 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -147.92 158.13 43.89 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.097 -1.075 . . . . 71.24 108.097 168.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 32.3 p -82.89 153.78 24.94 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 122.146 0.974 . . . . 63.01 112.585 167.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.544 HD12 ' HB3' ' A' ' 212' ' ' ALA . 25.8 tp -124.23 132.01 53.57 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 112.88 -1.964 . . . . 75.54 107.09 164.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -94.45 116.78 29.19 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.827 -0.805 . . . . 70.14 108.827 177.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.552 HG22 HG23 ' A' ' 210' ' ' VAL . 57.4 t -117.93 134.62 23.27 Favored Pre-proline 0 CA--C 1.549 0.923 0 CA-C-N 114.573 -1.194 . . . . 72.24 109.214 -177.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -67.5 146.7 75.17 Favored 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 122.185 1.923 . . . . 75.43 111.121 169.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.436 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.66 -45.76 98.58 Favored Pre-proline 0 CA--C 1.567 1.612 0 C-N-CA 123.65 0.78 . . . . 75.4 112.568 174.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 28.0 Cg_endo -60.73 -31.41 91.9 Favored 'Trans proline' 0 C--N 1.393 2.887 0 C-N-CA 122.202 1.934 . . . . 72.35 112.98 176.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -86.19 -24.47 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 109.441 -0.577 . . . . 73.11 109.441 -177.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -73.31 -37.7 66.09 Favored 'General case' 0 C--O 1.244 0.78 0 C-N-CA 123.053 0.541 . . . . 45.11 111.417 178.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 24.9 t -88.99 -36.66 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 CA-C-N 114.348 -1.296 . . . . 74.44 113.506 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 55.7 t -96.92 -42.3 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 O-C-N 121.486 -0.759 . . . . 74.11 111.007 -177.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 123.36 152.87 8.59 Favored Glycine 0 C--N 1.341 0.861 0 N-CA-C 110.727 -0.949 . . . . 55.03 110.727 -175.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.68 151.83 6.74 Favored Glycine 0 C--O 1.246 0.849 0 N-CA-C 111.578 -0.609 . . . . 75.2 111.578 177.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.614 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 4.2 ttmp? -84.2 130.2 34.84 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 108.667 -0.864 . . . . 73.21 108.667 174.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.552 HG23 HG22 ' A' ' 199' ' ' VAL . 15.8 m -129.9 152.24 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.383 1.073 . . . . 71.14 108.301 178.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . 0.405 ' HD2' ' N ' ' A' ' 212' ' ' ALA . 4.8 tmm_? -95.37 141.93 28.35 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 108.466 -0.939 . . . . 75.44 108.466 -172.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.544 ' HB3' HD12 ' A' ' 197' ' ' LEU . . . -132.14 124.92 30.06 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.959 0.903 . . . . 73.11 109.065 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 39.8 tpp -79.86 109.98 14.79 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 108.243 -1.021 . . . . 75.11 108.243 171.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 71.0 p -117.96 -175.59 2.87 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.838 0.855 . . . . 75.21 110.684 -177.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 63.0 tp -42.1 -50.65 4.72 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.809 1.244 . . . . 70.33 112.345 174.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -71.57 -27.08 62.91 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 114.552 -1.203 . . . . 74.55 111.595 -173.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 127.9 -163.35 21.58 Favored Glycine 0 C--N 1.34 0.791 0 N-CA-C 110.849 -0.9 . . . . 73.22 110.849 -170.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -65.49 129.84 23.57 Favored 'Trans proline' 0 C--N 1.371 1.741 0 C-N-CA 122.301 2.001 . . . . 75.11 111.594 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.414 HG22 ' O ' ' A' ' 212' ' ' ALA . 27.6 m -134.83 162.04 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 123.456 0.703 . . . . 73.31 111.041 -176.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.61 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 46.6 mt-10 -110.93 113.04 25.31 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.124 0.97 . . . . 75.05 109.77 -173.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.526 HG23 HG13 ' A' ' 168' ' ' VAL . 48.3 t -123.42 102.92 12.18 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 124.429 1.091 . . . . 74.33 109.815 -172.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.614 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -78.96 116.94 19.58 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 122.604 0.361 . . . . 71.11 110.505 175.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 35.3 m -88.79 152.44 48.87 Favored Pre-proline 0 N--CA 1.488 1.446 0 C-N-CA 123.252 0.621 . . . . 72.31 111.478 -175.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . 0.61 ' HB3' ' HB2' ' A' ' 173' ' ' TYR . 36.9 Cg_endo -63.13 166.36 14.77 Favored 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 122.838 2.359 . . . . 72.13 113.147 178.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -84.72 30.19 0.52 Allowed 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 122.838 2.359 . . . . 74.53 112.609 174.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -147.92 -0.72 0.6 Allowed 'General case' 0 N--CA 1.475 0.823 0 O-C-N 121.635 -0.666 . . . . 74.5 111.955 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.619 HG21 HG13 ' A' ' 253' ' ' VAL . 0.6 OUTLIER -61.18 152.53 28.44 Favored 'General case' 0 CA--C 1.567 1.633 0 N-CA-C 109.74 -0.467 . . . . 63.32 109.74 -167.482 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . 0.446 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 20.2 pt20 -135.05 161.47 35.21 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.456 0.703 . . . . 73.44 109.665 -173.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -61.33 111.23 1.68 Allowed 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 109.066 -0.716 . . . . 74.14 109.066 175.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 116.3 -0.47 20.68 Favored Glycine 0 N--CA 1.468 0.806 0 CA-C-N 114.783 -1.099 . . . . 74.34 112.787 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -70.92 127.36 32.32 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.83 0.852 . . . . 73.13 109.7 -175.671 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -97.62 99.22 10.6 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 109.324 -0.621 . . . . 74.14 109.324 -173.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.522 ' HB3' ' HA ' ' A' ' 172' ' ' SER . 22.8 mt -79.32 98.49 6.71 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.051 -1.463 . . . . 72.31 107.051 179.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 6.3 ppt_? -81.94 114.13 20.33 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-O 121.456 0.646 . . . . 75.35 111.972 -176.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.472 ' HA ' ' HG3' ' A' ' 171' ' ' MET . 7.2 mp -99.39 129.11 45.56 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 106.63 -1.619 . . . . 75.33 106.63 173.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 27.8 tptt -101.7 115.88 31.51 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 117.892 0.315 . . . . 75.03 110.721 -171.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.428 ' H ' ' HB3' ' A' ' 248' ' ' ASP . . . 78.12 29.38 53.98 Favored Glycine 0 C--N 1.344 1.019 0 O-C-N 123.832 0.708 . . . . 62.12 112.872 -178.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -119.31 20.05 12.64 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.841 0.856 . . . . 73.44 110.959 -177.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -95.95 -141.28 11.75 Favored Glycine 0 C--N 1.349 1.28 0 N-CA-C 110.453 -1.059 . . . . 54.2 110.453 178.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 7.2 m-30 -68.63 148.85 98.09 Favored Pre-proline 0 CA--C 1.548 0.881 0 CA-C-N 117.221 0.511 . . . . 75.2 111.592 -175.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -65.59 170.91 10.34 Favored 'Trans proline' 0 C--N 1.384 2.409 0 C-N-CA 123.209 2.606 . . . . 73.04 112.179 177.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -67.28 -39.65 92.07 Favored Glycine 0 CA--C 1.546 1.98 0 CA-C-O 118.719 -1.045 . . . . 53.31 114.186 -175.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_exo -50.39 -39.33 53.96 Favored 'Trans proline' 0 C--N 1.384 2.406 0 C-N-CA 122.601 2.201 . . . . 74.51 113.789 166.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -81.93 -24.22 35.72 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.045 0.538 . . . . 74.53 110.55 177.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 111.36 112.62 3.32 Favored Glycine 0 C--N 1.34 0.781 0 N-CA-C 109.112 -1.595 . . . . 74.45 109.112 -170.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -70.51 129.01 38.11 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 109.091 -0.707 . . . . 75.22 109.091 -172.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -148.9 -161.54 9.74 Favored Glycine 0 C--N 1.341 0.848 0 O-C-N 123.451 0.469 . . . . 72.21 112.751 173.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . 0.428 ' HB3' ' H ' ' A' ' 237' ' ' GLY . 15.8 p-10 -123.9 164.24 19.66 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.562 1.145 . . . . 72.13 110.782 -176.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 8.9 tp -132.0 136.28 47.16 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 109.27 -0.641 . . . . 64.02 109.27 -166.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -121.64 148.11 44.98 Favored 'General case' 0 C--O 1.247 0.939 0 N-CA-C 108.164 -1.05 . . . . 74.24 108.164 -176.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.418 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 71.5 mt -123.59 113.96 19.39 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 108.891 -0.781 . . . . 74.41 108.891 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -88.45 111.79 22.2 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.223 -1.028 . . . . 74.14 108.223 -177.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.619 HG13 HG21 ' A' ' 227' ' ' THR . 55.4 t -61.36 130.18 25.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 114.862 -1.063 . . . . 65.35 110.404 178.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 37.3 mtm180 -116.84 125.47 51.61 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 106.578 -1.638 . . . . 75.41 106.578 169.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 49.8 mm -84.27 127.5 39.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 108.727 -0.842 . . . . 70.42 108.727 -178.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.2 t . . . . . 0 CA--C 1.552 1.049 0 N-CA-C 108.369 -0.975 . . . . 70.3 108.369 -177.165 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 26.1 ptt? . . . . . 0 N--CA 1.474 0.748 0 N-CA-C 109.823 -0.436 . . . . 74.34 109.823 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.53 84.69 3.91 Favored 'General case' 0 CA--C 1.552 1.027 0 CA-C-O 121.915 0.864 . . . . 75.43 110.133 175.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -65.28 -15.0 62.05 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.903 1.281 . . . . 75.31 112.477 178.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -98.16 17.17 59.04 Favored Glycine 0 C--N 1.349 1.293 0 CA-C-N 116.588 -0.278 . . . . 72.1 112.575 175.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -153.13 171.25 18.74 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.249 1.02 . . . . 73.44 109.506 178.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 53.0 t -112.52 153.04 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-O 121.529 0.681 . . . . 74.14 111.403 -177.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 46.6 mtm -100.66 -176.83 3.3 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.282 1.833 . . . . 73.32 109.271 -173.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 11.2 p -98.97 88.74 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.321 0 CA-C-O 123.092 1.425 . . . . 72.41 107.758 163.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.92 -4.46 8.05 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 113.767 -1.56 . . . . 75.01 110.593 -172.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.516 ' HB3' HD22 ' A' ' 233' ' ' LEU . 70.3 m -40.7 -64.38 0.54 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.421 1.889 . . . . 75.5 114.187 -173.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . 0.61 ' HB2' ' HG3' ' A' ' 224' ' ' PRO . 45.2 t80 -69.64 -50.02 48.2 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 108.321 -0.992 . . . . 72.13 108.321 -178.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 39.6 48.73 3.11 Favored Glycine 0 C--N 1.364 2.132 0 O-C-N 125.491 1.744 . . . . 71.42 115.186 170.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 -75.44 -61.12 2.02 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 116.942 0.371 . . . . 73.42 110.25 -176.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 31.0 m -122.86 83.24 2.09 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.281 0.562 . . . . 73.44 109.675 -177.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -98.37 -28.01 13.84 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 107.925 -1.139 . . . . 71.44 107.925 168.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -80.3 172.71 13.41 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.613 1.565 . . . . 74.52 109.208 172.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -52.93 -36.47 59.73 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 123.551 0.741 . . . . 72.31 112.257 178.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -126.1 -88.79 0.71 Allowed Glycine 0 N--CA 1.454 -0.115 0 N-CA-C 109.044 -1.623 . . . . 73.41 109.044 170.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 42.3 t -170.43 114.46 0.46 Allowed 'General case' 0 C--O 1.242 0.665 0 N-CA-C 108.601 -0.889 . . . . 62.44 108.601 174.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -94.98 -58.16 1.18 Allowed Glycine 0 C--N 1.339 0.719 0 N-CA-C 111.313 -0.715 . . . . 73.13 111.313 174.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 60.69 42.87 99.51 Favored Glycine 0 C--N 1.35 1.316 0 N-CA-C 111.393 -0.683 . . . . 63.23 111.393 -171.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 59.0 m -62.48 110.98 1.85 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.697 0.799 . . . . 53.32 111.703 -172.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -86.27 128.53 8.9 Favored Glycine 0 C--N 1.34 0.797 0 CA-C-N 115.347 -0.842 . . . . 75.42 111.576 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -89.33 61.16 3.64 Favored Glycine 0 C--N 1.341 0.826 0 N-CA-C 111.669 -0.572 . . . . 74.32 111.669 178.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 30.3 p -68.32 132.93 47.96 Favored 'General case' 0 C--O 1.244 0.808 0 C-N-CA 123.223 0.609 . . . . 71.42 110.568 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -154.54 -164.65 13.09 Favored Glycine 0 C--O 1.242 0.618 0 CA-C-N 115.467 -0.788 . . . . 74.11 111.279 178.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -57.8 -42.31 94.46 Favored Glycine 0 C--N 1.348 1.219 0 N-CA-C 111.363 -0.695 . . . . 70.2 111.363 175.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 10.5 t -173.41 70.04 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.639 1.175 . . . . 75.0 107.865 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.409 ' HG2' ' HA3' ' A' ' 245' ' ' GLY . 73.4 mt-30 -116.71 -52.25 2.55 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 121.934 0.873 . . . . 75.42 109.625 -177.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -74.33 169.59 17.34 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 114.209 -1.359 . . . . 62.42 110.645 172.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 57.7 tp -150.63 141.12 22.48 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.995 0.518 . . . . 74.52 109.803 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -116.6 138.68 51.24 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 123.996 0.918 . . . . 74.44 109.231 172.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -149.32 159.23 44.45 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 108.703 -0.851 . . . . 72.52 108.703 169.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 31.1 p -85.88 153.07 22.48 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.931 0.872 . . . . 74.33 112.322 166.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.573 HD13 ' HB3' ' A' ' 212' ' ' ALA . 31.6 tp -124.58 132.76 53.43 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 113.086 -1.87 . . . . 75.13 107.245 166.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -95.1 113.26 24.93 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.953 0.882 . . . . 73.51 109.467 -176.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.56 HG22 HG21 ' A' ' 210' ' ' VAL . 60.9 t -118.62 132.09 24.0 Favored Pre-proline 0 CA--C 1.55 0.966 0 CA-C-N 114.711 -1.131 . . . . 65.35 109.967 -177.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -66.66 144.64 72.91 Favored 'Trans proline' 0 C--N 1.37 1.691 0 C-N-CA 122.281 1.987 . . . . 74.22 111.298 166.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.432 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.08 -43.75 95.45 Favored Pre-proline 0 CA--C 1.561 1.379 0 C-N-CA 124.245 1.018 . . . . 72.41 112.586 173.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 18.8 Cg_endo -57.89 -33.01 96.5 Favored 'Trans proline' 0 C--N 1.397 3.127 0 C-N-CA 121.681 1.588 . . . . 72.42 112.702 173.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -86.42 -23.69 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 N-CA-C 109.303 -0.628 . . . . 74.33 109.303 -177.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -76.0 -36.87 59.0 Favored 'General case' 0 C--O 1.248 0.982 0 C-N-CA 123.094 0.558 . . . . 70.51 111.691 178.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 31.9 t -88.89 -36.51 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 125.161 1.384 . . . . 72.45 112.555 -179.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.427 ' HB ' ' O ' ' A' ' 202' ' ' PRO . 60.3 t -98.21 -42.14 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 O-C-N 121.659 -0.651 . . . . 63.22 109.981 -176.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 122.85 153.86 8.91 Favored Glycine 0 C--N 1.342 0.901 0 N-CA-C 110.666 -0.974 . . . . 61.14 110.666 -175.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.81 149.32 5.77 Favored Glycine 0 C--O 1.241 0.567 0 N-CA-C 112.058 -0.417 . . . . 70.45 112.058 175.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.638 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 36.8 ttmt -85.24 128.46 34.69 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.491 -0.559 . . . . 74.5 109.491 176.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.56 HG21 HG22 ' A' ' 199' ' ' VAL . 15.4 m -129.81 149.51 33.7 Favored 'Isoleucine or valine' 0 C--O 1.245 0.847 0 N-CA-C 108.036 -1.098 . . . . 75.11 108.036 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 7.0 tmm_? -96.78 143.87 27.3 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.169 0.587 . . . . 75.35 109.716 -170.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.573 ' HB3' HD13 ' A' ' 197' ' ' LEU . . . -132.28 124.58 29.15 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.551 0.74 . . . . 55.04 109.163 -177.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 36.1 tpp -79.84 109.49 14.31 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.155 -1.054 . . . . 74.31 108.155 174.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 53.2 p -111.24 -177.59 3.24 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 123.324 0.65 . . . . 74.33 109.924 -176.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.539 HD21 ' HD3' ' A' ' 241' ' ' PRO . 62.1 tp -46.56 -52.82 12.65 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.292 1.037 . . . . 73.31 111.433 174.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -73.46 -27.69 61.54 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 113.674 -1.603 . . . . 72.31 111.554 -173.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 138.5 -166.99 25.16 Favored Glycine 0 C--N 1.35 1.308 0 CA-C-O 119.693 -0.504 . . . . 63.34 112.437 -176.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -65.47 130.1 24.27 Favored 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 122.454 2.103 . . . . 73.03 111.56 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 22.8 m -129.16 158.24 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 123.222 0.609 . . . . 74.24 110.055 -179.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.507 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 46.6 mt-10 -112.8 111.95 23.09 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.708 -0.849 . . . . 71.41 108.708 -174.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 99.3 t -124.84 104.13 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.207 1.003 . . . . 73.15 110.542 -169.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.638 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -77.31 117.61 18.98 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 122.658 0.383 . . . . 75.52 110.373 175.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.421 HG13 HG23 ' A' ' 199' ' ' VAL . 27.7 m -85.81 154.4 58.43 Favored Pre-proline 0 N--CA 1.479 1.012 0 C-N-CA 123.433 0.693 . . . . 75.32 111.329 -175.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . 0.61 ' HG3' ' HB2' ' A' ' 173' ' ' TYR . 36.7 Cg_exo -59.17 161.98 15.08 Favored 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 122.669 2.246 . . . . 74.13 113.231 178.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -89.28 25.99 0.57 Allowed 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 123.231 2.62 . . . . 74.2 112.632 173.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 14.4 mmt180 -146.04 0.76 0.84 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.74 0.816 . . . . 73.44 111.384 176.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.582 HG21 HG13 ' A' ' 253' ' ' VAL . 0.7 OUTLIER -62.05 153.38 29.9 Favored 'General case' 0 CA--C 1.568 1.647 0 O-C-N 123.382 0.426 . . . . 72.1 110.207 -167.56 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -133.8 162.03 33.1 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.634 0.774 . . . . 72.45 110.237 -176.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -60.23 110.63 1.28 Allowed 'General case' 0 C--N 1.351 0.672 0 O-C-N 123.446 0.466 . . . . 62.51 109.909 177.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 116.1 1.14 20.76 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-N 115.158 -0.928 . . . . 72.11 111.984 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.83 125.39 26.61 Favored 'General case' 0 C--N 1.359 1.004 0 N-CA-C 108.683 -0.858 . . . . 75.32 108.683 -177.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.55 ' HZ2' ' HB2' ' A' ' 252' ' ' GLU . 28.0 mmmt -97.39 97.56 9.22 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.35 -0.981 . . . . 74.01 108.35 -171.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.516 HD22 ' HB3' ' A' ' 172' ' ' SER . 25.0 mt -78.33 97.63 5.66 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 106.429 -1.693 . . . . 74.32 106.429 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 7.8 ppt_? -81.81 125.07 30.23 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 122.909 0.483 . . . . 74.43 110.862 -177.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 8.9 mp -108.78 130.05 55.38 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 106.697 -1.594 . . . . 75.44 106.697 175.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.51 113.62 25.21 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 122.734 0.413 . . . . 75.21 109.905 -170.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 76.71 24.69 66.71 Favored Glycine 0 C--N 1.343 0.954 0 O-C-N 123.596 0.56 . . . . 53.14 113.644 177.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -117.86 23.79 11.45 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.24 0.616 . . . . 74.4 110.547 -176.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -96.43 -131.21 6.74 Favored Glycine 0 C--N 1.346 1.089 0 CA-C-O 119.62 -0.545 . . . . 74.0 111.882 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 6.7 m-30 -72.15 154.68 92.19 Favored Pre-proline 0 CA--C 1.55 0.953 0 N-CA-C 112.746 0.647 . . . . 75.51 112.746 -176.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.539 ' HD3' HD21 ' A' ' 215' ' ' LEU . 73.7 Cg_endo -69.7 172.43 12.59 Favored 'Trans proline' 0 C--N 1.389 2.706 0 C-N-CA 123.428 2.752 . . . . 72.5 112.265 -179.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.407 ' N ' ' HD2' ' A' ' 243' ' ' PRO . . . -68.07 -39.33 88.81 Favored Glycine 0 CA--C 1.544 1.877 0 CA-C-O 118.257 -1.302 . . . . 50.15 114.395 -175.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . 0.407 ' HD2' ' N ' ' A' ' 242' ' ' GLY . 9.7 Cg_endo -55.14 -36.39 92.96 Favored 'Trans proline' 0 C--N 1.385 2.448 0 CA-C-N 120.725 2.263 . . . . 74.35 113.677 167.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -79.01 -24.04 43.97 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.053 0.541 . . . . 65.54 110.39 174.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . 0.409 ' HA3' ' HG2' ' A' ' 191' ' ' GLN . . . 107.69 112.38 3.62 Favored Glycine 0 C--N 1.344 1.023 0 N-CA-C 108.752 -1.739 . . . . 72.23 108.752 -169.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -69.7 122.18 18.64 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.614 -0.884 . . . . 75.24 108.614 -173.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -137.5 -159.51 8.24 Favored Glycine 0 C--N 1.342 0.878 0 O-C-N 123.551 0.532 . . . . 32.11 112.907 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -121.44 163.95 17.93 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.099 1.36 . . . . 72.14 110.549 -173.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 9.8 tp -134.89 134.21 40.45 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 109.628 -0.508 . . . . 71.05 109.628 -169.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -115.09 146.74 41.01 Favored 'General case' 0 C--O 1.244 0.766 0 N-CA-C 108.931 -0.766 . . . . 75.33 108.931 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 82.5 mt -123.86 113.81 19.02 Favored 'General case' 0 C--O 1.224 -0.241 0 N-CA-C 107.557 -1.275 . . . . 74.32 107.557 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . 0.55 ' HB2' ' HZ2' ' A' ' 232' ' ' LYS . 34.4 tt0 -91.03 111.86 23.51 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.251 -1.018 . . . . 74.3 108.251 -173.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.582 HG13 HG21 ' A' ' 227' ' ' THR . 53.8 t -60.04 126.75 18.34 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.423 0 O-C-N 124.238 0.961 . . . . 74.14 109.811 179.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 16.2 mtt180 -116.24 125.24 51.94 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.012 -1.477 . . . . 75.34 107.012 172.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 49.6 mm -86.33 123.06 39.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 108.718 -0.845 . . . . 75.03 108.718 -178.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.3 t . . . . . 0 CA--C 1.555 1.144 0 N-CA-C 109.271 -0.64 . . . . 73.03 109.271 -173.558 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 25.3 ptp . . . . . 0 N--CA 1.477 0.889 0 N-CA-C 110.229 -0.286 . . . . 75.4 110.229 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.43 149.23 22.33 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.278 0.631 . . . . 64.12 109.739 175.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -122.16 -37.82 2.78 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.18 0.992 . . . . 75.22 110.523 -173.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -97.68 33.55 5.8 Favored Glycine 0 C--N 1.344 0.988 0 CA-C-N 115.997 -0.547 . . . . 70.15 111.787 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -150.85 168.49 24.3 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 123.739 0.816 . . . . 73.45 110.37 -176.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.416 HG13 HG23 ' A' ' 221' ' ' VAL . 53.0 t -111.98 152.87 13.75 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 C-N-CA 124.734 1.213 . . . . 74.23 110.858 -170.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 42.1 mtm -99.32 -176.91 3.43 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.825 1.65 . . . . 74.53 109.032 -171.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 14.5 p -95.57 86.5 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 CA-C-O 123.457 1.599 . . . . 63.32 107.585 163.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' MET . . . . . 0.482 ' HG3' ' HA ' ' A' ' 235' ' ' LEU . 0.0 OUTLIER -122.62 -4.2 8.74 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 113.348 -1.751 . . . . 75.15 109.728 -175.912 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.471 ' HA ' ' HB3' ' A' ' 233' ' ' LEU . 66.3 m -41.95 -66.52 0.34 Allowed 'General case' 0 C--N 1.353 0.729 0 C-N-CA 126.202 1.801 . . . . 65.21 112.933 -169.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . 0.404 ' HB2' ' HG3' ' A' ' 224' ' ' PRO . 43.0 t80 -70.46 -43.01 70.72 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 108.925 -0.769 . . . . 73.25 108.925 -176.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 47.42 46.21 22.61 Favored Glycine 0 C--N 1.365 2.147 0 O-C-N 124.638 1.211 . . . . 64.45 114.041 172.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -163.26 139.86 7.2 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.267 1.027 . . . . 73.12 108.864 -170.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 50.2 m -71.5 122.89 21.24 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 107.359 -1.348 . . . . 61.34 107.359 167.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -17.85 -46.97 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 128.141 2.576 . . . . 73.14 117.51 -166.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -63.98 142.05 58.55 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 118.471 0.578 . . . . 72.53 109.972 175.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -57.03 -38.26 72.91 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 114.309 1.226 . . . . 73.53 114.309 -159.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -56.15 100.73 0.11 Allowed Glycine 0 N--CA 1.475 1.242 0 O-C-N 123.846 0.716 . . . . 71.33 112.881 -177.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 51.1 m -89.86 176.33 6.87 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.002 0.921 . . . . 73.24 112.019 -173.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -81.48 -144.9 4.54 Favored Glycine 0 C--N 1.349 1.263 0 CA-C-N 115.075 -0.966 . . . . 74.34 112.323 176.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -114.31 -152.84 10.65 Favored Glycine 0 C--N 1.343 0.95 0 CA-C-N 117.085 0.443 . . . . 71.33 113.23 -176.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 47.0 t -142.61 163.78 31.91 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.423 1.089 . . . . 75.33 109.267 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -97.11 -56.97 1.1 Allowed Glycine 0 C--N 1.348 1.207 0 CA-C-N 116.592 -0.276 . . . . 53.14 113.234 -176.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.409 ' HA3' ' HA2' ' A' ' 247' ' ' GLY . . . -131.29 105.96 0.65 Allowed Glycine 0 C--N 1.341 0.851 0 N-CA-C 111.308 -0.717 . . . . 72.11 111.308 -179.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.524 ' HA ' ' HB3' ' A' ' 192' ' ' ASP . 17.1 t -149.44 153.69 37.69 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 122.626 0.37 . . . . 71.14 110.712 -176.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 88.02 -33.5 4.01 Favored Glycine 0 C--N 1.353 1.491 0 CA-C-N 116.062 -0.517 . . . . 51.43 113.931 177.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -81.34 12.31 39.62 Favored Glycine 0 C--N 1.35 1.338 0 CA-C-O 119.235 -0.758 . . . . 63.4 114.268 -176.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 13.0 t 67.67 21.35 9.35 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.932 1.293 . . . . 73.21 110.989 -176.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -102.58 -23.04 13.91 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.349 1.46 . . . . 75.11 108.579 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.524 ' HB3' ' HA ' ' A' ' 187' ' ' SER . 30.2 p-10 -75.26 175.74 8.04 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-N 113.869 -1.514 . . . . 74.31 110.443 170.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 32.2 tp -152.31 138.64 18.46 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.597 -0.729 . . . . 53.21 109.246 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.415 ' HD2' ' HZ3' ' A' ' 232' ' ' LYS . 32.4 m-85 -116.01 139.29 50.41 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.581 0.753 . . . . 74.41 109.51 173.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -147.91 157.3 43.45 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.426 -0.953 . . . . 74.22 108.426 169.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 26.6 p -81.44 153.45 26.89 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 121.887 0.851 . . . . 75.52 111.272 164.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.583 HD13 ' HB3' ' A' ' 212' ' ' ALA . 37.3 tp -125.31 131.54 53.03 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 113.345 -1.752 . . . . 74.44 106.755 167.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.425 ' HB2' HG23 ' A' ' 256' ' ' THR . 5.7 p-10 -93.43 114.65 27.1 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 107.554 -1.276 . . . . 65.42 107.554 -178.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.548 HG23 HG23 ' A' ' 210' ' ' VAL . 55.0 t -121.05 131.04 24.59 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 114.85 -1.068 . . . . 63.42 109.198 -177.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . 0.406 ' HD2' ' HB ' ' A' ' 203' ' ' ILE . 20.8 Cg_exo -66.97 148.25 81.57 Favored 'Trans proline' 0 C--N 1.369 1.63 0 C-N-CA 122.321 2.014 . . . . 72.54 110.951 169.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.436 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.62 -45.88 98.48 Favored Pre-proline 0 CA--C 1.562 1.423 0 CA-C-O 118.38 -0.819 . . . . 73.3 112.205 172.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 20.6 Cg_endo -59.6 -31.14 93.93 Favored 'Trans proline' 0 C--N 1.396 3.053 0 C-N-CA 122.096 1.864 . . . . 74.0 112.814 176.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.406 ' HB ' ' HD2' ' A' ' 200' ' ' PRO . 1.8 mp -87.71 -24.55 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 109.52 -0.548 . . . . 74.21 109.52 -177.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -76.14 -37.3 58.15 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-O 121.064 0.459 . . . . 74.35 110.806 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 23.6 t -88.52 -38.52 11.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 CA-C-N 114.156 -1.384 . . . . 73.11 112.124 -177.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.423 ' HB ' ' O ' ' A' ' 202' ' ' PRO . 72.3 t -98.76 -40.44 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 O-C-N 121.959 -0.463 . . . . 75.25 110.89 -178.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 121.33 150.41 8.32 Favored Glycine 0 N--CA 1.472 1.072 0 N-CA-C 111.311 -0.715 . . . . 71.32 111.311 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 165.65 155.6 8.77 Favored Glycine 0 C--O 1.244 0.773 0 CA-C-N 116.869 0.334 . . . . 62.54 112.473 177.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.613 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 34.6 ttmt -86.33 129.76 34.74 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.106 0.562 . . . . 75.01 109.878 179.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.548 HG23 HG23 ' A' ' 199' ' ' VAL . 10.8 m -131.96 151.94 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 124.467 1.107 . . . . 74.33 108.863 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -93.96 144.14 25.72 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.409 -0.589 . . . . 75.3 109.409 -171.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.583 ' HB3' HD13 ' A' ' 197' ' ' LEU . . . -133.05 125.27 29.26 Favored 'General case' 0 C--N 1.349 0.56 0 N-CA-C 108.907 -0.775 . . . . 75.04 108.907 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 36.5 tpp -78.68 112.74 16.09 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 108.706 -0.85 . . . . 75.4 108.706 171.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 64.1 p -119.59 -175.01 2.86 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 123.71 0.804 . . . . 72.14 110.222 -176.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.524 HD23 ' HD3' ' A' ' 241' ' ' PRO . 67.2 tp -47.08 -52.93 13.93 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.239 1.016 . . . . 75.23 112.456 175.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -72.51 -27.85 62.51 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.178 -0.919 . . . . 74.52 110.977 -172.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 138.22 -165.26 25.48 Favored Glycine 0 C--N 1.34 0.794 0 N-CA-C 111.581 -0.608 . . . . 74.5 111.581 -172.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -66.18 131.15 25.96 Favored 'Trans proline' 0 C--N 1.37 1.707 0 C-N-CA 122.347 2.031 . . . . 73.23 110.779 177.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 29.4 m -130.93 161.12 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.642 0.777 . . . . 75.14 110.148 -178.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.504 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 43.7 mt-10 -111.65 111.94 23.29 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.742 0.817 . . . . 71.25 108.906 -175.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.416 HG23 HG13 ' A' ' 168' ' ' VAL . 57.4 t -121.75 103.76 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 124.164 0.986 . . . . 74.1 110.11 -171.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.613 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -78.32 118.29 20.37 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.437 0.695 . . . . 74.23 110.666 176.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 35.7 m -89.09 151.29 46.65 Favored Pre-proline 0 N--CA 1.481 1.093 0 C-N-CA 122.869 0.468 . . . . 72.21 110.975 -176.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . 0.666 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 28.6 Cg_endo -61.38 164.54 14.95 Favored 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 122.724 2.283 . . . . 73.32 113.102 176.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -91.75 37.65 0.28 Allowed 'Trans proline' 0 C--N 1.373 1.85 0 C-N-CA 123.427 2.751 . . . . 75.3 112.066 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 -148.37 -9.58 0.37 Allowed 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 116.579 -0.282 . . . . 74.45 111.356 176.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.666 ' HB ' ' HG2' ' A' ' 224' ' ' PRO . 0.7 OUTLIER -59.62 154.15 18.34 Favored 'General case' 0 CA--C 1.559 1.318 0 O-C-N 124.102 0.876 . . . . 74.44 110.633 -161.665 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . 0.46 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 4.5 pt20 -134.53 162.28 32.7 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.317 0.647 . . . . 74.23 110.371 -172.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -58.6 112.81 1.74 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 122.985 0.514 . . . . 73.4 110.841 177.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.52 1.6 21.53 Favored Glycine 0 CA--C 1.522 0.492 0 CA-C-N 115.135 -0.938 . . . . 65.32 111.877 178.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.46 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -69.82 125.52 26.97 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.121 0.569 . . . . 73.42 109.698 -175.769 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.461 ' HZ2' ' HB2' ' A' ' 252' ' ' GLU . 71.6 mmtt -97.09 100.6 12.09 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 109.241 -0.652 . . . . 72.42 109.241 -176.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.471 ' HB3' ' HA ' ' A' ' 172' ' ' SER . 39.7 mt -78.4 102.22 7.66 Favored 'General case' 0 C--N 1.341 0.236 0 N-CA-C 108.208 -1.034 . . . . 75.13 108.208 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . 0.62 ' HD2' ' H ' ' A' ' 234' ' ' ARG . 0.0 OUTLIER -79.98 117.73 21.09 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 124.733 1.271 . . . . 75.13 111.836 -174.773 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.609 ' HB3' ' HB2' ' A' ' 238' ' ' LYS . 8.2 mp -107.68 128.08 54.24 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 106.907 -1.516 . . . . 74.31 106.907 173.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -101.52 116.81 33.61 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.753 0.821 . . . . 72.23 111.441 -174.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 74.63 27.72 64.66 Favored Glycine 0 C--N 1.351 1.401 0 O-C-N 123.895 0.747 . . . . 62.31 111.857 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.609 ' HB2' ' HB3' ' A' ' 235' ' ' LEU . 28.7 mmmt -126.29 22.11 7.2 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.365 1.066 . . . . 73.23 111.134 -175.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -93.93 -128.31 5.04 Favored Glycine 0 C--N 1.341 0.815 0 N-CA-C 110.22 -1.152 . . . . 64.52 110.22 176.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . 0.452 ' O ' ' HA ' ' A' ' 246' ' ' ARG . 6.6 m-30 -70.08 153.81 95.06 Favored Pre-proline 0 CA--C 1.551 0.992 0 CA-C-N 117.65 0.725 . . . . 74.51 111.714 176.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.524 ' HD3' HD23 ' A' ' 215' ' ' LEU . 60.4 Cg_endo -68.35 171.73 12.38 Favored 'Trans proline' 0 C--N 1.381 2.239 0 C-N-CA 123.38 2.72 . . . . 71.11 112.078 178.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.432 ' N ' ' HD2' ' A' ' 243' ' ' PRO . . . -67.59 -39.55 90.75 Favored Glycine 0 CA--C 1.543 1.834 0 CA-C-O 118.4 -1.222 . . . . 73.43 114.634 -176.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 242' ' ' GLY . 9.1 Cg_endo -51.88 -38.81 68.94 Favored 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 122.698 2.265 . . . . 75.32 113.225 167.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -78.68 -25.29 44.81 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.449 0.699 . . . . 74.23 110.66 175.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 106.1 112.77 3.73 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 109.084 -1.606 . . . . 74.05 109.084 -168.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.452 ' HA ' ' O ' ' A' ' 240' ' ' PHE . 52.7 ttp180 -72.22 127.06 31.37 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 117.266 0.533 . . . . 74.33 110.977 -175.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.409 ' HA2' ' HA3' ' A' ' 186' ' ' GLY . . . -136.56 -157.18 7.65 Favored Glycine 0 C--O 1.239 0.452 0 CA-C-N 115.575 -0.739 . . . . 63.22 111.718 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -116.29 166.14 12.38 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.872 0.869 . . . . 72.41 109.028 -174.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 10.6 tp -134.78 134.14 40.6 Favored 'General case' 0 C--O 1.213 -0.827 0 N-CA-C 108.333 -0.988 . . . . 75.11 108.333 -176.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.445 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 8.1 m-85 -121.97 146.23 47.35 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 108.943 -0.762 . . . . 72.34 108.943 -177.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.426 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 77.6 mt -124.64 115.52 20.93 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.917 -0.772 . . . . 74.23 108.917 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . 0.461 ' HB2' ' HZ2' ' A' ' 232' ' ' LYS . 35.4 tt0 -88.94 106.71 18.59 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 107.873 -1.158 . . . . 72.4 107.873 -173.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.631 HG13 HG21 ' A' ' 227' ' ' THR . 52.7 t -59.93 125.26 15.74 Favored 'Isoleucine or valine' 0 C--N 1.34 0.184 0 O-C-N 124.09 0.869 . . . . 75.1 109.439 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -120.78 124.35 44.87 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.212 -1.403 . . . . 74.34 107.212 176.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 51.1 mm -85.75 118.45 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 O-C-N 124.124 0.89 . . . . 74.21 109.414 -173.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' THR . . . . . 0.425 HG23 ' HB2' ' A' ' 198' ' ' ASP . 1.0 OUTLIER . . . . . 0 CA--C 1.554 1.107 0 N-CA-C 108.582 -0.896 . . . . 73.53 108.582 -171.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' MET . . . . . 0.608 ' HG2' ' HG3' ' A' ' 164' ' ' LYS . 1.3 pmm? . . . . . 0 CA--C 1.545 0.768 0 N-CA-C 109.397 -0.594 . . . . 74.43 109.397 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.608 ' HG3' ' HG2' ' A' ' 163' ' ' MET . 0.0 OUTLIER -159.74 103.68 1.54 Allowed 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 124.132 0.973 . . . . 73.42 109.522 176.877 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -85.94 -41.01 15.28 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.911 0.884 . . . . 71.45 110.677 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -97.24 37.8 3.32 Favored Glycine 0 N--CA 1.471 0.986 0 CA-C-N 115.587 -0.733 . . . . 65.14 111.98 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.568 ' HB2' ' HB2' ' A' ' 164' ' ' LYS . . . -152.9 166.07 33.47 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.744 0.817 . . . . 75.14 110.124 177.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.467 HG13 HG22 ' A' ' 221' ' ' VAL . 54.9 t -111.23 156.45 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 124.701 1.201 . . . . 72.45 111.765 -167.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 44.1 mtm -98.75 -176.75 3.44 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.651 1.581 . . . . 72.13 109.651 -174.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 8.3 p -99.98 89.04 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 CA-C-O 122.964 1.364 . . . . 74.42 108.592 163.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' MET . . . . . 0.421 ' HG3' ' HA ' ' A' ' 235' ' ' LEU . 0.0 OUTLIER -123.76 -6.09 8.01 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 113.946 -1.479 . . . . 72.25 110.789 -174.478 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.47 ' HB3' HD23 ' A' ' 233' ' ' LEU . 66.1 m -39.64 -66.45 0.3 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.545 1.938 . . . . 75.02 114.638 -167.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -66.72 -48.45 69.15 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 122.603 0.361 . . . . 74.24 110.068 -175.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 49.4 59.77 6.84 Favored Glycine 0 C--N 1.357 1.704 0 O-C-N 124.377 1.048 . . . . 74.33 113.181 176.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -54.66 96.82 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.043 0.937 . . . . 62.22 111.535 -171.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 43.4 m -82.64 87.97 6.71 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 109.305 -0.628 . . . . 42.52 109.305 178.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -78.13 -30.43 49.32 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 122.067 0.937 . . . . 72.23 108.854 172.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -80.48 173.56 12.48 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 113.939 -1.482 . . . . 71.44 111.243 178.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -58.33 -26.93 63.67 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.323 1.049 . . . . 74.21 112.624 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -65.5 76.0 0.1 OUTLIER Glycine 0 N--CA 1.473 1.13 0 O-C-N 123.896 0.747 . . . . 73.03 113.265 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 31.8 m -129.27 -2.26 5.03 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.293 1.037 . . . . 73.21 111.371 -174.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -74.02 113.3 4.1 Favored Glycine 0 CA--C 1.533 1.18 0 CA-C-O 119.484 -0.62 . . . . 35.1 112.053 -178.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -69.43 78.4 0.33 Allowed Glycine 0 C--N 1.355 1.613 0 C-N-CA 123.454 0.55 . . . . 62.45 112.115 178.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 22.7 p -142.29 100.59 3.74 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.998 0.919 . . . . 72.12 108.949 -174.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -76.28 105.67 2.03 Favored Glycine 0 C--N 1.345 1.029 0 CA-C-N 116.582 -0.281 . . . . 64.53 112.642 -176.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 63.12 -118.68 14.59 Favored Glycine 0 C--N 1.343 0.967 0 N-CA-C 111.977 -0.449 . . . . 72.02 111.977 -176.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 33.7 t -95.3 -18.67 20.61 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.597 0.759 . . . . 74.14 110.033 173.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.403 ' HA2' ' HB2' ' A' ' 192' ' ' ASP . . . 70.9 19.22 76.8 Favored Glycine 0 C--N 1.351 1.377 0 N-CA-C 114.703 0.641 . . . . 74.44 114.703 176.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -77.99 -71.77 1.2 Allowed Glycine 0 C--N 1.353 1.485 0 CA-C-N 117.336 0.568 . . . . 70.01 112.037 179.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 29.0 m -142.34 29.41 1.61 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.167 0.987 . . . . 72.31 108.629 173.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.519 ' HG2' ' HA3' ' A' ' 245' ' ' GLY . 45.2 mt-30 -113.74 -32.93 5.98 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 114.817 -1.083 . . . . 71.01 110.47 -172.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.403 ' HB2' ' HA2' ' A' ' 188' ' ' GLY . 44.9 t0 -75.4 162.08 28.68 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 114.806 -1.088 . . . . 73.23 109.182 176.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.423 HD21 HD11 ' A' ' 249' ' ' LEU . 52.7 tp -149.96 136.52 19.14 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.128 -0.693 . . . . 71.53 109.128 171.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -113.17 139.58 48.64 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.011 -0.737 . . . . 74.54 109.011 170.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.469 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -148.38 155.05 40.76 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.491 0.716 . . . . 73.1 109.338 173.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 25.2 p -82.0 153.62 26.11 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 122.085 0.945 . . . . 75.45 112.774 171.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.589 HD13 ' HB3' ' A' ' 212' ' ' ALA . 39.3 tp -126.97 132.26 50.86 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 113.108 -1.86 . . . . 74.32 106.642 169.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -95.13 111.59 23.39 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.068 -1.086 . . . . 73.24 108.068 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.508 HG22 HG21 ' A' ' 210' ' ' VAL . 46.8 t -114.84 131.91 23.22 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-N 114.663 -1.153 . . . . 74.42 109.299 -178.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -68.59 145.3 63.61 Favored 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 122.229 1.953 . . . . 73.12 110.934 168.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.431 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.86 -45.56 98.82 Favored Pre-proline 0 CA--C 1.564 1.493 0 O-C-N 123.961 0.788 . . . . 71.12 111.845 174.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 19.6 Cg_endo -58.97 -32.9 98.38 Favored 'Trans proline' 0 C--N 1.403 3.442 0 C-N-CA 122.155 1.903 . . . . 71.52 112.777 175.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.7 mp -86.0 -24.85 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 109.509 -0.552 . . . . 75.42 109.509 -176.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -73.22 -37.71 66.32 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 122.942 0.497 . . . . 64.44 110.943 178.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 21.0 t -87.78 -37.28 10.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-N 114.426 -1.261 . . . . 74.34 112.981 -178.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 53.4 t -96.62 -42.2 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 O-C-N 122.203 -0.311 . . . . 71.32 110.484 -175.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 121.2 145.46 7.22 Favored Glycine 0 C--N 1.339 0.743 0 N-CA-C 110.76 -0.936 . . . . 73.11 110.76 -176.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 166.13 155.72 8.98 Favored Glycine 0 C--O 1.246 0.906 0 CA-C-O 121.29 0.383 . . . . 63.03 112.538 178.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.612 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 36.8 ttmt -86.32 131.73 34.14 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.564 0.745 . . . . 73.45 109.685 178.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.508 HG21 HG22 ' A' ' 199' ' ' VAL . 14.2 m -129.2 149.23 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 124.165 0.986 . . . . 71.22 109.197 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . 0.405 ' HD2' ' N ' ' A' ' 212' ' ' ALA . 4.4 tmm_? -95.98 141.55 29.26 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 108.918 -0.771 . . . . 72.31 108.918 -170.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.589 ' HB3' HD13 ' A' ' 197' ' ' LEU . . . -132.64 116.17 16.32 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.501 1.12 . . . . 61.35 109.223 -175.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 38.1 tpp -78.85 108.7 12.49 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 107.612 -1.255 . . . . 75.4 107.612 172.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 71.3 p -114.48 -175.17 2.62 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.811 0.844 . . . . 75.42 110.611 -175.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.567 HD21 ' HD3' ' A' ' 241' ' ' PRO . 61.8 tp -45.01 -52.4 8.9 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.757 1.223 . . . . 70.0 112.091 173.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -72.11 -28.08 63.06 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 114.189 -1.369 . . . . 65.02 111.031 -171.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 135.02 -166.23 24.43 Favored Glycine 0 C--O 1.243 0.717 0 CA-C-N 115.509 -0.769 . . . . 74.25 111.304 -173.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.0 131.43 23.83 Favored 'Trans proline' 0 C--N 1.363 1.3 0 C-N-CA 122.352 2.035 . . . . 73.15 111.672 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 28.9 m -134.26 157.76 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.749 0.82 . . . . 72.14 109.981 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.484 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 38.7 mt-10 -114.28 115.56 27.61 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.641 0.776 . . . . 73.51 110.568 -176.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.467 HG22 HG13 ' A' ' 168' ' ' VAL . 98.3 t -121.74 105.29 16.22 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 125.366 1.466 . . . . 75.21 110.245 -168.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.612 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -76.3 118.47 19.05 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 122.425 0.29 . . . . 72.42 110.621 176.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 35.0 m -87.25 151.72 51.67 Favored Pre-proline 0 N--CA 1.489 1.496 0 C-N-CA 123.178 0.591 . . . . 75.34 110.673 -178.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . 0.671 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 26.1 Cg_endo -61.06 163.59 16.31 Favored 'Trans proline' 0 C--N 1.38 2.215 0 C-N-CA 122.706 2.271 . . . . 64.4 113.193 177.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -87.27 34.02 0.43 Allowed 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 122.951 2.434 . . . . 74.12 112.572 178.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -149.73 -3.35 0.4 Allowed 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 112.321 0.489 . . . . 73.05 112.321 177.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.671 ' HB ' ' HG2' ' A' ' 224' ' ' PRO . 0.7 OUTLIER -61.97 154.34 26.75 Favored 'General case' 0 CA--C 1.563 1.461 0 O-C-N 123.304 0.377 . . . . 74.55 111.788 -165.099 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -136.82 161.04 37.08 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.472 0.709 . . . . 73.54 110.193 -178.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -58.56 113.12 1.85 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.45 0.7 . . . . 75.15 111.175 -177.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 116.69 0.31 19.96 Favored Glycine 0 CA--C 1.524 0.616 0 CA-C-N 115.064 -0.971 . . . . 73.44 112.395 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.417 ' HE ' HD22 ' A' ' 233' ' ' LEU . 0.0 OUTLIER -68.97 130.76 43.69 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 109.076 -0.713 . . . . 72.24 109.076 -176.396 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -97.76 96.18 8.06 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 109.018 -0.734 . . . . 74.11 109.018 -168.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.47 HD23 ' HB3' ' A' ' 172' ' ' SER . 24.4 mt -82.6 97.62 8.58 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 106.694 -1.595 . . . . 72.2 106.694 -178.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 3.5 ppt_? -83.23 125.29 31.42 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 123.97 0.794 . . . . 73.53 110.988 -179.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.421 ' HA ' ' HG3' ' A' ' 171' ' ' MET . 7.3 mp -110.02 126.65 54.2 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 106.286 -1.746 . . . . 74.24 106.286 177.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 11.3 tptp -98.6 115.28 28.29 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 110.048 -0.353 . . . . 75.4 110.048 -170.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.612 ' HA2' HH11 ' A' ' 246' ' ' ARG . . . 79.66 23.35 62.48 Favored Glycine 0 C--N 1.343 0.951 0 O-C-N 123.836 0.71 . . . . 40.14 113.65 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? -122.72 23.93 9.31 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.296 0.638 . . . . 75.33 111.292 -177.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . 0.43 ' HA2' ' HB2' ' A' ' 249' ' ' LEU . . . -93.79 -130.96 5.86 Favored Glycine 0 C--N 1.349 1.261 0 CA-C-O 119.296 -0.725 . . . . 74.23 111.919 -178.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -69.29 149.21 97.44 Favored Pre-proline 0 CA--C 1.553 1.093 0 CA-C-N 117.366 0.583 . . . . 74.15 111.53 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.567 ' HD3' HD21 ' A' ' 215' ' ' LEU . 44.1 Cg_endo -63.62 171.78 6.51 Favored 'Trans proline' 0 C--N 1.391 2.764 0 C-N-CA 123.574 2.849 . . . . 74.22 112.565 -178.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -66.02 -42.95 94.38 Favored Glycine 0 CA--C 1.544 1.849 0 CA-C-O 118.223 -1.321 . . . . 74.11 114.098 -173.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -58.92 -34.75 99.24 Favored 'Trans proline' 0 C--N 1.388 2.644 0 CA-C-N 120.812 2.306 . . . . 74.22 113.785 170.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -77.14 -24.54 51.61 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.18 0.592 . . . . 72.31 110.37 173.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . 0.519 ' HA3' ' HG2' ' A' ' 191' ' ' GLN . . . 110.51 117.74 3.84 Favored Glycine 0 C--N 1.344 0.973 0 N-CA-C 110.532 -1.027 . . . . 74.34 110.532 -172.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.612 HH11 ' HA2' ' A' ' 237' ' ' GLY . 2.3 tmm_? -68.6 124.74 24.43 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.18 -0.674 . . . . 74.42 109.18 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -143.12 -156.2 6.7 Favored Glycine 0 N--CA 1.47 0.943 0 O-C-N 123.517 0.511 . . . . 74.31 112.109 176.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -115.53 167.05 11.23 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 109.112 -0.699 . . . . 62.32 109.112 -176.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.43 ' HB2' ' HA2' ' A' ' 239' ' ' GLY . 17.9 tp -134.48 133.07 39.99 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 108.499 -0.926 . . . . 74.24 108.499 -175.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -114.06 147.6 38.45 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 123.598 0.759 . . . . 73.22 110.245 178.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.469 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 88.9 mt -125.65 113.85 17.91 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 114.017 -1.447 . . . . 64.24 107.511 174.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -89.73 112.64 23.98 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 107.671 -1.233 . . . . 75.42 107.671 -176.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.558 HG13 HG21 ' A' ' 227' ' ' THR . 54.6 t -59.65 127.31 18.79 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.117 0 O-C-N 124.46 1.1 . . . . 70.31 109.75 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 8.3 mmt180 -123.96 123.45 40.41 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.251 -1.018 . . . . 75.12 108.251 175.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 46.2 mm -87.15 118.73 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 123.258 0.623 . . . . 75.41 110.033 -174.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.4 t . . . . . 0 CA--C 1.56 1.357 0 C-N-CA 123.546 0.738 . . . . 62.41 109.251 -171.555 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.485 1.282 0 N-CA-C 110.323 -0.251 . . . . 74.55 110.323 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -67.1 96.5 0.45 Allowed 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 109.135 -0.691 . . . . 72.44 109.135 179.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -77.72 -69.46 0.54 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.572 0.749 . . . . 75.42 111.414 -168.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -98.66 30.47 9.62 Favored Glycine 0 N--CA 1.473 1.149 0 N-CA-C 111.281 -0.727 . . . . 73.11 111.281 173.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -142.92 167.4 22.17 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.942 1.297 . . . . 71.1 108.714 -178.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 47.5 t -113.2 155.61 14.36 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 123.748 0.819 . . . . 73.03 111.596 -173.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 47.9 mtm -99.11 -175.62 3.08 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 126.183 1.793 . . . . 75.42 109.703 -171.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 14.3 p -95.63 87.81 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.351 0 N-CA-C 107.107 -1.442 . . . . 74.42 107.107 161.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' MET . . . . . 0.403 ' SD ' ' HG ' ' A' ' 235' ' ' LEU . 0.0 OUTLIER -129.96 -4.79 4.52 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 114.211 -1.359 . . . . 74.41 110.9 -174.203 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.451 ' HA ' ' HB3' ' A' ' 233' ' ' LEU . 70.9 m -40.17 -65.13 0.43 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.666 1.986 . . . . 64.42 113.049 -171.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -73.45 -50.22 22.8 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 107.518 -1.29 . . . . 72.33 107.518 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 54.87 20.29 18.43 Favored Glycine 0 C--N 1.365 2.189 0 O-C-N 124.636 1.21 . . . . 73.23 115.494 172.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -132.33 156.24 46.96 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.81 0.844 . . . . 72.21 109.615 -167.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 51.0 m -68.65 127.15 32.02 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 108.401 -0.962 . . . . 75.23 108.401 169.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -24.11 -34.42 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 C-N-CA 128.227 2.611 . . . . 74.34 117.678 -171.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -62.38 173.1 1.28 Allowed 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.785 0.834 . . . . 74.11 111.765 171.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -55.76 -35.74 66.55 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 120.809 0.338 . . . . 72.34 111.478 177.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 56.79 -129.45 49.06 Favored Glycine 0 C--N 1.338 0.666 0 CA-C-N 114.805 -1.089 . . . . 72.15 113.825 171.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 21.5 t -170.9 -158.13 0.14 Allowed 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 124.764 1.226 . . . . 72.43 107.95 177.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 96.88 112.3 2.9 Favored Glycine 0 C--N 1.347 1.184 0 N-CA-C 111.156 -0.778 . . . . 61.3 111.156 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.594 ' HA2' ' HG2' ' A' ' 234' ' ' ARG . . . -167.71 -96.84 0.11 Allowed Glycine 0 C--N 1.346 1.088 0 CA-C-O 119.966 -0.352 . . . . 50.23 112.457 -177.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 15.7 m -66.27 122.58 17.81 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.942 0.897 . . . . 73.21 111.461 -173.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.479 ' HA3' ' HZ3' ' A' ' 236' ' ' LYS . . . -156.99 155.17 26.15 Favored Glycine 0 C--N 1.336 0.549 0 N-CA-C 110.755 -0.938 . . . . 74.31 110.755 175.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.407 ' O ' ' HB2' ' A' ' 191' ' ' GLN . . . 49.16 33.77 15.62 Favored Glycine 0 C--N 1.352 1.438 0 O-C-N 123.827 0.369 . . . . 41.32 112.893 -178.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 54.1 p -86.01 130.83 34.42 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 122.987 0.515 . . . . 74.33 110.189 -173.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -174.58 -140.65 3.36 Favored Glycine 0 C--N 1.345 1.071 0 CA-C-O 119.712 -0.493 . . . . 72.13 112.442 -178.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -65.64 -49.89 57.36 Favored Glycine 0 C--N 1.35 1.327 0 O-C-N 123.753 0.325 . . . . 52.51 113.379 -174.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 78.5 p -162.74 58.84 0.21 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.635 0.774 . . . . 73.03 109.813 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.41 ' HG2' ' HA3' ' A' ' 245' ' ' GLY . 21.9 mt-30 -114.53 -57.3 2.29 Favored 'General case' 0 C--O 1.245 0.819 0 N-CA-C 108.252 -1.018 . . . . 75.31 108.252 175.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 29.2 p-10 -74.17 167.64 21.17 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 114.722 -1.126 . . . . 52.34 110.548 174.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 52.8 tp -150.65 139.64 21.0 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.449 -0.796 . . . . 75.22 109.821 177.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -110.03 138.77 45.94 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 123.869 0.867 . . . . 74.34 109.509 171.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -148.05 157.78 43.7 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 108.185 -1.043 . . . . 63.12 108.185 168.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' THR . . . . . 0.435 HG22 ' HB3' ' A' ' 252' ' ' GLU . 27.8 p -92.87 152.58 19.32 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.957 0.884 . . . . 74.43 112.242 168.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.619 HD12 ' HB3' ' A' ' 212' ' ' ALA . 41.1 tp -123.86 130.79 53.17 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 113.073 -1.876 . . . . 74.34 106.826 167.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.417 ' HB2' HG22 ' A' ' 256' ' ' THR . 10.0 p-10 -94.63 112.39 24.14 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 121.951 0.881 . . . . 72.34 109.047 -178.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.574 HG22 HG23 ' A' ' 210' ' ' VAL . 61.0 t -119.35 132.81 23.85 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 124.119 0.968 . . . . 61.21 109.903 -175.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -68.46 144.35 60.96 Favored 'Trans proline' 0 C--N 1.369 1.608 0 C-N-CA 121.999 1.799 . . . . 70.1 111.337 167.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.432 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.0 -43.62 94.97 Favored Pre-proline 0 CA--C 1.559 1.301 0 CA-C-O 118.104 -0.95 . . . . 73.44 112.601 173.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 19.3 Cg_endo -56.86 -33.61 95.1 Favored 'Trans proline' 0 C--N 1.399 3.237 0 C-N-CA 121.728 1.618 . . . . 73.22 112.631 173.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -86.71 -24.25 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 N-CA-C 109.623 -0.51 . . . . 61.5 109.623 -177.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -73.5 -37.59 65.63 Favored 'General case' 0 C--O 1.246 0.89 0 C-N-CA 123.335 0.654 . . . . 62.32 110.866 178.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 41.4 t -90.04 -34.67 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.224 0 CA-C-N 113.498 -1.683 . . . . 74.32 113.414 -177.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 54.6 t -101.39 -42.39 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 O-C-N 121.479 -0.763 . . . . 73.41 111.096 -178.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 126.12 155.24 8.89 Favored Glycine 0 C--N 1.34 0.773 0 N-CA-C 110.941 -0.863 . . . . 34.4 110.941 -176.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.64 149.1 5.68 Favored Glycine 0 C--O 1.246 0.894 0 N-CA-C 111.48 -0.648 . . . . 74.5 111.48 176.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.579 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 34.3 ttpt -84.71 129.83 34.78 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 109.267 -0.642 . . . . 75.52 109.267 174.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.574 HG23 HG22 ' A' ' 199' ' ' VAL . 9.7 m -133.37 147.93 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 124.013 0.925 . . . . 71.43 108.77 -178.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . 0.42 ' HD2' ' N ' ' A' ' 212' ' ' ALA . 6.4 tmm_? -94.77 141.79 28.21 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.218 0.607 . . . . 73.01 109.429 -170.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.619 ' HB3' HD12 ' A' ' 197' ' ' LEU . . . -131.18 126.22 35.04 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.495 1.118 . . . . 73.52 108.498 -176.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 37.3 tpp -80.05 108.5 13.69 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 108.083 -1.08 . . . . 75.13 108.083 173.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 71.4 p -117.23 178.8 4.23 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.692 0.797 . . . . 75.02 110.741 -176.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 69.0 tp -45.33 -50.71 11.86 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.17 1.388 . . . . 72.24 112.276 176.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -71.96 -26.69 62.37 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 114.551 -1.204 . . . . 72.13 111.288 -173.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 138.6 -166.53 25.29 Favored Glycine 0 C--N 1.341 0.861 0 N-CA-C 111.389 -0.684 . . . . 74.35 111.389 -177.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -65.33 130.27 24.92 Favored 'Trans proline' 0 C--N 1.368 1.555 0 C-N-CA 121.9 1.733 . . . . 73.12 110.771 174.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 30.2 m -134.74 159.72 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 123.312 0.645 . . . . 74.22 110.532 -174.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.545 ' HB3' ' HD2' ' A' ' 209' ' ' LYS . 44.6 mt-10 -113.42 114.7 26.95 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.344 0.658 . . . . 72.2 109.764 -174.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 54.9 t -122.01 103.74 13.87 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 C-N-CA 125.009 1.324 . . . . 73.34 109.667 -169.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.579 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -77.48 117.88 19.37 Favored 'General case' 0 N--CA 1.478 0.943 0 O-C-N 122.167 -0.333 . . . . 52.12 110.478 175.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 27.5 m -85.23 152.8 58.85 Favored Pre-proline 0 N--CA 1.492 1.66 0 C-N-CA 123.202 0.601 . . . . 73.2 111.157 -176.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . 0.55 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 33.6 Cg_endo -65.99 163.03 32.71 Favored 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 121.75 1.633 . . . . 73.45 112.541 177.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -85.34 27.42 0.6 Allowed 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 122.854 2.369 . . . . 74.52 112.94 178.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 41.5 mmt-85 -144.93 0.11 0.93 Allowed 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.382 0.673 . . . . 70.32 111.447 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.615 HG21 HG13 ' A' ' 253' ' ' VAL . 0.7 OUTLIER -61.65 155.71 21.84 Favored 'General case' 0 CA--C 1.573 1.859 0 O-C-N 123.88 0.738 . . . . 65.25 109.529 -169.191 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . 0.421 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 4.8 pt20 -133.07 162.86 30.59 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.541 0.736 . . . . 73.4 110.844 -174.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -59.38 110.75 1.16 Allowed 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 109.444 -0.576 . . . . 75.34 109.444 171.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 114.35 0.36 23.6 Favored Glycine 0 CA--C 1.524 0.61 0 CA-C-N 115.379 -0.828 . . . . 75.12 111.686 178.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.421 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -72.04 125.5 27.4 Favored 'General case' 0 C--N 1.359 0.99 0 N-CA-C 109.022 -0.733 . . . . 75.4 109.022 -174.141 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -98.98 97.7 8.83 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 123.508 0.723 . . . . 75.21 109.457 -169.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.451 ' HB3' ' HA ' ' A' ' 172' ' ' SER . 30.7 mt -80.38 98.0 7.29 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 107.008 -1.479 . . . . 72.54 107.008 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . 0.594 ' HG2' ' HA2' ' A' ' 183' ' ' GLY . 2.0 ppt_? -83.61 117.37 23.12 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 121.493 0.663 . . . . 74.11 111.417 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.403 ' HG ' ' SD ' ' A' ' 171' ' ' MET . 6.3 mp -99.17 125.8 44.82 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 105.479 -2.045 . . . . 74.11 105.479 174.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.479 ' HZ3' ' HA3' ' A' ' 185' ' ' GLY . 18.3 tptt -101.79 117.43 34.84 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 118.657 0.662 . . . . 73.14 111.234 -168.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.459 ' H ' ' HB3' ' A' ' 248' ' ' ASP . . . 78.03 24.6 63.75 Favored Glycine 0 C--N 1.354 1.583 0 O-C-N 123.837 0.711 . . . . 74.34 112.549 -174.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -119.1 20.67 12.61 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.571 0.748 . . . . 75.42 110.943 -175.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -96.83 -139.56 10.69 Favored Glycine 0 C--N 1.346 1.097 0 N-CA-C 111.124 -0.79 . . . . 71.42 111.124 177.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 7.1 m-30 -68.89 149.53 97.85 Favored Pre-proline 0 N--CA 1.478 0.955 0 N-CA-C 112.372 0.508 . . . . 74.23 112.372 -174.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -63.12 170.87 7.02 Favored 'Trans proline' 0 C--N 1.386 2.549 0 C-N-CA 123.488 2.792 . . . . 64.11 112.65 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.426 ' N ' ' HD2' ' A' ' 243' ' ' PRO . . . -66.55 -40.03 94.1 Favored Glycine 0 CA--C 1.551 2.306 0 CA-C-O 118.244 -1.309 . . . . 64.44 114.695 -174.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' A' ' 242' ' ' GLY . 13.1 Cg_endo -56.64 -36.61 98.24 Favored 'Trans proline' 0 C--N 1.391 2.763 0 CA-C-N 120.792 2.296 . . . . 64.03 113.219 169.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -78.28 -25.36 46.67 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.148 0.579 . . . . 72.45 110.414 175.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . 0.41 ' HA3' ' HG2' ' A' ' 191' ' ' GLN . . . 113.18 117.08 3.39 Favored Glycine 0 C--N 1.344 1.007 0 N-CA-C 109.543 -1.423 . . . . 75.54 109.543 -169.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 45.9 ttm105 -72.11 125.98 28.64 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 117.283 0.541 . . . . 75.33 110.4 -178.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -148.54 -158.18 7.89 Favored Glycine 0 C--N 1.331 0.287 0 CA-C-N 116.008 -0.542 . . . . 74.2 112.094 175.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . 0.459 ' HB3' ' H ' ' A' ' 237' ' ' GLY . 0.1 OUTLIER -126.72 166.26 17.71 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.261 1.024 . . . . 73.15 110.526 -174.465 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 7.2 tp -132.86 134.66 44.91 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.667 -0.864 . . . . 72.24 108.667 -167.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -115.18 146.95 40.89 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 108.352 -0.981 . . . . 71.12 108.352 -175.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.416 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 84.6 mt -124.22 113.87 18.86 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 107.94 -1.133 . . . . 73.05 107.94 179.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . 0.435 ' HB3' HG22 ' A' ' 196' ' ' THR . 24.1 tt0 -88.74 110.39 20.96 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 107.698 -1.223 . . . . 72.24 107.698 -176.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.615 HG13 HG21 ' A' ' 227' ' ' THR . 55.5 t -60.77 125.63 17.26 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.263 0 O-C-N 124.116 0.885 . . . . 64.3 109.186 176.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 24.4 mtp85 -122.29 122.97 40.34 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 107.919 -1.141 . . . . 74.24 107.919 178.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.433 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 47.2 mm -85.84 118.67 32.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 O-C-N 123.635 0.584 . . . . 73.42 109.89 -171.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' THR . . . . . 0.417 HG22 ' HB2' ' A' ' 198' ' ' ASP . 1.7 t . . . . . 0 CA--C 1.551 1.008 0 C-N-CA 124.329 1.052 . . . . 74.44 109.357 -171.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' MET . . . . . 0.567 ' HA ' ' SD ' ' A' ' 169' ' ' MET . 21.9 mmt . . . . . 0 N--CA 1.486 1.35 0 N-CA-C 109.087 -0.708 . . . . 72.34 109.087 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -104.13 142.24 34.83 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 109.535 -0.543 . . . . 75.41 109.535 170.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -91.14 -56.01 3.32 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.354 1.062 . . . . 70.15 110.614 -170.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -98.69 16.8 59.22 Favored Glycine 0 C--N 1.343 0.958 0 CA-C-N 116.142 -0.481 . . . . 74.2 113.323 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -152.53 161.26 42.83 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.681 0.792 . . . . 74.41 109.526 -177.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 53.7 t -110.52 147.97 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 CA-C-O 121.885 0.85 . . . . 74.54 111.908 -171.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' MET . . . . . 0.567 ' SD ' ' HA ' ' A' ' 163' ' ' MET . 43.3 mtm -101.62 -176.06 3.03 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 126.625 1.97 . . . . 75.42 109.862 -168.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 10.2 p -99.23 87.14 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 CA-C-O 123.066 1.413 . . . . 73.52 107.534 162.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' MET . . . . . 0.473 ' HE2' HD12 ' A' ' 235' ' ' LEU . 0.0 OUTLIER -122.43 -4.45 8.83 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 113.883 -1.508 . . . . 74.11 110.285 -174.855 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.442 ' HB3' HD21 ' A' ' 233' ' ' LEU . 69.6 m -39.0 -68.3 0.17 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.775 2.03 . . . . 63.34 113.839 -166.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . 0.496 ' HB2' ' HG3' ' A' ' 224' ' ' PRO . 67.2 t80 -69.99 -44.55 69.16 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 109.372 -0.603 . . . . 75.22 109.372 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 64.92 61.37 5.89 Favored Glycine 0 C--N 1.355 1.625 0 CA-C-N 114.807 -1.088 . . . . 73.03 112.206 -177.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . 0.444 ' HB3' ' HD2' ' A' ' 173' ' ' TYR . 4.5 p-10 -79.5 128.96 34.01 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.75 0.786 . . . . 71.13 111.406 -176.221 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 68.9 p -121.08 124.8 45.68 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 106.869 -1.53 . . . . 74.51 106.869 167.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -63.42 -9.09 10.84 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 113.017 0.747 . . . . 71.04 113.017 -177.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -78.17 170.61 16.34 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.192 0.997 . . . . 74.15 110.069 166.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -70.82 -19.82 62.63 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 112.123 0.416 . . . . 72.43 112.123 -174.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -84.53 -150.59 11.89 Favored Glycine 0 CA--C 1.532 1.139 0 O-C-N 123.434 0.459 . . . . 75.31 113.215 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 37.5 t -159.9 -50.51 0.05 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.97 0.908 . . . . 50.4 109.25 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 107.76 114.23 3.8 Favored Glycine 0 C--N 1.344 0.977 0 N-CA-C 110.358 -1.097 . . . . 75.25 110.358 -172.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -153.26 87.61 0.13 Allowed Glycine 0 C--N 1.339 0.708 0 N-CA-C 112.077 -0.409 . . . . 62.32 112.077 -175.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 67.9 m -91.66 179.81 5.55 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.545 0.738 . . . . 74.15 110.357 172.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 177.47 134.33 2.0 Favored Glycine 0 C--N 1.345 1.082 0 N-CA-C 111.716 -0.553 . . . . 74.21 111.716 178.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -78.69 73.93 2.2 Favored Glycine 0 C--N 1.35 1.352 0 C-N-CA 123.435 0.541 . . . . 63.04 112.242 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 14.6 m -63.36 142.06 58.53 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.508 1.123 . . . . 75.35 111.445 -176.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 116.65 -71.11 0.28 Allowed Glycine 0 C--N 1.346 1.131 0 N-CA-C 113.619 0.208 . . . . 62.2 113.619 173.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -87.28 11.59 65.07 Favored Glycine 0 C--N 1.345 1.051 0 CA-C-O 118.726 -1.041 . . . . 62.11 115.166 -168.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 68.1 m 55.73 66.4 1.22 Allowed 'General case' 0 N--CA 1.484 1.244 0 CA-C-O 122.23 1.014 . . . . 75.3 110.489 -173.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -104.92 -24.54 12.84 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 113.767 -1.561 . . . . 74.31 109.439 -178.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -82.95 167.62 17.8 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 114.844 -1.071 . . . . 72.24 109.925 175.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 50.3 tp -150.55 138.73 20.24 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.161 -0.472 . . . . 74.41 109.766 -177.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -117.33 139.45 50.83 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.035 0.934 . . . . 72.43 109.207 172.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -148.39 158.65 44.24 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.737 -0.838 . . . . 72.24 108.737 171.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 33.2 p -80.95 153.63 27.4 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 122.13 0.967 . . . . 74.43 111.802 168.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.611 HD11 ' HB3' ' A' ' 212' ' ' ALA . 38.8 tp -124.09 133.42 53.62 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 112.961 -1.927 . . . . 73.42 106.402 166.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -93.05 114.76 27.39 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.785 -1.191 . . . . 73.53 107.785 178.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.578 HG22 HG23 ' A' ' 210' ' ' VAL . 61.0 t -122.93 130.51 24.58 Favored Pre-proline 0 CA--C 1.542 0.673 0 C-N-CA 124.202 1.001 . . . . 52.33 108.832 179.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -68.48 146.72 69.04 Favored 'Trans proline' 0 C--N 1.363 1.29 0 C-N-CA 122.402 2.068 . . . . 75.2 111.76 168.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.444 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.23 -44.79 98.08 Favored Pre-proline 0 CA--C 1.564 1.507 0 C-N-CA 124.178 0.991 . . . . 63.34 112.25 172.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 19.8 Cg_endo -58.11 -34.68 98.74 Favored 'Trans proline' 0 C--N 1.401 3.294 0 C-N-CA 122.127 1.885 . . . . 72.1 112.58 174.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -85.43 -23.37 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 N-CA-C 109.138 -0.69 . . . . 74.33 109.138 -177.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -74.25 -37.98 63.62 Favored 'General case' 0 C--O 1.247 0.95 0 C-N-CA 123.108 0.563 . . . . 73.22 111.589 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 35.0 t -88.89 -37.88 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 CA-C-N 114.443 -1.253 . . . . 65.15 112.798 -179.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.413 ' HB ' ' O ' ' A' ' 202' ' ' PRO . 54.5 t -95.82 -41.63 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 O-C-N 121.834 -0.541 . . . . 70.13 110.463 -175.234 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 121.59 151.1 8.43 Favored Glycine 0 C--N 1.344 1.012 0 N-CA-C 111.044 -0.822 . . . . 61.44 111.044 -177.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.77 154.48 7.96 Favored Glycine 0 C--O 1.246 0.862 0 N-CA-C 112.253 -0.339 . . . . 71.21 112.253 176.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.592 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 39.1 ttmt -85.32 132.68 34.21 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 123.472 0.709 . . . . 73.32 109.901 175.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.578 HG23 HG22 ' A' ' 199' ' ' VAL . 12.9 m -130.79 153.5 39.24 Favored 'Isoleucine or valine' 0 C--O 1.244 0.807 0 C-N-CA 124.713 1.205 . . . . 73.24 108.607 176.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -93.4 145.05 24.76 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.544 0.737 . . . . 74.32 110.239 -176.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.611 ' HB3' HD11 ' A' ' 197' ' ' LEU . . . -131.06 117.96 19.87 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 107.726 -1.213 . . . . 73.13 107.726 177.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 34.3 tpp -79.66 109.1 13.73 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 107.399 -1.334 . . . . 62.31 107.399 177.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 62.3 p -113.46 -172.38 2.06 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.253 0.621 . . . . 74.21 110.858 -172.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.595 HD21 ' HD3' ' A' ' 241' ' ' PRO . 63.1 tp -46.63 -52.1 14.4 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.561 1.144 . . . . 65.33 111.223 171.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -74.08 -28.96 61.63 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 114.294 -1.321 . . . . 73.31 112.3 -174.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 134.43 -166.72 24.1 Favored Glycine 0 C--N 1.346 1.102 0 CA-C-O 119.33 -0.706 . . . . 73.2 111.589 -173.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -62.32 136.06 57.57 Favored 'Trans proline' 0 C--N 1.372 1.766 0 C-N-CA 122.869 2.379 . . . . 74.3 111.301 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 212' ' ' ALA . 24.3 m -135.34 157.91 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 109.922 -0.399 . . . . 71.32 109.922 -176.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.563 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 44.6 mt-10 -110.01 105.44 14.58 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.773 0.829 . . . . 65.13 109.147 -167.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 58.7 t -122.11 101.98 10.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 115.198 -0.91 . . . . 75.2 109.335 -172.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.592 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -79.21 118.35 21.07 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 109.361 -0.607 . . . . 64.13 109.361 172.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 34.1 m -85.23 152.09 57.75 Favored Pre-proline 0 N--CA 1.482 1.164 0 C-N-CA 123.124 0.57 . . . . 73.32 110.363 -176.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . 0.496 ' HG3' ' HB2' ' A' ' 173' ' ' TYR . 36.2 Cg_endo -62.82 163.37 22.13 Favored 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 122.227 1.951 . . . . 74.14 112.362 176.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -85.37 32.96 0.47 Allowed 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 122.899 2.4 . . . . 74.12 112.729 175.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 13.2 tpt180 -149.41 4.32 0.6 Allowed 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 116.095 -0.502 . . . . 75.42 110.731 175.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.545 HG21 HG13 ' A' ' 253' ' ' VAL . 0.6 OUTLIER -59.94 154.35 19.05 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.896 -0.779 . . . . 74.43 108.896 -169.855 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -131.7 161.39 32.9 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.291 0.636 . . . . 75.03 110.384 -168.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -62.33 109.37 1.32 Allowed 'General case' 0 C--O 1.241 0.62 0 N-CA-C 107.922 -1.14 . . . . 53.45 107.922 167.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 113.85 2.76 23.74 Favored Glycine 0 C--N 1.337 0.589 0 CA-C-N 115.309 -0.859 . . . . 72.41 112.428 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.14 127.08 31.58 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.046 -0.724 . . . . 74.01 109.046 -175.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -99.73 98.19 9.04 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 123.466 0.706 . . . . 73.43 109.353 -171.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.469 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 20.3 mt -82.63 98.62 9.11 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 106.928 -1.508 . . . . 75.42 106.928 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 7.1 ppt_? -83.06 114.0 20.99 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-O 121.349 0.595 . . . . 74.15 111.374 -179.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.473 HD12 ' HE2' ' A' ' 171' ' ' MET . 8.0 mp -104.11 126.67 51.41 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 106.52 -1.659 . . . . 74.51 106.52 174.278 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -102.92 119.05 38.16 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.476 0.71 . . . . 72.34 111.35 -174.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 79.0 31.42 43.33 Favored Glycine 0 C--N 1.354 1.564 0 O-C-N 123.969 0.793 . . . . 63.54 112.309 -175.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -127.98 20.33 6.45 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.389 0.676 . . . . 74.23 111.053 -178.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -98.01 -131.27 7.08 Favored Glycine 0 C--N 1.349 1.267 0 CA-C-O 119.576 -0.569 . . . . 53.22 112.407 -177.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -71.16 155.18 93.45 Favored Pre-proline 0 CA--C 1.55 0.98 0 CA-C-N 117.453 0.627 . . . . 74.34 112.453 -178.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.595 ' HD3' HD21 ' A' ' 215' ' ' LEU . 88.8 Cg_endo -72.99 171.67 17.05 Favored 'Trans proline' 0 C--N 1.387 2.603 0 C-N-CA 123.502 2.801 . . . . 75.51 112.67 -174.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -66.41 -38.72 93.79 Favored Glycine 0 CA--C 1.545 1.958 0 CA-C-O 118.382 -1.232 . . . . 75.43 113.575 -179.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . 0.461 ' HD2' ' HB2' ' A' ' 241' ' ' PRO . 53.5 Cg_exo -46.3 -44.47 20.11 Favored 'Trans proline' 0 C--N 1.385 2.464 0 C-N-CA 123.047 2.498 . . . . 73.54 114.041 163.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -78.73 -23.81 45.22 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.675 0.79 . . . . 74.31 110.765 177.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 105.27 114.49 3.96 Favored Glycine 0 C--N 1.341 0.861 0 N-CA-C 108.458 -1.857 . . . . 74.55 108.458 -165.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.61 124.0 23.74 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.163 0.585 . . . . 72.33 109.53 -172.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -137.8 -156.69 7.28 Favored Glycine 0 N--CA 1.477 1.432 0 CA-C-O 119.886 -0.397 . . . . 34.22 112.305 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 235' ' ' LEU . 6.5 p30 -123.0 167.54 13.47 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.178 0.591 . . . . 71.44 111.706 -175.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 11.7 tp -134.67 134.41 41.09 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.634 0.774 . . . . 65.12 109.265 -170.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 4.2 m-30 -118.94 148.94 42.41 Favored 'General case' 0 C--O 1.25 1.114 0 N-CA-C 108.708 -0.849 . . . . 74.35 108.708 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.469 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 88.4 mt -120.72 124.42 45.12 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.446 -0.576 . . . . 61.43 109.446 -177.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -91.51 100.82 13.51 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 107.197 -1.408 . . . . 75.53 107.197 -177.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.545 HG13 HG21 ' A' ' 227' ' ' THR . 55.7 t -63.15 123.58 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-O 121.488 0.661 . . . . 74.44 110.7 -178.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -114.66 123.5 49.46 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 107.606 -1.257 . . . . 70.51 107.606 177.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 47.0 mm -88.21 111.57 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 O-C-N 123.981 0.801 . . . . 74.22 110.181 -175.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.6 t . . . . . 0 C--O 1.255 1.376 0 C-N-CA 124.143 0.977 . . . . 43.35 110.196 -173.526 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 64.0 mtt . . . . . 0 N--CA 1.48 1.027 0 CA-C-O 120.725 0.298 . . . . 72.42 110.211 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -155.62 85.7 1.05 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.734 1.214 . . . . 74.23 108.829 179.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -53.53 -49.17 68.18 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.687 1.195 . . . . 73.01 112.915 -168.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -97.37 32.92 6.22 Favored Glycine 0 C--N 1.346 1.102 0 CA-C-N 116.207 -0.451 . . . . 54.12 112.852 -176.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -153.48 172.93 16.38 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 123.805 0.842 . . . . 74.51 110.477 177.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 45.7 t -115.33 152.71 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.559 1.143 . . . . 73.45 110.61 178.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 50.6 mtm -98.8 -177.69 3.73 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 125.226 1.41 . . . . 71.51 110.212 -169.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 7.7 p -99.05 87.79 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.065 0 CA-C-O 122.989 1.376 . . . . 75.32 107.49 162.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.1 -4.97 8.97 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 125.495 1.518 . . . . 73.23 109.979 -176.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 69.9 m -36.36 -66.15 0.23 Allowed 'General case' 0 C--N 1.35 0.612 0 C-N-CA 126.906 2.082 . . . . 75.32 114.559 -167.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . 0.424 ' HB2' ' HG3' ' A' ' 224' ' ' PRO . 77.2 t80 -63.22 -49.28 74.79 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 110.1 -0.333 . . . . 73.52 110.1 -177.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 68.21 97.61 0.04 OUTLIER Glycine 0 C--N 1.348 1.249 0 CA-C-N 115.149 -0.932 . . . . 50.24 111.453 -174.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -76.17 -83.1 0.07 Allowed 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 123.068 0.547 . . . . 63.44 111.767 -171.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 58.7 m -121.39 121.32 37.35 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 113.079 0.77 . . . . 72.31 113.079 -172.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -95.95 17.95 14.32 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 124.812 1.245 . . . . 74.42 110.071 165.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -58.19 174.31 0.29 Allowed 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.697 1.199 . . . . 72.23 111.597 169.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -42.59 -27.03 0.14 Allowed 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 126.007 1.723 . . . . 74.42 115.224 -172.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -60.76 -53.87 41.72 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 123.604 0.621 . . . . 74.44 114.483 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 76.7 p -153.43 157.5 40.02 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 122.903 0.481 . . . . 75.13 110.819 -177.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 115.78 -146.18 18.8 Favored Glycine 0 C--N 1.343 0.957 0 N-CA-C 111.274 -0.73 . . . . 70.32 111.274 -178.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 72.32 26.61 71.61 Favored Glycine 0 C--N 1.347 1.151 0 N-CA-C 113.777 0.271 . . . . 71.01 113.777 176.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 24.5 m -144.32 101.81 3.75 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.473 0.709 . . . . 74.25 109.234 179.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.535 ' HA2' ' HE3' ' A' ' 236' ' ' LYS . . . -117.07 159.64 13.9 Favored Glycine 0 C--N 1.337 0.591 0 N-CA-C 111.389 -0.684 . . . . 72.11 111.389 176.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -69.43 -66.09 2.36 Favored Glycine 0 C--N 1.346 1.139 0 N-CA-C 111.298 -0.721 . . . . 33.44 111.298 176.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 88.4 p 56.31 28.0 12.73 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 125.873 1.669 . . . . 75.14 112.628 177.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -114.49 148.24 18.83 Favored Glycine 0 C--N 1.345 1.057 0 CA-C-O 119.456 -0.636 . . . . 54.1 111.532 178.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -58.86 -65.91 3.16 Favored Glycine 0 C--N 1.35 1.33 0 C-N-CA 123.266 0.46 . . . . 54.3 113.159 -174.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 78.3 p -95.03 34.04 1.43 Allowed 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.406 0.682 . . . . 75.54 110.427 176.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.437 ' HG2' ' HA3' ' A' ' 245' ' ' GLY . 70.9 mt-30 -117.9 -45.23 2.68 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.496 0.718 . . . . 73.42 109.675 177.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -77.0 165.09 25.11 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-N 115.051 -0.977 . . . . 61.4 109.625 177.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 35.2 tp -151.47 139.14 19.71 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.933 -0.576 . . . . 73.22 109.841 178.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -116.55 140.21 49.64 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.411 1.084 . . . . 74.33 109.555 174.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -149.59 160.87 43.13 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 123.908 0.883 . . . . 72.21 108.781 168.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 34.7 p -83.91 154.4 23.43 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 121.757 0.789 . . . . 75.33 111.458 163.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.562 HD12 ' HB3' ' A' ' 212' ' ' ALA . 37.4 tp -121.11 132.05 54.63 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 113.768 -1.56 . . . . 72.41 107.152 162.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -93.18 111.36 22.97 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 108.248 -1.019 . . . . 74.0 108.248 -178.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.567 HG22 HG23 ' A' ' 210' ' ' VAL . 56.4 t -120.36 131.73 24.34 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 123.87 0.868 . . . . 74.13 108.892 -178.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -66.49 148.19 83.45 Favored 'Trans proline' 0 C--N 1.369 1.631 0 C-N-CA 121.957 1.771 . . . . 72.11 111.253 168.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.45 ' HB2' ' HD3' ' A' ' 202' ' ' PRO . . . -53.77 -46.78 98.27 Favored Pre-proline 0 CA--C 1.56 1.336 0 CA-C-O 118.609 -0.71 . . . . 75.44 111.523 174.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.45 ' HD3' ' HB2' ' A' ' 201' ' ' ALA . 73.0 Cg_exo -51.37 -39.62 63.14 Favored 'Trans proline' 0 C--N 1.396 3.061 0 C-N-CA 122.744 2.296 . . . . 73.24 114.08 172.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -84.99 -24.73 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 N-CA-C 109.525 -0.546 . . . . 73.44 109.525 -174.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -74.21 -37.95 63.73 Favored 'General case' 0 C--O 1.247 0.955 0 CA-C-O 121.548 0.69 . . . . 73.42 111.552 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 14.1 t -88.14 -38.49 11.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 113.798 -1.547 . . . . 70.43 112.008 -177.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 90.3 t -97.15 -41.73 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 122.931 0.493 . . . . 71.51 110.37 -174.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 120.85 145.97 7.42 Favored Glycine 0 C--N 1.35 1.311 0 N-CA-C 110.803 -0.919 . . . . 73.14 110.803 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 166.96 154.66 8.55 Favored Glycine 0 C--O 1.247 0.959 0 CA-C-N 117.202 0.501 . . . . 63.21 112.715 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.636 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 38.8 ttmt -85.65 129.84 34.72 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.627 0.771 . . . . 72.51 110.09 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.567 HG23 HG22 ' A' ' 199' ' ' VAL . 14.0 m -131.05 151.46 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 123.917 0.887 . . . . 72.31 109.753 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -95.02 141.51 28.59 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 109.034 -0.728 . . . . 75.11 109.034 -172.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.562 ' HB3' HD12 ' A' ' 197' ' ' LEU . . . -132.37 120.96 22.74 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.841 0.856 . . . . 74.04 108.831 -176.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 34.6 tpp -77.79 110.16 12.42 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 108.625 -0.88 . . . . 73.03 108.625 173.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 61.0 p -116.92 -179.55 3.72 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.827 0.851 . . . . 75.41 110.068 -177.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.514 HD21 ' HD3' ' A' ' 241' ' ' PRO . 65.7 tp -46.03 -52.05 12.57 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.544 1.138 . . . . 72.51 112.159 175.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -72.97 -26.81 61.5 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.533 1.133 . . . . 62.41 111.738 -174.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 139.19 -166.61 25.42 Favored Glycine 0 C--N 1.343 0.941 0 CA-C-O 119.437 -0.646 . . . . 63.51 111.981 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.28 129.73 23.56 Favored 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 122.026 1.817 . . . . 74.25 111.021 175.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 24.7 m -130.37 160.84 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 123.363 0.665 . . . . 73.25 110.227 -177.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.612 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 45.2 mt-10 -112.81 111.42 22.18 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.393 0.677 . . . . 72.1 109.684 -173.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 62.7 t -121.63 103.18 13.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 124.887 1.275 . . . . 74.12 109.43 -173.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.636 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -78.95 118.12 20.67 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 110.004 -0.369 . . . . 72.32 110.004 175.173 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 33.7 m -86.18 150.08 51.39 Favored Pre-proline 0 N--CA 1.485 1.298 0 C-N-CA 122.936 0.494 . . . . 72.21 110.516 -177.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . 0.47 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 24.1 Cg_endo -62.66 163.1 22.46 Favored 'Trans proline' 0 C--N 1.384 2.411 0 C-N-CA 122.431 2.088 . . . . 73.15 112.912 178.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -83.85 35.58 0.56 Allowed 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 123.225 2.617 . . . . 74.35 112.945 177.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -150.6 -4.93 0.32 Allowed 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.06 0.544 . . . . 73.34 111.549 176.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.609 HG21 HG13 ' A' ' 253' ' ' VAL . 0.6 OUTLIER -60.59 151.14 29.61 Favored 'General case' 0 CA--C 1.57 1.735 0 N-CA-C 109.266 -0.642 . . . . 74.4 109.266 -165.529 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . 0.434 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 20.6 pt20 -134.2 162.43 32.16 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.025 0.53 . . . . 74.15 110.368 -170.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -56.53 111.33 0.97 Allowed 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 109.824 -0.436 . . . . 74.13 109.824 175.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 114.82 -0.29 23.01 Favored Glycine 0 C--N 1.337 0.615 0 CA-C-N 115.564 -0.744 . . . . 65.32 112.094 178.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.434 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -72.45 122.72 21.73 Favored 'General case' 0 C--N 1.354 0.782 0 N-CA-C 108.661 -0.866 . . . . 73.22 108.661 -173.808 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 10.8 mmmm -98.35 97.57 8.92 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 109.307 -0.627 . . . . 75.33 109.307 -168.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 22.2 mt -80.5 97.06 6.97 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.14 -1.43 . . . . 74.42 107.14 -177.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.07 117.26 23.31 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.772 -0.649 . . . . 75.24 111.328 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 7.5 mp -97.69 127.55 43.73 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 105.807 -1.923 . . . . 70.35 105.807 171.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.535 ' HE3' ' HA2' ' A' ' 185' ' ' GLY . 15.3 tptt -101.23 115.45 30.53 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.525 0.33 . . . . 72.23 110.478 -167.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 77.84 32.49 45.11 Favored Glycine 0 C--N 1.349 1.281 0 O-C-N 123.922 0.764 . . . . 64.31 112.144 -175.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -125.98 23.41 7.19 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.796 0.838 . . . . 73.04 111.611 -174.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -93.8 -129.44 5.37 Favored Glycine 0 C--N 1.342 0.891 0 N-CA-C 110.916 -0.874 . . . . 71.55 110.916 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 6.9 m-30 -70.89 151.19 95.15 Favored Pre-proline 0 CA--C 1.551 1.011 0 CA-C-N 117.72 0.76 . . . . 72.11 111.678 177.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.514 ' HD3' HD21 ' A' ' 215' ' ' LEU . 60.3 Cg_endo -66.27 172.69 8.5 Favored 'Trans proline' 0 C--N 1.385 2.469 0 C-N-CA 123.561 2.841 . . . . 63.2 112.157 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.419 ' N ' ' HD2' ' A' ' 243' ' ' PRO . . . -66.35 -42.18 94.12 Favored Glycine 0 CA--C 1.545 1.964 0 CA-C-O 118.311 -1.272 . . . . 73.33 114.067 -174.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . 0.419 ' HD2' ' N ' ' A' ' 242' ' ' GLY . 9.3 Cg_endo -53.76 -36.44 82.2 Favored 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 122.74 2.293 . . . . 74.45 113.441 169.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -78.98 -24.07 44.03 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.318 0.647 . . . . 73.44 110.692 174.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . 0.437 ' HA3' ' HG2' ' A' ' 191' ' ' GLN . . . 109.33 116.05 3.84 Favored Glycine 0 C--N 1.344 1.018 0 N-CA-C 109.599 -1.4 . . . . 73.22 109.599 -170.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -72.36 124.48 25.21 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 117.355 0.577 . . . . 72.32 110.402 -178.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -140.07 -157.46 7.25 Favored Glycine 0 N--CA 1.466 0.639 0 N-CA-C 111.044 -0.823 . . . . 72.13 111.044 174.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 8.4 p30 -119.86 167.56 11.99 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 117.515 0.657 . . . . 71.42 110.708 -177.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 9.8 tp -133.53 133.92 42.76 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 108.923 -0.769 . . . . 74.04 108.923 -172.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -115.46 146.05 42.01 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 109.105 -0.702 . . . . 74.5 109.105 -177.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 81.2 mt -125.79 113.09 16.82 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 107.896 -1.15 . . . . 74.34 107.896 178.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -89.6 113.36 24.79 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.846 -0.798 . . . . 74.23 108.846 -177.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.609 HG13 HG21 ' A' ' 227' ' ' THR . 55.8 t -59.36 124.28 13.3 Favored 'Isoleucine or valine' 0 C--N 1.344 0.365 0 O-C-N 124.089 0.868 . . . . 74.14 109.479 178.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 8.4 mmt180 -122.9 122.79 39.47 Favored 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 107.376 -1.342 . . . . 72.13 107.376 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 48.9 mm -84.17 120.67 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 O-C-N 124.216 0.948 . . . . 63.23 110.603 -170.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.4 t . . . . . 0 CA--C 1.558 1.267 0 CA-C-O 118.038 -0.982 . . . . 72.01 109.691 -169.794 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 70.8 mtm . . . . . 0 N--CA 1.482 1.17 0 N-CA-C 109.715 -0.476 . . . . 72.35 109.715 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.408 ' HB2' ' HB2' ' A' ' 167' ' ' ALA . 16.0 ptpt -160.68 114.31 2.07 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.761 0.824 . . . . 74.42 110.426 -178.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -85.78 -44.25 12.65 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.37 1.068 . . . . 71.22 110.391 -177.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -97.27 16.89 60.03 Favored Glycine 0 C--N 1.348 1.208 0 CA-C-N 115.635 -0.711 . . . . 72.44 113.204 -176.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.408 ' HB2' ' HB2' ' A' ' 164' ' ' LYS . . . -141.0 171.88 13.45 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 123.88 0.872 . . . . 72.22 109.365 176.159 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.452 HG13 HG22 ' A' ' 221' ' ' VAL . 52.9 t -111.65 149.28 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-O 121.806 0.812 . . . . 75.21 111.25 -173.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 43.2 mtm -100.48 -175.49 2.93 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 126.362 1.865 . . . . 73.32 109.433 -166.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 9.1 p -99.28 87.97 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.147 0 CA-C-O 123.022 1.391 . . . . 65.43 107.856 163.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' MET . . . . . 0.441 ' HE2' HD12 ' A' ' 235' ' ' LEU . 0.0 OUTLIER -123.51 -6.46 8.13 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 113.851 -1.522 . . . . 73.15 110.637 -175.562 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.553 ' HA ' ' HB3' ' A' ' 233' ' ' LEU . 68.5 m -44.36 -65.25 0.54 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.272 1.829 . . . . 75.35 113.586 -172.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . 0.445 ' HB2' ' HB3' ' A' ' 224' ' ' PRO . 42.6 t80 -75.0 -35.62 61.99 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.776 0.83 . . . . 73.0 109.588 -177.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 92.85 4.98 64.8 Favored Glycine 0 C--N 1.35 1.361 0 CA-C-N 115.113 -0.949 . . . . 63.13 112.835 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 12.9 m120 68.98 -1.09 2.18 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 124.907 1.283 . . . . 74.21 112.787 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 28.2 p -70.22 112.05 6.28 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.538 -0.912 . . . . 72.22 108.538 177.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -57.29 -24.86 57.67 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.289 1.036 . . . . 74.45 112.443 -171.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -68.08 141.79 56.02 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.594 0.758 . . . . 74.45 109.768 171.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -67.67 -36.87 81.51 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.783 0.833 . . . . 72.0 110.773 -171.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -86.04 142.54 19.13 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-N 114.426 -1.261 . . . . 54.3 111.938 175.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 39.0 p -162.72 131.87 4.2 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.04 0.936 . . . . 74.41 109.051 175.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -84.06 -94.35 0.67 Allowed Glycine 0 C--N 1.347 1.19 0 N-CA-C 112.711 -0.156 . . . . 72.41 112.711 -178.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 86.61 66.86 1.36 Allowed Glycine 0 C--N 1.343 0.952 0 C-N-CA 122.69 0.186 . . . . 74.13 112.675 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 80.2 p -84.61 177.57 8.02 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.375 0.67 . . . . 72.24 109.526 173.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -159.93 -125.15 0.77 Allowed Glycine 0 C--N 1.347 1.152 0 CA-C-O 119.328 -0.706 . . . . 61.15 113.371 -173.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -69.63 -72.88 0.8 Allowed Glycine 0 C--N 1.354 1.531 0 O-C-N 124.009 0.476 . . . . 73.55 113.721 -170.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.554 ' H ' ' HB2' ' A' ' 192' ' ' ASP . 14.8 m 73.76 -66.06 0.32 Allowed 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 125.84 1.656 . . . . 74.45 112.97 176.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -57.49 -40.11 91.77 Favored Glycine 0 C--N 1.351 1.412 0 N-CA-C 115.501 0.961 . . . . 71.51 115.501 -169.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -82.97 9.19 60.86 Favored Glycine 0 C--N 1.346 1.112 0 CA-C-O 118.867 -0.963 . . . . 71.13 114.396 -175.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 89.0 p 54.0 35.28 21.65 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 124.543 1.137 . . . . 74.12 112.005 -176.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -105.8 -22.83 12.85 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 125.219 1.408 . . . . 74.43 109.931 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.554 ' HB2' ' H ' ' A' ' 187' ' ' SER . 61.1 t0 -75.37 153.9 37.51 Favored 'General case' 0 C--O 1.244 0.791 0 CA-C-N 114.489 -1.232 . . . . 72.42 107.923 174.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 46.7 tp -147.54 141.42 25.82 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 122.802 0.441 . . . . 71.23 110.123 -170.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -116.69 139.44 50.55 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.322 0.649 . . . . 75.2 109.849 172.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -141.17 156.84 45.88 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 108.078 -1.082 . . . . 64.35 108.078 167.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 35.3 p -86.51 152.63 22.48 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-O 121.95 0.881 . . . . 64.55 111.656 168.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.613 HD12 ' HB3' ' A' ' 212' ' ' ALA . 42.4 tp -121.62 131.08 53.91 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 113.264 -1.789 . . . . 75.21 107.3 167.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -94.43 111.77 23.53 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 122.023 0.916 . . . . 71.1 108.982 -177.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.583 HG22 HG23 ' A' ' 210' ' ' VAL . 53.4 t -120.09 132.32 24.13 Favored Pre-proline 0 CA--C 1.546 0.789 0 CA-C-N 114.707 -1.133 . . . . 65.13 109.964 -176.195 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -68.96 147.28 67.65 Favored 'Trans proline' 0 C--N 1.372 1.807 0 C-N-CA 122.326 2.018 . . . . 72.22 111.269 167.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.422 ' HB2' ' HD3' ' A' ' 202' ' ' PRO . . . -53.2 -46.67 97.71 Favored Pre-proline 0 CA--C 1.569 1.686 0 C-N-CA 123.447 0.699 . . . . 75.2 111.945 174.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.422 ' HD3' ' HB2' ' A' ' 201' ' ' ALA . 78.2 Cg_exo -51.13 -39.97 60.49 Favored 'Trans proline' 0 C--N 1.396 3.033 0 C-N-CA 122.638 2.225 . . . . 63.4 113.817 172.092 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.7 mp -84.68 -23.13 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 N-CA-C 109.327 -0.62 . . . . 73.12 109.327 -174.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -73.32 -39.28 65.4 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 123.143 0.577 . . . . 75.24 111.897 178.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 39.7 t -88.93 -34.32 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 CA-C-N 114.787 -1.097 . . . . 75.34 113.201 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.419 ' HB ' ' O ' ' A' ' 202' ' ' PRO . 54.5 t -97.96 -42.17 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 O-C-N 121.514 -0.741 . . . . 75.32 110.636 -175.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 123.52 152.36 8.45 Favored Glycine 0 C--N 1.341 0.836 0 N-CA-C 111.05 -0.82 . . . . 72.44 111.05 -176.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.45 149.21 5.71 Favored Glycine 0 C--O 1.242 0.647 0 N-CA-C 111.476 -0.65 . . . . 74.32 111.476 176.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.646 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 36.0 ttmt -85.62 130.0 34.68 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 109.444 -0.576 . . . . 73.12 109.444 174.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.583 HG23 HG22 ' A' ' 199' ' ' VAL . 8.7 m -130.64 151.4 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.46 1.104 . . . . 74.41 108.693 -178.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 47.7 ttt180 -94.68 140.38 29.96 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.188 -0.914 . . . . 75.54 109.558 -167.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.613 ' HB3' HD12 ' A' ' 197' ' ' LEU . . . -132.23 115.35 15.56 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.028 0.931 . . . . 73.43 109.097 -171.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 32.5 tpp -78.78 110.9 14.38 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 108.167 -1.049 . . . . 75.24 108.167 175.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 69.6 p -115.28 -176.25 2.87 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.56 0.744 . . . . 74.23 110.456 -176.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.57 HD23 ' HD3' ' A' ' 241' ' ' PRO . 66.3 tp -47.57 -51.68 20.22 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.624 1.169 . . . . 71.11 111.998 177.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -72.17 -27.95 62.91 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 114.507 -1.224 . . . . 71.51 111.078 -174.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 136.64 -165.91 24.93 Favored Glycine 0 C--N 1.34 0.79 0 N-CA-C 111.464 -0.654 . . . . 74.33 111.464 -175.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -65.9 132.62 30.9 Favored 'Trans proline' 0 C--N 1.368 1.59 0 C-N-CA 122.565 2.176 . . . . 73.33 112.024 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 31.5 m -132.6 160.82 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.432 1.093 . . . . 72.5 109.333 177.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -113.16 115.73 28.71 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 122.959 0.504 . . . . 71.41 110.035 -176.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.452 HG22 HG13 ' A' ' 168' ' ' VAL . 59.0 t -121.77 105.73 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.16 1.384 . . . . 73.25 110.705 -168.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.646 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -73.82 118.52 16.88 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.889 0.476 . . . . 74.45 110.946 176.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 27.1 m -88.66 150.59 46.4 Favored Pre-proline 0 N--CA 1.483 1.184 0 C-N-CA 122.566 0.346 . . . . 73.3 110.776 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . 0.474 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 33.1 Cg_endo -64.97 165.57 21.1 Favored 'Trans proline' 0 C--N 1.373 1.829 0 C-N-CA 122.625 2.217 . . . . 75.21 113.653 176.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -83.68 29.1 0.55 Allowed 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 123.167 2.578 . . . . 74.13 113.664 172.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 35.4 mmt180 -143.97 -1.44 0.97 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.099 0.56 . . . . 73.52 111.505 177.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.582 HG21 HG13 ' A' ' 253' ' ' VAL . 0.6 OUTLIER -61.17 152.12 29.5 Favored 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 108.919 -0.771 . . . . 73.52 108.919 -166.27 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . 0.505 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 4.5 pt20 -135.31 163.03 30.91 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.314 0.645 . . . . 73.41 110.407 -174.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -61.1 110.76 1.46 Allowed 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 109.288 -0.634 . . . . 73.31 109.288 175.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.74 -0.25 21.57 Favored Glycine 0 CA--C 1.525 0.683 0 CA-C-N 115.369 -0.832 . . . . 75.44 112.308 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.505 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -68.26 125.45 26.45 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.737 0.815 . . . . 72.12 109.605 -174.189 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 49.2 mmtm -99.4 98.23 9.18 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.232 0.613 . . . . 75.31 109.504 -172.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.553 ' HB3' ' HA ' ' A' ' 172' ' ' SER . 22.5 mt -82.25 99.96 9.61 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 107.048 -1.464 . . . . 72.33 107.048 178.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -79.77 125.89 30.26 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 121.169 0.509 . . . . 75.25 110.99 -177.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.441 HD12 ' HE2' ' A' ' 171' ' ' MET . 7.7 mp -111.13 127.91 55.72 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 105.999 -1.852 . . . . 74.35 105.999 172.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 41.4 tptt -101.75 117.89 35.81 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 118.054 0.388 . . . . 73.31 110.84 -173.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 79.22 30.69 45.08 Favored Glycine 0 C--N 1.347 1.159 0 O-C-N 123.481 0.488 . . . . 75.32 111.98 -178.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -127.43 20.51 6.72 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.007 0.923 . . . . 62.11 110.424 -176.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -96.92 -130.5 6.6 Favored Glycine 0 C--N 1.347 1.155 0 N-CA-C 111.19 -0.764 . . . . 45.34 111.19 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . 0.47 ' O ' ' HA ' ' A' ' 246' ' ' ARG . 4.8 m-30 -71.16 155.53 93.0 Favored Pre-proline 0 N--CA 1.478 0.931 0 N-CA-C 112.479 0.548 . . . . 71.21 112.479 -178.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.57 ' HD3' HD23 ' A' ' 215' ' ' LEU . 73.2 Cg_endo -69.35 171.81 13.35 Favored 'Trans proline' 0 C--N 1.388 2.633 0 C-N-CA 123.297 2.665 . . . . 74.25 112.396 -174.067 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.441 ' N ' ' HD2' ' A' ' 243' ' ' PRO . . . -66.81 -38.05 92.73 Favored Glycine 0 CA--C 1.544 1.851 0 CA-C-O 118.204 -1.331 . . . . 75.43 114.424 -176.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' A' ' 242' ' ' GLY . 10.2 Cg_endo -52.27 -42.1 62.18 Favored 'Trans proline' 0 C--N 1.383 2.391 0 CA-C-N 120.696 2.248 . . . . 71.31 113.237 166.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -77.32 -23.04 51.06 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.546 0.738 . . . . 51.54 110.256 174.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 104.37 115.46 4.08 Favored Glycine 0 C--N 1.342 0.888 0 N-CA-C 109.33 -1.508 . . . . 74.33 109.33 -169.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 240' ' ' PHE . 38.4 ttp180 -69.04 124.08 22.79 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 117.663 0.731 . . . . 73.55 110.681 -178.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -133.93 -157.05 8.12 Favored Glycine 0 C--N 1.337 0.615 0 CA-C-N 115.193 -0.912 . . . . 73.21 111.003 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -121.04 160.62 23.22 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.412 0.685 . . . . 73.12 110.764 -171.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 11.6 tp -135.32 133.79 39.18 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.729 0.811 . . . . 74.35 108.994 -172.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -114.7 150.38 35.33 Favored 'General case' 0 C--O 1.245 0.867 0 N-CA-C 108.527 -0.916 . . . . 72.02 108.527 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 64.6 mt -121.13 113.4 19.96 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.548 -1.278 . . . . 71.4 107.548 178.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -88.61 112.16 22.74 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 107.556 -1.276 . . . . 72.12 107.556 -179.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.582 HG13 HG21 ' A' ' 227' ' ' THR . 55.7 t -62.28 128.69 24.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 115.085 -0.961 . . . . 71.4 110.509 177.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 42.5 mtp180 -115.08 125.27 53.32 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 106.805 -1.554 . . . . 75.2 106.805 171.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 48.3 mm -87.3 127.03 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 N-CA-C 109.576 -0.527 . . . . 73.35 109.576 -176.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.7 t . . . . . 0 CA--C 1.56 1.355 0 N-CA-C 108.275 -1.009 . . . . 64.3 108.275 -174.078 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' MET . . . . . 0.433 ' N ' ' SD ' ' A' ' 163' ' ' MET . 1.1 mpt? . . . . . 0 N--CA 1.483 1.219 0 CA-C-O 120.703 0.287 . . . . 72.15 110.434 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 14.9 ttmm -71.24 110.85 6.14 Favored 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 109.044 -0.724 . . . . 74.31 109.044 -177.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -69.07 -66.61 0.56 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.143 0.977 . . . . 71.44 112.488 -167.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -101.77 26.74 23.32 Favored Glycine 0 C--N 1.344 0.974 0 CA-C-N 116.32 -0.4 . . . . 63.54 113.623 -178.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -154.0 173.17 16.35 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.993 0.917 . . . . 65.32 109.45 176.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.416 ' HB ' ' HB ' ' A' ' 219' ' ' VAL . 55.5 t -109.54 149.59 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 CA-C-O 121.822 0.82 . . . . 74.5 112.22 -169.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 39.4 mtm -100.97 -176.18 3.09 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.526 1.931 . . . . 75.4 110.17 -165.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 9.4 p -96.88 88.13 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 CA-C-O 122.939 1.352 . . . . 73.43 108.238 163.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' MET . . . . . 0.434 ' HE3' HG11 ' A' ' 221' ' ' VAL . 0.0 OUTLIER -123.71 -4.8 8.14 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 114.418 -1.265 . . . . 75.31 110.64 -176.25 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.504 ' HA ' ' HB3' ' A' ' 233' ' ' LEU . 69.9 m -41.29 -66.12 0.37 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.493 1.917 . . . . 75.24 114.508 -169.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -67.18 -51.15 57.11 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.031 0.443 . . . . 74.41 110.829 -173.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 64.98 101.83 0.01 OUTLIER Glycine 0 C--N 1.341 0.846 0 CA-C-N 115.032 -0.986 . . . . 70.32 111.211 -169.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -61.51 90.79 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.399 0.68 . . . . 70.42 110.517 -176.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 50.2 m -84.14 117.72 23.66 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 114.853 -1.067 . . . . 74.41 111.418 -172.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -77.36 -5.41 49.54 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 114.58 -1.191 . . . . 73.42 110.487 166.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -79.56 160.54 26.41 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.088 0.955 . . . . 60.31 109.682 169.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -73.42 -18.2 61.17 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.211 0.604 . . . . 61.32 111.546 176.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -124.81 128.26 6.64 Favored Glycine 0 C--N 1.334 0.472 0 N-CA-C 111.399 -0.68 . . . . 64.11 111.399 175.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 16.4 t -94.11 120.44 34.37 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.693 0.797 . . . . 72.12 109.052 175.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -148.75 -101.19 0.24 Allowed Glycine 0 N--CA 1.467 0.747 0 N-CA-C 110.568 -1.013 . . . . 63.51 110.568 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 130.84 86.31 0.39 Allowed Glycine 0 C--N 1.346 1.094 0 N-CA-C 114.25 0.46 . . . . 74.22 114.25 170.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 54.5 p -86.36 156.66 20.11 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.876 0.87 . . . . 72.03 110.635 171.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -152.86 -138.43 2.71 Favored Glycine 0 C--N 1.34 0.796 0 N-CA-C 111.592 -0.603 . . . . 52.33 111.592 175.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -75.0 69.44 1.89 Allowed Glycine 0 C--N 1.344 0.978 0 C-N-CA 123.09 0.376 . . . . 61.13 112.818 176.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 23.1 t -80.64 110.72 16.4 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.604 -0.887 . . . . 75.51 108.604 178.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -153.17 -137.49 2.52 Favored Glycine 0 C--N 1.346 1.108 0 CA-C-O 120.171 -0.238 . . . . 72.31 113.182 -171.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -81.74 -59.32 2.36 Favored Glycine 0 C--N 1.347 1.179 0 C-N-CA 122.839 0.257 . . . . 62.24 113.518 -173.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 46.8 m -142.78 42.36 1.58 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.571 0.748 . . . . 64.45 109.802 -178.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.412 ' HA ' ' O ' ' A' ' 245' ' ' GLY . 23.1 mt-30 -108.94 -56.42 2.28 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 121.83 0.824 . . . . 74.25 109.085 175.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 29.3 p-10 -74.27 160.97 30.39 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 114.016 -1.447 . . . . 73.51 110.8 -177.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 48.5 tp -150.63 135.05 17.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.159 -0.928 . . . . 65.2 108.628 173.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -116.27 138.84 50.96 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.663 -0.866 . . . . 73.32 108.663 176.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -149.15 158.58 44.29 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.399 0.679 . . . . 60.33 109.406 171.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 37.0 p -81.33 154.37 26.54 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.924 0.869 . . . . 64.23 111.842 165.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.616 HD12 ' HB3' ' A' ' 212' ' ' ALA . 34.9 tp -125.74 133.48 52.07 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 113.52 -1.673 . . . . 74.43 106.924 170.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -94.68 111.7 23.47 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.79 -0.818 . . . . 75.02 108.79 -175.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.586 HG22 HG22 ' A' ' 210' ' ' VAL . 46.4 t -123.18 129.78 24.81 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 124.328 1.051 . . . . 72.21 109.813 -177.196 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -67.52 149.03 79.78 Favored 'Trans proline' 0 C--N 1.365 1.429 0 C-N-CA 122.586 2.191 . . . . 63.11 112.079 169.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.419 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.3 -46.96 97.67 Favored Pre-proline 0 CA--C 1.562 1.432 0 CA-C-O 118.353 -0.832 . . . . 64.34 112.446 173.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.479 ' O ' ' HB ' ' A' ' 206' ' ' VAL . 24.2 Cg_endo -60.43 -31.77 93.0 Favored 'Trans proline' 0 C--N 1.395 3.017 0 C-N-CA 121.719 1.613 . . . . 73.53 112.461 177.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.7 mp -86.2 -22.96 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 N-CA-C 109.475 -0.565 . . . . 74.22 109.475 -178.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -73.31 -37.96 65.99 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 122.989 0.516 . . . . 72.55 111.098 176.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 19.5 t -89.2 -33.18 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.977 1.311 . . . . 74.51 113.011 -178.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.479 ' HB ' ' O ' ' A' ' 202' ' ' PRO . 51.2 t -100.49 -43.18 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 O-C-N 121.611 -0.68 . . . . 75.2 110.726 -176.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 121.22 152.18 8.73 Favored Glycine 0 N--CA 1.466 0.699 0 N-CA-C 110.811 -0.916 . . . . 74.35 110.811 -176.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.71 152.98 7.25 Favored Glycine 0 C--O 1.243 0.658 0 N-CA-C 111.671 -0.572 . . . . 74.42 111.671 177.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.582 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 30.2 tttt -85.62 130.41 34.58 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.747 -0.834 . . . . 75.24 108.747 176.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.586 HG22 HG22 ' A' ' 199' ' ' VAL . 13.1 m -129.1 151.83 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 N-CA-C 108.632 -0.877 . . . . 75.41 108.632 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . 0.416 ' HD2' ' N ' ' A' ' 212' ' ' ALA . 6.2 tmm_? -94.09 142.14 27.73 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 109.322 -0.622 . . . . 74.04 109.322 -169.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.616 ' HB3' HD12 ' A' ' 197' ' ' LEU . . . -132.73 119.24 20.08 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.083 0.953 . . . . 73.41 108.612 -177.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 37.4 tpp -79.68 107.66 12.63 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 107.756 -1.201 . . . . 74.15 107.756 173.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 63.9 p -117.03 -174.8 2.66 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.24 0.616 . . . . 64.11 110.77 -172.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.497 HD22 ' HD3' ' A' ' 241' ' ' PRO . 64.9 tp -48.73 -51.94 26.19 Favored 'General case' 0 C--N 1.358 0.963 0 C-N-CA 123.896 0.879 . . . . 72.32 111.872 175.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -72.46 -28.31 62.84 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.234 -0.894 . . . . 74.34 110.701 -173.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 138.4 -166.58 25.23 Favored Glycine 0 C--N 1.341 0.829 0 CA-C-O 119.648 -0.529 . . . . 74.02 112.186 -174.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -64.92 129.56 23.56 Favored 'Trans proline' 0 C--N 1.369 1.609 0 C-N-CA 122.454 2.103 . . . . 73.4 111.286 176.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.423 HG21 ' O ' ' A' ' 212' ' ' ALA . 21.0 m -133.28 160.66 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 123.445 0.698 . . . . 74.53 110.558 -176.264 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -113.12 115.43 28.28 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.893 0.877 . . . . 65.53 109.746 -176.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.434 HG11 ' HE3' ' A' ' 171' ' ' MET . 58.5 t -121.96 103.55 13.62 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.887 0 C-N-CA 124.866 1.266 . . . . 74.21 110.103 -170.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.582 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -77.88 118.22 19.99 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.605 0.362 . . . . 73.43 110.673 177.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 34.0 m -89.01 152.33 48.17 Favored Pre-proline 0 N--CA 1.48 1.064 0 C-N-CA 123.27 0.628 . . . . 73.43 111.225 -177.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . 0.604 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 32.0 Cg_endo -63.73 164.08 22.55 Favored 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 122.593 2.195 . . . . 65.25 113.094 175.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -86.74 28.73 0.53 Allowed 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 123.137 2.558 . . . . 74.52 113.393 177.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 60.1 mmt-85 -145.64 1.21 0.9 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.335 0.654 . . . . 74.2 111.705 176.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.659 HG21 HG13 ' A' ' 253' ' ' VAL . 0.7 OUTLIER -61.26 154.97 22.19 Favored 'General case' 0 CA--C 1.57 1.747 0 O-C-N 123.383 0.427 . . . . 74.44 110.116 -168.986 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . 0.456 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 13.8 pt20 -140.7 162.62 34.98 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.318 0.647 . . . . 74.01 110.63 -174.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -59.27 111.56 1.4 Allowed 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 121.14 0.495 . . . . 74.42 110.527 -178.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.44 0.56 21.94 Favored Glycine 0 CA--C 1.519 0.324 0 CA-C-N 114.882 -1.053 . . . . 74.24 111.823 179.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.456 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -69.12 125.12 25.69 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 109.051 -0.722 . . . . 74.21 109.051 -175.065 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -98.55 98.44 9.62 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.146 0.578 . . . . 72.54 109.7 -169.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.504 ' HB3' ' HA ' ' A' ' 172' ' ' SER . 21.5 mt -81.87 100.31 9.54 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.253 -1.388 . . . . 72.51 107.253 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.61 126.11 30.84 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.245 0.545 . . . . 64.41 111.205 -178.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.534 ' HB3' ' HB2' ' A' ' 238' ' ' LYS . 7.3 mp -110.07 124.93 52.38 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 105.948 -1.871 . . . . 75.14 105.948 173.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.32 115.34 30.36 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.079 0.552 . . . . 73.02 111.652 -172.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 76.99 31.82 51.7 Favored Glycine 0 C--N 1.351 1.375 0 CA-C-N 115.05 -0.977 . . . . 73.23 111.92 -175.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.534 ' HB2' ' HB3' ' A' ' 235' ' ' LEU . 30.5 mmmt -128.91 19.96 5.99 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.833 0.853 . . . . 74.21 111.204 -176.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -96.93 -134.56 8.21 Favored Glycine 0 C--N 1.343 0.943 0 N-CA-C 111.633 -0.587 . . . . 74.3 111.633 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 4.6 m-30 -70.09 151.78 95.95 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 122.676 0.39 . . . . 63.24 111.754 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.497 ' HD3' HD22 ' A' ' 215' ' ' LEU . 60.8 Cg_endo -66.97 172.14 10.19 Favored 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 123.532 2.821 . . . . 74.32 112.373 -177.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -66.36 -38.68 93.82 Favored Glycine 0 CA--C 1.539 1.56 0 CA-C-O 118.158 -1.356 . . . . 75.12 114.012 -177.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . 0.48 ' HD2' ' HB2' ' A' ' 241' ' ' PRO . 73.8 Cg_exo -45.73 -45.99 15.87 Favored 'Trans proline' 0 C--N 1.385 2.475 0 C-N-CA 122.771 2.314 . . . . 74.25 114.033 165.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -80.34 -24.45 39.86 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.535 0.734 . . . . 72.21 111.05 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 191' ' ' GLN . . . 113.34 112.29 3.07 Favored Glycine 0 C--N 1.337 0.63 0 N-CA-C 109.617 -1.393 . . . . 73.2 109.617 -169.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.93 123.09 17.63 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.7 0.8 . . . . 73.0 110.457 -179.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -147.67 -155.63 6.68 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-N 116.236 -0.438 . . . . 64.15 113.319 -175.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -119.91 164.17 16.46 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.745 0.818 . . . . 63.21 110.197 -170.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 10.3 tp -134.02 133.53 41.36 Favored 'General case' 0 C--O 1.214 -0.815 0 N-CA-C 107.634 -1.247 . . . . 72.42 107.634 -178.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -122.11 146.18 47.45 Favored 'General case' 0 C--O 1.246 0.908 0 N-CA-C 108.389 -0.967 . . . . 64.52 108.389 -177.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 88.1 mt -124.82 115.91 21.42 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.807 0.843 . . . . 75.53 108.857 -176.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -89.09 110.16 20.92 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.815 -1.18 . . . . 73.23 107.815 -176.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.659 HG13 HG21 ' A' ' 227' ' ' THR . 45.4 t -60.04 128.54 21.21 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.365 0 O-C-N 123.872 0.733 . . . . 62.45 109.73 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.84 123.35 45.69 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 105.981 -1.859 . . . . 71.44 105.981 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 48.8 mm -86.38 117.95 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 109.006 -0.739 . . . . 74.22 109.006 -177.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.2 t . . . . . 0 CA--C 1.557 1.245 0 N-CA-C 107.687 -1.227 . . . . 73.34 107.687 -174.0 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 26.9 ttt . . . . . 0 N--CA 1.482 1.161 0 N-CA-C 110.227 -0.286 . . . . 75.1 110.227 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.617 ' HG2' ' HB2' ' A' ' 167' ' ' ALA . 36.2 ttpt -75.84 95.6 3.53 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 107.819 -1.178 . . . . 73.24 107.819 173.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -77.77 -45.71 23.8 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.676 1.19 . . . . 73.11 113.616 -162.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -98.34 20.02 52.13 Favored Glycine 0 N--CA 1.474 1.232 0 C-N-CA 122.761 0.22 . . . . 72.13 112.759 -175.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.617 ' HB2' ' HG2' ' A' ' 164' ' ' LYS . . . -148.06 172.06 14.85 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.722 0.809 . . . . 74.53 109.538 -179.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.461 HG13 HG22 ' A' ' 221' ' ' VAL . 53.6 t -111.43 150.58 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 CA-C-O 121.906 0.86 . . . . 73.43 112.139 -166.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 40.6 mtm -99.69 -175.68 3.05 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 126.051 1.74 . . . . 63.32 109.263 -169.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 10.3 p -97.28 88.12 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.184 0 CA-C-O 122.858 1.313 . . . . 74.41 108.275 164.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.27 -5.16 8.34 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 113.771 -1.559 . . . . 73.42 109.945 -178.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.425 ' HA ' ' HB3' ' A' ' 233' ' ' LEU . 67.0 m -39.22 -64.93 0.42 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 127.029 2.132 . . . . 74.0 114.578 -169.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . 0.426 ' HB2' ' HB3' ' A' ' 224' ' ' PRO . 72.6 t80 -62.68 -35.31 79.26 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.462 0.705 . . . . 75.32 110.901 -176.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 85.62 47.59 5.05 Favored Glycine 0 C--N 1.339 0.717 0 N-CA-C 108.727 -1.749 . . . . 74.21 108.727 -164.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -62.26 81.82 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.245 1.418 . . . . 71.45 111.892 -173.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 45.4 m -104.12 122.39 45.22 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.484 1.114 . . . . 70.21 109.447 -178.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -60.62 -33.6 73.0 Favored 'General case' 0 CA--C 1.55 0.966 0 O-C-N 123.831 0.707 . . . . 72.01 110.833 178.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 16.7 mp0 -97.31 171.34 8.48 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.427 1.091 . . . . 74.02 110.049 174.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -64.71 -35.41 80.97 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.831 0.852 . . . . 74.31 111.133 175.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -72.7 86.13 0.54 Allowed Glycine 0 C--N 1.34 0.8 0 CA-C-N 114.565 -1.198 . . . . 73.31 112.681 -176.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.442 ' HB3' ' NH2' ' A' ' 234' ' ' ARG . 27.1 m -83.8 -26.06 29.9 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.204 1.002 . . . . 74.04 110.669 175.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 86.78 -162.3 34.14 Favored Glycine 0 C--N 1.354 1.541 0 O-C-N 123.781 0.676 . . . . 72.44 112.696 -178.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -174.48 21.25 0.06 OUTLIER Glycine 0 N--CA 1.468 0.77 0 N-CA-C 111.823 -0.511 . . . . 74.03 111.823 175.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 31.5 m -82.05 116.75 21.79 Favored 'General case' 0 C--O 1.243 0.741 0 C-N-CA 123.533 0.733 . . . . 74.43 110.736 -176.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 177.03 58.74 0.06 OUTLIER Glycine 0 C--N 1.345 1.045 0 CA-C-N 115.979 -0.555 . . . . 75.23 111.823 177.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 82.19 -65.45 4.07 Favored Glycine 0 CA--C 1.531 1.051 0 N-CA-C 112.141 -0.384 . . . . 75.31 112.141 178.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 42.4 m 61.06 33.72 19.48 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.35 1.06 . . . . 73.42 111.93 173.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 117.82 43.22 0.58 Allowed Glycine 0 C--N 1.347 1.178 0 CA-C-N 115.222 -0.899 . . . . 64.11 111.486 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -113.96 0.45 24.24 Favored Glycine 0 C--N 1.351 1.383 0 CA-C-O 119.671 -0.516 . . . . 75.24 112.804 -178.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 23.1 t 62.03 17.51 9.13 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 124.556 1.142 . . . . 55.23 111.426 -174.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -106.03 -33.79 7.78 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.756 1.623 . . . . 74.04 107.482 176.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.438 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 17.9 p-10 -74.3 160.7 30.74 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 113.08 -1.873 . . . . 75.31 110.411 170.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.438 HD21 HD12 ' A' ' 249' ' ' LEU . 57.6 tp -149.22 143.74 26.11 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.779 -0.646 . . . . 72.4 109.749 -174.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.52 ' HD2' ' HZ1' ' A' ' 232' ' ' LYS . 64.3 m-85 -116.25 139.13 50.69 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.911 0.885 . . . . 74.02 110.169 174.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -148.59 157.39 43.43 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.257 1.023 . . . . 54.21 108.979 173.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 24.9 p -83.75 153.43 24.14 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 122.091 0.948 . . . . 72.52 112.663 168.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.623 HD13 ' HB3' ' A' ' 212' ' ' ALA . 31.6 tp -126.29 133.67 51.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 112.909 -1.951 . . . . 74.12 106.971 167.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -94.3 114.03 26.04 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.206 -1.035 . . . . 75.21 108.206 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.606 HG22 HG23 ' A' ' 210' ' ' VAL . 48.9 t -121.56 132.0 24.32 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 124.186 0.994 . . . . 72.05 109.688 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -69.24 144.21 56.0 Favored 'Trans proline' 0 C--N 1.37 1.703 0 C-N-CA 122.289 1.993 . . . . 74.43 111.014 166.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.434 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -54.48 -42.21 93.31 Favored Pre-proline 0 CA--C 1.565 1.54 0 CA-C-O 118.059 -0.972 . . . . 73.34 112.544 173.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.434 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 11.5 Cg_endo -55.22 -36.63 93.79 Favored 'Trans proline' 0 C--N 1.404 3.465 0 C-N-CA 121.885 1.723 . . . . 74.55 112.83 172.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -85.46 -23.89 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 N-CA-C 109.14 -0.689 . . . . 71.41 109.14 -177.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . 0.41 ' HA ' HG22 ' A' ' 227' ' ' THR . . . -73.83 -37.33 64.88 Favored 'General case' 0 C--O 1.247 0.934 0 CA-C-O 121.44 0.638 . . . . 75.21 111.299 179.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 25.2 t -88.71 -38.0 10.93 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-N 113.72 -1.582 . . . . 70.53 112.435 -177.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 76.1 t -97.51 -42.59 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 O-C-N 122.13 -0.356 . . . . 73.43 110.341 -176.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 121.1 148.95 8.06 Favored Glycine 0 C--N 1.341 0.855 0 N-CA-C 110.612 -0.995 . . . . 74.53 110.612 -176.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 165.73 155.39 8.66 Favored Glycine 0 C--O 1.246 0.876 0 N-CA-C 111.856 -0.497 . . . . 74.41 111.856 178.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.634 ' HD3' ' HB3' ' A' ' 220' ' ' GLU . 3.5 ttmp? -84.94 131.22 34.52 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.373 0.669 . . . . 75.43 109.701 178.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.606 HG23 HG22 ' A' ' 199' ' ' VAL . 9.5 m -130.04 151.76 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.444 1.098 . . . . 75.14 108.642 177.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? -95.5 140.84 29.78 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 108.976 -0.75 . . . . 74.31 108.976 -172.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.623 ' HB3' HD13 ' A' ' 197' ' ' LEU . . . -131.25 119.8 22.32 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.719 -0.845 . . . . 74.14 108.719 -177.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 37.3 tpp -79.35 107.35 12.05 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 107.592 -1.262 . . . . 74.53 107.592 172.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' THR . . . . . 0.416 HG22 HD23 ' A' ' 251' ' ' LEU . 71.5 p -112.43 -173.55 2.27 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.836 0.854 . . . . 71.54 110.878 -174.301 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 61.7 tp -44.98 -52.63 8.59 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.314 1.046 . . . . 75.52 112.063 167.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -71.81 -26.53 62.44 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 114.263 -1.335 . . . . 72.41 111.46 -169.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 131.09 -165.77 22.95 Favored Glycine 0 C--N 1.34 0.777 0 N-CA-C 110.661 -0.976 . . . . 65.41 110.661 -171.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -65.78 131.02 26.17 Favored 'Trans proline' 0 C--N 1.37 1.67 0 C-N-CA 121.89 1.727 . . . . 70.45 110.715 175.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.403 HG22 ' O ' ' A' ' 212' ' ' ALA . 26.6 m -133.36 162.82 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 123.754 0.821 . . . . 75.3 110.495 -178.283 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.634 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 38.3 mt-10 -112.02 116.07 29.96 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.395 1.078 . . . . 72.23 109.307 -175.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.461 HG22 HG13 ' A' ' 168' ' ' VAL . 44.5 t -124.32 103.28 12.31 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 C-N-CA 124.233 1.013 . . . . 75.33 109.635 -173.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.55 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -78.1 118.4 20.32 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.552 -0.536 . . . . 74.1 109.552 173.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 34.7 m -89.03 151.43 46.95 Favored Pre-proline 0 N--CA 1.483 1.182 0 C-N-CA 123.031 0.532 . . . . 71.14 110.54 -178.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . 0.451 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 41.4 Cg_endo -65.22 165.83 20.88 Favored 'Trans proline' 0 C--N 1.38 2.189 0 C-N-CA 122.939 2.426 . . . . 63.43 113.412 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -80.27 31.97 0.5 Allowed 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 123.163 2.575 . . . . 75.22 113.1 172.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -150.17 -2.32 0.39 Allowed 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 112.275 0.472 . . . . 74.4 112.275 178.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.59 HG21 HG13 ' A' ' 253' ' ' VAL . 0.6 OUTLIER -59.95 150.48 28.75 Favored 'General case' 0 CA--C 1.566 1.596 0 N-CA-C 108.901 -0.778 . . . . 74.34 108.901 -168.423 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . 0.436 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 4.5 pt20 -133.36 162.2 32.47 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.039 0.535 . . . . 74.21 109.876 -171.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . 0.572 ' HB1' HH21 ' A' ' 254' ' ' ARG . . . -59.18 111.52 1.37 Allowed 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 109.318 -0.623 . . . . 71.01 109.318 174.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 114.89 1.16 22.71 Favored Glycine 0 C--N 1.338 0.641 0 CA-C-N 115.696 -0.684 . . . . 71.04 112.013 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.436 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -69.66 123.76 22.21 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 108.967 -0.753 . . . . 73.45 108.967 -174.098 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.576 ' HZ3' ' HB2' ' A' ' 252' ' ' GLU . 30.7 mmmt -100.15 97.21 8.05 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 108.767 -0.827 . . . . 73.34 108.767 -172.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.495 ' O ' ' HA ' ' A' ' 250' ' ' TYR . 20.3 mt -81.51 99.07 8.58 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 106.406 -1.701 . . . . 72.01 106.406 -176.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . 0.688 ' HD3' ' HE2' ' A' ' 236' ' ' LYS . 0.5 OUTLIER -83.02 126.16 32.24 Favored 'General case' 0 CA--C 1.561 1.401 0 C-N-CA 123.854 0.862 . . . . 73.04 112.262 179.803 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.444 ' HB3' ' HB2' ' A' ' 238' ' ' LYS . 7.6 mp -113.72 124.44 52.3 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.964 1.306 . . . . 74.51 108.697 -176.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.688 ' HE2' ' HD3' ' A' ' 234' ' ' ARG . 5.2 mptp? -94.31 115.11 27.29 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 118.537 0.608 . . . . 73.41 110.942 -169.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 77.48 20.48 74.48 Favored Glycine 0 C--N 1.349 1.283 0 O-C-N 124.236 0.96 . . . . 72.44 112.305 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 235' ' ' LEU . 1.0 OUTLIER -117.45 19.46 14.0 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.814 0.846 . . . . 73.23 110.037 -178.575 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -95.85 -139.98 10.72 Favored Glycine 0 C--N 1.35 1.338 0 N-CA-C 110.951 -0.86 . . . . 75.43 110.951 176.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . 0.436 ' O ' ' HA ' ' A' ' 246' ' ' ARG . 6.1 m-30 -61.11 146.94 87.32 Favored Pre-proline 0 N--CA 1.477 0.878 0 N-CA-C 112.645 0.609 . . . . 72.4 112.645 -175.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -59.71 171.08 2.96 Favored 'Trans proline' 0 C--N 1.385 2.497 0 C-N-CA 123.486 2.791 . . . . 75.24 112.524 -178.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.416 ' N ' ' HD2' ' A' ' 243' ' ' PRO . . . -67.64 -41.34 89.74 Favored Glycine 0 CA--C 1.552 2.392 0 CA-C-O 118.284 -1.287 . . . . 73.11 114.237 -174.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' A' ' 242' ' ' GLY . 10.8 Cg_endo -55.57 -36.5 94.63 Favored 'Trans proline' 0 C--N 1.392 2.843 0 C-N-CA 122.749 2.299 . . . . 70.54 112.914 168.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -77.47 -24.67 50.17 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.24 0.616 . . . . 72.03 110.688 174.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 106.68 115.59 4.03 Favored Glycine 0 C--N 1.341 0.821 0 N-CA-C 109.34 -1.504 . . . . 72.22 109.34 -172.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.436 ' HA ' ' O ' ' A' ' 240' ' ' PHE . 29.0 ttm180 -72.87 123.9 24.32 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 117.603 0.702 . . . . 75.24 111.274 -177.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -139.65 -152.74 5.92 Favored Glycine 0 C--N 1.341 0.83 0 CA-C-N 114.808 -1.087 . . . . 74.12 112.304 -177.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . 0.438 ' O ' ' HA ' ' A' ' 192' ' ' ASP . 11.0 t70 -114.69 163.01 16.06 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.403 1.081 . . . . 72.12 108.705 -168.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.438 HD12 HD21 ' A' ' 193' ' ' LEU . 18.8 tp -134.84 132.77 39.01 Favored 'General case' 0 C--O 1.214 -0.804 0 N-CA-C 109.209 -0.663 . . . . 74.25 109.209 -177.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.495 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 0.4 OUTLIER -112.04 145.27 39.99 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-O 121.688 0.756 . . . . 73.21 109.691 178.856 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.416 HD23 HG22 ' A' ' 214' ' ' THR . 72.5 mt -125.65 113.85 17.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 113.909 -1.496 . . . . 74.51 107.602 174.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . 0.576 ' HB2' ' HZ3' ' A' ' 232' ' ' LYS . 35.1 tt0 -91.54 109.55 20.86 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 107.774 -1.195 . . . . 63.23 107.774 -173.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.59 HG13 HG21 ' A' ' 227' ' ' THR . 52.1 t -61.53 122.77 12.94 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 O-C-N 124.301 1.0 . . . . 74.01 109.988 -179.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . 0.572 HH21 ' HB1' ' A' ' 229' ' ' ALA . 0.3 OUTLIER -115.2 122.89 47.41 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 106.872 -1.529 . . . . 74.45 106.872 176.878 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 44.9 mm -87.62 114.97 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 O-C-N 123.918 0.761 . . . . 74.3 110.108 -174.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 CA--C 1.56 1.362 0 C-N-CA 124.09 0.956 . . . . 75.35 109.516 -172.057 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' MET . . . . . 0.557 ' HA ' ' SD ' ' A' ' 169' ' ' MET . 44.6 ttm . . . . . 0 N--CA 1.482 1.175 0 N-CA-C 109.363 -0.606 . . . . 70.33 109.363 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.512 ' HZ1' ' HA ' ' A' ' 169' ' ' MET . 37.7 mtmm -104.21 126.25 51.17 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 108.767 -0.827 . . . . 74.42 108.767 171.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -78.29 -52.85 8.02 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.783 0.833 . . . . 65.13 111.552 -173.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -97.26 13.01 65.03 Favored Glycine 0 C--N 1.346 1.089 0 CA-C-N 116.208 -0.451 . . . . 54.33 113.033 -177.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -146.27 169.24 19.21 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.851 0.86 . . . . 64.55 109.47 176.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 54.4 t -110.93 151.13 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 123.669 0.788 . . . . 72.24 110.119 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' MET . . . . . 0.557 ' SD ' ' HA ' ' A' ' 163' ' ' MET . 42.9 mtm -99.17 -176.91 3.45 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 125.552 1.541 . . . . 74.43 109.515 -167.029 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 12.6 p -100.53 86.32 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 CA-C-O 123.428 1.585 . . . . 73.53 107.453 165.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' MET . . . . . 0.451 ' HG3' ' HA ' ' A' ' 235' ' ' LEU . 0.0 OUTLIER -124.07 -3.86 8.03 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 113.394 -1.73 . . . . 54.32 110.263 -173.554 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.532 ' HB3' HD22 ' A' ' 233' ' ' LEU . 66.7 m -44.74 -69.84 0.12 Allowed 'General case' 0 C--N 1.351 0.65 0 C-N-CA 125.856 1.662 . . . . 74.41 113.542 -166.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . 0.534 ' HB2' ' HG3' ' A' ' 224' ' ' PRO . 50.8 t80 -69.47 -47.68 63.19 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 108.215 -1.031 . . . . 74.42 108.215 -179.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 47.89 44.47 24.79 Favored Glycine 0 C--N 1.361 1.959 0 O-C-N 125.007 1.442 . . . . 54.41 114.702 165.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -89.65 168.3 12.24 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.634 0.73 . . . . 74.11 111.12 -177.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 18.7 m -87.93 126.19 34.92 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 106.216 -1.772 . . . . 74.14 106.216 163.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -49.96 -23.87 2.25 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 124.271 1.028 . . . . 62.23 111.33 -178.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -60.02 176.84 0.28 Allowed 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 126.257 1.823 . . . . 73.12 111.709 169.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -43.62 -46.97 7.49 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 114.794 1.405 . . . . 73.34 114.794 -175.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -132.88 -164.26 10.83 Favored Glycine 0 N--CA 1.47 0.917 0 CA-C-N 115.843 -0.617 . . . . 41.22 112.256 -176.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 23.7 t -138.55 153.26 48.71 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.422 0.689 . . . . 70.21 109.884 176.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -132.77 102.37 0.48 Allowed Glycine 0 C--N 1.34 0.77 0 N-CA-C 109.981 -1.247 . . . . 71.15 109.981 178.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -155.04 59.34 0.38 Allowed Glycine 0 C--N 1.346 1.112 0 N-CA-C 111.748 -0.541 . . . . 72.24 111.748 -176.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 24.1 t -81.92 176.33 9.66 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.668 0.787 . . . . 74.42 110.221 177.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -69.25 163.81 50.83 Favored Glycine 0 C--N 1.346 1.131 0 N-CA-C 115.733 1.053 . . . . 72.44 115.733 -168.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -76.43 -29.26 58.38 Favored Glycine 0 C--N 1.349 1.269 0 CA-C-N 114.982 -0.609 . . . . 53.53 112.847 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 44.3 t -165.41 -58.03 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.033 0.533 . . . . 64.13 110.502 177.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 100.03 -9.25 59.72 Favored Glycine 0 C--N 1.35 1.355 0 CA-C-O 119.652 -0.527 . . . . 75.14 113.943 -178.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -65.29 -68.8 1.53 Allowed Glycine 0 C--N 1.349 1.303 0 CA-C-N 116.821 0.31 . . . . 62.24 112.396 179.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 44.4 m -145.94 30.22 1.07 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.994 0.918 . . . . 72.41 109.432 179.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.439 ' HG2' ' HA3' ' A' ' 245' ' ' GLY . 75.0 mt-30 -116.69 -50.19 2.62 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.734 0.813 . . . . 72.34 110.752 -173.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -85.35 158.8 20.17 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 114.908 -1.042 . . . . 72.41 110.081 -174.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 53.6 tp -150.31 142.48 24.1 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.04 0.536 . . . . 75.32 110.042 -176.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -114.1 142.07 46.68 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.677 0.791 . . . . 74.32 109.286 173.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -148.62 162.4 39.77 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.936 0.894 . . . . 73.21 108.916 173.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 34.6 p -85.95 154.6 21.36 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 122.015 0.912 . . . . 74.31 111.984 166.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.622 HD11 ' HB3' ' A' ' 212' ' ' ALA . 29.2 tp -124.55 133.63 53.24 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 113.404 -1.725 . . . . 73.41 107.172 160.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -93.33 114.03 26.37 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 108.205 -1.035 . . . . 74.42 108.205 178.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.577 HG22 HG23 ' A' ' 210' ' ' VAL . 46.1 t -121.56 131.15 24.51 Favored Pre-proline 0 CA--C 1.546 0.803 0 CA-C-N 115.049 -0.978 . . . . 74.52 109.018 -178.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -68.59 148.27 72.07 Favored 'Trans proline' 0 C--N 1.364 1.391 0 C-N-CA 122.522 2.148 . . . . 74.34 111.379 169.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.404 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.28 -45.75 98.24 Favored Pre-proline 0 CA--C 1.558 1.262 0 CA-C-O 118.597 -0.716 . . . . 62.43 112.887 174.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.45 ' O ' ' HB ' ' A' ' 206' ' ' VAL . 30.1 Cg_endo -61.16 -30.15 88.22 Favored 'Trans proline' 0 C--N 1.395 2.998 0 C-N-CA 121.685 1.59 . . . . 74.43 112.193 178.003 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -86.47 -25.37 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 N-CA-C 109.482 -0.562 . . . . 74.42 109.482 -177.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -73.4 -37.67 65.87 Favored 'General case' 0 C--O 1.247 0.936 0 C-N-CA 122.89 0.476 . . . . 74.04 111.18 178.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 25.6 t -88.36 -38.0 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 C-N-CA 124.884 1.274 . . . . 73.41 112.869 -178.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.45 ' HB ' ' O ' ' A' ' 202' ' ' PRO . 54.5 t -97.26 -41.47 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 O-C-N 121.841 -0.537 . . . . 74.24 110.545 -175.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 121.61 148.15 7.79 Favored Glycine 0 C--N 1.341 0.847 0 N-CA-C 110.789 -0.925 . . . . 73.41 110.789 -177.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 166.51 151.41 6.8 Favored Glycine 0 C--O 1.245 0.792 0 N-CA-C 112.098 -0.401 . . . . 62.11 112.098 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.639 ' HD3' ' HB3' ' A' ' 220' ' ' GLU . 37.5 ttmt -85.06 132.39 34.33 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.781 0.832 . . . . 73.13 109.615 175.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.577 HG23 HG22 ' A' ' 199' ' ' VAL . 11.2 m -136.11 152.18 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.365 1.066 . . . . 75.54 109.407 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 8.8 tmm_? -94.59 142.83 26.99 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.581 0.752 . . . . 72.41 110.711 -170.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.622 ' HB3' HD11 ' A' ' 197' ' ' LEU . . . -131.17 123.12 27.83 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.912 0.885 . . . . 74.11 109.366 -176.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 33.8 tpp -78.6 109.05 12.45 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 108.52 -0.918 . . . . 73.04 108.52 175.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 51.6 p -113.73 -178.35 3.36 Favored 'General case' 0 C--O 1.244 0.8 0 C-N-CA 123.242 0.617 . . . . 74.01 111.132 -174.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.507 HD22 ' HD3' ' A' ' 241' ' ' PRO . 65.5 tp -45.83 -51.66 12.55 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 124.278 0.986 . . . . 73.35 111.33 170.14 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -73.56 -29.4 62.4 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 114.05 -1.432 . . . . 74.54 111.442 -174.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 136.68 -167.18 24.64 Favored Glycine 0 C--N 1.348 1.211 0 CA-C-O 119.558 -0.579 . . . . 61.42 112.407 -177.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.91 129.47 24.71 Favored 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 122.329 2.019 . . . . 73.43 111.046 176.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 28.1 m -132.8 161.55 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 123.573 0.749 . . . . 74.45 110.138 -176.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.639 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 51.8 mt-10 -111.54 115.56 29.38 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.711 0.804 . . . . 75.22 109.416 -173.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 59.8 t -126.63 104.66 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 124.451 1.1 . . . . 72.33 110.102 -169.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.594 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -76.89 117.99 19.04 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 110.066 -0.346 . . . . 62.32 110.066 176.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 34.0 m -88.07 152.36 50.55 Favored Pre-proline 0 N--CA 1.48 1.034 0 C-N-CA 123.002 0.521 . . . . 74.24 110.765 -178.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . 0.543 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 34.6 Cg_endo -62.55 163.69 20.39 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.242 1.961 . . . . 73.42 112.231 174.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -86.76 32.94 0.44 Allowed 'Trans proline' 0 C--N 1.371 1.75 0 C-N-CA 123.249 2.633 . . . . 75.52 112.074 176.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 5.2 tpt180 -148.99 -0.71 0.5 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 122.764 0.426 . . . . 75.21 111.324 178.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.607 HG21 HG13 ' A' ' 253' ' ' VAL . 0.6 OUTLIER -61.12 153.01 26.84 Favored 'General case' 0 CA--C 1.563 1.476 0 N-CA-C 109.519 -0.549 . . . . 63.11 109.519 -167.242 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . 0.455 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 19.5 pt20 -132.77 161.56 33.75 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.182 0.593 . . . . 70.25 110.41 -170.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . 0.454 ' HB1' ' NH2' ' A' ' 254' ' ' ARG . . . -61.27 110.84 1.52 Allowed 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 109.509 -0.552 . . . . 73.15 109.509 174.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 113.92 0.46 24.21 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 111.28 -0.728 . . . . 64.11 111.28 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.455 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -68.84 126.93 31.31 Favored 'General case' 0 C--N 1.362 1.152 0 N-CA-C 109.187 -0.671 . . . . 74.25 109.187 -173.513 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -97.71 97.7 9.24 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 108.947 -0.76 . . . . 74.41 108.947 -169.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.532 HD22 ' HB3' ' A' ' 172' ' ' SER . 25.8 mt -81.11 99.56 8.57 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.696 -1.224 . . . . 73.53 107.696 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.44 113.32 17.49 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.733 -0.667 . . . . 73.34 110.363 -178.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.545 ' HB3' ' HB2' ' A' ' 238' ' ' LYS . 7.5 mp -99.55 124.73 45.01 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 105.943 -1.873 . . . . 73.44 105.943 169.268 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -102.68 118.05 36.0 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.563 0.745 . . . . 75.12 109.777 -176.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 78.42 31.2 46.96 Favored Glycine 0 C--N 1.349 1.264 0 O-C-N 124.103 0.877 . . . . 72.32 112.735 -177.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.545 ' HB2' ' HB3' ' A' ' 235' ' ' LEU . 29.9 mmmt -129.94 21.25 5.4 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.028 0.931 . . . . 74.32 111.042 -179.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -96.81 -131.1 6.8 Favored Glycine 0 C--N 1.346 1.089 0 N-CA-C 111.468 -0.653 . . . . 75.35 111.468 -179.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 7.1 m-30 -70.8 151.77 95.19 Favored Pre-proline 0 CA--C 1.553 1.093 0 C-N-CA 123.458 0.703 . . . . 73.24 112.321 -178.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.507 ' HD3' HD22 ' A' ' 215' ' ' LEU . 58.8 Cg_endo -66.3 171.36 10.51 Favored 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 124.142 3.228 . . . . 73.32 112.977 179.08 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -66.35 -40.5 94.6 Favored Glycine 0 CA--C 1.543 1.84 0 CA-C-O 118.233 -1.315 . . . . 74.01 115.604 -175.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -53.9 -36.86 84.77 Favored 'Trans proline' 0 C--N 1.379 2.18 0 CA-C-N 120.827 2.313 . . . . 64.24 113.029 168.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -79.56 -26.61 41.34 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 122.987 0.515 . . . . 72.44 110.398 174.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . 0.439 ' HA3' ' HG2' ' A' ' 191' ' ' GLN . . . 110.65 115.67 3.63 Favored Glycine 0 C--N 1.345 1.083 0 N-CA-C 109.413 -1.475 . . . . 74.32 109.413 -170.157 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 11.1 mmm-85 -67.91 121.98 17.2 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.02 0.528 . . . . 74.51 110.292 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -143.73 -156.15 6.69 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-N 115.823 -0.626 . . . . 72.14 112.131 -177.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -120.64 165.53 14.92 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 123.675 0.79 . . . . 62.23 110.749 -172.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 16.1 tp -135.46 134.49 39.64 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 107.828 -1.175 . . . . 75.43 107.828 -173.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 8.9 m-30 -114.39 148.48 37.62 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 109.144 -0.687 . . . . 74.33 109.144 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.451 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 69.9 mt -122.93 113.94 19.78 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.24 -1.393 . . . . 74.22 107.24 178.093 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -89.65 111.68 22.71 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 106.986 -1.487 . . . . 72.31 106.986 -176.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.607 HG13 HG21 ' A' ' 227' ' ' THR . 54.7 t -62.21 125.82 19.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 O-C-N 123.977 0.798 . . . . 73.05 110.278 -178.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . 0.454 ' NH2' ' HB1' ' A' ' 229' ' ' ALA . 3.8 mmp_? -117.0 122.53 44.49 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.036 -1.468 . . . . 74.22 107.036 176.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 48.7 mm -88.37 115.42 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 O-C-N 123.799 0.687 . . . . 71.23 110.273 -172.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.0 t . . . . . 0 CA--C 1.562 1.413 0 C-N-CA 124.389 1.076 . . . . 61.13 109.23 -169.377 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 66.4 mtt . . . . . 0 N--CA 1.483 1.187 0 N-CA-C 109.51 -0.552 . . . . 74.14 109.51 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -103.54 140.81 37.02 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.999 0.919 . . . . 74.3 110.474 179.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -100.41 -42.03 6.78 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.247 1.019 . . . . 75.43 110.922 -170.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -100.42 24.6 31.46 Favored Glycine 0 C--N 1.345 1.034 0 CA-C-N 115.639 -0.709 . . . . 70.25 113.391 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -140.78 166.97 23.31 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.031 0.932 . . . . 73.11 109.056 178.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.498 HG13 HG23 ' A' ' 221' ' ' VAL . 60.7 t -110.94 149.93 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-O 121.62 0.724 . . . . 75.52 112.301 -162.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 42.6 mtm -99.51 -176.05 3.17 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.618 1.967 . . . . 64.2 108.813 -171.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 9.9 p -101.57 86.58 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.179 0 CA-C-O 123.067 1.413 . . . . 72.22 108.642 166.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.7 -4.76 9.2 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 113.933 -1.485 . . . . 75.1 110.232 -174.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 68.9 m -39.92 -67.31 0.24 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.778 2.031 . . . . 61.32 114.661 -164.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -66.53 -42.82 86.67 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 122.482 0.313 . . . . 73.31 110.537 -169.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 56.45 69.38 1.29 Allowed Glycine 0 C--N 1.344 1.023 0 N-CA-C 111.489 -0.644 . . . . 74.25 111.489 -176.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -72.87 20.03 0.08 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.085 0.954 . . . . 74.41 113.282 -174.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' SER . . . . . 0.442 ' O ' ' HA ' ' A' ' 181' ' ' SER . 14.8 m -101.02 95.71 6.76 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.954 0.901 . . . . 72.41 109.188 170.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 13.2 mp0 -84.44 -28.57 26.75 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.776 0.798 . . . . 74.5 109.162 172.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -65.5 177.76 1.11 Allowed 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 114.046 -1.434 . . . . 74.01 110.091 167.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -10.51 -55.79 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.302 0 C-N-CA 127.949 2.5 . . . . 75.33 116.397 -174.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -81.18 55.25 4.81 Favored Glycine 0 N--CA 1.473 1.152 0 O-C-N 123.789 0.681 . . . . 60.33 112.649 178.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.442 ' HA ' ' O ' ' A' ' 176' ' ' SER . 34.8 t -79.36 -11.43 59.93 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.269 1.028 . . . . 70.1 112.992 -168.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 87.49 44.97 5.39 Favored Glycine 0 C--N 1.346 1.092 0 N-CA-C 111.737 -0.545 . . . . 71.15 111.737 -176.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -69.96 176.39 33.36 Favored Glycine 0 C--N 1.351 1.407 0 O-C-N 124.145 0.556 . . . . 65.41 113.257 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 51.4 p -69.16 101.75 1.52 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.827 0.851 . . . . 74.44 111.841 -173.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -92.91 -44.18 3.94 Favored Glycine 0 C--N 1.349 1.279 0 N-CA-C 111.54 -0.624 . . . . 64.33 111.54 173.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' A' ' 191' ' ' GLN . . . -70.16 -20.45 76.52 Favored Glycine 0 C--N 1.355 1.602 0 CA-C-N 115.457 -0.371 . . . . 43.21 112.471 176.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 18.3 m 60.26 22.57 11.98 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.683 1.193 . . . . 62.2 112.416 172.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 82.48 -78.2 2.01 Favored Glycine 0 C--N 1.352 1.456 0 CA-C-O 119.569 -0.573 . . . . 71.23 114.281 176.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -20.54 -72.1 0.01 OUTLIER Glycine 0 N--CA 1.486 1.99 0 C-N-CA 126.395 1.95 . . . . 72.54 117.854 -162.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 49.7 m -148.55 21.52 1.04 Allowed 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.38 0.672 . . . . 63.45 110.857 -177.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.402 ' HB2' ' O ' ' A' ' 186' ' ' GLY . 15.9 mt-30 -118.76 -42.22 2.74 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.095 0.558 . . . . 71.22 110.724 -177.386 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -76.04 154.93 35.31 Favored 'General case' 0 N--CA 1.481 1.125 0 CA-C-N 115.342 -0.845 . . . . 72.24 109.547 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 56.9 tp -148.23 140.39 24.14 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.028 0.531 . . . . 74.24 110.34 175.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -114.55 138.76 50.24 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.089 0.955 . . . . 73.02 110.097 173.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.414 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -147.8 156.59 42.89 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.792 -0.818 . . . . 74.51 108.792 167.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 30.0 p -81.85 151.46 27.32 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 122.113 0.959 . . . . 75.03 112.14 168.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.602 HD13 ' HB3' ' A' ' 212' ' ' ALA . 27.2 tp -120.74 132.38 55.02 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 112.977 -1.92 . . . . 72.13 107.155 164.054 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -94.93 114.53 26.38 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 107.973 -1.121 . . . . 72.12 107.973 178.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.577 HG22 HG22 ' A' ' 210' ' ' VAL . 46.4 t -113.52 130.23 23.91 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 114.866 -1.061 . . . . 74.22 108.649 178.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -66.01 146.22 81.78 Favored 'Trans proline' 0 C--N 1.373 1.83 0 C-N-CA 122.287 1.992 . . . . 74.14 110.924 169.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.418 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.64 -46.21 98.36 Favored Pre-proline 0 CA--C 1.568 1.672 0 CA-C-O 118.334 -0.841 . . . . 54.11 112.304 175.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.418 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 26.0 Cg_endo -60.82 -31.48 91.77 Favored 'Trans proline' 0 C--N 1.403 3.446 0 C-N-CA 121.697 1.598 . . . . 62.43 112.549 176.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -86.44 -23.69 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 N-CA-C 109.153 -0.684 . . . . 74.31 109.153 -177.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -74.17 -38.53 63.65 Favored 'General case' 0 C--O 1.247 0.931 0 C-N-CA 122.938 0.495 . . . . 73.24 110.933 179.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 22.1 t -88.64 -36.45 9.05 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 CA-C-N 113.532 -1.667 . . . . 73.2 112.504 -177.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.412 ' HB ' ' O ' ' A' ' 202' ' ' PRO . 55.5 t -98.61 -42.81 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 O-C-N 122.163 -0.335 . . . . 74.31 110.782 -177.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 122.26 152.14 8.57 Favored Glycine 0 N--CA 1.466 0.651 0 N-CA-C 110.919 -0.873 . . . . 72.1 110.919 -176.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.72 155.68 8.57 Favored Glycine 0 C--O 1.241 0.538 0 N-CA-C 111.444 -0.662 . . . . 72.01 111.444 178.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.583 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 35.4 ttmt -84.45 129.67 34.84 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 109.128 -0.693 . . . . 72.24 109.128 177.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.577 HG22 HG22 ' A' ' 199' ' ' VAL . 15.9 m -132.08 147.84 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.425 0.69 . . . . 71.33 109.594 179.062 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 14.4 ttp-105 -96.84 139.98 32.08 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.901 -1.045 . . . . 74.23 110.258 -167.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.602 ' HB3' HD13 ' A' ' 197' ' ' LEU . . . -132.24 120.59 22.39 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.001 0.92 . . . . 60.32 108.87 -174.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 33.5 tpp -78.04 110.02 12.62 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 108.826 -0.805 . . . . 75.55 108.826 174.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 56.4 p -112.33 -176.11 2.84 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 123.865 0.866 . . . . 72.3 109.971 -176.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.559 HD23 ' HD3' ' A' ' 241' ' ' PRO . 65.1 tp -47.9 -52.1 20.66 Favored 'General case' 0 C--N 1.354 0.782 0 C-N-CA 124.003 0.921 . . . . 74.22 111.55 173.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -72.84 -26.95 61.66 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 114.661 -1.154 . . . . 73.31 111.811 -171.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 137.85 -165.56 25.32 Favored Glycine 0 C--N 1.34 0.78 0 N-CA-C 111.299 -0.72 . . . . 60.33 111.299 -173.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.36 131.69 23.9 Favored 'Trans proline' 0 C--N 1.37 1.699 0 C-N-CA 122.081 1.854 . . . . 71.4 110.741 178.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 19.3 m -126.56 157.31 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 108.778 -0.823 . . . . 73.54 108.778 177.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.512 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 43.1 mt-10 -114.56 114.45 25.76 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 123.105 0.562 . . . . 73.33 109.511 -178.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.498 HG23 HG13 ' A' ' 168' ' ' VAL . 89.2 t -120.26 104.79 16.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 C-N-CA 125.474 1.51 . . . . 75.52 109.16 -169.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.583 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -76.11 117.63 18.01 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 122.836 0.454 . . . . 74.4 110.167 177.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 35.3 m -90.35 152.63 45.81 Favored Pre-proline 0 N--CA 1.478 0.927 0 C-N-CA 123.43 0.692 . . . . 74.3 111.289 -175.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . 0.525 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 45.2 Cg_endo -63.4 166.74 14.42 Favored 'Trans proline' 0 C--N 1.376 2.001 0 C-N-CA 123.507 2.805 . . . . 75.25 113.425 176.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -84.51 32.13 0.5 Allowed 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 122.83 2.353 . . . . 74.5 112.503 173.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 -150.51 -1.19 0.39 Allowed 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 112.561 0.578 . . . . 75.14 112.561 -179.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.546 HG21 HG13 ' A' ' 253' ' ' VAL . 0.6 OUTLIER -60.05 153.13 22.34 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 109.762 -0.458 . . . . 75.33 109.762 -167.101 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . 0.455 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 4.1 pt20 -133.08 161.51 34.21 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.55 0.74 . . . . 64.21 110.028 -174.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -63.46 110.66 2.02 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 109.024 -0.732 . . . . 70.42 109.024 174.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 114.72 3.74 21.87 Favored Glycine 0 C--O 1.241 0.545 0 CA-C-N 115.031 -0.986 . . . . 72.41 112.148 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.455 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -68.46 127.93 34.78 Favored 'General case' 0 CA--C 1.553 1.094 0 N-CA-C 109.288 -0.634 . . . . 75.22 109.288 -179.806 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -97.24 96.99 8.79 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.113 0.565 . . . . 74.02 109.776 -173.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.499 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 19.3 mt -81.83 99.21 8.88 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 106.558 -1.645 . . . . 75.32 106.558 179.092 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 5.0 ppt_? -82.56 116.2 21.87 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.832 -0.622 . . . . 74.43 111.396 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 7.3 mp -105.1 126.99 52.68 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 106.56 -1.645 . . . . 75.24 106.56 173.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 15.9 tptm -101.61 117.1 34.21 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 122.612 0.365 . . . . 72.31 110.668 -171.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 78.89 24.18 62.56 Favored Glycine 0 C--N 1.342 0.863 0 O-C-N 124.004 0.815 . . . . 64.34 112.907 -177.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 1.9 mmmp? -117.21 21.24 13.28 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 122.836 0.454 . . . . 72.22 111.144 -177.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -96.95 -129.95 6.4 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-O 119.406 -0.663 . . . . 64.54 112.095 -178.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 6.0 m-30 -71.04 152.76 94.82 Favored Pre-proline 0 CA--C 1.557 1.229 0 C-N-CA 123.264 0.626 . . . . 75.52 112.427 -177.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.559 ' HD3' HD23 ' A' ' 215' ' ' LEU . 74.3 Cg_endo -69.29 172.83 11.48 Favored 'Trans proline' 0 C--N 1.392 2.825 0 C-N-CA 123.837 3.025 . . . . 73.13 112.72 -179.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.405 ' N ' ' HD2' ' A' ' 243' ' ' PRO . . . -67.52 -39.73 91.04 Favored Glycine 0 CA--C 1.542 1.753 0 CA-C-O 118.058 -1.412 . . . . 72.14 114.671 -174.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . 0.405 ' HD2' ' N ' ' A' ' 242' ' ' GLY . 8.7 Cg_endo -52.28 -41.14 67.99 Favored 'Trans proline' 0 C--N 1.386 2.547 0 CA-C-N 121.071 2.435 . . . . 74.15 112.72 167.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -76.72 -25.21 53.28 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.16 0.584 . . . . 73.32 110.679 176.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 109.02 115.73 3.84 Favored Glycine 0 C--N 1.342 0.869 0 N-CA-C 109.354 -1.498 . . . . 73.22 109.354 -168.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -70.1 122.4 19.34 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 108.732 -0.84 . . . . 74.22 108.732 -178.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -142.82 -156.16 6.68 Favored Glycine 0 N--CA 1.465 0.596 0 N-CA-C 111.445 -0.662 . . . . 64.52 111.445 177.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 12.2 p30 -120.13 168.48 11.16 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-O 121.753 0.787 . . . . 71.54 111.357 -171.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 14.7 tp -135.5 133.46 38.49 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 107.84 -1.171 . . . . 74.43 107.84 -171.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -118.53 148.49 42.58 Favored 'General case' 0 C--O 1.253 1.28 0 N-CA-C 108.63 -0.878 . . . . 74.22 108.63 -178.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.499 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 91.6 mt -121.25 119.62 32.8 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.514 0.725 . . . . 72.21 109.162 -178.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -89.25 104.6 17.13 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 107.287 -1.375 . . . . 74.23 107.287 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.546 HG13 HG21 ' A' ' 227' ' ' THR . 55.4 t -62.89 128.43 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 121.271 0.558 . . . . 72.13 110.294 178.301 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 21.5 mtm105 -117.16 126.08 52.24 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.135 -1.432 . . . . 73.24 107.135 172.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 40.9 mm -88.5 127.28 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 109.751 -0.463 . . . . 72.2 109.751 -178.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.7 t . . . . . 0 CA--C 1.559 1.318 0 N-CA-C 107.775 -1.195 . . . . 74.24 107.775 -177.856 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 42.7 ttm . . . . . 0 N--CA 1.479 0.986 0 N-CA-C 109.72 -0.474 . . . . 55.04 109.72 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -138.24 73.18 1.43 Allowed 'General case' 0 N--CA 1.482 1.161 0 CA-C-O 122.233 1.015 . . . . 70.44 110.651 175.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -92.71 -12.08 32.35 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 115.341 -0.845 . . . . 75.21 110.87 176.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -96.26 7.73 66.74 Favored Glycine 0 C--N 1.35 1.329 0 CA-C-N 115.88 -0.6 . . . . 71.2 112.108 176.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -141.12 171.59 13.85 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.327 1.451 . . . . 75.24 107.328 172.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.46 HG13 HG22 ' A' ' 221' ' ' VAL . 55.9 t -108.65 152.52 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 123.498 0.719 . . . . 64.52 110.075 -176.027 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 46.5 mtm -99.28 -178.78 4.02 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.099 1.36 . . . . 73.1 109.212 -169.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 10.0 p -97.71 85.73 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 CA-C-O 123.429 1.585 . . . . 71.32 107.318 164.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' MET . . . . . 0.45 ' HE3' HG11 ' A' ' 221' ' ' VAL . 0.0 OUTLIER -121.65 -4.7 9.23 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 113.608 -1.633 . . . . 72.32 109.846 -174.66 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.541 ' HA ' ' HB3' ' A' ' 233' ' ' LEU . 67.5 m -43.1 -64.11 0.69 Allowed 'General case' 0 C--O 1.241 0.608 0 C-N-CA 126.681 1.992 . . . . 73.44 113.425 -176.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . 0.442 ' HB2' ' HB3' ' A' ' 224' ' ' PRO . 45.5 t80 -72.16 -35.54 69.07 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.535 0.734 . . . . 75.52 109.355 -178.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 94.86 -2.55 66.67 Favored Glycine 0 C--N 1.346 1.131 0 CA-C-N 114.529 -1.214 . . . . 64.33 112.634 -176.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 66.5 t30 67.32 5.93 4.54 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 125.039 1.336 . . . . 65.03 111.968 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 21.8 p -84.35 113.85 21.45 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.821 -0.807 . . . . 64.42 108.821 175.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -56.7 -17.02 7.46 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.382 1.073 . . . . 73.51 112.385 -174.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -56.06 158.35 3.99 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.514 1.126 . . . . 74.31 111.937 172.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -60.98 -23.16 65.15 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.695 0.798 . . . . 65.11 112.532 -175.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -160.32 -179.98 35.46 Favored Glycine 0 C--O 1.241 0.573 0 O-C-N 123.582 0.551 . . . . 52.43 112.38 177.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 27.3 t -161.28 140.44 10.15 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.658 0.783 . . . . 61.51 109.432 178.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -154.82 129.48 2.58 Favored Glycine 0 C--N 1.337 0.596 0 N-CA-C 111.075 -0.81 . . . . 74.12 111.075 179.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -145.45 123.41 1.89 Allowed Glycine 0 C--N 1.337 0.633 0 N-CA-C 111.248 -0.741 . . . . 75.11 111.248 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 43.7 p -80.1 151.78 29.65 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.815 0.846 . . . . 73.12 110.797 -178.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -135.03 -65.75 0.07 OUTLIER Glycine 0 C--N 1.347 1.176 0 N-CA-C 111.976 -0.45 . . . . 71.43 111.976 179.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -73.14 86.13 0.58 Allowed Glycine 0 C--N 1.343 0.971 0 N-CA-C 112.346 -0.302 . . . . 72.13 112.346 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 33.8 m -76.59 74.3 3.3 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.313 1.045 . . . . 73.34 111.747 -172.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 54.88 33.5 56.5 Favored Glycine 0 C--N 1.352 1.448 0 CA-C-N 115.708 -0.678 . . . . 74.53 113.037 -177.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -107.45 11.56 39.43 Favored Glycine 0 C--N 1.343 0.932 0 CA-C-O 119.295 -0.725 . . . . 61.2 113.305 -172.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 20.7 m 65.25 30.83 11.09 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.174 0.99 . . . . 73.12 110.241 -173.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.557 ' HB3' ' HA3' ' A' ' 247' ' ' GLY . 91.4 mt-30 -110.38 -41.87 4.27 Favored 'General case' 0 C--O 1.247 0.932 0 C-N-CA 124.647 1.179 . . . . 71.22 110.721 -173.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -73.53 153.8 40.13 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 114.407 -1.269 . . . . 70.2 108.978 -177.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 60.5 tp -148.89 138.91 22.18 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 123.841 0.856 . . . . 72.54 108.994 174.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -111.56 142.14 44.23 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.861 0.864 . . . . 74.24 108.74 171.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -147.67 156.37 42.71 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 108.734 -0.839 . . . . 72.23 108.734 167.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 33.0 p -84.69 153.01 23.36 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-O 122.368 1.08 . . . . 65.53 112.127 168.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.555 HD12 ' HB3' ' A' ' 212' ' ' ALA . 20.5 tp -125.52 132.86 52.53 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 112.507 -2.133 . . . . 73.23 106.361 167.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -95.26 112.24 23.98 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.875 0.845 . . . . 75.42 108.772 -179.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.626 HG23 HG23 ' A' ' 210' ' ' VAL . 41.1 t -117.18 132.13 23.65 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 124.589 1.156 . . . . 73.22 108.882 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -68.79 147.55 69.33 Favored 'Trans proline' 0 C--N 1.369 1.647 0 C-N-CA 122.108 1.872 . . . . 74.41 111.159 167.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -54.43 -45.69 99.28 Favored Pre-proline 0 N--CA 1.487 1.38 0 CA-C-O 118.3 -0.857 . . . . 62.12 111.784 174.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -50.85 -40.43 57.48 Favored 'Trans proline' 0 C--N 1.405 3.536 0 C-N-CA 122.172 1.915 . . . . 71.05 113.169 172.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -84.64 -23.25 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 109.398 -0.593 . . . . 75.12 109.398 -175.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . 0.459 ' HA ' HG22 ' A' ' 227' ' ' THR . . . -74.2 -39.57 63.07 Favored 'General case' 0 C--O 1.246 0.902 0 C-N-CA 123.06 0.544 . . . . 63.34 111.515 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 25.1 t -88.73 -36.92 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-N 114.558 -1.201 . . . . 75.2 112.598 -178.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 73.4 t -98.72 -41.02 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 O-C-N 122.136 -0.352 . . . . 73.3 110.807 -176.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 123.13 150.38 8.04 Favored Glycine 0 N--CA 1.475 1.236 0 CA-C-N 118.248 0.476 . . . . 75.03 112.068 177.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.91 153.6 7.57 Favored Glycine 0 C--N 1.343 0.946 0 N-CA-C 112.356 -0.297 . . . . 62.31 112.356 177.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.592 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 37.1 ttmt -84.63 131.95 34.54 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 122.945 0.498 . . . . 72.21 110.026 175.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.626 HG23 HG23 ' A' ' 199' ' ' VAL . 12.6 m -135.44 150.56 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.78 1.232 . . . . 75.32 108.639 -177.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -95.81 142.52 27.98 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.032 0.533 . . . . 74.32 110.563 -169.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.555 ' HB3' HD12 ' A' ' 197' ' ' LEU . . . -130.74 123.62 29.63 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.728 0.811 . . . . 64.2 109.301 -176.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 35.7 tpp -78.78 111.01 14.48 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 115.621 -0.718 . . . . 73.41 109.502 174.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 46.0 p -119.59 -177.05 3.29 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.955 0.902 . . . . 75.3 110.998 -174.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.533 HD23 ' HD3' ' A' ' 241' ' ' PRO . 59.6 tp -49.4 -51.16 36.93 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.465 1.106 . . . . 73.53 111.114 167.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -71.84 -25.75 62.1 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 113.444 -1.707 . . . . 74.43 111.002 -171.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 135.14 -166.6 24.37 Favored Glycine 0 C--N 1.342 0.897 0 N-CA-C 111.136 -0.786 . . . . 72.04 111.136 178.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -66.79 128.79 19.57 Favored 'Trans proline' 0 C--N 1.364 1.357 0 C-N-CA 121.44 1.427 . . . . 71.24 109.852 171.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 27.3 m -130.19 160.2 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.159 0.584 . . . . 75.01 110.143 -176.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.536 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 44.2 mt-10 -111.72 115.8 29.68 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.868 0.867 . . . . 65.52 109.016 -174.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.46 HG22 HG13 ' A' ' 168' ' ' VAL . 60.2 t -125.34 104.14 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 124.633 1.173 . . . . 61.24 110.414 -168.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.592 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -74.59 117.26 16.21 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.846 -0.427 . . . . 63.04 109.846 175.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 32.9 m -90.93 151.74 43.69 Favored Pre-proline 0 N--CA 1.482 1.168 0 C-N-CA 122.803 0.441 . . . . 75.31 109.96 179.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . 0.509 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 39.3 Cg_endo -65.17 166.03 20.19 Favored 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 122.535 2.157 . . . . 63.31 113.284 178.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -79.2 35.5 0.56 Allowed 'Trans proline' 0 C--N 1.37 1.673 0 C-N-CA 122.803 2.336 . . . . 72.22 112.626 167.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 19.3 tpt180 -147.88 -10.65 0.39 Allowed 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.339 0.496 . . . . 71.01 112.339 -178.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.573 HG21 HG13 ' A' ' 253' ' ' VAL . 0.6 OUTLIER -61.16 150.15 35.18 Favored 'General case' 0 CA--C 1.565 1.547 0 N-CA-C 109.226 -0.657 . . . . 75.21 109.226 -164.66 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . 0.495 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 10.7 pt20 -132.52 162.5 31.07 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 122.991 0.517 . . . . 63.12 109.917 -174.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . 0.651 ' HB1' HH21 ' A' ' 254' ' ' ARG . . . -56.91 111.47 1.04 Allowed 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 109.601 -0.518 . . . . 63.21 109.601 174.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.14 -0.83 22.59 Favored Glycine 0 C--N 1.336 0.553 0 CA-C-N 115.268 -0.878 . . . . 72.31 112.418 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.495 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -70.37 124.65 24.7 Favored 'General case' 0 C--N 1.358 0.939 0 N-CA-C 109.262 -0.644 . . . . 72.44 109.262 -171.129 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -98.87 96.62 7.98 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 109.599 -0.519 . . . . 74.34 109.599 -168.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.541 ' HB3' ' HA ' ' A' ' 172' ' ' SER . 19.7 mt -81.88 99.52 9.09 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 106.822 -1.547 . . . . 74.2 106.822 -175.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . 0.455 ' HD2' ' O ' ' A' ' 234' ' ' ARG . 5.1 ppt_? -79.84 121.52 25.5 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 123.645 0.591 . . . . 73.13 110.899 -176.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 8.1 mp -108.55 125.74 52.16 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 105.861 -1.903 . . . . 73.41 105.861 172.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 17.5 tptt -101.87 116.3 32.4 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 118.138 0.426 . . . . 73.44 109.929 -171.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 79.35 21.71 66.6 Favored Glycine 0 C--N 1.349 1.278 0 O-C-N 123.763 0.664 . . . . 60.53 113.834 -178.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.485 ' HZ1' ' HB3' ' A' ' 238' ' ' LYS . 0.8 OUTLIER -117.54 20.81 13.37 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.736 0.814 . . . . 73.34 109.884 -178.976 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -98.94 -132.61 7.75 Favored Glycine 0 C--N 1.349 1.303 0 CA-C-O 119.097 -0.835 . . . . 73.44 111.82 -178.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -70.29 152.1 95.67 Favored Pre-proline 0 N--CA 1.481 1.079 0 N-CA-C 112.943 0.72 . . . . 71.31 112.943 -172.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.533 ' HD3' HD23 ' A' ' 215' ' ' LEU . 61.0 Cg_endo -67.2 170.56 13.01 Favored 'Trans proline' 0 C--N 1.392 2.859 0 C-N-CA 122.928 2.419 . . . . 74.02 112.526 -178.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.437 ' N ' ' HD2' ' A' ' 243' ' ' PRO . . . -67.71 -38.58 89.95 Favored Glycine 0 CA--C 1.544 1.874 0 CA-C-O 117.973 -1.459 . . . . 75.23 114.357 -175.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 242' ' ' GLY . 10.1 Cg_endo -54.02 -36.28 83.87 Favored 'Trans proline' 0 C--N 1.388 2.644 0 CA-C-N 120.998 2.399 . . . . 55.54 113.438 167.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -81.33 -25.06 36.71 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-O 121.136 0.493 . . . . 74.53 110.125 174.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 112.22 114.8 3.37 Favored Glycine 0 C--N 1.341 0.82 0 N-CA-C 109.66 -1.376 . . . . 74.5 109.66 -168.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -72.38 122.64 21.53 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 117.825 0.812 . . . . 72.52 109.639 -177.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.557 ' HA3' ' HB3' ' A' ' 191' ' ' GLN . . . -148.34 -154.61 6.35 Favored Glycine 0 CA--C 1.503 -0.713 0 CA-C-N 116.003 -0.544 . . . . 71.04 112.315 -176.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 38.5 p-10 -121.46 163.54 18.61 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.507 0.723 . . . . 74.31 111.125 -167.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 9.5 tp -134.71 134.5 41.12 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.365 -0.976 . . . . 73.44 108.365 -171.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -115.81 148.46 39.87 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.471 -0.937 . . . . 73.13 108.471 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.402 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 67.7 mt -123.17 115.15 21.3 Favored 'General case' 0 C--O 1.22 -0.474 0 N-CA-C 108.29 -1.004 . . . . 73.32 108.29 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -89.38 113.54 24.87 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.618 -0.882 . . . . 73.03 108.618 -177.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.573 HG13 HG21 ' A' ' 227' ' ' THR . 50.3 t -60.75 124.79 15.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 O-C-N 124.019 0.824 . . . . 71.45 110.335 176.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . 0.651 HH21 ' HB1' ' A' ' 229' ' ' ALA . 0.5 OUTLIER -120.08 122.31 40.79 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 107.356 -1.35 . . . . 71.43 107.356 176.195 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.438 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 49.1 mm -83.8 122.36 37.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 O-C-N 123.984 0.803 . . . . 73.44 109.835 -173.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.2 t . . . . . 0 CA--C 1.565 1.549 0 C-N-CA 124.23 1.012 . . . . 70.05 108.822 -172.622 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' MET . . . . . 0.606 ' HA ' ' SD ' ' A' ' 169' ' ' MET . 26.8 ptt? . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 109.948 -0.389 . . . . 73.23 109.948 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 11.6 ttmm -118.27 128.41 54.65 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 107.388 -1.338 . . . . 73.42 107.388 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -83.93 -64.61 1.13 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.365 0.666 . . . . 70.11 112.255 -162.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -97.56 12.74 64.62 Favored Glycine 0 N--CA 1.472 1.077 0 CA-C-N 116.354 -0.384 . . . . 71.22 112.167 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -142.45 174.24 10.81 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.454 1.102 . . . . 70.42 109.35 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 52.4 t -110.67 150.99 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 123.442 0.697 . . . . 72.22 110.992 -176.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' MET . . . . . 0.606 ' SD ' ' HA ' ' A' ' 163' ' ' MET . 53.4 mtm -99.4 -176.68 3.36 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 125.915 1.686 . . . . 75.45 110.894 -164.121 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 8.5 p -101.88 86.17 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.073 0 N-CA-C 107.195 -1.409 . . . . 72.41 107.195 160.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.17 -4.25 7.95 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 114.148 -1.387 . . . . 75.01 110.76 -173.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.465 ' HA ' ' HB3' ' A' ' 233' ' ' LEU . 67.2 m -44.1 -65.82 0.46 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.995 1.718 . . . . 65.34 114.046 -168.23 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -70.85 -46.89 61.88 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 108.601 -0.889 . . . . 73.4 108.601 -176.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 68.28 28.95 73.07 Favored Glycine 0 C--N 1.354 1.54 0 CA-C-N 114.536 -1.211 . . . . 70.34 114.489 171.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . 0.581 HD22 ' HB2' ' A' ' 178' ' ' GLU . 59.7 t30 -161.0 158.31 27.75 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.031 0.443 . . . . 75.24 110.151 -177.074 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 16.1 p -87.96 115.76 25.66 Favored 'General case' 0 CA--C 1.555 1.163 0 N-CA-C 108.563 -0.903 . . . . 73.31 108.563 169.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -4.95 20.63 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.076 1 N-CA-C 122.062 4.097 . . . . 73.33 122.062 -159.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.581 ' HB2' HD22 ' A' ' 175' ' ' ASN . 43.4 mm-40 -86.9 157.5 19.5 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 119.872 1.214 . . . . 72.45 110.512 179.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -78.96 -62.43 1.7 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.235 1.014 . . . . 73.31 111.275 -173.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -66.82 91.81 0.19 Allowed Glycine 0 CA--C 1.529 0.943 0 O-C-N 124.366 1.041 . . . . 62.44 113.066 -175.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 29.7 p -155.84 142.73 18.94 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.593 0.757 . . . . 54.22 110.193 -177.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -134.54 -75.27 0.09 OUTLIER Glycine 0 C--N 1.343 0.972 0 CA-C-N 116.163 -0.471 . . . . 71.14 112.114 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 89.95 14.87 58.69 Favored Glycine 0 N--CA 1.473 1.137 0 O-C-N 123.824 0.367 . . . . 74.51 113.005 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 34.3 m -88.89 113.53 24.53 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.827 0.851 . . . . 75.11 109.78 178.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -170.36 165.1 38.4 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-O 120.008 -0.329 . . . . 70.23 112.883 -175.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 69.94 42.19 69.8 Favored Glycine 0 C--N 1.35 1.324 0 N-CA-C 111.907 -0.477 . . . . 63.22 111.907 -176.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 38.1 t -65.77 150.99 47.63 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.233 1.013 . . . . 73.41 113.267 -169.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -139.09 146.59 18.31 Favored Glycine 0 C--N 1.34 0.779 0 CA-C-N 115.031 -0.986 . . . . 74.44 110.903 173.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -62.73 -33.39 86.67 Favored Glycine 0 C--N 1.349 1.267 0 O-C-N 123.947 0.44 . . . . 73.21 113.734 -173.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 57.9 m -146.6 37.02 0.98 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.426 1.09 . . . . 70.12 109.233 174.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -105.47 -39.29 6.17 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 108.908 -0.775 . . . . 72.33 108.908 174.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -76.57 168.57 19.84 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-N 114.638 -1.165 . . . . 75.15 109.958 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 39.1 tp -152.44 142.97 22.72 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.269 -0.423 . . . . 74.41 110.104 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -116.13 138.14 51.51 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.797 0.839 . . . . 73.12 109.107 171.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -148.77 160.14 43.48 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.628 0.771 . . . . 73.51 109.42 174.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 37.9 p -84.42 154.54 22.74 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 122.276 1.036 . . . . 72.13 112.195 167.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.581 HD13 ' HB3' ' A' ' 212' ' ' ALA . 30.8 tp -120.47 134.4 55.28 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 112.844 -1.98 . . . . 73.44 106.789 165.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -97.52 111.72 23.87 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 109.107 -0.701 . . . . 74.34 109.107 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.626 HG22 HG23 ' A' ' 210' ' ' VAL . 28.1 t -123.01 130.98 24.39 Favored Pre-proline 0 N--CA 1.479 0.979 0 C-N-CA 124.549 1.139 . . . . 75.44 109.579 -177.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -69.95 144.93 54.55 Favored 'Trans proline' 0 C--N 1.366 1.489 0 C-N-CA 122.22 1.947 . . . . 73.33 111.232 165.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -53.13 -44.63 97.61 Favored Pre-proline 0 N--CA 1.487 1.413 0 CA-C-O 118.348 -0.834 . . . . 74.11 111.953 174.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -47.55 -41.49 29.87 Favored 'Trans proline' 0 C--N 1.401 3.317 0 C-N-CA 122.556 2.171 . . . . 75.15 113.416 171.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -85.91 -23.29 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 109.716 -0.476 . . . . 70.11 109.716 -175.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -72.45 -37.76 68.45 Favored 'General case' 0 C--O 1.249 1.051 0 CA-C-O 121.05 0.452 . . . . 74.42 111.535 178.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 20.3 t -89.73 -36.05 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.987 0 C-N-CA 125.444 1.497 . . . . 51.12 113.168 -178.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 54.4 t -97.12 -43.14 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 O-C-N 121.998 -0.438 . . . . 72.43 110.268 -176.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 120.95 151.51 8.62 Favored Glycine 0 C--N 1.339 0.744 0 N-CA-C 110.89 -0.884 . . . . 70.35 110.89 -176.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.6 155.89 8.65 Favored Glycine 0 C--O 1.246 0.886 0 N-CA-C 112.048 -0.421 . . . . 74.01 112.048 177.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.579 ' HD3' ' HB3' ' A' ' 220' ' ' GLU . 38.5 ttmt -84.54 131.6 34.62 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.319 0.648 . . . . 75.33 109.519 174.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.626 HG23 HG22 ' A' ' 199' ' ' VAL . 6.7 m -134.42 154.4 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.4 1.08 . . . . 72.41 110.581 -175.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 2.5 tmm_? -93.32 139.92 30.13 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.569 1.147 . . . . 75.01 109.751 -171.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.581 ' HB3' HD13 ' A' ' 197' ' ' LEU . . . -132.42 122.6 25.23 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.145 0.978 . . . . 73.01 108.734 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 31.3 tpp -77.68 110.2 12.32 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.679 -0.86 . . . . 64.43 108.679 173.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 62.2 p -121.25 -179.28 4.0 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.998 0.919 . . . . 75.23 110.221 -176.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.483 HD22 ' HD3' ' A' ' 241' ' ' PRO . 61.2 tp -45.09 -52.9 8.59 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.686 1.195 . . . . 75.22 112.485 176.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -72.39 -27.48 62.39 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 114.218 -1.355 . . . . 74.31 111.385 -173.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 138.02 -165.11 25.47 Favored Glycine 0 C--N 1.345 1.055 0 N-CA-C 111.561 -0.616 . . . . 64.44 111.561 -176.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -67.01 129.25 20.27 Favored 'Trans proline' 0 C--N 1.369 1.62 0 C-N-CA 122.147 1.898 . . . . 73.25 111.011 175.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 30.2 m -129.72 160.23 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 123.528 0.731 . . . . 74.44 110.659 -175.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.579 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 44.4 mt-10 -113.01 114.53 27.02 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.835 0.854 . . . . 72.22 109.655 -168.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 61.9 t -127.34 103.43 10.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 124.87 1.268 . . . . 74.03 109.39 -166.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.534 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -77.82 116.79 18.61 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.892 -0.41 . . . . 73.4 109.892 175.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 29.8 m -89.35 152.04 47.12 Favored Pre-proline 0 N--CA 1.492 1.626 0 C-N-CA 123.222 0.609 . . . . 72.13 111.116 -176.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . 0.582 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 29.7 Cg_endo -62.21 162.47 23.16 Favored 'Trans proline' 0 C--N 1.382 2.307 0 C-N-CA 122.197 1.931 . . . . 73.24 112.517 175.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -85.4 30.97 0.49 Allowed 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 123.115 2.543 . . . . 74.13 112.519 176.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -149.06 3.17 0.6 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 122.747 0.419 . . . . 75.11 111.447 176.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.582 ' HB ' ' HG2' ' A' ' 224' ' ' PRO . 0.7 OUTLIER -61.85 155.64 22.74 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 109.829 -0.434 . . . . 64.25 109.829 -171.776 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -136.55 162.41 33.19 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.078 0.551 . . . . 74.3 110.097 -176.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . 0.558 ' HB1' HH21 ' A' ' 254' ' ' ARG . . . -56.15 112.25 1.17 Allowed 'General case' 0 CA--C 1.538 0.505 0 O-C-N 123.471 0.482 . . . . 44.22 109.915 174.017 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.29 -1.07 22.37 Favored Glycine 0 C--O 1.239 0.418 0 CA-C-N 114.968 -1.014 . . . . 74.53 111.982 176.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.62 129.72 40.75 Favored 'General case' 0 C--N 1.361 1.108 0 N-CA-C 109.179 -0.674 . . . . 74.22 109.179 -174.071 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm -98.67 97.69 8.92 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.977 0.911 . . . . 75.32 110.065 -170.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.465 ' HB3' ' HA ' ' A' ' 172' ' ' SER . 17.3 mt -88.09 101.04 13.41 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 107.65 -1.241 . . . . 74.32 107.65 -178.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.48 125.53 29.69 Favored 'General case' 0 CA--C 1.551 1.009 0 CA-C-O 121.164 0.507 . . . . 74.44 110.213 178.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 6.9 mp -106.04 126.77 52.6 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 105.879 -1.897 . . . . 74.1 105.879 171.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 8.1 tptp -101.32 115.75 31.23 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 109.994 -0.373 . . . . 73.24 109.994 -168.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 77.5 29.25 56.03 Favored Glycine 0 C--N 1.354 1.574 0 O-C-N 123.676 0.61 . . . . 70.14 112.676 -178.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -124.53 23.85 8.04 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.807 0.843 . . . . 73.54 110.715 -177.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -94.41 -132.04 6.47 Favored Glycine 0 C--N 1.353 1.523 0 N-CA-C 111.167 -0.773 . . . . 74.32 111.167 178.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 6.2 m-30 -69.48 154.36 94.93 Favored Pre-proline 0 N--CA 1.481 1.08 0 CA-C-N 117.47 0.635 . . . . 64.01 112.043 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.483 ' HD3' HD22 ' A' ' 215' ' ' LEU . 72.8 Cg_endo -70.13 171.26 15.2 Favored 'Trans proline' 0 C--N 1.387 2.565 0 C-N-CA 122.826 2.351 . . . . 75.21 111.909 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -67.68 -38.96 90.43 Favored Glycine 0 CA--C 1.542 1.774 0 CA-C-O 118.479 -1.178 . . . . 75.23 114.078 -178.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . 0.429 ' HD2' ' HB2' ' A' ' 241' ' ' PRO . 87.8 Cg_exo -48.72 -35.19 29.56 Favored 'Trans proline' 0 C--N 1.383 2.36 0 C-N-CA 123.054 2.503 . . . . 75.13 114.09 165.267 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -88.3 -24.62 23.13 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.457 0.703 . . . . 73.34 110.998 174.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 105.76 115.23 4.03 Favored Glycine 0 C--N 1.345 1.06 0 N-CA-C 109.192 -1.563 . . . . 73.42 109.192 -169.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 35.3 mtt180 -73.1 134.07 44.38 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 122.988 0.515 . . . . 75.44 112.145 -178.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -145.75 -155.91 6.67 Favored Glycine 0 C--O 1.242 0.606 0 CA-C-N 114.654 -1.157 . . . . 74.44 110.304 174.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 12.6 p30 -118.01 168.03 10.91 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 122.949 0.5 . . . . 63.31 110.083 -175.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 9.7 tp -134.42 133.3 40.37 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 107.862 -1.162 . . . . 74.41 107.862 -172.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 10.0 m-30 -114.26 149.46 35.86 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.761 -0.829 . . . . 71.43 108.761 -177.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.413 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 92.1 mt -123.76 121.94 36.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.546 -0.752 . . . . 74.34 109.038 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -88.76 112.55 23.31 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 107.289 -1.375 . . . . 71.11 107.289 174.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.53 HG13 HG21 ' A' ' 227' ' ' THR . 54.1 t -60.8 123.47 13.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 108.868 -0.789 . . . . 75.13 108.868 173.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . 0.558 HH21 ' HB1' ' A' ' 229' ' ' ALA . 0.4 OUTLIER -114.65 123.29 48.92 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 106.71 -1.589 . . . . 73.24 106.71 176.411 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 38.1 mm -86.78 119.99 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 O-C-N 123.783 0.677 . . . . 74.51 109.721 -176.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.3 t . . . . . 0 CA--C 1.562 1.413 0 C-N-CA 125.292 1.437 . . . . 74.14 107.669 -170.533 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' MET . . . . . 0.439 ' N ' ' SD ' ' A' ' 163' ' ' MET . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.372 0 N-CA-C 109.268 -0.641 . . . . 74.52 109.268 . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -147.94 132.21 17.47 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.799 0.84 . . . . 75.21 110.201 176.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -89.2 -38.66 14.1 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.677 0.791 . . . . 64.5 111.972 -169.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -95.31 21.96 41.35 Favored Glycine 0 N--CA 1.476 1.359 0 N-CA-C 112.553 -0.219 . . . . 74.54 112.553 -174.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -153.63 173.24 16.03 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 124.579 1.151 . . . . 64.41 109.195 175.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.411 HG13 HG22 ' A' ' 221' ' ' VAL . 55.4 t -110.64 152.75 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 123.798 0.839 . . . . 72.52 110.39 -177.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 48.8 mtm -98.29 -176.2 3.33 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.88 1.672 . . . . 71.51 110.074 -168.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 8.7 p -101.71 88.47 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.026 0 CA-C-O 123.125 1.441 . . . . 72.23 108.079 161.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.81 -6.03 7.99 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 113.717 -1.583 . . . . 73.42 110.021 -177.129 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.452 ' HA ' ' HB3' ' A' ' 233' ' ' LEU . 68.5 m -37.64 -64.63 0.37 Allowed 'General case' 0 C--N 1.351 0.643 0 C-N-CA 126.97 2.108 . . . . 72.55 114.379 -168.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . 0.454 ' HB2' ' HB3' ' A' ' 224' ' ' PRO . 53.3 t80 -63.51 -53.37 53.02 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 123.661 0.6 . . . . 74.23 109.639 -174.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 64.15 -15.45 0.13 Allowed Glycine 0 CA--C 1.542 1.747 0 N-CA-C 115.937 1.135 . . . . 74.42 115.937 176.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -78.58 107.76 11.49 Favored 'General case' 0 C--N 1.349 0.566 0 C-N-CA 124.151 0.98 . . . . 72.31 108.725 -175.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 33.0 m -67.29 123.19 19.65 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 117.69 -1.148 . . . . 75.41 107.913 169.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -11.24 -46.72 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.806 0 C-N-CA 128.576 2.75 . . . . 65.34 116.884 -164.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -58.18 168.37 1.06 Allowed 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 124.647 1.179 . . . . 73.05 111.868 176.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -78.48 -6.16 54.61 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.164 0.585 . . . . 72.01 112.403 -179.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -76.65 -115.36 0.14 Allowed Glycine 0 CA--C 1.534 1.278 0 CA-C-O 119.899 -0.389 . . . . 71.3 113.691 -176.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 38.5 m 63.06 -83.14 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.904 1.281 . . . . 74.33 113.058 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 73.45 -88.65 0.61 Allowed Glycine 0 C--N 1.352 1.452 0 N-CA-C 111.64 -0.584 . . . . 61.11 111.64 -173.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 72.86 75.73 0.69 Allowed Glycine 0 C--N 1.351 1.414 0 C-N-CA 123.025 0.345 . . . . 72.51 113.275 173.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 34.5 p -138.45 123.1 18.62 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.501 0.72 . . . . 65.34 109.627 178.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -83.54 -77.83 1.1 Allowed Glycine 0 C--N 1.341 0.814 0 N-CA-C 110.757 -0.937 . . . . 60.52 110.757 177.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 86.32 -89.13 1.61 Allowed Glycine 0 C--N 1.342 0.892 0 CA-C-O 119.855 -0.414 . . . . 61.34 112.738 176.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 32.9 t 68.84 176.8 0.27 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 125.444 1.497 . . . . 53.21 111.236 -171.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -123.04 37.74 2.7 Favored Glycine 0 C--N 1.348 1.243 0 O-C-N 122.038 -0.414 . . . . 62.34 112.481 -177.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -120.5 11.97 10.34 Favored Glycine 0 N--CA 1.471 1.002 0 CA-C-O 119.18 -0.789 . . . . 53.2 113.852 -175.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 19.5 m 63.4 43.72 5.88 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 124.055 0.942 . . . . 62.52 110.652 -177.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -107.2 -37.5 6.25 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.817 1.247 . . . . 65.31 110.636 -172.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 35.1 p-10 -75.54 172.83 11.88 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-N 115.7 -0.682 . . . . 65.3 110.578 178.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 33.9 tp -152.96 140.7 20.0 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.878 -0.601 . . . . 73.42 110.545 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.569 ' HD2' ' HZ1' ' A' ' 232' ' ' LYS . 59.6 m-85 -112.36 137.95 49.78 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.508 -0.769 . . . . 72.54 108.927 169.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.428 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -148.13 158.01 43.83 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 107.919 -1.141 . . . . 73.32 107.919 170.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 25.1 p -89.87 154.11 20.13 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 122.188 0.994 . . . . 75.22 112.511 169.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.624 HD12 ' HB3' ' A' ' 212' ' ' ALA . 22.2 tp -124.28 132.84 53.59 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 112.997 -1.911 . . . . 74.13 107.352 164.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -94.72 113.7 25.51 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 108.372 -0.973 . . . . 73.53 108.372 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.616 HG22 HG21 ' A' ' 210' ' ' VAL . 24.8 t -118.0 130.9 24.43 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 114.95 -1.023 . . . . 74.04 108.578 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . 0.495 ' HG2' ' HB ' ' A' ' 203' ' ' ILE . 59.3 Cg_endo -73.76 149.76 43.5 Favored 'Trans proline' 0 C--N 1.366 1.475 0 C-N-CA 121.47 1.447 . . . . 73.24 110.833 168.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -53.45 -44.71 98.14 Favored Pre-proline 0 N--CA 1.483 1.202 0 CA-C-O 118.193 -0.908 . . . . 65.32 112.186 177.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.463 ' HD2' ' HB2' ' A' ' 200' ' ' PRO . 86.0 Cg_exo -50.56 -41.22 53.67 Favored 'Trans proline' 0 C--N 1.399 3.223 0 C-N-CA 122.46 2.107 . . . . 71.52 113.525 173.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.495 ' HB ' ' HG2' ' A' ' 200' ' ' PRO . 1.8 mp -86.42 -23.07 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 N-CA-C 109.718 -0.475 . . . . 74.31 109.718 -176.403 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -72.57 -36.71 68.25 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 122.934 0.494 . . . . 73.11 111.044 177.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 25.4 t -89.56 -36.37 8.57 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 125.663 1.585 . . . . 72.23 112.873 -178.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 50.2 t -98.23 -42.58 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 O-C-N 121.663 -0.648 . . . . 64.3 110.91 -176.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 120.82 153.95 9.19 Favored Glycine 0 C--N 1.341 0.855 0 N-CA-C 110.704 -0.958 . . . . 64.33 110.704 -176.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 161.03 154.94 7.61 Favored Glycine 0 C--O 1.245 0.786 0 N-CA-C 111.57 -0.612 . . . . 75.13 111.57 177.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.62 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 39.3 ttmt -86.54 128.95 35.02 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.905 0.352 . . . . 74.23 110.655 176.041 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.616 HG21 HG22 ' A' ' 199' ' ' VAL . 13.5 m -130.74 144.51 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.958 1.303 . . . . 74.34 108.533 -179.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 24.2 ttt180 -97.08 141.62 30.0 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.059 0.943 . . . . 73.52 110.437 -167.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.624 ' HB3' HD12 ' A' ' 197' ' ' LEU . . . -133.18 124.75 28.02 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.429 1.491 . . . . 72.31 110.187 -168.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 33.6 tpp -77.48 114.95 16.83 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 109.024 -0.732 . . . . 73.13 109.024 174.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 63.0 p -124.16 -176.3 3.46 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.193 0.997 . . . . 74.2 110.292 -177.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.514 HD23 ' HD3' ' A' ' 241' ' ' PRO . 66.9 tp -47.24 -51.58 18.38 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.623 1.169 . . . . 74.53 112.657 176.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -72.01 -27.22 62.58 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 114.75 -1.114 . . . . 74.21 111.085 -172.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 137.14 -165.2 25.22 Favored Glycine 0 C--O 1.244 0.774 0 N-CA-C 110.702 -0.959 . . . . 63.44 110.702 -173.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.79 131.54 24.44 Favored 'Trans proline' 0 CA--C 1.549 1.226 0 C-N-CA 121.979 1.786 . . . . 73.33 111.187 175.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 25.7 m -129.65 157.25 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 124.087 0.955 . . . . 74.45 108.742 -179.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.512 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 47.0 mt-10 -115.24 117.23 29.91 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-O 121.145 0.498 . . . . 71.12 111.358 -176.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.411 HG22 HG13 ' A' ' 168' ' ' VAL . 100.0 t -121.86 107.15 19.31 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 125.65 1.58 . . . . 62.43 110.893 -165.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.62 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -75.19 118.19 17.84 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.583 0.353 . . . . 71.42 111.122 176.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 26.8 m -89.6 154.4 48.32 Favored Pre-proline 0 N--CA 1.489 1.48 0 C-N-CA 123.71 0.804 . . . . 74.2 111.693 -176.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . 0.576 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 34.2 Cg_endo -63.02 164.04 20.63 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 122.658 2.239 . . . . 74.12 113.057 174.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -87.08 32.13 0.44 Allowed 'Trans proline' 0 C--N 1.37 1.66 0 C-N-CA 122.779 2.319 . . . . 74.22 113.19 174.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -147.97 1.46 0.66 Allowed 'General case' 0 N--CA 1.485 1.29 0 CA-C-O 118.903 -0.57 . . . . 74.53 112.333 175.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.576 ' HB ' ' HG2' ' A' ' 224' ' ' PRO . 0.7 OUTLIER -60.57 154.64 20.57 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 123.466 0.479 . . . . 72.24 110.406 -168.144 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . 0.475 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 4.9 pt20 -134.38 161.19 35.68 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.27 0.628 . . . . 71.03 110.698 -174.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -60.29 112.15 1.82 Allowed 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.906 -0.405 . . . . 71.53 109.906 176.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.41 0.75 21.96 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-N 115.083 -0.962 . . . . 75.3 112.122 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -72.81 126.05 28.99 Favored 'General case' 0 C--N 1.359 0.98 0 N-CA-C 108.835 -0.802 . . . . 71.24 108.835 -174.735 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.656 ' HZ3' ' HB2' ' A' ' 252' ' ' GLU . 30.1 mmmt -97.17 98.15 9.78 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 108.255 -1.016 . . . . 73.02 108.255 -173.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.452 ' HB3' ' HA ' ' A' ' 172' ' ' SER . 30.9 mt -77.96 99.94 6.24 Favored 'General case' 0 C--N 1.343 0.297 0 N-CA-C 106.803 -1.555 . . . . 72.42 106.803 -179.271 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . 0.538 ' HB2' ' HE2' ' A' ' 236' ' ' LYS . 0.0 OUTLIER -81.4 111.42 17.74 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 114.282 -1.326 . . . . 64.42 111.642 -173.952 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.512 ' O ' ' HB2' ' A' ' 248' ' ' ASP . 7.3 mp -100.28 127.85 46.48 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 106.193 -1.78 . . . . 73.42 106.193 173.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.538 ' HE2' ' HB2' ' A' ' 234' ' ' ARG . 5.3 mptp? -101.48 119.49 38.85 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.46 0.704 . . . . 73.31 110.868 -175.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 78.19 23.58 65.62 Favored Glycine 0 C--N 1.354 1.546 0 O-C-N 123.89 0.744 . . . . 60.41 112.662 -179.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.483 ' HB2' ' HB3' ' A' ' 235' ' ' LEU . 26.8 mmmt -119.06 21.28 12.42 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.297 1.039 . . . . 74.33 111.052 -175.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -94.12 -128.6 5.19 Favored Glycine 0 C--N 1.345 1.043 0 N-CA-C 110.243 -1.143 . . . . 74.11 110.243 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . 0.435 ' O ' ' HA ' ' A' ' 246' ' ' ARG . 7.3 m-30 -70.98 152.41 94.95 Favored Pre-proline 0 CA--C 1.551 0.985 0 CA-C-N 117.479 0.64 . . . . 71.45 111.668 178.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.514 ' HD3' HD23 ' A' ' 215' ' ' LEU . 48.2 Cg_endo -64.92 171.8 8.15 Favored 'Trans proline' 0 C--N 1.387 2.6 0 C-N-CA 123.182 2.588 . . . . 74.33 112.166 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -66.19 -41.87 94.62 Favored Glycine 0 CA--C 1.541 1.706 0 CA-C-O 118.489 -1.173 . . . . 72.1 113.445 -177.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . 0.45 ' HD2' ' HB2' ' A' ' 241' ' ' PRO . 81.4 Cg_exo -54.67 -39.9 86.84 Favored 'Trans proline' 0 C--N 1.388 2.632 0 C-N-CA 122.556 2.171 . . . . 72.44 114.095 168.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -76.68 -22.43 54.0 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.479 0.712 . . . . 71.23 110.646 177.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 106.93 111.78 3.61 Favored Glycine 0 C--N 1.343 0.953 0 N-CA-C 108.679 -1.768 . . . . 62.51 108.679 -172.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.435 ' HA ' ' O ' ' A' ' 240' ' ' PHE . 54.1 ttp180 -73.4 124.66 26.21 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 117.086 0.443 . . . . 72.44 110.76 -174.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -135.84 -158.8 8.3 Favored Glycine 0 CA--C 1.505 -0.552 0 N-CA-C 110.488 -1.045 . . . . 73.34 110.488 174.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . 0.512 ' HB2' ' O ' ' A' ' 235' ' ' LEU . 34.2 p-10 -123.14 161.96 23.42 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.137 0.575 . . . . 72.22 110.125 -174.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 8.4 tp -132.0 134.89 46.09 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 108.375 -0.972 . . . . 72.1 108.375 -168.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -115.67 148.96 39.1 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 108.53 -0.915 . . . . 74.33 108.53 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.428 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 75.0 mt -122.38 112.49 18.15 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 108.594 -0.891 . . . . 72.33 108.594 179.045 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . 0.656 ' HB2' ' HZ3' ' A' ' 232' ' ' LYS . 34.1 tt0 -89.76 112.28 23.53 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.285 -1.006 . . . . 72.11 108.285 -173.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.557 HG11 HG21 ' A' ' 227' ' ' THR . 53.8 t -61.6 125.9 18.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 114.969 -1.014 . . . . 74.13 110.222 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 41.8 mtp180 -115.54 122.51 45.9 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 106.571 -1.64 . . . . 74.4 106.571 171.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.468 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 46.8 mm -83.76 123.57 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 122.665 0.386 . . . . 71.31 110.123 -175.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.2 t . . . . . 0 CA--C 1.561 1.4 0 C-N-CA 124.273 1.029 . . . . 75.43 109.056 -172.275 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 53.8 t . . . . . 0 N--CA 1.471 0.591 0 CA-C-O 121.49 0.662 . . . . 73.120000000000005 110.395 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 44.8 mtm -102.64 -175.54 2.85 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.183 1.793 . . . . 65.140000000000001 110.132 -166.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 8.3 p -94.25 87.7 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.115 0 CA-C-O 123.196 1.474 . . . . 74.010000000000005 108.037 159.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.28 -5.09 7.81 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 113.737 -1.574 . . . . 73.299999999999997 110.308 -177.149 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.51 ' HA ' ' HB3' ' A' ' 233' ' ' LEU . 69.9 m -37.54 -63.48 0.45 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.972 2.109 . . . . 35.409999999999997 114.488 -170.261 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 62.0 t80 . . . . . 0 N--CA 1.477 0.889 0 CA-C-O 121.116 0.484 . . . . 73.120000000000005 111.234 -172.517 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 . . . . . 0 N--CA 1.475 0.789 0 N-CA-C 108.071 -1.085 . . . . 63.520000000000003 108.071 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -74.39 170.06 16.41 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 114.587 -1.188 . . . . 72.299999999999997 110.086 175.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 35.6 tp -152.71 139.08 18.5 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 115.904 -0.589 . . . . 71.439999999999998 109.5 176.041 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -112.5 139.94 47.66 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.53 -0.915 . . . . 74.439999999999998 108.53 169.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -147.76 156.35 42.65 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.464 -0.939 . . . . 44.100000000000001 108.464 166.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 20.4 p -84.28 150.94 25.08 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 122.446 1.117 . . . . 63.420000000000002 112.248 169.082 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.599 HD13 ' HB2' ' A' ' 212' ' ' ALA . 36.7 tp -126.03 133.66 51.67 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 113.063 -1.881 . . . . 71.340000000000003 106.774 170.255 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.442 ' HB2' HG21 ' A' ' 256' ' ' THR . 12.7 p-10 -94.69 111.55 23.32 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 108.535 -0.913 . . . . 74.129999999999995 108.535 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.596 HG22 HG21 ' A' ' 210' ' ' VAL . 58.1 t -115.94 129.48 25.15 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-N 114.783 -1.099 . . . . 73.209999999999994 108.884 -179.093 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -65.73 146.41 83.73 Favored 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 122.398 2.066 . . . . 73.319999999999993 111.513 169.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.436 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.62 -45.7 98.56 Favored Pre-proline 0 CA--C 1.565 1.527 0 C-N-CA 123.612 0.765 . . . . 75.239999999999995 111.918 174.604 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 27.6 Cg_endo -61.06 -31.03 90.52 Favored 'Trans proline' 0 C--N 1.404 3.462 0 C-N-CA 122.293 1.996 . . . . 74.319999999999993 112.618 176.419 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -86.25 -24.17 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 N-CA-C 108.962 -0.755 . . . . 70.209999999999994 108.962 -177.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -74.25 -37.03 63.88 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 123.079 0.552 . . . . 71.129999999999995 110.764 178.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 28.4 t -87.45 -38.71 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 O-C-N 124.68 1.238 . . . . 74.209999999999994 112.711 -178.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 54.9 t -98.4 -42.26 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 O-C-N 121.953 -0.467 . . . . 72.349999999999994 111.149 -175.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 123.06 155.56 9.34 Favored Glycine 0 C--N 1.339 0.732 0 N-CA-C 111.021 -0.832 . . . . 41.25 111.021 -175.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 161.38 156.09 8.16 Favored Glycine 0 C--O 1.245 0.819 0 N-CA-C 111.29 -0.724 . . . . 74.400000000000006 111.29 177.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.618 ' HD3' ' HB3' ' A' ' 220' ' ' GLU . 37.3 ttmt -84.28 136.66 33.83 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 109.437 -0.579 . . . . 44.439999999999998 109.437 175.163 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.596 HG21 HG22 ' A' ' 199' ' ' VAL . 11.4 m -135.16 151.48 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.363 1.065 . . . . 73.400000000000006 108.776 175.267 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 211' ' ' ARG . . . . . 0.402 ' HD2' ' N ' ' A' ' 212' ' ' ALA . 2.2 tmm_? -96.34 141.79 29.25 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.419 0.688 . . . . 61.43 109.734 -171.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.599 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -131.1 123.88 29.57 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.536 0.734 . . . . 34.0 109.03 -177.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 37.8 tpp -80.36 109.78 15.18 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 107.837 -1.172 . . . . 71.230000000000004 107.837 172.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 73.4 p -113.0 -172.64 2.09 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.418 0.687 . . . . 63.299999999999997 110.536 -176.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.626 HD21 ' HD3' ' A' ' 241' ' ' PRO . 66.6 tp -46.18 -50.82 15.23 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.439 1.095 . . . . 72.329999999999998 111.598 170.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -72.09 -30.05 64.71 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.055 -0.975 . . . . 45.109999999999999 111.753 -174.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 132.45 -164.45 23.91 Favored Glycine 0 C--N 1.342 0.871 0 CA-C-O 119.344 -0.698 . . . . 75.519999999999996 111.676 -170.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -66.68 129.02 20.1 Favored 'Trans proline' 0 C--N 1.374 1.89 0 C-N-CA 122.437 2.091 . . . . 75.310000000000002 111.346 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.445 HG22 ' O ' ' A' ' 212' ' ' ALA . 28.4 m -134.26 164.17 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 123.472 0.709 . . . . 74.219999999999999 110.975 -175.011 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.618 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 41.9 mt-10 -109.07 114.61 28.49 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.257 1.023 . . . . 64.049999999999997 108.689 -171.556 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 34.9 t -125.6 100.81 7.4 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 123.471 0.709 . . . . 74.129999999999995 109.665 -174.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.555 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -79.21 117.6 20.38 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 122.556 0.342 . . . . 60.329999999999998 110.243 174.622 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 30.2 m -88.09 152.12 50.18 Favored Pre-proline 0 N--CA 1.49 1.569 0 C-N-CA 123.253 0.621 . . . . 62.409999999999997 111.877 -175.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' PRO . . . . . 0.523 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 33.5 Cg_endo -63.62 163.71 23.46 Favored 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 122.651 2.234 . . . . 72.310000000000002 113.432 176.531 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -84.16 33.73 0.51 Allowed 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 123.237 2.625 . . . . 74.200000000000003 113.263 175.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' ARG . . . . . 0.418 ' HD2' ' HA ' ' A' ' 226' ' ' ARG . 10.0 tpt180 -150.07 -1.61 0.41 Allowed 'General case' 0 N--CA 1.477 0.897 0 O-C-N 121.805 -0.559 . . . . 73.319999999999993 112.217 175.022 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.576 HG23 HG11 ' A' ' 253' ' ' VAL . 0.6 OUTLIER -59.6 152.45 22.18 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 123.683 0.615 . . . . 71.340000000000003 109.639 -164.457 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 228' ' ' GLN . . . . . 0.492 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 5.2 pt20 -132.46 161.42 33.74 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.081 0.553 . . . . 75.25 110.29 -169.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -60.47 112.11 1.84 Allowed 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 109.818 -0.438 . . . . 50.32 109.818 174.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.25 -3.31 22.23 Favored Glycine 0 C--O 1.244 0.774 0 CA-C-N 115.269 -0.878 . . . . 71.019999999999996 111.895 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.492 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -67.79 126.85 30.71 Favored 'General case' 0 C--N 1.361 1.078 0 N-CA-C 109.016 -0.735 . . . . 75.219999999999999 109.016 -172.114 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -97.27 98.73 10.24 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 108.944 -0.761 . . . . 74.120000000000005 108.944 -173.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.51 ' HB3' ' HA ' ' A' ' 172' ' ' SER . 31.5 mt -79.16 100.78 7.59 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.059 -1.46 . . . . 63.509999999999998 107.059 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -79.69 124.97 29.06 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 124.381 1.05 . . . . 64.230000000000004 110.164 -175.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.583 ' HB3' ' HB2' ' A' ' 238' ' ' LYS . 7.1 mp -111.41 123.94 51.24 Favored 'General case' 0 C--O 1.219 -0.504 0 N-CA-C 104.769 -2.308 . . . . 70.450000000000003 104.769 170.226 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.478 ' HA ' ' HB3' ' A' ' 248' ' ' ASP . 44.2 tptt -103.07 117.34 34.35 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 118.92 0.782 . . . . 72.430000000000007 110.58 -171.382 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 79.03 27.03 57.05 Favored Glycine 0 C--N 1.345 1.045 0 O-C-N 123.429 0.455 . . . . 55.350000000000001 112.012 -175.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.583 ' HB2' ' HB3' ' A' ' 235' ' ' LEU . 29.4 mmmt -128.82 24.0 5.72 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.219 1.008 . . . . 72.0 111.68 -176.219 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 239' ' ' GLY . . . . . 0.455 ' HA2' ' HB2' ' A' ' 249' ' ' LEU . . . -95.73 -129.47 5.92 Favored Glycine 0 N--CA 1.469 0.876 0 N-CA-C 110.857 -0.897 . . . . 64.329999999999998 110.857 178.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 240' ' ' PHE . . . . . 0.459 ' O ' ' HA ' ' A' ' 246' ' ' ARG . 4.8 m-30 -68.58 153.13 96.16 Favored Pre-proline 0 CA--C 1.548 0.894 0 CA-C-N 117.374 0.587 . . . . 51.340000000000003 111.45 177.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.626 ' HD3' HD21 ' A' ' 215' ' ' LEU . 89.3 Cg_endo -69.95 172.64 12.45 Favored 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 123.346 2.697 . . . . 73.430000000000007 112.74 -174.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -66.33 -38.19 93.46 Favored Glycine 0 CA--C 1.545 1.943 0 CA-C-O 118.353 -1.248 . . . . 75.019999999999996 113.733 -178.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 243' ' ' PRO . . . . . 0.592 ' HD2' ' HB2' ' A' ' 241' ' ' PRO . 79.3 Cg_exo -52.75 -39.05 78.05 Favored 'Trans proline' 0 C--N 1.392 2.859 0 CA-C-N 120.918 2.359 . . . . 62.200000000000003 113.619 167.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -78.73 -23.5 45.43 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.583 0.753 . . . . 71.329999999999998 110.635 175.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 102.83 113.3 3.77 Favored Glycine 0 C--N 1.342 0.864 0 N-CA-C 108.4 -1.88 . . . . 40.229999999999997 108.4 -168.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.459 ' HA ' ' O ' ' A' ' 240' ' ' PHE . 15.9 ttp180 -70.81 131.22 43.47 Favored 'General case' 0 C--N 1.348 0.526 0 CA-C-N 117.473 0.636 . . . . 72.540000000000006 110.033 -172.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -136.23 -157.15 7.7 Favored Glycine 0 CA--C 1.502 -0.775 0 N-CA-C 110.879 -0.888 . . . . 63.420000000000002 110.879 176.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 248' ' ' ASP . . . . . 0.478 ' HB3' ' HA ' ' A' ' 236' ' ' LYS . 0.4 OUTLIER -124.24 159.03 31.08 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.698 0.799 . . . . 71.120000000000005 111.081 -175.945 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.455 ' HB2' ' HA2' ' A' ' 239' ' ' GLY . 8.0 tp -130.12 135.35 48.12 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.222 1.009 . . . . 72.349999999999994 108.512 -167.245 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -118.86 146.35 44.94 Favored 'General case' 0 C--O 1.247 0.922 0 N-CA-C 107.137 -1.431 . . . . 75.129999999999995 107.137 -174.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.459 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 71.1 mt -123.04 114.21 20.08 Favored 'General case' 0 C--O 1.223 -0.329 0 N-CA-C 108.078 -1.082 . . . . 50.109999999999999 108.078 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -88.59 111.71 22.2 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 107.712 -1.218 . . . . 72.25 107.712 -175.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.576 HG11 HG23 ' A' ' 227' ' ' THR . 56.0 t -62.06 127.35 21.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 114.871 -1.058 . . . . 65.109999999999999 110.176 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 14.5 mmt85 -117.1 122.24 43.58 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 106.89 -1.522 . . . . 73.430000000000007 106.89 173.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 46.3 mm -82.65 118.55 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 115.491 -0.777 . . . . 74.540000000000006 110.411 -174.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 256' ' ' THR . . . . . 0.442 HG21 ' HB2' ' A' ' 198' ' ' ASP . 1.4 t . . . . . 0 CA--C 1.556 1.188 0 C-N-CA 124.928 1.291 . . . . 74.140000000000001 107.697 -175.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.407 HG11 HG22 ' A' ' 221' ' ' VAL . 56.1 t . . . . . 0 N--CA 1.476 0.872 0 CA-C-O 121.761 0.791 . . . . 72.430000000000007 111.715 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 46.2 mtm -99.38 -176.72 3.37 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.794 1.638 . . . . 74.319999999999993 109.898 -169.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 8.7 p -94.5 87.11 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.027 0 CA-C-O 122.986 1.375 . . . . 75.409999999999997 108.324 163.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.57 -4.84 7.68 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 125.552 1.541 . . . . 62.32 110.024 -178.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 68.4 m -41.85 -64.81 0.52 Allowed 'General case' 0 C--O 1.246 0.909 0 C-N-CA 126.369 1.868 . . . . 74.25 113.042 -168.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' TYR . . . . . 0.623 ' HB2' ' HB3' ' A' ' 224' ' ' PRO . 63.1 t80 . . . . . 0 C--N 1.352 0.696 0 N-CA-C 108.764 -0.828 . . . . 73.400000000000006 108.764 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 . . . . . 0 N--CA 1.477 0.915 0 CA-C-O 121.079 0.466 . . . . 73.450000000000003 111.076 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.58 171.03 15.32 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-N 115.187 -0.915 . . . . 52.32 109.299 -176.485 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.423 ' O ' ' HA ' ' A' ' 249' ' ' LEU . 37.1 tp -152.3 131.53 12.78 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.44 -0.948 . . . . 61.210000000000001 108.44 174.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -117.26 138.29 51.83 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 123.41 0.684 . . . . 74.549999999999997 109.158 171.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -148.14 165.79 29.81 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.49 1.116 . . . . 73.519999999999996 108.165 176.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' THR . . . . . 0.435 HG21 ' HE ' ' A' ' 254' ' ' ARG . 39.8 p -93.67 154.74 17.65 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 122.395 1.093 . . . . 50.020000000000003 112.275 168.077 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.638 HD13 ' HB2' ' A' ' 212' ' ' ALA . 35.4 tp -125.6 132.16 52.57 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 112.767 -2.015 . . . . 75.340000000000003 106.421 165.217 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -95.27 117.42 30.24 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 107.879 -1.156 . . . . 73.040000000000006 107.879 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.592 HG22 HG21 ' A' ' 210' ' ' VAL . 58.0 t -119.57 131.55 24.34 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 124.353 1.061 . . . . 72.340000000000003 110.019 -178.326 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -65.1 144.23 81.03 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.326 2.017 . . . . 61.149999999999999 111.418 168.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.451 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.47 -44.94 98.62 Favored Pre-proline 0 CA--C 1.564 1.517 0 C-N-CA 123.799 0.84 . . . . 72.310000000000002 112.167 174.227 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 17.8 Cg_endo -58.72 -33.45 98.35 Favored 'Trans proline' 0 C--N 1.404 3.499 0 C-N-CA 121.784 1.656 . . . . 73.239999999999995 112.361 175.01 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -86.06 -23.61 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 N-CA-C 109.357 -0.609 . . . . 75.120000000000005 109.357 -177.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -74.12 -39.33 63.41 Favored 'General case' 0 C--O 1.243 0.729 0 C-N-CA 123.046 0.538 . . . . 40.039999999999999 110.897 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 38.6 t -89.42 -36.05 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.818 1.247 . . . . 61.149999999999999 112.962 -178.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.436 ' HB ' ' O ' ' A' ' 202' ' ' PRO . 47.6 t -95.98 -41.47 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 O-C-N 121.538 -0.726 . . . . 72.109999999999999 110.184 -177.274 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 121.57 152.12 8.66 Favored Glycine 0 C--N 1.344 0.98 0 N-CA-C 110.57 -1.012 . . . . 63.310000000000002 110.57 -178.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.89 155.99 8.77 Favored Glycine 0 C--O 1.242 0.606 0 N-CA-C 112.289 -0.324 . . . . 65.230000000000004 112.289 176.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.619 ' HD3' ' HB3' ' A' ' 220' ' ' GLU . 38.3 ttmt -84.25 132.47 34.64 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.049 0.54 . . . . 71.420000000000002 109.781 175.275 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.592 HG21 HG22 ' A' ' 199' ' ' VAL . 8.3 m -131.07 150.62 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.674 1.19 . . . . 61.409999999999997 108.225 174.367 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -95.73 143.62 26.83 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 109.226 -0.657 . . . . 73.549999999999997 109.226 -174.132 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.638 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -130.76 128.02 39.92 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.976 0.91 . . . . 50.140000000000001 109.035 -177.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 31.7 tpp -79.39 116.37 19.59 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.642 -0.873 . . . . 61.210000000000001 108.642 171.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 68.8 p -121.06 -176.59 3.3 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.787 0.835 . . . . 64.150000000000006 110.001 -177.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.53 HD21 ' HD3' ' A' ' 241' ' ' PRO . 66.6 tp -46.72 -51.38 16.27 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.497 1.119 . . . . 54.32 111.894 172.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -72.1 -27.19 62.49 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 114.044 -1.434 . . . . 74.319999999999993 111.269 -172.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 131.98 -164.39 23.71 Favored Glycine 0 C--N 1.338 0.677 0 N-CA-C 111.508 -0.637 . . . . 75.430000000000007 111.508 -174.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -66.45 129.83 22.29 Favored 'Trans proline' 0 C--N 1.361 1.21 0 C-N-CA 122.407 2.071 . . . . 74.430000000000007 111.35 178.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 31.8 m -133.18 161.33 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 123.738 0.815 . . . . 54.130000000000003 110.816 -177.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.619 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 53.1 mt-10 -110.32 110.77 21.7 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.559 1.144 . . . . 74.409999999999997 109.842 -173.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.407 HG22 HG11 ' A' ' 168' ' ' VAL . 48.8 t -121.15 102.39 12.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 C-N-CA 124.352 1.061 . . . . 73.109999999999999 109.228 -172.079 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.603 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -79.2 117.08 19.89 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 122.796 0.439 . . . . 54.329999999999998 110.532 174.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 34.8 m -86.52 153.59 55.93 Favored Pre-proline 0 N--CA 1.487 1.392 0 C-N-CA 123.737 0.815 . . . . 74.219999999999999 111.457 -176.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' PRO . . . . . 0.623 ' HB3' ' HB2' ' A' ' 173' ' ' TYR . 32.7 Cg_endo -63.02 164.94 17.86 Favored 'Trans proline' 0 C--N 1.379 2.155 0 C-N-CA 122.737 2.291 . . . . 74.430000000000007 113.189 175.539 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -84.0 29.53 0.54 Allowed 'Trans proline' 0 C--N 1.369 1.606 0 C-N-CA 123.258 2.639 . . . . 74.219999999999999 113.178 172.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -145.9 0.1 0.83 Allowed 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 118.618 -0.706 . . . . 75.120000000000005 112.499 177.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.563 HG23 HG11 ' A' ' 253' ' ' VAL . 0.6 OUTLIER -60.95 154.66 21.85 Favored 'General case' 0 CA--C 1.573 1.84 0 O-C-N 123.375 0.422 . . . . 73.129999999999995 109.906 -167.117 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 228' ' ' GLN . . . . . 0.492 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 4.8 pt20 -135.26 161.94 33.98 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.563 0.745 . . . . 70.219999999999999 110.948 -169.566 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -62.75 110.86 1.88 Allowed 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.244 -0.65 . . . . 73.340000000000003 109.244 176.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.09 -0.55 22.65 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-N 115.187 -0.915 . . . . 40.140000000000001 111.903 178.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.492 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -67.92 123.85 21.75 Favored 'General case' 0 C--N 1.362 1.128 0 N-CA-C 108.824 -0.806 . . . . 75.310000000000002 108.824 -171.041 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -100.08 96.72 7.7 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.222 -0.658 . . . . 75.540000000000006 109.222 -170.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.464 ' O ' ' HA ' ' A' ' 250' ' ' TYR . 24.4 mt -80.21 98.57 7.41 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 106.378 -1.712 . . . . 73.430000000000007 106.378 -177.32 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 234' ' ' ARG . . . . . 0.671 ' HD3' ' HE2' ' A' ' 236' ' ' LYS . 0.0 OUTLIER -82.19 125.61 31.11 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.476 0.71 . . . . 52.450000000000003 111.501 178.631 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.563 ' HB3' ' HB2' ' A' ' 238' ' ' LYS . 7.2 mp -111.17 128.52 55.93 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 106.627 -1.619 . . . . 74.519999999999996 106.627 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.671 ' HE2' ' HD3' ' A' ' 234' ' ' ARG . 5.6 mptp? -97.07 116.84 30.0 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.253 0.621 . . . . 74.209999999999994 110.986 -173.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 76.46 29.27 58.31 Favored Glycine 0 C--N 1.35 1.307 0 O-C-N 124.06 0.85 . . . . 41.030000000000001 112.047 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.563 ' HB2' ' HB3' ' A' ' 235' ' ' LEU . 29.3 mmmt -127.27 20.38 6.82 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.113 0.965 . . . . 75.450000000000003 111.124 -175.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -94.95 -127.84 5.22 Favored Glycine 0 C--N 1.343 0.942 0 N-CA-C 110.059 -1.217 . . . . 43.509999999999998 110.059 178.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 240' ' ' PHE . . . . . 0.431 ' O ' ' HA ' ' A' ' 246' ' ' ARG . 7.3 m-30 -71.53 152.07 93.83 Favored Pre-proline 0 CA--C 1.554 1.098 0 CA-C-N 117.121 0.46 . . . . 72.409999999999997 111.767 177.21 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.53 ' HD3' HD21 ' A' ' 215' ' ' LEU . 59.2 Cg_endo -65.67 172.08 8.67 Favored 'Trans proline' 0 C--N 1.384 2.426 0 C-N-CA 123.468 2.779 . . . . 74.430000000000007 112.332 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.416 ' N ' ' HD2' ' A' ' 243' ' ' PRO . . . -66.31 -42.24 94.16 Favored Glycine 0 CA--C 1.541 1.672 0 CA-C-O 118.241 -1.311 . . . . 44.5 114.185 -176.205 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 243' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' A' ' 242' ' ' GLY . 10.2 Cg_endo -51.77 -38.78 67.72 Favored 'Trans proline' 0 C--N 1.392 2.825 0 C-N-CA 122.697 2.265 . . . . 51.219999999999999 113.223 168.341 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -79.19 -23.68 43.7 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.168 0.587 . . . . 31.52 110.839 176.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 105.79 111.33 3.58 Favored Glycine 0 C--N 1.343 0.919 0 N-CA-C 108.757 -1.737 . . . . 74.109999999999999 108.757 -170.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.431 ' HA ' ' O ' ' A' ' 240' ' ' PHE . 74.3 mtt180 -63.6 124.54 21.64 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.46 0.704 . . . . 73.530000000000001 110.965 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -136.81 -158.15 7.9 Favored Glycine 0 C--O 1.24 0.517 0 CA-C-N 115.582 -0.736 . . . . 52.210000000000001 112.253 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -117.32 164.74 14.38 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.839 0.856 . . . . 54.200000000000003 109.517 -176.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.423 ' HA ' ' O ' ' A' ' 193' ' ' LEU . 12.3 tp -133.78 132.53 40.61 Favored 'General case' 0 C--O 1.217 -0.654 0 N-CA-C 108.541 -0.911 . . . . 65.549999999999997 108.541 -176.165 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.464 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 0.4 OUTLIER -113.27 145.55 40.84 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 123.48 0.712 . . . . 73.450000000000003 109.433 177.803 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 73.5 mt -124.28 112.5 17.08 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.361 -1.348 . . . . 71.540000000000006 107.361 176.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -92.19 106.57 18.55 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 107.526 -1.287 . . . . 64.329999999999998 107.526 -172.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.563 HG11 HG23 ' A' ' 227' ' ' THR . 56.0 t -61.88 125.86 18.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 115.005 -0.998 . . . . 73.349999999999994 110.623 -177.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 254' ' ' ARG . . . . . 0.435 ' HE ' HG21 ' A' ' 196' ' ' THR . 26.4 mtm180 -113.6 123.77 50.75 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 106.644 -1.613 . . . . 70.030000000000001 106.644 171.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 46.5 mm -84.78 130.77 35.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 C-N-CA 123.181 0.592 . . . . 73.430000000000007 109.851 -175.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.4 t . . . . . 0 CA--C 1.563 1.471 0 C-N-CA 124.24 1.016 . . . . 72.400000000000006 108.355 -172.109 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.46 HG11 HG22 ' A' ' 221' ' ' VAL . 51.1 t . . . . . 0 N--CA 1.476 0.847 0 CA-C-O 121.441 0.639 . . . . 51.130000000000003 110.54 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 43.3 mtm -98.35 -177.78 3.82 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 125.544 1.538 . . . . 62.509999999999998 109.656 -169.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 9.0 p -100.52 90.4 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 N-CA-C 107.42 -1.326 . . . . 73.430000000000007 107.42 162.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' MET . . . . . 0.435 ' HG3' ' HA ' ' A' ' 235' ' ' LEU . 0.0 OUTLIER -125.3 -6.14 7.13 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 114.096 -1.411 . . . . 75.310000000000002 110.297 -175.863 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.448 ' HA ' ' HB3' ' A' ' 233' ' ' LEU . 67.2 m -40.77 -65.29 0.43 Allowed 'General case' 0 C--N 1.353 0.728 0 C-N-CA 126.461 1.904 . . . . 61.43 113.682 -165.399 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 72.8 t80 . . . . . 0 C--O 1.238 0.486 0 O-C-N 123.504 0.502 . . . . 74.409999999999997 110.187 -177.636 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 . . . . . 0 N--CA 1.472 0.653 0 N-CA-C 108.563 -0.903 . . . . 63.140000000000001 108.563 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.428 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 38.5 p-10 -74.72 165.15 25.7 Favored 'General case' 0 C--O 1.247 0.948 0 CA-C-N 115.343 -0.844 . . . . 73.510000000000005 109.984 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.411 HD13 ' CE1' ' A' ' 240' ' ' PHE . 53.1 tp -149.94 143.34 25.18 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.902 -0.59 . . . . 62.420000000000002 109.548 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -115.52 138.47 51.0 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.969 0.908 . . . . 73.319999999999993 108.636 173.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -149.09 158.32 44.09 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.73 -0.841 . . . . 44.409999999999997 108.73 170.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 26.5 p -81.3 153.08 27.26 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 122.187 0.994 . . . . 53.340000000000003 111.851 166.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.691 HD13 ' HB2' ' A' ' 212' ' ' ALA . 33.5 tp -122.62 134.5 54.51 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 113.053 -1.885 . . . . 74.230000000000004 106.911 162.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -94.7 117.47 30.18 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 108.142 -1.058 . . . . 74.109999999999999 108.142 177.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.603 HG22 HG21 ' A' ' 210' ' ' VAL . 45.1 t -122.51 132.21 24.29 Favored Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 124.049 0.94 . . . . 65.540000000000006 109.153 178.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -69.57 145.55 58.6 Favored 'Trans proline' 0 C--N 1.365 1.433 0 C-N-CA 122.352 2.035 . . . . 63.109999999999999 110.52 169.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.458 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -52.91 -43.56 94.36 Favored Pre-proline 0 N--CA 1.486 1.332 0 N-CA-C 112.567 0.58 . . . . 54.009999999999998 112.567 173.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 10.6 Cg_endo -55.21 -37.72 94.1 Favored 'Trans proline' 0 C--N 1.399 3.217 0 C-N-CA 122.006 1.804 . . . . 43.200000000000003 112.736 174.187 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -86.55 -23.66 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 N-CA-C 109.841 -0.429 . . . . 71.329999999999998 109.841 -175.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -73.48 -38.0 65.56 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 123.146 0.578 . . . . 61.100000000000001 111.029 178.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 39.8 t -89.01 -35.43 7.71 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 C-N-CA 125.022 1.329 . . . . 74.510000000000005 112.648 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.414 ' HB ' ' O ' ' A' ' 202' ' ' PRO . 51.5 t -97.92 -42.93 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 O-C-N 121.547 -0.721 . . . . 61.340000000000003 111.129 -176.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 121.82 152.45 8.7 Favored Glycine 0 C--N 1.339 0.743 0 N-CA-C 110.707 -0.957 . . . . 74.349999999999994 110.707 -176.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 161.81 155.55 7.98 Favored Glycine 0 C--O 1.245 0.839 0 N-CA-C 111.307 -0.717 . . . . 71.109999999999999 111.307 177.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.62 ' HD3' ' HB3' ' A' ' 220' ' ' GLU . 36.3 ttmt -84.85 133.66 34.31 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 122.998 0.519 . . . . 73.329999999999998 110.026 174.141 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.603 HG21 HG22 ' A' ' 199' ' ' VAL . 15.5 m -131.24 153.4 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.417 1.087 . . . . 75.409999999999997 109.665 177.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 211' ' ' ARG . . . . . 0.667 ' HE ' ' HB3' ' A' ' 218' ' ' PRO . 0.0 OUTLIER -95.14 142.69 27.3 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.266 1.026 . . . . 74.040000000000006 109.352 -171.79 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.691 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -132.85 122.35 24.28 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.561 0.745 . . . . 65.310000000000002 109.459 -177.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 34.2 tpp -78.9 109.91 13.62 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 108.958 -0.756 . . . . 74.150000000000006 108.958 172.074 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 67.5 p -120.36 -175.08 2.93 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.928 0.891 . . . . 51.340000000000003 110.387 -175.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.534 HD21 ' HD3' ' A' ' 241' ' ' PRO . 64.0 tp -44.19 -53.32 6.64 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.298 1.039 . . . . 72.109999999999999 112.754 174.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -73.32 -27.89 61.77 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 114.821 -1.081 . . . . 74.340000000000003 111.392 -172.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 135.05 -164.45 24.78 Favored Glycine 0 C--N 1.341 0.855 0 N-CA-C 111.687 -0.565 . . . . 44.219999999999999 111.687 -171.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' PRO . . . . . 0.667 ' HB3' ' HE ' ' A' ' 211' ' ' ARG . 41.3 Cg_endo -63.93 130.73 28.45 Favored 'Trans proline' 0 C--N 1.369 1.639 0 C-N-CA 122.848 2.365 . . . . 73.400000000000006 111.335 176.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.406 HG22 ' O ' ' A' ' 212' ' ' ALA . 23.2 m -131.84 161.82 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.707 0.803 . . . . 60.539999999999999 110.723 -177.122 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.62 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 43.9 mt-10 -112.0 112.68 24.49 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.445 1.098 . . . . 65.530000000000001 109.899 -171.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.46 HG22 HG11 ' A' ' 168' ' ' VAL . 50.5 t -126.39 102.61 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 124.221 1.008 . . . . 74.209999999999994 110.174 -171.042 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.608 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -78.06 118.19 20.09 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.948 0.499 . . . . 63.520000000000003 110.391 174.514 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 36.0 m -90.71 152.33 44.74 Favored Pre-proline 0 N--CA 1.482 1.159 0 C-N-CA 123.445 0.698 . . . . 73.430000000000007 111.296 -176.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' PRO . . . . . 0.528 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 36.1 Cg_endo -63.91 165.4 18.96 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.839 2.359 . . . . 61.039999999999999 113.054 175.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -84.78 28.98 0.55 Allowed 'Trans proline' 0 C--N 1.378 2.091 0 C-N-CA 123.222 2.614 . . . . 63.210000000000001 113.032 175.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 35.4 mmt180 -145.07 -2.8 0.78 Allowed 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.335 0.654 . . . . 74.200000000000003 112.259 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.535 HG23 HG11 ' A' ' 253' ' ' VAL . 0.6 OUTLIER -60.81 149.47 35.77 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.433 -0.58 . . . . 70.319999999999993 109.433 -165.864 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 228' ' ' GLN . . . . . 0.471 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 13.2 pt20 -133.81 162.3 32.38 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.123 0.569 . . . . 74.010000000000005 110.417 -173.212 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -59.73 110.97 1.27 Allowed 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.145 0.498 . . . . 62.439999999999998 110.05 178.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.63 -0.66 21.79 Favored Glycine 0 C--N 1.335 0.49 0 CA-C-N 114.675 -1.148 . . . . 74.239999999999995 112.095 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -68.18 125.24 25.75 Favored 'General case' 0 C--N 1.359 0.992 0 N-CA-C 108.901 -0.777 . . . . 74.209999999999994 108.901 -175.002 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -98.9 97.58 8.75 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.283 0.633 . . . . 72.540000000000006 109.571 -168.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.479 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 22.2 mt -82.68 100.01 9.96 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 107.839 -1.171 . . . . 72.140000000000001 107.839 -176.536 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 234' ' ' ARG . . . . . 0.618 ' HD3' ' H ' ' A' ' 234' ' ' ARG . 0.0 OUTLIER -82.95 113.76 20.77 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.154 -0.93 . . . . 64.409999999999997 111.185 -176.964 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.485 ' O ' ' HB2' ' A' ' 248' ' ' ASP . 7.3 mp -100.66 127.25 47.12 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 106.772 -1.566 . . . . 75.140000000000001 106.772 173.303 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -101.74 117.12 34.21 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.342 0.657 . . . . 73.019999999999996 110.636 -175.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 79.08 32.35 39.83 Favored Glycine 0 C--N 1.348 1.227 0 O-C-N 124.268 0.98 . . . . 73.230000000000004 112.309 -177.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.46 ' HB2' ' HB3' ' A' ' 235' ' ' LEU . 29.3 mmmt -128.7 19.59 6.14 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.607 0.763 . . . . 74.209999999999994 111.66 -178.02 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -98.04 -134.03 8.18 Favored Glycine 0 C--N 1.343 0.953 0 N-CA-C 111.039 -0.824 . . . . 74.299999999999997 111.039 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 240' ' ' PHE . . . . . 0.48 ' O ' ' HA ' ' A' ' 246' ' ' ARG . 5.9 m-30 -66.18 154.91 89.04 Favored Pre-proline 0 CA--C 1.547 0.854 0 N-CA-C 112.699 0.629 . . . . 63.240000000000002 112.699 -177.112 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.534 ' HD3' HD21 ' A' ' 215' ' ' LEU . 86.2 Cg_endo -71.99 171.54 16.47 Favored 'Trans proline' 0 C--N 1.383 2.348 0 C-N-CA 123.285 2.657 . . . . 64.209999999999994 112.797 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.465 ' N ' ' HD2' ' A' ' 243' ' ' PRO . . . -67.17 -38.33 91.99 Favored Glycine 0 CA--C 1.545 1.962 0 CA-C-O 118.364 -1.242 . . . . 71.420000000000002 114.713 -177.257 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 243' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 242' ' ' GLY . 10.0 Cg_endo -53.72 -37.18 83.94 Favored 'Trans proline' 0 C--N 1.39 2.74 0 CA-C-N 120.974 2.387 . . . . 74.25 112.511 169.466 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -80.16 -24.6 40.28 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.513 0.725 . . . . 72.209999999999994 110.834 175.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 105.95 111.35 3.58 Favored Glycine 0 C--N 1.341 0.819 0 N-CA-C 107.802 -2.119 . . . . 73.200000000000003 107.802 -167.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.48 ' HA ' ' O ' ' A' ' 240' ' ' PHE . 1.5 tmm_? -73.12 128.52 35.73 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 109.738 -0.468 . . . . 73.0 109.738 -170.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -137.09 -156.79 7.43 Favored Glycine 0 C--N 1.342 0.911 0 CA-C-N 115.982 -0.554 . . . . 43.399999999999999 112.951 -175.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 248' ' ' ASP . . . . . 0.485 ' HB2' ' O ' ' A' ' 235' ' ' LEU . 32.4 p-10 -123.78 165.23 17.65 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.327 1.051 . . . . 45.119999999999997 110.526 -174.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 10.8 tp -135.56 135.37 40.28 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.191 -0.67 . . . . 63.200000000000003 109.191 -170.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -115.66 145.81 42.39 Favored 'General case' 0 C--O 1.246 0.88 0 N-CA-C 107.637 -1.246 . . . . 63.100000000000001 107.637 -178.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.479 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 82.2 mt -123.82 113.79 19.01 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 108.558 -0.904 . . . . 41.43 108.558 -179.141 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -89.78 110.49 21.4 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.83 -1.174 . . . . 64.530000000000001 107.83 -176.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.535 HG11 HG23 ' A' ' 227' ' ' THR . 51.2 t -61.81 134.16 27.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 115.162 -0.927 . . . . 54.020000000000003 110.527 -178.475 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 18.1 mtp85 -120.73 125.22 47.08 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.337 -1.357 . . . . 63.520000000000003 107.337 172.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 48.0 mm -84.92 112.83 22.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 108.948 -0.76 . . . . 74.219999999999999 108.948 -179.002 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 CA--C 1.557 1.248 0 CA-C-O 117.415 -1.279 . . . . 73.340000000000003 108.912 -171.734 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.405 HG11 HG22 ' A' ' 221' ' ' VAL . 54.6 t . . . . . 0 N--CA 1.475 0.823 0 CA-C-O 121.731 0.777 . . . . 64.340000000000003 111.415 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 43.4 mtm -101.42 -176.05 3.03 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.619 1.968 . . . . 74.530000000000001 109.462 -170.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 10.3 p -101.77 88.84 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.079 0 CA-C-O 122.973 1.368 . . . . 72.239999999999995 107.791 163.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.72 -5.66 8.61 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 114.05 -1.432 . . . . 53.530000000000001 110.587 -174.489 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.46 ' HA ' ' HB3' ' A' ' 233' ' ' LEU . 69.3 m -36.25 -64.96 0.29 Allowed 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 127.014 2.126 . . . . 72.25 115.617 -167.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' TYR . . . . . 0.442 ' HB2' ' HG3' ' A' ' 224' ' ' PRO . 66.9 t80 . . . . . 0 N--CA 1.479 1.005 0 C-N-CA 123.165 0.586 . . . . 74.319999999999993 111.517 -170.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 . . . . . 0 N--CA 1.478 0.949 0 CA-C-O 121.246 0.546 . . . . 73.109999999999999 110.169 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -76.28 164.29 26.2 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-N 115.394 -0.821 . . . . 64.439999999999998 110.458 -177.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 40.9 tp -151.1 140.14 21.07 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.344 -0.844 . . . . 62.5 109.846 176.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -114.77 140.04 49.22 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.649 0.78 . . . . 74.120000000000005 109.421 168.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -145.16 157.03 44.19 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 108.353 -0.98 . . . . 63.340000000000003 108.353 167.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 30.0 p -81.46 154.38 26.37 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 122.139 0.971 . . . . 75.109999999999999 111.516 167.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.656 HD13 ' HB2' ' A' ' 212' ' ' ALA . 42.3 tp -121.17 133.32 55.18 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 113.286 -1.779 . . . . 73.219999999999999 107.026 168.348 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -92.55 112.35 24.26 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 106.95 -1.5 . . . . 72.549999999999997 106.95 -177.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.551 HG22 HG21 ' A' ' 210' ' ' VAL . 43.3 t -124.55 130.41 24.3 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 123.333 0.653 . . . . 73.319999999999993 109.275 -177.035 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -66.81 144.13 69.95 Favored 'Trans proline' 0 C--N 1.368 1.6 0 C-N-CA 121.984 1.789 . . . . 75.549999999999997 110.974 166.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.439 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.16 -45.19 98.41 Favored Pre-proline 0 CA--C 1.562 1.421 0 CA-C-O 118.309 -0.853 . . . . 42.119999999999997 112.322 174.229 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.467 ' O ' ' HB ' ' A' ' 206' ' ' VAL . 22.9 Cg_endo -59.35 -30.98 94.17 Favored 'Trans proline' 0 C--N 1.4 3.252 0 C-N-CA 121.909 1.739 . . . . 62.119999999999997 112.537 175.417 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.7 mp -85.88 -25.97 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 O-C-N 121.645 -0.659 . . . . 74.099999999999994 109.68 -178.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -74.25 -38.81 63.37 Favored 'General case' 0 C--O 1.246 0.913 0 CA-C-O 121.13 0.49 . . . . 62.409999999999997 111.078 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 41.2 t -88.96 -37.21 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 C-N-CA 124.809 1.244 . . . . 74.310000000000002 112.653 -177.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.467 ' HB ' ' O ' ' A' ' 202' ' ' PRO . 53.1 t -96.85 -42.4 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 O-C-N 121.648 -0.658 . . . . 61.009999999999998 109.71 -176.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 124.31 148.66 7.48 Favored Glycine 0 C--N 1.349 1.287 0 N-CA-C 111.306 -0.718 . . . . 54.399999999999999 111.306 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 165.48 156.07 9.0 Favored Glycine 0 C--N 1.342 0.876 0 N-CA-C 112.259 -0.336 . . . . 52.409999999999997 112.259 177.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.606 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 38.1 ttmt -85.01 131.93 34.4 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.284 0.634 . . . . 65.019999999999996 110.16 176.594 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.551 HG21 HG22 ' A' ' 199' ' ' VAL . 13.8 m -131.07 153.22 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 124.023 0.929 . . . . 63.109999999999999 110.106 178.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -94.5 142.73 27.1 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.159 0.984 . . . . 65.030000000000001 109.468 -171.037 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.656 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -132.74 119.51 20.43 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.388 0.675 . . . . 74.200000000000003 109.774 -176.321 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 35.5 tpp -78.68 110.13 13.54 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 108.759 -0.83 . . . . 73.099999999999994 108.759 171.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 67.1 p -119.17 -175.26 2.89 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.085 0.954 . . . . 73.239999999999995 110.706 -174.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.539 HD21 ' HD3' ' A' ' 241' ' ' PRO . 65.5 tp -49.77 -50.66 43.77 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.984 0.914 . . . . 74.129999999999995 111.439 169.143 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -71.86 -26.7 62.46 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 114.567 -1.197 . . . . 74.329999999999998 111.84 -173.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 133.09 -165.17 24.08 Favored Glycine 0 C--N 1.344 1.004 0 N-CA-C 111.488 -0.645 . . . . 52.539999999999999 111.488 -178.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -67.56 128.08 17.52 Favored 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 121.709 1.606 . . . . 75.150000000000006 110.566 174.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 25.1 m -132.98 162.3 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 123.329 0.652 . . . . 65.25 110.397 -174.251 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.599 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 45.1 mt-10 -111.78 111.64 22.75 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.647 0.779 . . . . 74.329999999999998 109.446 -173.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.405 HG22 HG11 ' A' ' 168' ' ' VAL . 57.4 t -122.65 103.81 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 124.812 1.245 . . . . 64.420000000000002 109.646 -172.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.606 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -75.34 117.57 17.29 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 110.061 -0.348 . . . . 71.120000000000005 110.061 174.376 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 28.3 m -85.47 153.5 58.8 Favored Pre-proline 0 N--CA 1.489 1.495 0 C-N-CA 122.889 0.475 . . . . 74.5 110.796 -176.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' PRO . . . . . 0.442 ' HG3' ' HB2' ' A' ' 173' ' ' TYR . 34.2 Cg_exo -59.7 162.36 15.74 Favored 'Trans proline' 0 C--N 1.383 2.373 0 C-N-CA 122.43 2.087 . . . . 73.299999999999997 112.757 177.38 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -91.02 30.12 0.36 Allowed 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 123.219 2.613 . . . . 72.340000000000003 112.039 177.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 -145.12 -9.12 0.59 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.061 0.945 . . . . 55.240000000000002 111.403 178.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.556 HG23 HG11 ' A' ' 253' ' ' VAL . 0.8 OUTLIER -59.39 156.39 12.96 Favored 'General case' 0 CA--C 1.567 1.633 0 O-C-N 123.885 0.741 . . . . 73.219999999999999 111.603 -158.906 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 228' ' ' GLN . . . . . 0.41 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 19.7 pt20 -130.22 162.55 28.67 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.341 0.657 . . . . 70.420000000000002 110.851 -171.38 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 229' ' ' ALA . . . . . 0.421 ' HB1' HH21 ' A' ' 254' ' ' ARG . . . -61.4 112.64 2.26 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.903 -0.59 . . . . 30.399999999999999 109.438 174.156 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.44 -3.86 21.74 Favored Glycine 0 N--CA 1.466 0.68 0 CA-C-N 115.642 -0.708 . . . . 72.549999999999997 112.067 178.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -68.69 126.24 29.08 Favored 'General case' 0 C--N 1.358 0.948 0 N-CA-C 109.268 -0.641 . . . . 71.439999999999998 109.268 -173.065 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -98.39 98.47 9.69 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.373 -0.603 . . . . 74.450000000000003 109.373 -171.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.46 ' HB3' ' HA ' ' A' ' 172' ' ' SER . 25.0 mt -79.64 99.77 7.52 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 106.917 -1.512 . . . . 62.219999999999999 106.917 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -81.34 115.68 20.81 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-O 121.546 0.689 . . . . 65.239999999999995 110.871 -176.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.425 ' HB3' ' HB2' ' A' ' 238' ' ' LYS . 7.3 mp -99.52 124.82 45.04 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 105.458 -2.053 . . . . 64.310000000000002 105.458 170.528 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 41.0 tptt -102.14 117.93 35.83 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 117.909 0.322 . . . . 63.439999999999998 110.156 -171.065 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 77.65 22.02 70.69 Favored Glycine 0 C--N 1.342 0.913 0 O-C-N 123.542 0.526 . . . . 73.140000000000001 112.86 -178.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.425 ' HB2' ' HB3' ' A' ' 235' ' ' LEU . 1.5 mmmp? -120.65 20.74 11.7 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.012 0.925 . . . . 55.210000000000001 110.035 -177.119 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -96.75 -135.09 8.38 Favored Glycine 0 C--N 1.349 1.285 0 N-CA-C 111.258 -0.737 . . . . 72.239999999999995 111.258 178.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 6.3 m-30 -65.1 150.59 95.21 Favored Pre-proline 0 N--CA 1.48 1.035 0 N-CA-C 112.339 0.496 . . . . 63.009999999999998 112.339 -177.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.539 ' HD3' HD21 ' A' ' 215' ' ' LEU . 60.0 Cg_endo -67.37 170.38 13.59 Favored 'Trans proline' 0 C--N 1.383 2.376 0 C-N-CA 123.13 2.553 . . . . 73.409999999999997 113.075 -177.049 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -68.37 -39.58 87.44 Favored Glycine 0 CA--C 1.538 1.509 0 CA-C-O 118.613 -1.104 . . . . 63.32 114.361 -177.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -48.38 -40.27 36.08 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 122.515 2.144 . . . . 32.299999999999997 113.871 164.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -77.9 -24.64 48.32 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.51 0.724 . . . . 31.420000000000002 110.705 175.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 106.65 111.45 3.58 Favored Glycine 0 C--N 1.336 0.546 0 N-CA-C 108.095 -2.002 . . . . 71.239999999999995 108.095 -167.043 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -71.84 125.23 26.64 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-N 117.458 0.629 . . . . 70.310000000000002 110.198 -172.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -138.81 -157.73 7.45 Favored Glycine 0 C--N 1.337 0.599 0 CA-C-N 116.085 -0.507 . . . . 72.239999999999995 112.727 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -119.78 165.22 14.84 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.945 0.898 . . . . 74.340000000000003 110.085 -173.218 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 10.5 tp -134.39 133.24 40.35 Favored 'General case' 0 C--O 1.219 -0.523 0 N-CA-C 107.683 -1.228 . . . . 75.519999999999996 107.683 -173.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 7.7 m-30 -116.13 147.89 40.88 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 108.063 -1.088 . . . . 73.409999999999997 108.063 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 78.2 mt -122.8 114.27 20.29 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 107.89 -1.152 . . . . 74.349999999999994 107.89 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -88.05 111.75 21.88 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 107.816 -1.179 . . . . 74.010000000000005 107.816 -178.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.556 HG11 HG23 ' A' ' 227' ' ' THR . 53.2 t -60.92 125.74 17.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 O-C-N 123.976 0.797 . . . . 74.129999999999995 109.891 178.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 254' ' ' ARG . . . . . 0.421 HH21 ' HB1' ' A' ' 229' ' ' ALA . 0.2 OUTLIER -112.01 124.28 52.07 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 106.658 -1.608 . . . . 75.25 106.658 174.667 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 51.3 mm -88.51 126.7 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 O-C-N 123.931 0.77 . . . . 63.329999999999998 109.527 -177.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 CA--C 1.558 1.278 0 N-CA-C 107.605 -1.257 . . . . 74.299999999999997 107.605 -177.07 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 78.9 t . . . . . 0 N--CA 1.481 1.09 0 CA-C-O 121.342 0.591 . . . . 73.150000000000006 111.52 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 44.5 mtm -101.97 -174.92 2.7 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.936 1.694 . . . . 73.510000000000005 110.059 -168.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 10.9 p -95.3 87.85 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.188 0 CA-C-O 123.195 1.474 . . . . 65.540000000000006 108.126 162.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.15 -3.76 8.5 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 114.053 -1.431 . . . . 75.030000000000001 110.106 -177.08 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.519 ' HA ' ' HB3' ' A' ' 233' ' ' LEU . 68.1 m -41.51 -66.52 0.33 Allowed 'General case' 0 C--N 1.353 0.741 0 C-N-CA 126.348 1.859 . . . . 62.539999999999999 113.454 -170.324 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 54.1 t80 . . . . . 0 C--O 1.242 0.702 0 N-CA-C 108.422 -0.955 . . . . 64.239999999999995 108.422 178.499 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 . . . . . 0 N--CA 1.481 1.104 0 N-CA-C 109.147 -0.686 . . . . 65.230000000000004 109.147 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -75.23 154.78 37.36 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-N 114.717 -1.129 . . . . 72.030000000000001 108.849 -177.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 57.6 tp -148.88 132.41 16.73 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.305 -0.628 . . . . 72.430000000000007 109.305 -174.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -117.04 140.14 49.85 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.386 0.674 . . . . 65.439999999999998 109.213 174.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -147.8 158.19 43.91 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.69 0.796 . . . . 70.409999999999997 108.985 174.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 24.0 p -83.86 152.12 24.75 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 122.339 1.066 . . . . 74.450000000000003 112.292 167.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.656 HD13 ' HB2' ' A' ' 212' ' ' ALA . 33.3 tp -124.46 134.11 53.16 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 112.695 -2.048 . . . . 75.430000000000007 107.008 167.394 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -93.35 116.77 29.32 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.216 -1.031 . . . . 75.349999999999994 108.216 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.589 HG22 HG21 ' A' ' 210' ' ' VAL . 61.7 t -123.14 130.55 24.53 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 124.141 0.976 . . . . 75.120000000000005 109.174 178.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -66.09 143.63 72.55 Favored 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 122.161 1.907 . . . . 62.43 111.015 167.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.432 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.47 -43.75 96.22 Favored Pre-proline 0 CA--C 1.566 1.568 0 CA-C-O 118.141 -0.933 . . . . 72.450000000000003 112.572 175.086 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 19.1 Cg_endo -57.65 -31.28 91.48 Favored 'Trans proline' 0 C--N 1.403 3.445 0 C-N-CA 121.876 1.717 . . . . 73.239999999999995 112.634 173.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -87.14 -25.64 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 N-CA-C 109.487 -0.56 . . . . 74.310000000000002 109.487 -178.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' ALA . . . . . 0.4 ' HA ' HG22 ' A' ' 227' ' ' THR . . . -73.43 -37.95 65.7 Favored 'General case' 0 C--O 1.244 0.794 0 C-N-CA 122.983 0.513 . . . . 72.140000000000001 110.987 178.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 25.4 t -88.29 -38.65 11.93 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 125.368 1.467 . . . . 54.420000000000002 112.875 -177.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 79.5 t -98.5 -41.46 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 O-C-N 121.664 -0.647 . . . . 64.340000000000003 110.45 -176.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 126.98 152.73 8.09 Favored Glycine 0 N--CA 1.468 0.815 0 N-CA-C 111.287 -0.725 . . . . 53.329999999999998 111.287 -178.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.98 154.16 7.84 Favored Glycine 0 C--O 1.244 0.74 0 CA-C-N 116.978 0.389 . . . . 63.310000000000002 112.675 175.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.576 ' HD3' ' HB3' ' A' ' 220' ' ' GLU . 36.7 ttmt -85.95 131.29 34.32 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.572 0.749 . . . . 75.329999999999998 109.215 175.158 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.589 HG21 HG22 ' A' ' 199' ' ' VAL . 15.8 m -130.0 154.45 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 123.734 0.814 . . . . 61.200000000000003 109.633 -177.389 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.11 135.91 33.86 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.732 0.813 . . . . 74.25 109.274 -171.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.656 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -132.73 116.49 16.66 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.813 -0.81 . . . . 43.119999999999997 108.813 -176.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 36.7 tpp -80.78 109.87 15.75 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 107.819 -1.178 . . . . 60.119999999999997 107.819 173.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 64.8 p -113.22 -175.42 2.66 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.125 0.57 . . . . 74.420000000000002 110.533 -174.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.456 HD21 ' HD3' ' A' ' 241' ' ' PRO . 60.5 tp -47.67 -51.17 22.61 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 124.323 1.014 . . . . 54.240000000000002 110.888 169.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -72.31 -27.03 62.19 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 113.884 -1.507 . . . . 73.310000000000002 110.944 -174.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 129.73 -166.14 22.0 Favored Glycine 0 C--N 1.341 0.81 0 CA-C-N 116.133 -0.485 . . . . 74.140000000000001 112.007 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -62.67 130.76 30.76 Favored 'Trans proline' 0 CA--C 1.552 1.419 0 C-N-CA 122.649 2.233 . . . . 74.430000000000007 111.84 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.436 HG22 ' O ' ' A' ' 212' ' ' ALA . 20.6 m -139.61 160.3 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 123.061 0.544 . . . . 64.450000000000003 110.408 -172.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.576 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 40.2 mt-10 -110.88 111.82 23.23 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.738 0.815 . . . . 52.420000000000002 109.311 -175.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 60.4 t -120.56 102.96 13.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 124.25 1.02 . . . . 74.010000000000005 108.937 -173.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.54 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -76.72 117.2 18.1 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 109.98 -0.378 . . . . 71.540000000000006 109.98 175.242 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 35.5 m -87.85 152.02 50.64 Favored Pre-proline 0 N--CA 1.487 1.399 0 C-N-CA 122.996 0.518 . . . . 61.329999999999998 110.562 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 224' ' ' PRO . . . . . 0.565 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 35.5 Cg_endo -63.48 163.48 23.77 Favored 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 122.213 1.942 . . . . 74.25 113.034 176.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -80.63 29.8 0.52 Allowed 'Trans proline' 0 C--N 1.373 1.864 0 C-N-CA 123.354 2.702 . . . . 71.409999999999997 113.416 174.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 -150.7 0.69 0.42 Allowed 'General case' 0 N--CA 1.474 0.738 0 O-C-N 122.113 -0.367 . . . . 55.210000000000001 111.839 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.63 HG23 HG11 ' A' ' 253' ' ' VAL . 0.7 OUTLIER -60.82 153.23 25.05 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.497 -0.557 . . . . 72.340000000000003 109.497 -169.058 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 228' ' ' GLN . . . . . 0.446 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 19.6 pt20 -132.73 162.11 32.28 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.403 0.681 . . . . 73.519999999999996 110.44 -171.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -61.13 111.46 1.72 Allowed 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 108.946 -0.761 . . . . 72.040000000000006 108.946 172.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.69 -1.62 21.68 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-N 115.087 -0.961 . . . . 72.230000000000004 112.501 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -68.79 127.08 31.82 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.445 0.698 . . . . 70.099999999999994 109.494 -173.971 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -98.21 97.1 8.56 Favored 'General case' 0 C--O 1.244 0.767 0 C-N-CA 123.413 0.685 . . . . 74.319999999999993 109.309 -170.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.519 ' HB3' ' HA ' ' A' ' 172' ' ' SER . 24.3 mt -80.23 99.24 7.73 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 107.504 -1.295 . . . . 71.329999999999998 107.504 -178.36 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 2.3 ppt_? -81.51 117.39 21.88 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.761 0.825 . . . . 74.129999999999995 112.579 -174.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.456 ' HB2' ' O ' ' A' ' 249' ' ' LEU . 7.6 mp -110.18 126.98 54.67 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 107.035 -1.468 . . . . 45.210000000000001 107.035 174.433 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -103.44 118.06 35.87 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.715 0.806 . . . . 75.209999999999994 111.024 -173.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 78.97 22.4 66.05 Favored Glycine 0 C--N 1.347 1.192 0 O-C-N 123.882 0.739 . . . . 13.140000000000001 112.304 -178.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -120.5 19.33 12.01 Favored 'General case' 0 C--N 1.347 0.486 0 C-N-CA 123.462 0.705 . . . . 62.43 109.984 -178.078 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -95.69 -136.61 8.77 Favored Glycine 0 C--N 1.35 1.361 0 N-CA-C 111.06 -0.816 . . . . 64.109999999999999 111.06 177.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 6.3 m-30 -68.28 148.27 98.24 Favored Pre-proline 0 CA--C 1.551 0.988 0 CA-C-N 117.559 0.68 . . . . 65.540000000000006 111.429 -178.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.456 ' HD3' HD21 ' A' ' 215' ' ' LEU . 65.7 Cg_endo -67.01 172.33 9.96 Favored 'Trans proline' 0 C--N 1.38 2.19 0 C-N-CA 123.399 2.733 . . . . 65.209999999999994 112.416 -177.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.451 ' N ' ' HD2' ' A' ' 243' ' ' PRO . . . -66.34 -38.29 93.52 Favored Glycine 0 CA--C 1.545 1.941 0 CA-C-O 117.92 -1.489 . . . . 64.439999999999998 114.163 -176.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 243' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 242' ' ' GLY . 9.7 Cg_endo -53.19 -35.28 72.83 Favored 'Trans proline' 0 C--N 1.392 2.867 0 CA-C-N 120.892 2.346 . . . . 74.140000000000001 113.351 167.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -85.45 -25.11 27.13 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.079 0.552 . . . . 43.210000000000001 110.464 176.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 112.52 114.19 3.29 Favored Glycine 0 C--N 1.343 0.962 0 N-CA-C 109.866 -1.294 . . . . 71.219999999999999 109.866 -169.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 32.2 ttm180 -66.22 128.44 36.13 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 117.389 0.594 . . . . 74.140000000000001 110.591 -176.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -148.1 -156.48 7.08 Favored Glycine 0 C--N 1.336 0.534 0 CA-C-N 115.657 -0.702 . . . . 72.319999999999993 112.48 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -118.58 165.86 13.43 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.214 0.605 . . . . 73.530000000000001 109.373 -171.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.456 ' O ' ' HB2' ' A' ' 235' ' ' LEU . 11.3 tp -133.83 132.07 39.97 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 107.31 -1.367 . . . . 64.409999999999997 107.31 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 9.8 m-30 -122.73 147.22 46.74 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.127 -1.064 . . . . 72.099999999999994 108.127 -178.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.413 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 86.0 mt -123.08 115.92 22.63 Favored 'General case' 0 C--O 1.222 -0.364 0 N-CA-C 108.327 -0.99 . . . . 53.109999999999999 108.327 -176.602 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -88.39 111.62 21.96 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 107.574 -1.269 . . . . 73.420000000000002 107.574 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.63 HG11 HG23 ' A' ' 227' ' ' THR . 55.6 t -61.35 128.35 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 CA-C-N 115.126 -0.943 . . . . 74.310000000000002 110.088 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 8.1 mmt180 -119.89 123.44 43.6 Favored 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 107.809 -1.182 . . . . 70.450000000000003 107.809 177.007 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 47.9 mm -82.76 122.11 36.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 114.718 -1.128 . . . . 65.450000000000003 109.945 -174.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.7 t . . . . . 0 CA--C 1.557 1.233 0 N-CA-C 107.229 -1.397 . . . . 72.530000000000001 107.229 -179.182 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.577 HG11 HG22 ' A' ' 221' ' ' VAL . 53.2 t . . . . . 0 N--CA 1.475 0.811 0 CA-C-O 121.21 0.528 . . . . 72.319999999999993 110.863 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 50.2 mtm -99.43 -176.47 3.3 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 125.8 1.64 . . . . 73.299999999999997 110.019 -169.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 8.8 p -99.97 86.48 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 CA-C-O 123.149 1.452 . . . . 74.519999999999996 107.94 163.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' MET . . . . . 0.503 ' HG3' ' HA ' ' A' ' 235' ' ' LEU . 0.0 OUTLIER -122.63 -5.36 8.67 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 113.675 -1.602 . . . . 63.520000000000003 110.041 -176.96 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.539 ' HA ' ' HB3' ' A' ' 233' ' ' LEU . 69.4 m -40.93 -63.33 0.68 Allowed 'General case' 0 C--N 1.35 0.608 0 C-N-CA 126.818 2.047 . . . . 52.439999999999998 114.553 -168.344 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' TYR . . . . . 0.598 ' HB2' ' HB3' ' A' ' 224' ' ' PRO . 67.3 t80 . . . . . 0 N--CA 1.474 0.761 0 CA-C-O 121.224 0.535 . . . . 64.040000000000006 110.9 -176.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 . . . . . 0 N--CA 1.479 1.008 0 N-CA-C 107.213 -1.403 . . . . 75.120000000000005 107.213 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 24.5 p-10 -74.21 172.67 11.36 Favored 'General case' 0 C--O 1.245 0.843 0 CA-C-N 113.425 -1.716 . . . . 63.119999999999997 109.724 167.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 33.0 tp -152.06 140.39 20.48 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.847 0.356 . . . . 72.129999999999995 110.324 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -115.46 139.69 49.81 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.269 1.028 . . . . 71.310000000000002 108.632 168.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.424 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -147.92 158.13 43.89 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.097 -1.075 . . . . 71.239999999999995 108.097 168.188 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 32.3 p -82.89 153.78 24.94 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 122.146 0.974 . . . . 54.340000000000003 112.585 167.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.598 HD13 ' HB2' ' A' ' 212' ' ' ALA . 25.8 tp -124.23 132.01 53.57 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 112.88 -1.964 . . . . 75.540000000000006 107.09 164.179 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -94.45 116.78 29.19 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.827 -0.805 . . . . 64.329999999999998 108.827 177.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.558 HG22 HG21 ' A' ' 210' ' ' VAL . 57.4 t -117.93 134.62 23.27 Favored Pre-proline 0 CA--C 1.549 0.923 0 CA-C-N 114.573 -1.194 . . . . 64.109999999999999 109.214 -177.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -67.5 146.7 75.17 Favored 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 122.185 1.923 . . . . 75.430000000000007 111.121 169.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.443 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.66 -45.76 98.58 Favored Pre-proline 0 CA--C 1.567 1.612 0 C-N-CA 123.65 0.78 . . . . 75.400000000000006 112.568 174.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 28.0 Cg_endo -60.73 -31.41 91.9 Favored 'Trans proline' 0 C--N 1.393 2.887 0 C-N-CA 122.202 1.934 . . . . 60.109999999999999 112.98 176.011 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -86.19 -24.47 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 109.441 -0.577 . . . . 73.109999999999999 109.441 -177.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -73.31 -37.7 66.09 Favored 'General case' 0 C--O 1.244 0.78 0 C-N-CA 123.053 0.541 . . . . 42.43 111.417 178.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 24.9 t -88.99 -36.66 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 CA-C-N 114.348 -1.296 . . . . 71.299999999999997 113.506 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 55.7 t -96.92 -42.3 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 O-C-N 121.486 -0.759 . . . . 64.239999999999995 111.007 -177.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 123.36 152.87 8.59 Favored Glycine 0 C--N 1.341 0.861 0 N-CA-C 110.727 -0.949 . . . . 55.030000000000001 110.727 -175.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.68 151.83 6.74 Favored Glycine 0 C--O 1.246 0.849 0 N-CA-C 111.578 -0.609 . . . . 75.200000000000003 111.578 177.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.623 ' HD3' ' HB3' ' A' ' 220' ' ' GLU . 4.2 ttmp? -84.2 130.2 34.84 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 108.667 -0.864 . . . . 73.209999999999994 108.667 174.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.558 HG21 HG22 ' A' ' 199' ' ' VAL . 15.8 m -129.9 152.24 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.383 1.073 . . . . 50.340000000000003 108.301 178.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 4.8 tmm_? -95.37 141.93 28.35 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 108.466 -0.939 . . . . 72.230000000000004 108.466 -172.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.598 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -132.14 124.92 30.06 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.959 0.903 . . . . 63.32 109.065 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 39.8 tpp -79.86 109.98 14.79 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 108.243 -1.021 . . . . 75.109999999999999 108.243 171.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 71.0 p -117.96 -175.59 2.87 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.838 0.855 . . . . 75.209999999999994 110.684 -177.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 63.0 tp -42.1 -50.65 4.72 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.809 1.244 . . . . 65.310000000000002 112.345 174.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -71.57 -27.08 62.91 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 114.552 -1.203 . . . . 74.549999999999997 111.595 -173.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 127.9 -163.35 21.58 Favored Glycine 0 C--N 1.34 0.791 0 N-CA-C 110.849 -0.9 . . . . 71.019999999999996 110.849 -170.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -65.49 129.84 23.57 Favored 'Trans proline' 0 C--N 1.371 1.741 0 C-N-CA 122.301 2.001 . . . . 75.109999999999999 111.594 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.442 HG22 ' O ' ' A' ' 212' ' ' ALA . 27.6 m -134.83 162.04 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 123.456 0.703 . . . . 60.219999999999999 111.041 -176.293 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.623 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 46.6 mt-10 -110.93 113.04 25.31 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.124 0.97 . . . . 75.049999999999997 109.77 -173.243 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.577 HG22 HG11 ' A' ' 168' ' ' VAL . 48.3 t -123.42 102.92 12.18 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 124.429 1.091 . . . . 72.310000000000002 109.815 -172.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.6 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -78.96 116.94 19.58 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 122.604 0.361 . . . . 52.219999999999999 110.505 175.257 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 35.3 m -88.79 152.44 48.87 Favored Pre-proline 0 N--CA 1.488 1.446 0 C-N-CA 123.252 0.621 . . . . 71.129999999999995 111.478 -175.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' PRO . . . . . 0.598 ' HB3' ' HB2' ' A' ' 173' ' ' TYR . 36.9 Cg_endo -63.13 166.36 14.77 Favored 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 122.838 2.359 . . . . 72.129999999999995 113.147 178.388 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -84.72 30.19 0.52 Allowed 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 122.838 2.359 . . . . 60.509999999999998 112.609 174.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -147.92 -0.72 0.6 Allowed 'General case' 0 N--CA 1.475 0.823 0 O-C-N 121.635 -0.666 . . . . 74.5 111.955 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.58 HG23 HG11 ' A' ' 253' ' ' VAL . 0.6 OUTLIER -61.18 152.53 28.44 Favored 'General case' 0 CA--C 1.567 1.633 0 N-CA-C 109.74 -0.467 . . . . 52.420000000000002 109.74 -167.482 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 228' ' ' GLN . . . . . 0.447 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 20.2 pt20 -135.05 161.47 35.21 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.456 0.703 . . . . 53.340000000000003 109.665 -173.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -61.33 111.23 1.68 Allowed 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 109.066 -0.716 . . . . 74.140000000000001 109.066 175.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 116.3 -0.47 20.68 Favored Glycine 0 N--CA 1.468 0.806 0 CA-C-N 114.783 -1.099 . . . . 74.340000000000003 112.787 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.447 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -70.92 127.36 32.32 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.83 0.852 . . . . 73.129999999999995 109.7 -175.671 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -97.62 99.22 10.6 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 109.324 -0.621 . . . . 60.229999999999997 109.324 -173.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.539 ' HB3' ' HA ' ' A' ' 172' ' ' SER . 22.8 mt -79.32 98.49 6.71 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.051 -1.463 . . . . 72.140000000000001 107.051 179.246 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 6.3 ppt_? -81.94 114.13 20.33 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-O 121.456 0.646 . . . . 74.129999999999995 111.972 -176.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.503 ' HA ' ' HG3' ' A' ' 171' ' ' MET . 7.2 mp -99.39 129.11 45.56 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 106.63 -1.619 . . . . 63.439999999999998 106.63 173.236 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 27.8 tptt -101.7 115.88 31.51 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 117.892 0.315 . . . . 73.450000000000003 110.721 -171.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.484 ' H ' ' HB3' ' A' ' 248' ' ' ASP . . . 78.12 29.38 53.98 Favored Glycine 0 C--N 1.344 1.019 0 O-C-N 123.832 0.708 . . . . 40.409999999999997 112.872 -178.496 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -119.31 20.05 12.64 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.841 0.856 . . . . 61.310000000000002 110.959 -177.009 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -95.95 -141.28 11.75 Favored Glycine 0 C--N 1.349 1.28 0 N-CA-C 110.453 -1.059 . . . . 54.200000000000003 110.453 178.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 7.2 m-30 -68.63 148.85 98.09 Favored Pre-proline 0 CA--C 1.548 0.881 0 CA-C-N 117.221 0.511 . . . . 63.229999999999997 111.592 -175.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -65.59 170.91 10.34 Favored 'Trans proline' 0 C--N 1.384 2.409 0 C-N-CA 123.209 2.606 . . . . 73.040000000000006 112.179 177.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -67.28 -39.65 92.07 Favored Glycine 0 CA--C 1.546 1.98 0 CA-C-O 118.719 -1.045 . . . . 33.140000000000001 114.186 -175.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_exo -50.39 -39.33 53.96 Favored 'Trans proline' 0 C--N 1.384 2.406 0 C-N-CA 122.601 2.201 . . . . 74.099999999999994 113.789 166.067 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -81.93 -24.22 35.72 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.045 0.538 . . . . 74.530000000000001 110.55 177.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 111.36 112.62 3.32 Favored Glycine 0 C--N 1.34 0.781 0 N-CA-C 109.112 -1.595 . . . . 62.240000000000002 109.112 -170.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -70.51 129.01 38.11 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 109.091 -0.707 . . . . 75.219999999999999 109.091 -172.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -148.9 -161.54 9.74 Favored Glycine 0 C--N 1.341 0.848 0 O-C-N 123.451 0.469 . . . . 72.209999999999994 112.751 173.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 248' ' ' ASP . . . . . 0.484 ' HB3' ' H ' ' A' ' 237' ' ' GLY . 15.8 p-10 -123.9 164.24 19.66 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.562 1.145 . . . . 63.539999999999999 110.782 -176.313 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 8.9 tp -132.0 136.28 47.16 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 109.27 -0.641 . . . . 64.019999999999996 109.27 -166.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -121.64 148.11 44.98 Favored 'General case' 0 C--O 1.247 0.939 0 N-CA-C 108.164 -1.05 . . . . 74.239999999999995 108.164 -176.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.424 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 71.5 mt -123.59 113.96 19.39 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 108.891 -0.781 . . . . 74.409999999999997 108.891 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -88.45 111.79 22.2 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.223 -1.028 . . . . 72.450000000000003 108.223 -177.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.58 HG11 HG23 ' A' ' 227' ' ' THR . 55.4 t -61.36 130.18 25.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 114.862 -1.063 . . . . 65.349999999999994 110.404 178.199 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 37.3 mtm180 -116.84 125.47 51.61 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 106.578 -1.638 . . . . 72.319999999999993 106.578 169.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 49.8 mm -84.27 127.5 39.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 108.727 -0.842 . . . . 43.119999999999997 108.727 -178.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.2 t . . . . . 0 CA--C 1.552 1.049 0 N-CA-C 108.369 -0.975 . . . . 70.299999999999997 108.369 -177.165 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 53.0 t . . . . . 0 N--CA 1.479 1.01 0 CA-C-O 121.529 0.681 . . . . 74.140000000000001 111.403 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 46.6 mtm -100.66 -176.83 3.3 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.282 1.833 . . . . 73.129999999999995 109.271 -173.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 11.2 p -98.97 88.74 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.321 0 CA-C-O 123.092 1.425 . . . . 72.409999999999997 107.758 163.055 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' MET . . . . . 0.41 ' HG3' ' HA ' ' A' ' 235' ' ' LEU . 0.0 OUTLIER -123.92 -4.46 8.05 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 113.767 -1.56 . . . . 61.210000000000001 110.593 -172.926 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.532 ' HB3' HD22 ' A' ' 233' ' ' LEU . 70.3 m -40.7 -64.38 0.54 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.421 1.889 . . . . 75.5 114.187 -173.301 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' TYR . . . . . 0.624 ' HB2' ' HG3' ' A' ' 224' ' ' PRO . 45.2 t80 . . . . . 0 C--O 1.242 0.692 0 N-CA-C 108.321 -0.992 . . . . 72.129999999999995 108.321 -178.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.403 ' HG2' ' HA3' ' A' ' 245' ' ' GLY . 73.4 mt-30 . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 121.934 0.873 . . . . 62.219999999999999 109.625 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -74.33 169.59 17.34 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 114.209 -1.359 . . . . 62.420000000000002 110.645 172.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 57.7 tp -150.63 141.12 22.48 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.995 0.518 . . . . 72.25 109.803 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -116.6 138.68 51.24 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 123.996 0.918 . . . . 74.439999999999998 109.231 172.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -149.32 159.23 44.45 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 108.703 -0.851 . . . . 33.450000000000003 108.703 169.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 31.1 p -85.88 153.07 22.48 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.931 0.872 . . . . 74.329999999999998 112.322 166.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.638 HD13 ' HB2' ' A' ' 212' ' ' ALA . 31.6 tp -124.58 132.76 53.43 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 113.086 -1.87 . . . . 75.129999999999995 107.245 166.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -95.1 113.26 24.93 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.953 0.882 . . . . 73.510000000000005 109.467 -176.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.582 HG22 HG21 ' A' ' 210' ' ' VAL . 60.9 t -118.62 132.09 24.0 Favored Pre-proline 0 CA--C 1.55 0.966 0 CA-C-N 114.711 -1.131 . . . . 55.299999999999997 109.967 -177.632 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -66.66 144.64 72.91 Favored 'Trans proline' 0 C--N 1.37 1.691 0 C-N-CA 122.281 1.987 . . . . 73.519999999999996 111.298 166.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.434 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.08 -43.75 95.45 Favored Pre-proline 0 CA--C 1.561 1.379 0 C-N-CA 124.245 1.018 . . . . 63.420000000000002 112.586 173.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.434 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 18.8 Cg_endo -57.89 -33.01 96.5 Favored 'Trans proline' 0 C--N 1.397 3.127 0 C-N-CA 121.681 1.588 . . . . 61.32 112.702 173.369 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -86.42 -23.69 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 N-CA-C 109.303 -0.628 . . . . 74.329999999999998 109.303 -177.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -76.0 -36.87 59.0 Favored 'General case' 0 C--O 1.248 0.982 0 C-N-CA 123.094 0.558 . . . . 24.140000000000001 111.691 178.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 31.9 t -88.89 -36.51 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 125.161 1.384 . . . . 71.420000000000002 112.555 -179.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.409 ' HB ' ' O ' ' A' ' 202' ' ' PRO . 60.3 t -98.21 -42.14 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 O-C-N 121.659 -0.651 . . . . 63.219999999999999 109.981 -176.388 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 122.85 153.86 8.91 Favored Glycine 0 C--N 1.342 0.901 0 N-CA-C 110.666 -0.974 . . . . 51.520000000000003 110.666 -175.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.81 149.32 5.77 Favored Glycine 0 C--O 1.241 0.567 0 N-CA-C 112.058 -0.417 . . . . 70.450000000000003 112.058 175.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.618 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 36.8 ttmt -85.24 128.46 34.69 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.491 -0.559 . . . . 74.5 109.491 176.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.582 HG21 HG22 ' A' ' 199' ' ' VAL . 15.4 m -129.81 149.51 33.7 Favored 'Isoleucine or valine' 0 C--O 1.245 0.847 0 N-CA-C 108.036 -1.098 . . . . 75.109999999999999 108.036 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 7.0 tmm_? -96.78 143.87 27.3 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.169 0.587 . . . . 73.219999999999999 109.716 -170.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.638 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -132.28 124.58 29.15 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.551 0.74 . . . . 52.020000000000003 109.163 -177.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 36.1 tpp -79.84 109.49 14.31 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.155 -1.054 . . . . 63.130000000000003 108.155 174.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 53.2 p -111.24 -177.59 3.24 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 123.324 0.65 . . . . 74.329999999999998 109.924 -176.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.571 HD21 ' HD3' ' A' ' 241' ' ' PRO . 62.1 tp -46.56 -52.82 12.65 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.292 1.037 . . . . 70.420000000000002 111.433 174.587 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -73.46 -27.69 61.54 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 113.674 -1.603 . . . . 72.310000000000002 111.554 -173.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 138.5 -166.99 25.16 Favored Glycine 0 C--N 1.35 1.308 0 CA-C-O 119.693 -0.504 . . . . 54.32 112.437 -176.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -65.47 130.1 24.27 Favored 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 122.454 2.103 . . . . 70.099999999999994 111.56 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 22.8 m -129.16 158.24 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 123.222 0.609 . . . . 74.239999999999995 110.055 -179.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.521 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 46.6 mt-10 -112.8 111.95 23.09 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.708 -0.849 . . . . 71.409999999999997 108.708 -174.207 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 99.3 t -124.84 104.13 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.207 1.003 . . . . 60.009999999999998 110.542 -169.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.618 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -77.31 117.61 18.98 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 122.658 0.383 . . . . 71.25 110.373 175.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.453 HG11 HG21 ' A' ' 199' ' ' VAL . 27.7 m -85.81 154.4 58.43 Favored Pre-proline 0 N--CA 1.479 1.012 0 C-N-CA 123.433 0.693 . . . . 75.319999999999993 111.329 -175.73 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 224' ' ' PRO . . . . . 0.624 ' HG3' ' HB2' ' A' ' 173' ' ' TYR . 36.7 Cg_exo -59.17 161.98 15.08 Favored 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 122.669 2.246 . . . . 70.5 113.231 178.179 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -89.28 25.99 0.57 Allowed 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 123.231 2.62 . . . . 74.200000000000003 112.632 173.122 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 14.4 mmt180 -146.04 0.76 0.84 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.74 0.816 . . . . 72.310000000000002 111.384 176.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.531 HG23 HG11 ' A' ' 253' ' ' VAL . 0.7 OUTLIER -62.05 153.38 29.9 Favored 'General case' 0 CA--C 1.568 1.647 0 O-C-N 123.382 0.426 . . . . 53.32 110.207 -167.56 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -133.8 162.03 33.1 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.634 0.774 . . . . 71.519999999999996 110.237 -176.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -60.23 110.63 1.28 Allowed 'General case' 0 C--N 1.351 0.672 0 O-C-N 123.446 0.466 . . . . 33.030000000000001 109.909 177.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 116.1 1.14 20.76 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-N 115.158 -0.928 . . . . 65.540000000000006 111.984 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.83 125.39 26.61 Favored 'General case' 0 C--N 1.359 1.004 0 N-CA-C 108.683 -0.858 . . . . 75.319999999999993 108.683 -177.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -97.39 97.56 9.22 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.35 -0.981 . . . . 74.010000000000005 108.35 -171.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.532 HD22 ' HB3' ' A' ' 172' ' ' SER . 25.0 mt -78.33 97.63 5.66 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 106.429 -1.693 . . . . 52.140000000000001 106.429 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 7.8 ppt_? -81.81 125.07 30.23 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 122.909 0.483 . . . . 74.430000000000007 110.862 -177.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.41 ' HA ' ' HG3' ' A' ' 171' ' ' MET . 8.9 mp -108.78 130.05 55.38 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 106.697 -1.594 . . . . 75.439999999999998 106.697 175.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.51 113.62 25.21 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 122.734 0.413 . . . . 53.310000000000002 109.905 -170.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 76.71 24.69 66.71 Favored Glycine 0 C--N 1.343 0.954 0 O-C-N 123.596 0.56 . . . . 53.140000000000001 113.644 177.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -117.86 23.79 11.45 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.24 0.616 . . . . 74.400000000000006 110.547 -176.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -96.43 -131.21 6.74 Favored Glycine 0 C--N 1.346 1.089 0 CA-C-O 119.62 -0.545 . . . . 74.0 111.882 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 6.7 m-30 -72.15 154.68 92.19 Favored Pre-proline 0 CA--C 1.55 0.953 0 N-CA-C 112.746 0.647 . . . . 71.430000000000007 112.746 -176.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.571 ' HD3' HD21 ' A' ' 215' ' ' LEU . 73.7 Cg_endo -69.7 172.43 12.59 Favored 'Trans proline' 0 C--N 1.389 2.706 0 C-N-CA 123.428 2.752 . . . . 72.5 112.265 -179.032 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.411 ' N ' ' HD2' ' A' ' 243' ' ' PRO . . . -68.07 -39.33 88.81 Favored Glycine 0 CA--C 1.544 1.877 0 CA-C-O 118.257 -1.302 . . . . 50.149999999999999 114.395 -175.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 243' ' ' PRO . . . . . 0.411 ' HD2' ' N ' ' A' ' 242' ' ' GLY . 9.7 Cg_endo -55.14 -36.39 92.96 Favored 'Trans proline' 0 C--N 1.385 2.448 0 CA-C-N 120.725 2.263 . . . . 72.319999999999993 113.677 167.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -79.01 -24.04 43.97 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.053 0.541 . . . . 61.130000000000003 110.39 174.157 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 245' ' ' GLY . . . . . 0.403 ' HA3' ' HG2' ' A' ' 191' ' ' GLN . . . 107.69 112.38 3.62 Favored Glycine 0 C--N 1.344 1.023 0 N-CA-C 108.752 -1.739 . . . . 72.230000000000004 108.752 -169.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -69.7 122.18 18.64 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.614 -0.884 . . . . 75.239999999999995 108.614 -173.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -137.5 -159.51 8.24 Favored Glycine 0 C--N 1.342 0.878 0 O-C-N 123.551 0.532 . . . . 32.109999999999999 112.907 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -121.44 163.95 17.93 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.099 1.36 . . . . 72.140000000000001 110.549 -173.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 9.8 tp -134.89 134.21 40.45 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 109.628 -0.508 . . . . 71.049999999999997 109.628 -169.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -115.09 146.74 41.01 Favored 'General case' 0 C--O 1.244 0.766 0 N-CA-C 108.931 -0.766 . . . . 75.329999999999998 108.931 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 82.5 mt -123.86 113.81 19.02 Favored 'General case' 0 C--O 1.224 -0.241 0 N-CA-C 107.557 -1.275 . . . . 74.319999999999993 107.557 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -91.03 111.86 23.51 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.251 -1.018 . . . . 64.450000000000003 108.251 -173.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.531 HG11 HG23 ' A' ' 227' ' ' THR . 53.8 t -60.04 126.75 18.34 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.423 0 O-C-N 124.238 0.961 . . . . 62.130000000000003 109.811 179.064 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 16.2 mtt180 -116.24 125.24 51.94 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.012 -1.477 . . . . 75.340000000000003 107.012 172.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 49.6 mm -86.33 123.06 39.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 108.718 -0.845 . . . . 71.420000000000002 108.718 -178.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.3 t . . . . . 0 CA--C 1.555 1.144 0 N-CA-C 109.271 -0.64 . . . . 65.409999999999997 109.271 -173.558 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.431 HG11 HG22 ' A' ' 221' ' ' VAL . 53.0 t . . . . . 0 CA--C 1.544 0.72 0 CA-C-O 121.213 0.53 . . . . 63.310000000000002 110.858 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 42.1 mtm -99.32 -176.91 3.43 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.825 1.65 . . . . 71.310000000000002 109.032 -171.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 14.5 p -95.57 86.5 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 CA-C-O 123.457 1.599 . . . . 61.530000000000001 107.585 163.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' MET . . . . . 0.529 ' HG3' ' HA ' ' A' ' 235' ' ' LEU . 0.0 OUTLIER -122.62 -4.2 8.74 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 113.348 -1.751 . . . . 71.329999999999998 109.728 -175.912 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.488 ' HA ' ' HB3' ' A' ' 233' ' ' LEU . 66.3 m -41.95 -66.52 0.34 Allowed 'General case' 0 C--N 1.353 0.729 0 C-N-CA 126.202 1.801 . . . . 43.200000000000003 112.933 -169.065 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 43.0 t80 . . . . . 0 CA--C 1.541 0.63 0 N-CA-C 108.925 -0.769 . . . . 64.040000000000006 108.925 -176.91 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 . . . . . 0 N--CA 1.479 1.014 0 N-CA-C 108.579 -0.897 . . . . 72.209999999999994 108.579 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 30.2 p-10 -75.26 175.74 8.04 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-N 113.869 -1.514 . . . . 71.310000000000002 110.443 170.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 32.2 tp -152.31 138.64 18.46 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.597 -0.729 . . . . 51.130000000000003 109.246 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -116.01 139.29 50.41 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.581 0.753 . . . . 74.409999999999997 109.51 173.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -147.91 157.3 43.45 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.426 -0.953 . . . . 53.210000000000001 108.426 169.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 26.6 p -81.44 153.45 26.89 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 121.887 0.851 . . . . 71.409999999999997 111.272 164.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.636 HD13 ' HB2' ' A' ' 212' ' ' ALA . 37.3 tp -125.31 131.54 53.03 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 113.345 -1.752 . . . . 74.439999999999998 106.755 167.013 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.428 ' HB2' HG21 ' A' ' 256' ' ' THR . 5.7 p-10 -93.43 114.65 27.1 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 107.554 -1.276 . . . . 65.420000000000002 107.554 -178.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.561 HG22 HG21 ' A' ' 210' ' ' VAL . 55.0 t -121.05 131.04 24.59 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 114.85 -1.068 . . . . 52.219999999999999 109.198 -177.407 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -66.97 148.25 81.57 Favored 'Trans proline' 0 C--N 1.369 1.63 0 C-N-CA 122.321 2.014 . . . . 63.329999999999998 110.951 169.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.44 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.62 -45.88 98.48 Favored Pre-proline 0 CA--C 1.562 1.423 0 CA-C-O 118.38 -0.819 . . . . 63.43 112.205 172.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.44 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 20.6 Cg_endo -59.6 -31.14 93.93 Favored 'Trans proline' 0 C--N 1.396 3.053 0 C-N-CA 122.096 1.864 . . . . 74.0 112.814 176.184 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -87.71 -24.55 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 109.52 -0.548 . . . . 74.209999999999994 109.52 -177.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -76.14 -37.3 58.15 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-O 121.064 0.459 . . . . 65.519999999999996 110.806 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 23.6 t -88.52 -38.52 11.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 CA-C-N 114.156 -1.384 . . . . 73.109999999999999 112.124 -177.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.413 ' HB ' ' O ' ' A' ' 202' ' ' PRO . 72.3 t -98.76 -40.44 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 O-C-N 121.959 -0.463 . . . . 75.25 110.89 -178.42 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 121.33 150.41 8.32 Favored Glycine 0 N--CA 1.472 1.072 0 N-CA-C 111.311 -0.715 . . . . 71.319999999999993 111.311 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 165.65 155.6 8.77 Favored Glycine 0 C--O 1.244 0.773 0 CA-C-N 116.869 0.334 . . . . 62.539999999999999 112.473 177.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.584 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 34.6 ttmt -86.33 129.76 34.74 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.106 0.562 . . . . 75.010000000000005 109.878 179.063 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.561 HG21 HG22 ' A' ' 199' ' ' VAL . 10.8 m -131.96 151.94 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 124.467 1.107 . . . . 74.329999999999998 108.863 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -93.96 144.14 25.72 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.409 -0.589 . . . . 75.299999999999997 109.409 -171.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.636 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -133.05 125.27 29.26 Favored 'General case' 0 C--N 1.349 0.56 0 N-CA-C 108.907 -0.775 . . . . 75.040000000000006 108.907 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 36.5 tpp -78.68 112.74 16.09 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 108.706 -0.85 . . . . 70.420000000000002 108.706 171.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 64.1 p -119.59 -175.01 2.86 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 123.71 0.804 . . . . 52.329999999999998 110.222 -176.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.54 HD21 ' HD3' ' A' ' 241' ' ' PRO . 67.2 tp -47.08 -52.93 13.93 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.239 1.016 . . . . 75.230000000000004 112.456 175.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -72.51 -27.85 62.51 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.178 -0.919 . . . . 62.439999999999998 110.977 -172.198 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 138.22 -165.26 25.48 Favored Glycine 0 C--N 1.34 0.794 0 N-CA-C 111.581 -0.608 . . . . 32.140000000000001 111.581 -172.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -66.18 131.15 25.96 Favored 'Trans proline' 0 C--N 1.37 1.707 0 C-N-CA 122.347 2.031 . . . . 63.200000000000003 110.779 177.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 29.4 m -130.93 161.12 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.642 0.777 . . . . 71.340000000000003 110.148 -178.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.519 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 43.7 mt-10 -111.65 111.94 23.29 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.742 0.817 . . . . 62.340000000000003 108.906 -175.319 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.431 HG22 HG11 ' A' ' 168' ' ' VAL . 57.4 t -121.75 103.76 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 124.164 0.986 . . . . 74.099999999999994 110.11 -171.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.584 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -78.32 118.29 20.37 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.437 0.695 . . . . 74.230000000000004 110.666 176.49 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 35.7 m -89.09 151.29 46.65 Favored Pre-proline 0 N--CA 1.481 1.093 0 C-N-CA 122.869 0.468 . . . . 72.209999999999994 110.975 -176.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' PRO . . . . . 0.625 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 28.6 Cg_endo -61.38 164.54 14.95 Favored 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 122.724 2.283 . . . . 63.210000000000001 113.102 176.532 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -91.75 37.65 0.28 Allowed 'Trans proline' 0 C--N 1.373 1.85 0 C-N-CA 123.427 2.751 . . . . 74.519999999999996 112.066 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 -148.37 -9.58 0.37 Allowed 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 116.579 -0.282 . . . . 74.450000000000003 111.356 176.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.625 ' HB ' ' HG2' ' A' ' 224' ' ' PRO . 0.7 OUTLIER -59.62 154.15 18.34 Favored 'General case' 0 CA--C 1.559 1.318 0 O-C-N 124.102 0.876 . . . . 74.439999999999998 110.633 -161.665 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 228' ' ' GLN . . . . . 0.468 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 4.5 pt20 -134.53 162.28 32.7 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.317 0.647 . . . . 73.230000000000004 110.371 -172.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -58.6 112.81 1.74 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 122.985 0.514 . . . . 51.219999999999999 110.841 177.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.52 1.6 21.53 Favored Glycine 0 CA--C 1.522 0.492 0 CA-C-N 115.135 -0.938 . . . . 61.219999999999999 111.877 178.015 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.468 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -69.82 125.52 26.97 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.121 0.569 . . . . 73.420000000000002 109.698 -175.769 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -97.09 100.6 12.09 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 109.241 -0.652 . . . . 72.420000000000002 109.241 -176.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.488 ' HB3' ' HA ' ' A' ' 172' ' ' SER . 39.7 mt -78.4 102.22 7.66 Favored 'General case' 0 C--N 1.341 0.236 0 N-CA-C 108.208 -1.034 . . . . 62.43 108.208 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 234' ' ' ARG . . . . . 0.684 ' HD2' ' H ' ' A' ' 234' ' ' ARG . 0.0 OUTLIER -79.98 117.73 21.09 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 124.733 1.271 . . . . 75.129999999999995 111.836 -174.773 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.62 ' HB3' ' HB2' ' A' ' 238' ' ' LYS . 8.2 mp -107.68 128.08 54.24 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 106.907 -1.516 . . . . 72.0 106.907 173.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -101.52 116.81 33.61 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.753 0.821 . . . . 62.539999999999999 111.441 -174.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 74.63 27.72 64.66 Favored Glycine 0 C--N 1.351 1.401 0 O-C-N 123.895 0.747 . . . . 53.340000000000003 111.857 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.62 ' HB2' ' HB3' ' A' ' 235' ' ' LEU . 28.7 mmmt -126.29 22.11 7.2 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.365 1.066 . . . . 72.019999999999996 111.134 -175.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -93.93 -128.31 5.04 Favored Glycine 0 C--N 1.341 0.815 0 N-CA-C 110.22 -1.152 . . . . 64.519999999999996 110.22 176.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 240' ' ' PHE . . . . . 0.454 ' O ' ' HA ' ' A' ' 246' ' ' ARG . 6.6 m-30 -70.08 153.81 95.06 Favored Pre-proline 0 CA--C 1.551 0.992 0 CA-C-N 117.65 0.725 . . . . 60.409999999999997 111.714 176.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.54 ' HD3' HD21 ' A' ' 215' ' ' LEU . 60.4 Cg_endo -68.35 171.73 12.38 Favored 'Trans proline' 0 C--N 1.381 2.239 0 C-N-CA 123.38 2.72 . . . . 63.420000000000002 112.078 178.183 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.429 ' N ' ' HD2' ' A' ' 243' ' ' PRO . . . -67.59 -39.55 90.75 Favored Glycine 0 CA--C 1.543 1.834 0 CA-C-O 118.4 -1.222 . . . . 73.430000000000007 114.634 -176.009 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 243' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' A' ' 242' ' ' GLY . 9.1 Cg_endo -51.88 -38.81 68.94 Favored 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 122.698 2.265 . . . . 71.409999999999997 113.225 167.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -78.68 -25.29 44.81 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.449 0.699 . . . . 74.230000000000004 110.66 175.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 106.1 112.77 3.73 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 109.084 -1.606 . . . . 74.049999999999997 109.084 -168.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.454 ' HA ' ' O ' ' A' ' 240' ' ' PHE . 52.7 ttp180 -72.22 127.06 31.37 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 117.266 0.533 . . . . 72.219999999999999 110.977 -175.435 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -136.56 -157.18 7.65 Favored Glycine 0 C--O 1.239 0.452 0 CA-C-N 115.575 -0.739 . . . . 44.329999999999998 111.718 178.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -116.29 166.14 12.38 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.872 0.869 . . . . 72.409999999999997 109.028 -174.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 10.6 tp -134.78 134.14 40.6 Favored 'General case' 0 C--O 1.213 -0.827 0 N-CA-C 108.333 -0.988 . . . . 75.109999999999999 108.333 -176.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.445 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 8.1 m-85 -121.97 146.23 47.35 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 108.943 -0.762 . . . . 72.319999999999993 108.943 -177.064 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.419 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 77.6 mt -124.64 115.52 20.93 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.917 -0.772 . . . . 74.230000000000004 108.917 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -88.94 106.71 18.59 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 107.873 -1.158 . . . . 72.400000000000006 107.873 -173.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.599 HG11 HG23 ' A' ' 227' ' ' THR . 52.7 t -59.93 125.26 15.74 Favored 'Isoleucine or valine' 0 C--N 1.34 0.184 0 O-C-N 124.09 0.869 . . . . 75.099999999999994 109.439 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -120.78 124.35 44.87 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.212 -1.403 . . . . 74.219999999999999 107.212 176.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 51.1 mm -85.75 118.45 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 O-C-N 124.124 0.89 . . . . 74.209999999999994 109.414 -173.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 256' ' ' THR . . . . . 0.428 HG21 ' HB2' ' A' ' 198' ' ' ASP . 1.0 OUTLIER . . . . . 0 CA--C 1.554 1.107 0 N-CA-C 108.582 -0.896 . . . . 70.209999999999994 108.582 -171.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.465 HG11 HG22 ' A' ' 221' ' ' VAL . 54.9 t . . . . . 0 N--CA 1.475 0.787 0 CA-C-O 121.323 0.582 . . . . 53.43 111.765 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 44.1 mtm -98.75 -176.75 3.44 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.651 1.581 . . . . 65.150000000000006 109.651 -174.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 8.3 p -99.98 89.04 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 CA-C-O 122.964 1.364 . . . . 73.209999999999994 108.592 163.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' MET . . . . . 0.457 ' HG3' ' HA ' ' A' ' 235' ' ' LEU . 0.0 OUTLIER -123.76 -6.09 8.01 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 113.946 -1.479 . . . . 63.43 110.789 -174.478 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.472 ' HB3' HD22 ' A' ' 233' ' ' LEU . 66.1 m -39.64 -66.45 0.3 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.545 1.938 . . . . 75.019999999999996 114.638 -167.138 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 57.5 t80 . . . . . 0 N--CA 1.472 0.625 0 C-N-CA 122.603 0.361 . . . . 74.239999999999995 110.068 -175.386 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.518 ' HG2' ' HA3' ' A' ' 245' ' ' GLY . 45.2 mt-30 . . . . . 0 N--CA 1.477 0.916 0 CA-C-O 121.338 0.59 . . . . 63.310000000000002 110.47 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -75.4 162.08 28.68 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 114.806 -1.088 . . . . 73.230000000000004 109.182 176.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.444 HD23 HD13 ' A' ' 249' ' ' LEU . 52.7 tp -149.96 136.52 19.14 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.128 -0.693 . . . . 71.530000000000001 109.128 171.531 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -113.17 139.58 48.64 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.011 -0.737 . . . . 74.540000000000006 109.011 170.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.456 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -148.38 155.05 40.76 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.491 0.716 . . . . 73.099999999999994 109.338 173.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 25.2 p -82.0 153.62 26.11 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 122.085 0.945 . . . . 75.450000000000003 112.774 171.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.656 HD13 ' HB2' ' A' ' 212' ' ' ALA . 39.3 tp -126.97 132.26 50.86 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 113.108 -1.86 . . . . 72.209999999999994 106.642 169.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -95.13 111.59 23.39 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.068 -1.086 . . . . 73.239999999999995 108.068 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.516 HG22 HG21 ' A' ' 210' ' ' VAL . 46.8 t -114.84 131.91 23.22 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-N 114.663 -1.153 . . . . 71.349999999999994 109.299 -178.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -68.59 145.3 63.61 Favored 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 122.229 1.953 . . . . 62.420000000000002 110.934 168.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.432 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.86 -45.56 98.82 Favored Pre-proline 0 CA--C 1.564 1.493 0 O-C-N 123.961 0.788 . . . . 53.450000000000003 111.845 174.23 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 19.6 Cg_endo -58.97 -32.9 98.38 Favored 'Trans proline' 0 C--N 1.403 3.442 0 C-N-CA 122.155 1.903 . . . . 71.519999999999996 112.777 175.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.7 mp -86.0 -24.85 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 109.509 -0.552 . . . . 75.420000000000002 109.509 -176.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -73.22 -37.71 66.32 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 122.942 0.497 . . . . 64.439999999999998 110.943 178.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 21.0 t -87.78 -37.28 10.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-N 114.426 -1.261 . . . . 70.109999999999999 112.981 -178.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 53.4 t -96.62 -42.2 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 O-C-N 122.203 -0.311 . . . . 62.439999999999998 110.484 -175.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 121.2 145.46 7.22 Favored Glycine 0 C--N 1.339 0.743 0 N-CA-C 110.76 -0.936 . . . . 73.109999999999999 110.76 -176.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 166.13 155.72 8.98 Favored Glycine 0 C--O 1.246 0.906 0 CA-C-O 121.29 0.383 . . . . 63.030000000000001 112.538 178.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.58 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 36.8 ttmt -86.32 131.73 34.14 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.564 0.745 . . . . 72.040000000000006 109.685 178.337 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.516 HG21 HG22 ' A' ' 199' ' ' VAL . 14.2 m -129.2 149.23 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 124.165 0.986 . . . . 71.219999999999999 109.197 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 4.4 tmm_? -95.98 141.55 29.26 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 108.918 -0.771 . . . . 72.310000000000002 108.918 -170.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.656 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -132.64 116.17 16.32 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.501 1.12 . . . . 61.350000000000001 109.223 -175.15 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 38.1 tpp -78.85 108.7 12.49 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 107.612 -1.255 . . . . 63.340000000000003 107.612 172.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 71.3 p -114.48 -175.17 2.62 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.811 0.844 . . . . 75.420000000000002 110.611 -175.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.614 HD21 ' HD3' ' A' ' 241' ' ' PRO . 61.8 tp -45.01 -52.4 8.9 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.757 1.223 . . . . 65.519999999999996 112.091 173.288 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -72.11 -28.08 63.06 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 114.189 -1.369 . . . . 63.25 111.031 -171.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 135.02 -166.23 24.43 Favored Glycine 0 C--O 1.243 0.717 0 CA-C-N 115.509 -0.769 . . . . 25.219999999999999 111.304 -173.068 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.0 131.43 23.83 Favored 'Trans proline' 0 C--N 1.363 1.3 0 C-N-CA 122.352 2.035 . . . . 72.25 111.672 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 28.9 m -134.26 157.76 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.749 0.82 . . . . 61.140000000000001 109.981 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.504 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 38.7 mt-10 -114.28 115.56 27.61 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.641 0.776 . . . . 73.510000000000005 110.568 -176.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.465 HG22 HG11 ' A' ' 168' ' ' VAL . 98.3 t -121.74 105.29 16.22 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 125.366 1.466 . . . . 75.209999999999994 110.245 -168.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.58 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -76.3 118.47 19.05 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 122.425 0.29 . . . . 72.420000000000002 110.621 176.361 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 35.0 m -87.25 151.72 51.67 Favored Pre-proline 0 N--CA 1.489 1.496 0 C-N-CA 123.178 0.591 . . . . 64.219999999999999 110.673 -178.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' PRO . . . . . 0.658 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 26.1 Cg_endo -61.06 163.59 16.31 Favored 'Trans proline' 0 C--N 1.38 2.215 0 C-N-CA 122.706 2.271 . . . . 64.400000000000006 113.193 177.411 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -87.27 34.02 0.43 Allowed 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 122.951 2.434 . . . . 63.32 112.572 178.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -149.73 -3.35 0.4 Allowed 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 112.321 0.489 . . . . 73.049999999999997 112.321 177.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.658 ' HB ' ' HG2' ' A' ' 224' ' ' PRO . 0.7 OUTLIER -61.97 154.34 26.75 Favored 'General case' 0 CA--C 1.563 1.461 0 O-C-N 123.304 0.377 . . . . 73.420000000000002 111.788 -165.099 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -136.82 161.04 37.08 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.472 0.709 . . . . 73.540000000000006 110.193 -178.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -58.56 113.12 1.85 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.45 0.7 . . . . 75.150000000000006 111.175 -177.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 116.69 0.31 19.96 Favored Glycine 0 CA--C 1.524 0.616 0 CA-C-N 115.064 -0.971 . . . . 71.099999999999994 112.395 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.434 ' HE ' HD23 ' A' ' 233' ' ' LEU . 0.0 OUTLIER -68.97 130.76 43.69 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 109.076 -0.713 . . . . 71.310000000000002 109.076 -176.396 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -97.76 96.18 8.06 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 109.018 -0.734 . . . . 74.109999999999999 109.018 -168.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.472 HD22 ' HB3' ' A' ' 172' ' ' SER . 24.4 mt -82.6 97.62 8.58 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 106.694 -1.595 . . . . 72.200000000000003 106.694 -178.425 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 3.5 ppt_? -83.23 125.29 31.42 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 123.97 0.794 . . . . 71.299999999999997 110.988 -179.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.457 ' HA ' ' HG3' ' A' ' 171' ' ' MET . 7.3 mp -110.02 126.65 54.2 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 106.286 -1.746 . . . . 74.239999999999995 106.286 177.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 11.3 tptp -98.6 115.28 28.29 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 110.048 -0.353 . . . . 75.400000000000006 110.048 -170.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.621 ' HA2' HH11 ' A' ' 246' ' ' ARG . . . 79.66 23.35 62.48 Favored Glycine 0 C--N 1.343 0.951 0 O-C-N 123.836 0.71 . . . . 33.140000000000001 113.65 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? -122.72 23.93 9.31 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.296 0.638 . . . . 53.140000000000001 111.292 -177.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 239' ' ' GLY . . . . . 0.444 ' HA2' ' HB2' ' A' ' 249' ' ' LEU . . . -93.79 -130.96 5.86 Favored Glycine 0 C--N 1.349 1.261 0 CA-C-O 119.296 -0.725 . . . . 63.149999999999999 111.919 -178.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -69.29 149.21 97.44 Favored Pre-proline 0 CA--C 1.553 1.093 0 CA-C-N 117.366 0.583 . . . . 74.150000000000006 111.53 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.614 ' HD3' HD21 ' A' ' 215' ' ' LEU . 44.1 Cg_endo -63.62 171.78 6.51 Favored 'Trans proline' 0 C--N 1.391 2.764 0 C-N-CA 123.574 2.849 . . . . 63.509999999999998 112.565 -178.237 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -66.02 -42.95 94.38 Favored Glycine 0 CA--C 1.544 1.849 0 CA-C-O 118.223 -1.321 . . . . 73.430000000000007 114.098 -173.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -58.92 -34.75 99.24 Favored 'Trans proline' 0 C--N 1.388 2.644 0 CA-C-N 120.812 2.306 . . . . 73.209999999999994 113.785 170.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -77.14 -24.54 51.61 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.18 0.592 . . . . 64.530000000000001 110.37 173.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 245' ' ' GLY . . . . . 0.518 ' HA3' ' HG2' ' A' ' 191' ' ' GLN . . . 110.51 117.74 3.84 Favored Glycine 0 C--N 1.344 0.973 0 N-CA-C 110.532 -1.027 . . . . 70.109999999999999 110.532 -172.151 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.621 HH11 ' HA2' ' A' ' 237' ' ' GLY . 2.3 tmm_? -68.6 124.74 24.43 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.18 -0.674 . . . . 60.030000000000001 109.18 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -143.12 -156.2 6.7 Favored Glycine 0 N--CA 1.47 0.943 0 O-C-N 123.517 0.511 . . . . 63.310000000000002 112.109 176.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -115.53 167.05 11.23 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 109.112 -0.699 . . . . 62.32 109.112 -176.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.444 ' HB2' ' HA2' ' A' ' 239' ' ' GLY . 17.9 tp -134.48 133.07 39.99 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 108.499 -0.926 . . . . 73.310000000000002 108.499 -175.531 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -114.06 147.6 38.45 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 123.598 0.759 . . . . 73.219999999999999 110.245 178.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.456 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 88.9 mt -125.65 113.85 17.91 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 114.017 -1.447 . . . . 64.239999999999995 107.511 174.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -89.73 112.64 23.98 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 107.671 -1.233 . . . . 75.420000000000002 107.671 -176.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.515 HG11 HG23 ' A' ' 227' ' ' THR . 54.6 t -59.65 127.31 18.79 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.117 0 O-C-N 124.46 1.1 . . . . 70.310000000000002 109.75 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 8.3 mmt180 -123.96 123.45 40.41 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.251 -1.018 . . . . 55.049999999999997 108.251 175.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 46.2 mm -87.15 118.73 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 123.258 0.623 . . . . 52.219999999999999 110.033 -174.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.4 t . . . . . 0 CA--C 1.56 1.357 0 C-N-CA 123.546 0.738 . . . . 44.039999999999999 109.251 -171.555 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 47.5 t . . . . . 0 CA--C 1.545 0.76 0 CA-C-O 121.12 0.486 . . . . 65.120000000000005 111.596 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 47.9 mtm -99.11 -175.62 3.08 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 126.183 1.793 . . . . 75.420000000000002 109.703 -171.118 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 14.3 p -95.63 87.81 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.351 0 N-CA-C 107.107 -1.442 . . . . 74.340000000000003 107.107 161.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' MET . . . . . 0.411 ' SD ' ' HG ' ' A' ' 235' ' ' LEU . 0.0 OUTLIER -129.96 -4.79 4.52 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 114.211 -1.359 . . . . 71.25 110.9 -174.203 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.468 ' HA ' ' HB3' ' A' ' 233' ' ' LEU . 70.9 m -40.17 -65.13 0.43 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.666 1.986 . . . . 64.420000000000002 113.049 -171.305 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 55.4 t80 . . . . . 0 CA--C 1.543 0.677 0 N-CA-C 107.518 -1.29 . . . . 72.329999999999998 107.518 179.542 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.423 ' HA ' ' O ' ' A' ' 245' ' ' GLY . 89.4 mt-30 . . . . . 0 C--O 1.245 0.819 0 N-CA-C 108.252 -1.018 . . . . 75.310000000000002 108.252 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 29.2 p-10 -74.17 167.64 21.17 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 114.722 -1.126 . . . . 44.350000000000001 110.548 174.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 52.8 tp -150.65 139.64 21.0 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.449 -0.796 . . . . 64.530000000000001 109.821 177.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -110.03 138.77 45.94 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 123.869 0.867 . . . . 74.340000000000003 109.509 171.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -148.05 157.78 43.7 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 108.185 -1.043 . . . . 63.119999999999997 108.185 168.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' THR . . . . . 0.439 HG22 ' HB3' ' A' ' 252' ' ' GLU . 27.8 p -92.87 152.58 19.32 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.957 0.884 . . . . 74.430000000000007 112.242 168.396 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.671 HD13 ' HB2' ' A' ' 212' ' ' ALA . 41.1 tp -123.86 130.79 53.17 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 113.073 -1.876 . . . . 73.219999999999999 106.826 167.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.431 ' HB2' HG21 ' A' ' 256' ' ' THR . 10.0 p-10 -94.63 112.39 24.14 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 121.951 0.881 . . . . 72.340000000000003 109.047 -178.244 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.594 HG22 HG21 ' A' ' 210' ' ' VAL . 61.0 t -119.35 132.81 23.85 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 124.119 0.968 . . . . 61.119999999999997 109.903 -175.644 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -68.46 144.35 60.96 Favored 'Trans proline' 0 C--N 1.369 1.608 0 C-N-CA 121.999 1.799 . . . . 70.099999999999994 111.337 167.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.431 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.0 -43.62 94.97 Favored Pre-proline 0 CA--C 1.559 1.301 0 CA-C-O 118.104 -0.95 . . . . 72.409999999999997 112.601 173.598 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 19.3 Cg_endo -56.86 -33.61 95.1 Favored 'Trans proline' 0 C--N 1.399 3.237 0 C-N-CA 121.728 1.618 . . . . 73.219999999999999 112.631 173.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -86.71 -24.25 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 N-CA-C 109.623 -0.51 . . . . 55.340000000000003 109.623 -177.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' ALA . . . . . 0.417 ' HA ' HG22 ' A' ' 227' ' ' THR . . . -73.5 -37.59 65.63 Favored 'General case' 0 C--O 1.246 0.89 0 C-N-CA 123.335 0.654 . . . . 62.32 110.866 178.593 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 41.4 t -90.04 -34.67 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.224 0 CA-C-N 113.498 -1.683 . . . . 74.319999999999993 113.414 -177.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 54.6 t -101.39 -42.39 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 O-C-N 121.479 -0.763 . . . . 73.409999999999997 111.096 -178.213 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 126.12 155.24 8.89 Favored Glycine 0 C--N 1.34 0.773 0 N-CA-C 110.941 -0.863 . . . . 34.399999999999999 110.941 -176.203 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.64 149.1 5.68 Favored Glycine 0 C--O 1.246 0.894 0 N-CA-C 111.48 -0.648 . . . . 62.409999999999997 111.48 176.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.579 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 34.3 ttpt -84.71 129.83 34.78 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 109.267 -0.642 . . . . 70.439999999999998 109.267 174.27 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.594 HG21 HG22 ' A' ' 199' ' ' VAL . 9.7 m -133.37 147.93 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 124.013 0.925 . . . . 61.43 108.77 -178.565 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 211' ' ' ARG . . . . . 0.419 ' HD2' ' N ' ' A' ' 212' ' ' ALA . 6.4 tmm_? -94.77 141.79 28.21 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.218 0.607 . . . . 73.010000000000005 109.429 -170.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.671 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -131.18 126.22 35.04 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.495 1.118 . . . . 73.519999999999996 108.498 -176.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 37.3 tpp -80.05 108.5 13.69 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 108.083 -1.08 . . . . 75.129999999999995 108.083 173.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 71.4 p -117.23 178.8 4.23 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.692 0.797 . . . . 75.019999999999996 110.741 -176.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 69.0 tp -45.33 -50.71 11.86 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.17 1.388 . . . . 62.219999999999999 112.276 176.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -71.96 -26.69 62.37 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 114.551 -1.204 . . . . 71.340000000000003 111.288 -173.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 138.6 -166.53 25.29 Favored Glycine 0 C--N 1.341 0.861 0 N-CA-C 111.389 -0.684 . . . . 52.020000000000003 111.389 -177.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -65.33 130.27 24.92 Favored 'Trans proline' 0 C--N 1.368 1.555 0 C-N-CA 121.9 1.733 . . . . 73.120000000000005 110.771 174.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 30.2 m -134.74 159.72 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 123.312 0.645 . . . . 72.329999999999998 110.532 -174.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.555 ' HB3' ' HD2' ' A' ' 209' ' ' LYS . 44.6 mt-10 -113.42 114.7 26.95 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.344 0.658 . . . . 53.210000000000001 109.764 -174.476 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 54.9 t -122.01 103.74 13.87 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 C-N-CA 125.009 1.324 . . . . 72.540000000000006 109.667 -169.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.579 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -77.48 117.88 19.37 Favored 'General case' 0 N--CA 1.478 0.943 0 O-C-N 122.167 -0.333 . . . . 52.119999999999997 110.478 175.296 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.416 HG11 HG21 ' A' ' 199' ' ' VAL . 27.5 m -85.23 152.8 58.85 Favored Pre-proline 0 N--CA 1.492 1.66 0 C-N-CA 123.202 0.601 . . . . 73.200000000000003 111.157 -176.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 224' ' ' PRO . . . . . 0.543 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 33.6 Cg_endo -65.99 163.03 32.71 Favored 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 121.75 1.633 . . . . 52.009999999999998 112.541 177.051 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -85.34 27.42 0.6 Allowed 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 122.854 2.369 . . . . 33.409999999999997 112.94 178.045 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 41.5 mmt-85 -144.93 0.11 0.93 Allowed 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.382 0.673 . . . . 70.319999999999993 111.447 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.594 HG23 HG11 ' A' ' 253' ' ' VAL . 0.7 OUTLIER -61.65 155.71 21.84 Favored 'General case' 0 CA--C 1.573 1.859 0 O-C-N 123.88 0.738 . . . . 65.25 109.529 -169.191 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 228' ' ' GLN . . . . . 0.429 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 4.8 pt20 -133.07 162.86 30.59 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.541 0.736 . . . . 73.400000000000006 110.844 -174.349 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -59.38 110.75 1.16 Allowed 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 109.444 -0.576 . . . . 75.340000000000003 109.444 171.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 114.35 0.36 23.6 Favored Glycine 0 CA--C 1.524 0.61 0 CA-C-N 115.379 -0.828 . . . . 43.43 111.686 178.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.429 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -72.04 125.5 27.4 Favored 'General case' 0 C--N 1.359 0.99 0 N-CA-C 109.022 -0.733 . . . . 75.209999999999994 109.022 -174.141 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -98.98 97.7 8.83 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 123.508 0.723 . . . . 72.0 109.457 -169.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.468 ' HB3' ' HA ' ' A' ' 172' ' ' SER . 30.7 mt -80.38 98.0 7.29 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 107.008 -1.479 . . . . 64.430000000000007 107.008 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 2.0 ppt_? -83.61 117.37 23.12 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 121.493 0.663 . . . . 73.200000000000003 111.417 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.411 ' HG ' ' SD ' ' A' ' 171' ' ' MET . 6.3 mp -99.17 125.8 44.82 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 105.479 -2.045 . . . . 74.109999999999999 105.479 174.316 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.406 ' HA ' ' HB3' ' A' ' 248' ' ' ASP . 18.3 tptt -101.79 117.43 34.84 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 118.657 0.662 . . . . 73.140000000000001 111.234 -168.229 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.49 ' H ' ' HB3' ' A' ' 248' ' ' ASP . . . 78.03 24.6 63.75 Favored Glycine 0 C--N 1.354 1.583 0 O-C-N 123.837 0.711 . . . . 61.240000000000002 112.549 -174.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.406 ' HB2' ' HB3' ' A' ' 235' ' ' LEU . 30.1 mmmt -119.1 20.67 12.61 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.571 0.748 . . . . 75.420000000000002 110.943 -175.566 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -96.83 -139.56 10.69 Favored Glycine 0 C--N 1.346 1.097 0 N-CA-C 111.124 -0.79 . . . . 71.420000000000002 111.124 177.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 7.1 m-30 -68.89 149.53 97.85 Favored Pre-proline 0 N--CA 1.478 0.955 0 N-CA-C 112.372 0.508 . . . . 65.420000000000002 112.372 -174.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -63.12 170.87 7.02 Favored 'Trans proline' 0 C--N 1.386 2.549 0 C-N-CA 123.488 2.792 . . . . 64.109999999999999 112.65 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.43 ' N ' ' HD2' ' A' ' 243' ' ' PRO . . . -66.55 -40.03 94.1 Favored Glycine 0 CA--C 1.551 2.306 0 CA-C-O 118.244 -1.309 . . . . 64.439999999999998 114.695 -174.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 243' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 242' ' ' GLY . 13.1 Cg_endo -56.64 -36.61 98.24 Favored 'Trans proline' 0 C--N 1.391 2.763 0 CA-C-N 120.792 2.296 . . . . 62.43 113.219 169.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -78.28 -25.36 46.67 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.148 0.579 . . . . 63.130000000000003 110.414 175.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 245' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 191' ' ' GLN . . . 113.18 117.08 3.39 Favored Glycine 0 C--N 1.344 1.007 0 N-CA-C 109.543 -1.423 . . . . 75.540000000000006 109.543 -169.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 45.9 ttm105 -72.11 125.98 28.64 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 117.283 0.541 . . . . 75.310000000000002 110.4 -178.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -148.54 -158.18 7.89 Favored Glycine 0 C--N 1.331 0.287 0 CA-C-N 116.008 -0.542 . . . . 74.200000000000003 112.094 175.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 248' ' ' ASP . . . . . 0.49 ' HB3' ' H ' ' A' ' 237' ' ' GLY . 0.1 OUTLIER -126.72 166.26 17.71 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.261 1.024 . . . . 72.120000000000005 110.526 -174.465 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 7.2 tp -132.86 134.66 44.91 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.667 -0.864 . . . . 63.340000000000003 108.667 -167.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -115.18 146.95 40.89 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 108.352 -0.981 . . . . 71.120000000000005 108.352 -175.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.413 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 84.6 mt -124.22 113.87 18.86 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 107.94 -1.133 . . . . 73.049999999999997 107.94 179.067 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 252' ' ' GLU . . . . . 0.439 ' HB3' HG22 ' A' ' 196' ' ' THR . 24.1 tt0 -88.74 110.39 20.96 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 107.698 -1.223 . . . . 71.120000000000005 107.698 -176.078 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.594 HG11 HG23 ' A' ' 227' ' ' THR . 55.5 t -60.77 125.63 17.26 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.263 0 O-C-N 124.116 0.885 . . . . 53.310000000000002 109.186 176.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 24.4 mtp85 -122.29 122.97 40.34 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 107.919 -1.141 . . . . 74.239999999999995 107.919 178.178 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.427 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 47.2 mm -85.84 118.67 32.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 O-C-N 123.635 0.584 . . . . 72.140000000000001 109.89 -171.528 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 256' ' ' THR . . . . . 0.431 HG21 ' HB2' ' A' ' 198' ' ' ASP . 1.7 t . . . . . 0 CA--C 1.551 1.008 0 C-N-CA 124.329 1.052 . . . . 74.439999999999998 109.357 -171.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 53.7 t . . . . . 0 N--CA 1.478 0.925 0 CA-C-O 121.885 0.85 . . . . 55.299999999999997 111.908 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 43.3 mtm -101.62 -176.06 3.03 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 126.625 1.97 . . . . 64.510000000000005 109.862 -168.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 10.2 p -99.23 87.14 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 CA-C-O 123.066 1.413 . . . . 73.519999999999996 107.534 162.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.43 -4.45 8.83 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 113.883 -1.508 . . . . 70.340000000000003 110.285 -174.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.449 ' O ' ' HA ' ' A' ' 233' ' ' LEU . 69.6 m -39.0 -68.3 0.17 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.775 2.03 . . . . 63.340000000000003 113.839 -166.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' TYR . . . . . 0.474 ' HB2' ' HG3' ' A' ' 224' ' ' PRO . 67.2 t80 . . . . . 0 CA--C 1.538 0.494 0 N-CA-C 109.372 -0.603 . . . . 75.219999999999999 109.372 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 . . . . . 0 N--CA 1.468 0.428 0 CA-C-O 121.369 0.604 . . . . 74.310000000000002 109.439 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -82.95 167.62 17.8 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 114.844 -1.071 . . . . 52.329999999999998 109.925 175.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 50.3 tp -150.55 138.73 20.24 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.161 -0.472 . . . . 71.25 109.766 -177.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -117.33 139.45 50.83 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.035 0.934 . . . . 54.030000000000001 109.207 172.308 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -148.39 158.65 44.24 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.737 -0.838 . . . . 45.119999999999997 108.737 171.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 33.2 p -80.95 153.63 27.4 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 122.13 0.967 . . . . 74.430000000000007 111.802 168.267 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.66 HD13 ' HB2' ' A' ' 212' ' ' ALA . 38.8 tp -124.09 133.42 53.62 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 112.961 -1.927 . . . . 73.420000000000002 106.402 166.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -93.05 114.76 27.39 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.785 -1.191 . . . . 72.25 107.785 178.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.607 HG22 HG21 ' A' ' 210' ' ' VAL . 61.0 t -122.93 130.51 24.58 Favored Pre-proline 0 CA--C 1.542 0.673 0 C-N-CA 124.202 1.001 . . . . 52.329999999999998 108.832 179.37 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -68.48 146.72 69.04 Favored 'Trans proline' 0 C--N 1.363 1.29 0 C-N-CA 122.402 2.068 . . . . 63.039999999999999 111.76 168.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.449 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.23 -44.79 98.08 Favored Pre-proline 0 CA--C 1.564 1.507 0 C-N-CA 124.178 0.991 . . . . 61.43 112.25 172.717 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 19.8 Cg_endo -58.11 -34.68 98.74 Favored 'Trans proline' 0 C--N 1.401 3.294 0 C-N-CA 122.127 1.885 . . . . 72.099999999999994 112.58 174.504 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -85.43 -23.37 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 N-CA-C 109.138 -0.69 . . . . 74.329999999999998 109.138 -177.154 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -74.25 -37.98 63.62 Favored 'General case' 0 C--O 1.247 0.95 0 C-N-CA 123.108 0.563 . . . . 73.219999999999999 111.589 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 35.0 t -88.89 -37.88 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 CA-C-N 114.443 -1.253 . . . . 65.150000000000006 112.798 -179.489 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 54.5 t -95.82 -41.63 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 O-C-N 121.834 -0.541 . . . . 63.340000000000003 110.463 -175.234 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 121.59 151.1 8.43 Favored Glycine 0 C--N 1.344 1.012 0 N-CA-C 111.044 -0.822 . . . . 44.299999999999997 111.044 -177.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.77 154.48 7.96 Favored Glycine 0 C--O 1.246 0.862 0 N-CA-C 112.253 -0.339 . . . . 62.399999999999999 112.253 176.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.588 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 39.1 ttmt -85.32 132.68 34.21 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 123.472 0.709 . . . . 73.319999999999993 109.901 175.228 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.607 HG21 HG22 ' A' ' 199' ' ' VAL . 12.9 m -130.79 153.5 39.24 Favored 'Isoleucine or valine' 0 C--O 1.244 0.807 0 C-N-CA 124.713 1.205 . . . . 52.350000000000001 108.607 176.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -93.4 145.05 24.76 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.544 0.737 . . . . 74.310000000000002 110.239 -176.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.66 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -131.06 117.96 19.87 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 107.726 -1.213 . . . . 31.25 107.726 177.479 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 34.3 tpp -79.66 109.1 13.73 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 107.399 -1.334 . . . . 55.450000000000003 107.399 177.077 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 62.3 p -113.46 -172.38 2.06 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.253 0.621 . . . . 74.209999999999994 110.858 -172.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.653 HD21 ' HD3' ' A' ' 241' ' ' PRO . 63.1 tp -46.63 -52.1 14.4 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.561 1.144 . . . . 65.329999999999998 111.223 171.028 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -74.08 -28.96 61.63 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 114.294 -1.321 . . . . 73.310000000000002 112.3 -174.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 134.43 -166.72 24.1 Favored Glycine 0 C--N 1.346 1.102 0 CA-C-O 119.33 -0.706 . . . . 71.340000000000003 111.589 -173.489 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -62.32 136.06 57.57 Favored 'Trans proline' 0 C--N 1.372 1.766 0 C-N-CA 122.869 2.379 . . . . 53.109999999999999 111.301 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 212' ' ' ALA . 24.3 m -135.34 157.91 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 109.922 -0.399 . . . . 71.319999999999993 109.922 -176.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.555 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 44.6 mt-10 -110.01 105.44 14.58 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.773 0.829 . . . . 65.129999999999995 109.147 -167.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 58.7 t -122.11 101.98 10.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 115.198 -0.91 . . . . 75.200000000000003 109.335 -172.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.588 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -79.21 118.35 21.07 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 109.361 -0.607 . . . . 41.530000000000001 109.361 172.067 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 34.1 m -85.23 152.09 57.75 Favored Pre-proline 0 N--CA 1.482 1.164 0 C-N-CA 123.124 0.57 . . . . 33.450000000000003 110.363 -176.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 224' ' ' PRO . . . . . 0.474 ' HG3' ' HB2' ' A' ' 173' ' ' TYR . 36.2 Cg_endo -62.82 163.37 22.13 Favored 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 122.227 1.951 . . . . 65.409999999999997 112.362 176.161 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -85.37 32.96 0.47 Allowed 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 122.899 2.4 . . . . 72.540000000000006 112.729 175.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 226' ' ' ARG . . . . . 0.42 ' HA ' ' HD2' ' A' ' 226' ' ' ARG . 13.2 tpt180 -149.41 4.32 0.6 Allowed 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 116.095 -0.502 . . . . 75.420000000000002 110.731 175.335 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.506 HG23 HG11 ' A' ' 253' ' ' VAL . 0.6 OUTLIER -59.94 154.35 19.05 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.896 -0.779 . . . . 74.430000000000007 108.896 -169.855 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -131.7 161.39 32.9 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.291 0.636 . . . . 72.439999999999998 110.384 -168.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -62.33 109.37 1.32 Allowed 'General case' 0 C--O 1.241 0.62 0 N-CA-C 107.922 -1.14 . . . . 45.549999999999997 107.922 167.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 113.85 2.76 23.74 Favored Glycine 0 C--N 1.337 0.589 0 CA-C-N 115.309 -0.859 . . . . 61.329999999999998 112.428 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.14 127.08 31.58 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.046 -0.724 . . . . 72.010000000000005 109.046 -175.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -99.73 98.19 9.04 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 123.466 0.706 . . . . 73.430000000000007 109.353 -171.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.466 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 20.3 mt -82.63 98.62 9.11 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 106.928 -1.508 . . . . 75.420000000000002 106.928 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 7.1 ppt_? -83.06 114.0 20.99 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-O 121.349 0.595 . . . . 74.150000000000006 111.374 -179.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.483 ' O ' ' HB2' ' A' ' 248' ' ' ASP . 8.0 mp -104.11 126.67 51.41 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 106.52 -1.659 . . . . 74.510000000000005 106.52 174.278 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -102.92 119.05 38.16 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.476 0.71 . . . . 72.340000000000003 111.35 -174.286 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 79.0 31.42 43.33 Favored Glycine 0 C--N 1.354 1.564 0 O-C-N 123.969 0.793 . . . . 51.43 112.309 -175.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -127.98 20.33 6.45 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.389 0.676 . . . . 71.319999999999993 111.053 -178.703 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -98.01 -131.27 7.08 Favored Glycine 0 C--N 1.349 1.267 0 CA-C-O 119.576 -0.569 . . . . 53.219999999999999 112.407 -177.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -71.16 155.18 93.45 Favored Pre-proline 0 CA--C 1.55 0.98 0 CA-C-N 117.453 0.627 . . . . 74.340000000000003 112.453 -178.063 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.653 ' HD3' HD21 ' A' ' 215' ' ' LEU . 88.8 Cg_endo -72.99 171.67 17.05 Favored 'Trans proline' 0 C--N 1.387 2.603 0 C-N-CA 123.502 2.801 . . . . 75.510000000000005 112.67 -174.075 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -66.41 -38.72 93.79 Favored Glycine 0 CA--C 1.545 1.958 0 CA-C-O 118.382 -1.232 . . . . 75.430000000000007 113.575 -179.099 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 243' ' ' PRO . . . . . 0.447 ' HD2' ' HB2' ' A' ' 241' ' ' PRO . 53.5 Cg_exo -46.3 -44.47 20.11 Favored 'Trans proline' 0 C--N 1.385 2.464 0 C-N-CA 123.047 2.498 . . . . 73.209999999999994 114.041 163.603 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -78.73 -23.81 45.22 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.675 0.79 . . . . 72.140000000000001 110.765 177.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 105.27 114.49 3.96 Favored Glycine 0 C--N 1.341 0.861 0 N-CA-C 108.458 -1.857 . . . . 44.310000000000002 108.458 -165.218 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.61 124.0 23.74 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.163 0.585 . . . . 72.329999999999998 109.53 -172.496 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -137.8 -156.69 7.28 Favored Glycine 0 N--CA 1.477 1.432 0 CA-C-O 119.886 -0.397 . . . . 24.210000000000001 112.305 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 248' ' ' ASP . . . . . 0.483 ' HB2' ' O ' ' A' ' 235' ' ' LEU . 6.5 p30 -123.0 167.54 13.47 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.178 0.591 . . . . 64.319999999999993 111.706 -175.408 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 11.7 tp -134.67 134.41 41.09 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.634 0.774 . . . . 62.109999999999999 109.265 -170.233 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 4.2 m-30 -118.94 148.94 42.41 Favored 'General case' 0 C--O 1.25 1.114 0 N-CA-C 108.708 -0.849 . . . . 74.349999999999994 108.708 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.466 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 88.4 mt -120.72 124.42 45.12 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.446 -0.576 . . . . 61.399999999999999 109.446 -177.17 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -91.51 100.82 13.51 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 107.197 -1.408 . . . . 74.450000000000003 107.197 -177.249 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.506 HG11 HG23 ' A' ' 227' ' ' THR . 55.7 t -63.15 123.58 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-O 121.488 0.661 . . . . 62.539999999999999 110.7 -178.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -114.66 123.5 49.46 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 107.606 -1.257 . . . . 70.510000000000005 107.606 177.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 47.0 mm -88.21 111.57 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 O-C-N 123.981 0.801 . . . . 74.219999999999999 110.181 -175.249 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.6 t . . . . . 0 C--O 1.255 1.376 0 C-N-CA 124.143 0.977 . . . . 42.039999999999999 110.196 -173.526 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 45.7 t . . . . . 0 N--CA 1.478 0.946 0 CA-C-O 121.196 0.522 . . . . 73.340000000000003 110.61 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 50.6 mtm -98.8 -177.69 3.73 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 125.226 1.41 . . . . 71.510000000000005 110.212 -169.451 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 7.7 p -99.05 87.79 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.065 0 CA-C-O 122.989 1.376 . . . . 53.140000000000001 107.49 162.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.1 -4.97 8.97 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 125.495 1.518 . . . . 63.140000000000001 109.979 -176.572 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 69.9 m -36.36 -66.15 0.23 Allowed 'General case' 0 C--N 1.35 0.612 0 C-N-CA 126.906 2.082 . . . . 74.099999999999994 114.559 -167.004 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' TYR . . . . . 0.409 ' HB2' ' HG3' ' A' ' 224' ' ' PRO . 77.2 t80 . . . . . 0 CA--C 1.54 0.579 0 N-CA-C 110.1 -0.333 . . . . 73.519999999999996 110.1 -177.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.431 ' HG2' ' HA3' ' A' ' 245' ' ' GLY . 70.9 mt-30 . . . . . 0 N--CA 1.477 0.907 0 CA-C-O 121.301 0.572 . . . . 61.409999999999997 109.675 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -77.0 165.09 25.11 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-N 115.051 -0.977 . . . . 55.140000000000001 109.625 177.085 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 35.2 tp -151.47 139.14 19.71 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.933 -0.576 . . . . 71.25 109.841 178.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -116.55 140.21 49.64 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.411 1.084 . . . . 74.329999999999998 109.555 174.202 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -149.59 160.87 43.13 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 123.908 0.883 . . . . 54.340000000000003 108.781 168.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 34.7 p -83.91 154.4 23.43 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 121.757 0.789 . . . . 75.329999999999998 111.458 163.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.662 HD13 ' HB2' ' A' ' 212' ' ' ALA . 37.4 tp -121.11 132.05 54.63 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 113.768 -1.56 . . . . 62.340000000000003 107.152 162.747 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -93.18 111.36 22.97 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 108.248 -1.019 . . . . 63.409999999999997 108.248 -178.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.578 HG22 HG21 ' A' ' 210' ' ' VAL . 56.4 t -120.36 131.73 24.34 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 123.87 0.868 . . . . 72.319999999999993 108.892 -178.143 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -66.49 148.19 83.45 Favored 'Trans proline' 0 C--N 1.369 1.631 0 C-N-CA 121.957 1.771 . . . . 64.319999999999993 111.253 168.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.433 ' HB3' ' HD3' ' A' ' 202' ' ' PRO . . . -53.77 -46.78 98.27 Favored Pre-proline 0 CA--C 1.56 1.336 0 CA-C-O 118.609 -0.71 . . . . 41.109999999999999 111.523 174.24 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.433 ' HD3' ' HB3' ' A' ' 201' ' ' ALA . 73.0 Cg_exo -51.37 -39.62 63.14 Favored 'Trans proline' 0 C--N 1.396 3.061 0 C-N-CA 122.744 2.296 . . . . 73.239999999999995 114.08 172.192 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -84.99 -24.73 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 N-CA-C 109.525 -0.546 . . . . 73.439999999999998 109.525 -174.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 204' ' ' ALA . . . . . 0.433 ' HA ' HG22 ' A' ' 227' ' ' THR . . . -74.21 -37.95 63.73 Favored 'General case' 0 C--O 1.247 0.955 0 CA-C-O 121.548 0.69 . . . . 73.420000000000002 111.552 179.052 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 14.1 t -88.14 -38.49 11.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 113.798 -1.547 . . . . 70.430000000000007 112.008 -177.082 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 90.3 t -97.15 -41.73 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 122.931 0.493 . . . . 53.409999999999997 110.37 -174.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 120.85 145.97 7.42 Favored Glycine 0 C--N 1.35 1.311 0 N-CA-C 110.803 -0.919 . . . . 73.140000000000001 110.803 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 166.96 154.66 8.55 Favored Glycine 0 C--O 1.247 0.959 0 CA-C-N 117.202 0.501 . . . . 52.450000000000003 112.715 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.626 ' HD3' ' HB3' ' A' ' 220' ' ' GLU . 38.8 ttmt -85.65 129.84 34.72 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.627 0.771 . . . . 70.319999999999993 110.09 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.578 HG21 HG22 ' A' ' 199' ' ' VAL . 14.0 m -131.05 151.46 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 123.917 0.887 . . . . 72.310000000000002 109.753 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -95.02 141.51 28.59 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 109.034 -0.728 . . . . 62.210000000000001 109.034 -172.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.662 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -132.37 120.96 22.74 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.841 0.856 . . . . 63.32 108.831 -176.281 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 34.6 tpp -77.79 110.16 12.42 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 108.625 -0.88 . . . . 73.030000000000001 108.625 173.258 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 61.0 p -116.92 -179.55 3.72 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.827 0.851 . . . . 73.109999999999999 110.068 -177.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.541 HD21 ' HD3' ' A' ' 241' ' ' PRO . 65.7 tp -46.03 -52.05 12.57 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.544 1.138 . . . . 64.329999999999998 112.159 175.407 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -72.97 -26.81 61.5 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.533 1.133 . . . . 62.409999999999997 111.738 -174.12 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 139.19 -166.61 25.42 Favored Glycine 0 C--N 1.343 0.941 0 CA-C-O 119.437 -0.646 . . . . 63.509999999999998 111.981 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.28 129.73 23.56 Favored 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 122.026 1.817 . . . . 73.239999999999995 111.021 175.239 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 24.7 m -130.37 160.84 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 123.363 0.665 . . . . 45.539999999999999 110.227 -177.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.626 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 45.2 mt-10 -112.81 111.42 22.18 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.393 0.677 . . . . 72.099999999999994 109.684 -173.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 62.7 t -121.63 103.18 13.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 124.887 1.275 . . . . 71.409999999999997 109.43 -173.053 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.618 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -78.95 118.12 20.67 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 110.004 -0.369 . . . . 42.439999999999998 110.004 175.173 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 33.7 m -86.18 150.08 51.39 Favored Pre-proline 0 N--CA 1.485 1.298 0 C-N-CA 122.936 0.494 . . . . 72.209999999999994 110.516 -177.003 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 224' ' ' PRO . . . . . 0.467 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 24.1 Cg_endo -62.66 163.1 22.46 Favored 'Trans proline' 0 C--N 1.384 2.411 0 C-N-CA 122.431 2.088 . . . . 73.150000000000006 112.912 178.689 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -83.85 35.58 0.56 Allowed 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 123.225 2.617 . . . . 55.509999999999998 112.945 177.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -150.6 -4.93 0.32 Allowed 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.06 0.544 . . . . 73.129999999999995 111.549 176.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.583 HG23 HG11 ' A' ' 253' ' ' VAL . 0.6 OUTLIER -60.59 151.14 29.61 Favored 'General case' 0 CA--C 1.57 1.735 0 N-CA-C 109.266 -0.642 . . . . 74.400000000000006 109.266 -165.529 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 228' ' ' GLN . . . . . 0.438 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 20.6 pt20 -134.2 162.43 32.16 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.025 0.53 . . . . 74.150000000000006 110.368 -170.473 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -56.53 111.33 0.97 Allowed 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 109.824 -0.436 . . . . 74.129999999999995 109.824 175.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 114.82 -0.29 23.01 Favored Glycine 0 C--N 1.337 0.615 0 CA-C-N 115.564 -0.744 . . . . 65.319999999999993 112.094 178.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.438 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -72.45 122.72 21.73 Favored 'General case' 0 C--N 1.354 0.782 0 N-CA-C 108.661 -0.866 . . . . 73.0 108.661 -173.808 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 10.8 mmmm -98.35 97.57 8.92 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 109.307 -0.627 . . . . 70.030000000000001 109.307 -168.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 22.2 mt -80.5 97.06 6.97 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.14 -1.43 . . . . 74.420000000000002 107.14 -177.282 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.07 117.26 23.31 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.772 -0.649 . . . . 74.420000000000002 111.328 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 7.5 mp -97.69 127.55 43.73 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 105.807 -1.923 . . . . 70.349999999999994 105.807 171.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 15.3 tptt -101.23 115.45 30.53 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.525 0.33 . . . . 61.409999999999997 110.478 -167.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 77.84 32.49 45.11 Favored Glycine 0 C--N 1.349 1.281 0 O-C-N 123.922 0.764 . . . . 62.439999999999998 112.144 -175.387 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -125.98 23.41 7.19 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.796 0.838 . . . . 73.040000000000006 111.611 -174.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -93.8 -129.44 5.37 Favored Glycine 0 C--N 1.342 0.891 0 N-CA-C 110.916 -0.874 . . . . 3.4100000000000001 110.916 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 6.9 m-30 -70.89 151.19 95.15 Favored Pre-proline 0 CA--C 1.551 1.011 0 CA-C-N 117.72 0.76 . . . . 64.030000000000001 111.678 177.036 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.541 ' HD3' HD21 ' A' ' 215' ' ' LEU . 60.3 Cg_endo -66.27 172.69 8.5 Favored 'Trans proline' 0 C--N 1.385 2.469 0 C-N-CA 123.561 2.841 . . . . 52.039999999999999 112.157 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.422 ' N ' ' HD2' ' A' ' 243' ' ' PRO . . . -66.35 -42.18 94.12 Favored Glycine 0 CA--C 1.545 1.964 0 CA-C-O 118.311 -1.272 . . . . 64.349999999999994 114.067 -174.002 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 243' ' ' PRO . . . . . 0.422 ' HD2' ' N ' ' A' ' 242' ' ' GLY . 9.3 Cg_endo -53.76 -36.44 82.2 Favored 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 122.74 2.293 . . . . 74.450000000000003 113.441 169.221 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -78.98 -24.07 44.03 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.318 0.647 . . . . 44.009999999999998 110.692 174.113 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 245' ' ' GLY . . . . . 0.431 ' HA3' ' HG2' ' A' ' 191' ' ' GLN . . . 109.33 116.05 3.84 Favored Glycine 0 C--N 1.344 1.018 0 N-CA-C 109.599 -1.4 . . . . 73.219999999999999 109.599 -170.362 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -72.36 124.48 25.21 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 117.355 0.577 . . . . 71.310000000000002 110.402 -178.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -140.07 -157.46 7.25 Favored Glycine 0 N--CA 1.466 0.639 0 N-CA-C 111.044 -0.823 . . . . 70.510000000000005 111.044 174.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 8.4 p30 -119.86 167.56 11.99 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 117.515 0.657 . . . . 71.420000000000002 110.708 -177.062 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 9.8 tp -133.53 133.92 42.76 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 108.923 -0.769 . . . . 61.049999999999997 108.923 -172.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -115.46 146.05 42.01 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 109.105 -0.702 . . . . 74.5 109.105 -177.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 81.2 mt -125.79 113.09 16.82 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 107.896 -1.15 . . . . 74.340000000000003 107.896 178.105 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -89.6 113.36 24.79 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.846 -0.798 . . . . 74.230000000000004 108.846 -177.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.583 HG11 HG23 ' A' ' 227' ' ' THR . 55.8 t -59.36 124.28 13.3 Favored 'Isoleucine or valine' 0 C--N 1.344 0.365 0 O-C-N 124.089 0.868 . . . . 71.239999999999995 109.479 178.317 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 8.4 mmt180 -122.9 122.79 39.47 Favored 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 107.376 -1.342 . . . . 64.010000000000005 107.376 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 48.9 mm -84.17 120.67 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 O-C-N 124.216 0.948 . . . . 63.200000000000003 110.603 -170.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.4 t . . . . . 0 CA--C 1.558 1.267 0 CA-C-O 118.038 -0.982 . . . . 51.200000000000003 109.691 -169.794 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.46 HG11 HG22 ' A' ' 221' ' ' VAL . 52.9 t . . . . . 0 N--CA 1.471 0.62 0 CA-C-O 121.806 0.812 . . . . 74.109999999999999 111.25 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 43.2 mtm -100.48 -175.49 2.93 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 126.362 1.865 . . . . 73.049999999999997 109.433 -166.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 9.1 p -99.28 87.97 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.147 0 CA-C-O 123.022 1.391 . . . . 65.430000000000007 107.856 163.117 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.51 -6.46 8.13 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 113.851 -1.522 . . . . 64.430000000000007 110.637 -175.562 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.54 ' HA ' ' HB3' ' A' ' 233' ' ' LEU . 68.5 m -44.36 -65.25 0.54 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.272 1.829 . . . . 75.349999999999994 113.586 -172.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' TYR . . . . . 0.42 ' HB2' ' HB3' ' A' ' 224' ' ' PRO . 42.6 t80 . . . . . 0 CA--C 1.536 0.44 0 C-N-CA 123.776 0.83 . . . . 73.0 109.588 -177.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 121.1 0.476 . . . . 74.430000000000007 109.931 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.4 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 61.1 t0 -75.37 153.9 37.51 Favored 'General case' 0 C--O 1.244 0.791 0 CA-C-N 114.489 -1.232 . . . . 72.420000000000002 107.923 174.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 46.7 tp -147.54 141.42 25.82 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 122.802 0.441 . . . . 71.230000000000004 110.123 -170.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -116.69 139.44 50.55 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.322 0.649 . . . . 75.200000000000003 109.849 172.334 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -141.17 156.84 45.88 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 108.078 -1.082 . . . . 54.43 108.078 167.027 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 35.3 p -86.51 152.63 22.48 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-O 121.95 0.881 . . . . 64.549999999999997 111.656 168.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.674 HD13 ' HB2' ' A' ' 212' ' ' ALA . 42.4 tp -121.62 131.08 53.91 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 113.264 -1.789 . . . . 75.209999999999994 107.3 167.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -94.43 111.77 23.53 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 122.023 0.916 . . . . 53.43 108.982 -177.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.6 HG22 HG21 ' A' ' 210' ' ' VAL . 53.4 t -120.09 132.32 24.13 Favored Pre-proline 0 CA--C 1.546 0.789 0 CA-C-N 114.707 -1.133 . . . . 65.129999999999995 109.964 -176.195 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -68.96 147.28 67.65 Favored 'Trans proline' 0 C--N 1.372 1.807 0 C-N-CA 122.326 2.018 . . . . 52.329999999999998 111.269 167.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.418 ' HB3' ' HD3' ' A' ' 202' ' ' PRO . . . -53.2 -46.67 97.71 Favored Pre-proline 0 CA--C 1.569 1.686 0 C-N-CA 123.447 0.699 . . . . 75.200000000000003 111.945 174.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.418 ' HD3' ' HB3' ' A' ' 201' ' ' ALA . 78.2 Cg_exo -51.13 -39.97 60.49 Favored 'Trans proline' 0 C--N 1.396 3.033 0 C-N-CA 122.638 2.225 . . . . 61.530000000000001 113.817 172.092 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.7 mp -84.68 -23.13 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 N-CA-C 109.327 -0.62 . . . . 73.120000000000005 109.327 -174.477 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -73.32 -39.28 65.4 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 123.143 0.577 . . . . 53.310000000000002 111.897 178.552 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 39.7 t -88.93 -34.32 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 CA-C-N 114.787 -1.097 . . . . 75.340000000000003 113.201 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 54.5 t -97.96 -42.17 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 O-C-N 121.514 -0.741 . . . . 75.319999999999993 110.636 -175.52 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 123.52 152.36 8.45 Favored Glycine 0 C--N 1.341 0.836 0 N-CA-C 111.05 -0.82 . . . . 34.439999999999998 111.05 -176.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.45 149.21 5.71 Favored Glycine 0 C--O 1.242 0.647 0 N-CA-C 111.476 -0.65 . . . . 74.319999999999993 111.476 176.379 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.64 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 36.0 ttmt -85.62 130.0 34.68 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 109.444 -0.576 . . . . 73.120000000000005 109.444 174.516 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.6 HG21 HG22 ' A' ' 199' ' ' VAL . 8.7 m -130.64 151.4 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.46 1.104 . . . . 72.299999999999997 108.693 -178.423 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 47.7 ttt180 -94.68 140.38 29.96 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.188 -0.914 . . . . 75.540000000000006 109.558 -167.143 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.674 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -132.23 115.35 15.56 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.028 0.931 . . . . 73.430000000000007 109.097 -171.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 32.5 tpp -78.78 110.9 14.38 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 108.167 -1.049 . . . . 75.239999999999995 108.167 175.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 69.6 p -115.28 -176.25 2.87 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.56 0.744 . . . . 73.430000000000007 110.456 -176.101 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.598 HD21 ' HD3' ' A' ' 241' ' ' PRO . 66.3 tp -47.57 -51.68 20.22 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.624 1.169 . . . . 45.310000000000002 111.998 177.433 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -72.17 -27.95 62.91 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 114.507 -1.224 . . . . 70.129999999999995 111.078 -174.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 136.64 -165.91 24.93 Favored Glycine 0 C--N 1.34 0.79 0 N-CA-C 111.464 -0.654 . . . . 44.399999999999999 111.464 -175.458 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -65.9 132.62 30.9 Favored 'Trans proline' 0 C--N 1.368 1.59 0 C-N-CA 122.565 2.176 . . . . 73.329999999999998 112.024 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 31.5 m -132.6 160.82 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.432 1.093 . . . . 72.5 109.333 177.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.403 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 47.9 mt-10 -113.16 115.73 28.71 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 122.959 0.504 . . . . 63.219999999999999 110.035 -176.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.46 HG22 HG11 ' A' ' 168' ' ' VAL . 59.0 t -121.77 105.73 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.16 1.384 . . . . 73.25 110.705 -168.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.64 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -73.82 118.52 16.88 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.889 0.476 . . . . 71.549999999999997 110.946 176.667 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 27.1 m -88.66 150.59 46.4 Favored Pre-proline 0 N--CA 1.483 1.184 0 C-N-CA 122.566 0.346 . . . . 73.299999999999997 110.776 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 224' ' ' PRO . . . . . 0.491 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 33.1 Cg_endo -64.97 165.57 21.1 Favored 'Trans proline' 0 C--N 1.373 1.829 0 C-N-CA 122.625 2.217 . . . . 73.099999999999994 113.653 176.146 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -83.68 29.1 0.55 Allowed 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 123.167 2.578 . . . . 74.129999999999995 113.664 172.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 35.4 mmt180 -143.97 -1.44 0.97 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.099 0.56 . . . . 73.409999999999997 111.505 177.167 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.544 HG23 HG11 ' A' ' 253' ' ' VAL . 0.6 OUTLIER -61.17 152.12 29.5 Favored 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 108.919 -0.771 . . . . 53.509999999999998 108.919 -166.27 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 228' ' ' GLN . . . . . 0.512 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 29.8 pt20 -135.31 163.03 30.91 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.314 0.645 . . . . 65.310000000000002 110.407 -174.262 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -61.1 110.76 1.46 Allowed 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 109.288 -0.634 . . . . 73.310000000000002 109.288 175.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.74 -0.25 21.57 Favored Glycine 0 CA--C 1.525 0.683 0 CA-C-N 115.369 -0.832 . . . . 75.439999999999998 112.308 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.512 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -68.26 125.45 26.45 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.737 0.815 . . . . 71.109999999999999 109.605 -174.189 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 49.2 mmtm -99.4 98.23 9.18 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.232 0.613 . . . . 74.400000000000006 109.504 -172.36 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.54 ' HB3' ' HA ' ' A' ' 172' ' ' SER . 22.5 mt -82.25 99.96 9.61 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 107.048 -1.464 . . . . 72.329999999999998 107.048 178.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -79.77 125.89 30.26 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 121.169 0.509 . . . . 75.25 110.99 -177.21 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 7.7 mp -111.13 127.91 55.72 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 105.999 -1.852 . . . . 74.349999999999994 105.999 172.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 41.4 tptt -101.75 117.89 35.81 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 118.054 0.388 . . . . 63.039999999999999 110.84 -173.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 79.22 30.69 45.08 Favored Glycine 0 C--N 1.347 1.159 0 O-C-N 123.481 0.488 . . . . 74.129999999999995 111.98 -178.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -127.43 20.51 6.72 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.007 0.923 . . . . 62.109999999999999 110.424 -176.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -96.92 -130.5 6.6 Favored Glycine 0 C--N 1.347 1.155 0 N-CA-C 111.19 -0.764 . . . . 45.340000000000003 111.19 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 240' ' ' PHE . . . . . 0.47 ' O ' ' HA ' ' A' ' 246' ' ' ARG . 4.8 m-30 -71.16 155.53 93.0 Favored Pre-proline 0 N--CA 1.478 0.931 0 N-CA-C 112.479 0.548 . . . . 62.409999999999997 112.479 -178.134 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.598 ' HD3' HD21 ' A' ' 215' ' ' LEU . 73.2 Cg_endo -69.35 171.81 13.35 Favored 'Trans proline' 0 C--N 1.388 2.633 0 C-N-CA 123.297 2.665 . . . . 74.25 112.396 -174.067 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.436 ' N ' ' HD2' ' A' ' 243' ' ' PRO . . . -66.81 -38.05 92.73 Favored Glycine 0 CA--C 1.544 1.851 0 CA-C-O 118.204 -1.331 . . . . 75.430000000000007 114.424 -176.707 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 243' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 242' ' ' GLY . 10.2 Cg_endo -52.27 -42.1 62.18 Favored 'Trans proline' 0 C--N 1.383 2.391 0 CA-C-N 120.696 2.248 . . . . 60.450000000000003 113.237 166.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -77.32 -23.04 51.06 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.546 0.738 . . . . 51.539999999999999 110.256 174.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 104.37 115.46 4.08 Favored Glycine 0 C--N 1.342 0.888 0 N-CA-C 109.33 -1.508 . . . . 74.329999999999998 109.33 -169.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 240' ' ' PHE . 38.4 ttp180 -69.04 124.08 22.79 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 117.663 0.731 . . . . 73.439999999999998 110.681 -178.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -133.93 -157.05 8.12 Favored Glycine 0 C--N 1.337 0.615 0 CA-C-N 115.193 -0.912 . . . . 72.010000000000005 111.003 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 248' ' ' ASP . . . . . 0.4 ' O ' ' HA ' ' A' ' 192' ' ' ASP . 0.2 OUTLIER -121.04 160.62 23.22 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.412 0.685 . . . . 73.120000000000005 110.764 -171.259 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 11.6 tp -135.32 133.79 39.18 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.729 0.811 . . . . 70.230000000000004 108.994 -172.22 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -114.7 150.38 35.33 Favored 'General case' 0 C--O 1.245 0.867 0 N-CA-C 108.527 -0.916 . . . . 72.019999999999996 108.527 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 64.6 mt -121.13 113.4 19.96 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.548 -1.278 . . . . 64.450000000000003 107.548 178.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -88.61 112.16 22.74 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 107.556 -1.276 . . . . 72.120000000000005 107.556 -179.174 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.544 HG11 HG23 ' A' ' 227' ' ' THR . 55.7 t -62.28 128.69 24.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 115.085 -0.961 . . . . 63.219999999999999 110.509 177.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 42.5 mtp180 -115.08 125.27 53.32 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 106.805 -1.554 . . . . 64.129999999999995 106.805 171.38 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 48.3 mm -87.3 127.03 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 N-CA-C 109.576 -0.527 . . . . 73.349999999999994 109.576 -176.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.7 t . . . . . 0 CA--C 1.56 1.355 0 N-CA-C 108.275 -1.009 . . . . 64.299999999999997 108.275 -174.078 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 55.5 t . . . . . 0 N--CA 1.482 1.135 0 CA-C-O 121.822 0.82 . . . . 51.130000000000003 112.22 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 39.4 mtm -100.97 -176.18 3.09 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.526 1.931 . . . . 62.509999999999998 110.17 -165.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 9.4 p -96.88 88.13 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 CA-C-O 122.939 1.352 . . . . 73.430000000000007 108.238 163.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.71 -4.8 8.14 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 114.418 -1.265 . . . . 75.310000000000002 110.64 -176.25 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.514 ' HA ' ' HB3' ' A' ' 233' ' ' LEU . 69.9 m -41.29 -66.12 0.37 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.493 1.917 . . . . 61.43 114.508 -169.415 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 70.9 t80 . . . . . 0 CA--C 1.536 0.404 0 CA-C-O 121.031 0.443 . . . . 74.409999999999997 110.829 -173.115 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.421 ' HA ' ' O ' ' A' ' 245' ' ' GLY . 93.1 mt-30 . . . . . 0 N--CA 1.479 0.997 0 CA-C-O 121.83 0.824 . . . . 63.140000000000001 109.085 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 29.3 p-10 -74.27 160.97 30.39 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 114.016 -1.447 . . . . 73.510000000000005 110.8 -177.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 48.5 tp -150.63 135.05 17.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.159 -0.928 . . . . 62.420000000000002 108.628 173.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -116.27 138.84 50.96 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.663 -0.866 . . . . 73.319999999999993 108.663 176.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -149.15 158.58 44.29 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.399 0.679 . . . . 44.409999999999997 109.406 171.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 37.0 p -81.33 154.37 26.54 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.924 0.869 . . . . 53.340000000000003 111.842 165.059 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.695 HD13 ' HB2' ' A' ' 212' ' ' ALA . 34.9 tp -125.74 133.48 52.07 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 113.52 -1.673 . . . . 74.230000000000004 106.924 170.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -94.68 111.7 23.47 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.79 -0.818 . . . . 74.109999999999999 108.79 -175.216 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.611 HG22 HG21 ' A' ' 210' ' ' VAL . 46.4 t -123.18 129.78 24.81 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 124.328 1.051 . . . . 65.540000000000006 109.813 -177.196 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -67.52 149.03 79.78 Favored 'Trans proline' 0 C--N 1.365 1.429 0 C-N-CA 122.586 2.191 . . . . 63.109999999999999 112.079 169.136 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.426 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.3 -46.96 97.67 Favored Pre-proline 0 CA--C 1.562 1.432 0 CA-C-O 118.353 -0.832 . . . . 54.009999999999998 112.446 173.403 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.459 ' O ' ' HB ' ' A' ' 206' ' ' VAL . 24.2 Cg_endo -60.43 -31.77 93.0 Favored 'Trans proline' 0 C--N 1.395 3.017 0 C-N-CA 121.719 1.613 . . . . 43.200000000000003 112.461 177.435 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.7 mp -86.2 -22.96 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 N-CA-C 109.475 -0.565 . . . . 71.329999999999998 109.475 -178.208 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 204' ' ' ALA . . . . . 0.407 ' HA ' HG22 ' A' ' 227' ' ' THR . . . -73.31 -37.96 65.99 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 122.989 0.516 . . . . 61.100000000000001 111.098 176.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 19.5 t -89.2 -33.18 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.977 1.311 . . . . 74.510000000000005 113.011 -178.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.459 ' HB ' ' O ' ' A' ' 202' ' ' PRO . 51.2 t -100.49 -43.18 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 O-C-N 121.611 -0.68 . . . . 61.340000000000003 110.726 -176.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 121.22 152.18 8.73 Favored Glycine 0 N--CA 1.466 0.699 0 N-CA-C 110.811 -0.916 . . . . 74.349999999999994 110.811 -176.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.71 152.98 7.25 Favored Glycine 0 C--O 1.243 0.658 0 N-CA-C 111.671 -0.572 . . . . 71.109999999999999 111.671 177.219 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.572 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 30.2 tttt -85.62 130.41 34.58 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.747 -0.834 . . . . 73.329999999999998 108.747 176.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.611 HG21 HG22 ' A' ' 199' ' ' VAL . 13.1 m -129.1 151.83 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 N-CA-C 108.632 -0.877 . . . . 75.409999999999997 108.632 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 211' ' ' ARG . . . . . 0.409 ' HD2' ' N ' ' A' ' 212' ' ' ALA . 6.2 tmm_? -94.09 142.14 27.73 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 109.322 -0.622 . . . . 74.040000000000006 109.322 -169.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.695 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -132.73 119.24 20.08 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.083 0.953 . . . . 65.310000000000002 108.612 -177.484 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 37.4 tpp -79.68 107.66 12.63 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 107.756 -1.201 . . . . 74.150000000000006 107.756 173.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 63.9 p -117.03 -174.8 2.66 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.24 0.616 . . . . 51.340000000000003 110.77 -172.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.519 HD21 ' HD3' ' A' ' 241' ' ' PRO . 64.9 tp -48.73 -51.94 26.19 Favored 'General case' 0 C--N 1.358 0.963 0 C-N-CA 123.896 0.879 . . . . 72.109999999999999 111.872 175.294 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -72.46 -28.31 62.84 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.234 -0.894 . . . . 74.340000000000003 110.701 -173.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 138.4 -166.58 25.23 Favored Glycine 0 C--N 1.341 0.829 0 CA-C-O 119.648 -0.529 . . . . 44.219999999999999 112.186 -174.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -64.92 129.56 23.56 Favored 'Trans proline' 0 C--N 1.369 1.609 0 C-N-CA 122.454 2.103 . . . . 73.400000000000006 111.286 176.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.437 HG22 ' O ' ' A' ' 212' ' ' ALA . 21.0 m -133.28 160.66 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 123.445 0.698 . . . . 60.539999999999999 110.558 -176.264 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -113.12 115.43 28.28 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.893 0.877 . . . . 65.530000000000001 109.746 -176.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 58.5 t -121.96 103.55 13.62 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.887 0 C-N-CA 124.866 1.266 . . . . 74.209999999999994 110.103 -170.724 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.572 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -77.88 118.22 19.99 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.605 0.362 . . . . 63.520000000000003 110.673 177.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 34.0 m -89.01 152.33 48.17 Favored Pre-proline 0 N--CA 1.48 1.064 0 C-N-CA 123.27 0.628 . . . . 73.430000000000007 111.225 -177.243 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 224' ' ' PRO . . . . . 0.584 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 32.0 Cg_endo -63.73 164.08 22.55 Favored 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 122.593 2.195 . . . . 61.039999999999999 113.094 175.168 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -86.74 28.73 0.53 Allowed 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 123.137 2.558 . . . . 63.210000000000001 113.393 177.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 60.1 mmt-85 -145.64 1.21 0.9 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.335 0.654 . . . . 74.200000000000003 111.705 176.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.637 HG23 HG11 ' A' ' 253' ' ' VAL . 0.7 OUTLIER -61.26 154.97 22.19 Favored 'General case' 0 CA--C 1.57 1.747 0 O-C-N 123.383 0.427 . . . . 70.319999999999993 110.116 -168.986 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 228' ' ' GLN . . . . . 0.465 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 13.8 pt20 -140.7 162.62 34.98 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.318 0.647 . . . . 74.010000000000005 110.63 -174.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -59.27 111.56 1.4 Allowed 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 121.14 0.495 . . . . 62.439999999999998 110.527 -178.51 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.44 0.56 21.94 Favored Glycine 0 CA--C 1.519 0.324 0 CA-C-N 114.882 -1.053 . . . . 74.239999999999995 111.823 179.027 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -69.12 125.12 25.69 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 109.051 -0.722 . . . . 74.209999999999994 109.051 -175.065 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -98.55 98.44 9.62 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.146 0.578 . . . . 72.540000000000006 109.7 -169.091 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.514 ' HB3' ' HA ' ' A' ' 172' ' ' SER . 21.5 mt -81.87 100.31 9.54 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.253 -1.388 . . . . 72.140000000000001 107.253 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.61 126.11 30.84 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.245 0.545 . . . . 64.409999999999997 111.205 -178.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.546 ' HB3' ' HB2' ' A' ' 238' ' ' LYS . 7.3 mp -110.07 124.93 52.38 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 105.948 -1.871 . . . . 75.140000000000001 105.948 173.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.32 115.34 30.36 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.079 0.552 . . . . 73.019999999999996 111.652 -172.257 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 76.99 31.82 51.7 Favored Glycine 0 C--N 1.351 1.375 0 CA-C-N 115.05 -0.977 . . . . 73.230000000000004 111.92 -175.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.546 ' HB2' ' HB3' ' A' ' 235' ' ' LEU . 30.5 mmmt -128.91 19.96 5.99 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.833 0.853 . . . . 74.209999999999994 111.204 -176.301 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -96.93 -134.56 8.21 Favored Glycine 0 C--N 1.343 0.943 0 N-CA-C 111.633 -0.587 . . . . 74.299999999999997 111.633 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 4.6 m-30 -70.09 151.78 95.95 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 122.676 0.39 . . . . 63.240000000000002 111.754 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.519 ' HD3' HD21 ' A' ' 215' ' ' LEU . 60.8 Cg_endo -66.97 172.14 10.19 Favored 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 123.532 2.821 . . . . 64.209999999999994 112.373 -177.006 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -66.36 -38.68 93.82 Favored Glycine 0 CA--C 1.539 1.56 0 CA-C-O 118.158 -1.356 . . . . 71.420000000000002 114.012 -177.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 243' ' ' PRO . . . . . 0.463 ' HD2' ' HB2' ' A' ' 241' ' ' PRO . 73.8 Cg_exo -45.73 -45.99 15.87 Favored 'Trans proline' 0 C--N 1.385 2.475 0 C-N-CA 122.771 2.314 . . . . 74.25 114.033 165.127 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -80.34 -24.45 39.86 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.535 0.734 . . . . 72.209999999999994 111.05 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 245' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 191' ' ' GLN . . . 113.34 112.29 3.07 Favored Glycine 0 C--N 1.337 0.63 0 N-CA-C 109.617 -1.393 . . . . 73.200000000000003 109.617 -169.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.93 123.09 17.63 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.7 0.8 . . . . 73.0 110.457 -179.142 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -147.67 -155.63 6.68 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-N 116.236 -0.438 . . . . 43.399999999999999 113.319 -175.359 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -119.91 164.17 16.46 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.745 0.818 . . . . 45.119999999999997 110.197 -170.463 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 10.3 tp -134.02 133.53 41.36 Favored 'General case' 0 C--O 1.214 -0.815 0 N-CA-C 107.634 -1.247 . . . . 63.200000000000003 107.634 -178.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -122.11 146.18 47.45 Favored 'General case' 0 C--O 1.246 0.908 0 N-CA-C 108.389 -0.967 . . . . 63.100000000000001 108.389 -177.075 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 88.1 mt -124.82 115.91 21.42 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.807 0.843 . . . . 41.43 108.857 -176.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -89.09 110.16 20.92 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.815 -1.18 . . . . 64.530000000000001 107.815 -176.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.637 HG11 HG23 ' A' ' 227' ' ' THR . 45.4 t -60.04 128.54 21.21 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.365 0 O-C-N 123.872 0.733 . . . . 54.020000000000003 109.73 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.84 123.35 45.69 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 105.981 -1.859 . . . . 63.520000000000003 105.981 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 48.8 mm -86.38 117.95 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 109.006 -0.739 . . . . 74.219999999999999 109.006 -177.591 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.2 t . . . . . 0 CA--C 1.557 1.245 0 N-CA-C 107.687 -1.227 . . . . 73.340000000000003 107.687 -174.0 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.435 HG11 HG22 ' A' ' 221' ' ' VAL . 53.6 t . . . . . 0 N--CA 1.475 0.799 0 CA-C-O 121.906 0.86 . . . . 54.439999999999998 112.139 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 40.6 mtm -99.69 -175.68 3.05 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 126.051 1.74 . . . . 63.32 109.263 -169.025 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 10.3 p -97.28 88.12 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.184 0 CA-C-O 122.858 1.313 . . . . 74.409999999999997 108.275 164.272 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.27 -5.16 8.34 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 113.771 -1.559 . . . . 73.420000000000002 109.945 -178.478 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.426 ' HA ' ' HB3' ' A' ' 233' ' ' LEU . 67.0 m -39.22 -64.93 0.42 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 127.029 2.132 . . . . 62.039999999999999 114.578 -169.699 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' TYR . . . . . 0.419 ' HB2' ' HB3' ' A' ' 224' ' ' PRO . 72.6 t80 . . . . . 0 N--CA 1.471 0.6 0 C-N-CA 123.462 0.705 . . . . 73.430000000000007 110.901 -176.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 . . . . . 0 N--CA 1.473 0.698 0 N-CA-C 107.482 -1.303 . . . . 74.040000000000006 107.482 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.444 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 17.9 p-10 -74.3 160.7 30.74 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 113.08 -1.873 . . . . 72.129999999999995 110.411 170.443 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.456 HD23 HD13 ' A' ' 249' ' ' LEU . 57.6 tp -149.22 143.74 26.11 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.779 -0.646 . . . . 72.349999999999994 109.749 -174.4 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -116.25 139.13 50.69 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.911 0.885 . . . . 70.049999999999997 110.169 174.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -148.59 157.39 43.43 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.257 1.023 . . . . 33.119999999999997 108.979 173.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 24.9 p -83.75 153.43 24.14 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 122.091 0.948 . . . . 72.519999999999996 112.663 168.03 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.669 HD13 ' HB2' ' A' ' 212' ' ' ALA . 31.6 tp -126.29 133.67 51.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 112.909 -1.951 . . . . 64.049999999999997 106.971 167.325 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -94.3 114.03 26.04 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.206 -1.035 . . . . 75.209999999999994 108.206 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.621 HG22 HG21 ' A' ' 210' ' ' VAL . 48.9 t -121.56 132.0 24.32 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 124.186 0.994 . . . . 62.43 109.688 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -69.24 144.21 56.0 Favored 'Trans proline' 0 C--N 1.37 1.703 0 C-N-CA 122.289 1.993 . . . . 74.430000000000007 111.014 166.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.435 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -54.48 -42.21 93.31 Favored Pre-proline 0 CA--C 1.565 1.54 0 CA-C-O 118.059 -0.972 . . . . 73.340000000000003 112.544 173.424 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 11.5 Cg_endo -55.22 -36.63 93.79 Favored 'Trans proline' 0 C--N 1.404 3.465 0 C-N-CA 121.885 1.723 . . . . 74.549999999999997 112.83 172.411 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -85.46 -23.89 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 N-CA-C 109.14 -0.689 . . . . 71.409999999999997 109.14 -177.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 204' ' ' ALA . . . . . 0.461 ' HA ' HG22 ' A' ' 227' ' ' THR . . . -73.83 -37.33 64.88 Favored 'General case' 0 C--O 1.247 0.934 0 CA-C-O 121.44 0.638 . . . . 75.209999999999994 111.299 179.27 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 25.2 t -88.71 -38.0 10.93 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-N 113.72 -1.582 . . . . 63.409999999999997 112.435 -177.009 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 76.1 t -97.51 -42.59 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 O-C-N 122.13 -0.356 . . . . 73.109999999999999 110.341 -176.367 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 121.1 148.95 8.06 Favored Glycine 0 C--N 1.341 0.855 0 N-CA-C 110.612 -0.995 . . . . 63.340000000000003 110.612 -176.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 165.73 155.39 8.66 Favored Glycine 0 C--O 1.246 0.876 0 N-CA-C 111.856 -0.497 . . . . 63.340000000000003 111.856 178.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.648 ' HD3' ' HB3' ' A' ' 220' ' ' GLU . 3.5 ttmp? -84.94 131.22 34.52 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.373 0.669 . . . . 75.430000000000007 109.701 178.343 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.621 HG21 HG22 ' A' ' 199' ' ' VAL . 9.5 m -130.04 151.76 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.444 1.098 . . . . 75.140000000000001 108.642 177.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? -95.5 140.84 29.78 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 108.976 -0.75 . . . . 74.310000000000002 108.976 -172.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.669 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -131.25 119.8 22.32 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.719 -0.845 . . . . 74.140000000000001 108.719 -177.557 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 37.3 tpp -79.35 107.35 12.05 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 107.592 -1.262 . . . . 74.530000000000001 107.592 172.009 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 214' ' ' THR . . . . . 0.42 HG22 HD21 ' A' ' 251' ' ' LEU . 71.5 p -112.43 -173.55 2.27 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.836 0.854 . . . . 62.32 110.878 -174.301 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 61.7 tp -44.98 -52.63 8.59 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.314 1.046 . . . . 64.530000000000001 112.063 167.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -71.81 -26.53 62.44 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 114.263 -1.335 . . . . 62.200000000000003 111.46 -169.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 131.09 -165.77 22.95 Favored Glycine 0 C--N 1.34 0.777 0 N-CA-C 110.661 -0.976 . . . . 52.5 110.661 -171.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -65.78 131.02 26.17 Favored 'Trans proline' 0 C--N 1.37 1.67 0 C-N-CA 121.89 1.727 . . . . 64.420000000000002 110.715 175.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 212' ' ' ALA . 26.6 m -133.36 162.82 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 123.754 0.821 . . . . 62.409999999999997 110.495 -178.283 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.648 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 38.3 mt-10 -112.02 116.07 29.96 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.395 1.078 . . . . 72.230000000000004 109.307 -175.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.435 HG22 HG11 ' A' ' 168' ' ' VAL . 44.5 t -124.32 103.28 12.31 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 C-N-CA 124.233 1.013 . . . . 75.329999999999998 109.635 -173.121 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.534 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -78.1 118.4 20.32 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.552 -0.536 . . . . 74.099999999999994 109.552 173.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 34.7 m -89.03 151.43 46.95 Favored Pre-proline 0 N--CA 1.483 1.182 0 C-N-CA 123.031 0.532 . . . . 52.43 110.54 -178.061 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 224' ' ' PRO . . . . . 0.468 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 41.4 Cg_endo -65.22 165.83 20.88 Favored 'Trans proline' 0 C--N 1.38 2.189 0 C-N-CA 122.939 2.426 . . . . 54.439999999999998 113.412 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -80.27 31.97 0.5 Allowed 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 123.163 2.575 . . . . 54.399999999999999 113.1 172.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -150.17 -2.32 0.39 Allowed 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 112.275 0.472 . . . . 74.400000000000006 112.275 178.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.569 HG23 HG11 ' A' ' 253' ' ' VAL . 0.6 OUTLIER -59.95 150.48 28.75 Favored 'General case' 0 CA--C 1.566 1.596 0 N-CA-C 108.901 -0.778 . . . . 74.340000000000003 108.901 -168.423 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 228' ' ' GLN . . . . . 0.441 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 4.5 pt20 -133.36 162.2 32.47 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.039 0.535 . . . . 74.209999999999994 109.876 -171.521 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 229' ' ' ALA . . . . . 0.589 ' HB1' HH21 ' A' ' 254' ' ' ARG . . . -59.18 111.52 1.37 Allowed 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 109.318 -0.623 . . . . 71.010000000000005 109.318 174.281 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 114.89 1.16 22.71 Favored Glycine 0 C--N 1.338 0.641 0 CA-C-N 115.696 -0.684 . . . . 71.040000000000006 112.013 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.441 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -69.66 123.76 22.21 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 108.967 -0.753 . . . . 72.540000000000006 108.967 -174.098 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.439 ' HB3' ' HD1' ' A' ' 250' ' ' TYR . 30.7 mmmt -100.15 97.21 8.05 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 108.767 -0.827 . . . . 73.340000000000003 108.767 -172.663 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 250' ' ' TYR . 20.3 mt -81.51 99.07 8.58 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 106.406 -1.701 . . . . 64.219999999999999 106.406 -176.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 234' ' ' ARG . . . . . 0.696 ' HD3' ' HE2' ' A' ' 236' ' ' LYS . 0.5 OUTLIER -83.02 126.16 32.24 Favored 'General case' 0 CA--C 1.561 1.401 0 C-N-CA 123.854 0.862 . . . . 71.430000000000007 112.262 179.803 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.442 ' HB3' ' HB2' ' A' ' 238' ' ' LYS . 7.6 mp -113.72 124.44 52.3 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.964 1.306 . . . . 72.140000000000001 108.697 -176.507 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.696 ' HE2' ' HD3' ' A' ' 234' ' ' ARG . 5.2 mptp? -94.31 115.11 27.29 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 118.537 0.608 . . . . 73.409999999999997 110.942 -169.056 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 77.48 20.48 74.48 Favored Glycine 0 C--N 1.349 1.283 0 O-C-N 124.236 0.96 . . . . 72.439999999999998 112.305 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.442 ' HB2' ' HB3' ' A' ' 235' ' ' LEU . 1.0 OUTLIER -117.45 19.46 14.0 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.814 0.846 . . . . 62.119999999999997 110.037 -178.575 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -95.85 -139.98 10.72 Favored Glycine 0 C--N 1.35 1.338 0 N-CA-C 110.951 -0.86 . . . . 53.210000000000001 110.951 176.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 240' ' ' PHE . . . . . 0.435 ' O ' ' HA ' ' A' ' 246' ' ' ARG . 6.1 m-30 -61.11 146.94 87.32 Favored Pre-proline 0 N--CA 1.477 0.878 0 N-CA-C 112.645 0.609 . . . . 72.400000000000006 112.645 -175.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -59.71 171.08 2.96 Favored 'Trans proline' 0 C--N 1.385 2.497 0 C-N-CA 123.486 2.791 . . . . 75.239999999999995 112.524 -178.2 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.42 ' N ' ' HD2' ' A' ' 243' ' ' PRO . . . -67.64 -41.34 89.74 Favored Glycine 0 CA--C 1.552 2.392 0 CA-C-O 118.284 -1.287 . . . . 73.109999999999999 114.237 -174.372 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 243' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' A' ' 242' ' ' GLY . 10.8 Cg_endo -55.57 -36.5 94.63 Favored 'Trans proline' 0 C--N 1.392 2.843 0 C-N-CA 122.749 2.299 . . . . 70.540000000000006 112.914 168.43 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -77.47 -24.67 50.17 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.24 0.616 . . . . 65.510000000000005 110.688 174.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 106.68 115.59 4.03 Favored Glycine 0 C--N 1.341 0.821 0 N-CA-C 109.34 -1.504 . . . . 42.420000000000002 109.34 -172.674 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.435 ' HA ' ' O ' ' A' ' 240' ' ' PHE . 29.0 ttm180 -72.87 123.9 24.32 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 117.603 0.702 . . . . 71.299999999999997 111.274 -177.691 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -139.65 -152.74 5.92 Favored Glycine 0 C--N 1.341 0.83 0 CA-C-N 114.808 -1.087 . . . . 73.0 112.304 -177.06 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 248' ' ' ASP . . . . . 0.444 ' O ' ' HA ' ' A' ' 192' ' ' ASP . 11.0 t70 -114.69 163.01 16.06 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.403 1.081 . . . . 71.120000000000005 108.705 -168.473 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.456 HD13 HD23 ' A' ' 193' ' ' LEU . 18.8 tp -134.84 132.77 39.01 Favored 'General case' 0 C--O 1.214 -0.804 0 N-CA-C 109.209 -0.663 . . . . 71.25 109.209 -177.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.471 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 0.4 OUTLIER -112.04 145.27 39.99 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-O 121.688 0.756 . . . . 73.209999999999994 109.691 178.856 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.42 HD21 HG22 ' A' ' 214' ' ' THR . 72.5 mt -125.65 113.85 17.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 113.909 -1.496 . . . . 74.510000000000005 107.602 174.634 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -91.54 109.55 20.86 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 107.774 -1.195 . . . . 52.149999999999999 107.774 -173.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.569 HG11 HG23 ' A' ' 227' ' ' THR . 52.1 t -61.53 122.77 12.94 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 O-C-N 124.301 1.0 . . . . 72.310000000000002 109.988 -179.55 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 254' ' ' ARG . . . . . 0.589 HH21 ' HB1' ' A' ' 229' ' ' ALA . 0.3 OUTLIER -115.2 122.89 47.41 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 106.872 -1.529 . . . . 74.450000000000003 106.872 176.878 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 44.9 mm -87.62 114.97 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 O-C-N 123.918 0.761 . . . . 63.329999999999998 110.108 -174.26 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 CA--C 1.56 1.362 0 C-N-CA 124.09 0.956 . . . . 75.349999999999994 109.516 -172.057 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.422 HG11 HG22 ' A' ' 221' ' ' VAL . 54.4 t . . . . . 0 N--CA 1.472 0.67 0 CA-C-O 121.68 0.752 . . . . 72.239999999999995 110.119 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 42.9 mtm -99.17 -176.91 3.45 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 125.552 1.541 . . . . 73.140000000000001 109.515 -167.029 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 12.6 p -100.53 86.32 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 CA-C-O 123.428 1.585 . . . . 73.310000000000002 107.453 165.208 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' MET . . . . . 0.485 ' HG3' ' HA ' ' A' ' 235' ' ' LEU . 0.0 OUTLIER -124.07 -3.86 8.03 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 113.394 -1.73 . . . . 54.32 110.263 -173.554 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.559 ' HB3' HD22 ' A' ' 233' ' ' LEU . 66.7 m -44.74 -69.84 0.12 Allowed 'General case' 0 C--N 1.351 0.65 0 C-N-CA 125.856 1.662 . . . . 74.409999999999997 113.542 -166.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' TYR . . . . . 0.516 ' HB2' ' HG3' ' A' ' 224' ' ' PRO . 50.8 t80 . . . . . 0 CA--C 1.541 0.614 0 N-CA-C 108.215 -1.031 . . . . 74.420000000000002 108.215 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.435 ' HG2' ' HA3' ' A' ' 245' ' ' GLY . 75.0 mt-30 . . . . . 0 N--CA 1.475 0.816 0 CA-C-O 121.599 0.714 . . . . 62.509999999999998 110.752 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -85.35 158.8 20.17 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 114.908 -1.042 . . . . 72.409999999999997 110.081 -174.322 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 53.6 tp -150.31 142.48 24.1 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.04 0.536 . . . . 62.229999999999997 110.042 -176.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -114.1 142.07 46.68 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.677 0.791 . . . . 74.319999999999993 109.286 173.335 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -148.62 162.4 39.77 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.936 0.894 . . . . 73.209999999999994 108.916 173.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 34.6 p -85.95 154.6 21.36 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 122.015 0.912 . . . . 65.150000000000006 111.984 166.132 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.678 HD13 ' HB2' ' A' ' 212' ' ' ALA . 29.2 tp -124.55 133.63 53.24 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 113.404 -1.725 . . . . 73.409999999999997 107.172 160.774 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -93.33 114.03 26.37 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 108.205 -1.035 . . . . 74.420000000000002 108.205 178.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.611 HG22 HG21 ' A' ' 210' ' ' VAL . 46.1 t -121.56 131.15 24.51 Favored Pre-proline 0 CA--C 1.546 0.803 0 CA-C-N 115.049 -0.978 . . . . 74.519999999999996 109.018 -178.455 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -68.59 148.27 72.07 Favored 'Trans proline' 0 C--N 1.364 1.391 0 C-N-CA 122.522 2.148 . . . . 61.43 111.379 169.117 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.411 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.28 -45.75 98.24 Favored Pre-proline 0 CA--C 1.558 1.262 0 CA-C-O 118.597 -0.716 . . . . 53.539999999999999 112.887 174.323 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.432 ' O ' ' HB ' ' A' ' 206' ' ' VAL . 30.1 Cg_endo -61.16 -30.15 88.22 Favored 'Trans proline' 0 C--N 1.395 2.998 0 C-N-CA 121.685 1.59 . . . . 74.430000000000007 112.193 178.003 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -86.47 -25.37 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 N-CA-C 109.482 -0.562 . . . . 74.420000000000002 109.482 -177.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -73.4 -37.67 65.87 Favored 'General case' 0 C--O 1.247 0.936 0 C-N-CA 122.89 0.476 . . . . 74.040000000000006 111.18 178.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 25.6 t -88.36 -38.0 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 C-N-CA 124.884 1.274 . . . . 73.409999999999997 112.869 -178.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.432 ' HB ' ' O ' ' A' ' 202' ' ' PRO . 54.5 t -97.26 -41.47 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 O-C-N 121.841 -0.537 . . . . 74.239999999999995 110.545 -175.349 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 121.61 148.15 7.79 Favored Glycine 0 C--N 1.341 0.847 0 N-CA-C 110.789 -0.925 . . . . 73.409999999999997 110.789 -177.033 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 166.51 151.41 6.8 Favored Glycine 0 C--O 1.245 0.792 0 N-CA-C 112.098 -0.401 . . . . 44.399999999999999 112.098 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.664 ' HD3' ' HB3' ' A' ' 220' ' ' GLU . 37.5 ttmt -85.06 132.39 34.33 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.781 0.832 . . . . 71.150000000000006 109.615 175.696 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.611 HG21 HG22 ' A' ' 199' ' ' VAL . 11.2 m -136.11 152.18 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.365 1.066 . . . . 75.540000000000006 109.407 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 8.8 tmm_? -94.59 142.83 26.99 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.581 0.752 . . . . 70.099999999999994 110.711 -170.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.678 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -131.17 123.12 27.83 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.912 0.885 . . . . 63.200000000000003 109.366 -176.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 33.8 tpp -78.6 109.05 12.45 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 108.52 -0.918 . . . . 32.119999999999997 108.52 175.006 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 51.6 p -113.73 -178.35 3.36 Favored 'General case' 0 C--O 1.244 0.8 0 C-N-CA 123.242 0.617 . . . . 72.430000000000007 111.132 -174.055 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.531 HD21 ' HD3' ' A' ' 241' ' ' PRO . 65.5 tp -45.83 -51.66 12.55 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 124.278 0.986 . . . . 73.349999999999994 111.33 170.14 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -73.56 -29.4 62.4 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 114.05 -1.432 . . . . 74.540000000000006 111.442 -174.129 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 136.68 -167.18 24.64 Favored Glycine 0 C--N 1.348 1.211 0 CA-C-O 119.558 -0.579 . . . . 61.420000000000002 112.407 -177.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.91 129.47 24.71 Favored 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 122.329 2.019 . . . . 43.25 111.046 176.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.408 HG22 ' O ' ' A' ' 212' ' ' ALA . 28.1 m -132.8 161.55 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 123.573 0.749 . . . . 74.450000000000003 110.138 -176.297 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.664 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 51.8 mt-10 -111.54 115.56 29.38 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.711 0.804 . . . . 75.219999999999999 109.416 -173.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.422 HG22 HG11 ' A' ' 168' ' ' VAL . 59.8 t -126.63 104.66 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 124.451 1.1 . . . . 72.329999999999998 110.102 -169.473 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.574 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -76.89 117.99 19.04 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 110.066 -0.346 . . . . 54.119999999999997 110.066 176.044 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 34.0 m -88.07 152.36 50.55 Favored Pre-proline 0 N--CA 1.48 1.034 0 C-N-CA 123.002 0.521 . . . . 70.319999999999993 110.765 -178.044 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 224' ' ' PRO . . . . . 0.548 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 34.6 Cg_endo -62.55 163.69 20.39 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.242 1.961 . . . . 64.310000000000002 112.231 174.822 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -86.76 32.94 0.44 Allowed 'Trans proline' 0 C--N 1.371 1.75 0 C-N-CA 123.249 2.633 . . . . 75.519999999999996 112.074 176.481 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 5.2 tpt180 -148.99 -0.71 0.5 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 122.764 0.426 . . . . 74.340000000000003 111.324 178.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.585 HG23 HG11 ' A' ' 253' ' ' VAL . 0.6 OUTLIER -61.12 153.01 26.84 Favored 'General case' 0 CA--C 1.563 1.476 0 N-CA-C 109.519 -0.549 . . . . 41.329999999999998 109.519 -167.242 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 228' ' ' GLN . . . . . 0.464 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 19.5 pt20 -132.77 161.56 33.75 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.182 0.593 . . . . 70.230000000000004 110.41 -170.483 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 229' ' ' ALA . . . . . 0.461 ' HB1' ' NH2' ' A' ' 254' ' ' ARG . . . -61.27 110.84 1.52 Allowed 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 109.509 -0.552 . . . . 71.25 109.509 174.289 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 113.92 0.46 24.21 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 111.28 -0.728 . . . . 64.109999999999999 111.28 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.464 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -68.84 126.93 31.31 Favored 'General case' 0 C--N 1.362 1.152 0 N-CA-C 109.187 -0.671 . . . . 74.25 109.187 -173.513 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -97.71 97.7 9.24 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 108.947 -0.76 . . . . 64.439999999999998 108.947 -169.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.559 HD22 ' HB3' ' A' ' 172' ' ' SER . 25.8 mt -81.11 99.56 8.57 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.696 -1.224 . . . . 61.219999999999999 107.696 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.44 113.32 17.49 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.733 -0.667 . . . . 71.329999999999998 110.363 -178.525 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.555 ' HB3' ' HB2' ' A' ' 238' ' ' LYS . 7.5 mp -99.55 124.73 45.01 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 105.943 -1.873 . . . . 62.020000000000003 105.943 169.268 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -102.68 118.05 36.0 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.563 0.745 . . . . 64.310000000000002 109.777 -176.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 78.42 31.2 46.96 Favored Glycine 0 C--N 1.349 1.264 0 O-C-N 124.103 0.877 . . . . 53.229999999999997 112.735 -177.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.555 ' HB2' ' HB3' ' A' ' 235' ' ' LEU . 29.9 mmmt -129.94 21.25 5.4 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.028 0.931 . . . . 74.319999999999993 111.042 -179.285 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -96.81 -131.1 6.8 Favored Glycine 0 C--N 1.346 1.089 0 N-CA-C 111.468 -0.653 . . . . 75.349999999999994 111.468 -179.207 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 7.1 m-30 -70.8 151.77 95.19 Favored Pre-proline 0 CA--C 1.553 1.093 0 C-N-CA 123.458 0.703 . . . . 73.239999999999995 112.321 -178.486 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.531 ' HD3' HD21 ' A' ' 215' ' ' LEU . 58.8 Cg_endo -66.3 171.36 10.51 Favored 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 124.142 3.228 . . . . 73.109999999999999 112.977 179.08 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -66.35 -40.5 94.6 Favored Glycine 0 CA--C 1.543 1.84 0 CA-C-O 118.233 -1.315 . . . . 74.010000000000005 115.604 -175.246 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -53.9 -36.86 84.77 Favored 'Trans proline' 0 C--N 1.379 2.18 0 CA-C-N 120.827 2.313 . . . . 64.239999999999995 113.029 168.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -79.56 -26.61 41.34 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 122.987 0.515 . . . . 42.039999999999999 110.398 174.597 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 245' ' ' GLY . . . . . 0.435 ' HA3' ' HG2' ' A' ' 191' ' ' GLN . . . 110.65 115.67 3.63 Favored Glycine 0 C--N 1.345 1.083 0 N-CA-C 109.413 -1.475 . . . . 60.299999999999997 109.413 -170.157 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 11.1 mmm-85 -67.91 121.98 17.2 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.02 0.528 . . . . 61.130000000000003 110.292 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -143.73 -156.15 6.69 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-N 115.823 -0.626 . . . . 72.140000000000001 112.131 -177.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -120.64 165.53 14.92 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 123.675 0.79 . . . . 61.219999999999999 110.749 -172.713 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 16.1 tp -135.46 134.49 39.64 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 107.828 -1.175 . . . . 73.349999999999994 107.828 -173.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 8.9 m-30 -114.39 148.48 37.62 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 109.144 -0.687 . . . . 72.310000000000002 109.144 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.448 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 69.9 mt -122.93 113.94 19.78 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.24 -1.393 . . . . 74.219999999999999 107.24 178.093 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -89.65 111.68 22.71 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 106.986 -1.487 . . . . 72.310000000000002 106.986 -176.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.585 HG11 HG23 ' A' ' 227' ' ' THR . 54.7 t -62.21 125.82 19.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 O-C-N 123.977 0.798 . . . . 73.049999999999997 110.278 -178.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 254' ' ' ARG . . . . . 0.461 ' NH2' ' HB1' ' A' ' 229' ' ' ALA . 3.8 mmp_? -117.0 122.53 44.49 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.036 -1.468 . . . . 74.219999999999999 107.036 176.462 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 48.7 mm -88.37 115.42 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 O-C-N 123.799 0.687 . . . . 62.409999999999997 110.273 -172.074 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.0 t . . . . . 0 CA--C 1.562 1.413 0 C-N-CA 124.389 1.076 . . . . 54.240000000000002 109.23 -169.377 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.526 HG11 HG22 ' A' ' 221' ' ' VAL . 60.7 t . . . . . 0 N--CA 1.473 0.722 0 CA-C-O 121.62 0.724 . . . . 75.519999999999996 112.301 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 42.6 mtm -99.51 -176.05 3.17 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.618 1.967 . . . . 64.200000000000003 108.813 -171.11 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 9.9 p -101.57 86.58 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.179 0 CA-C-O 123.067 1.413 . . . . 72.219999999999999 108.642 166.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.7 -4.76 9.2 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 113.933 -1.485 . . . . 75.099999999999994 110.232 -174.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 68.9 m -39.92 -67.31 0.24 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.778 2.031 . . . . 42.240000000000002 114.661 -164.549 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 51.1 t80 . . . . . 0 N--CA 1.469 0.498 0 C-N-CA 122.482 0.313 . . . . 73.310000000000002 110.537 -169.271 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.406 ' HB3' ' HA3' ' A' ' 247' ' ' GLY . 15.9 mt-30 . . . . . 0 N--CA 1.478 0.952 0 CA-C-O 120.952 0.406 . . . . 65.219999999999999 110.724 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -76.04 154.93 35.31 Favored 'General case' 0 N--CA 1.481 1.125 0 CA-C-N 115.342 -0.845 . . . . 72.239999999999995 109.547 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 56.9 tp -148.23 140.39 24.14 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.028 0.531 . . . . 74.239999999999995 110.34 175.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -114.55 138.76 50.24 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.089 0.955 . . . . 73.019999999999996 110.097 173.504 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -147.8 156.59 42.89 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.792 -0.818 . . . . 74.510000000000005 108.792 167.176 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 30.0 p -81.85 151.46 27.32 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 122.113 0.959 . . . . 75.030000000000001 112.14 168.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.634 HD13 ' HB2' ' A' ' 212' ' ' ALA . 27.2 tp -120.74 132.38 55.02 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 112.977 -1.92 . . . . 71.329999999999998 107.155 164.054 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -94.93 114.53 26.38 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 107.973 -1.121 . . . . 64.319999999999993 107.973 178.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.59 HG22 HG21 ' A' ' 210' ' ' VAL . 46.4 t -113.52 130.23 23.91 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 114.866 -1.061 . . . . 52.219999999999999 108.649 178.678 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -66.01 146.22 81.78 Favored 'Trans proline' 0 C--N 1.373 1.83 0 C-N-CA 122.287 1.992 . . . . 74.140000000000001 110.924 169.071 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.421 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.64 -46.21 98.36 Favored Pre-proline 0 CA--C 1.568 1.672 0 CA-C-O 118.334 -0.841 . . . . 45.219999999999999 112.304 175.371 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.421 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 26.0 Cg_endo -60.82 -31.48 91.77 Favored 'Trans proline' 0 C--N 1.403 3.446 0 C-N-CA 121.697 1.598 . . . . 62.43 112.549 176.747 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -86.44 -23.69 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 N-CA-C 109.153 -0.684 . . . . 74.310000000000002 109.153 -177.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -74.17 -38.53 63.65 Favored 'General case' 0 C--O 1.247 0.931 0 C-N-CA 122.938 0.495 . . . . 73.239999999999995 110.933 179.172 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 22.1 t -88.64 -36.45 9.05 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 CA-C-N 113.532 -1.667 . . . . 73.200000000000003 112.504 -177.142 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 55.5 t -98.61 -42.81 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 O-C-N 122.163 -0.335 . . . . 74.310000000000002 110.782 -177.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 122.26 152.14 8.57 Favored Glycine 0 N--CA 1.466 0.651 0 N-CA-C 110.919 -0.873 . . . . 72.099999999999994 110.919 -176.139 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.72 155.68 8.57 Favored Glycine 0 C--O 1.241 0.538 0 N-CA-C 111.444 -0.662 . . . . 63.299999999999997 111.444 178.303 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.571 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 35.4 ttmt -84.45 129.67 34.84 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 109.128 -0.693 . . . . 53.039999999999999 109.128 177.402 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.59 HG21 HG22 ' A' ' 199' ' ' VAL . 15.9 m -132.08 147.84 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.425 0.69 . . . . 65.010000000000005 109.594 179.062 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 14.4 ttp-105 -96.84 139.98 32.08 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.901 -1.045 . . . . 73.010000000000005 110.258 -167.548 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.634 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -132.24 120.59 22.39 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.001 0.92 . . . . 60.32 108.87 -174.08 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 33.5 tpp -78.04 110.02 12.62 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 108.826 -0.805 . . . . 74.439999999999998 108.826 174.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 56.4 p -112.33 -176.11 2.84 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 123.865 0.866 . . . . 72.299999999999997 109.971 -176.457 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.584 HD21 ' HD3' ' A' ' 241' ' ' PRO . 65.1 tp -47.9 -52.1 20.66 Favored 'General case' 0 C--N 1.354 0.782 0 C-N-CA 124.003 0.921 . . . . 74.219999999999999 111.55 173.65 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -72.84 -26.95 61.66 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 114.661 -1.154 . . . . 73.310000000000002 111.811 -171.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 137.85 -165.56 25.32 Favored Glycine 0 C--N 1.34 0.78 0 N-CA-C 111.299 -0.72 . . . . 23.129999999999999 111.299 -173.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.36 131.69 23.9 Favored 'Trans proline' 0 C--N 1.37 1.699 0 C-N-CA 122.081 1.854 . . . . 71.400000000000006 110.741 178.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 19.3 m -126.56 157.31 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 108.778 -0.823 . . . . 73.540000000000006 108.778 177.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.529 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 43.1 mt-10 -114.56 114.45 25.76 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 123.105 0.562 . . . . 60.32 109.511 -178.508 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.526 HG22 HG11 ' A' ' 168' ' ' VAL . 89.2 t -120.26 104.79 16.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 C-N-CA 125.474 1.51 . . . . 53.140000000000001 109.16 -169.46 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.571 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -76.11 117.63 18.01 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 122.836 0.454 . . . . 74.400000000000006 110.167 177.713 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 35.3 m -90.35 152.63 45.81 Favored Pre-proline 0 N--CA 1.478 0.927 0 C-N-CA 123.43 0.692 . . . . 64.239999999999995 111.289 -175.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 224' ' ' PRO . . . . . 0.539 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 45.2 Cg_endo -63.4 166.74 14.42 Favored 'Trans proline' 0 C--N 1.376 2.001 0 C-N-CA 123.507 2.805 . . . . 71.230000000000004 113.425 176.705 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -84.51 32.13 0.5 Allowed 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 122.83 2.353 . . . . 64.319999999999993 112.503 173.425 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 -150.51 -1.19 0.39 Allowed 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 112.561 0.578 . . . . 75.140000000000001 112.561 -179.236 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.539 ' HB ' ' HG2' ' A' ' 224' ' ' PRO . 0.6 OUTLIER -60.05 153.13 22.34 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 109.762 -0.458 . . . . 72.129999999999995 109.762 -167.101 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 228' ' ' GLN . . . . . 0.462 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 29.6 pt20 -133.08 161.51 34.21 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.55 0.74 . . . . 64.209999999999994 110.028 -174.687 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -63.46 110.66 2.02 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 109.024 -0.732 . . . . 64.129999999999995 109.024 174.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 114.72 3.74 21.87 Favored Glycine 0 C--O 1.241 0.545 0 CA-C-N 115.031 -0.986 . . . . 72.409999999999997 112.148 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.462 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -68.46 127.93 34.78 Favored 'General case' 0 CA--C 1.553 1.094 0 N-CA-C 109.288 -0.634 . . . . 74.430000000000007 109.288 -179.806 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -97.24 96.99 8.79 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.113 0.565 . . . . 74.019999999999996 109.776 -173.084 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.493 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 19.3 mt -81.83 99.21 8.88 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 106.558 -1.645 . . . . 61.509999999999998 106.558 179.092 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 5.0 ppt_? -82.56 116.2 21.87 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.832 -0.622 . . . . 72.439999999999998 111.396 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 7.3 mp -105.1 126.99 52.68 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 106.56 -1.645 . . . . 72.400000000000006 106.56 173.268 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 15.9 tptm -101.61 117.1 34.21 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 122.612 0.365 . . . . 72.310000000000002 110.668 -171.265 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 78.89 24.18 62.56 Favored Glycine 0 C--N 1.342 0.863 0 O-C-N 124.004 0.815 . . . . 64.340000000000003 112.907 -177.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 1.9 mmmp? -117.21 21.24 13.28 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 122.836 0.454 . . . . 72.219999999999999 111.144 -177.723 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -96.95 -129.95 6.4 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-O 119.406 -0.663 . . . . 64.540000000000006 112.095 -178.051 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 6.0 m-30 -71.04 152.76 94.82 Favored Pre-proline 0 CA--C 1.557 1.229 0 C-N-CA 123.264 0.626 . . . . 75.519999999999996 112.427 -177.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.584 ' HD3' HD21 ' A' ' 215' ' ' LEU . 74.3 Cg_endo -69.29 172.83 11.48 Favored 'Trans proline' 0 C--N 1.392 2.825 0 C-N-CA 123.837 3.025 . . . . 73.129999999999995 112.72 -179.184 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.4 ' N ' ' HD2' ' A' ' 243' ' ' PRO . . . -67.52 -39.73 91.04 Favored Glycine 0 CA--C 1.542 1.753 0 CA-C-O 118.058 -1.412 . . . . 61.140000000000001 114.671 -174.812 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 243' ' ' PRO . . . . . 0.4 ' HD2' ' N ' ' A' ' 242' ' ' GLY . 8.7 Cg_endo -52.28 -41.14 67.99 Favored 'Trans proline' 0 C--N 1.386 2.547 0 CA-C-N 121.071 2.435 . . . . 72.030000000000001 112.72 167.63 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -76.72 -25.21 53.28 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.16 0.584 . . . . 73.319999999999993 110.679 176.106 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 109.02 115.73 3.84 Favored Glycine 0 C--N 1.342 0.869 0 N-CA-C 109.354 -1.498 . . . . 73.219999999999999 109.354 -168.4 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -70.1 122.4 19.34 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 108.732 -0.84 . . . . 74.049999999999997 108.732 -178.536 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 247' ' ' GLY . . . . . 0.406 ' HA3' ' HB3' ' A' ' 191' ' ' GLN . . . -142.82 -156.16 6.68 Favored Glycine 0 N--CA 1.465 0.596 0 N-CA-C 111.445 -0.662 . . . . 55.140000000000001 111.445 177.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 12.2 p30 -120.13 168.48 11.16 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-O 121.753 0.787 . . . . 71.540000000000006 111.357 -171.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 14.7 tp -135.5 133.46 38.49 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 107.84 -1.171 . . . . 74.430000000000007 107.84 -171.223 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -118.53 148.49 42.58 Favored 'General case' 0 C--O 1.253 1.28 0 N-CA-C 108.63 -0.878 . . . . 74.219999999999999 108.63 -178.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.493 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 91.6 mt -121.25 119.62 32.8 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.514 0.725 . . . . 71.200000000000003 109.162 -178.591 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -89.25 104.6 17.13 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 107.287 -1.375 . . . . 64.099999999999994 107.287 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.484 HG11 HG23 ' A' ' 227' ' ' THR . 55.4 t -62.89 128.43 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 121.271 0.558 . . . . 52.329999999999998 110.294 178.301 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 21.5 mtm105 -117.16 126.08 52.24 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.135 -1.432 . . . . 73.239999999999995 107.135 172.604 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 40.9 mm -88.5 127.28 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 109.751 -0.463 . . . . 64.049999999999997 109.751 -178.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.7 t . . . . . 0 CA--C 1.559 1.318 0 N-CA-C 107.775 -1.195 . . . . 72.530000000000001 107.775 -177.856 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.475 HG11 HG22 ' A' ' 221' ' ' VAL . 55.9 t . . . . . 0 N--CA 1.473 0.676 0 CA-C-O 121.36 0.6 . . . . 42.200000000000003 110.075 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 46.5 mtm -99.28 -178.78 4.02 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.099 1.36 . . . . 73.099999999999994 109.212 -169.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 10.0 p -97.71 85.73 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 CA-C-O 123.429 1.585 . . . . 71.319999999999993 107.318 164.096 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.65 -4.7 9.23 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 113.608 -1.633 . . . . 70.209999999999994 109.846 -174.66 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.537 ' HA ' ' HB3' ' A' ' 233' ' ' LEU . 67.5 m -43.1 -64.11 0.69 Allowed 'General case' 0 C--O 1.241 0.608 0 C-N-CA 126.681 1.992 . . . . 64.319999999999993 113.425 -176.514 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' TYR . . . . . 0.419 ' HB2' ' HB3' ' A' ' 224' ' ' PRO . 45.5 t80 . . . . . 0 CA--C 1.536 0.427 0 C-N-CA 123.535 0.734 . . . . 63.030000000000001 109.355 -178.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 191' ' ' GLN . . . . . 0.579 ' HB3' ' HA3' ' A' ' 247' ' ' GLY . 91.4 mt-30 . . . . . 0 C--O 1.247 0.932 0 CA-C-O 121.279 0.561 . . . . 71.219999999999999 110.721 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -73.53 153.8 40.13 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 114.407 -1.269 . . . . 70.200000000000003 108.978 -177.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 60.5 tp -148.89 138.91 22.18 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 123.841 0.856 . . . . 72.540000000000006 108.994 174.137 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -111.56 142.14 44.23 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.861 0.864 . . . . 71.530000000000001 108.74 171.057 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -147.67 156.37 42.71 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 108.734 -0.839 . . . . 72.230000000000004 108.734 167.021 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 33.0 p -84.69 153.01 23.36 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-O 122.368 1.08 . . . . 65.530000000000001 112.127 168.599 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.593 HD13 ' HB2' ' A' ' 212' ' ' ALA . 20.5 tp -125.52 132.86 52.53 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 112.507 -2.133 . . . . 73.230000000000004 106.361 167.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -95.26 112.24 23.98 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.875 0.845 . . . . 75.420000000000002 108.772 -179.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.649 HG22 HG21 ' A' ' 210' ' ' VAL . 41.1 t -117.18 132.13 23.65 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 124.589 1.156 . . . . 63.229999999999997 108.882 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -68.79 147.55 69.33 Favored 'Trans proline' 0 C--N 1.369 1.647 0 C-N-CA 122.108 1.872 . . . . 74.409999999999997 111.159 167.594 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -54.43 -45.69 99.28 Favored Pre-proline 0 N--CA 1.487 1.38 0 CA-C-O 118.3 -0.857 . . . . 55.409999999999997 111.784 174.029 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -50.85 -40.43 57.48 Favored 'Trans proline' 0 C--N 1.405 3.536 0 C-N-CA 122.172 1.915 . . . . 54.030000000000001 113.169 172.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -84.64 -23.25 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 109.398 -0.593 . . . . 75.120000000000005 109.398 -175.531 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 204' ' ' ALA . . . . . 0.498 ' HA ' HG22 ' A' ' 227' ' ' THR . . . -74.2 -39.57 63.07 Favored 'General case' 0 C--O 1.246 0.902 0 C-N-CA 123.06 0.544 . . . . 61.119999999999997 111.515 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 25.1 t -88.73 -36.92 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-N 114.558 -1.201 . . . . 75.200000000000003 112.598 -178.423 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 73.4 t -98.72 -41.02 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 O-C-N 122.136 -0.352 . . . . 73.299999999999997 110.807 -176.209 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 123.13 150.38 8.04 Favored Glycine 0 N--CA 1.475 1.236 0 CA-C-N 118.248 0.476 . . . . 55.329999999999998 112.068 177.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.91 153.6 7.57 Favored Glycine 0 C--N 1.343 0.946 0 N-CA-C 112.356 -0.297 . . . . 42.219999999999999 112.356 177.23 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 37.1 ttmt -84.63 131.95 34.54 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 122.945 0.498 . . . . 71.310000000000002 110.026 175.543 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.649 HG21 HG22 ' A' ' 199' ' ' VAL . 12.6 m -135.44 150.56 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.78 1.232 . . . . 72.319999999999993 108.639 -177.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -95.81 142.52 27.98 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.032 0.533 . . . . 74.319999999999993 110.563 -169.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.593 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -130.74 123.62 29.63 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.728 0.811 . . . . 53.299999999999997 109.301 -176.721 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 35.7 tpp -78.78 111.01 14.48 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 115.621 -0.718 . . . . 73.409999999999997 109.502 174.343 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 46.0 p -119.59 -177.05 3.29 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.955 0.902 . . . . 75.299999999999997 110.998 -174.082 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.571 HD21 ' HD3' ' A' ' 241' ' ' PRO . 59.6 tp -49.4 -51.16 36.93 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.465 1.106 . . . . 51.329999999999998 111.114 167.635 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -71.84 -25.75 62.1 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 113.444 -1.707 . . . . 74.430000000000007 111.002 -171.054 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 135.14 -166.6 24.37 Favored Glycine 0 C--N 1.342 0.897 0 N-CA-C 111.136 -0.786 . . . . 72.040000000000006 111.136 178.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -66.79 128.79 19.57 Favored 'Trans proline' 0 C--N 1.364 1.357 0 C-N-CA 121.44 1.427 . . . . 63.509999999999998 109.852 171.012 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.4 HG22 ' O ' ' A' ' 212' ' ' ALA . 27.3 m -130.19 160.2 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.159 0.584 . . . . 73.540000000000006 110.143 -176.102 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.557 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 44.2 mt-10 -111.72 115.8 29.68 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.868 0.867 . . . . 65.519999999999996 109.016 -174.815 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.475 HG22 HG11 ' A' ' 168' ' ' VAL . 60.2 t -125.34 104.14 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 124.633 1.173 . . . . 61.240000000000002 110.414 -168.791 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.562 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -74.59 117.26 16.21 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.846 -0.427 . . . . 63.039999999999999 109.846 175.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 32.9 m -90.93 151.74 43.69 Favored Pre-proline 0 N--CA 1.482 1.168 0 C-N-CA 122.803 0.441 . . . . 71.109999999999999 109.96 179.572 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 224' ' ' PRO . . . . . 0.528 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 39.3 Cg_endo -65.17 166.03 20.19 Favored 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 122.535 2.157 . . . . 45.210000000000001 113.284 178.528 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -79.2 35.5 0.56 Allowed 'Trans proline' 0 C--N 1.37 1.673 0 C-N-CA 122.803 2.336 . . . . 62.43 112.626 167.361 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 19.3 tpt180 -147.88 -10.65 0.39 Allowed 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.339 0.496 . . . . 71.010000000000005 112.339 -178.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.554 HG23 HG11 ' A' ' 253' ' ' VAL . 0.6 OUTLIER -61.16 150.15 35.18 Favored 'General case' 0 CA--C 1.565 1.547 0 N-CA-C 109.226 -0.657 . . . . 73.040000000000006 109.226 -164.66 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 228' ' ' GLN . . . . . 0.503 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 10.7 pt20 -132.52 162.5 31.07 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 122.991 0.517 . . . . 60.310000000000002 109.917 -174.301 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 229' ' ' ALA . . . . . 0.659 ' HB1' HH21 ' A' ' 254' ' ' ARG . . . -56.91 111.47 1.04 Allowed 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 109.601 -0.518 . . . . 54.5 109.601 174.559 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.14 -0.83 22.59 Favored Glycine 0 C--N 1.336 0.553 0 CA-C-N 115.268 -0.878 . . . . 60.539999999999999 112.418 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.503 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -70.37 124.65 24.7 Favored 'General case' 0 C--N 1.358 0.939 0 N-CA-C 109.262 -0.644 . . . . 72.439999999999998 109.262 -171.129 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -98.87 96.62 7.98 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 109.599 -0.519 . . . . 74.340000000000003 109.599 -168.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.537 ' HB3' ' HA ' ' A' ' 172' ' ' SER . 19.7 mt -81.88 99.52 9.09 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 106.822 -1.547 . . . . 64.420000000000002 106.822 -175.775 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 234' ' ' ARG . . . . . 0.46 ' O ' ' HD2' ' A' ' 234' ' ' ARG . 5.1 ppt_? -79.84 121.52 25.5 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 123.645 0.591 . . . . 73.129999999999995 110.899 -176.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 8.1 mp -108.55 125.74 52.16 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 105.861 -1.903 . . . . 54.219999999999999 105.861 172.106 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 17.5 tptt -101.87 116.3 32.4 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 118.138 0.426 . . . . 73.439999999999998 109.929 -171.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 79.35 21.71 66.6 Favored Glycine 0 C--N 1.349 1.278 0 O-C-N 123.763 0.664 . . . . 40.009999999999998 113.834 -178.302 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -117.54 20.81 13.37 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.736 0.814 . . . . 71.439999999999998 109.884 -178.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -98.94 -132.61 7.75 Favored Glycine 0 C--N 1.349 1.303 0 CA-C-O 119.097 -0.835 . . . . 72.439999999999998 111.82 -178.074 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -70.29 152.1 95.67 Favored Pre-proline 0 N--CA 1.481 1.079 0 N-CA-C 112.943 0.72 . . . . 70.530000000000001 112.943 -172.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.571 ' HD3' HD21 ' A' ' 215' ' ' LEU . 61.0 Cg_endo -67.2 170.56 13.01 Favored 'Trans proline' 0 C--N 1.392 2.859 0 C-N-CA 122.928 2.419 . . . . 74.019999999999996 112.526 -178.471 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.432 ' N ' ' HD2' ' A' ' 243' ' ' PRO . . . -67.71 -38.58 89.95 Favored Glycine 0 CA--C 1.544 1.874 0 CA-C-O 117.973 -1.459 . . . . 75.230000000000004 114.357 -175.323 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 243' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 242' ' ' GLY . 10.1 Cg_endo -54.02 -36.28 83.87 Favored 'Trans proline' 0 C--N 1.388 2.644 0 CA-C-N 120.998 2.399 . . . . 55.539999999999999 113.438 167.379 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -81.33 -25.06 36.71 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-O 121.136 0.493 . . . . 63.509999999999998 110.125 174.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 112.22 114.8 3.37 Favored Glycine 0 C--N 1.341 0.82 0 N-CA-C 109.66 -1.376 . . . . 74.5 109.66 -168.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -72.38 122.64 21.53 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 117.825 0.812 . . . . 72.519999999999996 109.639 -177.505 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 247' ' ' GLY . . . . . 0.579 ' HA3' ' HB3' ' A' ' 191' ' ' GLN . . . -148.34 -154.61 6.35 Favored Glycine 0 CA--C 1.503 -0.713 0 CA-C-N 116.003 -0.544 . . . . 45.140000000000001 112.315 -176.043 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 38.5 p-10 -121.46 163.54 18.61 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.507 0.723 . . . . 74.310000000000002 111.125 -167.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 9.5 tp -134.71 134.5 41.12 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.365 -0.976 . . . . 72.219999999999999 108.365 -171.215 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -115.81 148.46 39.87 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.471 -0.937 . . . . 71.420000000000002 108.471 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 67.7 mt -123.17 115.15 21.3 Favored 'General case' 0 C--O 1.22 -0.474 0 N-CA-C 108.29 -1.004 . . . . 53.25 108.29 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -89.38 113.54 24.87 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.618 -0.882 . . . . 73.030000000000001 108.618 -177.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.554 HG11 HG23 ' A' ' 227' ' ' THR . 50.3 t -60.75 124.79 15.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 O-C-N 124.019 0.824 . . . . 71.450000000000003 110.335 176.313 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 254' ' ' ARG . . . . . 0.659 HH21 ' HB1' ' A' ' 229' ' ' ALA . 0.5 OUTLIER -120.08 122.31 40.79 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 107.356 -1.35 . . . . 71.120000000000005 107.356 176.195 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.433 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 49.1 mm -83.8 122.36 37.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 O-C-N 123.984 0.803 . . . . 54.140000000000001 109.835 -173.301 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.2 t . . . . . 0 CA--C 1.565 1.549 0 C-N-CA 124.23 1.012 . . . . 64.450000000000003 108.822 -172.622 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 52.4 t . . . . . 0 N--CA 1.48 1.053 0 CA-C-O 121.385 0.612 . . . . 72.219999999999999 110.992 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 169' ' ' MET . . . . . 0.402 ' HB2' ' SD ' ' A' ' 171' ' ' MET . 53.4 mtm -99.4 -176.68 3.36 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 125.915 1.686 . . . . 75.450000000000003 110.894 -164.121 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 8.5 p -101.88 86.17 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.073 0 N-CA-C 107.195 -1.409 . . . . 72.409999999999997 107.195 160.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' MET . . . . . 0.402 ' SD ' ' HB2' ' A' ' 169' ' ' MET . 0.0 OUTLIER -124.17 -4.25 7.95 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 114.148 -1.387 . . . . 75.010000000000005 110.76 -173.365 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.477 ' HA ' ' HB3' ' A' ' 233' ' ' LEU . 67.2 m -44.1 -65.82 0.46 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.995 1.718 . . . . 65.340000000000003 114.046 -168.23 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 55.3 t80 . . . . . 0 C--O 1.243 0.754 0 N-CA-C 108.601 -0.889 . . . . 62.009999999999998 108.601 -176.614 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 . . . . . 0 N--CA 1.477 0.895 0 N-CA-C 108.908 -0.775 . . . . 72.329999999999998 108.908 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -76.57 168.57 19.84 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-N 114.638 -1.165 . . . . 75.150000000000006 109.958 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 39.1 tp -152.44 142.97 22.72 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.269 -0.423 . . . . 74.409999999999997 110.104 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -116.13 138.14 51.51 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.797 0.839 . . . . 72.530000000000001 109.107 171.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -148.77 160.14 43.48 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.628 0.771 . . . . 73.510000000000005 109.42 174.574 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 37.9 p -84.42 154.54 22.74 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 122.276 1.036 . . . . 72.129999999999995 112.195 167.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.766 HD13 ' HB2' ' A' ' 212' ' ' ALA . 30.8 tp -120.47 134.4 55.28 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 112.844 -1.98 . . . . 53.43 106.789 165.317 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -97.52 111.72 23.87 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 109.107 -0.701 . . . . 74.340000000000003 109.107 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.65 HG22 HG21 ' A' ' 210' ' ' VAL . 28.1 t -123.01 130.98 24.39 Favored Pre-proline 0 N--CA 1.479 0.979 0 C-N-CA 124.549 1.139 . . . . 75.439999999999998 109.579 -177.431 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -69.95 144.93 54.55 Favored 'Trans proline' 0 C--N 1.366 1.489 0 C-N-CA 122.22 1.947 . . . . 43.109999999999999 111.232 165.412 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -53.13 -44.63 97.61 Favored Pre-proline 0 N--CA 1.487 1.413 0 CA-C-O 118.348 -0.834 . . . . 74.109999999999999 111.953 174.267 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -47.55 -41.49 29.87 Favored 'Trans proline' 0 C--N 1.401 3.317 0 C-N-CA 122.556 2.171 . . . . 73.530000000000001 113.416 171.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -85.91 -23.29 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 109.716 -0.476 . . . . 70.109999999999999 109.716 -175.013 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 204' ' ' ALA . . . . . 0.417 ' HA ' HG22 ' A' ' 227' ' ' THR . . . -72.45 -37.76 68.45 Favored 'General case' 0 C--O 1.249 1.051 0 CA-C-O 121.05 0.452 . . . . 63.210000000000001 111.535 178.217 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 20.3 t -89.73 -36.05 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.987 0 C-N-CA 125.444 1.497 . . . . 34.030000000000001 113.168 -178.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 54.4 t -97.12 -43.14 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 O-C-N 121.998 -0.438 . . . . 72.239999999999995 110.268 -176.439 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 120.95 151.51 8.62 Favored Glycine 0 C--N 1.339 0.744 0 N-CA-C 110.89 -0.884 . . . . 70.349999999999994 110.89 -176.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.6 155.89 8.65 Favored Glycine 0 C--O 1.246 0.886 0 N-CA-C 112.048 -0.421 . . . . 64.340000000000003 112.048 177.235 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.594 ' HD3' ' HB3' ' A' ' 220' ' ' GLU . 38.5 ttmt -84.54 131.6 34.62 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.319 0.648 . . . . 74.510000000000005 109.519 174.752 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.65 HG21 HG22 ' A' ' 199' ' ' VAL . 6.7 m -134.42 154.4 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.4 1.08 . . . . 61.439999999999998 110.581 -175.548 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 2.5 tmm_? -93.32 139.92 30.13 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.569 1.147 . . . . 64.329999999999998 109.751 -171.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.766 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -132.42 122.6 25.23 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.145 0.978 . . . . 73.010000000000005 108.734 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 31.3 tpp -77.68 110.2 12.32 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.679 -0.86 . . . . 61.329999999999998 108.679 173.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 62.2 p -121.25 -179.28 4.0 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.998 0.919 . . . . 73.219999999999999 110.221 -176.199 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.503 HD21 ' HD3' ' A' ' 241' ' ' PRO . 61.2 tp -45.09 -52.9 8.59 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.686 1.195 . . . . 75.219999999999999 112.485 176.394 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -72.39 -27.48 62.39 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 114.218 -1.355 . . . . 73.239999999999995 111.385 -173.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 138.02 -165.11 25.47 Favored Glycine 0 C--N 1.345 1.055 0 N-CA-C 111.561 -0.616 . . . . 54.210000000000001 111.561 -176.131 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -67.01 129.25 20.27 Favored 'Trans proline' 0 C--N 1.369 1.62 0 C-N-CA 122.147 1.898 . . . . 61.310000000000002 111.011 175.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 30.2 m -129.72 160.23 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 123.528 0.731 . . . . 73.409999999999997 110.659 -175.215 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.594 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 44.4 mt-10 -113.01 114.53 27.02 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.835 0.854 . . . . 72.219999999999999 109.655 -168.243 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 61.9 t -127.34 103.43 10.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 124.87 1.268 . . . . 74.030000000000001 109.39 -166.525 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.511 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -77.82 116.79 18.61 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.892 -0.41 . . . . 73.400000000000006 109.892 175.672 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 29.8 m -89.35 152.04 47.12 Favored Pre-proline 0 N--CA 1.492 1.626 0 C-N-CA 123.222 0.609 . . . . 63.210000000000001 111.116 -176.31 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 224' ' ' PRO . . . . . 0.57 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 29.7 Cg_endo -62.21 162.47 23.16 Favored 'Trans proline' 0 C--N 1.382 2.307 0 C-N-CA 122.197 1.931 . . . . 73.239999999999995 112.517 175.711 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -85.4 30.97 0.49 Allowed 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 123.115 2.543 . . . . 73.519999999999996 112.519 176.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -149.06 3.17 0.6 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 122.747 0.419 . . . . 75.109999999999999 111.447 176.178 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.57 ' HB ' ' HG2' ' A' ' 224' ' ' PRO . 0.7 OUTLIER -61.85 155.64 22.74 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 109.829 -0.434 . . . . 64.25 109.829 -171.776 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -136.55 162.41 33.19 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.078 0.551 . . . . 74.299999999999997 110.097 -176.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 229' ' ' ALA . . . . . 0.567 ' HB1' HH21 ' A' ' 254' ' ' ARG . . . -56.15 112.25 1.17 Allowed 'General case' 0 CA--C 1.538 0.505 0 O-C-N 123.471 0.482 . . . . 44.219999999999999 109.915 174.017 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.29 -1.07 22.37 Favored Glycine 0 C--O 1.239 0.418 0 CA-C-N 114.968 -1.014 . . . . 71.140000000000001 111.982 176.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.62 129.72 40.75 Favored 'General case' 0 C--N 1.361 1.108 0 N-CA-C 109.179 -0.674 . . . . 70.040000000000006 109.179 -174.071 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm -98.67 97.69 8.92 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.977 0.911 . . . . 74.420000000000002 110.065 -170.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.477 ' HB3' ' HA ' ' A' ' 172' ' ' SER . 17.3 mt -88.09 101.04 13.41 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 107.65 -1.241 . . . . 71.409999999999997 107.65 -178.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.48 125.53 29.69 Favored 'General case' 0 CA--C 1.551 1.009 0 CA-C-O 121.164 0.507 . . . . 71.530000000000001 110.213 178.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.4 ' HB3' ' HB2' ' A' ' 238' ' ' LYS . 6.9 mp -106.04 126.77 52.6 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 105.879 -1.897 . . . . 53.140000000000001 105.879 171.771 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 8.1 tptp -101.32 115.75 31.23 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 109.994 -0.373 . . . . 72.120000000000005 109.994 -168.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 77.5 29.25 56.03 Favored Glycine 0 C--N 1.354 1.574 0 O-C-N 123.676 0.61 . . . . 70.140000000000001 112.676 -178.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.4 ' HB2' ' HB3' ' A' ' 235' ' ' LEU . 30.8 mmmt -124.53 23.85 8.04 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.807 0.843 . . . . 73.540000000000006 110.715 -177.098 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -94.41 -132.04 6.47 Favored Glycine 0 C--N 1.353 1.523 0 N-CA-C 111.167 -0.773 . . . . 74.140000000000001 111.167 178.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 6.2 m-30 -69.48 154.36 94.93 Favored Pre-proline 0 N--CA 1.481 1.08 0 CA-C-N 117.47 0.635 . . . . 62.520000000000003 112.043 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.503 ' HD3' HD21 ' A' ' 215' ' ' LEU . 72.8 Cg_endo -70.13 171.26 15.2 Favored 'Trans proline' 0 C--N 1.387 2.565 0 C-N-CA 122.826 2.351 . . . . 75.209999999999994 111.909 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -67.68 -38.96 90.43 Favored Glycine 0 CA--C 1.542 1.774 0 CA-C-O 118.479 -1.178 . . . . 75.230000000000004 114.078 -178.107 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 243' ' ' PRO . . . . . 0.424 ' HD2' ' HB2' ' A' ' 241' ' ' PRO . 87.8 Cg_exo -48.72 -35.19 29.56 Favored 'Trans proline' 0 C--N 1.383 2.36 0 C-N-CA 123.054 2.503 . . . . 70.430000000000007 114.09 165.267 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -88.3 -24.62 23.13 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.457 0.703 . . . . 51.310000000000002 110.998 174.037 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 105.76 115.23 4.03 Favored Glycine 0 C--N 1.345 1.06 0 N-CA-C 109.192 -1.563 . . . . 73.420000000000002 109.192 -169.63 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 35.3 mtt180 -73.1 134.07 44.38 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 122.988 0.515 . . . . 62.149999999999999 112.145 -178.008 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -145.75 -155.91 6.67 Favored Glycine 0 C--O 1.242 0.606 0 CA-C-N 114.654 -1.157 . . . . 53.530000000000001 110.304 174.684 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 12.6 p30 -118.01 168.03 10.91 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 122.949 0.5 . . . . 50.409999999999997 110.083 -175.316 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 9.7 tp -134.42 133.3 40.37 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 107.862 -1.162 . . . . 74.409999999999997 107.862 -172.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 10.0 m-30 -114.26 149.46 35.86 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.761 -0.829 . . . . 64.040000000000006 108.761 -177.292 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.403 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 92.1 mt -123.76 121.94 36.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.546 -0.752 . . . . 74.340000000000003 109.038 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -88.76 112.55 23.31 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 107.289 -1.375 . . . . 71.109999999999999 107.289 174.578 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.497 HG11 HG23 ' A' ' 227' ' ' THR . 54.1 t -60.8 123.47 13.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 108.868 -0.789 . . . . 62.119999999999997 108.868 173.586 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 254' ' ' ARG . . . . . 0.567 HH21 ' HB1' ' A' ' 229' ' ' ALA . 0.4 OUTLIER -114.65 123.29 48.92 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 106.71 -1.589 . . . . 73.040000000000006 106.71 176.411 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 38.1 mm -86.78 119.99 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 O-C-N 123.783 0.677 . . . . 74.319999999999993 109.721 -176.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.3 t . . . . . 0 CA--C 1.562 1.413 0 C-N-CA 125.292 1.437 . . . . 63.009999999999998 107.669 -170.533 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.423 HG11 HG22 ' A' ' 221' ' ' VAL . 55.4 t . . . . . 0 N--CA 1.473 0.686 0 CA-C-O 121.474 0.654 . . . . 72.519999999999996 110.39 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 48.8 mtm -98.29 -176.2 3.33 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.88 1.672 . . . . 64.219999999999999 110.074 -168.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 8.7 p -101.71 88.47 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.026 0 CA-C-O 123.125 1.441 . . . . 72.230000000000004 108.079 161.184 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' MET . . . . . 0.417 ' HG3' ' HA ' ' A' ' 235' ' ' LEU . 0.0 OUTLIER -123.81 -6.03 7.99 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 113.717 -1.583 . . . . 73.200000000000003 110.021 -177.129 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.459 ' HA ' ' HB3' ' A' ' 233' ' ' LEU . 68.5 m -37.64 -64.63 0.37 Allowed 'General case' 0 C--N 1.351 0.643 0 C-N-CA 126.97 2.108 . . . . 44.229999999999997 114.379 -168.68 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 173' ' ' TYR . . . . . 0.43 ' HB2' ' HB3' ' A' ' 224' ' ' PRO . 53.3 t80 . . . . . 0 CA--C 1.538 0.488 0 O-C-N 123.661 0.6 . . . . 74.230000000000004 109.639 -174.482 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 . . . . . 0 N--CA 1.478 0.971 0 CA-C-O 120.938 0.399 . . . . 65.310000000000002 110.636 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 35.1 p-10 -75.54 172.83 11.88 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-N 115.7 -0.682 . . . . 65.299999999999997 110.578 178.245 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.414 HD13 ' CE1' ' A' ' 240' ' ' PHE . 33.9 tp -152.96 140.7 20.0 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.878 -0.601 . . . . 73.420000000000002 110.545 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -112.36 137.95 49.78 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.508 -0.769 . . . . 72.420000000000002 108.927 169.507 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.417 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -148.13 158.01 43.83 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 107.919 -1.141 . . . . 73.319999999999993 107.919 170.069 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 25.1 p -89.87 154.11 20.13 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 122.188 0.994 . . . . 65.200000000000003 112.511 169.127 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.68 HD13 ' HB2' ' A' ' 212' ' ' ALA . 22.2 tp -124.28 132.84 53.59 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 112.997 -1.911 . . . . 61.310000000000002 107.352 164.541 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -94.72 113.7 25.51 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 108.372 -0.973 . . . . 73.530000000000001 108.372 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.637 HG22 HG21 ' A' ' 210' ' ' VAL . 24.8 t -118.0 130.9 24.43 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 114.95 -1.023 . . . . 74.040000000000006 108.578 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 200' ' ' PRO . . . . . 0.494 ' HG2' ' HB ' ' A' ' 203' ' ' ILE . 59.3 Cg_endo -73.76 149.76 43.5 Favored 'Trans proline' 0 C--N 1.366 1.475 0 C-N-CA 121.47 1.447 . . . . 73.230000000000004 110.833 168.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -53.45 -44.71 98.14 Favored Pre-proline 0 N--CA 1.483 1.202 0 CA-C-O 118.193 -0.908 . . . . 50.140000000000001 112.186 177.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.453 ' HD2' ' HB2' ' A' ' 200' ' ' PRO . 86.0 Cg_exo -50.56 -41.22 53.67 Favored 'Trans proline' 0 C--N 1.399 3.223 0 C-N-CA 122.46 2.107 . . . . 71.519999999999996 113.525 173.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.494 ' HB ' ' HG2' ' A' ' 200' ' ' PRO . 1.8 mp -86.42 -23.07 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 N-CA-C 109.718 -0.475 . . . . 74.310000000000002 109.718 -176.403 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -72.57 -36.71 68.25 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 122.934 0.494 . . . . 73.109999999999999 111.044 177.586 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 25.4 t -89.56 -36.37 8.57 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 125.663 1.585 . . . . 72.230000000000004 112.873 -178.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 50.2 t -98.23 -42.58 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 O-C-N 121.663 -0.648 . . . . 64.0 110.91 -176.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 120.82 153.95 9.19 Favored Glycine 0 C--N 1.341 0.855 0 N-CA-C 110.704 -0.958 . . . . 42.5 110.704 -176.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 161.03 154.94 7.61 Favored Glycine 0 C--O 1.245 0.786 0 N-CA-C 111.57 -0.612 . . . . 41.130000000000003 111.57 177.279 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 39.3 ttmt -86.54 128.95 35.02 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.905 0.352 . . . . 63.310000000000002 110.655 176.041 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.637 HG21 HG22 ' A' ' 199' ' ' VAL . 13.5 m -130.74 144.51 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.958 1.303 . . . . 74.340000000000003 108.533 -179.394 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 24.2 ttt180 -97.08 141.62 30.0 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.059 0.943 . . . . 73.140000000000001 110.437 -167.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.68 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -133.18 124.75 28.02 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.429 1.491 . . . . 72.030000000000001 110.187 -168.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 33.6 tpp -77.48 114.95 16.83 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 109.024 -0.732 . . . . 73.129999999999995 109.024 174.302 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 63.0 p -124.16 -176.3 3.46 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.193 0.997 . . . . 61.240000000000002 110.292 -177.036 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.537 HD21 ' HD3' ' A' ' 241' ' ' PRO . 66.9 tp -47.24 -51.58 18.38 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.623 1.169 . . . . 72.239999999999995 112.657 176.71 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -72.01 -27.22 62.58 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 114.75 -1.114 . . . . 74.209999999999994 111.085 -172.335 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 137.14 -165.2 25.22 Favored Glycine 0 C--O 1.244 0.774 0 N-CA-C 110.702 -0.959 . . . . 53.420000000000002 110.702 -173.046 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.79 131.54 24.44 Favored 'Trans proline' 0 CA--C 1.549 1.226 0 C-N-CA 121.979 1.786 . . . . 73.329999999999998 111.187 175.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 25.7 m -129.65 157.25 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 124.087 0.955 . . . . 74.450000000000003 108.742 -179.369 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.538 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 47.0 mt-10 -115.24 117.23 29.91 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-O 121.145 0.498 . . . . 71.120000000000005 111.358 -176.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.423 HG22 HG11 ' A' ' 168' ' ' VAL . 100.0 t -121.86 107.15 19.31 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 125.65 1.58 . . . . 61.43 110.893 -165.697 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.603 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -75.19 118.19 17.84 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.583 0.353 . . . . 71.420000000000002 111.122 176.513 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 26.8 m -89.6 154.4 48.32 Favored Pre-proline 0 N--CA 1.489 1.48 0 C-N-CA 123.71 0.804 . . . . 71.430000000000007 111.693 -176.011 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 224' ' ' PRO . . . . . 0.566 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 34.2 Cg_endo -63.02 164.04 20.63 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 122.658 2.239 . . . . 74.120000000000005 113.057 174.033 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -87.08 32.13 0.44 Allowed 'Trans proline' 0 C--N 1.37 1.66 0 C-N-CA 122.779 2.319 . . . . 74.219999999999999 113.19 174.664 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -147.97 1.46 0.66 Allowed 'General case' 0 N--CA 1.485 1.29 0 CA-C-O 118.903 -0.57 . . . . 65.019999999999996 112.333 175.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.566 ' HB ' ' HG2' ' A' ' 224' ' ' PRO . 0.7 OUTLIER -60.57 154.64 20.57 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 123.466 0.479 . . . . 44.43 110.406 -168.144 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 228' ' ' GLN . . . . . 0.48 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 4.9 pt20 -134.38 161.19 35.68 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.27 0.628 . . . . 71.030000000000001 110.698 -174.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -60.29 112.15 1.82 Allowed 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.906 -0.405 . . . . 63.310000000000002 109.906 176.299 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.41 0.75 21.96 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-N 115.083 -0.962 . . . . 63.020000000000003 112.122 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.48 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -72.81 126.05 28.99 Favored 'General case' 0 C--N 1.359 0.98 0 N-CA-C 108.835 -0.802 . . . . 63.109999999999999 108.835 -174.735 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -97.17 98.15 9.78 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 108.255 -1.016 . . . . 71.349999999999994 108.255 -173.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.459 ' HB3' ' HA ' ' A' ' 172' ' ' SER . 30.9 mt -77.96 99.94 6.24 Favored 'General case' 0 C--N 1.343 0.297 0 N-CA-C 106.803 -1.555 . . . . 52.420000000000002 106.803 -179.271 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 234' ' ' ARG . . . . . 0.521 ' HB2' ' HE2' ' A' ' 236' ' ' LYS . 0.0 OUTLIER -81.4 111.42 17.74 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 114.282 -1.326 . . . . 64.420000000000002 111.642 -173.952 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.527 ' O ' ' HB2' ' A' ' 248' ' ' ASP . 7.3 mp -100.28 127.85 46.48 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 106.193 -1.78 . . . . 22.120000000000001 106.193 173.71 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.521 ' HE2' ' HB2' ' A' ' 234' ' ' ARG . 5.3 mptp? -101.48 119.49 38.85 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.46 0.704 . . . . 73.310000000000002 110.868 -175.308 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 78.19 23.58 65.62 Favored Glycine 0 C--N 1.354 1.546 0 O-C-N 123.89 0.744 . . . . 41.43 112.662 -179.085 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.496 ' HB2' ' HB3' ' A' ' 235' ' ' LEU . 26.8 mmmt -119.06 21.28 12.42 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.297 1.039 . . . . 60.530000000000001 111.052 -175.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -94.12 -128.6 5.19 Favored Glycine 0 C--N 1.345 1.043 0 N-CA-C 110.243 -1.143 . . . . 74.109999999999999 110.243 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 240' ' ' PHE . . . . . 0.436 ' O ' ' HA ' ' A' ' 246' ' ' ARG . 7.3 m-30 -70.98 152.41 94.95 Favored Pre-proline 0 CA--C 1.551 0.985 0 CA-C-N 117.479 0.64 . . . . 70.040000000000006 111.668 178.716 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.537 ' HD3' HD21 ' A' ' 215' ' ' LEU . 48.2 Cg_endo -64.92 171.8 8.15 Favored 'Trans proline' 0 C--N 1.387 2.6 0 C-N-CA 123.182 2.588 . . . . 74.329999999999998 112.166 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -66.19 -41.87 94.62 Favored Glycine 0 CA--C 1.541 1.706 0 CA-C-O 118.489 -1.173 . . . . 55.450000000000003 113.445 -177.075 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 243' ' ' PRO . . . . . 0.449 ' HD2' ' HB2' ' A' ' 241' ' ' PRO . 81.4 Cg_exo -54.67 -39.9 86.84 Favored 'Trans proline' 0 C--N 1.388 2.632 0 C-N-CA 122.556 2.171 . . . . 61.399999999999999 114.095 168.668 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -76.68 -22.43 54.0 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.479 0.712 . . . . 71.230000000000004 110.646 177.186 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 106.93 111.78 3.61 Favored Glycine 0 C--N 1.343 0.953 0 N-CA-C 108.679 -1.768 . . . . 62.509999999999998 108.679 -172.621 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.436 ' HA ' ' O ' ' A' ' 240' ' ' PHE . 54.1 ttp180 -73.4 124.66 26.21 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 117.086 0.443 . . . . 62.140000000000001 110.76 -174.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -135.84 -158.8 8.3 Favored Glycine 0 CA--C 1.505 -0.552 0 N-CA-C 110.488 -1.045 . . . . 43.200000000000003 110.488 174.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 248' ' ' ASP . . . . . 0.527 ' HB2' ' O ' ' A' ' 235' ' ' LEU . 34.2 p-10 -123.14 161.96 23.42 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.137 0.575 . . . . 72.219999999999999 110.125 -174.796 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 8.4 tp -132.0 134.89 46.09 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 108.375 -0.972 . . . . 43.520000000000003 108.375 -168.147 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -115.67 148.96 39.1 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 108.53 -0.915 . . . . 74.329999999999998 108.53 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.417 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 75.0 mt -122.38 112.49 18.15 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 108.594 -0.891 . . . . 71.109999999999999 108.594 179.045 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -89.76 112.28 23.53 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.285 -1.006 . . . . 70.209999999999994 108.285 -173.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.505 HG11 HG23 ' A' ' 227' ' ' THR . 53.8 t -61.6 125.9 18.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 114.969 -1.014 . . . . 72.519999999999996 110.222 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 41.8 mtp180 -115.54 122.51 45.9 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 106.571 -1.64 . . . . 74.319999999999993 106.571 171.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.459 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 46.8 mm -83.76 123.57 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 122.665 0.386 . . . . 62.130000000000003 110.123 -175.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.2 t . . . . . 0 CA--C 1.561 1.4 0 C-N-CA 124.273 1.029 . . . . 75.430000000000007 109.056 -172.275 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 12.5 tmm? . . . . . 0 N--CA 1.478 0.969 0 N-CA-C 108.894 -0.78 . . . . 63.509999999999998 108.894 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.494 ' HB2' ' HB3' ' A' ' 167' ' ' ALA . 0.0 OUTLIER -126.61 85.43 2.38 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.2 1.0 . . . . 72.040000000000006 110.442 -174.863 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -71.7 -33.49 68.82 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.898 0.879 . . . . 45.219999999999999 111.538 -178.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -96.26 37.45 3.43 Favored Glycine 0 N--CA 1.472 1.039 0 N-CA-C 111.894 -0.482 . . . . 41.020000000000003 111.894 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.494 ' HB3' ' HB2' ' A' ' 164' ' ' LYS . . . -153.39 172.91 16.34 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.491 1.117 . . . . 62.350000000000001 109.133 178.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 53.8 t -108.9 147.06 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 123.572 0.749 . . . . 73.120000000000005 110.395 -173.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 44.8 mtm -102.64 -175.54 2.85 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.183 1.793 . . . . 65.140000000000001 110.132 -166.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 8.3 p -94.25 87.7 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.115 0 CA-C-O 123.196 1.474 . . . . 74.010000000000005 108.037 159.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.28 -5.09 7.81 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 113.737 -1.574 . . . . 73.299999999999997 110.308 -177.149 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.51 ' HA ' ' HB3' ' A' ' 233' ' ' LEU . 69.9 m -37.54 -63.48 0.45 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.972 2.109 . . . . 35.409999999999997 114.488 -170.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -58.7 -34.02 70.84 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 121.116 0.484 . . . . 73.120000000000005 111.234 -172.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 92.55 75.97 1.32 Allowed Glycine 0 C--N 1.341 0.818 0 N-CA-C 108.429 -1.868 . . . . 54.439999999999998 108.429 -172.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -60.0 88.71 0.01 OUTLIER 'General case' 0 C--N 1.354 0.774 0 C-N-CA 124.242 1.017 . . . . 71.430000000000007 110.09 -177.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 47.1 m -120.69 124.76 45.97 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 113.828 -1.533 . . . . 51.530000000000001 108.605 -176.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -57.66 -21.91 42.69 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.525 0.73 . . . . 75.040000000000006 111.398 173.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -67.66 171.61 6.16 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 124.871 1.268 . . . . 75.519999999999996 111.903 170.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -61.81 -40.96 97.08 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.843 0.857 . . . . 71.329999999999998 110.887 176.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -170.73 115.06 0.57 Allowed Glycine 0 C--N 1.328 0.121 0 CA-C-N 115.033 -0.985 . . . . 53.219999999999999 110.989 178.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 50.5 m -147.36 169.99 18.28 Favored 'General case' 0 C--O 1.244 0.784 0 C-N-CA 123.366 0.666 . . . . 75.329999999999998 110.524 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -148.1 -42.97 0.03 OUTLIER Glycine 0 C--N 1.341 0.83 0 CA-C-N 115.737 -0.665 . . . . 54.130000000000003 111.787 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 69.12 66.41 2.27 Favored Glycine 0 C--N 1.346 1.11 0 N-CA-C 111.945 -0.462 . . . . 51.119999999999997 111.945 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 71.4 p -71.89 147.06 47.44 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 123.132 0.573 . . . . 73.310000000000002 110.596 177.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -160.37 175.38 37.13 Favored Glycine 0 C--N 1.341 0.849 0 N-CA-C 111.942 -0.463 . . . . 75.129999999999995 111.942 -177.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 72.91 14.15 78.64 Favored Glycine 0 C--N 1.35 1.316 0 C-N-CA 122.591 0.139 . . . . 55.43 112.979 -175.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 63.2 p -73.9 145.96 44.39 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.085 0.954 . . . . 72.420000000000002 111.342 -176.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.71 -57.88 2.97 Favored Glycine 0 C--N 1.345 1.079 0 CA-C-N 116.255 -0.429 . . . . 65.150000000000006 112.082 177.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -82.34 6.64 67.34 Favored Glycine 0 C--N 1.348 1.248 0 CA-C-O 119.5 -0.611 . . . . 62.240000000000002 114.157 -177.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 38.9 t 62.9 52.29 2.7 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.912 0.885 . . . . 75.129999999999995 111.253 175.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -105.88 -31.9 8.6 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 114.768 -1.105 . . . . 63.520000000000003 108.071 170.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -74.39 170.06 16.41 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 114.587 -1.188 . . . . 72.299999999999997 110.086 175.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 35.6 tp -152.71 139.08 18.5 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 115.904 -0.589 . . . . 71.439999999999998 109.5 176.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -112.5 139.94 47.66 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.53 -0.915 . . . . 74.439999999999998 108.53 169.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -147.76 156.35 42.65 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.464 -0.939 . . . . 44.100000000000001 108.464 166.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 20.4 p -84.28 150.94 25.08 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 122.446 1.117 . . . . 63.420000000000002 112.248 169.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.599 HD13 ' HB2' ' A' ' 212' ' ' ALA . 36.7 tp -126.03 133.66 51.67 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 113.063 -1.881 . . . . 71.340000000000003 106.774 170.255 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.442 ' HB2' HG21 ' A' ' 256' ' ' THR . 12.7 p-10 -94.69 111.55 23.32 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 108.535 -0.913 . . . . 74.129999999999995 108.535 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.596 HG22 HG21 ' A' ' 210' ' ' VAL . 58.1 t -115.94 129.48 25.15 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-N 114.783 -1.099 . . . . 73.209999999999994 108.884 -179.093 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -65.73 146.41 83.73 Favored 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 122.398 2.066 . . . . 73.319999999999993 111.513 169.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.436 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.62 -45.7 98.56 Favored Pre-proline 0 CA--C 1.565 1.527 0 C-N-CA 123.612 0.765 . . . . 75.239999999999995 111.918 174.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 27.6 Cg_endo -61.06 -31.03 90.52 Favored 'Trans proline' 0 C--N 1.404 3.462 0 C-N-CA 122.293 1.996 . . . . 74.319999999999993 112.618 176.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -86.25 -24.17 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 N-CA-C 108.962 -0.755 . . . . 70.209999999999994 108.962 -177.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -74.25 -37.03 63.88 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 123.079 0.552 . . . . 71.129999999999995 110.764 178.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 28.4 t -87.45 -38.71 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 O-C-N 124.68 1.238 . . . . 74.209999999999994 112.711 -178.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 54.9 t -98.4 -42.26 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 O-C-N 121.953 -0.467 . . . . 72.349999999999994 111.149 -175.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 123.06 155.56 9.34 Favored Glycine 0 C--N 1.339 0.732 0 N-CA-C 111.021 -0.832 . . . . 41.25 111.021 -175.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 161.38 156.09 8.16 Favored Glycine 0 C--O 1.245 0.819 0 N-CA-C 111.29 -0.724 . . . . 74.400000000000006 111.29 177.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.618 ' HD3' ' HB3' ' A' ' 220' ' ' GLU . 37.3 ttmt -84.28 136.66 33.83 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 109.437 -0.579 . . . . 44.439999999999998 109.437 175.163 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.596 HG21 HG22 ' A' ' 199' ' ' VAL . 11.4 m -135.16 151.48 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.363 1.065 . . . . 73.400000000000006 108.776 175.267 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' ARG . . . . . 0.402 ' HD2' ' N ' ' A' ' 212' ' ' ALA . 2.2 tmm_? -96.34 141.79 29.25 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.419 0.688 . . . . 61.43 109.734 -171.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.599 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -131.1 123.88 29.57 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.536 0.734 . . . . 34.0 109.03 -177.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 37.8 tpp -80.36 109.78 15.18 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 107.837 -1.172 . . . . 71.230000000000004 107.837 172.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 73.4 p -113.0 -172.64 2.09 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.418 0.687 . . . . 63.299999999999997 110.536 -176.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.626 HD21 ' HD3' ' A' ' 241' ' ' PRO . 66.6 tp -46.18 -50.82 15.23 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.439 1.095 . . . . 72.329999999999998 111.598 170.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -72.09 -30.05 64.71 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.055 -0.975 . . . . 45.109999999999999 111.753 -174.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 132.45 -164.45 23.91 Favored Glycine 0 C--N 1.342 0.871 0 CA-C-O 119.344 -0.698 . . . . 75.519999999999996 111.676 -170.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -66.68 129.02 20.1 Favored 'Trans proline' 0 C--N 1.374 1.89 0 C-N-CA 122.437 2.091 . . . . 75.310000000000002 111.346 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.445 HG22 ' O ' ' A' ' 212' ' ' ALA . 28.4 m -134.26 164.17 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 123.472 0.709 . . . . 74.219999999999999 110.975 -175.011 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.618 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 41.9 mt-10 -109.07 114.61 28.49 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.257 1.023 . . . . 64.049999999999997 108.689 -171.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 34.9 t -125.6 100.81 7.4 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 123.471 0.709 . . . . 74.129999999999995 109.665 -174.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.555 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -79.21 117.6 20.38 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 122.556 0.342 . . . . 60.329999999999998 110.243 174.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 30.2 m -88.09 152.12 50.18 Favored Pre-proline 0 N--CA 1.49 1.569 0 C-N-CA 123.253 0.621 . . . . 62.409999999999997 111.877 -175.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' PRO . . . . . 0.523 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 33.5 Cg_endo -63.62 163.71 23.46 Favored 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 122.651 2.234 . . . . 72.310000000000002 113.432 176.531 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -84.16 33.73 0.51 Allowed 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 123.237 2.625 . . . . 74.200000000000003 113.263 175.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' ARG . . . . . 0.418 ' HD2' ' HA ' ' A' ' 226' ' ' ARG . 10.0 tpt180 -150.07 -1.61 0.41 Allowed 'General case' 0 N--CA 1.477 0.897 0 O-C-N 121.805 -0.559 . . . . 73.319999999999993 112.217 175.022 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.576 HG23 HG11 ' A' ' 253' ' ' VAL . 0.6 OUTLIER -59.6 152.45 22.18 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 123.683 0.615 . . . . 71.340000000000003 109.639 -164.457 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 228' ' ' GLN . . . . . 0.492 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 5.2 pt20 -132.46 161.42 33.74 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.081 0.553 . . . . 75.25 110.29 -169.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -60.47 112.11 1.84 Allowed 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 109.818 -0.438 . . . . 50.32 109.818 174.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.25 -3.31 22.23 Favored Glycine 0 C--O 1.244 0.774 0 CA-C-N 115.269 -0.878 . . . . 71.019999999999996 111.895 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.492 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -67.79 126.85 30.71 Favored 'General case' 0 C--N 1.361 1.078 0 N-CA-C 109.016 -0.735 . . . . 75.219999999999999 109.016 -172.114 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -97.27 98.73 10.24 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 108.944 -0.761 . . . . 74.120000000000005 108.944 -173.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.51 ' HB3' ' HA ' ' A' ' 172' ' ' SER . 31.5 mt -79.16 100.78 7.59 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.059 -1.46 . . . . 63.509999999999998 107.059 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -79.69 124.97 29.06 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 124.381 1.05 . . . . 64.230000000000004 110.164 -175.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.583 ' HB3' ' HB2' ' A' ' 238' ' ' LYS . 7.1 mp -111.41 123.94 51.24 Favored 'General case' 0 C--O 1.219 -0.504 0 N-CA-C 104.769 -2.308 . . . . 70.450000000000003 104.769 170.226 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.478 ' HA ' ' HB3' ' A' ' 248' ' ' ASP . 44.2 tptt -103.07 117.34 34.35 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 118.92 0.782 . . . . 72.430000000000007 110.58 -171.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 79.03 27.03 57.05 Favored Glycine 0 C--N 1.345 1.045 0 O-C-N 123.429 0.455 . . . . 55.350000000000001 112.012 -175.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.583 ' HB2' ' HB3' ' A' ' 235' ' ' LEU . 29.4 mmmt -128.82 24.0 5.72 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.219 1.008 . . . . 72.0 111.68 -176.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 239' ' ' GLY . . . . . 0.455 ' HA2' ' HB2' ' A' ' 249' ' ' LEU . . . -95.73 -129.47 5.92 Favored Glycine 0 N--CA 1.469 0.876 0 N-CA-C 110.857 -0.897 . . . . 64.329999999999998 110.857 178.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 240' ' ' PHE . . . . . 0.459 ' O ' ' HA ' ' A' ' 246' ' ' ARG . 4.8 m-30 -68.58 153.13 96.16 Favored Pre-proline 0 CA--C 1.548 0.894 0 CA-C-N 117.374 0.587 . . . . 51.340000000000003 111.45 177.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.626 ' HD3' HD21 ' A' ' 215' ' ' LEU . 89.3 Cg_endo -69.95 172.64 12.45 Favored 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 123.346 2.697 . . . . 73.430000000000007 112.74 -174.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -66.33 -38.19 93.46 Favored Glycine 0 CA--C 1.545 1.943 0 CA-C-O 118.353 -1.248 . . . . 75.019999999999996 113.733 -178.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' PRO . . . . . 0.592 ' HD2' ' HB2' ' A' ' 241' ' ' PRO . 79.3 Cg_exo -52.75 -39.05 78.05 Favored 'Trans proline' 0 C--N 1.392 2.859 0 CA-C-N 120.918 2.359 . . . . 62.200000000000003 113.619 167.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -78.73 -23.5 45.43 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.583 0.753 . . . . 71.329999999999998 110.635 175.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 102.83 113.3 3.77 Favored Glycine 0 C--N 1.342 0.864 0 N-CA-C 108.4 -1.88 . . . . 40.229999999999997 108.4 -168.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.459 ' HA ' ' O ' ' A' ' 240' ' ' PHE . 15.9 ttp180 -70.81 131.22 43.47 Favored 'General case' 0 C--N 1.348 0.526 0 CA-C-N 117.473 0.636 . . . . 72.540000000000006 110.033 -172.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -136.23 -157.15 7.7 Favored Glycine 0 CA--C 1.502 -0.775 0 N-CA-C 110.879 -0.888 . . . . 63.420000000000002 110.879 176.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' ASP . . . . . 0.478 ' HB3' ' HA ' ' A' ' 236' ' ' LYS . 0.4 OUTLIER -124.24 159.03 31.08 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.698 0.799 . . . . 71.120000000000005 111.081 -175.945 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.455 ' HB2' ' HA2' ' A' ' 239' ' ' GLY . 8.0 tp -130.12 135.35 48.12 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.222 1.009 . . . . 72.349999999999994 108.512 -167.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -118.86 146.35 44.94 Favored 'General case' 0 C--O 1.247 0.922 0 N-CA-C 107.137 -1.431 . . . . 75.129999999999995 107.137 -174.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.459 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 71.1 mt -123.04 114.21 20.08 Favored 'General case' 0 C--O 1.223 -0.329 0 N-CA-C 108.078 -1.082 . . . . 50.109999999999999 108.078 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -88.59 111.71 22.2 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 107.712 -1.218 . . . . 72.25 107.712 -175.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.576 HG11 HG23 ' A' ' 227' ' ' THR . 56.0 t -62.06 127.35 21.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 114.871 -1.058 . . . . 65.109999999999999 110.176 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 14.5 mmt85 -117.1 122.24 43.58 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 106.89 -1.522 . . . . 73.430000000000007 106.89 173.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 46.3 mm -82.65 118.55 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 115.491 -0.777 . . . . 74.540000000000006 110.411 -174.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' THR . . . . . 0.442 HG21 ' HB2' ' A' ' 198' ' ' ASP . 1.4 t . . . . . 0 CA--C 1.556 1.188 0 C-N-CA 124.928 1.291 . . . . 74.140000000000001 107.697 -175.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 19.7 mmt . . . . . 0 N--CA 1.482 1.14 0 CA-C-O 120.72 0.295 . . . . 53.329999999999998 110.501 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 22.8 pttm -79.83 87.84 5.28 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.411 -0.813 . . . . 73.530000000000001 109.118 171.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -81.19 -14.47 57.53 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-N 115.716 -0.675 . . . . 73.099999999999994 112.129 -174.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -101.41 9.11 57.31 Favored Glycine 0 N--CA 1.472 1.096 0 O-C-N 123.433 0.458 . . . . 72.299999999999997 112.945 174.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -142.29 168.92 18.59 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.027 0.931 . . . . 61.329999999999998 109.798 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.407 HG11 HG22 ' A' ' 221' ' ' VAL . 56.1 t -110.33 151.08 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-O 121.761 0.791 . . . . 72.430000000000007 111.715 -168.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 46.2 mtm -99.38 -176.72 3.37 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.794 1.638 . . . . 74.319999999999993 109.898 -169.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 8.7 p -94.5 87.11 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.027 0 CA-C-O 122.986 1.375 . . . . 75.409999999999997 108.324 163.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.57 -4.84 7.68 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 125.552 1.541 . . . . 62.32 110.024 -178.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 68.4 m -41.85 -64.81 0.52 Allowed 'General case' 0 C--O 1.246 0.909 0 C-N-CA 126.369 1.868 . . . . 74.25 113.042 -168.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' TYR . . . . . 0.623 ' HB2' ' HB3' ' A' ' 224' ' ' PRO . 63.1 t80 -67.36 -49.94 61.9 Favored 'General case' 0 C--N 1.352 0.696 0 N-CA-C 108.764 -0.828 . . . . 73.400000000000006 108.764 178.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 56.87 90.84 0.01 OUTLIER Glycine 0 C--N 1.363 2.045 0 O-C-N 125.09 1.494 . . . . 73.319999999999993 111.028 -173.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -52.44 85.7 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.936 1.294 . . . . 65.25 112.233 -172.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 31.5 m -78.07 121.46 24.3 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.06 -0.973 . . . . 63.100000000000001 108.737 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -64.1 -25.22 68.0 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 116.186 -0.461 . . . . 74.140000000000001 110.328 171.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -64.49 157.78 25.74 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.987 0.915 . . . . 74.140000000000001 110.599 168.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -71.39 -24.02 61.99 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.114 0.566 . . . . 72.439999999999998 110.561 176.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -118.7 173.34 14.87 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-N 115.385 -0.825 . . . . 55.310000000000002 112.331 177.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 46.6 m -83.17 135.25 34.86 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.581 0.752 . . . . 52.420000000000002 110.224 178.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -58.14 96.22 0.06 OUTLIER Glycine 0 C--N 1.347 1.164 0 O-C-N 123.935 0.772 . . . . 62.409999999999997 112.201 176.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -78.23 77.51 1.68 Allowed Glycine 0 C--N 1.349 1.3 0 C-N-CA 123.292 0.472 . . . . 52.119999999999997 111.929 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 23.0 t -160.5 136.07 8.14 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 107.897 -1.149 . . . . 41.329999999999998 107.897 -177.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -169.84 140.1 5.9 Favored Glycine 0 C--N 1.342 0.863 0 C-N-CA 121.359 -0.448 . . . . 70.209999999999994 113.599 -176.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 65.46 -87.49 0.09 OUTLIER Glycine 0 C--N 1.351 1.363 0 O-C-N 124.521 0.777 . . . . 64.340000000000003 114.26 173.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 33.5 t -175.33 -40.32 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.403 1.081 . . . . 73.230000000000004 109.92 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 118.46 -18.17 11.05 Favored Glycine 0 C--N 1.354 1.536 0 N-CA-C 114.678 0.631 . . . . 44.539999999999999 114.678 176.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -78.19 -71.43 1.23 Allowed Glycine 0 N--CA 1.471 1.01 0 CA-C-N 117.557 0.678 . . . . 71.219999999999999 113.362 -172.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 58.1 m -150.21 20.75 0.86 Allowed 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.43 0.692 . . . . 65.120000000000005 110.602 -177.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -106.95 -31.54 8.28 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.702 0.801 . . . . 73.450000000000003 111.076 -170.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.58 171.03 15.32 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-N 115.187 -0.915 . . . . 52.32 109.299 -176.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.423 ' O ' ' HA ' ' A' ' 249' ' ' LEU . 37.1 tp -152.3 131.53 12.78 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.44 -0.948 . . . . 61.210000000000001 108.44 174.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -117.26 138.29 51.83 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 123.41 0.684 . . . . 74.549999999999997 109.158 171.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -148.14 165.79 29.81 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.49 1.116 . . . . 73.519999999999996 108.165 176.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' THR . . . . . 0.435 HG21 ' HE ' ' A' ' 254' ' ' ARG . 39.8 p -93.67 154.74 17.65 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 122.395 1.093 . . . . 50.020000000000003 112.275 168.077 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.638 HD13 ' HB2' ' A' ' 212' ' ' ALA . 35.4 tp -125.6 132.16 52.57 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 112.767 -2.015 . . . . 75.340000000000003 106.421 165.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -95.27 117.42 30.24 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 107.879 -1.156 . . . . 73.040000000000006 107.879 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.592 HG22 HG21 ' A' ' 210' ' ' VAL . 58.0 t -119.57 131.55 24.34 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 124.353 1.061 . . . . 72.340000000000003 110.019 -178.326 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -65.1 144.23 81.03 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.326 2.017 . . . . 61.149999999999999 111.418 168.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.451 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.47 -44.94 98.62 Favored Pre-proline 0 CA--C 1.564 1.517 0 C-N-CA 123.799 0.84 . . . . 72.310000000000002 112.167 174.227 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 17.8 Cg_endo -58.72 -33.45 98.35 Favored 'Trans proline' 0 C--N 1.404 3.499 0 C-N-CA 121.784 1.656 . . . . 73.239999999999995 112.361 175.01 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -86.06 -23.61 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 N-CA-C 109.357 -0.609 . . . . 75.120000000000005 109.357 -177.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -74.12 -39.33 63.41 Favored 'General case' 0 C--O 1.243 0.729 0 C-N-CA 123.046 0.538 . . . . 40.039999999999999 110.897 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 38.6 t -89.42 -36.05 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.818 1.247 . . . . 61.149999999999999 112.962 -178.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.436 ' HB ' ' O ' ' A' ' 202' ' ' PRO . 47.6 t -95.98 -41.47 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 O-C-N 121.538 -0.726 . . . . 72.109999999999999 110.184 -177.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 121.57 152.12 8.66 Favored Glycine 0 C--N 1.344 0.98 0 N-CA-C 110.57 -1.012 . . . . 63.310000000000002 110.57 -178.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.89 155.99 8.77 Favored Glycine 0 C--O 1.242 0.606 0 N-CA-C 112.289 -0.324 . . . . 65.230000000000004 112.289 176.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.619 ' HD3' ' HB3' ' A' ' 220' ' ' GLU . 38.3 ttmt -84.25 132.47 34.64 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.049 0.54 . . . . 71.420000000000002 109.781 175.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.592 HG21 HG22 ' A' ' 199' ' ' VAL . 8.3 m -131.07 150.62 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.674 1.19 . . . . 61.409999999999997 108.225 174.367 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -95.73 143.62 26.83 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 109.226 -0.657 . . . . 73.549999999999997 109.226 -174.132 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.638 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -130.76 128.02 39.92 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.976 0.91 . . . . 50.140000000000001 109.035 -177.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 31.7 tpp -79.39 116.37 19.59 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.642 -0.873 . . . . 61.210000000000001 108.642 171.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 68.8 p -121.06 -176.59 3.3 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.787 0.835 . . . . 64.150000000000006 110.001 -177.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.53 HD21 ' HD3' ' A' ' 241' ' ' PRO . 66.6 tp -46.72 -51.38 16.27 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.497 1.119 . . . . 54.32 111.894 172.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -72.1 -27.19 62.49 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 114.044 -1.434 . . . . 74.319999999999993 111.269 -172.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 131.98 -164.39 23.71 Favored Glycine 0 C--N 1.338 0.677 0 N-CA-C 111.508 -0.637 . . . . 75.430000000000007 111.508 -174.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -66.45 129.83 22.29 Favored 'Trans proline' 0 C--N 1.361 1.21 0 C-N-CA 122.407 2.071 . . . . 74.430000000000007 111.35 178.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 31.8 m -133.18 161.33 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 123.738 0.815 . . . . 54.130000000000003 110.816 -177.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.619 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 53.1 mt-10 -110.32 110.77 21.7 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.559 1.144 . . . . 74.409999999999997 109.842 -173.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.407 HG22 HG11 ' A' ' 168' ' ' VAL . 48.8 t -121.15 102.39 12.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 C-N-CA 124.352 1.061 . . . . 73.109999999999999 109.228 -172.079 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.603 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -79.2 117.08 19.89 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 122.796 0.439 . . . . 54.329999999999998 110.532 174.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 34.8 m -86.52 153.59 55.93 Favored Pre-proline 0 N--CA 1.487 1.392 0 C-N-CA 123.737 0.815 . . . . 74.219999999999999 111.457 -176.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' PRO . . . . . 0.623 ' HB3' ' HB2' ' A' ' 173' ' ' TYR . 32.7 Cg_endo -63.02 164.94 17.86 Favored 'Trans proline' 0 C--N 1.379 2.155 0 C-N-CA 122.737 2.291 . . . . 74.430000000000007 113.189 175.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -84.0 29.53 0.54 Allowed 'Trans proline' 0 C--N 1.369 1.606 0 C-N-CA 123.258 2.639 . . . . 74.219999999999999 113.178 172.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -145.9 0.1 0.83 Allowed 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 118.618 -0.706 . . . . 75.120000000000005 112.499 177.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.563 HG23 HG11 ' A' ' 253' ' ' VAL . 0.6 OUTLIER -60.95 154.66 21.85 Favored 'General case' 0 CA--C 1.573 1.84 0 O-C-N 123.375 0.422 . . . . 73.129999999999995 109.906 -167.117 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 228' ' ' GLN . . . . . 0.492 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 4.8 pt20 -135.26 161.94 33.98 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.563 0.745 . . . . 70.219999999999999 110.948 -169.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -62.75 110.86 1.88 Allowed 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.244 -0.65 . . . . 73.340000000000003 109.244 176.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.09 -0.55 22.65 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-N 115.187 -0.915 . . . . 40.140000000000001 111.903 178.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.492 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -67.92 123.85 21.75 Favored 'General case' 0 C--N 1.362 1.128 0 N-CA-C 108.824 -0.806 . . . . 75.310000000000002 108.824 -171.041 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -100.08 96.72 7.7 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.222 -0.658 . . . . 75.540000000000006 109.222 -170.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.464 ' O ' ' HA ' ' A' ' 250' ' ' TYR . 24.4 mt -80.21 98.57 7.41 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 106.378 -1.712 . . . . 73.430000000000007 106.378 -177.32 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 234' ' ' ARG . . . . . 0.671 ' HD3' ' HE2' ' A' ' 236' ' ' LYS . 0.0 OUTLIER -82.19 125.61 31.11 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.476 0.71 . . . . 52.450000000000003 111.501 178.631 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.563 ' HB3' ' HB2' ' A' ' 238' ' ' LYS . 7.2 mp -111.17 128.52 55.93 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 106.627 -1.619 . . . . 74.519999999999996 106.627 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.671 ' HE2' ' HD3' ' A' ' 234' ' ' ARG . 5.6 mptp? -97.07 116.84 30.0 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.253 0.621 . . . . 74.209999999999994 110.986 -173.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 76.46 29.27 58.31 Favored Glycine 0 C--N 1.35 1.307 0 O-C-N 124.06 0.85 . . . . 41.030000000000001 112.047 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.563 ' HB2' ' HB3' ' A' ' 235' ' ' LEU . 29.3 mmmt -127.27 20.38 6.82 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.113 0.965 . . . . 75.450000000000003 111.124 -175.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -94.95 -127.84 5.22 Favored Glycine 0 C--N 1.343 0.942 0 N-CA-C 110.059 -1.217 . . . . 43.509999999999998 110.059 178.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' PHE . . . . . 0.431 ' O ' ' HA ' ' A' ' 246' ' ' ARG . 7.3 m-30 -71.53 152.07 93.83 Favored Pre-proline 0 CA--C 1.554 1.098 0 CA-C-N 117.121 0.46 . . . . 72.409999999999997 111.767 177.21 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.53 ' HD3' HD21 ' A' ' 215' ' ' LEU . 59.2 Cg_endo -65.67 172.08 8.67 Favored 'Trans proline' 0 C--N 1.384 2.426 0 C-N-CA 123.468 2.779 . . . . 74.430000000000007 112.332 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.416 ' N ' ' HD2' ' A' ' 243' ' ' PRO . . . -66.31 -42.24 94.16 Favored Glycine 0 CA--C 1.541 1.672 0 CA-C-O 118.241 -1.311 . . . . 44.5 114.185 -176.205 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 243' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' A' ' 242' ' ' GLY . 10.2 Cg_endo -51.77 -38.78 67.72 Favored 'Trans proline' 0 C--N 1.392 2.825 0 C-N-CA 122.697 2.265 . . . . 51.219999999999999 113.223 168.341 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -79.19 -23.68 43.7 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.168 0.587 . . . . 31.52 110.839 176.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 105.79 111.33 3.58 Favored Glycine 0 C--N 1.343 0.919 0 N-CA-C 108.757 -1.737 . . . . 74.109999999999999 108.757 -170.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.431 ' HA ' ' O ' ' A' ' 240' ' ' PHE . 74.3 mtt180 -63.6 124.54 21.64 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.46 0.704 . . . . 73.530000000000001 110.965 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -136.81 -158.15 7.9 Favored Glycine 0 C--O 1.24 0.517 0 CA-C-N 115.582 -0.736 . . . . 52.210000000000001 112.253 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -117.32 164.74 14.38 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.839 0.856 . . . . 54.200000000000003 109.517 -176.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.423 ' HA ' ' O ' ' A' ' 193' ' ' LEU . 12.3 tp -133.78 132.53 40.61 Favored 'General case' 0 C--O 1.217 -0.654 0 N-CA-C 108.541 -0.911 . . . . 65.549999999999997 108.541 -176.165 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.464 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 0.4 OUTLIER -113.27 145.55 40.84 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 123.48 0.712 . . . . 73.450000000000003 109.433 177.803 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 73.5 mt -124.28 112.5 17.08 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.361 -1.348 . . . . 71.540000000000006 107.361 176.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -92.19 106.57 18.55 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 107.526 -1.287 . . . . 64.329999999999998 107.526 -172.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.563 HG11 HG23 ' A' ' 227' ' ' THR . 56.0 t -61.88 125.86 18.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 115.005 -0.998 . . . . 73.349999999999994 110.623 -177.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 254' ' ' ARG . . . . . 0.435 ' HE ' HG21 ' A' ' 196' ' ' THR . 26.4 mtm180 -113.6 123.77 50.75 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 106.644 -1.613 . . . . 70.030000000000001 106.644 171.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 46.5 mm -84.78 130.77 35.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 C-N-CA 123.181 0.592 . . . . 73.430000000000007 109.851 -175.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.4 t . . . . . 0 CA--C 1.563 1.471 0 C-N-CA 124.24 1.016 . . . . 72.400000000000006 108.355 -172.109 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 163' ' ' MET . . . . . 0.503 ' HA ' ' SD ' ' A' ' 169' ' ' MET . 1.0 OUTLIER . . . . . 0 N--CA 1.482 1.158 0 N-CA-C 109.31 -0.626 . . . . 72.150000000000006 109.31 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 32.6 mtmm -84.69 131.43 34.58 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 122.944 0.498 . . . . 73.25 109.809 173.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -86.62 -52.76 5.35 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.855 0.862 . . . . 71.439999999999998 111.477 -173.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -98.19 17.35 58.75 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-N 115.878 -0.601 . . . . 63.539999999999999 112.954 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -151.95 172.14 16.7 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.226 1.01 . . . . 42.140000000000001 109.405 176.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.46 HG11 HG22 ' A' ' 221' ' ' VAL . 51.1 t -111.05 149.96 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.999 0.919 . . . . 51.130000000000003 110.54 -178.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.503 ' SD ' ' HA ' ' A' ' 163' ' ' MET . 43.3 mtm -98.35 -177.78 3.82 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 125.544 1.538 . . . . 62.509999999999998 109.656 -169.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 9.0 p -100.52 90.4 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 N-CA-C 107.42 -1.326 . . . . 73.430000000000007 107.42 162.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' MET . . . . . 0.435 ' HG3' ' HA ' ' A' ' 235' ' ' LEU . 0.0 OUTLIER -125.3 -6.14 7.13 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 114.096 -1.411 . . . . 75.310000000000002 110.297 -175.863 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.448 ' HA ' ' HB3' ' A' ' 233' ' ' LEU . 67.2 m -40.77 -65.29 0.43 Allowed 'General case' 0 C--N 1.353 0.728 0 C-N-CA 126.461 1.904 . . . . 61.43 113.682 -165.399 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -63.54 -48.53 77.14 Favored 'General case' 0 C--O 1.238 0.486 0 O-C-N 123.504 0.502 . . . . 74.409999999999997 110.187 -177.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 60.91 93.03 0.01 OUTLIER Glycine 0 C--N 1.346 1.11 0 N-CA-C 109.715 -1.354 . . . . 64.040000000000006 109.715 -167.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -55.82 95.34 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.86 0.864 . . . . 70.420000000000002 110.215 -177.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 51.1 m -82.52 120.71 25.85 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-N 114.688 -1.142 . . . . 61.25 109.869 -174.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -70.43 -20.9 62.87 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 115.52 -0.764 . . . . 73.420000000000002 109.763 170.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -72.3 161.8 30.35 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.459 1.104 . . . . 60.049999999999997 110.933 173.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -81.9 2.96 28.07 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.185 0.594 . . . . 61.32 111.576 176.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -143.16 139.71 9.14 Favored Glycine 0 C--N 1.346 1.118 0 N-CA-C 111.069 -0.812 . . . . 64.109999999999999 111.069 173.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 23.0 t -106.4 106.3 16.75 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.746 0.818 . . . . 72.120000000000005 109.459 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -99.02 -123.35 4.91 Favored Glycine 0 C--N 1.347 1.166 0 O-C-N 123.16 0.288 . . . . 33.299999999999997 112.555 -178.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 146.02 82.9 0.05 OUTLIER Glycine 0 C--N 1.347 1.15 0 CA-C-N 116.606 0.203 . . . . 61.210000000000001 112.874 175.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 62.0 p -131.13 162.42 29.92 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.865 0.866 . . . . 70.430000000000007 109.673 177.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -172.42 -84.91 0.06 OUTLIER Glycine 0 C--N 1.346 1.12 0 C-N-CA 121.665 -0.302 . . . . 43.009999999999998 113.253 175.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.421 ' O ' ' HB2' ' A' ' 191' ' ' GLN . . . -87.01 50.23 4.12 Favored Glycine 0 C--N 1.347 1.192 0 C-N-CA 123.118 0.39 . . . . 41.049999999999997 113.289 -172.352 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 9.6 t -97.27 93.56 6.59 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.516 0.726 . . . . 73.219999999999999 109.936 -173.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -136.28 -83.1 0.14 Allowed Glycine 0 C--N 1.346 1.108 0 CA-C-N 116.232 -0.44 . . . . 72.310000000000002 112.473 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -106.27 -72.41 0.82 Allowed Glycine 0 C--N 1.351 1.399 0 N-CA-C 110.358 -1.097 . . . . 51.539999999999999 110.358 178.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 67.1 m -154.57 76.54 1.02 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.778 0.831 . . . . 53.420000000000002 109.38 174.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.421 ' HB2' ' O ' ' A' ' 186' ' ' GLY . 98.8 mt-30 -117.39 -48.21 2.62 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 114.575 -1.193 . . . . 63.140000000000001 108.563 172.018 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.428 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 38.5 p-10 -74.72 165.15 25.7 Favored 'General case' 0 C--O 1.247 0.948 0 CA-C-N 115.343 -0.844 . . . . 73.510000000000005 109.984 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.411 HD13 ' CE1' ' A' ' 240' ' ' PHE . 53.1 tp -149.94 143.34 25.18 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.902 -0.59 . . . . 62.420000000000002 109.548 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -115.52 138.47 51.0 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.969 0.908 . . . . 73.319999999999993 108.636 173.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -149.09 158.32 44.09 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.73 -0.841 . . . . 44.409999999999997 108.73 170.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 26.5 p -81.3 153.08 27.26 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 122.187 0.994 . . . . 53.340000000000003 111.851 166.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.691 HD13 ' HB2' ' A' ' 212' ' ' ALA . 33.5 tp -122.62 134.5 54.51 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 113.053 -1.885 . . . . 74.230000000000004 106.911 162.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -94.7 117.47 30.18 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 108.142 -1.058 . . . . 74.109999999999999 108.142 177.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.603 HG22 HG21 ' A' ' 210' ' ' VAL . 45.1 t -122.51 132.21 24.29 Favored Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 124.049 0.94 . . . . 65.540000000000006 109.153 178.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -69.57 145.55 58.6 Favored 'Trans proline' 0 C--N 1.365 1.433 0 C-N-CA 122.352 2.035 . . . . 63.109999999999999 110.52 169.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.458 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -52.91 -43.56 94.36 Favored Pre-proline 0 N--CA 1.486 1.332 0 N-CA-C 112.567 0.58 . . . . 54.009999999999998 112.567 173.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 10.6 Cg_endo -55.21 -37.72 94.1 Favored 'Trans proline' 0 C--N 1.399 3.217 0 C-N-CA 122.006 1.804 . . . . 43.200000000000003 112.736 174.187 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -86.55 -23.66 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 N-CA-C 109.841 -0.429 . . . . 71.329999999999998 109.841 -175.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -73.48 -38.0 65.56 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 123.146 0.578 . . . . 61.100000000000001 111.029 178.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 39.8 t -89.01 -35.43 7.71 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 C-N-CA 125.022 1.329 . . . . 74.510000000000005 112.648 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.414 ' HB ' ' O ' ' A' ' 202' ' ' PRO . 51.5 t -97.92 -42.93 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 O-C-N 121.547 -0.721 . . . . 61.340000000000003 111.129 -176.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 121.82 152.45 8.7 Favored Glycine 0 C--N 1.339 0.743 0 N-CA-C 110.707 -0.957 . . . . 74.349999999999994 110.707 -176.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 161.81 155.55 7.98 Favored Glycine 0 C--O 1.245 0.839 0 N-CA-C 111.307 -0.717 . . . . 71.109999999999999 111.307 177.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.62 ' HD3' ' HB3' ' A' ' 220' ' ' GLU . 36.3 ttmt -84.85 133.66 34.31 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 122.998 0.519 . . . . 73.329999999999998 110.026 174.141 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.603 HG21 HG22 ' A' ' 199' ' ' VAL . 15.5 m -131.24 153.4 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.417 1.087 . . . . 75.409999999999997 109.665 177.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 211' ' ' ARG . . . . . 0.667 ' HE ' ' HB3' ' A' ' 218' ' ' PRO . 0.0 OUTLIER -95.14 142.69 27.3 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.266 1.026 . . . . 74.040000000000006 109.352 -171.79 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.691 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -132.85 122.35 24.28 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.561 0.745 . . . . 65.310000000000002 109.459 -177.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 34.2 tpp -78.9 109.91 13.62 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 108.958 -0.756 . . . . 74.150000000000006 108.958 172.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 67.5 p -120.36 -175.08 2.93 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.928 0.891 . . . . 51.340000000000003 110.387 -175.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.534 HD21 ' HD3' ' A' ' 241' ' ' PRO . 64.0 tp -44.19 -53.32 6.64 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.298 1.039 . . . . 72.109999999999999 112.754 174.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -73.32 -27.89 61.77 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 114.821 -1.081 . . . . 74.340000000000003 111.392 -172.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 135.05 -164.45 24.78 Favored Glycine 0 C--N 1.341 0.855 0 N-CA-C 111.687 -0.565 . . . . 44.219999999999999 111.687 -171.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' PRO . . . . . 0.667 ' HB3' ' HE ' ' A' ' 211' ' ' ARG . 41.3 Cg_endo -63.93 130.73 28.45 Favored 'Trans proline' 0 C--N 1.369 1.639 0 C-N-CA 122.848 2.365 . . . . 73.400000000000006 111.335 176.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.406 HG22 ' O ' ' A' ' 212' ' ' ALA . 23.2 m -131.84 161.82 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.707 0.803 . . . . 60.539999999999999 110.723 -177.122 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.62 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 43.9 mt-10 -112.0 112.68 24.49 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.445 1.098 . . . . 65.530000000000001 109.899 -171.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.46 HG22 HG11 ' A' ' 168' ' ' VAL . 50.5 t -126.39 102.61 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 124.221 1.008 . . . . 74.209999999999994 110.174 -171.042 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.608 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -78.06 118.19 20.09 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.948 0.499 . . . . 63.520000000000003 110.391 174.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 36.0 m -90.71 152.33 44.74 Favored Pre-proline 0 N--CA 1.482 1.159 0 C-N-CA 123.445 0.698 . . . . 73.430000000000007 111.296 -176.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' PRO . . . . . 0.528 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 36.1 Cg_endo -63.91 165.4 18.96 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.839 2.359 . . . . 61.039999999999999 113.054 175.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -84.78 28.98 0.55 Allowed 'Trans proline' 0 C--N 1.378 2.091 0 C-N-CA 123.222 2.614 . . . . 63.210000000000001 113.032 175.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 35.4 mmt180 -145.07 -2.8 0.78 Allowed 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.335 0.654 . . . . 74.200000000000003 112.259 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.535 HG23 HG11 ' A' ' 253' ' ' VAL . 0.6 OUTLIER -60.81 149.47 35.77 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.433 -0.58 . . . . 70.319999999999993 109.433 -165.864 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 228' ' ' GLN . . . . . 0.471 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 13.2 pt20 -133.81 162.3 32.38 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.123 0.569 . . . . 74.010000000000005 110.417 -173.212 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -59.73 110.97 1.27 Allowed 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.145 0.498 . . . . 62.439999999999998 110.05 178.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.63 -0.66 21.79 Favored Glycine 0 C--N 1.335 0.49 0 CA-C-N 114.675 -1.148 . . . . 74.239999999999995 112.095 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -68.18 125.24 25.75 Favored 'General case' 0 C--N 1.359 0.992 0 N-CA-C 108.901 -0.777 . . . . 74.209999999999994 108.901 -175.002 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -98.9 97.58 8.75 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.283 0.633 . . . . 72.540000000000006 109.571 -168.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.479 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 22.2 mt -82.68 100.01 9.96 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 107.839 -1.171 . . . . 72.140000000000001 107.839 -176.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 234' ' ' ARG . . . . . 0.618 ' HD3' ' H ' ' A' ' 234' ' ' ARG . 0.0 OUTLIER -82.95 113.76 20.77 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.154 -0.93 . . . . 64.409999999999997 111.185 -176.964 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.485 ' O ' ' HB2' ' A' ' 248' ' ' ASP . 7.3 mp -100.66 127.25 47.12 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 106.772 -1.566 . . . . 75.140000000000001 106.772 173.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -101.74 117.12 34.21 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.342 0.657 . . . . 73.019999999999996 110.636 -175.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 79.08 32.35 39.83 Favored Glycine 0 C--N 1.348 1.227 0 O-C-N 124.268 0.98 . . . . 73.230000000000004 112.309 -177.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.46 ' HB2' ' HB3' ' A' ' 235' ' ' LEU . 29.3 mmmt -128.7 19.59 6.14 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.607 0.763 . . . . 74.209999999999994 111.66 -178.02 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -98.04 -134.03 8.18 Favored Glycine 0 C--N 1.343 0.953 0 N-CA-C 111.039 -0.824 . . . . 74.299999999999997 111.039 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' PHE . . . . . 0.48 ' O ' ' HA ' ' A' ' 246' ' ' ARG . 5.9 m-30 -66.18 154.91 89.04 Favored Pre-proline 0 CA--C 1.547 0.854 0 N-CA-C 112.699 0.629 . . . . 63.240000000000002 112.699 -177.112 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.534 ' HD3' HD21 ' A' ' 215' ' ' LEU . 86.2 Cg_endo -71.99 171.54 16.47 Favored 'Trans proline' 0 C--N 1.383 2.348 0 C-N-CA 123.285 2.657 . . . . 64.209999999999994 112.797 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.465 ' N ' ' HD2' ' A' ' 243' ' ' PRO . . . -67.17 -38.33 91.99 Favored Glycine 0 CA--C 1.545 1.962 0 CA-C-O 118.364 -1.242 . . . . 71.420000000000002 114.713 -177.257 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 243' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 242' ' ' GLY . 10.0 Cg_endo -53.72 -37.18 83.94 Favored 'Trans proline' 0 C--N 1.39 2.74 0 CA-C-N 120.974 2.387 . . . . 74.25 112.511 169.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -80.16 -24.6 40.28 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.513 0.725 . . . . 72.209999999999994 110.834 175.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 105.95 111.35 3.58 Favored Glycine 0 C--N 1.341 0.819 0 N-CA-C 107.802 -2.119 . . . . 73.200000000000003 107.802 -167.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.48 ' HA ' ' O ' ' A' ' 240' ' ' PHE . 1.5 tmm_? -73.12 128.52 35.73 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 109.738 -0.468 . . . . 73.0 109.738 -170.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -137.09 -156.79 7.43 Favored Glycine 0 C--N 1.342 0.911 0 CA-C-N 115.982 -0.554 . . . . 43.399999999999999 112.951 -175.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' ASP . . . . . 0.485 ' HB2' ' O ' ' A' ' 235' ' ' LEU . 32.4 p-10 -123.78 165.23 17.65 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.327 1.051 . . . . 45.119999999999997 110.526 -174.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 10.8 tp -135.56 135.37 40.28 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.191 -0.67 . . . . 63.200000000000003 109.191 -170.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -115.66 145.81 42.39 Favored 'General case' 0 C--O 1.246 0.88 0 N-CA-C 107.637 -1.246 . . . . 63.100000000000001 107.637 -178.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.479 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 82.2 mt -123.82 113.79 19.01 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 108.558 -0.904 . . . . 41.43 108.558 -179.141 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -89.78 110.49 21.4 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.83 -1.174 . . . . 64.530000000000001 107.83 -176.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.535 HG11 HG23 ' A' ' 227' ' ' THR . 51.2 t -61.81 134.16 27.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 115.162 -0.927 . . . . 54.020000000000003 110.527 -178.475 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 18.1 mtp85 -120.73 125.22 47.08 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.337 -1.357 . . . . 63.520000000000003 107.337 172.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 48.0 mm -84.92 112.83 22.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 108.948 -0.76 . . . . 74.219999999999999 108.948 -179.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 CA--C 1.557 1.248 0 CA-C-O 117.415 -1.279 . . . . 73.340000000000003 108.912 -171.734 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 50.6 ttm . . . . . 0 N--CA 1.473 0.704 0 N-CA-C 109.576 -0.528 . . . . 75.299999999999997 109.576 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.475 ' HB2' ' HB3' ' A' ' 167' ' ' ALA . 0.0 OUTLIER -77.69 93.05 4.2 Favored 'General case' 0 CA--C 1.555 1.168 0 CA-C-O 121.823 0.82 . . . . 71.310000000000002 111.711 -179.734 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -78.18 -21.4 50.22 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.554 0.741 . . . . 71.439999999999998 111.457 176.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -97.48 17.07 59.61 Favored Glycine 0 C--N 1.345 1.059 0 O-C-N 123.555 0.534 . . . . 74.239999999999995 112.625 178.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.475 ' HB3' ' HB2' ' A' ' 164' ' ' LYS . . . -148.08 172.84 13.62 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.58 1.152 . . . . 62.109999999999999 108.837 176.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.405 HG11 HG22 ' A' ' 221' ' ' VAL . 54.6 t -110.22 152.3 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-O 121.731 0.777 . . . . 64.340000000000003 111.415 -170.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 43.4 mtm -101.42 -176.05 3.03 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.619 1.968 . . . . 74.530000000000001 109.462 -170.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 10.3 p -101.77 88.84 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.079 0 CA-C-O 122.973 1.368 . . . . 72.239999999999995 107.791 163.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.72 -5.66 8.61 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 114.05 -1.432 . . . . 53.530000000000001 110.587 -174.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.46 ' HA ' ' HB3' ' A' ' 233' ' ' LEU . 69.3 m -36.25 -64.96 0.29 Allowed 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 127.014 2.126 . . . . 72.25 115.617 -167.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' TYR . . . . . 0.442 ' HB2' ' HG3' ' A' ' 224' ' ' PRO . 66.9 t80 -61.4 -33.42 73.65 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.165 0.586 . . . . 74.319999999999993 111.517 -170.144 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 79.39 39.85 17.5 Favored Glycine 0 C--N 1.343 0.919 0 N-CA-C 110.191 -1.164 . . . . 75.409999999999997 110.191 -173.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -70.07 102.15 1.98 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.353 1.061 . . . . 53.039999999999999 110.494 -173.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 58.3 p -110.12 124.94 52.43 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.937 1.295 . . . . 54.549999999999997 108.995 176.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -65.52 -13.09 58.15 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.922 0.489 . . . . 64.120000000000005 112.315 176.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -90.51 161.7 15.38 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.539 1.136 . . . . 61.229999999999997 109.071 168.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -59.81 -36.52 76.93 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 112.168 0.433 . . . . 73.340000000000003 112.168 -175.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -159.7 -176.53 31.87 Favored Glycine 0 CA--C 1.522 0.527 0 CA-C-N 115.302 -0.863 . . . . 72.239999999999995 111.999 177.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 36.2 m -110.92 7.38 21.71 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.559 0.744 . . . . 74.129999999999995 111.169 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 84.63 -57.75 5.01 Favored Glycine 0 C--N 1.354 1.565 0 N-CA-C 112.03 -0.428 . . . . 74.030000000000001 112.03 -178.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -169.3 -128.83 1.04 Allowed Glycine 0 C--N 1.34 0.77 0 N-CA-C 111.035 -0.826 . . . . 71.129999999999995 111.035 177.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 46.6 t -143.28 125.15 15.13 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 123.601 0.76 . . . . 54.219999999999999 109.931 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -78.41 68.17 2.98 Favored Glycine 0 C--N 1.35 1.352 0 N-CA-C 111.347 -0.701 . . . . 73.439999999999998 111.347 169.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -157.58 -97.14 0.12 Allowed Glycine 0 C--O 1.241 0.541 0 N-CA-C 109.304 -1.518 . . . . 73.219999999999999 109.304 -178.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 23.7 m 57.72 26.28 12.84 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 124.76 1.224 . . . . 72.140000000000001 112.53 171.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -102.33 147.03 17.07 Favored Glycine 0 C--N 1.343 0.954 0 CA-C-N 115.599 -0.728 . . . . 64.0 112.549 -176.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -64.82 -62.32 5.1 Favored Glycine 0 C--N 1.346 1.119 0 N-CA-C 111.696 -0.562 . . . . 43.32 111.696 178.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 67.8 p -89.47 22.31 3.01 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.705 0.802 . . . . 62.310000000000002 111.439 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -117.59 -56.11 2.24 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.19 0.596 . . . . 73.109999999999999 110.169 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -76.28 164.29 26.2 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-N 115.394 -0.821 . . . . 64.439999999999998 110.458 -177.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 40.9 tp -151.1 140.14 21.07 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.344 -0.844 . . . . 62.5 109.846 176.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -114.77 140.04 49.22 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.649 0.78 . . . . 74.120000000000005 109.421 168.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -145.16 157.03 44.19 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 108.353 -0.98 . . . . 63.340000000000003 108.353 167.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 30.0 p -81.46 154.38 26.37 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 122.139 0.971 . . . . 75.109999999999999 111.516 167.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.656 HD13 ' HB2' ' A' ' 212' ' ' ALA . 42.3 tp -121.17 133.32 55.18 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 113.286 -1.779 . . . . 73.219999999999999 107.026 168.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -92.55 112.35 24.26 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 106.95 -1.5 . . . . 72.549999999999997 106.95 -177.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.551 HG22 HG21 ' A' ' 210' ' ' VAL . 43.3 t -124.55 130.41 24.3 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 123.333 0.653 . . . . 73.319999999999993 109.275 -177.035 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -66.81 144.13 69.95 Favored 'Trans proline' 0 C--N 1.368 1.6 0 C-N-CA 121.984 1.789 . . . . 75.549999999999997 110.974 166.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.439 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.16 -45.19 98.41 Favored Pre-proline 0 CA--C 1.562 1.421 0 CA-C-O 118.309 -0.853 . . . . 42.119999999999997 112.322 174.229 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.467 ' O ' ' HB ' ' A' ' 206' ' ' VAL . 22.9 Cg_endo -59.35 -30.98 94.17 Favored 'Trans proline' 0 C--N 1.4 3.252 0 C-N-CA 121.909 1.739 . . . . 62.119999999999997 112.537 175.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.7 mp -85.88 -25.97 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 O-C-N 121.645 -0.659 . . . . 74.099999999999994 109.68 -178.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -74.25 -38.81 63.37 Favored 'General case' 0 C--O 1.246 0.913 0 CA-C-O 121.13 0.49 . . . . 62.409999999999997 111.078 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 41.2 t -88.96 -37.21 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 C-N-CA 124.809 1.244 . . . . 74.310000000000002 112.653 -177.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.467 ' HB ' ' O ' ' A' ' 202' ' ' PRO . 53.1 t -96.85 -42.4 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 O-C-N 121.648 -0.658 . . . . 61.009999999999998 109.71 -176.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 124.31 148.66 7.48 Favored Glycine 0 C--N 1.349 1.287 0 N-CA-C 111.306 -0.718 . . . . 54.399999999999999 111.306 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 165.48 156.07 9.0 Favored Glycine 0 C--N 1.342 0.876 0 N-CA-C 112.259 -0.336 . . . . 52.409999999999997 112.259 177.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.606 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 38.1 ttmt -85.01 131.93 34.4 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.284 0.634 . . . . 65.019999999999996 110.16 176.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.551 HG21 HG22 ' A' ' 199' ' ' VAL . 13.8 m -131.07 153.22 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 124.023 0.929 . . . . 63.109999999999999 110.106 178.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -94.5 142.73 27.1 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.159 0.984 . . . . 65.030000000000001 109.468 -171.037 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.656 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -132.74 119.51 20.43 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.388 0.675 . . . . 74.200000000000003 109.774 -176.321 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 35.5 tpp -78.68 110.13 13.54 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 108.759 -0.83 . . . . 73.099999999999994 108.759 171.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 67.1 p -119.17 -175.26 2.89 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.085 0.954 . . . . 73.239999999999995 110.706 -174.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.539 HD21 ' HD3' ' A' ' 241' ' ' PRO . 65.5 tp -49.77 -50.66 43.77 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.984 0.914 . . . . 74.129999999999995 111.439 169.143 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -71.86 -26.7 62.46 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 114.567 -1.197 . . . . 74.329999999999998 111.84 -173.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 133.09 -165.17 24.08 Favored Glycine 0 C--N 1.344 1.004 0 N-CA-C 111.488 -0.645 . . . . 52.539999999999999 111.488 -178.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -67.56 128.08 17.52 Favored 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 121.709 1.606 . . . . 75.150000000000006 110.566 174.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 25.1 m -132.98 162.3 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 123.329 0.652 . . . . 65.25 110.397 -174.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.599 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 45.1 mt-10 -111.78 111.64 22.75 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.647 0.779 . . . . 74.329999999999998 109.446 -173.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.405 HG22 HG11 ' A' ' 168' ' ' VAL . 57.4 t -122.65 103.81 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 124.812 1.245 . . . . 64.420000000000002 109.646 -172.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.606 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -75.34 117.57 17.29 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 110.061 -0.348 . . . . 71.120000000000005 110.061 174.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 28.3 m -85.47 153.5 58.8 Favored Pre-proline 0 N--CA 1.489 1.495 0 C-N-CA 122.889 0.475 . . . . 74.5 110.796 -176.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' PRO . . . . . 0.442 ' HG3' ' HB2' ' A' ' 173' ' ' TYR . 34.2 Cg_exo -59.7 162.36 15.74 Favored 'Trans proline' 0 C--N 1.383 2.373 0 C-N-CA 122.43 2.087 . . . . 73.299999999999997 112.757 177.38 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -91.02 30.12 0.36 Allowed 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 123.219 2.613 . . . . 72.340000000000003 112.039 177.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 -145.12 -9.12 0.59 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.061 0.945 . . . . 55.240000000000002 111.403 178.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.556 HG23 HG11 ' A' ' 253' ' ' VAL . 0.8 OUTLIER -59.39 156.39 12.96 Favored 'General case' 0 CA--C 1.567 1.633 0 O-C-N 123.885 0.741 . . . . 73.219999999999999 111.603 -158.906 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 228' ' ' GLN . . . . . 0.41 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 19.7 pt20 -130.22 162.55 28.67 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.341 0.657 . . . . 70.420000000000002 110.851 -171.38 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 229' ' ' ALA . . . . . 0.421 ' HB1' HH21 ' A' ' 254' ' ' ARG . . . -61.4 112.64 2.26 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.903 -0.59 . . . . 30.399999999999999 109.438 174.156 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.44 -3.86 21.74 Favored Glycine 0 N--CA 1.466 0.68 0 CA-C-N 115.642 -0.708 . . . . 72.549999999999997 112.067 178.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -68.69 126.24 29.08 Favored 'General case' 0 C--N 1.358 0.948 0 N-CA-C 109.268 -0.641 . . . . 71.439999999999998 109.268 -173.065 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -98.39 98.47 9.69 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.373 -0.603 . . . . 74.450000000000003 109.373 -171.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.46 ' HB3' ' HA ' ' A' ' 172' ' ' SER . 25.0 mt -79.64 99.77 7.52 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 106.917 -1.512 . . . . 62.219999999999999 106.917 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -81.34 115.68 20.81 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-O 121.546 0.689 . . . . 65.239999999999995 110.871 -176.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.425 ' HB3' ' HB2' ' A' ' 238' ' ' LYS . 7.3 mp -99.52 124.82 45.04 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 105.458 -2.053 . . . . 64.310000000000002 105.458 170.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 41.0 tptt -102.14 117.93 35.83 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 117.909 0.322 . . . . 63.439999999999998 110.156 -171.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 77.65 22.02 70.69 Favored Glycine 0 C--N 1.342 0.913 0 O-C-N 123.542 0.526 . . . . 73.140000000000001 112.86 -178.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.425 ' HB2' ' HB3' ' A' ' 235' ' ' LEU . 1.5 mmmp? -120.65 20.74 11.7 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.012 0.925 . . . . 55.210000000000001 110.035 -177.119 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -96.75 -135.09 8.38 Favored Glycine 0 C--N 1.349 1.285 0 N-CA-C 111.258 -0.737 . . . . 72.239999999999995 111.258 178.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 6.3 m-30 -65.1 150.59 95.21 Favored Pre-proline 0 N--CA 1.48 1.035 0 N-CA-C 112.339 0.496 . . . . 63.009999999999998 112.339 -177.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.539 ' HD3' HD21 ' A' ' 215' ' ' LEU . 60.0 Cg_endo -67.37 170.38 13.59 Favored 'Trans proline' 0 C--N 1.383 2.376 0 C-N-CA 123.13 2.553 . . . . 73.409999999999997 113.075 -177.049 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -68.37 -39.58 87.44 Favored Glycine 0 CA--C 1.538 1.509 0 CA-C-O 118.613 -1.104 . . . . 63.32 114.361 -177.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -48.38 -40.27 36.08 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 122.515 2.144 . . . . 32.299999999999997 113.871 164.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -77.9 -24.64 48.32 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.51 0.724 . . . . 31.420000000000002 110.705 175.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 106.65 111.45 3.58 Favored Glycine 0 C--N 1.336 0.546 0 N-CA-C 108.095 -2.002 . . . . 71.239999999999995 108.095 -167.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -71.84 125.23 26.64 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-N 117.458 0.629 . . . . 70.310000000000002 110.198 -172.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -138.81 -157.73 7.45 Favored Glycine 0 C--N 1.337 0.599 0 CA-C-N 116.085 -0.507 . . . . 72.239999999999995 112.727 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -119.78 165.22 14.84 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.945 0.898 . . . . 74.340000000000003 110.085 -173.218 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 10.5 tp -134.39 133.24 40.35 Favored 'General case' 0 C--O 1.219 -0.523 0 N-CA-C 107.683 -1.228 . . . . 75.519999999999996 107.683 -173.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 7.7 m-30 -116.13 147.89 40.88 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 108.063 -1.088 . . . . 73.409999999999997 108.063 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 78.2 mt -122.8 114.27 20.29 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 107.89 -1.152 . . . . 74.349999999999994 107.89 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -88.05 111.75 21.88 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 107.816 -1.179 . . . . 74.010000000000005 107.816 -178.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.556 HG11 HG23 ' A' ' 227' ' ' THR . 53.2 t -60.92 125.74 17.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 O-C-N 123.976 0.797 . . . . 74.129999999999995 109.891 178.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 254' ' ' ARG . . . . . 0.421 HH21 ' HB1' ' A' ' 229' ' ' ALA . 0.2 OUTLIER -112.01 124.28 52.07 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 106.658 -1.608 . . . . 75.25 106.658 174.667 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 51.3 mm -88.51 126.7 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 O-C-N 123.931 0.77 . . . . 63.329999999999998 109.527 -177.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 CA--C 1.558 1.278 0 N-CA-C 107.605 -1.257 . . . . 74.299999999999997 107.605 -177.07 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 57.9 ttp . . . . . 0 N--CA 1.484 1.24 0 N-CA-C 109.675 -0.491 . . . . 64.140000000000001 109.675 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.52 153.05 35.82 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.084 0.554 . . . . 55.340000000000003 110.416 172.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -105.17 -36.42 7.26 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.885 0.874 . . . . 74.329999999999998 111.165 -172.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -98.72 24.55 31.67 Favored Glycine 0 C--N 1.343 0.918 0 CA-C-N 115.972 -0.558 . . . . 70.030000000000001 113.07 -177.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -147.87 165.83 29.43 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.681 0.793 . . . . 64.329999999999998 109.978 178.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 78.9 t -109.19 146.07 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 123.598 0.759 . . . . 73.150000000000006 111.52 -169.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 44.5 mtm -101.97 -174.92 2.7 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.936 1.694 . . . . 73.510000000000005 110.059 -168.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 10.9 p -95.3 87.85 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.188 0 CA-C-O 123.195 1.474 . . . . 65.540000000000006 108.126 162.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.15 -3.76 8.5 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 114.053 -1.431 . . . . 75.030000000000001 110.106 -177.08 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.519 ' HA ' ' HB3' ' A' ' 233' ' ' LEU . 68.1 m -41.51 -66.52 0.33 Allowed 'General case' 0 C--N 1.353 0.741 0 C-N-CA 126.348 1.859 . . . . 62.539999999999999 113.454 -170.324 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -71.62 -43.26 66.48 Favored 'General case' 0 C--O 1.242 0.702 0 N-CA-C 108.422 -0.955 . . . . 64.239999999999995 108.422 178.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 57.12 67.1 2.39 Favored Glycine 0 C--N 1.359 1.824 0 O-C-N 124.683 1.239 . . . . 73.010000000000005 110.192 -176.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -62.29 88.14 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.007 0 CA-C-O 122.13 0.967 . . . . 73.319999999999993 112.725 -169.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 17.1 p -87.91 117.86 27.05 Favored 'General case' 0 C--O 1.245 0.821 0 N-CA-C 106.876 -1.527 . . . . 63.340000000000003 106.876 166.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -59.85 -29.77 68.51 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.531 0.732 . . . . 75.120000000000005 111.564 -173.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -97.49 129.65 44.65 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 107.758 -1.201 . . . . 70.450000000000003 107.758 163.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -68.66 -37.31 79.54 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.761 0.824 . . . . 74.530000000000001 111.255 -171.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -73.8 -8.37 77.25 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-N 115.053 -0.976 . . . . 42.329999999999998 113.688 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 34.8 m -82.84 146.7 28.77 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.357 0.663 . . . . 74.230000000000004 110.443 176.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 82.0 29.24 38.69 Favored Glycine 0 C--N 1.347 1.173 0 O-C-N 123.503 0.502 . . . . 63.409999999999997 112.601 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -86.92 9.72 70.98 Favored Glycine 0 C--N 1.349 1.299 0 C-N-CA 123.101 0.381 . . . . 62.43 113.195 177.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 39.8 p -66.7 157.98 31.29 Favored 'General case' 0 C--O 1.246 0.872 0 C-N-CA 123.862 0.865 . . . . 73.129999999999995 111.014 174.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -179.0 141.13 4.73 Favored Glycine 0 C--N 1.336 0.538 0 CA-C-N 116.062 -0.517 . . . . 51.420000000000002 112.462 -178.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -90.51 59.37 3.36 Favored Glycine 0 C--N 1.347 1.186 0 N-CA-C 111.948 -0.461 . . . . 64.430000000000007 111.948 178.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.411 ' HA ' ' HB2' ' A' ' 192' ' ' ASP . 49.3 m -63.08 109.19 1.42 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.142 0.577 . . . . 72.430000000000007 111.04 -177.457 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -154.79 157.86 27.89 Favored Glycine 0 C--O 1.243 0.68 0 N-CA-C 110.651 -0.979 . . . . 72.439999999999998 110.651 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -57.29 -36.41 75.76 Favored Glycine 0 C--N 1.349 1.251 0 O-C-N 124.284 0.638 . . . . 52.43 113.873 -174.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 43.5 m -135.61 42.84 2.65 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.279 0.632 . . . . 54.32 110.374 173.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -118.64 -66.8 1.04 Allowed 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 109.147 -0.686 . . . . 65.230000000000004 109.147 172.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.411 ' HB2' ' HA ' ' A' ' 187' ' ' SER . 31.0 t0 -75.23 154.78 37.36 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-N 114.717 -1.129 . . . . 72.030000000000001 108.849 -177.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 57.6 tp -148.88 132.41 16.73 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.305 -0.628 . . . . 72.430000000000007 109.305 -174.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -117.04 140.14 49.85 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.386 0.674 . . . . 65.439999999999998 109.213 174.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -147.8 158.19 43.91 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.69 0.796 . . . . 70.409999999999997 108.985 174.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 24.0 p -83.86 152.12 24.75 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 122.339 1.066 . . . . 74.450000000000003 112.292 167.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.656 HD13 ' HB2' ' A' ' 212' ' ' ALA . 33.3 tp -124.46 134.11 53.16 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 112.695 -2.048 . . . . 75.430000000000007 107.008 167.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -93.35 116.77 29.32 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.216 -1.031 . . . . 75.349999999999994 108.216 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.589 HG22 HG21 ' A' ' 210' ' ' VAL . 61.7 t -123.14 130.55 24.53 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 124.141 0.976 . . . . 75.120000000000005 109.174 178.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -66.09 143.63 72.55 Favored 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 122.161 1.907 . . . . 62.43 111.015 167.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.432 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.47 -43.75 96.22 Favored Pre-proline 0 CA--C 1.566 1.568 0 CA-C-O 118.141 -0.933 . . . . 72.450000000000003 112.572 175.086 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 19.1 Cg_endo -57.65 -31.28 91.48 Favored 'Trans proline' 0 C--N 1.403 3.445 0 C-N-CA 121.876 1.717 . . . . 73.239999999999995 112.634 173.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -87.14 -25.64 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 N-CA-C 109.487 -0.56 . . . . 74.310000000000002 109.487 -178.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.4 ' HA ' HG22 ' A' ' 227' ' ' THR . . . -73.43 -37.95 65.7 Favored 'General case' 0 C--O 1.244 0.794 0 C-N-CA 122.983 0.513 . . . . 72.140000000000001 110.987 178.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 25.4 t -88.29 -38.65 11.93 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 125.368 1.467 . . . . 54.420000000000002 112.875 -177.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 79.5 t -98.5 -41.46 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 O-C-N 121.664 -0.647 . . . . 64.340000000000003 110.45 -176.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 126.98 152.73 8.09 Favored Glycine 0 N--CA 1.468 0.815 0 N-CA-C 111.287 -0.725 . . . . 53.329999999999998 111.287 -178.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.98 154.16 7.84 Favored Glycine 0 C--O 1.244 0.74 0 CA-C-N 116.978 0.389 . . . . 63.310000000000002 112.675 175.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.576 ' HD3' ' HB3' ' A' ' 220' ' ' GLU . 36.7 ttmt -85.95 131.29 34.32 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.572 0.749 . . . . 75.329999999999998 109.215 175.158 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.589 HG21 HG22 ' A' ' 199' ' ' VAL . 15.8 m -130.0 154.45 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 123.734 0.814 . . . . 61.200000000000003 109.633 -177.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.11 135.91 33.86 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.732 0.813 . . . . 74.25 109.274 -171.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.656 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -132.73 116.49 16.66 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.813 -0.81 . . . . 43.119999999999997 108.813 -176.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 36.7 tpp -80.78 109.87 15.75 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 107.819 -1.178 . . . . 60.119999999999997 107.819 173.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 64.8 p -113.22 -175.42 2.66 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.125 0.57 . . . . 74.420000000000002 110.533 -174.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.456 HD21 ' HD3' ' A' ' 241' ' ' PRO . 60.5 tp -47.67 -51.17 22.61 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 124.323 1.014 . . . . 54.240000000000002 110.888 169.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -72.31 -27.03 62.19 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 113.884 -1.507 . . . . 73.310000000000002 110.944 -174.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 129.73 -166.14 22.0 Favored Glycine 0 C--N 1.341 0.81 0 CA-C-N 116.133 -0.485 . . . . 74.140000000000001 112.007 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -62.67 130.76 30.76 Favored 'Trans proline' 0 CA--C 1.552 1.419 0 C-N-CA 122.649 2.233 . . . . 74.430000000000007 111.84 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.436 HG22 ' O ' ' A' ' 212' ' ' ALA . 20.6 m -139.61 160.3 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 123.061 0.544 . . . . 64.450000000000003 110.408 -172.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.576 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 40.2 mt-10 -110.88 111.82 23.23 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.738 0.815 . . . . 52.420000000000002 109.311 -175.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 60.4 t -120.56 102.96 13.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 124.25 1.02 . . . . 74.010000000000005 108.937 -173.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.54 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -76.72 117.2 18.1 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 109.98 -0.378 . . . . 71.540000000000006 109.98 175.242 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 35.5 m -87.85 152.02 50.64 Favored Pre-proline 0 N--CA 1.487 1.399 0 C-N-CA 122.996 0.518 . . . . 61.329999999999998 110.562 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' PRO . . . . . 0.565 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 35.5 Cg_endo -63.48 163.48 23.77 Favored 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 122.213 1.942 . . . . 74.25 113.034 176.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -80.63 29.8 0.52 Allowed 'Trans proline' 0 C--N 1.373 1.864 0 C-N-CA 123.354 2.702 . . . . 71.409999999999997 113.416 174.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 -150.7 0.69 0.42 Allowed 'General case' 0 N--CA 1.474 0.738 0 O-C-N 122.113 -0.367 . . . . 55.210000000000001 111.839 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.63 HG23 HG11 ' A' ' 253' ' ' VAL . 0.7 OUTLIER -60.82 153.23 25.05 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.497 -0.557 . . . . 72.340000000000003 109.497 -169.058 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 228' ' ' GLN . . . . . 0.446 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 19.6 pt20 -132.73 162.11 32.28 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.403 0.681 . . . . 73.519999999999996 110.44 -171.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -61.13 111.46 1.72 Allowed 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 108.946 -0.761 . . . . 72.040000000000006 108.946 172.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.69 -1.62 21.68 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-N 115.087 -0.961 . . . . 72.230000000000004 112.501 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -68.79 127.08 31.82 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.445 0.698 . . . . 70.099999999999994 109.494 -173.971 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -98.21 97.1 8.56 Favored 'General case' 0 C--O 1.244 0.767 0 C-N-CA 123.413 0.685 . . . . 74.319999999999993 109.309 -170.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.519 ' HB3' ' HA ' ' A' ' 172' ' ' SER . 24.3 mt -80.23 99.24 7.73 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 107.504 -1.295 . . . . 71.329999999999998 107.504 -178.36 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 2.3 ppt_? -81.51 117.39 21.88 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.761 0.825 . . . . 74.129999999999995 112.579 -174.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.456 ' HB2' ' O ' ' A' ' 249' ' ' LEU . 7.6 mp -110.18 126.98 54.67 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 107.035 -1.468 . . . . 45.210000000000001 107.035 174.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -103.44 118.06 35.87 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.715 0.806 . . . . 75.209999999999994 111.024 -173.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 78.97 22.4 66.05 Favored Glycine 0 C--N 1.347 1.192 0 O-C-N 123.882 0.739 . . . . 13.140000000000001 112.304 -178.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -120.5 19.33 12.01 Favored 'General case' 0 C--N 1.347 0.486 0 C-N-CA 123.462 0.705 . . . . 62.43 109.984 -178.078 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -95.69 -136.61 8.77 Favored Glycine 0 C--N 1.35 1.361 0 N-CA-C 111.06 -0.816 . . . . 64.109999999999999 111.06 177.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 6.3 m-30 -68.28 148.27 98.24 Favored Pre-proline 0 CA--C 1.551 0.988 0 CA-C-N 117.559 0.68 . . . . 65.540000000000006 111.429 -178.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.456 ' HD3' HD21 ' A' ' 215' ' ' LEU . 65.7 Cg_endo -67.01 172.33 9.96 Favored 'Trans proline' 0 C--N 1.38 2.19 0 C-N-CA 123.399 2.733 . . . . 65.209999999999994 112.416 -177.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.451 ' N ' ' HD2' ' A' ' 243' ' ' PRO . . . -66.34 -38.29 93.52 Favored Glycine 0 CA--C 1.545 1.941 0 CA-C-O 117.92 -1.489 . . . . 64.439999999999998 114.163 -176.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 243' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 242' ' ' GLY . 9.7 Cg_endo -53.19 -35.28 72.83 Favored 'Trans proline' 0 C--N 1.392 2.867 0 CA-C-N 120.892 2.346 . . . . 74.140000000000001 113.351 167.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -85.45 -25.11 27.13 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.079 0.552 . . . . 43.210000000000001 110.464 176.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 112.52 114.19 3.29 Favored Glycine 0 C--N 1.343 0.962 0 N-CA-C 109.866 -1.294 . . . . 71.219999999999999 109.866 -169.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 32.2 ttm180 -66.22 128.44 36.13 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 117.389 0.594 . . . . 74.140000000000001 110.591 -176.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -148.1 -156.48 7.08 Favored Glycine 0 C--N 1.336 0.534 0 CA-C-N 115.657 -0.702 . . . . 72.319999999999993 112.48 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -118.58 165.86 13.43 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.214 0.605 . . . . 73.530000000000001 109.373 -171.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.456 ' O ' ' HB2' ' A' ' 235' ' ' LEU . 11.3 tp -133.83 132.07 39.97 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 107.31 -1.367 . . . . 64.409999999999997 107.31 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 9.8 m-30 -122.73 147.22 46.74 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.127 -1.064 . . . . 72.099999999999994 108.127 -178.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.413 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 86.0 mt -123.08 115.92 22.63 Favored 'General case' 0 C--O 1.222 -0.364 0 N-CA-C 108.327 -0.99 . . . . 53.109999999999999 108.327 -176.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -88.39 111.62 21.96 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 107.574 -1.269 . . . . 73.420000000000002 107.574 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.63 HG11 HG23 ' A' ' 227' ' ' THR . 55.6 t -61.35 128.35 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 CA-C-N 115.126 -0.943 . . . . 74.310000000000002 110.088 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 8.1 mmt180 -119.89 123.44 43.6 Favored 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 107.809 -1.182 . . . . 70.450000000000003 107.809 177.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 47.9 mm -82.76 122.11 36.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 114.718 -1.128 . . . . 65.450000000000003 109.945 -174.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.7 t . . . . . 0 CA--C 1.557 1.233 0 N-CA-C 107.229 -1.397 . . . . 72.530000000000001 107.229 -179.182 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 27.3 ttt . . . . . 0 N--CA 1.479 0.997 0 N-CA-C 109.039 -0.726 . . . . 71.319999999999993 109.039 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.495 ' HB2' ' HB3' ' A' ' 167' ' ' ALA . 0.0 OUTLIER -65.8 93.81 0.19 Allowed 'General case' 0 CA--C 1.557 1.25 0 C-N-CA 123.53 0.732 . . . . 74.150000000000006 111.559 -179.925 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -72.71 -24.93 61.06 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.444 0.698 . . . . 72.319999999999993 110.987 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -98.69 25.59 27.39 Favored Glycine 0 C--N 1.349 1.279 0 CA-C-N 116.158 -0.474 . . . . 64.099999999999994 112.63 176.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.495 ' HB3' ' HB2' ' A' ' 164' ' ' LYS . . . -152.66 173.2 15.53 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.939 0.896 . . . . 63.229999999999997 108.876 173.154 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.577 HG11 HG22 ' A' ' 221' ' ' VAL . 53.2 t -109.41 151.07 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.107 0.563 . . . . 72.319999999999993 110.863 -172.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 50.2 mtm -99.43 -176.47 3.3 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 125.8 1.64 . . . . 73.299999999999997 110.019 -169.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 8.8 p -99.97 86.48 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 CA-C-O 123.149 1.452 . . . . 74.519999999999996 107.94 163.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' MET . . . . . 0.503 ' HG3' ' HA ' ' A' ' 235' ' ' LEU . 0.0 OUTLIER -122.63 -5.36 8.67 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 113.675 -1.602 . . . . 63.520000000000003 110.041 -176.96 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.539 ' HA ' ' HB3' ' A' ' 233' ' ' LEU . 69.4 m -40.93 -63.33 0.68 Allowed 'General case' 0 C--N 1.35 0.608 0 C-N-CA 126.818 2.047 . . . . 52.439999999999998 114.553 -168.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' TYR . . . . . 0.598 ' HB2' ' HB3' ' A' ' 224' ' ' PRO . 67.3 t80 -59.03 -35.76 73.83 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.224 0.535 . . . . 64.040000000000006 110.9 -176.4 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 106.94 63.82 0.59 Allowed Glycine 0 N--CA 1.439 -1.114 0 N-CA-C 108.032 -2.027 . . . . 71.120000000000005 108.032 -167.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -60.62 98.22 0.06 Allowed 'General case' 0 C--O 1.241 0.62 0 C-N-CA 124.493 1.117 . . . . 71.340000000000003 110.023 -176.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 48.5 m -120.87 120.79 36.55 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.843 0.857 . . . . 61.32 111.01 -175.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -78.18 -8.77 58.72 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 109.259 -0.645 . . . . 74.340000000000003 109.259 160.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -75.4 174.07 10.09 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.525 1.53 . . . . 74.129999999999995 110.777 165.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -56.11 -37.99 70.16 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.464 0.706 . . . . 62.119999999999997 111.449 172.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 160.63 54.6 0.01 OUTLIER Glycine 0 C--N 1.338 0.677 0 CA-C-N 115.256 -0.884 . . . . 72.209999999999994 111.401 176.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 14.6 m -93.83 117.32 29.93 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.281 0.632 . . . . 61.509999999999998 110.845 -173.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -121.52 -72.69 0.3 Allowed Glycine 0 C--N 1.349 1.285 0 N-CA-C 111.633 -0.587 . . . . 54.450000000000003 111.633 177.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 72.09 174.0 21.67 Favored Glycine 0 C--N 1.351 1.372 0 CA-C-O 121.375 0.431 . . . . 71.109999999999999 114.055 175.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.597 ' HB3' ' HB2' ' A' ' 187' ' ' SER . 73.2 m -113.38 126.96 55.93 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.97 0.908 . . . . 71.129999999999995 109.838 177.011 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -85.1 -75.66 1.22 Allowed Glycine 0 C--N 1.344 0.999 0 O-C-N 123.631 0.582 . . . . 74.340000000000003 111.87 -176.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 191' ' ' GLN . . . -94.32 52.95 2.12 Favored Glycine 0 C--N 1.342 0.877 0 N-CA-C 111.728 -0.549 . . . . 71.5 111.728 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.597 ' HB2' ' HB3' ' A' ' 184' ' ' SER . 23.1 t -77.23 119.3 20.7 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 122.424 0.29 . . . . 70.129999999999995 110.409 -177.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -167.65 -131.22 1.25 Allowed Glycine 0 C--N 1.342 0.872 0 N-CA-C 111.865 -0.494 . . . . 53.210000000000001 111.865 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -83.33 -56.96 2.57 Favored Glycine 0 C--N 1.347 1.167 0 N-CA-C 112.14 -0.384 . . . . 42.240000000000002 112.14 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 17.7 m -152.93 60.69 0.79 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.144 0.978 . . . . 73.400000000000006 109.182 -175.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.479 ' HB2' ' O ' ' A' ' 186' ' ' GLY . 93.9 mt-30 -119.17 -52.47 2.29 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 107.213 -1.403 . . . . 75.120000000000005 107.213 172.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 24.5 p-10 -74.21 172.67 11.36 Favored 'General case' 0 C--O 1.245 0.843 0 CA-C-N 113.425 -1.716 . . . . 63.119999999999997 109.724 167.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 33.0 tp -152.06 140.39 20.48 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.847 0.356 . . . . 72.129999999999995 110.324 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -115.46 139.69 49.81 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.269 1.028 . . . . 71.310000000000002 108.632 168.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.424 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -147.92 158.13 43.89 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.097 -1.075 . . . . 71.239999999999995 108.097 168.188 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 32.3 p -82.89 153.78 24.94 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 122.146 0.974 . . . . 54.340000000000003 112.585 167.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.598 HD13 ' HB2' ' A' ' 212' ' ' ALA . 25.8 tp -124.23 132.01 53.57 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 112.88 -1.964 . . . . 75.540000000000006 107.09 164.179 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -94.45 116.78 29.19 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.827 -0.805 . . . . 64.329999999999998 108.827 177.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.558 HG22 HG21 ' A' ' 210' ' ' VAL . 57.4 t -117.93 134.62 23.27 Favored Pre-proline 0 CA--C 1.549 0.923 0 CA-C-N 114.573 -1.194 . . . . 64.109999999999999 109.214 -177.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -67.5 146.7 75.17 Favored 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 122.185 1.923 . . . . 75.430000000000007 111.121 169.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.443 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.66 -45.76 98.58 Favored Pre-proline 0 CA--C 1.567 1.612 0 C-N-CA 123.65 0.78 . . . . 75.400000000000006 112.568 174.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 28.0 Cg_endo -60.73 -31.41 91.9 Favored 'Trans proline' 0 C--N 1.393 2.887 0 C-N-CA 122.202 1.934 . . . . 60.109999999999999 112.98 176.011 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -86.19 -24.47 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 109.441 -0.577 . . . . 73.109999999999999 109.441 -177.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -73.31 -37.7 66.09 Favored 'General case' 0 C--O 1.244 0.78 0 C-N-CA 123.053 0.541 . . . . 42.43 111.417 178.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 24.9 t -88.99 -36.66 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 CA-C-N 114.348 -1.296 . . . . 71.299999999999997 113.506 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 55.7 t -96.92 -42.3 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 O-C-N 121.486 -0.759 . . . . 64.239999999999995 111.007 -177.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 123.36 152.87 8.59 Favored Glycine 0 C--N 1.341 0.861 0 N-CA-C 110.727 -0.949 . . . . 55.030000000000001 110.727 -175.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.68 151.83 6.74 Favored Glycine 0 C--O 1.246 0.849 0 N-CA-C 111.578 -0.609 . . . . 75.200000000000003 111.578 177.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.623 ' HD3' ' HB3' ' A' ' 220' ' ' GLU . 4.2 ttmp? -84.2 130.2 34.84 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 108.667 -0.864 . . . . 73.209999999999994 108.667 174.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.558 HG21 HG22 ' A' ' 199' ' ' VAL . 15.8 m -129.9 152.24 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.383 1.073 . . . . 50.340000000000003 108.301 178.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 4.8 tmm_? -95.37 141.93 28.35 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 108.466 -0.939 . . . . 72.230000000000004 108.466 -172.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.598 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -132.14 124.92 30.06 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.959 0.903 . . . . 63.32 109.065 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 39.8 tpp -79.86 109.98 14.79 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 108.243 -1.021 . . . . 75.109999999999999 108.243 171.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 71.0 p -117.96 -175.59 2.87 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.838 0.855 . . . . 75.209999999999994 110.684 -177.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 63.0 tp -42.1 -50.65 4.72 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.809 1.244 . . . . 65.310000000000002 112.345 174.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -71.57 -27.08 62.91 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 114.552 -1.203 . . . . 74.549999999999997 111.595 -173.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 127.9 -163.35 21.58 Favored Glycine 0 C--N 1.34 0.791 0 N-CA-C 110.849 -0.9 . . . . 71.019999999999996 110.849 -170.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -65.49 129.84 23.57 Favored 'Trans proline' 0 C--N 1.371 1.741 0 C-N-CA 122.301 2.001 . . . . 75.109999999999999 111.594 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.442 HG22 ' O ' ' A' ' 212' ' ' ALA . 27.6 m -134.83 162.04 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 123.456 0.703 . . . . 60.219999999999999 111.041 -176.293 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.623 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 46.6 mt-10 -110.93 113.04 25.31 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.124 0.97 . . . . 75.049999999999997 109.77 -173.243 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.577 HG22 HG11 ' A' ' 168' ' ' VAL . 48.3 t -123.42 102.92 12.18 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 124.429 1.091 . . . . 72.310000000000002 109.815 -172.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.6 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -78.96 116.94 19.58 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 122.604 0.361 . . . . 52.219999999999999 110.505 175.257 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 35.3 m -88.79 152.44 48.87 Favored Pre-proline 0 N--CA 1.488 1.446 0 C-N-CA 123.252 0.621 . . . . 71.129999999999995 111.478 -175.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' PRO . . . . . 0.598 ' HB3' ' HB2' ' A' ' 173' ' ' TYR . 36.9 Cg_endo -63.13 166.36 14.77 Favored 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 122.838 2.359 . . . . 72.129999999999995 113.147 178.388 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -84.72 30.19 0.52 Allowed 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 122.838 2.359 . . . . 60.509999999999998 112.609 174.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -147.92 -0.72 0.6 Allowed 'General case' 0 N--CA 1.475 0.823 0 O-C-N 121.635 -0.666 . . . . 74.5 111.955 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.58 HG23 HG11 ' A' ' 253' ' ' VAL . 0.6 OUTLIER -61.18 152.53 28.44 Favored 'General case' 0 CA--C 1.567 1.633 0 N-CA-C 109.74 -0.467 . . . . 52.420000000000002 109.74 -167.482 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 228' ' ' GLN . . . . . 0.447 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 20.2 pt20 -135.05 161.47 35.21 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.456 0.703 . . . . 53.340000000000003 109.665 -173.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -61.33 111.23 1.68 Allowed 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 109.066 -0.716 . . . . 74.140000000000001 109.066 175.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 116.3 -0.47 20.68 Favored Glycine 0 N--CA 1.468 0.806 0 CA-C-N 114.783 -1.099 . . . . 74.340000000000003 112.787 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.447 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -70.92 127.36 32.32 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.83 0.852 . . . . 73.129999999999995 109.7 -175.671 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -97.62 99.22 10.6 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 109.324 -0.621 . . . . 60.229999999999997 109.324 -173.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.539 ' HB3' ' HA ' ' A' ' 172' ' ' SER . 22.8 mt -79.32 98.49 6.71 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.051 -1.463 . . . . 72.140000000000001 107.051 179.246 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 6.3 ppt_? -81.94 114.13 20.33 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-O 121.456 0.646 . . . . 74.129999999999995 111.972 -176.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.503 ' HA ' ' HG3' ' A' ' 171' ' ' MET . 7.2 mp -99.39 129.11 45.56 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 106.63 -1.619 . . . . 63.439999999999998 106.63 173.236 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 27.8 tptt -101.7 115.88 31.51 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 117.892 0.315 . . . . 73.450000000000003 110.721 -171.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.484 ' H ' ' HB3' ' A' ' 248' ' ' ASP . . . 78.12 29.38 53.98 Favored Glycine 0 C--N 1.344 1.019 0 O-C-N 123.832 0.708 . . . . 40.409999999999997 112.872 -178.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -119.31 20.05 12.64 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.841 0.856 . . . . 61.310000000000002 110.959 -177.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -95.95 -141.28 11.75 Favored Glycine 0 C--N 1.349 1.28 0 N-CA-C 110.453 -1.059 . . . . 54.200000000000003 110.453 178.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 7.2 m-30 -68.63 148.85 98.09 Favored Pre-proline 0 CA--C 1.548 0.881 0 CA-C-N 117.221 0.511 . . . . 63.229999999999997 111.592 -175.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -65.59 170.91 10.34 Favored 'Trans proline' 0 C--N 1.384 2.409 0 C-N-CA 123.209 2.606 . . . . 73.040000000000006 112.179 177.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -67.28 -39.65 92.07 Favored Glycine 0 CA--C 1.546 1.98 0 CA-C-O 118.719 -1.045 . . . . 33.140000000000001 114.186 -175.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_exo -50.39 -39.33 53.96 Favored 'Trans proline' 0 C--N 1.384 2.406 0 C-N-CA 122.601 2.201 . . . . 74.099999999999994 113.789 166.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -81.93 -24.22 35.72 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.045 0.538 . . . . 74.530000000000001 110.55 177.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 111.36 112.62 3.32 Favored Glycine 0 C--N 1.34 0.781 0 N-CA-C 109.112 -1.595 . . . . 62.240000000000002 109.112 -170.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -70.51 129.01 38.11 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 109.091 -0.707 . . . . 75.219999999999999 109.091 -172.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -148.9 -161.54 9.74 Favored Glycine 0 C--N 1.341 0.848 0 O-C-N 123.451 0.469 . . . . 72.209999999999994 112.751 173.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' ASP . . . . . 0.484 ' HB3' ' H ' ' A' ' 237' ' ' GLY . 15.8 p-10 -123.9 164.24 19.66 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.562 1.145 . . . . 63.539999999999999 110.782 -176.313 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 8.9 tp -132.0 136.28 47.16 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 109.27 -0.641 . . . . 64.019999999999996 109.27 -166.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -121.64 148.11 44.98 Favored 'General case' 0 C--O 1.247 0.939 0 N-CA-C 108.164 -1.05 . . . . 74.239999999999995 108.164 -176.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.424 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 71.5 mt -123.59 113.96 19.39 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 108.891 -0.781 . . . . 74.409999999999997 108.891 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -88.45 111.79 22.2 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.223 -1.028 . . . . 72.450000000000003 108.223 -177.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.58 HG11 HG23 ' A' ' 227' ' ' THR . 55.4 t -61.36 130.18 25.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 114.862 -1.063 . . . . 65.349999999999994 110.404 178.199 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 37.3 mtm180 -116.84 125.47 51.61 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 106.578 -1.638 . . . . 72.319999999999993 106.578 169.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 49.8 mm -84.27 127.5 39.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 108.727 -0.842 . . . . 43.119999999999997 108.727 -178.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.2 t . . . . . 0 CA--C 1.552 1.049 0 N-CA-C 108.369 -0.975 . . . . 70.299999999999997 108.369 -177.165 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 26.1 ptt? . . . . . 0 N--CA 1.474 0.748 0 N-CA-C 109.823 -0.436 . . . . 74.340000000000003 109.823 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.53 84.69 3.91 Favored 'General case' 0 CA--C 1.552 1.027 0 CA-C-O 121.915 0.864 . . . . 75.430000000000007 110.133 175.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -65.28 -15.0 62.05 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.903 1.281 . . . . 64.129999999999995 112.477 178.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -98.16 17.17 59.04 Favored Glycine 0 C--N 1.349 1.293 0 CA-C-N 116.588 -0.278 . . . . 72.099999999999994 112.575 175.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -153.13 171.25 18.74 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.249 1.02 . . . . 71.400000000000006 109.506 178.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 53.0 t -112.52 153.04 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-O 121.529 0.681 . . . . 74.140000000000001 111.403 -177.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 46.6 mtm -100.66 -176.83 3.3 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.282 1.833 . . . . 73.129999999999995 109.271 -173.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 11.2 p -98.97 88.74 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.321 0 CA-C-O 123.092 1.425 . . . . 72.409999999999997 107.758 163.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' MET . . . . . 0.41 ' HG3' ' HA ' ' A' ' 235' ' ' LEU . 0.0 OUTLIER -123.92 -4.46 8.05 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 113.767 -1.56 . . . . 61.210000000000001 110.593 -172.926 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.532 ' HB3' HD22 ' A' ' 233' ' ' LEU . 70.3 m -40.7 -64.38 0.54 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.421 1.889 . . . . 75.5 114.187 -173.301 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' TYR . . . . . 0.624 ' HB2' ' HG3' ' A' ' 224' ' ' PRO . 45.2 t80 -69.64 -50.02 48.2 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 108.321 -0.992 . . . . 72.129999999999995 108.321 -178.333 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 39.6 48.73 3.11 Favored Glycine 0 C--N 1.364 2.132 0 O-C-N 125.491 1.744 . . . . 33.329999999999998 115.186 170.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 -75.44 -61.12 2.02 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 116.942 0.371 . . . . 51.240000000000002 110.25 -176.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 31.0 m -122.86 83.24 2.09 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.281 0.562 . . . . 73.439999999999998 109.675 -177.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -98.37 -28.01 13.84 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 107.925 -1.139 . . . . 65.25 107.925 168.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -80.3 172.71 13.41 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.613 1.565 . . . . 40.420000000000002 109.208 172.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -52.93 -36.47 59.73 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 123.551 0.741 . . . . 72.310000000000002 112.257 178.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -126.1 -88.79 0.71 Allowed Glycine 0 N--CA 1.454 -0.115 0 N-CA-C 109.044 -1.623 . . . . 43.030000000000001 109.044 170.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 42.3 t -170.43 114.46 0.46 Allowed 'General case' 0 C--O 1.242 0.665 0 N-CA-C 108.601 -0.889 . . . . 62.439999999999998 108.601 174.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -94.98 -58.16 1.18 Allowed Glycine 0 C--N 1.339 0.719 0 N-CA-C 111.313 -0.715 . . . . 73.129999999999995 111.313 174.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 60.69 42.87 99.51 Favored Glycine 0 C--N 1.35 1.316 0 N-CA-C 111.393 -0.683 . . . . 63.229999999999997 111.393 -171.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 59.0 m -62.48 110.98 1.85 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.697 0.799 . . . . 34.43 111.703 -172.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -86.27 128.53 8.9 Favored Glycine 0 C--N 1.34 0.797 0 CA-C-N 115.347 -0.842 . . . . 75.420000000000002 111.576 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -89.33 61.16 3.64 Favored Glycine 0 C--N 1.341 0.826 0 N-CA-C 111.669 -0.572 . . . . 74.319999999999993 111.669 178.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 30.3 p -68.32 132.93 47.96 Favored 'General case' 0 C--O 1.244 0.808 0 C-N-CA 123.223 0.609 . . . . 65.420000000000002 110.568 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -154.54 -164.65 13.09 Favored Glycine 0 C--O 1.242 0.618 0 CA-C-N 115.467 -0.788 . . . . 74.109999999999999 111.279 178.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -57.8 -42.31 94.46 Favored Glycine 0 C--N 1.348 1.219 0 N-CA-C 111.363 -0.695 . . . . 70.200000000000003 111.363 175.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 10.5 t -173.41 70.04 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.639 1.175 . . . . 75.0 107.865 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.403 ' HG2' ' HA3' ' A' ' 245' ' ' GLY . 73.4 mt-30 -116.71 -52.25 2.55 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 121.934 0.873 . . . . 62.219999999999999 109.625 -177.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -74.33 169.59 17.34 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 114.209 -1.359 . . . . 62.420000000000002 110.645 172.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 57.7 tp -150.63 141.12 22.48 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.995 0.518 . . . . 72.25 109.803 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -116.6 138.68 51.24 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 123.996 0.918 . . . . 74.439999999999998 109.231 172.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -149.32 159.23 44.45 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 108.703 -0.851 . . . . 33.450000000000003 108.703 169.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 31.1 p -85.88 153.07 22.48 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.931 0.872 . . . . 74.329999999999998 112.322 166.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.638 HD13 ' HB2' ' A' ' 212' ' ' ALA . 31.6 tp -124.58 132.76 53.43 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 113.086 -1.87 . . . . 75.129999999999995 107.245 166.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -95.1 113.26 24.93 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.953 0.882 . . . . 73.510000000000005 109.467 -176.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.582 HG22 HG21 ' A' ' 210' ' ' VAL . 60.9 t -118.62 132.09 24.0 Favored Pre-proline 0 CA--C 1.55 0.966 0 CA-C-N 114.711 -1.131 . . . . 55.299999999999997 109.967 -177.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -66.66 144.64 72.91 Favored 'Trans proline' 0 C--N 1.37 1.691 0 C-N-CA 122.281 1.987 . . . . 73.519999999999996 111.298 166.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.434 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.08 -43.75 95.45 Favored Pre-proline 0 CA--C 1.561 1.379 0 C-N-CA 124.245 1.018 . . . . 63.420000000000002 112.586 173.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.434 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 18.8 Cg_endo -57.89 -33.01 96.5 Favored 'Trans proline' 0 C--N 1.397 3.127 0 C-N-CA 121.681 1.588 . . . . 61.32 112.702 173.369 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -86.42 -23.69 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 N-CA-C 109.303 -0.628 . . . . 74.329999999999998 109.303 -177.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -76.0 -36.87 59.0 Favored 'General case' 0 C--O 1.248 0.982 0 C-N-CA 123.094 0.558 . . . . 24.140000000000001 111.691 178.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 31.9 t -88.89 -36.51 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 125.161 1.384 . . . . 71.420000000000002 112.555 -179.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.409 ' HB ' ' O ' ' A' ' 202' ' ' PRO . 60.3 t -98.21 -42.14 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 O-C-N 121.659 -0.651 . . . . 63.219999999999999 109.981 -176.388 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 122.85 153.86 8.91 Favored Glycine 0 C--N 1.342 0.901 0 N-CA-C 110.666 -0.974 . . . . 51.520000000000003 110.666 -175.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.81 149.32 5.77 Favored Glycine 0 C--O 1.241 0.567 0 N-CA-C 112.058 -0.417 . . . . 70.450000000000003 112.058 175.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.618 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 36.8 ttmt -85.24 128.46 34.69 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.491 -0.559 . . . . 74.5 109.491 176.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.582 HG21 HG22 ' A' ' 199' ' ' VAL . 15.4 m -129.81 149.51 33.7 Favored 'Isoleucine or valine' 0 C--O 1.245 0.847 0 N-CA-C 108.036 -1.098 . . . . 75.109999999999999 108.036 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 7.0 tmm_? -96.78 143.87 27.3 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.169 0.587 . . . . 73.219999999999999 109.716 -170.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.638 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -132.28 124.58 29.15 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.551 0.74 . . . . 52.020000000000003 109.163 -177.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 36.1 tpp -79.84 109.49 14.31 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.155 -1.054 . . . . 63.130000000000003 108.155 174.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 53.2 p -111.24 -177.59 3.24 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 123.324 0.65 . . . . 74.329999999999998 109.924 -176.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.571 HD21 ' HD3' ' A' ' 241' ' ' PRO . 62.1 tp -46.56 -52.82 12.65 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.292 1.037 . . . . 70.420000000000002 111.433 174.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -73.46 -27.69 61.54 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 113.674 -1.603 . . . . 72.310000000000002 111.554 -173.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 138.5 -166.99 25.16 Favored Glycine 0 C--N 1.35 1.308 0 CA-C-O 119.693 -0.504 . . . . 54.32 112.437 -176.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -65.47 130.1 24.27 Favored 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 122.454 2.103 . . . . 70.099999999999994 111.56 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 22.8 m -129.16 158.24 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 123.222 0.609 . . . . 74.239999999999995 110.055 -179.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.521 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 46.6 mt-10 -112.8 111.95 23.09 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.708 -0.849 . . . . 71.409999999999997 108.708 -174.207 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 99.3 t -124.84 104.13 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.207 1.003 . . . . 60.009999999999998 110.542 -169.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.618 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -77.31 117.61 18.98 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 122.658 0.383 . . . . 71.25 110.373 175.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.453 HG11 HG21 ' A' ' 199' ' ' VAL . 27.7 m -85.81 154.4 58.43 Favored Pre-proline 0 N--CA 1.479 1.012 0 C-N-CA 123.433 0.693 . . . . 75.319999999999993 111.329 -175.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 224' ' ' PRO . . . . . 0.624 ' HG3' ' HB2' ' A' ' 173' ' ' TYR . 36.7 Cg_exo -59.17 161.98 15.08 Favored 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 122.669 2.246 . . . . 70.5 113.231 178.179 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -89.28 25.99 0.57 Allowed 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 123.231 2.62 . . . . 74.200000000000003 112.632 173.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 14.4 mmt180 -146.04 0.76 0.84 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.74 0.816 . . . . 72.310000000000002 111.384 176.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.531 HG23 HG11 ' A' ' 253' ' ' VAL . 0.7 OUTLIER -62.05 153.38 29.9 Favored 'General case' 0 CA--C 1.568 1.647 0 O-C-N 123.382 0.426 . . . . 53.32 110.207 -167.56 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -133.8 162.03 33.1 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.634 0.774 . . . . 71.519999999999996 110.237 -176.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -60.23 110.63 1.28 Allowed 'General case' 0 C--N 1.351 0.672 0 O-C-N 123.446 0.466 . . . . 33.030000000000001 109.909 177.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 116.1 1.14 20.76 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-N 115.158 -0.928 . . . . 65.540000000000006 111.984 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.83 125.39 26.61 Favored 'General case' 0 C--N 1.359 1.004 0 N-CA-C 108.683 -0.858 . . . . 75.319999999999993 108.683 -177.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -97.39 97.56 9.22 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.35 -0.981 . . . . 74.010000000000005 108.35 -171.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.532 HD22 ' HB3' ' A' ' 172' ' ' SER . 25.0 mt -78.33 97.63 5.66 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 106.429 -1.693 . . . . 52.140000000000001 106.429 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 7.8 ppt_? -81.81 125.07 30.23 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 122.909 0.483 . . . . 74.430000000000007 110.862 -177.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.41 ' HA ' ' HG3' ' A' ' 171' ' ' MET . 8.9 mp -108.78 130.05 55.38 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 106.697 -1.594 . . . . 75.439999999999998 106.697 175.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.51 113.62 25.21 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 122.734 0.413 . . . . 53.310000000000002 109.905 -170.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 76.71 24.69 66.71 Favored Glycine 0 C--N 1.343 0.954 0 O-C-N 123.596 0.56 . . . . 53.140000000000001 113.644 177.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -117.86 23.79 11.45 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.24 0.616 . . . . 74.400000000000006 110.547 -176.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -96.43 -131.21 6.74 Favored Glycine 0 C--N 1.346 1.089 0 CA-C-O 119.62 -0.545 . . . . 74.0 111.882 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 6.7 m-30 -72.15 154.68 92.19 Favored Pre-proline 0 CA--C 1.55 0.953 0 N-CA-C 112.746 0.647 . . . . 71.430000000000007 112.746 -176.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.571 ' HD3' HD21 ' A' ' 215' ' ' LEU . 73.7 Cg_endo -69.7 172.43 12.59 Favored 'Trans proline' 0 C--N 1.389 2.706 0 C-N-CA 123.428 2.752 . . . . 72.5 112.265 -179.032 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.411 ' N ' ' HD2' ' A' ' 243' ' ' PRO . . . -68.07 -39.33 88.81 Favored Glycine 0 CA--C 1.544 1.877 0 CA-C-O 118.257 -1.302 . . . . 50.149999999999999 114.395 -175.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 243' ' ' PRO . . . . . 0.411 ' HD2' ' N ' ' A' ' 242' ' ' GLY . 9.7 Cg_endo -55.14 -36.39 92.96 Favored 'Trans proline' 0 C--N 1.385 2.448 0 CA-C-N 120.725 2.263 . . . . 72.319999999999993 113.677 167.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -79.01 -24.04 43.97 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.053 0.541 . . . . 61.130000000000003 110.39 174.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' GLY . . . . . 0.403 ' HA3' ' HG2' ' A' ' 191' ' ' GLN . . . 107.69 112.38 3.62 Favored Glycine 0 C--N 1.344 1.023 0 N-CA-C 108.752 -1.739 . . . . 72.230000000000004 108.752 -169.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -69.7 122.18 18.64 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.614 -0.884 . . . . 75.239999999999995 108.614 -173.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -137.5 -159.51 8.24 Favored Glycine 0 C--N 1.342 0.878 0 O-C-N 123.551 0.532 . . . . 32.109999999999999 112.907 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -121.44 163.95 17.93 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.099 1.36 . . . . 72.140000000000001 110.549 -173.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 9.8 tp -134.89 134.21 40.45 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 109.628 -0.508 . . . . 71.049999999999997 109.628 -169.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -115.09 146.74 41.01 Favored 'General case' 0 C--O 1.244 0.766 0 N-CA-C 108.931 -0.766 . . . . 75.329999999999998 108.931 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 82.5 mt -123.86 113.81 19.02 Favored 'General case' 0 C--O 1.224 -0.241 0 N-CA-C 107.557 -1.275 . . . . 74.319999999999993 107.557 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -91.03 111.86 23.51 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.251 -1.018 . . . . 64.450000000000003 108.251 -173.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.531 HG11 HG23 ' A' ' 227' ' ' THR . 53.8 t -60.04 126.75 18.34 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.423 0 O-C-N 124.238 0.961 . . . . 62.130000000000003 109.811 179.064 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 16.2 mtt180 -116.24 125.24 51.94 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.012 -1.477 . . . . 75.340000000000003 107.012 172.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 49.6 mm -86.33 123.06 39.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 108.718 -0.845 . . . . 71.420000000000002 108.718 -178.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.3 t . . . . . 0 CA--C 1.555 1.144 0 N-CA-C 109.271 -0.64 . . . . 65.409999999999997 109.271 -173.558 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 25.3 ptp . . . . . 0 N--CA 1.477 0.889 0 N-CA-C 110.229 -0.286 . . . . 73.120000000000005 110.229 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.43 149.23 22.33 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.278 0.631 . . . . 64.120000000000005 109.739 175.162 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -122.16 -37.82 2.78 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.18 0.992 . . . . 75.219999999999999 110.523 -173.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -97.68 33.55 5.8 Favored Glycine 0 C--N 1.344 0.988 0 CA-C-N 115.997 -0.547 . . . . 70.150000000000006 111.787 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -150.85 168.49 24.3 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 123.739 0.816 . . . . 73.450000000000003 110.37 -176.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.431 HG11 HG22 ' A' ' 221' ' ' VAL . 53.0 t -111.98 152.87 13.75 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 C-N-CA 124.734 1.213 . . . . 63.310000000000002 110.858 -170.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 42.1 mtm -99.32 -176.91 3.43 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.825 1.65 . . . . 71.310000000000002 109.032 -171.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 14.5 p -95.57 86.5 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 CA-C-O 123.457 1.599 . . . . 61.530000000000001 107.585 163.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' MET . . . . . 0.529 ' HG3' ' HA ' ' A' ' 235' ' ' LEU . 0.0 OUTLIER -122.62 -4.2 8.74 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 113.348 -1.751 . . . . 71.329999999999998 109.728 -175.912 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.488 ' HA ' ' HB3' ' A' ' 233' ' ' LEU . 66.3 m -41.95 -66.52 0.34 Allowed 'General case' 0 C--N 1.353 0.729 0 C-N-CA 126.202 1.801 . . . . 43.200000000000003 112.933 -169.065 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -70.46 -43.01 70.72 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 108.925 -0.769 . . . . 64.040000000000006 108.925 -176.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 47.42 46.21 22.61 Favored Glycine 0 C--N 1.365 2.147 0 O-C-N 124.638 1.211 . . . . 23.41 114.041 172.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -163.26 139.86 7.2 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.267 1.027 . . . . 70.120000000000005 108.864 -170.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 50.2 m -71.5 122.89 21.24 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 107.359 -1.348 . . . . 44.299999999999997 107.359 167.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -17.85 -46.97 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 128.141 2.576 . . . . 73.140000000000001 117.51 -166.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -63.98 142.05 58.55 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 118.471 0.578 . . . . 72.310000000000002 109.972 175.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -57.03 -38.26 72.91 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 114.309 1.226 . . . . 73.530000000000001 114.309 -159.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -56.15 100.73 0.11 Allowed Glycine 0 N--CA 1.475 1.242 0 O-C-N 123.846 0.716 . . . . 60.100000000000001 112.881 -177.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 51.1 m -89.86 176.33 6.87 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.002 0.921 . . . . 73.239999999999995 112.019 -173.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -81.48 -144.9 4.54 Favored Glycine 0 C--N 1.349 1.263 0 CA-C-N 115.075 -0.966 . . . . 74.340000000000003 112.323 176.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -114.31 -152.84 10.65 Favored Glycine 0 C--N 1.343 0.95 0 CA-C-N 117.085 0.443 . . . . 71.329999999999998 113.23 -176.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 47.0 t -142.61 163.78 31.91 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.423 1.089 . . . . 62.210000000000001 109.267 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -97.11 -56.97 1.1 Allowed Glycine 0 C--N 1.348 1.207 0 CA-C-N 116.592 -0.276 . . . . 53.140000000000001 113.234 -176.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.4 ' HA3' ' HA2' ' A' ' 247' ' ' GLY . . . -131.29 105.96 0.65 Allowed Glycine 0 C--N 1.341 0.851 0 N-CA-C 111.308 -0.717 . . . . 61.109999999999999 111.308 -179.312 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.513 ' HA ' ' HB3' ' A' ' 192' ' ' ASP . 17.1 t -149.44 153.69 37.69 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 122.626 0.37 . . . . 71.140000000000001 110.712 -176.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 88.02 -33.5 4.01 Favored Glycine 0 C--N 1.353 1.491 0 CA-C-N 116.062 -0.517 . . . . 33.109999999999999 113.931 177.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -81.34 12.31 39.62 Favored Glycine 0 C--N 1.35 1.338 0 CA-C-O 119.235 -0.758 . . . . 63.399999999999999 114.268 -176.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 13.0 t 67.67 21.35 9.35 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.932 1.293 . . . . 73.209999999999994 110.989 -176.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -102.58 -23.04 13.91 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.349 1.46 . . . . 72.209999999999994 108.579 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.513 ' HB3' ' HA ' ' A' ' 187' ' ' SER . 30.2 p-10 -75.26 175.74 8.04 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-N 113.869 -1.514 . . . . 71.310000000000002 110.443 170.024 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 32.2 tp -152.31 138.64 18.46 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.597 -0.729 . . . . 51.130000000000003 109.246 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -116.01 139.29 50.41 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.581 0.753 . . . . 74.409999999999997 109.51 173.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -147.91 157.3 43.45 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.426 -0.953 . . . . 53.210000000000001 108.426 169.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 26.6 p -81.44 153.45 26.89 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 121.887 0.851 . . . . 71.409999999999997 111.272 164.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.636 HD13 ' HB2' ' A' ' 212' ' ' ALA . 37.3 tp -125.31 131.54 53.03 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 113.345 -1.752 . . . . 74.439999999999998 106.755 167.013 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.428 ' HB2' HG21 ' A' ' 256' ' ' THR . 5.7 p-10 -93.43 114.65 27.1 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 107.554 -1.276 . . . . 65.420000000000002 107.554 -178.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.561 HG22 HG21 ' A' ' 210' ' ' VAL . 55.0 t -121.05 131.04 24.59 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 114.85 -1.068 . . . . 52.219999999999999 109.198 -177.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -66.97 148.25 81.57 Favored 'Trans proline' 0 C--N 1.369 1.63 0 C-N-CA 122.321 2.014 . . . . 63.329999999999998 110.951 169.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.44 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.62 -45.88 98.48 Favored Pre-proline 0 CA--C 1.562 1.423 0 CA-C-O 118.38 -0.819 . . . . 63.43 112.205 172.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.44 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 20.6 Cg_endo -59.6 -31.14 93.93 Favored 'Trans proline' 0 C--N 1.396 3.053 0 C-N-CA 122.096 1.864 . . . . 74.0 112.814 176.184 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -87.71 -24.55 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 109.52 -0.548 . . . . 74.209999999999994 109.52 -177.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -76.14 -37.3 58.15 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-O 121.064 0.459 . . . . 65.519999999999996 110.806 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 23.6 t -88.52 -38.52 11.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 CA-C-N 114.156 -1.384 . . . . 73.109999999999999 112.124 -177.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.413 ' HB ' ' O ' ' A' ' 202' ' ' PRO . 72.3 t -98.76 -40.44 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 O-C-N 121.959 -0.463 . . . . 75.25 110.89 -178.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 121.33 150.41 8.32 Favored Glycine 0 N--CA 1.472 1.072 0 N-CA-C 111.311 -0.715 . . . . 71.319999999999993 111.311 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 165.65 155.6 8.77 Favored Glycine 0 C--O 1.244 0.773 0 CA-C-N 116.869 0.334 . . . . 62.539999999999999 112.473 177.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.584 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 34.6 ttmt -86.33 129.76 34.74 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.106 0.562 . . . . 75.010000000000005 109.878 179.063 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.561 HG21 HG22 ' A' ' 199' ' ' VAL . 10.8 m -131.96 151.94 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 124.467 1.107 . . . . 74.329999999999998 108.863 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -93.96 144.14 25.72 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.409 -0.589 . . . . 75.299999999999997 109.409 -171.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.636 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -133.05 125.27 29.26 Favored 'General case' 0 C--N 1.349 0.56 0 N-CA-C 108.907 -0.775 . . . . 75.040000000000006 108.907 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 36.5 tpp -78.68 112.74 16.09 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 108.706 -0.85 . . . . 70.420000000000002 108.706 171.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 64.1 p -119.59 -175.01 2.86 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 123.71 0.804 . . . . 52.329999999999998 110.222 -176.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.54 HD21 ' HD3' ' A' ' 241' ' ' PRO . 67.2 tp -47.08 -52.93 13.93 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.239 1.016 . . . . 75.230000000000004 112.456 175.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -72.51 -27.85 62.51 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.178 -0.919 . . . . 62.439999999999998 110.977 -172.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 138.22 -165.26 25.48 Favored Glycine 0 C--N 1.34 0.794 0 N-CA-C 111.581 -0.608 . . . . 32.140000000000001 111.581 -172.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -66.18 131.15 25.96 Favored 'Trans proline' 0 C--N 1.37 1.707 0 C-N-CA 122.347 2.031 . . . . 63.200000000000003 110.779 177.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 29.4 m -130.93 161.12 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.642 0.777 . . . . 71.340000000000003 110.148 -178.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.519 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 43.7 mt-10 -111.65 111.94 23.29 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.742 0.817 . . . . 62.340000000000003 108.906 -175.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.431 HG22 HG11 ' A' ' 168' ' ' VAL . 57.4 t -121.75 103.76 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 124.164 0.986 . . . . 74.099999999999994 110.11 -171.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.584 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -78.32 118.29 20.37 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.437 0.695 . . . . 74.230000000000004 110.666 176.49 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 35.7 m -89.09 151.29 46.65 Favored Pre-proline 0 N--CA 1.481 1.093 0 C-N-CA 122.869 0.468 . . . . 72.209999999999994 110.975 -176.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' PRO . . . . . 0.625 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 28.6 Cg_endo -61.38 164.54 14.95 Favored 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 122.724 2.283 . . . . 63.210000000000001 113.102 176.532 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -91.75 37.65 0.28 Allowed 'Trans proline' 0 C--N 1.373 1.85 0 C-N-CA 123.427 2.751 . . . . 74.519999999999996 112.066 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 -148.37 -9.58 0.37 Allowed 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 116.579 -0.282 . . . . 74.450000000000003 111.356 176.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.625 ' HB ' ' HG2' ' A' ' 224' ' ' PRO . 0.7 OUTLIER -59.62 154.15 18.34 Favored 'General case' 0 CA--C 1.559 1.318 0 O-C-N 124.102 0.876 . . . . 74.439999999999998 110.633 -161.665 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 228' ' ' GLN . . . . . 0.468 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 4.5 pt20 -134.53 162.28 32.7 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.317 0.647 . . . . 73.230000000000004 110.371 -172.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -58.6 112.81 1.74 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 122.985 0.514 . . . . 51.219999999999999 110.841 177.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.52 1.6 21.53 Favored Glycine 0 CA--C 1.522 0.492 0 CA-C-N 115.135 -0.938 . . . . 61.219999999999999 111.877 178.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.468 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -69.82 125.52 26.97 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.121 0.569 . . . . 73.420000000000002 109.698 -175.769 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -97.09 100.6 12.09 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 109.241 -0.652 . . . . 72.420000000000002 109.241 -176.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.488 ' HB3' ' HA ' ' A' ' 172' ' ' SER . 39.7 mt -78.4 102.22 7.66 Favored 'General case' 0 C--N 1.341 0.236 0 N-CA-C 108.208 -1.034 . . . . 62.43 108.208 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 234' ' ' ARG . . . . . 0.684 ' HD2' ' H ' ' A' ' 234' ' ' ARG . 0.0 OUTLIER -79.98 117.73 21.09 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 124.733 1.271 . . . . 75.129999999999995 111.836 -174.773 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.62 ' HB3' ' HB2' ' A' ' 238' ' ' LYS . 8.2 mp -107.68 128.08 54.24 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 106.907 -1.516 . . . . 72.0 106.907 173.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -101.52 116.81 33.61 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.753 0.821 . . . . 62.539999999999999 111.441 -174.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 74.63 27.72 64.66 Favored Glycine 0 C--N 1.351 1.401 0 O-C-N 123.895 0.747 . . . . 53.340000000000003 111.857 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.62 ' HB2' ' HB3' ' A' ' 235' ' ' LEU . 28.7 mmmt -126.29 22.11 7.2 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.365 1.066 . . . . 72.019999999999996 111.134 -175.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -93.93 -128.31 5.04 Favored Glycine 0 C--N 1.341 0.815 0 N-CA-C 110.22 -1.152 . . . . 64.519999999999996 110.22 176.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' PHE . . . . . 0.454 ' O ' ' HA ' ' A' ' 246' ' ' ARG . 6.6 m-30 -70.08 153.81 95.06 Favored Pre-proline 0 CA--C 1.551 0.992 0 CA-C-N 117.65 0.725 . . . . 60.409999999999997 111.714 176.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.54 ' HD3' HD21 ' A' ' 215' ' ' LEU . 60.4 Cg_endo -68.35 171.73 12.38 Favored 'Trans proline' 0 C--N 1.381 2.239 0 C-N-CA 123.38 2.72 . . . . 63.420000000000002 112.078 178.183 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.429 ' N ' ' HD2' ' A' ' 243' ' ' PRO . . . -67.59 -39.55 90.75 Favored Glycine 0 CA--C 1.543 1.834 0 CA-C-O 118.4 -1.222 . . . . 73.430000000000007 114.634 -176.009 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 243' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' A' ' 242' ' ' GLY . 9.1 Cg_endo -51.88 -38.81 68.94 Favored 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 122.698 2.265 . . . . 71.409999999999997 113.225 167.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -78.68 -25.29 44.81 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.449 0.699 . . . . 74.230000000000004 110.66 175.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 106.1 112.77 3.73 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 109.084 -1.606 . . . . 74.049999999999997 109.084 -168.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.454 ' HA ' ' O ' ' A' ' 240' ' ' PHE . 52.7 ttp180 -72.22 127.06 31.37 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 117.266 0.533 . . . . 72.219999999999999 110.977 -175.435 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.4 ' HA2' ' HA3' ' A' ' 186' ' ' GLY . . . -136.56 -157.18 7.65 Favored Glycine 0 C--O 1.239 0.452 0 CA-C-N 115.575 -0.739 . . . . 44.329999999999998 111.718 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -116.29 166.14 12.38 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.872 0.869 . . . . 72.409999999999997 109.028 -174.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 10.6 tp -134.78 134.14 40.6 Favored 'General case' 0 C--O 1.213 -0.827 0 N-CA-C 108.333 -0.988 . . . . 75.109999999999999 108.333 -176.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.445 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 8.1 m-85 -121.97 146.23 47.35 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 108.943 -0.762 . . . . 72.319999999999993 108.943 -177.064 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.419 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 77.6 mt -124.64 115.52 20.93 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.917 -0.772 . . . . 74.230000000000004 108.917 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -88.94 106.71 18.59 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 107.873 -1.158 . . . . 72.400000000000006 107.873 -173.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.599 HG11 HG23 ' A' ' 227' ' ' THR . 52.7 t -59.93 125.26 15.74 Favored 'Isoleucine or valine' 0 C--N 1.34 0.184 0 O-C-N 124.09 0.869 . . . . 75.099999999999994 109.439 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -120.78 124.35 44.87 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.212 -1.403 . . . . 74.219999999999999 107.212 176.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 51.1 mm -85.75 118.45 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 O-C-N 124.124 0.89 . . . . 74.209999999999994 109.414 -173.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 256' ' ' THR . . . . . 0.428 HG21 ' HB2' ' A' ' 198' ' ' ASP . 1.0 OUTLIER . . . . . 0 CA--C 1.554 1.107 0 N-CA-C 108.582 -0.896 . . . . 70.209999999999994 108.582 -171.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' MET . . . . . 0.616 ' HG2' ' HG3' ' A' ' 164' ' ' LYS . 1.3 pmm? . . . . . 0 CA--C 1.545 0.768 0 N-CA-C 109.397 -0.594 . . . . 53.530000000000001 109.397 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.616 ' HG3' ' HG2' ' A' ' 163' ' ' MET . 0.0 OUTLIER -159.74 103.68 1.54 Allowed 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 124.132 0.973 . . . . 63.420000000000002 109.522 176.877 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -85.94 -41.01 15.28 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.911 0.884 . . . . 70.439999999999998 110.677 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -97.24 37.8 3.32 Favored Glycine 0 N--CA 1.471 0.986 0 CA-C-N 115.587 -0.733 . . . . 65.140000000000001 111.98 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.612 ' HB3' ' HB2' ' A' ' 164' ' ' LYS . . . -152.9 166.07 33.47 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.744 0.817 . . . . 75.140000000000001 110.124 177.3 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.465 HG11 HG22 ' A' ' 221' ' ' VAL . 54.9 t -111.23 156.45 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 124.701 1.201 . . . . 53.43 111.765 -167.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 44.1 mtm -98.75 -176.75 3.44 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.651 1.581 . . . . 65.150000000000006 109.651 -174.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 8.3 p -99.98 89.04 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 CA-C-O 122.964 1.364 . . . . 73.209999999999994 108.592 163.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' MET . . . . . 0.457 ' HG3' ' HA ' ' A' ' 235' ' ' LEU . 0.0 OUTLIER -123.76 -6.09 8.01 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 113.946 -1.479 . . . . 63.43 110.789 -174.478 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.472 ' HB3' HD22 ' A' ' 233' ' ' LEU . 66.1 m -39.64 -66.45 0.3 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.545 1.938 . . . . 75.019999999999996 114.638 -167.138 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -66.72 -48.45 69.15 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 122.603 0.361 . . . . 74.239999999999995 110.068 -175.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 49.4 59.77 6.84 Favored Glycine 0 C--N 1.357 1.704 0 O-C-N 124.377 1.048 . . . . 74.329999999999998 113.181 176.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -54.66 96.82 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.043 0.937 . . . . 62.219999999999999 111.535 -171.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 43.4 m -82.64 87.97 6.71 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 109.305 -0.628 . . . . 31.399999999999999 109.305 178.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -78.13 -30.43 49.32 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 122.067 0.937 . . . . 70.510000000000005 108.854 172.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -80.48 173.56 12.48 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 113.939 -1.482 . . . . 61.119999999999997 111.243 178.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -58.33 -26.93 63.67 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.323 1.049 . . . . 74.209999999999994 112.624 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -65.5 76.0 0.1 OUTLIER Glycine 0 N--CA 1.473 1.13 0 O-C-N 123.896 0.747 . . . . 72.109999999999999 113.265 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 31.8 m -129.27 -2.26 5.03 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.293 1.037 . . . . 53.240000000000002 111.371 -174.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -74.02 113.3 4.1 Favored Glycine 0 CA--C 1.533 1.18 0 CA-C-O 119.484 -0.62 . . . . 35.100000000000001 112.053 -178.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -69.43 78.4 0.33 Allowed Glycine 0 C--N 1.355 1.613 0 C-N-CA 123.454 0.55 . . . . 62.450000000000003 112.115 178.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 22.7 p -142.29 100.59 3.74 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.998 0.919 . . . . 72.120000000000005 108.949 -174.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -76.28 105.67 2.03 Favored Glycine 0 C--N 1.345 1.029 0 CA-C-N 116.582 -0.281 . . . . 64.040000000000006 112.642 -176.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 63.12 -118.68 14.59 Favored Glycine 0 C--N 1.343 0.967 0 N-CA-C 111.977 -0.449 . . . . 72.019999999999996 111.977 -176.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 33.7 t -95.3 -18.67 20.61 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.597 0.759 . . . . 73.439999999999998 110.033 173.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.437 ' HA2' ' HB2' ' A' ' 192' ' ' ASP . . . 70.9 19.22 76.8 Favored Glycine 0 C--N 1.351 1.377 0 N-CA-C 114.703 0.641 . . . . 74.439999999999998 114.703 176.057 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -77.99 -71.77 1.2 Allowed Glycine 0 C--N 1.353 1.485 0 CA-C-N 117.336 0.568 . . . . 61.299999999999997 112.037 179.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 29.0 m -142.34 29.41 1.61 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.167 0.987 . . . . 71.230000000000004 108.629 173.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.518 ' HG2' ' HA3' ' A' ' 245' ' ' GLY . 44.2 mt-30 -113.74 -32.93 5.98 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 114.817 -1.083 . . . . 63.310000000000002 110.47 -172.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.437 ' HB2' ' HA2' ' A' ' 188' ' ' GLY . 44.9 t0 -75.4 162.08 28.68 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 114.806 -1.088 . . . . 73.230000000000004 109.182 176.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.444 HD23 HD13 ' A' ' 249' ' ' LEU . 52.7 tp -149.96 136.52 19.14 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.128 -0.693 . . . . 71.530000000000001 109.128 171.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -113.17 139.58 48.64 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.011 -0.737 . . . . 74.540000000000006 109.011 170.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.456 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -148.38 155.05 40.76 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.491 0.716 . . . . 73.099999999999994 109.338 173.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 25.2 p -82.0 153.62 26.11 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 122.085 0.945 . . . . 75.450000000000003 112.774 171.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.656 HD13 ' HB2' ' A' ' 212' ' ' ALA . 39.3 tp -126.97 132.26 50.86 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 113.108 -1.86 . . . . 72.209999999999994 106.642 169.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -95.13 111.59 23.39 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.068 -1.086 . . . . 73.239999999999995 108.068 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.516 HG22 HG21 ' A' ' 210' ' ' VAL . 46.8 t -114.84 131.91 23.22 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-N 114.663 -1.153 . . . . 71.349999999999994 109.299 -178.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -68.59 145.3 63.61 Favored 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 122.229 1.953 . . . . 62.420000000000002 110.934 168.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.432 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.86 -45.56 98.82 Favored Pre-proline 0 CA--C 1.564 1.493 0 O-C-N 123.961 0.788 . . . . 53.450000000000003 111.845 174.23 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 19.6 Cg_endo -58.97 -32.9 98.38 Favored 'Trans proline' 0 C--N 1.403 3.442 0 C-N-CA 122.155 1.903 . . . . 71.519999999999996 112.777 175.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.7 mp -86.0 -24.85 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 109.509 -0.552 . . . . 75.420000000000002 109.509 -176.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -73.22 -37.71 66.32 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 122.942 0.497 . . . . 64.439999999999998 110.943 178.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 21.0 t -87.78 -37.28 10.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-N 114.426 -1.261 . . . . 70.109999999999999 112.981 -178.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 53.4 t -96.62 -42.2 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 O-C-N 122.203 -0.311 . . . . 62.439999999999998 110.484 -175.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 121.2 145.46 7.22 Favored Glycine 0 C--N 1.339 0.743 0 N-CA-C 110.76 -0.936 . . . . 73.109999999999999 110.76 -176.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 166.13 155.72 8.98 Favored Glycine 0 C--O 1.246 0.906 0 CA-C-O 121.29 0.383 . . . . 63.030000000000001 112.538 178.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.58 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 36.8 ttmt -86.32 131.73 34.14 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.564 0.745 . . . . 72.040000000000006 109.685 178.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.516 HG21 HG22 ' A' ' 199' ' ' VAL . 14.2 m -129.2 149.23 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 124.165 0.986 . . . . 71.219999999999999 109.197 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 4.4 tmm_? -95.98 141.55 29.26 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 108.918 -0.771 . . . . 72.310000000000002 108.918 -170.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.656 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -132.64 116.17 16.32 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.501 1.12 . . . . 61.350000000000001 109.223 -175.15 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 38.1 tpp -78.85 108.7 12.49 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 107.612 -1.255 . . . . 63.340000000000003 107.612 172.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 71.3 p -114.48 -175.17 2.62 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.811 0.844 . . . . 75.420000000000002 110.611 -175.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.614 HD21 ' HD3' ' A' ' 241' ' ' PRO . 61.8 tp -45.01 -52.4 8.9 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.757 1.223 . . . . 65.519999999999996 112.091 173.288 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -72.11 -28.08 63.06 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 114.189 -1.369 . . . . 63.25 111.031 -171.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 135.02 -166.23 24.43 Favored Glycine 0 C--O 1.243 0.717 0 CA-C-N 115.509 -0.769 . . . . 25.219999999999999 111.304 -173.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.0 131.43 23.83 Favored 'Trans proline' 0 C--N 1.363 1.3 0 C-N-CA 122.352 2.035 . . . . 72.25 111.672 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 28.9 m -134.26 157.76 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.749 0.82 . . . . 61.140000000000001 109.981 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.504 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 38.7 mt-10 -114.28 115.56 27.61 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.641 0.776 . . . . 73.510000000000005 110.568 -176.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.465 HG22 HG11 ' A' ' 168' ' ' VAL . 98.3 t -121.74 105.29 16.22 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 125.366 1.466 . . . . 75.209999999999994 110.245 -168.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.58 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -76.3 118.47 19.05 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 122.425 0.29 . . . . 72.420000000000002 110.621 176.361 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 35.0 m -87.25 151.72 51.67 Favored Pre-proline 0 N--CA 1.489 1.496 0 C-N-CA 123.178 0.591 . . . . 64.219999999999999 110.673 -178.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' PRO . . . . . 0.658 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 26.1 Cg_endo -61.06 163.59 16.31 Favored 'Trans proline' 0 C--N 1.38 2.215 0 C-N-CA 122.706 2.271 . . . . 64.400000000000006 113.193 177.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -87.27 34.02 0.43 Allowed 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 122.951 2.434 . . . . 63.32 112.572 178.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -149.73 -3.35 0.4 Allowed 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 112.321 0.489 . . . . 73.049999999999997 112.321 177.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.658 ' HB ' ' HG2' ' A' ' 224' ' ' PRO . 0.7 OUTLIER -61.97 154.34 26.75 Favored 'General case' 0 CA--C 1.563 1.461 0 O-C-N 123.304 0.377 . . . . 73.420000000000002 111.788 -165.099 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -136.82 161.04 37.08 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.472 0.709 . . . . 73.540000000000006 110.193 -178.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -58.56 113.12 1.85 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.45 0.7 . . . . 75.150000000000006 111.175 -177.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 116.69 0.31 19.96 Favored Glycine 0 CA--C 1.524 0.616 0 CA-C-N 115.064 -0.971 . . . . 71.099999999999994 112.395 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.434 ' HE ' HD23 ' A' ' 233' ' ' LEU . 0.0 OUTLIER -68.97 130.76 43.69 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 109.076 -0.713 . . . . 71.310000000000002 109.076 -176.396 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -97.76 96.18 8.06 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 109.018 -0.734 . . . . 74.109999999999999 109.018 -168.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.472 HD22 ' HB3' ' A' ' 172' ' ' SER . 24.4 mt -82.6 97.62 8.58 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 106.694 -1.595 . . . . 72.200000000000003 106.694 -178.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 3.5 ppt_? -83.23 125.29 31.42 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 123.97 0.794 . . . . 71.299999999999997 110.988 -179.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.457 ' HA ' ' HG3' ' A' ' 171' ' ' MET . 7.3 mp -110.02 126.65 54.2 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 106.286 -1.746 . . . . 74.239999999999995 106.286 177.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 11.3 tptp -98.6 115.28 28.29 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 110.048 -0.353 . . . . 75.400000000000006 110.048 -170.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.621 ' HA2' HH11 ' A' ' 246' ' ' ARG . . . 79.66 23.35 62.48 Favored Glycine 0 C--N 1.343 0.951 0 O-C-N 123.836 0.71 . . . . 33.140000000000001 113.65 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? -122.72 23.93 9.31 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.296 0.638 . . . . 53.140000000000001 111.292 -177.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' GLY . . . . . 0.444 ' HA2' ' HB2' ' A' ' 249' ' ' LEU . . . -93.79 -130.96 5.86 Favored Glycine 0 C--N 1.349 1.261 0 CA-C-O 119.296 -0.725 . . . . 63.149999999999999 111.919 -178.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -69.29 149.21 97.44 Favored Pre-proline 0 CA--C 1.553 1.093 0 CA-C-N 117.366 0.583 . . . . 74.150000000000006 111.53 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.614 ' HD3' HD21 ' A' ' 215' ' ' LEU . 44.1 Cg_endo -63.62 171.78 6.51 Favored 'Trans proline' 0 C--N 1.391 2.764 0 C-N-CA 123.574 2.849 . . . . 63.509999999999998 112.565 -178.237 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -66.02 -42.95 94.38 Favored Glycine 0 CA--C 1.544 1.849 0 CA-C-O 118.223 -1.321 . . . . 73.430000000000007 114.098 -173.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -58.92 -34.75 99.24 Favored 'Trans proline' 0 C--N 1.388 2.644 0 CA-C-N 120.812 2.306 . . . . 73.209999999999994 113.785 170.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -77.14 -24.54 51.61 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.18 0.592 . . . . 64.530000000000001 110.37 173.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' GLY . . . . . 0.518 ' HA3' ' HG2' ' A' ' 191' ' ' GLN . . . 110.51 117.74 3.84 Favored Glycine 0 C--N 1.344 0.973 0 N-CA-C 110.532 -1.027 . . . . 70.109999999999999 110.532 -172.151 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.621 HH11 ' HA2' ' A' ' 237' ' ' GLY . 2.3 tmm_? -68.6 124.74 24.43 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.18 -0.674 . . . . 60.030000000000001 109.18 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -143.12 -156.2 6.7 Favored Glycine 0 N--CA 1.47 0.943 0 O-C-N 123.517 0.511 . . . . 63.310000000000002 112.109 176.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -115.53 167.05 11.23 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 109.112 -0.699 . . . . 62.32 109.112 -176.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.444 HD13 HD23 ' A' ' 193' ' ' LEU . 17.9 tp -134.48 133.07 39.99 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 108.499 -0.926 . . . . 73.310000000000002 108.499 -175.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -114.06 147.6 38.45 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 123.598 0.759 . . . . 73.219999999999999 110.245 178.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.456 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 88.9 mt -125.65 113.85 17.91 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 114.017 -1.447 . . . . 64.239999999999995 107.511 174.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -89.73 112.64 23.98 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 107.671 -1.233 . . . . 75.420000000000002 107.671 -176.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.515 HG11 HG23 ' A' ' 227' ' ' THR . 54.6 t -59.65 127.31 18.79 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.117 0 O-C-N 124.46 1.1 . . . . 70.310000000000002 109.75 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 8.3 mmt180 -123.96 123.45 40.41 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.251 -1.018 . . . . 55.049999999999997 108.251 175.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 46.2 mm -87.15 118.73 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 123.258 0.623 . . . . 52.219999999999999 110.033 -174.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.4 t . . . . . 0 CA--C 1.56 1.357 0 C-N-CA 123.546 0.738 . . . . 44.039999999999999 109.251 -171.555 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.485 1.282 0 N-CA-C 110.323 -0.251 . . . . 65.120000000000005 110.323 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -67.1 96.5 0.45 Allowed 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 109.135 -0.691 . . . . 72.439999999999998 109.135 179.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -77.72 -69.46 0.54 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.572 0.749 . . . . 75.420000000000002 111.414 -168.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -98.66 30.47 9.62 Favored Glycine 0 N--CA 1.473 1.149 0 N-CA-C 111.281 -0.727 . . . . 73.109999999999999 111.281 173.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -142.92 167.4 22.17 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.942 1.297 . . . . 63.509999999999998 108.714 -178.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 47.5 t -113.2 155.61 14.36 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 123.748 0.819 . . . . 65.120000000000005 111.596 -173.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 47.9 mtm -99.11 -175.62 3.08 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 126.183 1.793 . . . . 75.420000000000002 109.703 -171.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 14.3 p -95.63 87.81 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.351 0 N-CA-C 107.107 -1.442 . . . . 74.340000000000003 107.107 161.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' MET . . . . . 0.411 ' SD ' ' HG ' ' A' ' 235' ' ' LEU . 0.0 OUTLIER -129.96 -4.79 4.52 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 114.211 -1.359 . . . . 71.25 110.9 -174.203 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.468 ' HA ' ' HB3' ' A' ' 233' ' ' LEU . 70.9 m -40.17 -65.13 0.43 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.666 1.986 . . . . 64.420000000000002 113.049 -171.305 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -73.45 -50.22 22.8 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 107.518 -1.29 . . . . 72.329999999999998 107.518 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 54.87 20.29 18.43 Favored Glycine 0 C--N 1.365 2.189 0 O-C-N 124.636 1.21 . . . . 73.230000000000004 115.494 172.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -132.33 156.24 46.96 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.81 0.844 . . . . 72.209999999999994 109.615 -167.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 51.0 m -68.65 127.15 32.02 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 108.401 -0.962 . . . . 62.329999999999998 108.401 169.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -24.11 -34.42 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 C-N-CA 128.227 2.611 . . . . 74.340000000000003 117.678 -171.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -62.38 173.1 1.28 Allowed 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.785 0.834 . . . . 74.109999999999999 111.765 171.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -55.76 -35.74 66.55 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 120.809 0.338 . . . . 72.340000000000003 111.478 177.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 56.79 -129.45 49.06 Favored Glycine 0 C--N 1.338 0.666 0 CA-C-N 114.805 -1.089 . . . . 72.150000000000006 113.825 171.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 21.5 t -170.9 -158.13 0.14 Allowed 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 124.764 1.226 . . . . 34.420000000000002 107.95 177.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 96.88 112.3 2.9 Favored Glycine 0 C--N 1.347 1.184 0 N-CA-C 111.156 -0.778 . . . . 61.130000000000003 111.156 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.604 ' HA2' ' HG2' ' A' ' 234' ' ' ARG . . . -167.71 -96.84 0.11 Allowed Glycine 0 C--N 1.346 1.088 0 CA-C-O 119.966 -0.352 . . . . 33.229999999999997 112.457 -177.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 15.7 m -66.27 122.58 17.81 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.942 0.897 . . . . 73.209999999999994 111.461 -173.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -156.99 155.17 26.15 Favored Glycine 0 C--N 1.336 0.549 0 N-CA-C 110.755 -0.938 . . . . 74.310000000000002 110.755 175.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.419 ' O ' ' HB2' ' A' ' 191' ' ' GLN . . . 49.16 33.77 15.62 Favored Glycine 0 C--N 1.352 1.438 0 O-C-N 123.827 0.369 . . . . 41.32 112.893 -178.279 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 54.1 p -86.01 130.83 34.42 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 122.987 0.515 . . . . 74.329999999999998 110.189 -173.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -174.58 -140.65 3.36 Favored Glycine 0 C--N 1.345 1.071 0 CA-C-O 119.712 -0.493 . . . . 53.229999999999997 112.442 -178.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -65.64 -49.89 57.36 Favored Glycine 0 C--N 1.35 1.327 0 O-C-N 123.753 0.325 . . . . 52.509999999999998 113.379 -174.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 78.5 p -162.74 58.84 0.21 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.635 0.774 . . . . 72.150000000000006 109.813 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.423 ' HA ' ' O ' ' A' ' 245' ' ' GLY . 21.9 mt-30 -114.53 -57.3 2.29 Favored 'General case' 0 C--O 1.245 0.819 0 N-CA-C 108.252 -1.018 . . . . 75.310000000000002 108.252 175.108 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 29.2 p-10 -74.17 167.64 21.17 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 114.722 -1.126 . . . . 44.350000000000001 110.548 174.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 52.8 tp -150.65 139.64 21.0 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.449 -0.796 . . . . 64.530000000000001 109.821 177.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -110.03 138.77 45.94 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 123.869 0.867 . . . . 74.340000000000003 109.509 171.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -148.05 157.78 43.7 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 108.185 -1.043 . . . . 63.119999999999997 108.185 168.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' THR . . . . . 0.439 HG22 ' HB3' ' A' ' 252' ' ' GLU . 27.8 p -92.87 152.58 19.32 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.957 0.884 . . . . 74.430000000000007 112.242 168.396 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.671 HD13 ' HB2' ' A' ' 212' ' ' ALA . 41.1 tp -123.86 130.79 53.17 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 113.073 -1.876 . . . . 73.219999999999999 106.826 167.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.431 ' HB2' HG21 ' A' ' 256' ' ' THR . 10.0 p-10 -94.63 112.39 24.14 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 121.951 0.881 . . . . 72.340000000000003 109.047 -178.244 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.594 HG22 HG21 ' A' ' 210' ' ' VAL . 61.0 t -119.35 132.81 23.85 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 124.119 0.968 . . . . 61.119999999999997 109.903 -175.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -68.46 144.35 60.96 Favored 'Trans proline' 0 C--N 1.369 1.608 0 C-N-CA 121.999 1.799 . . . . 70.099999999999994 111.337 167.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.431 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.0 -43.62 94.97 Favored Pre-proline 0 CA--C 1.559 1.301 0 CA-C-O 118.104 -0.95 . . . . 72.409999999999997 112.601 173.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 19.3 Cg_endo -56.86 -33.61 95.1 Favored 'Trans proline' 0 C--N 1.399 3.237 0 C-N-CA 121.728 1.618 . . . . 73.219999999999999 112.631 173.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -86.71 -24.25 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 N-CA-C 109.623 -0.51 . . . . 55.340000000000003 109.623 -177.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.417 ' HA ' HG22 ' A' ' 227' ' ' THR . . . -73.5 -37.59 65.63 Favored 'General case' 0 C--O 1.246 0.89 0 C-N-CA 123.335 0.654 . . . . 62.32 110.866 178.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 41.4 t -90.04 -34.67 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.224 0 CA-C-N 113.498 -1.683 . . . . 74.319999999999993 113.414 -177.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 54.6 t -101.39 -42.39 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 O-C-N 121.479 -0.763 . . . . 73.409999999999997 111.096 -178.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 126.12 155.24 8.89 Favored Glycine 0 C--N 1.34 0.773 0 N-CA-C 110.941 -0.863 . . . . 34.399999999999999 110.941 -176.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.64 149.1 5.68 Favored Glycine 0 C--O 1.246 0.894 0 N-CA-C 111.48 -0.648 . . . . 62.409999999999997 111.48 176.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.579 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 34.3 ttpt -84.71 129.83 34.78 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 109.267 -0.642 . . . . 70.439999999999998 109.267 174.27 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.594 HG21 HG22 ' A' ' 199' ' ' VAL . 9.7 m -133.37 147.93 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 124.013 0.925 . . . . 61.43 108.77 -178.565 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' ARG . . . . . 0.419 ' HD2' ' N ' ' A' ' 212' ' ' ALA . 6.4 tmm_? -94.77 141.79 28.21 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.218 0.607 . . . . 73.010000000000005 109.429 -170.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.671 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -131.18 126.22 35.04 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.495 1.118 . . . . 73.519999999999996 108.498 -176.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 37.3 tpp -80.05 108.5 13.69 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 108.083 -1.08 . . . . 75.129999999999995 108.083 173.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 71.4 p -117.23 178.8 4.23 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.692 0.797 . . . . 75.019999999999996 110.741 -176.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 69.0 tp -45.33 -50.71 11.86 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.17 1.388 . . . . 62.219999999999999 112.276 176.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -71.96 -26.69 62.37 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 114.551 -1.204 . . . . 71.340000000000003 111.288 -173.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 138.6 -166.53 25.29 Favored Glycine 0 C--N 1.341 0.861 0 N-CA-C 111.389 -0.684 . . . . 52.020000000000003 111.389 -177.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -65.33 130.27 24.92 Favored 'Trans proline' 0 C--N 1.368 1.555 0 C-N-CA 121.9 1.733 . . . . 73.120000000000005 110.771 174.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 30.2 m -134.74 159.72 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 123.312 0.645 . . . . 72.329999999999998 110.532 -174.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.555 ' HB3' ' HD2' ' A' ' 209' ' ' LYS . 44.6 mt-10 -113.42 114.7 26.95 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.344 0.658 . . . . 53.210000000000001 109.764 -174.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 54.9 t -122.01 103.74 13.87 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 C-N-CA 125.009 1.324 . . . . 72.540000000000006 109.667 -169.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.579 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -77.48 117.88 19.37 Favored 'General case' 0 N--CA 1.478 0.943 0 O-C-N 122.167 -0.333 . . . . 52.119999999999997 110.478 175.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.416 HG11 HG21 ' A' ' 199' ' ' VAL . 27.5 m -85.23 152.8 58.85 Favored Pre-proline 0 N--CA 1.492 1.66 0 C-N-CA 123.202 0.601 . . . . 73.200000000000003 111.157 -176.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 224' ' ' PRO . . . . . 0.543 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 33.6 Cg_endo -65.99 163.03 32.71 Favored 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 121.75 1.633 . . . . 52.009999999999998 112.541 177.051 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -85.34 27.42 0.6 Allowed 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 122.854 2.369 . . . . 33.409999999999997 112.94 178.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 41.5 mmt-85 -144.93 0.11 0.93 Allowed 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.382 0.673 . . . . 70.319999999999993 111.447 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.594 HG23 HG11 ' A' ' 253' ' ' VAL . 0.7 OUTLIER -61.65 155.71 21.84 Favored 'General case' 0 CA--C 1.573 1.859 0 O-C-N 123.88 0.738 . . . . 65.25 109.529 -169.191 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 228' ' ' GLN . . . . . 0.429 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 4.8 pt20 -133.07 162.86 30.59 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.541 0.736 . . . . 73.400000000000006 110.844 -174.349 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -59.38 110.75 1.16 Allowed 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 109.444 -0.576 . . . . 75.340000000000003 109.444 171.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 114.35 0.36 23.6 Favored Glycine 0 CA--C 1.524 0.61 0 CA-C-N 115.379 -0.828 . . . . 43.43 111.686 178.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.429 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -72.04 125.5 27.4 Favored 'General case' 0 C--N 1.359 0.99 0 N-CA-C 109.022 -0.733 . . . . 75.209999999999994 109.022 -174.141 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -98.98 97.7 8.83 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 123.508 0.723 . . . . 72.0 109.457 -169.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.468 ' HB3' ' HA ' ' A' ' 172' ' ' SER . 30.7 mt -80.38 98.0 7.29 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 107.008 -1.479 . . . . 64.430000000000007 107.008 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 234' ' ' ARG . . . . . 0.604 ' HG2' ' HA2' ' A' ' 183' ' ' GLY . 2.0 ppt_? -83.61 117.37 23.12 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 121.493 0.663 . . . . 73.200000000000003 111.417 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.411 ' HG ' ' SD ' ' A' ' 171' ' ' MET . 6.3 mp -99.17 125.8 44.82 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 105.479 -2.045 . . . . 74.109999999999999 105.479 174.316 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.406 ' HA ' ' HB3' ' A' ' 248' ' ' ASP . 18.3 tptt -101.79 117.43 34.84 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 118.657 0.662 . . . . 73.140000000000001 111.234 -168.229 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.49 ' H ' ' HB3' ' A' ' 248' ' ' ASP . . . 78.03 24.6 63.75 Favored Glycine 0 C--N 1.354 1.583 0 O-C-N 123.837 0.711 . . . . 61.240000000000002 112.549 -174.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.406 ' HB2' ' HB3' ' A' ' 235' ' ' LEU . 30.1 mmmt -119.1 20.67 12.61 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.571 0.748 . . . . 75.420000000000002 110.943 -175.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -96.83 -139.56 10.69 Favored Glycine 0 C--N 1.346 1.097 0 N-CA-C 111.124 -0.79 . . . . 71.420000000000002 111.124 177.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 7.1 m-30 -68.89 149.53 97.85 Favored Pre-proline 0 N--CA 1.478 0.955 0 N-CA-C 112.372 0.508 . . . . 65.420000000000002 112.372 -174.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -63.12 170.87 7.02 Favored 'Trans proline' 0 C--N 1.386 2.549 0 C-N-CA 123.488 2.792 . . . . 64.109999999999999 112.65 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.43 ' N ' ' HD2' ' A' ' 243' ' ' PRO . . . -66.55 -40.03 94.1 Favored Glycine 0 CA--C 1.551 2.306 0 CA-C-O 118.244 -1.309 . . . . 64.439999999999998 114.695 -174.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 243' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 242' ' ' GLY . 13.1 Cg_endo -56.64 -36.61 98.24 Favored 'Trans proline' 0 C--N 1.391 2.763 0 CA-C-N 120.792 2.296 . . . . 62.43 113.219 169.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -78.28 -25.36 46.67 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.148 0.579 . . . . 63.130000000000003 110.414 175.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 191' ' ' GLN . . . 113.18 117.08 3.39 Favored Glycine 0 C--N 1.344 1.007 0 N-CA-C 109.543 -1.423 . . . . 75.540000000000006 109.543 -169.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 45.9 ttm105 -72.11 125.98 28.64 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 117.283 0.541 . . . . 75.310000000000002 110.4 -178.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -148.54 -158.18 7.89 Favored Glycine 0 C--N 1.331 0.287 0 CA-C-N 116.008 -0.542 . . . . 74.200000000000003 112.094 175.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' ASP . . . . . 0.49 ' HB3' ' H ' ' A' ' 237' ' ' GLY . 0.1 OUTLIER -126.72 166.26 17.71 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.261 1.024 . . . . 72.120000000000005 110.526 -174.465 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 7.2 tp -132.86 134.66 44.91 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.667 -0.864 . . . . 63.340000000000003 108.667 -167.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -115.18 146.95 40.89 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 108.352 -0.981 . . . . 71.120000000000005 108.352 -175.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.413 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 84.6 mt -124.22 113.87 18.86 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 107.94 -1.133 . . . . 73.049999999999997 107.94 179.067 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.439 ' HB3' HG22 ' A' ' 196' ' ' THR . 24.1 tt0 -88.74 110.39 20.96 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 107.698 -1.223 . . . . 71.120000000000005 107.698 -176.078 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.594 HG11 HG23 ' A' ' 227' ' ' THR . 55.5 t -60.77 125.63 17.26 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.263 0 O-C-N 124.116 0.885 . . . . 53.310000000000002 109.186 176.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 24.4 mtp85 -122.29 122.97 40.34 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 107.919 -1.141 . . . . 74.239999999999995 107.919 178.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.427 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 47.2 mm -85.84 118.67 32.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 O-C-N 123.635 0.584 . . . . 72.140000000000001 109.89 -171.528 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 256' ' ' THR . . . . . 0.431 HG21 ' HB2' ' A' ' 198' ' ' ASP . 1.7 t . . . . . 0 CA--C 1.551 1.008 0 C-N-CA 124.329 1.052 . . . . 74.439999999999998 109.357 -171.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' MET . . . . . 0.585 ' HA ' ' SD ' ' A' ' 169' ' ' MET . 21.9 mmt . . . . . 0 N--CA 1.486 1.35 0 N-CA-C 109.087 -0.708 . . . . 72.340000000000003 109.087 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -104.13 142.24 34.83 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 109.535 -0.543 . . . . 74.540000000000006 109.535 170.056 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -91.14 -56.01 3.32 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.354 1.062 . . . . 70.150000000000006 110.614 -170.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -98.69 16.8 59.22 Favored Glycine 0 C--N 1.343 0.958 0 CA-C-N 116.142 -0.481 . . . . 63.420000000000002 113.323 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -152.53 161.26 42.83 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.681 0.792 . . . . 65.150000000000006 109.526 -177.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 53.7 t -110.52 147.97 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 CA-C-O 121.885 0.85 . . . . 55.299999999999997 111.908 -171.096 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.585 ' SD ' ' HA ' ' A' ' 163' ' ' MET . 43.3 mtm -101.62 -176.06 3.03 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 126.625 1.97 . . . . 64.510000000000005 109.862 -168.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 10.2 p -99.23 87.14 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 CA-C-O 123.066 1.413 . . . . 73.519999999999996 107.534 162.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.43 -4.45 8.83 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 113.883 -1.508 . . . . 70.340000000000003 110.285 -174.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.449 ' O ' ' HA ' ' A' ' 233' ' ' LEU . 69.6 m -39.0 -68.3 0.17 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.775 2.03 . . . . 63.340000000000003 113.839 -166.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' TYR . . . . . 0.474 ' HB2' ' HG3' ' A' ' 224' ' ' PRO . 67.2 t80 -69.99 -44.55 69.16 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 109.372 -0.603 . . . . 75.219999999999999 109.372 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 64.92 61.37 5.89 Favored Glycine 0 C--N 1.355 1.625 0 CA-C-N 114.807 -1.088 . . . . 73.030000000000001 112.206 -177.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ASN . . . . . 0.455 ' HB3' ' HD2' ' A' ' 173' ' ' TYR . 4.5 p-10 -79.5 128.96 34.01 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.75 0.786 . . . . 71.129999999999995 111.406 -176.221 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 68.9 p -121.08 124.8 45.68 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 106.869 -1.53 . . . . 73.150000000000006 106.869 167.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -63.42 -9.09 10.84 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 113.017 0.747 . . . . 71.040000000000006 113.017 -177.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -78.17 170.61 16.34 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.192 0.997 . . . . 74.150000000000006 110.069 166.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -70.82 -19.82 62.63 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 112.123 0.416 . . . . 64.420000000000002 112.123 -174.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -84.53 -150.59 11.89 Favored Glycine 0 CA--C 1.532 1.139 0 O-C-N 123.434 0.459 . . . . 55.509999999999998 113.215 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 37.5 t -159.9 -50.51 0.05 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.97 0.908 . . . . 50.399999999999999 109.25 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 107.76 114.23 3.8 Favored Glycine 0 C--N 1.344 0.977 0 N-CA-C 110.358 -1.097 . . . . 73.319999999999993 110.358 -172.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -153.26 87.61 0.13 Allowed Glycine 0 C--N 1.339 0.708 0 N-CA-C 112.077 -0.409 . . . . 62.32 112.077 -175.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 67.9 m -91.66 179.81 5.55 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.545 0.738 . . . . 74.150000000000006 110.357 172.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 177.47 134.33 2.0 Favored Glycine 0 C--N 1.345 1.082 0 N-CA-C 111.716 -0.553 . . . . 74.209999999999994 111.716 178.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -78.69 73.93 2.2 Favored Glycine 0 C--N 1.35 1.352 0 C-N-CA 123.435 0.541 . . . . 43.409999999999997 112.242 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 14.6 m -63.36 142.06 58.53 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.508 1.123 . . . . 74.120000000000005 111.445 -176.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 116.65 -71.11 0.28 Allowed Glycine 0 C--N 1.346 1.131 0 N-CA-C 113.619 0.208 . . . . 62.200000000000003 113.619 173.202 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -87.28 11.59 65.07 Favored Glycine 0 C--N 1.345 1.051 0 CA-C-O 118.726 -1.041 . . . . 62.109999999999999 115.166 -168.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 68.1 m 55.73 66.4 1.22 Allowed 'General case' 0 N--CA 1.484 1.244 0 CA-C-O 122.23 1.014 . . . . 75.299999999999997 110.489 -173.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -104.92 -24.54 12.84 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 113.767 -1.561 . . . . 74.310000000000002 109.439 -178.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -82.95 167.62 17.8 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 114.844 -1.071 . . . . 52.329999999999998 109.925 175.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 50.3 tp -150.55 138.73 20.24 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.161 -0.472 . . . . 71.25 109.766 -177.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -117.33 139.45 50.83 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.035 0.934 . . . . 54.030000000000001 109.207 172.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -148.39 158.65 44.24 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.737 -0.838 . . . . 45.119999999999997 108.737 171.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 33.2 p -80.95 153.63 27.4 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 122.13 0.967 . . . . 74.430000000000007 111.802 168.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.66 HD13 ' HB2' ' A' ' 212' ' ' ALA . 38.8 tp -124.09 133.42 53.62 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 112.961 -1.927 . . . . 73.420000000000002 106.402 166.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -93.05 114.76 27.39 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.785 -1.191 . . . . 72.25 107.785 178.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.607 HG22 HG21 ' A' ' 210' ' ' VAL . 61.0 t -122.93 130.51 24.58 Favored Pre-proline 0 CA--C 1.542 0.673 0 C-N-CA 124.202 1.001 . . . . 52.329999999999998 108.832 179.37 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -68.48 146.72 69.04 Favored 'Trans proline' 0 C--N 1.363 1.29 0 C-N-CA 122.402 2.068 . . . . 63.039999999999999 111.76 168.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.449 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.23 -44.79 98.08 Favored Pre-proline 0 CA--C 1.564 1.507 0 C-N-CA 124.178 0.991 . . . . 61.43 112.25 172.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 19.8 Cg_endo -58.11 -34.68 98.74 Favored 'Trans proline' 0 C--N 1.401 3.294 0 C-N-CA 122.127 1.885 . . . . 72.099999999999994 112.58 174.504 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -85.43 -23.37 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 N-CA-C 109.138 -0.69 . . . . 74.329999999999998 109.138 -177.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -74.25 -37.98 63.62 Favored 'General case' 0 C--O 1.247 0.95 0 C-N-CA 123.108 0.563 . . . . 73.219999999999999 111.589 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 35.0 t -88.89 -37.88 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 CA-C-N 114.443 -1.253 . . . . 65.150000000000006 112.798 -179.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 54.5 t -95.82 -41.63 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 O-C-N 121.834 -0.541 . . . . 63.340000000000003 110.463 -175.234 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 121.59 151.1 8.43 Favored Glycine 0 C--N 1.344 1.012 0 N-CA-C 111.044 -0.822 . . . . 44.299999999999997 111.044 -177.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.77 154.48 7.96 Favored Glycine 0 C--O 1.246 0.862 0 N-CA-C 112.253 -0.339 . . . . 62.399999999999999 112.253 176.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.588 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 39.1 ttmt -85.32 132.68 34.21 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 123.472 0.709 . . . . 73.319999999999993 109.901 175.228 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.607 HG21 HG22 ' A' ' 199' ' ' VAL . 12.9 m -130.79 153.5 39.24 Favored 'Isoleucine or valine' 0 C--O 1.244 0.807 0 C-N-CA 124.713 1.205 . . . . 52.350000000000001 108.607 176.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -93.4 145.05 24.76 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.544 0.737 . . . . 74.310000000000002 110.239 -176.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.66 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -131.06 117.96 19.87 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 107.726 -1.213 . . . . 31.25 107.726 177.479 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 34.3 tpp -79.66 109.1 13.73 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 107.399 -1.334 . . . . 55.450000000000003 107.399 177.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 62.3 p -113.46 -172.38 2.06 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.253 0.621 . . . . 74.209999999999994 110.858 -172.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.653 HD21 ' HD3' ' A' ' 241' ' ' PRO . 63.1 tp -46.63 -52.1 14.4 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.561 1.144 . . . . 65.329999999999998 111.223 171.028 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -74.08 -28.96 61.63 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 114.294 -1.321 . . . . 73.310000000000002 112.3 -174.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 134.43 -166.72 24.1 Favored Glycine 0 C--N 1.346 1.102 0 CA-C-O 119.33 -0.706 . . . . 71.340000000000003 111.589 -173.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -62.32 136.06 57.57 Favored 'Trans proline' 0 C--N 1.372 1.766 0 C-N-CA 122.869 2.379 . . . . 53.109999999999999 111.301 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 212' ' ' ALA . 24.3 m -135.34 157.91 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 109.922 -0.399 . . . . 71.319999999999993 109.922 -176.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.555 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 44.6 mt-10 -110.01 105.44 14.58 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.773 0.829 . . . . 65.129999999999995 109.147 -167.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 58.7 t -122.11 101.98 10.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 115.198 -0.91 . . . . 75.200000000000003 109.335 -172.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.588 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -79.21 118.35 21.07 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 109.361 -0.607 . . . . 41.530000000000001 109.361 172.067 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 34.1 m -85.23 152.09 57.75 Favored Pre-proline 0 N--CA 1.482 1.164 0 C-N-CA 123.124 0.57 . . . . 33.450000000000003 110.363 -176.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 224' ' ' PRO . . . . . 0.474 ' HG3' ' HB2' ' A' ' 173' ' ' TYR . 36.2 Cg_endo -62.82 163.37 22.13 Favored 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 122.227 1.951 . . . . 65.409999999999997 112.362 176.161 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -85.37 32.96 0.47 Allowed 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 122.899 2.4 . . . . 72.540000000000006 112.729 175.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' ARG . . . . . 0.42 ' HA ' ' HD2' ' A' ' 226' ' ' ARG . 13.2 tpt180 -149.41 4.32 0.6 Allowed 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 116.095 -0.502 . . . . 75.420000000000002 110.731 175.335 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.506 HG23 HG11 ' A' ' 253' ' ' VAL . 0.6 OUTLIER -59.94 154.35 19.05 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.896 -0.779 . . . . 74.430000000000007 108.896 -169.855 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -131.7 161.39 32.9 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.291 0.636 . . . . 72.439999999999998 110.384 -168.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -62.33 109.37 1.32 Allowed 'General case' 0 C--O 1.241 0.62 0 N-CA-C 107.922 -1.14 . . . . 45.549999999999997 107.922 167.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 113.85 2.76 23.74 Favored Glycine 0 C--N 1.337 0.589 0 CA-C-N 115.309 -0.859 . . . . 61.329999999999998 112.428 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.14 127.08 31.58 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.046 -0.724 . . . . 72.010000000000005 109.046 -175.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -99.73 98.19 9.04 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 123.466 0.706 . . . . 73.430000000000007 109.353 -171.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.466 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 20.3 mt -82.63 98.62 9.11 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 106.928 -1.508 . . . . 75.420000000000002 106.928 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 7.1 ppt_? -83.06 114.0 20.99 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-O 121.349 0.595 . . . . 74.150000000000006 111.374 -179.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.483 ' O ' ' HB2' ' A' ' 248' ' ' ASP . 8.0 mp -104.11 126.67 51.41 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 106.52 -1.659 . . . . 74.510000000000005 106.52 174.278 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -102.92 119.05 38.16 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.476 0.71 . . . . 72.340000000000003 111.35 -174.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 79.0 31.42 43.33 Favored Glycine 0 C--N 1.354 1.564 0 O-C-N 123.969 0.793 . . . . 51.43 112.309 -175.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -127.98 20.33 6.45 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.389 0.676 . . . . 71.319999999999993 111.053 -178.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -98.01 -131.27 7.08 Favored Glycine 0 C--N 1.349 1.267 0 CA-C-O 119.576 -0.569 . . . . 53.219999999999999 112.407 -177.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -71.16 155.18 93.45 Favored Pre-proline 0 CA--C 1.55 0.98 0 CA-C-N 117.453 0.627 . . . . 74.340000000000003 112.453 -178.063 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.653 ' HD3' HD21 ' A' ' 215' ' ' LEU . 88.8 Cg_endo -72.99 171.67 17.05 Favored 'Trans proline' 0 C--N 1.387 2.603 0 C-N-CA 123.502 2.801 . . . . 75.510000000000005 112.67 -174.075 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -66.41 -38.72 93.79 Favored Glycine 0 CA--C 1.545 1.958 0 CA-C-O 118.382 -1.232 . . . . 75.430000000000007 113.575 -179.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 243' ' ' PRO . . . . . 0.447 ' HD2' ' HB2' ' A' ' 241' ' ' PRO . 53.5 Cg_exo -46.3 -44.47 20.11 Favored 'Trans proline' 0 C--N 1.385 2.464 0 C-N-CA 123.047 2.498 . . . . 73.209999999999994 114.041 163.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -78.73 -23.81 45.22 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.675 0.79 . . . . 72.140000000000001 110.765 177.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 105.27 114.49 3.96 Favored Glycine 0 C--N 1.341 0.861 0 N-CA-C 108.458 -1.857 . . . . 44.310000000000002 108.458 -165.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.61 124.0 23.74 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.163 0.585 . . . . 72.329999999999998 109.53 -172.496 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -137.8 -156.69 7.28 Favored Glycine 0 N--CA 1.477 1.432 0 CA-C-O 119.886 -0.397 . . . . 24.210000000000001 112.305 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 248' ' ' ASP . . . . . 0.483 ' HB2' ' O ' ' A' ' 235' ' ' LEU . 6.5 p30 -123.0 167.54 13.47 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.178 0.591 . . . . 64.319999999999993 111.706 -175.408 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 11.7 tp -134.67 134.41 41.09 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.634 0.774 . . . . 62.109999999999999 109.265 -170.233 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 4.2 m-30 -118.94 148.94 42.41 Favored 'General case' 0 C--O 1.25 1.114 0 N-CA-C 108.708 -0.849 . . . . 74.349999999999994 108.708 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.466 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 88.4 mt -120.72 124.42 45.12 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.446 -0.576 . . . . 61.399999999999999 109.446 -177.17 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -91.51 100.82 13.51 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 107.197 -1.408 . . . . 74.450000000000003 107.197 -177.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.506 HG11 HG23 ' A' ' 227' ' ' THR . 55.7 t -63.15 123.58 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-O 121.488 0.661 . . . . 62.539999999999999 110.7 -178.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -114.66 123.5 49.46 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 107.606 -1.257 . . . . 70.510000000000005 107.606 177.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 47.0 mm -88.21 111.57 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 O-C-N 123.981 0.801 . . . . 74.219999999999999 110.181 -175.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.6 t . . . . . 0 C--O 1.255 1.376 0 C-N-CA 124.143 0.977 . . . . 42.039999999999999 110.196 -173.526 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 64.0 mtt . . . . . 0 N--CA 1.48 1.027 0 CA-C-O 120.725 0.298 . . . . 72.420000000000002 110.211 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -155.62 85.7 1.05 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.734 1.214 . . . . 74.230000000000004 108.829 179.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -53.53 -49.17 68.18 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.687 1.195 . . . . 73.010000000000005 112.915 -168.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -97.37 32.92 6.22 Favored Glycine 0 C--N 1.346 1.102 0 CA-C-N 116.207 -0.451 . . . . 54.119999999999997 112.852 -176.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -153.48 172.93 16.38 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 123.805 0.842 . . . . 65.109999999999999 110.477 177.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 45.7 t -115.33 152.71 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.559 1.143 . . . . 73.340000000000003 110.61 178.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 50.6 mtm -98.8 -177.69 3.73 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 125.226 1.41 . . . . 71.510000000000005 110.212 -169.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 7.7 p -99.05 87.79 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.065 0 CA-C-O 122.989 1.376 . . . . 53.140000000000001 107.49 162.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.1 -4.97 8.97 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 125.495 1.518 . . . . 63.140000000000001 109.979 -176.572 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 69.9 m -36.36 -66.15 0.23 Allowed 'General case' 0 C--N 1.35 0.612 0 C-N-CA 126.906 2.082 . . . . 74.099999999999994 114.559 -167.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' TYR . . . . . 0.409 ' HB2' ' HG3' ' A' ' 224' ' ' PRO . 77.2 t80 -63.22 -49.28 74.79 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 110.1 -0.333 . . . . 73.519999999999996 110.1 -177.536 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 68.21 97.61 0.04 OUTLIER Glycine 0 C--N 1.348 1.249 0 CA-C-N 115.149 -0.932 . . . . 35.420000000000002 111.453 -174.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -76.17 -83.1 0.07 Allowed 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 123.068 0.547 . . . . 63.439999999999998 111.767 -171.177 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 58.7 m -121.39 121.32 37.35 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 113.079 0.77 . . . . 62.200000000000003 113.079 -172.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -95.95 17.95 14.32 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 124.812 1.245 . . . . 74.420000000000002 110.071 165.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -58.19 174.31 0.29 Allowed 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.697 1.199 . . . . 72.230000000000004 111.597 169.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -42.59 -27.03 0.14 Allowed 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 126.007 1.723 . . . . 63.399999999999999 115.224 -172.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -60.76 -53.87 41.72 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 123.604 0.621 . . . . 72.219999999999999 114.483 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 76.7 p -153.43 157.5 40.02 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 122.903 0.481 . . . . 75.129999999999995 110.819 -177.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 115.78 -146.18 18.8 Favored Glycine 0 C--N 1.343 0.957 0 N-CA-C 111.274 -0.73 . . . . 70.319999999999993 111.274 -178.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 72.32 26.61 71.61 Favored Glycine 0 C--N 1.347 1.151 0 N-CA-C 113.777 0.271 . . . . 71.010000000000005 113.777 176.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 24.5 m -144.32 101.81 3.75 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.473 0.709 . . . . 71.219999999999999 109.234 179.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.541 ' HA2' ' HE3' ' A' ' 236' ' ' LYS . . . -117.07 159.64 13.9 Favored Glycine 0 C--N 1.337 0.591 0 N-CA-C 111.389 -0.684 . . . . 40.439999999999998 111.389 176.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -69.43 -66.09 2.36 Favored Glycine 0 C--N 1.346 1.139 0 N-CA-C 111.298 -0.721 . . . . 21.210000000000001 111.298 176.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 88.4 p 56.31 28.0 12.73 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 125.873 1.669 . . . . 75.140000000000001 112.628 177.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -114.49 148.24 18.83 Favored Glycine 0 C--N 1.345 1.057 0 CA-C-O 119.456 -0.636 . . . . 54.100000000000001 111.532 178.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -58.86 -65.91 3.16 Favored Glycine 0 C--N 1.35 1.33 0 C-N-CA 123.266 0.46 . . . . 54.039999999999999 113.159 -174.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 78.3 p -95.03 34.04 1.43 Allowed 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.406 0.682 . . . . 75.540000000000006 110.427 176.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.431 ' HG2' ' HA3' ' A' ' 245' ' ' GLY . 70.9 mt-30 -117.9 -45.23 2.68 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.496 0.718 . . . . 61.409999999999997 109.675 177.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -77.0 165.09 25.11 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-N 115.051 -0.977 . . . . 55.140000000000001 109.625 177.085 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 35.2 tp -151.47 139.14 19.71 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.933 -0.576 . . . . 71.25 109.841 178.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -116.55 140.21 49.64 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.411 1.084 . . . . 74.329999999999998 109.555 174.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -149.59 160.87 43.13 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 123.908 0.883 . . . . 54.340000000000003 108.781 168.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 34.7 p -83.91 154.4 23.43 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 121.757 0.789 . . . . 75.329999999999998 111.458 163.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.662 HD13 ' HB2' ' A' ' 212' ' ' ALA . 37.4 tp -121.11 132.05 54.63 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 113.768 -1.56 . . . . 62.340000000000003 107.152 162.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -93.18 111.36 22.97 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 108.248 -1.019 . . . . 63.409999999999997 108.248 -178.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.578 HG22 HG21 ' A' ' 210' ' ' VAL . 56.4 t -120.36 131.73 24.34 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 123.87 0.868 . . . . 72.319999999999993 108.892 -178.143 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -66.49 148.19 83.45 Favored 'Trans proline' 0 C--N 1.369 1.631 0 C-N-CA 121.957 1.771 . . . . 64.319999999999993 111.253 168.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.433 ' HB3' ' HD3' ' A' ' 202' ' ' PRO . . . -53.77 -46.78 98.27 Favored Pre-proline 0 CA--C 1.56 1.336 0 CA-C-O 118.609 -0.71 . . . . 41.109999999999999 111.523 174.24 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.433 ' HD3' ' HB3' ' A' ' 201' ' ' ALA . 73.0 Cg_exo -51.37 -39.62 63.14 Favored 'Trans proline' 0 C--N 1.396 3.061 0 C-N-CA 122.744 2.296 . . . . 73.239999999999995 114.08 172.192 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -84.99 -24.73 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 N-CA-C 109.525 -0.546 . . . . 73.439999999999998 109.525 -174.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.433 ' HA ' HG22 ' A' ' 227' ' ' THR . . . -74.21 -37.95 63.73 Favored 'General case' 0 C--O 1.247 0.955 0 CA-C-O 121.548 0.69 . . . . 73.420000000000002 111.552 179.052 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 14.1 t -88.14 -38.49 11.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 113.798 -1.547 . . . . 70.430000000000007 112.008 -177.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 90.3 t -97.15 -41.73 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 122.931 0.493 . . . . 53.409999999999997 110.37 -174.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 120.85 145.97 7.42 Favored Glycine 0 C--N 1.35 1.311 0 N-CA-C 110.803 -0.919 . . . . 73.140000000000001 110.803 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 166.96 154.66 8.55 Favored Glycine 0 C--O 1.247 0.959 0 CA-C-N 117.202 0.501 . . . . 52.450000000000003 112.715 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.626 ' HD3' ' HB3' ' A' ' 220' ' ' GLU . 38.8 ttmt -85.65 129.84 34.72 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.627 0.771 . . . . 70.319999999999993 110.09 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.578 HG21 HG22 ' A' ' 199' ' ' VAL . 14.0 m -131.05 151.46 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 123.917 0.887 . . . . 72.310000000000002 109.753 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -95.02 141.51 28.59 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 109.034 -0.728 . . . . 62.210000000000001 109.034 -172.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.662 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -132.37 120.96 22.74 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.841 0.856 . . . . 63.32 108.831 -176.281 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 34.6 tpp -77.79 110.16 12.42 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 108.625 -0.88 . . . . 73.030000000000001 108.625 173.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 61.0 p -116.92 -179.55 3.72 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.827 0.851 . . . . 73.109999999999999 110.068 -177.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.541 HD21 ' HD3' ' A' ' 241' ' ' PRO . 65.7 tp -46.03 -52.05 12.57 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.544 1.138 . . . . 64.329999999999998 112.159 175.407 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -72.97 -26.81 61.5 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.533 1.133 . . . . 62.409999999999997 111.738 -174.12 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 139.19 -166.61 25.42 Favored Glycine 0 C--N 1.343 0.941 0 CA-C-O 119.437 -0.646 . . . . 63.509999999999998 111.981 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.28 129.73 23.56 Favored 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 122.026 1.817 . . . . 73.239999999999995 111.021 175.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 24.7 m -130.37 160.84 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 123.363 0.665 . . . . 45.539999999999999 110.227 -177.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.626 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 45.2 mt-10 -112.81 111.42 22.18 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.393 0.677 . . . . 72.099999999999994 109.684 -173.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 62.7 t -121.63 103.18 13.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 124.887 1.275 . . . . 71.409999999999997 109.43 -173.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.618 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -78.95 118.12 20.67 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 110.004 -0.369 . . . . 42.439999999999998 110.004 175.173 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 33.7 m -86.18 150.08 51.39 Favored Pre-proline 0 N--CA 1.485 1.298 0 C-N-CA 122.936 0.494 . . . . 72.209999999999994 110.516 -177.003 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' PRO . . . . . 0.467 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 24.1 Cg_endo -62.66 163.1 22.46 Favored 'Trans proline' 0 C--N 1.384 2.411 0 C-N-CA 122.431 2.088 . . . . 73.150000000000006 112.912 178.689 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -83.85 35.58 0.56 Allowed 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 123.225 2.617 . . . . 55.509999999999998 112.945 177.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -150.6 -4.93 0.32 Allowed 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.06 0.544 . . . . 73.129999999999995 111.549 176.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.583 HG23 HG11 ' A' ' 253' ' ' VAL . 0.6 OUTLIER -60.59 151.14 29.61 Favored 'General case' 0 CA--C 1.57 1.735 0 N-CA-C 109.266 -0.642 . . . . 74.400000000000006 109.266 -165.529 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 228' ' ' GLN . . . . . 0.438 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 20.6 pt20 -134.2 162.43 32.16 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.025 0.53 . . . . 74.150000000000006 110.368 -170.473 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -56.53 111.33 0.97 Allowed 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 109.824 -0.436 . . . . 74.129999999999995 109.824 175.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 114.82 -0.29 23.01 Favored Glycine 0 C--N 1.337 0.615 0 CA-C-N 115.564 -0.744 . . . . 65.319999999999993 112.094 178.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.438 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -72.45 122.72 21.73 Favored 'General case' 0 C--N 1.354 0.782 0 N-CA-C 108.661 -0.866 . . . . 73.0 108.661 -173.808 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 10.8 mmmm -98.35 97.57 8.92 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 109.307 -0.627 . . . . 70.030000000000001 109.307 -168.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 22.2 mt -80.5 97.06 6.97 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.14 -1.43 . . . . 74.420000000000002 107.14 -177.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.07 117.26 23.31 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.772 -0.649 . . . . 74.420000000000002 111.328 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 7.5 mp -97.69 127.55 43.73 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 105.807 -1.923 . . . . 70.349999999999994 105.807 171.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.541 ' HE3' ' HA2' ' A' ' 185' ' ' GLY . 15.3 tptt -101.23 115.45 30.53 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.525 0.33 . . . . 61.409999999999997 110.478 -167.395 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 77.84 32.49 45.11 Favored Glycine 0 C--N 1.349 1.281 0 O-C-N 123.922 0.764 . . . . 62.439999999999998 112.144 -175.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -125.98 23.41 7.19 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.796 0.838 . . . . 73.040000000000006 111.611 -174.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -93.8 -129.44 5.37 Favored Glycine 0 C--N 1.342 0.891 0 N-CA-C 110.916 -0.874 . . . . 3.4100000000000001 110.916 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 6.9 m-30 -70.89 151.19 95.15 Favored Pre-proline 0 CA--C 1.551 1.011 0 CA-C-N 117.72 0.76 . . . . 64.030000000000001 111.678 177.036 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.541 ' HD3' HD21 ' A' ' 215' ' ' LEU . 60.3 Cg_endo -66.27 172.69 8.5 Favored 'Trans proline' 0 C--N 1.385 2.469 0 C-N-CA 123.561 2.841 . . . . 52.039999999999999 112.157 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.422 ' N ' ' HD2' ' A' ' 243' ' ' PRO . . . -66.35 -42.18 94.12 Favored Glycine 0 CA--C 1.545 1.964 0 CA-C-O 118.311 -1.272 . . . . 64.349999999999994 114.067 -174.002 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 243' ' ' PRO . . . . . 0.422 ' HD2' ' N ' ' A' ' 242' ' ' GLY . 9.3 Cg_endo -53.76 -36.44 82.2 Favored 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 122.74 2.293 . . . . 74.450000000000003 113.441 169.221 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -78.98 -24.07 44.03 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.318 0.647 . . . . 44.009999999999998 110.692 174.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 245' ' ' GLY . . . . . 0.431 ' HA3' ' HG2' ' A' ' 191' ' ' GLN . . . 109.33 116.05 3.84 Favored Glycine 0 C--N 1.344 1.018 0 N-CA-C 109.599 -1.4 . . . . 73.219999999999999 109.599 -170.362 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -72.36 124.48 25.21 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 117.355 0.577 . . . . 71.310000000000002 110.402 -178.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -140.07 -157.46 7.25 Favored Glycine 0 N--CA 1.466 0.639 0 N-CA-C 111.044 -0.823 . . . . 70.510000000000005 111.044 174.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 8.4 p30 -119.86 167.56 11.99 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 117.515 0.657 . . . . 71.420000000000002 110.708 -177.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 9.8 tp -133.53 133.92 42.76 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 108.923 -0.769 . . . . 61.049999999999997 108.923 -172.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -115.46 146.05 42.01 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 109.105 -0.702 . . . . 74.5 109.105 -177.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 81.2 mt -125.79 113.09 16.82 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 107.896 -1.15 . . . . 74.340000000000003 107.896 178.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -89.6 113.36 24.79 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.846 -0.798 . . . . 74.230000000000004 108.846 -177.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.583 HG11 HG23 ' A' ' 227' ' ' THR . 55.8 t -59.36 124.28 13.3 Favored 'Isoleucine or valine' 0 C--N 1.344 0.365 0 O-C-N 124.089 0.868 . . . . 71.239999999999995 109.479 178.317 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 8.4 mmt180 -122.9 122.79 39.47 Favored 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 107.376 -1.342 . . . . 64.010000000000005 107.376 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 48.9 mm -84.17 120.67 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 O-C-N 124.216 0.948 . . . . 63.200000000000003 110.603 -170.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.4 t . . . . . 0 CA--C 1.558 1.267 0 CA-C-O 118.038 -0.982 . . . . 51.200000000000003 109.691 -169.794 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 70.8 mtm . . . . . 0 N--CA 1.482 1.17 0 N-CA-C 109.715 -0.476 . . . . 72.349999999999994 109.715 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.415 ' HB2' ' HB3' ' A' ' 167' ' ' ALA . 16.0 ptpt -160.68 114.31 2.07 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.761 0.824 . . . . 74.420000000000002 110.426 -178.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -85.78 -44.25 12.65 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.37 1.068 . . . . 71.219999999999999 110.391 -177.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -97.27 16.89 60.03 Favored Glycine 0 C--N 1.348 1.208 0 CA-C-N 115.635 -0.711 . . . . 71.329999999999998 113.204 -176.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.415 ' HB3' ' HB2' ' A' ' 164' ' ' LYS . . . -141.0 171.88 13.45 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 123.88 0.872 . . . . 44.530000000000001 109.365 176.159 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.46 HG11 HG22 ' A' ' 221' ' ' VAL . 52.9 t -111.65 149.28 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-O 121.806 0.812 . . . . 74.109999999999999 111.25 -173.598 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 43.2 mtm -100.48 -175.49 2.93 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 126.362 1.865 . . . . 73.049999999999997 109.433 -166.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 9.1 p -99.28 87.97 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.147 0 CA-C-O 123.022 1.391 . . . . 65.430000000000007 107.856 163.117 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.51 -6.46 8.13 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 113.851 -1.522 . . . . 64.430000000000007 110.637 -175.562 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.54 ' HA ' ' HB3' ' A' ' 233' ' ' LEU . 68.5 m -44.36 -65.25 0.54 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.272 1.829 . . . . 75.349999999999994 113.586 -172.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' TYR . . . . . 0.42 ' HB2' ' HB3' ' A' ' 224' ' ' PRO . 42.6 t80 -75.0 -35.62 61.99 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.776 0.83 . . . . 73.0 109.588 -177.684 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 92.85 4.98 64.8 Favored Glycine 0 C--N 1.35 1.361 0 CA-C-N 115.113 -0.949 . . . . 44.450000000000003 112.835 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 12.9 m120 68.98 -1.09 2.18 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 124.907 1.283 . . . . 65.409999999999997 112.787 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 28.2 p -70.22 112.05 6.28 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.538 -0.912 . . . . 62.219999999999999 108.538 177.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -57.29 -24.86 57.67 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.289 1.036 . . . . 74.450000000000003 112.443 -171.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -68.08 141.79 56.02 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.594 0.758 . . . . 72.430000000000007 109.768 171.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -67.67 -36.87 81.51 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.783 0.833 . . . . 72.0 110.773 -171.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -86.04 142.54 19.13 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-N 114.426 -1.261 . . . . 54.299999999999997 111.938 175.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 39.0 p -162.72 131.87 4.2 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.04 0.936 . . . . 64.310000000000002 109.051 175.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -84.06 -94.35 0.67 Allowed Glycine 0 C--N 1.347 1.19 0 N-CA-C 112.711 -0.156 . . . . 72.409999999999997 112.711 -178.306 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 86.61 66.86 1.36 Allowed Glycine 0 C--N 1.343 0.952 0 C-N-CA 122.69 0.186 . . . . 74.129999999999995 112.675 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 80.2 p -84.61 177.57 8.02 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.375 0.67 . . . . 72.239999999999995 109.526 173.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -159.93 -125.15 0.77 Allowed Glycine 0 C--N 1.347 1.152 0 CA-C-O 119.328 -0.706 . . . . 61.149999999999999 113.371 -173.033 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -69.63 -72.88 0.8 Allowed Glycine 0 C--N 1.354 1.531 0 O-C-N 124.009 0.476 . . . . 73.549999999999997 113.721 -170.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.637 ' H ' ' HB2' ' A' ' 192' ' ' ASP . 14.8 m 73.76 -66.06 0.32 Allowed 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 125.84 1.656 . . . . 74.450000000000003 112.97 176.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -57.49 -40.11 91.77 Favored Glycine 0 C--N 1.351 1.412 0 N-CA-C 115.501 0.961 . . . . 71.510000000000005 115.501 -169.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -82.97 9.19 60.86 Favored Glycine 0 C--N 1.346 1.112 0 CA-C-O 118.867 -0.963 . . . . 71.129999999999995 114.396 -175.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 89.0 p 54.0 35.28 21.65 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 124.543 1.137 . . . . 74.120000000000005 112.005 -176.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -105.8 -22.83 12.85 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 125.219 1.408 . . . . 74.430000000000007 109.931 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.637 ' HB2' ' H ' ' A' ' 187' ' ' SER . 61.1 t0 -75.37 153.9 37.51 Favored 'General case' 0 C--O 1.244 0.791 0 CA-C-N 114.489 -1.232 . . . . 72.420000000000002 107.923 174.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 46.7 tp -147.54 141.42 25.82 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 122.802 0.441 . . . . 71.230000000000004 110.123 -170.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -116.69 139.44 50.55 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.322 0.649 . . . . 75.200000000000003 109.849 172.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -141.17 156.84 45.88 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 108.078 -1.082 . . . . 54.43 108.078 167.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 35.3 p -86.51 152.63 22.48 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-O 121.95 0.881 . . . . 64.549999999999997 111.656 168.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.674 HD13 ' HB2' ' A' ' 212' ' ' ALA . 42.4 tp -121.62 131.08 53.91 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 113.264 -1.789 . . . . 75.209999999999994 107.3 167.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -94.43 111.77 23.53 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 122.023 0.916 . . . . 53.43 108.982 -177.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.6 HG22 HG21 ' A' ' 210' ' ' VAL . 53.4 t -120.09 132.32 24.13 Favored Pre-proline 0 CA--C 1.546 0.789 0 CA-C-N 114.707 -1.133 . . . . 65.129999999999995 109.964 -176.195 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -68.96 147.28 67.65 Favored 'Trans proline' 0 C--N 1.372 1.807 0 C-N-CA 122.326 2.018 . . . . 52.329999999999998 111.269 167.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.418 ' HB3' ' HD3' ' A' ' 202' ' ' PRO . . . -53.2 -46.67 97.71 Favored Pre-proline 0 CA--C 1.569 1.686 0 C-N-CA 123.447 0.699 . . . . 75.200000000000003 111.945 174.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.418 ' HD3' ' HB3' ' A' ' 201' ' ' ALA . 78.2 Cg_exo -51.13 -39.97 60.49 Favored 'Trans proline' 0 C--N 1.396 3.033 0 C-N-CA 122.638 2.225 . . . . 61.530000000000001 113.817 172.092 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.7 mp -84.68 -23.13 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 N-CA-C 109.327 -0.62 . . . . 73.120000000000005 109.327 -174.477 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -73.32 -39.28 65.4 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 123.143 0.577 . . . . 53.310000000000002 111.897 178.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 39.7 t -88.93 -34.32 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 CA-C-N 114.787 -1.097 . . . . 75.340000000000003 113.201 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 54.5 t -97.96 -42.17 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 O-C-N 121.514 -0.741 . . . . 75.319999999999993 110.636 -175.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 123.52 152.36 8.45 Favored Glycine 0 C--N 1.341 0.836 0 N-CA-C 111.05 -0.82 . . . . 34.439999999999998 111.05 -176.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.45 149.21 5.71 Favored Glycine 0 C--O 1.242 0.647 0 N-CA-C 111.476 -0.65 . . . . 74.319999999999993 111.476 176.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.64 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 36.0 ttmt -85.62 130.0 34.68 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 109.444 -0.576 . . . . 73.120000000000005 109.444 174.516 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.6 HG21 HG22 ' A' ' 199' ' ' VAL . 8.7 m -130.64 151.4 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.46 1.104 . . . . 72.299999999999997 108.693 -178.423 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 47.7 ttt180 -94.68 140.38 29.96 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.188 -0.914 . . . . 75.540000000000006 109.558 -167.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.674 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -132.23 115.35 15.56 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.028 0.931 . . . . 73.430000000000007 109.097 -171.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 32.5 tpp -78.78 110.9 14.38 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 108.167 -1.049 . . . . 75.239999999999995 108.167 175.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 69.6 p -115.28 -176.25 2.87 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.56 0.744 . . . . 73.430000000000007 110.456 -176.101 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.598 HD21 ' HD3' ' A' ' 241' ' ' PRO . 66.3 tp -47.57 -51.68 20.22 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.624 1.169 . . . . 45.310000000000002 111.998 177.433 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -72.17 -27.95 62.91 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 114.507 -1.224 . . . . 70.129999999999995 111.078 -174.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 136.64 -165.91 24.93 Favored Glycine 0 C--N 1.34 0.79 0 N-CA-C 111.464 -0.654 . . . . 44.399999999999999 111.464 -175.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -65.9 132.62 30.9 Favored 'Trans proline' 0 C--N 1.368 1.59 0 C-N-CA 122.565 2.176 . . . . 73.329999999999998 112.024 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 31.5 m -132.6 160.82 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.432 1.093 . . . . 72.5 109.333 177.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.403 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 47.9 mt-10 -113.16 115.73 28.71 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 122.959 0.504 . . . . 63.219999999999999 110.035 -176.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.46 HG22 HG11 ' A' ' 168' ' ' VAL . 59.0 t -121.77 105.73 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.16 1.384 . . . . 73.25 110.705 -168.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.64 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -73.82 118.52 16.88 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.889 0.476 . . . . 71.549999999999997 110.946 176.667 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 27.1 m -88.66 150.59 46.4 Favored Pre-proline 0 N--CA 1.483 1.184 0 C-N-CA 122.566 0.346 . . . . 73.299999999999997 110.776 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' PRO . . . . . 0.491 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 33.1 Cg_endo -64.97 165.57 21.1 Favored 'Trans proline' 0 C--N 1.373 1.829 0 C-N-CA 122.625 2.217 . . . . 73.099999999999994 113.653 176.146 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -83.68 29.1 0.55 Allowed 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 123.167 2.578 . . . . 74.129999999999995 113.664 172.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 35.4 mmt180 -143.97 -1.44 0.97 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.099 0.56 . . . . 73.409999999999997 111.505 177.167 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.544 HG23 HG11 ' A' ' 253' ' ' VAL . 0.6 OUTLIER -61.17 152.12 29.5 Favored 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 108.919 -0.771 . . . . 53.509999999999998 108.919 -166.27 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 228' ' ' GLN . . . . . 0.512 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 29.8 pt20 -135.31 163.03 30.91 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.314 0.645 . . . . 65.310000000000002 110.407 -174.262 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -61.1 110.76 1.46 Allowed 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 109.288 -0.634 . . . . 73.310000000000002 109.288 175.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.74 -0.25 21.57 Favored Glycine 0 CA--C 1.525 0.683 0 CA-C-N 115.369 -0.832 . . . . 75.439999999999998 112.308 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.512 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -68.26 125.45 26.45 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.737 0.815 . . . . 71.109999999999999 109.605 -174.189 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 49.2 mmtm -99.4 98.23 9.18 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.232 0.613 . . . . 74.400000000000006 109.504 -172.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.54 ' HB3' ' HA ' ' A' ' 172' ' ' SER . 22.5 mt -82.25 99.96 9.61 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 107.048 -1.464 . . . . 72.329999999999998 107.048 178.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -79.77 125.89 30.26 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 121.169 0.509 . . . . 75.25 110.99 -177.21 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 7.7 mp -111.13 127.91 55.72 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 105.999 -1.852 . . . . 74.349999999999994 105.999 172.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 41.4 tptt -101.75 117.89 35.81 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 118.054 0.388 . . . . 63.039999999999999 110.84 -173.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 79.22 30.69 45.08 Favored Glycine 0 C--N 1.347 1.159 0 O-C-N 123.481 0.488 . . . . 74.129999999999995 111.98 -178.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -127.43 20.51 6.72 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.007 0.923 . . . . 62.109999999999999 110.424 -176.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -96.92 -130.5 6.6 Favored Glycine 0 C--N 1.347 1.155 0 N-CA-C 111.19 -0.764 . . . . 45.340000000000003 111.19 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 240' ' ' PHE . . . . . 0.47 ' O ' ' HA ' ' A' ' 246' ' ' ARG . 4.8 m-30 -71.16 155.53 93.0 Favored Pre-proline 0 N--CA 1.478 0.931 0 N-CA-C 112.479 0.548 . . . . 62.409999999999997 112.479 -178.134 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.598 ' HD3' HD21 ' A' ' 215' ' ' LEU . 73.2 Cg_endo -69.35 171.81 13.35 Favored 'Trans proline' 0 C--N 1.388 2.633 0 C-N-CA 123.297 2.665 . . . . 74.25 112.396 -174.067 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.436 ' N ' ' HD2' ' A' ' 243' ' ' PRO . . . -66.81 -38.05 92.73 Favored Glycine 0 CA--C 1.544 1.851 0 CA-C-O 118.204 -1.331 . . . . 75.430000000000007 114.424 -176.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 243' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 242' ' ' GLY . 10.2 Cg_endo -52.27 -42.1 62.18 Favored 'Trans proline' 0 C--N 1.383 2.391 0 CA-C-N 120.696 2.248 . . . . 60.450000000000003 113.237 166.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -77.32 -23.04 51.06 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.546 0.738 . . . . 51.539999999999999 110.256 174.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 104.37 115.46 4.08 Favored Glycine 0 C--N 1.342 0.888 0 N-CA-C 109.33 -1.508 . . . . 74.329999999999998 109.33 -169.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 240' ' ' PHE . 38.4 ttp180 -69.04 124.08 22.79 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 117.663 0.731 . . . . 73.439999999999998 110.681 -178.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -133.93 -157.05 8.12 Favored Glycine 0 C--N 1.337 0.615 0 CA-C-N 115.193 -0.912 . . . . 72.010000000000005 111.003 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 248' ' ' ASP . . . . . 0.4 ' O ' ' HA ' ' A' ' 192' ' ' ASP . 0.2 OUTLIER -121.04 160.62 23.22 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.412 0.685 . . . . 73.120000000000005 110.764 -171.259 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 11.6 tp -135.32 133.79 39.18 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.729 0.811 . . . . 70.230000000000004 108.994 -172.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -114.7 150.38 35.33 Favored 'General case' 0 C--O 1.245 0.867 0 N-CA-C 108.527 -0.916 . . . . 72.019999999999996 108.527 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 64.6 mt -121.13 113.4 19.96 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.548 -1.278 . . . . 64.450000000000003 107.548 178.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -88.61 112.16 22.74 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 107.556 -1.276 . . . . 72.120000000000005 107.556 -179.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.544 HG11 HG23 ' A' ' 227' ' ' THR . 55.7 t -62.28 128.69 24.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 115.085 -0.961 . . . . 63.219999999999999 110.509 177.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 42.5 mtp180 -115.08 125.27 53.32 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 106.805 -1.554 . . . . 64.129999999999995 106.805 171.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 48.3 mm -87.3 127.03 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 N-CA-C 109.576 -0.527 . . . . 73.349999999999994 109.576 -176.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.7 t . . . . . 0 CA--C 1.56 1.355 0 N-CA-C 108.275 -1.009 . . . . 64.299999999999997 108.275 -174.078 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 163' ' ' MET . . . . . 0.438 ' N ' ' SD ' ' A' ' 163' ' ' MET . 1.1 mpt? . . . . . 0 N--CA 1.483 1.219 0 CA-C-O 120.703 0.287 . . . . 72.150000000000006 110.434 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 14.9 ttmm -71.24 110.85 6.14 Favored 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 109.044 -0.724 . . . . 73.25 109.044 -177.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -69.07 -66.61 0.56 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.143 0.977 . . . . 71.439999999999998 112.488 -167.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -101.77 26.74 23.32 Favored Glycine 0 C--N 1.344 0.974 0 CA-C-N 116.32 -0.4 . . . . 63.539999999999999 113.623 -178.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -154.0 173.17 16.35 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.993 0.917 . . . . 42.140000000000001 109.45 176.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 55.5 t -109.54 149.59 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 CA-C-O 121.822 0.82 . . . . 51.130000000000003 112.22 -169.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 39.4 mtm -100.97 -176.18 3.09 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.526 1.931 . . . . 62.509999999999998 110.17 -165.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 9.4 p -96.88 88.13 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 CA-C-O 122.939 1.352 . . . . 73.430000000000007 108.238 163.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.71 -4.8 8.14 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 114.418 -1.265 . . . . 75.310000000000002 110.64 -176.25 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.514 ' HA ' ' HB3' ' A' ' 233' ' ' LEU . 69.9 m -41.29 -66.12 0.37 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.493 1.917 . . . . 61.43 114.508 -169.415 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -67.18 -51.15 57.11 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.031 0.443 . . . . 74.409999999999997 110.829 -173.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 64.98 101.83 0.01 OUTLIER Glycine 0 C--N 1.341 0.846 0 CA-C-N 115.032 -0.986 . . . . 64.040000000000006 111.211 -169.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -61.51 90.79 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.399 0.68 . . . . 70.420000000000002 110.517 -176.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 50.2 m -84.14 117.72 23.66 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 114.853 -1.067 . . . . 61.25 111.418 -172.144 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -77.36 -5.41 49.54 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 114.58 -1.191 . . . . 73.420000000000002 110.487 166.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -79.56 160.54 26.41 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.088 0.955 . . . . 60.049999999999997 109.682 169.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -73.42 -18.2 61.17 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.211 0.604 . . . . 61.32 111.546 176.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -124.81 128.26 6.64 Favored Glycine 0 C--N 1.334 0.472 0 N-CA-C 111.399 -0.68 . . . . 64.109999999999999 111.399 175.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 16.4 t -94.11 120.44 34.37 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.693 0.797 . . . . 72.120000000000005 109.052 175.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -148.75 -101.19 0.24 Allowed Glycine 0 N--CA 1.467 0.747 0 N-CA-C 110.568 -1.013 . . . . 33.299999999999997 110.568 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 130.84 86.31 0.39 Allowed Glycine 0 C--N 1.346 1.094 0 N-CA-C 114.25 0.46 . . . . 61.210000000000001 114.25 170.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 54.5 p -86.36 156.66 20.11 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.876 0.87 . . . . 70.430000000000007 110.635 171.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -152.86 -138.43 2.71 Favored Glycine 0 C--N 1.34 0.796 0 N-CA-C 111.592 -0.603 . . . . 43.009999999999998 111.592 175.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -75.0 69.44 1.89 Allowed Glycine 0 C--N 1.344 0.978 0 C-N-CA 123.09 0.376 . . . . 41.049999999999997 112.818 176.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 23.1 t -80.64 110.72 16.4 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.604 -0.887 . . . . 73.219999999999999 108.604 178.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -153.17 -137.49 2.52 Favored Glycine 0 C--N 1.346 1.108 0 CA-C-O 120.171 -0.238 . . . . 72.310000000000002 113.182 -171.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -81.74 -59.32 2.36 Favored Glycine 0 C--N 1.347 1.179 0 C-N-CA 122.839 0.257 . . . . 51.539999999999999 113.518 -173.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 46.8 m -142.78 42.36 1.58 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.571 0.748 . . . . 53.420000000000002 109.802 -178.212 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.421 ' HA ' ' O ' ' A' ' 245' ' ' GLY . 93.1 mt-30 -108.94 -56.42 2.28 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 121.83 0.824 . . . . 63.140000000000001 109.085 175.33 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 29.3 p-10 -74.27 160.97 30.39 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 114.016 -1.447 . . . . 73.510000000000005 110.8 -177.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 48.5 tp -150.63 135.05 17.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.159 -0.928 . . . . 62.420000000000002 108.628 173.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -116.27 138.84 50.96 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.663 -0.866 . . . . 73.319999999999993 108.663 176.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -149.15 158.58 44.29 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.399 0.679 . . . . 44.409999999999997 109.406 171.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 37.0 p -81.33 154.37 26.54 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.924 0.869 . . . . 53.340000000000003 111.842 165.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.695 HD13 ' HB2' ' A' ' 212' ' ' ALA . 34.9 tp -125.74 133.48 52.07 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 113.52 -1.673 . . . . 74.230000000000004 106.924 170.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -94.68 111.7 23.47 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.79 -0.818 . . . . 74.109999999999999 108.79 -175.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.611 HG22 HG21 ' A' ' 210' ' ' VAL . 46.4 t -123.18 129.78 24.81 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 124.328 1.051 . . . . 65.540000000000006 109.813 -177.196 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -67.52 149.03 79.78 Favored 'Trans proline' 0 C--N 1.365 1.429 0 C-N-CA 122.586 2.191 . . . . 63.109999999999999 112.079 169.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.426 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.3 -46.96 97.67 Favored Pre-proline 0 CA--C 1.562 1.432 0 CA-C-O 118.353 -0.832 . . . . 54.009999999999998 112.446 173.403 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.459 ' O ' ' HB ' ' A' ' 206' ' ' VAL . 24.2 Cg_endo -60.43 -31.77 93.0 Favored 'Trans proline' 0 C--N 1.395 3.017 0 C-N-CA 121.719 1.613 . . . . 43.200000000000003 112.461 177.435 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.7 mp -86.2 -22.96 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 N-CA-C 109.475 -0.565 . . . . 71.329999999999998 109.475 -178.208 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.407 ' HA ' HG22 ' A' ' 227' ' ' THR . . . -73.31 -37.96 65.99 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 122.989 0.516 . . . . 61.100000000000001 111.098 176.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 19.5 t -89.2 -33.18 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.977 1.311 . . . . 74.510000000000005 113.011 -178.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.459 ' HB ' ' O ' ' A' ' 202' ' ' PRO . 51.2 t -100.49 -43.18 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 O-C-N 121.611 -0.68 . . . . 61.340000000000003 110.726 -176.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 121.22 152.18 8.73 Favored Glycine 0 N--CA 1.466 0.699 0 N-CA-C 110.811 -0.916 . . . . 74.349999999999994 110.811 -176.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.71 152.98 7.25 Favored Glycine 0 C--O 1.243 0.658 0 N-CA-C 111.671 -0.572 . . . . 71.109999999999999 111.671 177.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.572 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 30.2 tttt -85.62 130.41 34.58 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.747 -0.834 . . . . 73.329999999999998 108.747 176.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.611 HG21 HG22 ' A' ' 199' ' ' VAL . 13.1 m -129.1 151.83 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 N-CA-C 108.632 -0.877 . . . . 75.409999999999997 108.632 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 211' ' ' ARG . . . . . 0.409 ' HD2' ' N ' ' A' ' 212' ' ' ALA . 6.2 tmm_? -94.09 142.14 27.73 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 109.322 -0.622 . . . . 74.040000000000006 109.322 -169.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.695 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -132.73 119.24 20.08 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.083 0.953 . . . . 65.310000000000002 108.612 -177.484 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 37.4 tpp -79.68 107.66 12.63 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 107.756 -1.201 . . . . 74.150000000000006 107.756 173.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 63.9 p -117.03 -174.8 2.66 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.24 0.616 . . . . 51.340000000000003 110.77 -172.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.519 HD21 ' HD3' ' A' ' 241' ' ' PRO . 64.9 tp -48.73 -51.94 26.19 Favored 'General case' 0 C--N 1.358 0.963 0 C-N-CA 123.896 0.879 . . . . 72.109999999999999 111.872 175.294 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -72.46 -28.31 62.84 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.234 -0.894 . . . . 74.340000000000003 110.701 -173.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 138.4 -166.58 25.23 Favored Glycine 0 C--N 1.341 0.829 0 CA-C-O 119.648 -0.529 . . . . 44.219999999999999 112.186 -174.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -64.92 129.56 23.56 Favored 'Trans proline' 0 C--N 1.369 1.609 0 C-N-CA 122.454 2.103 . . . . 73.400000000000006 111.286 176.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.437 HG22 ' O ' ' A' ' 212' ' ' ALA . 21.0 m -133.28 160.66 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 123.445 0.698 . . . . 60.539999999999999 110.558 -176.264 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -113.12 115.43 28.28 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.893 0.877 . . . . 65.530000000000001 109.746 -176.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 58.5 t -121.96 103.55 13.62 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.887 0 C-N-CA 124.866 1.266 . . . . 74.209999999999994 110.103 -170.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.572 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -77.88 118.22 19.99 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.605 0.362 . . . . 63.520000000000003 110.673 177.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 34.0 m -89.01 152.33 48.17 Favored Pre-proline 0 N--CA 1.48 1.064 0 C-N-CA 123.27 0.628 . . . . 73.430000000000007 111.225 -177.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 224' ' ' PRO . . . . . 0.584 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 32.0 Cg_endo -63.73 164.08 22.55 Favored 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 122.593 2.195 . . . . 61.039999999999999 113.094 175.168 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -86.74 28.73 0.53 Allowed 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 123.137 2.558 . . . . 63.210000000000001 113.393 177.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 60.1 mmt-85 -145.64 1.21 0.9 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.335 0.654 . . . . 74.200000000000003 111.705 176.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.637 HG23 HG11 ' A' ' 253' ' ' VAL . 0.7 OUTLIER -61.26 154.97 22.19 Favored 'General case' 0 CA--C 1.57 1.747 0 O-C-N 123.383 0.427 . . . . 70.319999999999993 110.116 -168.986 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 228' ' ' GLN . . . . . 0.465 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 13.8 pt20 -140.7 162.62 34.98 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.318 0.647 . . . . 74.010000000000005 110.63 -174.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -59.27 111.56 1.4 Allowed 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 121.14 0.495 . . . . 62.439999999999998 110.527 -178.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.44 0.56 21.94 Favored Glycine 0 CA--C 1.519 0.324 0 CA-C-N 114.882 -1.053 . . . . 74.239999999999995 111.823 179.027 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -69.12 125.12 25.69 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 109.051 -0.722 . . . . 74.209999999999994 109.051 -175.065 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -98.55 98.44 9.62 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.146 0.578 . . . . 72.540000000000006 109.7 -169.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.514 ' HB3' ' HA ' ' A' ' 172' ' ' SER . 21.5 mt -81.87 100.31 9.54 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.253 -1.388 . . . . 72.140000000000001 107.253 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.61 126.11 30.84 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.245 0.545 . . . . 64.409999999999997 111.205 -178.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.546 ' HB3' ' HB2' ' A' ' 238' ' ' LYS . 7.3 mp -110.07 124.93 52.38 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 105.948 -1.871 . . . . 75.140000000000001 105.948 173.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.32 115.34 30.36 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.079 0.552 . . . . 73.019999999999996 111.652 -172.257 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 76.99 31.82 51.7 Favored Glycine 0 C--N 1.351 1.375 0 CA-C-N 115.05 -0.977 . . . . 73.230000000000004 111.92 -175.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.546 ' HB2' ' HB3' ' A' ' 235' ' ' LEU . 30.5 mmmt -128.91 19.96 5.99 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.833 0.853 . . . . 74.209999999999994 111.204 -176.301 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -96.93 -134.56 8.21 Favored Glycine 0 C--N 1.343 0.943 0 N-CA-C 111.633 -0.587 . . . . 74.299999999999997 111.633 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 4.6 m-30 -70.09 151.78 95.95 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 122.676 0.39 . . . . 63.240000000000002 111.754 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.519 ' HD3' HD21 ' A' ' 215' ' ' LEU . 60.8 Cg_endo -66.97 172.14 10.19 Favored 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 123.532 2.821 . . . . 64.209999999999994 112.373 -177.006 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -66.36 -38.68 93.82 Favored Glycine 0 CA--C 1.539 1.56 0 CA-C-O 118.158 -1.356 . . . . 71.420000000000002 114.012 -177.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 243' ' ' PRO . . . . . 0.463 ' HD2' ' HB2' ' A' ' 241' ' ' PRO . 73.8 Cg_exo -45.73 -45.99 15.87 Favored 'Trans proline' 0 C--N 1.385 2.475 0 C-N-CA 122.771 2.314 . . . . 74.25 114.033 165.127 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -80.34 -24.45 39.86 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.535 0.734 . . . . 72.209999999999994 111.05 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 245' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 191' ' ' GLN . . . 113.34 112.29 3.07 Favored Glycine 0 C--N 1.337 0.63 0 N-CA-C 109.617 -1.393 . . . . 73.200000000000003 109.617 -169.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.93 123.09 17.63 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.7 0.8 . . . . 73.0 110.457 -179.142 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -147.67 -155.63 6.68 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-N 116.236 -0.438 . . . . 43.399999999999999 113.319 -175.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -119.91 164.17 16.46 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.745 0.818 . . . . 45.119999999999997 110.197 -170.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 10.3 tp -134.02 133.53 41.36 Favored 'General case' 0 C--O 1.214 -0.815 0 N-CA-C 107.634 -1.247 . . . . 63.200000000000003 107.634 -178.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -122.11 146.18 47.45 Favored 'General case' 0 C--O 1.246 0.908 0 N-CA-C 108.389 -0.967 . . . . 63.100000000000001 108.389 -177.075 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 88.1 mt -124.82 115.91 21.42 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.807 0.843 . . . . 41.43 108.857 -176.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -89.09 110.16 20.92 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.815 -1.18 . . . . 64.530000000000001 107.815 -176.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.637 HG11 HG23 ' A' ' 227' ' ' THR . 45.4 t -60.04 128.54 21.21 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.365 0 O-C-N 123.872 0.733 . . . . 54.020000000000003 109.73 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.84 123.35 45.69 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 105.981 -1.859 . . . . 63.520000000000003 105.981 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 48.8 mm -86.38 117.95 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 109.006 -0.739 . . . . 74.219999999999999 109.006 -177.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.2 t . . . . . 0 CA--C 1.557 1.245 0 N-CA-C 107.687 -1.227 . . . . 73.340000000000003 107.687 -174.0 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 26.9 ttt . . . . . 0 N--CA 1.482 1.161 0 N-CA-C 110.227 -0.286 . . . . 75.099999999999994 110.227 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.627 ' HG2' ' HB3' ' A' ' 167' ' ' ALA . 36.2 ttpt -75.84 95.6 3.53 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 107.819 -1.178 . . . . 64.200000000000003 107.819 173.37 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -77.77 -45.71 23.8 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.676 1.19 . . . . 73.109999999999999 113.616 -162.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -98.34 20.02 52.13 Favored Glycine 0 N--CA 1.474 1.232 0 C-N-CA 122.761 0.22 . . . . 70.25 112.759 -175.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.627 ' HB3' ' HG2' ' A' ' 164' ' ' LYS . . . -148.06 172.06 14.85 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.722 0.809 . . . . 74.530000000000001 109.538 -179.173 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.435 HG11 HG22 ' A' ' 221' ' ' VAL . 53.6 t -111.43 150.58 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 CA-C-O 121.906 0.86 . . . . 54.439999999999998 112.139 -166.33 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 40.6 mtm -99.69 -175.68 3.05 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 126.051 1.74 . . . . 63.32 109.263 -169.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 10.3 p -97.28 88.12 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.184 0 CA-C-O 122.858 1.313 . . . . 74.409999999999997 108.275 164.272 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.27 -5.16 8.34 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 113.771 -1.559 . . . . 73.420000000000002 109.945 -178.478 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.426 ' HA ' ' HB3' ' A' ' 233' ' ' LEU . 67.0 m -39.22 -64.93 0.42 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 127.029 2.132 . . . . 62.039999999999999 114.578 -169.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' TYR . . . . . 0.419 ' HB2' ' HB3' ' A' ' 224' ' ' PRO . 72.6 t80 -62.68 -35.31 79.26 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.462 0.705 . . . . 73.430000000000007 110.901 -176.518 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 85.62 47.59 5.05 Favored Glycine 0 C--N 1.339 0.717 0 N-CA-C 108.727 -1.749 . . . . 74.209999999999994 108.727 -164.019 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -62.26 81.82 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.245 1.418 . . . . 71.450000000000003 111.892 -173.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 45.4 m -104.12 122.39 45.22 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.484 1.114 . . . . 70.209999999999994 109.447 -178.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -60.62 -33.6 73.0 Favored 'General case' 0 CA--C 1.55 0.966 0 O-C-N 123.831 0.707 . . . . 64.230000000000004 110.833 178.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 16.7 mp0 -97.31 171.34 8.48 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.427 1.091 . . . . 74.019999999999996 110.049 174.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -64.71 -35.41 80.97 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.831 0.852 . . . . 74.310000000000002 111.133 175.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -72.7 86.13 0.54 Allowed Glycine 0 C--N 1.34 0.8 0 CA-C-N 114.565 -1.198 . . . . 73.310000000000002 112.681 -176.047 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' SER . . . . . 0.45 ' HB3' ' NH2' ' A' ' 234' ' ' ARG . 27.1 m -83.8 -26.06 29.9 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.204 1.002 . . . . 54.210000000000001 110.669 175.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 86.78 -162.3 34.14 Favored Glycine 0 C--N 1.354 1.541 0 O-C-N 123.781 0.676 . . . . 72.439999999999998 112.696 -178.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -174.48 21.25 0.06 OUTLIER Glycine 0 N--CA 1.468 0.77 0 N-CA-C 111.823 -0.511 . . . . 62.130000000000003 111.823 175.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 31.5 m -82.05 116.75 21.79 Favored 'General case' 0 C--O 1.243 0.741 0 C-N-CA 123.533 0.733 . . . . 71.200000000000003 110.736 -176.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 177.03 58.74 0.06 OUTLIER Glycine 0 C--N 1.345 1.045 0 CA-C-N 115.979 -0.555 . . . . 75.230000000000004 111.823 177.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 82.19 -65.45 4.07 Favored Glycine 0 CA--C 1.531 1.051 0 N-CA-C 112.141 -0.384 . . . . 75.310000000000002 112.141 178.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 42.4 m 61.06 33.72 19.48 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.35 1.06 . . . . 62.43 111.93 173.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 117.82 43.22 0.58 Allowed Glycine 0 C--N 1.347 1.178 0 CA-C-N 115.222 -0.899 . . . . 64.109999999999999 111.486 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -113.96 0.45 24.24 Favored Glycine 0 C--N 1.351 1.383 0 CA-C-O 119.671 -0.516 . . . . 72.120000000000005 112.804 -178.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 23.1 t 62.03 17.51 9.13 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 124.556 1.142 . . . . 42.210000000000001 111.426 -174.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -106.03 -33.79 7.78 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.756 1.623 . . . . 74.040000000000006 107.482 176.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.444 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 17.9 p-10 -74.3 160.7 30.74 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 113.08 -1.873 . . . . 72.129999999999995 110.411 170.443 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.456 HD23 HD13 ' A' ' 249' ' ' LEU . 57.6 tp -149.22 143.74 26.11 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.779 -0.646 . . . . 72.349999999999994 109.749 -174.4 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -116.25 139.13 50.69 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.911 0.885 . . . . 70.049999999999997 110.169 174.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -148.59 157.39 43.43 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.257 1.023 . . . . 33.119999999999997 108.979 173.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 24.9 p -83.75 153.43 24.14 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 122.091 0.948 . . . . 72.519999999999996 112.663 168.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.669 HD13 ' HB2' ' A' ' 212' ' ' ALA . 31.6 tp -126.29 133.67 51.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 112.909 -1.951 . . . . 64.049999999999997 106.971 167.325 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -94.3 114.03 26.04 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.206 -1.035 . . . . 75.209999999999994 108.206 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.621 HG22 HG21 ' A' ' 210' ' ' VAL . 48.9 t -121.56 132.0 24.32 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 124.186 0.994 . . . . 62.43 109.688 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -69.24 144.21 56.0 Favored 'Trans proline' 0 C--N 1.37 1.703 0 C-N-CA 122.289 1.993 . . . . 74.430000000000007 111.014 166.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.435 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -54.48 -42.21 93.31 Favored Pre-proline 0 CA--C 1.565 1.54 0 CA-C-O 118.059 -0.972 . . . . 73.340000000000003 112.544 173.424 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 11.5 Cg_endo -55.22 -36.63 93.79 Favored 'Trans proline' 0 C--N 1.404 3.465 0 C-N-CA 121.885 1.723 . . . . 74.549999999999997 112.83 172.411 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -85.46 -23.89 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 N-CA-C 109.14 -0.689 . . . . 71.409999999999997 109.14 -177.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.461 ' HA ' HG22 ' A' ' 227' ' ' THR . . . -73.83 -37.33 64.88 Favored 'General case' 0 C--O 1.247 0.934 0 CA-C-O 121.44 0.638 . . . . 75.209999999999994 111.299 179.27 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 25.2 t -88.71 -38.0 10.93 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-N 113.72 -1.582 . . . . 63.409999999999997 112.435 -177.009 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 76.1 t -97.51 -42.59 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 O-C-N 122.13 -0.356 . . . . 73.109999999999999 110.341 -176.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 121.1 148.95 8.06 Favored Glycine 0 C--N 1.341 0.855 0 N-CA-C 110.612 -0.995 . . . . 63.340000000000003 110.612 -176.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 165.73 155.39 8.66 Favored Glycine 0 C--O 1.246 0.876 0 N-CA-C 111.856 -0.497 . . . . 63.340000000000003 111.856 178.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.648 ' HD3' ' HB3' ' A' ' 220' ' ' GLU . 3.5 ttmp? -84.94 131.22 34.52 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.373 0.669 . . . . 75.430000000000007 109.701 178.343 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.621 HG21 HG22 ' A' ' 199' ' ' VAL . 9.5 m -130.04 151.76 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.444 1.098 . . . . 75.140000000000001 108.642 177.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? -95.5 140.84 29.78 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 108.976 -0.75 . . . . 74.310000000000002 108.976 -172.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.669 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -131.25 119.8 22.32 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.719 -0.845 . . . . 74.140000000000001 108.719 -177.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 37.3 tpp -79.35 107.35 12.05 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 107.592 -1.262 . . . . 74.530000000000001 107.592 172.009 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 214' ' ' THR . . . . . 0.42 HG22 HD21 ' A' ' 251' ' ' LEU . 71.5 p -112.43 -173.55 2.27 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.836 0.854 . . . . 62.32 110.878 -174.301 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 61.7 tp -44.98 -52.63 8.59 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.314 1.046 . . . . 64.530000000000001 112.063 167.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -71.81 -26.53 62.44 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 114.263 -1.335 . . . . 62.200000000000003 111.46 -169.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 131.09 -165.77 22.95 Favored Glycine 0 C--N 1.34 0.777 0 N-CA-C 110.661 -0.976 . . . . 52.5 110.661 -171.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -65.78 131.02 26.17 Favored 'Trans proline' 0 C--N 1.37 1.67 0 C-N-CA 121.89 1.727 . . . . 64.420000000000002 110.715 175.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 212' ' ' ALA . 26.6 m -133.36 162.82 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 123.754 0.821 . . . . 62.409999999999997 110.495 -178.283 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.648 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 38.3 mt-10 -112.02 116.07 29.96 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.395 1.078 . . . . 72.230000000000004 109.307 -175.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.435 HG22 HG11 ' A' ' 168' ' ' VAL . 44.5 t -124.32 103.28 12.31 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 C-N-CA 124.233 1.013 . . . . 75.329999999999998 109.635 -173.121 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.534 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -78.1 118.4 20.32 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.552 -0.536 . . . . 74.099999999999994 109.552 173.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 34.7 m -89.03 151.43 46.95 Favored Pre-proline 0 N--CA 1.483 1.182 0 C-N-CA 123.031 0.532 . . . . 52.43 110.54 -178.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' PRO . . . . . 0.468 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 41.4 Cg_endo -65.22 165.83 20.88 Favored 'Trans proline' 0 C--N 1.38 2.189 0 C-N-CA 122.939 2.426 . . . . 54.439999999999998 113.412 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -80.27 31.97 0.5 Allowed 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 123.163 2.575 . . . . 54.399999999999999 113.1 172.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -150.17 -2.32 0.39 Allowed 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 112.275 0.472 . . . . 74.400000000000006 112.275 178.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.569 HG23 HG11 ' A' ' 253' ' ' VAL . 0.6 OUTLIER -59.95 150.48 28.75 Favored 'General case' 0 CA--C 1.566 1.596 0 N-CA-C 108.901 -0.778 . . . . 74.340000000000003 108.901 -168.423 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 228' ' ' GLN . . . . . 0.441 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 4.5 pt20 -133.36 162.2 32.47 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.039 0.535 . . . . 74.209999999999994 109.876 -171.521 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 229' ' ' ALA . . . . . 0.589 ' HB1' HH21 ' A' ' 254' ' ' ARG . . . -59.18 111.52 1.37 Allowed 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 109.318 -0.623 . . . . 71.010000000000005 109.318 174.281 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 114.89 1.16 22.71 Favored Glycine 0 C--N 1.338 0.641 0 CA-C-N 115.696 -0.684 . . . . 71.040000000000006 112.013 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.441 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -69.66 123.76 22.21 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 108.967 -0.753 . . . . 72.540000000000006 108.967 -174.098 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.439 ' HB3' ' HD1' ' A' ' 250' ' ' TYR . 30.7 mmmt -100.15 97.21 8.05 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 108.767 -0.827 . . . . 73.340000000000003 108.767 -172.663 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 250' ' ' TYR . 20.3 mt -81.51 99.07 8.58 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 106.406 -1.701 . . . . 64.219999999999999 106.406 -176.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 234' ' ' ARG . . . . . 0.696 ' HD3' ' HE2' ' A' ' 236' ' ' LYS . 0.5 OUTLIER -83.02 126.16 32.24 Favored 'General case' 0 CA--C 1.561 1.401 0 C-N-CA 123.854 0.862 . . . . 71.430000000000007 112.262 179.803 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.442 ' HB3' ' HB2' ' A' ' 238' ' ' LYS . 7.6 mp -113.72 124.44 52.3 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.964 1.306 . . . . 72.140000000000001 108.697 -176.507 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.696 ' HE2' ' HD3' ' A' ' 234' ' ' ARG . 5.2 mptp? -94.31 115.11 27.29 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 118.537 0.608 . . . . 73.409999999999997 110.942 -169.056 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 77.48 20.48 74.48 Favored Glycine 0 C--N 1.349 1.283 0 O-C-N 124.236 0.96 . . . . 72.439999999999998 112.305 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.442 ' HB2' ' HB3' ' A' ' 235' ' ' LEU . 1.0 OUTLIER -117.45 19.46 14.0 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.814 0.846 . . . . 62.119999999999997 110.037 -178.575 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -95.85 -139.98 10.72 Favored Glycine 0 C--N 1.35 1.338 0 N-CA-C 110.951 -0.86 . . . . 53.210000000000001 110.951 176.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 240' ' ' PHE . . . . . 0.435 ' O ' ' HA ' ' A' ' 246' ' ' ARG . 6.1 m-30 -61.11 146.94 87.32 Favored Pre-proline 0 N--CA 1.477 0.878 0 N-CA-C 112.645 0.609 . . . . 72.400000000000006 112.645 -175.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -59.71 171.08 2.96 Favored 'Trans proline' 0 C--N 1.385 2.497 0 C-N-CA 123.486 2.791 . . . . 75.239999999999995 112.524 -178.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.42 ' N ' ' HD2' ' A' ' 243' ' ' PRO . . . -67.64 -41.34 89.74 Favored Glycine 0 CA--C 1.552 2.392 0 CA-C-O 118.284 -1.287 . . . . 73.109999999999999 114.237 -174.372 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 243' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' A' ' 242' ' ' GLY . 10.8 Cg_endo -55.57 -36.5 94.63 Favored 'Trans proline' 0 C--N 1.392 2.843 0 C-N-CA 122.749 2.299 . . . . 70.540000000000006 112.914 168.43 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -77.47 -24.67 50.17 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.24 0.616 . . . . 65.510000000000005 110.688 174.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 106.68 115.59 4.03 Favored Glycine 0 C--N 1.341 0.821 0 N-CA-C 109.34 -1.504 . . . . 42.420000000000002 109.34 -172.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.435 ' HA ' ' O ' ' A' ' 240' ' ' PHE . 29.0 ttm180 -72.87 123.9 24.32 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 117.603 0.702 . . . . 71.299999999999997 111.274 -177.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -139.65 -152.74 5.92 Favored Glycine 0 C--N 1.341 0.83 0 CA-C-N 114.808 -1.087 . . . . 73.0 112.304 -177.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 248' ' ' ASP . . . . . 0.444 ' O ' ' HA ' ' A' ' 192' ' ' ASP . 11.0 t70 -114.69 163.01 16.06 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.403 1.081 . . . . 71.120000000000005 108.705 -168.473 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.456 HD13 HD23 ' A' ' 193' ' ' LEU . 18.8 tp -134.84 132.77 39.01 Favored 'General case' 0 C--O 1.214 -0.804 0 N-CA-C 109.209 -0.663 . . . . 71.25 109.209 -177.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.471 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 0.4 OUTLIER -112.04 145.27 39.99 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-O 121.688 0.756 . . . . 73.209999999999994 109.691 178.856 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.42 HD21 HG22 ' A' ' 214' ' ' THR . 72.5 mt -125.65 113.85 17.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 113.909 -1.496 . . . . 74.510000000000005 107.602 174.634 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -91.54 109.55 20.86 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 107.774 -1.195 . . . . 52.149999999999999 107.774 -173.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.569 HG11 HG23 ' A' ' 227' ' ' THR . 52.1 t -61.53 122.77 12.94 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 O-C-N 124.301 1.0 . . . . 72.310000000000002 109.988 -179.55 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 254' ' ' ARG . . . . . 0.589 HH21 ' HB1' ' A' ' 229' ' ' ALA . 0.3 OUTLIER -115.2 122.89 47.41 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 106.872 -1.529 . . . . 74.450000000000003 106.872 176.878 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 44.9 mm -87.62 114.97 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 O-C-N 123.918 0.761 . . . . 63.329999999999998 110.108 -174.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 CA--C 1.56 1.362 0 C-N-CA 124.09 0.956 . . . . 75.349999999999994 109.516 -172.057 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 163' ' ' MET . . . . . 0.571 ' HA ' ' SD ' ' A' ' 169' ' ' MET . 44.6 ttm . . . . . 0 N--CA 1.482 1.175 0 N-CA-C 109.363 -0.606 . . . . 62.200000000000003 109.363 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -104.21 126.25 51.17 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 108.767 -0.827 . . . . 74.420000000000002 108.767 171.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -78.29 -52.85 8.02 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.783 0.833 . . . . 65.129999999999995 111.552 -173.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -97.26 13.01 65.03 Favored Glycine 0 C--N 1.346 1.089 0 CA-C-N 116.208 -0.451 . . . . 54.329999999999998 113.033 -177.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -146.27 169.24 19.21 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.851 0.86 . . . . 50.299999999999997 109.47 176.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.422 HG11 HG22 ' A' ' 221' ' ' VAL . 54.4 t -110.93 151.13 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 123.669 0.788 . . . . 72.239999999999995 110.119 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.571 ' SD ' ' HA ' ' A' ' 163' ' ' MET . 42.9 mtm -99.17 -176.91 3.45 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 125.552 1.541 . . . . 73.140000000000001 109.515 -167.029 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 12.6 p -100.53 86.32 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 CA-C-O 123.428 1.585 . . . . 73.310000000000002 107.453 165.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' MET . . . . . 0.485 ' HG3' ' HA ' ' A' ' 235' ' ' LEU . 0.0 OUTLIER -124.07 -3.86 8.03 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 113.394 -1.73 . . . . 54.32 110.263 -173.554 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.559 ' HB3' HD22 ' A' ' 233' ' ' LEU . 66.7 m -44.74 -69.84 0.12 Allowed 'General case' 0 C--N 1.351 0.65 0 C-N-CA 125.856 1.662 . . . . 74.409999999999997 113.542 -166.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' TYR . . . . . 0.516 ' HB2' ' HG3' ' A' ' 224' ' ' PRO . 50.8 t80 -69.47 -47.68 63.19 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 108.215 -1.031 . . . . 74.420000000000002 108.215 -179.318 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 47.89 44.47 24.79 Favored Glycine 0 C--N 1.361 1.959 0 O-C-N 125.007 1.442 . . . . 54.409999999999997 114.702 165.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -89.65 168.3 12.24 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.634 0.73 . . . . 74.109999999999999 111.12 -177.017 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 18.7 m -87.93 126.19 34.92 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 106.216 -1.772 . . . . 74.140000000000001 106.216 163.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -49.96 -23.87 2.25 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 124.271 1.028 . . . . 62.229999999999997 111.33 -178.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -60.02 176.84 0.28 Allowed 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 126.257 1.823 . . . . 73.120000000000005 111.709 169.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -43.62 -46.97 7.49 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 114.794 1.405 . . . . 73.340000000000003 114.794 -175.158 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -132.88 -164.26 10.83 Favored Glycine 0 N--CA 1.47 0.917 0 CA-C-N 115.843 -0.617 . . . . 41.219999999999999 112.256 -176.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 23.7 t -138.55 153.26 48.71 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.422 0.689 . . . . 70.209999999999994 109.884 176.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -132.77 102.37 0.48 Allowed Glycine 0 C--N 1.34 0.77 0 N-CA-C 109.981 -1.247 . . . . 63.340000000000003 109.981 178.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -155.04 59.34 0.38 Allowed Glycine 0 C--N 1.346 1.112 0 N-CA-C 111.748 -0.541 . . . . 63.439999999999998 111.748 -176.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 24.1 t -81.92 176.33 9.66 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.668 0.787 . . . . 74.420000000000002 110.221 177.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -69.25 163.81 50.83 Favored Glycine 0 C--N 1.346 1.131 0 N-CA-C 115.733 1.053 . . . . 72.439999999999998 115.733 -168.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -76.43 -29.26 58.38 Favored Glycine 0 C--N 1.349 1.269 0 CA-C-N 114.982 -0.609 . . . . 53.530000000000001 112.847 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 44.3 t -165.41 -58.03 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.033 0.533 . . . . 64.129999999999995 110.502 177.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 100.03 -9.25 59.72 Favored Glycine 0 C--N 1.35 1.355 0 CA-C-O 119.652 -0.527 . . . . 74.230000000000004 113.943 -178.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -65.29 -68.8 1.53 Allowed Glycine 0 C--N 1.349 1.303 0 CA-C-N 116.821 0.31 . . . . 62.240000000000002 112.396 179.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 44.4 m -145.94 30.22 1.07 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.994 0.918 . . . . 72.409999999999997 109.432 179.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.435 ' HG2' ' HA3' ' A' ' 245' ' ' GLY . 75.0 mt-30 -116.69 -50.19 2.62 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.734 0.813 . . . . 62.509999999999998 110.752 -173.503 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -85.35 158.8 20.17 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 114.908 -1.042 . . . . 72.409999999999997 110.081 -174.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 53.6 tp -150.31 142.48 24.1 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.04 0.536 . . . . 62.229999999999997 110.042 -176.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -114.1 142.07 46.68 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.677 0.791 . . . . 74.319999999999993 109.286 173.335 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -148.62 162.4 39.77 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.936 0.894 . . . . 73.209999999999994 108.916 173.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 34.6 p -85.95 154.6 21.36 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 122.015 0.912 . . . . 65.150000000000006 111.984 166.132 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.678 HD13 ' HB2' ' A' ' 212' ' ' ALA . 29.2 tp -124.55 133.63 53.24 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 113.404 -1.725 . . . . 73.409999999999997 107.172 160.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -93.33 114.03 26.37 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 108.205 -1.035 . . . . 74.420000000000002 108.205 178.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.611 HG22 HG21 ' A' ' 210' ' ' VAL . 46.1 t -121.56 131.15 24.51 Favored Pre-proline 0 CA--C 1.546 0.803 0 CA-C-N 115.049 -0.978 . . . . 74.519999999999996 109.018 -178.455 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -68.59 148.27 72.07 Favored 'Trans proline' 0 C--N 1.364 1.391 0 C-N-CA 122.522 2.148 . . . . 61.43 111.379 169.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.411 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.28 -45.75 98.24 Favored Pre-proline 0 CA--C 1.558 1.262 0 CA-C-O 118.597 -0.716 . . . . 53.539999999999999 112.887 174.323 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.432 ' O ' ' HB ' ' A' ' 206' ' ' VAL . 30.1 Cg_endo -61.16 -30.15 88.22 Favored 'Trans proline' 0 C--N 1.395 2.998 0 C-N-CA 121.685 1.59 . . . . 74.430000000000007 112.193 178.003 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -86.47 -25.37 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 N-CA-C 109.482 -0.562 . . . . 74.420000000000002 109.482 -177.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -73.4 -37.67 65.87 Favored 'General case' 0 C--O 1.247 0.936 0 C-N-CA 122.89 0.476 . . . . 74.040000000000006 111.18 178.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 25.6 t -88.36 -38.0 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 C-N-CA 124.884 1.274 . . . . 73.409999999999997 112.869 -178.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.432 ' HB ' ' O ' ' A' ' 202' ' ' PRO . 54.5 t -97.26 -41.47 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 O-C-N 121.841 -0.537 . . . . 74.239999999999995 110.545 -175.349 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 121.61 148.15 7.79 Favored Glycine 0 C--N 1.341 0.847 0 N-CA-C 110.789 -0.925 . . . . 73.409999999999997 110.789 -177.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 166.51 151.41 6.8 Favored Glycine 0 C--O 1.245 0.792 0 N-CA-C 112.098 -0.401 . . . . 44.399999999999999 112.098 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.664 ' HD3' ' HB3' ' A' ' 220' ' ' GLU . 37.5 ttmt -85.06 132.39 34.33 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.781 0.832 . . . . 71.150000000000006 109.615 175.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.611 HG21 HG22 ' A' ' 199' ' ' VAL . 11.2 m -136.11 152.18 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.365 1.066 . . . . 75.540000000000006 109.407 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 8.8 tmm_? -94.59 142.83 26.99 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.581 0.752 . . . . 70.099999999999994 110.711 -170.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.678 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -131.17 123.12 27.83 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.912 0.885 . . . . 63.200000000000003 109.366 -176.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 33.8 tpp -78.6 109.05 12.45 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 108.52 -0.918 . . . . 32.119999999999997 108.52 175.006 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 51.6 p -113.73 -178.35 3.36 Favored 'General case' 0 C--O 1.244 0.8 0 C-N-CA 123.242 0.617 . . . . 72.430000000000007 111.132 -174.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.531 HD21 ' HD3' ' A' ' 241' ' ' PRO . 65.5 tp -45.83 -51.66 12.55 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 124.278 0.986 . . . . 73.349999999999994 111.33 170.14 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -73.56 -29.4 62.4 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 114.05 -1.432 . . . . 74.540000000000006 111.442 -174.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 136.68 -167.18 24.64 Favored Glycine 0 C--N 1.348 1.211 0 CA-C-O 119.558 -0.579 . . . . 61.420000000000002 112.407 -177.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.91 129.47 24.71 Favored 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 122.329 2.019 . . . . 43.25 111.046 176.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.408 HG22 ' O ' ' A' ' 212' ' ' ALA . 28.1 m -132.8 161.55 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 123.573 0.749 . . . . 74.450000000000003 110.138 -176.297 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.664 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 51.8 mt-10 -111.54 115.56 29.38 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.711 0.804 . . . . 75.219999999999999 109.416 -173.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.422 HG22 HG11 ' A' ' 168' ' ' VAL . 59.8 t -126.63 104.66 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 124.451 1.1 . . . . 72.329999999999998 110.102 -169.473 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.574 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -76.89 117.99 19.04 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 110.066 -0.346 . . . . 54.119999999999997 110.066 176.044 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 34.0 m -88.07 152.36 50.55 Favored Pre-proline 0 N--CA 1.48 1.034 0 C-N-CA 123.002 0.521 . . . . 70.319999999999993 110.765 -178.044 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 224' ' ' PRO . . . . . 0.548 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 34.6 Cg_endo -62.55 163.69 20.39 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.242 1.961 . . . . 64.310000000000002 112.231 174.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -86.76 32.94 0.44 Allowed 'Trans proline' 0 C--N 1.371 1.75 0 C-N-CA 123.249 2.633 . . . . 75.519999999999996 112.074 176.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 5.2 tpt180 -148.99 -0.71 0.5 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 122.764 0.426 . . . . 74.340000000000003 111.324 178.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.585 HG23 HG11 ' A' ' 253' ' ' VAL . 0.6 OUTLIER -61.12 153.01 26.84 Favored 'General case' 0 CA--C 1.563 1.476 0 N-CA-C 109.519 -0.549 . . . . 41.329999999999998 109.519 -167.242 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 228' ' ' GLN . . . . . 0.464 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 19.5 pt20 -132.77 161.56 33.75 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.182 0.593 . . . . 70.230000000000004 110.41 -170.483 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 229' ' ' ALA . . . . . 0.461 ' HB1' ' NH2' ' A' ' 254' ' ' ARG . . . -61.27 110.84 1.52 Allowed 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 109.509 -0.552 . . . . 71.25 109.509 174.289 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 113.92 0.46 24.21 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 111.28 -0.728 . . . . 64.109999999999999 111.28 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.464 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -68.84 126.93 31.31 Favored 'General case' 0 C--N 1.362 1.152 0 N-CA-C 109.187 -0.671 . . . . 74.25 109.187 -173.513 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -97.71 97.7 9.24 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 108.947 -0.76 . . . . 64.439999999999998 108.947 -169.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.559 HD22 ' HB3' ' A' ' 172' ' ' SER . 25.8 mt -81.11 99.56 8.57 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.696 -1.224 . . . . 61.219999999999999 107.696 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.44 113.32 17.49 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.733 -0.667 . . . . 71.329999999999998 110.363 -178.525 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.555 ' HB3' ' HB2' ' A' ' 238' ' ' LYS . 7.5 mp -99.55 124.73 45.01 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 105.943 -1.873 . . . . 62.020000000000003 105.943 169.268 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -102.68 118.05 36.0 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.563 0.745 . . . . 64.310000000000002 109.777 -176.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 78.42 31.2 46.96 Favored Glycine 0 C--N 1.349 1.264 0 O-C-N 124.103 0.877 . . . . 53.229999999999997 112.735 -177.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.555 ' HB2' ' HB3' ' A' ' 235' ' ' LEU . 29.9 mmmt -129.94 21.25 5.4 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.028 0.931 . . . . 74.319999999999993 111.042 -179.285 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -96.81 -131.1 6.8 Favored Glycine 0 C--N 1.346 1.089 0 N-CA-C 111.468 -0.653 . . . . 75.349999999999994 111.468 -179.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 7.1 m-30 -70.8 151.77 95.19 Favored Pre-proline 0 CA--C 1.553 1.093 0 C-N-CA 123.458 0.703 . . . . 73.239999999999995 112.321 -178.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.531 ' HD3' HD21 ' A' ' 215' ' ' LEU . 58.8 Cg_endo -66.3 171.36 10.51 Favored 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 124.142 3.228 . . . . 73.109999999999999 112.977 179.08 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -66.35 -40.5 94.6 Favored Glycine 0 CA--C 1.543 1.84 0 CA-C-O 118.233 -1.315 . . . . 74.010000000000005 115.604 -175.246 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -53.9 -36.86 84.77 Favored 'Trans proline' 0 C--N 1.379 2.18 0 CA-C-N 120.827 2.313 . . . . 64.239999999999995 113.029 168.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -79.56 -26.61 41.34 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 122.987 0.515 . . . . 42.039999999999999 110.398 174.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 245' ' ' GLY . . . . . 0.435 ' HA3' ' HG2' ' A' ' 191' ' ' GLN . . . 110.65 115.67 3.63 Favored Glycine 0 C--N 1.345 1.083 0 N-CA-C 109.413 -1.475 . . . . 60.299999999999997 109.413 -170.157 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 11.1 mmm-85 -67.91 121.98 17.2 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.02 0.528 . . . . 61.130000000000003 110.292 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -143.73 -156.15 6.69 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-N 115.823 -0.626 . . . . 72.140000000000001 112.131 -177.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -120.64 165.53 14.92 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 123.675 0.79 . . . . 61.219999999999999 110.749 -172.713 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 16.1 tp -135.46 134.49 39.64 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 107.828 -1.175 . . . . 73.349999999999994 107.828 -173.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 8.9 m-30 -114.39 148.48 37.62 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 109.144 -0.687 . . . . 72.310000000000002 109.144 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.448 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 69.9 mt -122.93 113.94 19.78 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.24 -1.393 . . . . 74.219999999999999 107.24 178.093 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -89.65 111.68 22.71 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 106.986 -1.487 . . . . 72.310000000000002 106.986 -176.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.585 HG11 HG23 ' A' ' 227' ' ' THR . 54.7 t -62.21 125.82 19.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 O-C-N 123.977 0.798 . . . . 73.049999999999997 110.278 -178.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 254' ' ' ARG . . . . . 0.461 ' NH2' ' HB1' ' A' ' 229' ' ' ALA . 3.8 mmp_? -117.0 122.53 44.49 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.036 -1.468 . . . . 74.219999999999999 107.036 176.462 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 48.7 mm -88.37 115.42 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 O-C-N 123.799 0.687 . . . . 62.409999999999997 110.273 -172.074 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.0 t . . . . . 0 CA--C 1.562 1.413 0 C-N-CA 124.389 1.076 . . . . 54.240000000000002 109.23 -169.377 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 66.4 mtt . . . . . 0 N--CA 1.483 1.187 0 N-CA-C 109.51 -0.552 . . . . 73.430000000000007 109.51 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -103.54 140.81 37.02 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.999 0.919 . . . . 74.299999999999997 110.474 179.362 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -100.41 -42.03 6.78 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.247 1.019 . . . . 75.430000000000007 110.922 -170.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -100.42 24.6 31.46 Favored Glycine 0 C--N 1.345 1.034 0 CA-C-N 115.639 -0.709 . . . . 70.25 113.391 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -140.78 166.97 23.31 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.031 0.932 . . . . 34.299999999999997 109.056 178.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.526 HG11 HG22 ' A' ' 221' ' ' VAL . 60.7 t -110.94 149.93 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-O 121.62 0.724 . . . . 75.519999999999996 112.301 -162.6 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 42.6 mtm -99.51 -176.05 3.17 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.618 1.967 . . . . 64.200000000000003 108.813 -171.11 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 9.9 p -101.57 86.58 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.179 0 CA-C-O 123.067 1.413 . . . . 72.219999999999999 108.642 166.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.7 -4.76 9.2 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 113.933 -1.485 . . . . 75.099999999999994 110.232 -174.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 68.9 m -39.92 -67.31 0.24 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.778 2.031 . . . . 42.240000000000002 114.661 -164.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -66.53 -42.82 86.67 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 122.482 0.313 . . . . 73.310000000000002 110.537 -169.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 56.45 69.38 1.29 Allowed Glycine 0 C--N 1.344 1.023 0 N-CA-C 111.489 -0.644 . . . . 74.25 111.489 -176.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -72.87 20.03 0.08 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.085 0.954 . . . . 74.409999999999997 113.282 -174.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' SER . . . . . 0.451 ' O ' ' HA ' ' A' ' 181' ' ' SER . 14.8 m -101.02 95.71 6.76 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.954 0.901 . . . . 64.120000000000005 109.188 170.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 13.2 mp0 -84.44 -28.57 26.75 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.776 0.798 . . . . 74.5 109.162 172.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -65.5 177.76 1.11 Allowed 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 114.046 -1.434 . . . . 74.010000000000005 110.091 167.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -10.51 -55.79 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.302 0 C-N-CA 127.949 2.5 . . . . 75.329999999999998 116.397 -174.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -81.18 55.25 4.81 Favored Glycine 0 N--CA 1.473 1.152 0 O-C-N 123.789 0.681 . . . . 31.239999999999998 112.649 178.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 176' ' ' SER . 34.8 t -79.36 -11.43 59.93 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.269 1.028 . . . . 65.25 112.992 -168.168 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 87.49 44.97 5.39 Favored Glycine 0 C--N 1.346 1.092 0 N-CA-C 111.737 -0.545 . . . . 65.120000000000005 111.737 -176.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -69.96 176.39 33.36 Favored Glycine 0 C--N 1.351 1.407 0 O-C-N 124.145 0.556 . . . . 65.150000000000006 113.257 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 51.4 p -69.16 101.75 1.52 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.827 0.851 . . . . 74.439999999999998 111.841 -173.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -92.91 -44.18 3.94 Favored Glycine 0 C--N 1.349 1.279 0 N-CA-C 111.54 -0.624 . . . . 64.329999999999998 111.54 173.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' ' 191' ' ' GLN . . . -70.16 -20.45 76.52 Favored Glycine 0 C--N 1.355 1.602 0 CA-C-N 115.457 -0.371 . . . . 32.509999999999998 112.471 176.6 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 18.3 m 60.26 22.57 11.98 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.683 1.193 . . . . 62.200000000000003 112.416 172.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 82.48 -78.2 2.01 Favored Glycine 0 C--N 1.352 1.456 0 CA-C-O 119.569 -0.573 . . . . 71.230000000000004 114.281 176.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -20.54 -72.1 0.01 OUTLIER Glycine 0 N--CA 1.486 1.99 0 C-N-CA 126.395 1.95 . . . . 24.530000000000001 117.854 -162.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 49.7 m -148.55 21.52 1.04 Allowed 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.38 0.672 . . . . 63.450000000000003 110.857 -177.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.406 ' HB3' ' HA3' ' A' ' 247' ' ' GLY . 15.9 mt-30 -118.76 -42.22 2.74 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.095 0.558 . . . . 65.219999999999999 110.724 -177.386 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -76.04 154.93 35.31 Favored 'General case' 0 N--CA 1.481 1.125 0 CA-C-N 115.342 -0.845 . . . . 72.239999999999995 109.547 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 56.9 tp -148.23 140.39 24.14 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.028 0.531 . . . . 74.239999999999995 110.34 175.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -114.55 138.76 50.24 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.089 0.955 . . . . 73.019999999999996 110.097 173.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -147.8 156.59 42.89 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.792 -0.818 . . . . 74.510000000000005 108.792 167.176 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 30.0 p -81.85 151.46 27.32 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 122.113 0.959 . . . . 75.030000000000001 112.14 168.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.634 HD13 ' HB2' ' A' ' 212' ' ' ALA . 27.2 tp -120.74 132.38 55.02 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 112.977 -1.92 . . . . 71.329999999999998 107.155 164.054 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -94.93 114.53 26.38 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 107.973 -1.121 . . . . 64.319999999999993 107.973 178.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.59 HG22 HG21 ' A' ' 210' ' ' VAL . 46.4 t -113.52 130.23 23.91 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 114.866 -1.061 . . . . 52.219999999999999 108.649 178.678 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -66.01 146.22 81.78 Favored 'Trans proline' 0 C--N 1.373 1.83 0 C-N-CA 122.287 1.992 . . . . 74.140000000000001 110.924 169.071 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.421 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.64 -46.21 98.36 Favored Pre-proline 0 CA--C 1.568 1.672 0 CA-C-O 118.334 -0.841 . . . . 45.219999999999999 112.304 175.371 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.421 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 26.0 Cg_endo -60.82 -31.48 91.77 Favored 'Trans proline' 0 C--N 1.403 3.446 0 C-N-CA 121.697 1.598 . . . . 62.43 112.549 176.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -86.44 -23.69 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 N-CA-C 109.153 -0.684 . . . . 74.310000000000002 109.153 -177.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -74.17 -38.53 63.65 Favored 'General case' 0 C--O 1.247 0.931 0 C-N-CA 122.938 0.495 . . . . 73.239999999999995 110.933 179.172 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 22.1 t -88.64 -36.45 9.05 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 CA-C-N 113.532 -1.667 . . . . 73.200000000000003 112.504 -177.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 55.5 t -98.61 -42.81 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 O-C-N 122.163 -0.335 . . . . 74.310000000000002 110.782 -177.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 122.26 152.14 8.57 Favored Glycine 0 N--CA 1.466 0.651 0 N-CA-C 110.919 -0.873 . . . . 72.099999999999994 110.919 -176.139 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.72 155.68 8.57 Favored Glycine 0 C--O 1.241 0.538 0 N-CA-C 111.444 -0.662 . . . . 63.299999999999997 111.444 178.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.571 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 35.4 ttmt -84.45 129.67 34.84 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 109.128 -0.693 . . . . 53.039999999999999 109.128 177.402 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.59 HG21 HG22 ' A' ' 199' ' ' VAL . 15.9 m -132.08 147.84 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.425 0.69 . . . . 65.010000000000005 109.594 179.062 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 14.4 ttp-105 -96.84 139.98 32.08 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.901 -1.045 . . . . 73.010000000000005 110.258 -167.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.634 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -132.24 120.59 22.39 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.001 0.92 . . . . 60.32 108.87 -174.08 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 33.5 tpp -78.04 110.02 12.62 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 108.826 -0.805 . . . . 74.439999999999998 108.826 174.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 56.4 p -112.33 -176.11 2.84 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 123.865 0.866 . . . . 72.299999999999997 109.971 -176.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.584 HD21 ' HD3' ' A' ' 241' ' ' PRO . 65.1 tp -47.9 -52.1 20.66 Favored 'General case' 0 C--N 1.354 0.782 0 C-N-CA 124.003 0.921 . . . . 74.219999999999999 111.55 173.65 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -72.84 -26.95 61.66 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 114.661 -1.154 . . . . 73.310000000000002 111.811 -171.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 137.85 -165.56 25.32 Favored Glycine 0 C--N 1.34 0.78 0 N-CA-C 111.299 -0.72 . . . . 23.129999999999999 111.299 -173.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.36 131.69 23.9 Favored 'Trans proline' 0 C--N 1.37 1.699 0 C-N-CA 122.081 1.854 . . . . 71.400000000000006 110.741 178.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 19.3 m -126.56 157.31 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 108.778 -0.823 . . . . 73.540000000000006 108.778 177.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.529 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 43.1 mt-10 -114.56 114.45 25.76 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 123.105 0.562 . . . . 60.32 109.511 -178.508 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.526 HG22 HG11 ' A' ' 168' ' ' VAL . 89.2 t -120.26 104.79 16.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 C-N-CA 125.474 1.51 . . . . 53.140000000000001 109.16 -169.46 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.571 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -76.11 117.63 18.01 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 122.836 0.454 . . . . 74.400000000000006 110.167 177.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 35.3 m -90.35 152.63 45.81 Favored Pre-proline 0 N--CA 1.478 0.927 0 C-N-CA 123.43 0.692 . . . . 64.239999999999995 111.289 -175.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 224' ' ' PRO . . . . . 0.539 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 45.2 Cg_endo -63.4 166.74 14.42 Favored 'Trans proline' 0 C--N 1.376 2.001 0 C-N-CA 123.507 2.805 . . . . 71.230000000000004 113.425 176.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -84.51 32.13 0.5 Allowed 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 122.83 2.353 . . . . 64.319999999999993 112.503 173.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 -150.51 -1.19 0.39 Allowed 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 112.561 0.578 . . . . 75.140000000000001 112.561 -179.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.539 ' HB ' ' HG2' ' A' ' 224' ' ' PRO . 0.6 OUTLIER -60.05 153.13 22.34 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 109.762 -0.458 . . . . 72.129999999999995 109.762 -167.101 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 228' ' ' GLN . . . . . 0.462 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 29.6 pt20 -133.08 161.51 34.21 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.55 0.74 . . . . 64.209999999999994 110.028 -174.687 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -63.46 110.66 2.02 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 109.024 -0.732 . . . . 64.129999999999995 109.024 174.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 114.72 3.74 21.87 Favored Glycine 0 C--O 1.241 0.545 0 CA-C-N 115.031 -0.986 . . . . 72.409999999999997 112.148 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.462 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -68.46 127.93 34.78 Favored 'General case' 0 CA--C 1.553 1.094 0 N-CA-C 109.288 -0.634 . . . . 74.430000000000007 109.288 -179.806 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -97.24 96.99 8.79 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.113 0.565 . . . . 74.019999999999996 109.776 -173.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.493 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 19.3 mt -81.83 99.21 8.88 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 106.558 -1.645 . . . . 61.509999999999998 106.558 179.092 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 5.0 ppt_? -82.56 116.2 21.87 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.832 -0.622 . . . . 72.439999999999998 111.396 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 7.3 mp -105.1 126.99 52.68 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 106.56 -1.645 . . . . 72.400000000000006 106.56 173.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 15.9 tptm -101.61 117.1 34.21 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 122.612 0.365 . . . . 72.310000000000002 110.668 -171.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 78.89 24.18 62.56 Favored Glycine 0 C--N 1.342 0.863 0 O-C-N 124.004 0.815 . . . . 64.340000000000003 112.907 -177.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 1.9 mmmp? -117.21 21.24 13.28 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 122.836 0.454 . . . . 72.219999999999999 111.144 -177.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -96.95 -129.95 6.4 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-O 119.406 -0.663 . . . . 64.540000000000006 112.095 -178.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 6.0 m-30 -71.04 152.76 94.82 Favored Pre-proline 0 CA--C 1.557 1.229 0 C-N-CA 123.264 0.626 . . . . 75.519999999999996 112.427 -177.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.584 ' HD3' HD21 ' A' ' 215' ' ' LEU . 74.3 Cg_endo -69.29 172.83 11.48 Favored 'Trans proline' 0 C--N 1.392 2.825 0 C-N-CA 123.837 3.025 . . . . 73.129999999999995 112.72 -179.184 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.4 ' N ' ' HD2' ' A' ' 243' ' ' PRO . . . -67.52 -39.73 91.04 Favored Glycine 0 CA--C 1.542 1.753 0 CA-C-O 118.058 -1.412 . . . . 61.140000000000001 114.671 -174.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 243' ' ' PRO . . . . . 0.4 ' HD2' ' N ' ' A' ' 242' ' ' GLY . 8.7 Cg_endo -52.28 -41.14 67.99 Favored 'Trans proline' 0 C--N 1.386 2.547 0 CA-C-N 121.071 2.435 . . . . 72.030000000000001 112.72 167.63 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -76.72 -25.21 53.28 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.16 0.584 . . . . 73.319999999999993 110.679 176.106 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 109.02 115.73 3.84 Favored Glycine 0 C--N 1.342 0.869 0 N-CA-C 109.354 -1.498 . . . . 73.219999999999999 109.354 -168.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -70.1 122.4 19.34 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 108.732 -0.84 . . . . 74.049999999999997 108.732 -178.536 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.406 ' HA3' ' HB3' ' A' ' 191' ' ' GLN . . . -142.82 -156.16 6.68 Favored Glycine 0 N--CA 1.465 0.596 0 N-CA-C 111.445 -0.662 . . . . 55.140000000000001 111.445 177.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 12.2 p30 -120.13 168.48 11.16 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-O 121.753 0.787 . . . . 71.540000000000006 111.357 -171.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 14.7 tp -135.5 133.46 38.49 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 107.84 -1.171 . . . . 74.430000000000007 107.84 -171.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -118.53 148.49 42.58 Favored 'General case' 0 C--O 1.253 1.28 0 N-CA-C 108.63 -0.878 . . . . 74.219999999999999 108.63 -178.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.493 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 91.6 mt -121.25 119.62 32.8 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.514 0.725 . . . . 71.200000000000003 109.162 -178.591 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -89.25 104.6 17.13 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 107.287 -1.375 . . . . 64.099999999999994 107.287 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.484 HG11 HG23 ' A' ' 227' ' ' THR . 55.4 t -62.89 128.43 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 121.271 0.558 . . . . 52.329999999999998 110.294 178.301 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 21.5 mtm105 -117.16 126.08 52.24 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.135 -1.432 . . . . 73.239999999999995 107.135 172.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 40.9 mm -88.5 127.28 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 109.751 -0.463 . . . . 64.049999999999997 109.751 -178.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.7 t . . . . . 0 CA--C 1.559 1.318 0 N-CA-C 107.775 -1.195 . . . . 72.530000000000001 107.775 -177.856 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 42.7 ttm . . . . . 0 N--CA 1.479 0.986 0 N-CA-C 109.72 -0.474 . . . . 54.350000000000001 109.72 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -138.24 73.18 1.43 Allowed 'General case' 0 N--CA 1.482 1.161 0 CA-C-O 122.233 1.015 . . . . 70.439999999999998 110.651 175.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -92.71 -12.08 32.35 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 115.341 -0.845 . . . . 75.209999999999994 110.87 176.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -96.26 7.73 66.74 Favored Glycine 0 C--N 1.35 1.329 0 CA-C-N 115.88 -0.6 . . . . 44.539999999999999 112.108 176.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -141.12 171.59 13.85 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.327 1.451 . . . . 75.239999999999995 107.328 172.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.475 HG11 HG22 ' A' ' 221' ' ' VAL . 55.9 t -108.65 152.52 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 123.498 0.719 . . . . 42.200000000000003 110.075 -176.027 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 46.5 mtm -99.28 -178.78 4.02 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.099 1.36 . . . . 73.099999999999994 109.212 -169.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 10.0 p -97.71 85.73 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 CA-C-O 123.429 1.585 . . . . 71.319999999999993 107.318 164.096 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.65 -4.7 9.23 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 113.608 -1.633 . . . . 70.209999999999994 109.846 -174.66 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.537 ' HA ' ' HB3' ' A' ' 233' ' ' LEU . 67.5 m -43.1 -64.11 0.69 Allowed 'General case' 0 C--O 1.241 0.608 0 C-N-CA 126.681 1.992 . . . . 64.319999999999993 113.425 -176.514 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' TYR . . . . . 0.419 ' HB2' ' HB3' ' A' ' 224' ' ' PRO . 45.5 t80 -72.16 -35.54 69.07 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.535 0.734 . . . . 63.030000000000001 109.355 -178.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 94.86 -2.55 66.67 Favored Glycine 0 C--N 1.346 1.131 0 CA-C-N 114.529 -1.214 . . . . 64.329999999999998 112.634 -176.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 66.5 t30 67.32 5.93 4.54 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 125.039 1.336 . . . . 62.310000000000002 111.968 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 21.8 p -84.35 113.85 21.45 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.821 -0.807 . . . . 64.420000000000002 108.821 175.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -56.7 -17.02 7.46 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.382 1.073 . . . . 72.400000000000006 112.385 -174.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -56.06 158.35 3.99 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.514 1.126 . . . . 74.310000000000002 111.937 172.11 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -60.98 -23.16 65.15 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.695 0.798 . . . . 64.450000000000003 112.532 -175.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -160.32 -179.98 35.46 Favored Glycine 0 C--O 1.241 0.573 0 O-C-N 123.582 0.551 . . . . 52.43 112.38 177.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 27.3 t -161.28 140.44 10.15 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.658 0.783 . . . . 51.520000000000003 109.432 178.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -154.82 129.48 2.58 Favored Glycine 0 C--N 1.337 0.596 0 N-CA-C 111.075 -0.81 . . . . 45.119999999999997 111.075 179.114 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -145.45 123.41 1.89 Allowed Glycine 0 C--N 1.337 0.633 0 N-CA-C 111.248 -0.741 . . . . 75.109999999999999 111.248 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 43.7 p -80.1 151.78 29.65 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.815 0.846 . . . . 73.120000000000005 110.797 -178.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -135.03 -65.75 0.07 OUTLIER Glycine 0 C--N 1.347 1.176 0 N-CA-C 111.976 -0.45 . . . . 71.430000000000007 111.976 179.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -73.14 86.13 0.58 Allowed Glycine 0 C--N 1.343 0.971 0 N-CA-C 112.346 -0.302 . . . . 72.129999999999995 112.346 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 33.8 m -76.59 74.3 3.3 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.313 1.045 . . . . 62.200000000000003 111.747 -172.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 54.88 33.5 56.5 Favored Glycine 0 C--N 1.352 1.448 0 CA-C-N 115.708 -0.678 . . . . 74.530000000000001 113.037 -177.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -107.45 11.56 39.43 Favored Glycine 0 C--N 1.343 0.932 0 CA-C-O 119.295 -0.725 . . . . 61.200000000000003 113.305 -172.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 20.7 m 65.25 30.83 11.09 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.174 0.99 . . . . 73.120000000000005 110.241 -173.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.579 ' HB3' ' HA3' ' A' ' 247' ' ' GLY . 91.4 mt-30 -110.38 -41.87 4.27 Favored 'General case' 0 C--O 1.247 0.932 0 C-N-CA 124.647 1.179 . . . . 71.219999999999999 110.721 -173.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -73.53 153.8 40.13 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 114.407 -1.269 . . . . 70.200000000000003 108.978 -177.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 60.5 tp -148.89 138.91 22.18 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 123.841 0.856 . . . . 72.540000000000006 108.994 174.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -111.56 142.14 44.23 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.861 0.864 . . . . 71.530000000000001 108.74 171.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -147.67 156.37 42.71 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 108.734 -0.839 . . . . 72.230000000000004 108.734 167.021 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 33.0 p -84.69 153.01 23.36 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-O 122.368 1.08 . . . . 65.530000000000001 112.127 168.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.593 HD13 ' HB2' ' A' ' 212' ' ' ALA . 20.5 tp -125.52 132.86 52.53 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 112.507 -2.133 . . . . 73.230000000000004 106.361 167.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -95.26 112.24 23.98 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.875 0.845 . . . . 75.420000000000002 108.772 -179.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.649 HG22 HG21 ' A' ' 210' ' ' VAL . 41.1 t -117.18 132.13 23.65 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 124.589 1.156 . . . . 63.229999999999997 108.882 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -68.79 147.55 69.33 Favored 'Trans proline' 0 C--N 1.369 1.647 0 C-N-CA 122.108 1.872 . . . . 74.409999999999997 111.159 167.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -54.43 -45.69 99.28 Favored Pre-proline 0 N--CA 1.487 1.38 0 CA-C-O 118.3 -0.857 . . . . 55.409999999999997 111.784 174.029 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -50.85 -40.43 57.48 Favored 'Trans proline' 0 C--N 1.405 3.536 0 C-N-CA 122.172 1.915 . . . . 54.030000000000001 113.169 172.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -84.64 -23.25 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 109.398 -0.593 . . . . 75.120000000000005 109.398 -175.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.498 ' HA ' HG22 ' A' ' 227' ' ' THR . . . -74.2 -39.57 63.07 Favored 'General case' 0 C--O 1.246 0.902 0 C-N-CA 123.06 0.544 . . . . 61.119999999999997 111.515 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 25.1 t -88.73 -36.92 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-N 114.558 -1.201 . . . . 75.200000000000003 112.598 -178.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 73.4 t -98.72 -41.02 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 O-C-N 122.136 -0.352 . . . . 73.299999999999997 110.807 -176.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 123.13 150.38 8.04 Favored Glycine 0 N--CA 1.475 1.236 0 CA-C-N 118.248 0.476 . . . . 55.329999999999998 112.068 177.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.91 153.6 7.57 Favored Glycine 0 C--N 1.343 0.946 0 N-CA-C 112.356 -0.297 . . . . 42.219999999999999 112.356 177.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 37.1 ttmt -84.63 131.95 34.54 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 122.945 0.498 . . . . 71.310000000000002 110.026 175.543 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.649 HG21 HG22 ' A' ' 199' ' ' VAL . 12.6 m -135.44 150.56 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.78 1.232 . . . . 72.319999999999993 108.639 -177.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -95.81 142.52 27.98 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.032 0.533 . . . . 74.319999999999993 110.563 -169.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.593 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -130.74 123.62 29.63 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.728 0.811 . . . . 53.299999999999997 109.301 -176.721 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 35.7 tpp -78.78 111.01 14.48 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 115.621 -0.718 . . . . 73.409999999999997 109.502 174.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 46.0 p -119.59 -177.05 3.29 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.955 0.902 . . . . 75.299999999999997 110.998 -174.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.571 HD21 ' HD3' ' A' ' 241' ' ' PRO . 59.6 tp -49.4 -51.16 36.93 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.465 1.106 . . . . 51.329999999999998 111.114 167.635 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -71.84 -25.75 62.1 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 113.444 -1.707 . . . . 74.430000000000007 111.002 -171.054 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 135.14 -166.6 24.37 Favored Glycine 0 C--N 1.342 0.897 0 N-CA-C 111.136 -0.786 . . . . 72.040000000000006 111.136 178.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -66.79 128.79 19.57 Favored 'Trans proline' 0 C--N 1.364 1.357 0 C-N-CA 121.44 1.427 . . . . 63.509999999999998 109.852 171.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.4 HG22 ' O ' ' A' ' 212' ' ' ALA . 27.3 m -130.19 160.2 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.159 0.584 . . . . 73.540000000000006 110.143 -176.102 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.557 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 44.2 mt-10 -111.72 115.8 29.68 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.868 0.867 . . . . 65.519999999999996 109.016 -174.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.475 HG22 HG11 ' A' ' 168' ' ' VAL . 60.2 t -125.34 104.14 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 124.633 1.173 . . . . 61.240000000000002 110.414 -168.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.562 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -74.59 117.26 16.21 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.846 -0.427 . . . . 63.039999999999999 109.846 175.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 32.9 m -90.93 151.74 43.69 Favored Pre-proline 0 N--CA 1.482 1.168 0 C-N-CA 122.803 0.441 . . . . 71.109999999999999 109.96 179.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 224' ' ' PRO . . . . . 0.528 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 39.3 Cg_endo -65.17 166.03 20.19 Favored 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 122.535 2.157 . . . . 45.210000000000001 113.284 178.528 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -79.2 35.5 0.56 Allowed 'Trans proline' 0 C--N 1.37 1.673 0 C-N-CA 122.803 2.336 . . . . 62.43 112.626 167.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 19.3 tpt180 -147.88 -10.65 0.39 Allowed 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.339 0.496 . . . . 71.010000000000005 112.339 -178.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.554 HG23 HG11 ' A' ' 253' ' ' VAL . 0.6 OUTLIER -61.16 150.15 35.18 Favored 'General case' 0 CA--C 1.565 1.547 0 N-CA-C 109.226 -0.657 . . . . 73.040000000000006 109.226 -164.66 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 228' ' ' GLN . . . . . 0.503 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 10.7 pt20 -132.52 162.5 31.07 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 122.991 0.517 . . . . 60.310000000000002 109.917 -174.301 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 229' ' ' ALA . . . . . 0.659 ' HB1' HH21 ' A' ' 254' ' ' ARG . . . -56.91 111.47 1.04 Allowed 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 109.601 -0.518 . . . . 54.5 109.601 174.559 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.14 -0.83 22.59 Favored Glycine 0 C--N 1.336 0.553 0 CA-C-N 115.268 -0.878 . . . . 60.539999999999999 112.418 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.503 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -70.37 124.65 24.7 Favored 'General case' 0 C--N 1.358 0.939 0 N-CA-C 109.262 -0.644 . . . . 72.439999999999998 109.262 -171.129 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -98.87 96.62 7.98 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 109.599 -0.519 . . . . 74.340000000000003 109.599 -168.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.537 ' HB3' ' HA ' ' A' ' 172' ' ' SER . 19.7 mt -81.88 99.52 9.09 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 106.822 -1.547 . . . . 64.420000000000002 106.822 -175.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 234' ' ' ARG . . . . . 0.46 ' O ' ' HD2' ' A' ' 234' ' ' ARG . 5.1 ppt_? -79.84 121.52 25.5 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 123.645 0.591 . . . . 73.129999999999995 110.899 -176.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 8.1 mp -108.55 125.74 52.16 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 105.861 -1.903 . . . . 54.219999999999999 105.861 172.106 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 17.5 tptt -101.87 116.3 32.4 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 118.138 0.426 . . . . 73.439999999999998 109.929 -171.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 79.35 21.71 66.6 Favored Glycine 0 C--N 1.349 1.278 0 O-C-N 123.763 0.664 . . . . 40.009999999999998 113.834 -178.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -117.54 20.81 13.37 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.736 0.814 . . . . 71.439999999999998 109.884 -178.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -98.94 -132.61 7.75 Favored Glycine 0 C--N 1.349 1.303 0 CA-C-O 119.097 -0.835 . . . . 72.439999999999998 111.82 -178.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -70.29 152.1 95.67 Favored Pre-proline 0 N--CA 1.481 1.079 0 N-CA-C 112.943 0.72 . . . . 70.530000000000001 112.943 -172.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.571 ' HD3' HD21 ' A' ' 215' ' ' LEU . 61.0 Cg_endo -67.2 170.56 13.01 Favored 'Trans proline' 0 C--N 1.392 2.859 0 C-N-CA 122.928 2.419 . . . . 74.019999999999996 112.526 -178.471 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.432 ' N ' ' HD2' ' A' ' 243' ' ' PRO . . . -67.71 -38.58 89.95 Favored Glycine 0 CA--C 1.544 1.874 0 CA-C-O 117.973 -1.459 . . . . 75.230000000000004 114.357 -175.323 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 243' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 242' ' ' GLY . 10.1 Cg_endo -54.02 -36.28 83.87 Favored 'Trans proline' 0 C--N 1.388 2.644 0 CA-C-N 120.998 2.399 . . . . 55.539999999999999 113.438 167.379 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -81.33 -25.06 36.71 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-O 121.136 0.493 . . . . 63.509999999999998 110.125 174.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 112.22 114.8 3.37 Favored Glycine 0 C--N 1.341 0.82 0 N-CA-C 109.66 -1.376 . . . . 74.5 109.66 -168.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -72.38 122.64 21.53 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 117.825 0.812 . . . . 72.519999999999996 109.639 -177.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.579 ' HA3' ' HB3' ' A' ' 191' ' ' GLN . . . -148.34 -154.61 6.35 Favored Glycine 0 CA--C 1.503 -0.713 0 CA-C-N 116.003 -0.544 . . . . 45.140000000000001 112.315 -176.043 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 38.5 p-10 -121.46 163.54 18.61 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.507 0.723 . . . . 74.310000000000002 111.125 -167.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 9.5 tp -134.71 134.5 41.12 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.365 -0.976 . . . . 72.219999999999999 108.365 -171.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -115.81 148.46 39.87 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.471 -0.937 . . . . 71.420000000000002 108.471 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 67.7 mt -123.17 115.15 21.3 Favored 'General case' 0 C--O 1.22 -0.474 0 N-CA-C 108.29 -1.004 . . . . 53.25 108.29 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -89.38 113.54 24.87 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.618 -0.882 . . . . 73.030000000000001 108.618 -177.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.554 HG11 HG23 ' A' ' 227' ' ' THR . 50.3 t -60.75 124.79 15.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 O-C-N 124.019 0.824 . . . . 71.450000000000003 110.335 176.313 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 254' ' ' ARG . . . . . 0.659 HH21 ' HB1' ' A' ' 229' ' ' ALA . 0.5 OUTLIER -120.08 122.31 40.79 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 107.356 -1.35 . . . . 71.120000000000005 107.356 176.195 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.433 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 49.1 mm -83.8 122.36 37.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 O-C-N 123.984 0.803 . . . . 54.140000000000001 109.835 -173.301 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.2 t . . . . . 0 CA--C 1.565 1.549 0 C-N-CA 124.23 1.012 . . . . 64.450000000000003 108.822 -172.622 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 163' ' ' MET . . . . . 0.615 ' HA ' ' SD ' ' A' ' 169' ' ' MET . 26.8 ptt? . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 109.948 -0.389 . . . . 73.230000000000004 109.948 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.436 ' HB2' ' HG2' ' A' ' 169' ' ' MET . 11.6 ttmm -118.27 128.41 54.65 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 107.388 -1.338 . . . . 73.400000000000006 107.388 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -83.93 -64.61 1.13 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.365 0.666 . . . . 70.109999999999999 112.255 -162.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -97.56 12.74 64.62 Favored Glycine 0 N--CA 1.472 1.077 0 CA-C-N 116.354 -0.384 . . . . 71.219999999999999 112.167 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -142.45 174.24 10.81 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.454 1.102 . . . . 70.420000000000002 109.35 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 52.4 t -110.67 150.99 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 123.442 0.697 . . . . 72.219999999999999 110.992 -176.11 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' MET . . . . . 0.615 ' SD ' ' HA ' ' A' ' 163' ' ' MET . 53.4 mtm -99.4 -176.68 3.36 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 125.915 1.686 . . . . 75.450000000000003 110.894 -164.121 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 8.5 p -101.88 86.17 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.073 0 N-CA-C 107.195 -1.409 . . . . 72.409999999999997 107.195 160.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' MET . . . . . 0.402 ' SD ' ' HB2' ' A' ' 169' ' ' MET . 0.0 OUTLIER -124.17 -4.25 7.95 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 114.148 -1.387 . . . . 75.010000000000005 110.76 -173.365 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.477 ' HA ' ' HB3' ' A' ' 233' ' ' LEU . 67.2 m -44.1 -65.82 0.46 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.995 1.718 . . . . 65.340000000000003 114.046 -168.23 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -70.85 -46.89 61.88 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 108.601 -0.889 . . . . 62.009999999999998 108.601 -176.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 68.28 28.95 73.07 Favored Glycine 0 C--N 1.354 1.54 0 CA-C-N 114.536 -1.211 . . . . 55.030000000000001 114.489 171.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -161.0 158.31 27.75 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.031 0.443 . . . . 75.239999999999995 110.151 -177.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 16.1 p -87.96 115.76 25.66 Favored 'General case' 0 CA--C 1.555 1.163 0 N-CA-C 108.563 -0.903 . . . . 73.150000000000006 108.563 169.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -4.95 20.63 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.076 1 N-CA-C 122.062 4.097 . . . . 73.329999999999998 122.062 -159.359 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -86.9 157.5 19.5 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 119.872 1.214 . . . . 63.140000000000001 110.512 179.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -78.96 -62.43 1.7 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.235 1.014 . . . . 73.310000000000002 111.275 -173.48 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -66.82 91.81 0.19 Allowed Glycine 0 CA--C 1.529 0.943 0 O-C-N 124.366 1.041 . . . . 62.109999999999999 113.066 -175.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 29.7 p -155.84 142.73 18.94 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.593 0.757 . . . . 42.310000000000002 110.193 -177.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -134.54 -75.27 0.09 OUTLIER Glycine 0 C--N 1.343 0.972 0 CA-C-N 116.163 -0.471 . . . . 64.109999999999999 112.114 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 89.95 14.87 58.69 Favored Glycine 0 N--CA 1.473 1.137 0 O-C-N 123.824 0.367 . . . . 51.219999999999999 113.005 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 34.3 m -88.89 113.53 24.53 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.827 0.851 . . . . 52.409999999999997 109.78 178.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -170.36 165.1 38.4 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-O 120.008 -0.329 . . . . 70.230000000000004 112.883 -175.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 69.94 42.19 69.8 Favored Glycine 0 C--N 1.35 1.324 0 N-CA-C 111.907 -0.477 . . . . 44.310000000000002 111.907 -176.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 38.1 t -65.77 150.99 47.63 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.233 1.013 . . . . 70.230000000000004 113.267 -169.075 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -139.09 146.59 18.31 Favored Glycine 0 C--N 1.34 0.779 0 CA-C-N 115.031 -0.986 . . . . 74.439999999999998 110.903 173.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -62.73 -33.39 86.67 Favored Glycine 0 C--N 1.349 1.267 0 O-C-N 123.947 0.44 . . . . 72.140000000000001 113.734 -173.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 57.9 m -146.6 37.02 0.98 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.426 1.09 . . . . 70.120000000000005 109.233 174.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -105.47 -39.29 6.17 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 108.908 -0.775 . . . . 72.329999999999998 108.908 174.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -76.57 168.57 19.84 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-N 114.638 -1.165 . . . . 75.150000000000006 109.958 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 39.1 tp -152.44 142.97 22.72 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.269 -0.423 . . . . 74.409999999999997 110.104 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -116.13 138.14 51.51 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.797 0.839 . . . . 72.530000000000001 109.107 171.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -148.77 160.14 43.48 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.628 0.771 . . . . 73.510000000000005 109.42 174.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 37.9 p -84.42 154.54 22.74 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 122.276 1.036 . . . . 72.129999999999995 112.195 167.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.766 HD13 ' HB2' ' A' ' 212' ' ' ALA . 30.8 tp -120.47 134.4 55.28 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 112.844 -1.98 . . . . 53.43 106.789 165.317 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -97.52 111.72 23.87 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 109.107 -0.701 . . . . 74.340000000000003 109.107 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.65 HG22 HG21 ' A' ' 210' ' ' VAL . 28.1 t -123.01 130.98 24.39 Favored Pre-proline 0 N--CA 1.479 0.979 0 C-N-CA 124.549 1.139 . . . . 75.439999999999998 109.579 -177.431 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -69.95 144.93 54.55 Favored 'Trans proline' 0 C--N 1.366 1.489 0 C-N-CA 122.22 1.947 . . . . 43.109999999999999 111.232 165.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -53.13 -44.63 97.61 Favored Pre-proline 0 N--CA 1.487 1.413 0 CA-C-O 118.348 -0.834 . . . . 74.109999999999999 111.953 174.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -47.55 -41.49 29.87 Favored 'Trans proline' 0 C--N 1.401 3.317 0 C-N-CA 122.556 2.171 . . . . 73.530000000000001 113.416 171.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -85.91 -23.29 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 109.716 -0.476 . . . . 70.109999999999999 109.716 -175.013 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.417 ' HA ' HG22 ' A' ' 227' ' ' THR . . . -72.45 -37.76 68.45 Favored 'General case' 0 C--O 1.249 1.051 0 CA-C-O 121.05 0.452 . . . . 63.210000000000001 111.535 178.217 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 20.3 t -89.73 -36.05 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.987 0 C-N-CA 125.444 1.497 . . . . 34.030000000000001 113.168 -178.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 54.4 t -97.12 -43.14 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 O-C-N 121.998 -0.438 . . . . 72.239999999999995 110.268 -176.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 120.95 151.51 8.62 Favored Glycine 0 C--N 1.339 0.744 0 N-CA-C 110.89 -0.884 . . . . 70.349999999999994 110.89 -176.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.6 155.89 8.65 Favored Glycine 0 C--O 1.246 0.886 0 N-CA-C 112.048 -0.421 . . . . 64.340000000000003 112.048 177.235 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.594 ' HD3' ' HB3' ' A' ' 220' ' ' GLU . 38.5 ttmt -84.54 131.6 34.62 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.319 0.648 . . . . 74.510000000000005 109.519 174.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.65 HG21 HG22 ' A' ' 199' ' ' VAL . 6.7 m -134.42 154.4 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.4 1.08 . . . . 61.439999999999998 110.581 -175.548 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 2.5 tmm_? -93.32 139.92 30.13 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.569 1.147 . . . . 64.329999999999998 109.751 -171.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.766 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -132.42 122.6 25.23 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.145 0.978 . . . . 73.010000000000005 108.734 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 31.3 tpp -77.68 110.2 12.32 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.679 -0.86 . . . . 61.329999999999998 108.679 173.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 62.2 p -121.25 -179.28 4.0 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.998 0.919 . . . . 73.219999999999999 110.221 -176.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.503 HD21 ' HD3' ' A' ' 241' ' ' PRO . 61.2 tp -45.09 -52.9 8.59 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.686 1.195 . . . . 75.219999999999999 112.485 176.394 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -72.39 -27.48 62.39 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 114.218 -1.355 . . . . 73.239999999999995 111.385 -173.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 138.02 -165.11 25.47 Favored Glycine 0 C--N 1.345 1.055 0 N-CA-C 111.561 -0.616 . . . . 54.210000000000001 111.561 -176.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -67.01 129.25 20.27 Favored 'Trans proline' 0 C--N 1.369 1.62 0 C-N-CA 122.147 1.898 . . . . 61.310000000000002 111.011 175.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 30.2 m -129.72 160.23 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 123.528 0.731 . . . . 73.409999999999997 110.659 -175.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.594 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 44.4 mt-10 -113.01 114.53 27.02 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.835 0.854 . . . . 72.219999999999999 109.655 -168.243 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 61.9 t -127.34 103.43 10.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 124.87 1.268 . . . . 74.030000000000001 109.39 -166.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.511 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -77.82 116.79 18.61 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.892 -0.41 . . . . 73.400000000000006 109.892 175.672 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 29.8 m -89.35 152.04 47.12 Favored Pre-proline 0 N--CA 1.492 1.626 0 C-N-CA 123.222 0.609 . . . . 63.210000000000001 111.116 -176.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 224' ' ' PRO . . . . . 0.57 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 29.7 Cg_endo -62.21 162.47 23.16 Favored 'Trans proline' 0 C--N 1.382 2.307 0 C-N-CA 122.197 1.931 . . . . 73.239999999999995 112.517 175.711 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -85.4 30.97 0.49 Allowed 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 123.115 2.543 . . . . 73.519999999999996 112.519 176.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -149.06 3.17 0.6 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 122.747 0.419 . . . . 75.109999999999999 111.447 176.178 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.57 ' HB ' ' HG2' ' A' ' 224' ' ' PRO . 0.7 OUTLIER -61.85 155.64 22.74 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 109.829 -0.434 . . . . 64.25 109.829 -171.776 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -136.55 162.41 33.19 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.078 0.551 . . . . 74.299999999999997 110.097 -176.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 229' ' ' ALA . . . . . 0.567 ' HB1' HH21 ' A' ' 254' ' ' ARG . . . -56.15 112.25 1.17 Allowed 'General case' 0 CA--C 1.538 0.505 0 O-C-N 123.471 0.482 . . . . 44.219999999999999 109.915 174.017 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.29 -1.07 22.37 Favored Glycine 0 C--O 1.239 0.418 0 CA-C-N 114.968 -1.014 . . . . 71.140000000000001 111.982 176.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.62 129.72 40.75 Favored 'General case' 0 C--N 1.361 1.108 0 N-CA-C 109.179 -0.674 . . . . 70.040000000000006 109.179 -174.071 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm -98.67 97.69 8.92 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.977 0.911 . . . . 74.420000000000002 110.065 -170.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.477 ' HB3' ' HA ' ' A' ' 172' ' ' SER . 17.3 mt -88.09 101.04 13.41 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 107.65 -1.241 . . . . 71.409999999999997 107.65 -178.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.48 125.53 29.69 Favored 'General case' 0 CA--C 1.551 1.009 0 CA-C-O 121.164 0.507 . . . . 71.530000000000001 110.213 178.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.4 ' HB3' ' HB2' ' A' ' 238' ' ' LYS . 6.9 mp -106.04 126.77 52.6 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 105.879 -1.897 . . . . 53.140000000000001 105.879 171.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 8.1 tptp -101.32 115.75 31.23 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 109.994 -0.373 . . . . 72.120000000000005 109.994 -168.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 77.5 29.25 56.03 Favored Glycine 0 C--N 1.354 1.574 0 O-C-N 123.676 0.61 . . . . 70.140000000000001 112.676 -178.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.4 ' HB2' ' HB3' ' A' ' 235' ' ' LEU . 30.8 mmmt -124.53 23.85 8.04 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.807 0.843 . . . . 73.540000000000006 110.715 -177.098 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -94.41 -132.04 6.47 Favored Glycine 0 C--N 1.353 1.523 0 N-CA-C 111.167 -0.773 . . . . 74.140000000000001 111.167 178.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 6.2 m-30 -69.48 154.36 94.93 Favored Pre-proline 0 N--CA 1.481 1.08 0 CA-C-N 117.47 0.635 . . . . 62.520000000000003 112.043 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.503 ' HD3' HD21 ' A' ' 215' ' ' LEU . 72.8 Cg_endo -70.13 171.26 15.2 Favored 'Trans proline' 0 C--N 1.387 2.565 0 C-N-CA 122.826 2.351 . . . . 75.209999999999994 111.909 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -67.68 -38.96 90.43 Favored Glycine 0 CA--C 1.542 1.774 0 CA-C-O 118.479 -1.178 . . . . 75.230000000000004 114.078 -178.107 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 243' ' ' PRO . . . . . 0.424 ' HD2' ' HB2' ' A' ' 241' ' ' PRO . 87.8 Cg_exo -48.72 -35.19 29.56 Favored 'Trans proline' 0 C--N 1.383 2.36 0 C-N-CA 123.054 2.503 . . . . 70.430000000000007 114.09 165.267 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -88.3 -24.62 23.13 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.457 0.703 . . . . 51.310000000000002 110.998 174.037 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 105.76 115.23 4.03 Favored Glycine 0 C--N 1.345 1.06 0 N-CA-C 109.192 -1.563 . . . . 73.420000000000002 109.192 -169.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 35.3 mtt180 -73.1 134.07 44.38 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 122.988 0.515 . . . . 62.149999999999999 112.145 -178.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -145.75 -155.91 6.67 Favored Glycine 0 C--O 1.242 0.606 0 CA-C-N 114.654 -1.157 . . . . 53.530000000000001 110.304 174.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 12.6 p30 -118.01 168.03 10.91 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 122.949 0.5 . . . . 50.409999999999997 110.083 -175.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 9.7 tp -134.42 133.3 40.37 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 107.862 -1.162 . . . . 74.409999999999997 107.862 -172.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 10.0 m-30 -114.26 149.46 35.86 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.761 -0.829 . . . . 64.040000000000006 108.761 -177.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.403 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 92.1 mt -123.76 121.94 36.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.546 -0.752 . . . . 74.340000000000003 109.038 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -88.76 112.55 23.31 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 107.289 -1.375 . . . . 71.109999999999999 107.289 174.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.497 HG11 HG23 ' A' ' 227' ' ' THR . 54.1 t -60.8 123.47 13.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 108.868 -0.789 . . . . 62.119999999999997 108.868 173.586 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 254' ' ' ARG . . . . . 0.567 HH21 ' HB1' ' A' ' 229' ' ' ALA . 0.4 OUTLIER -114.65 123.29 48.92 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 106.71 -1.589 . . . . 73.040000000000006 106.71 176.411 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 38.1 mm -86.78 119.99 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 O-C-N 123.783 0.677 . . . . 74.319999999999993 109.721 -176.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.3 t . . . . . 0 CA--C 1.562 1.413 0 C-N-CA 125.292 1.437 . . . . 63.009999999999998 107.669 -170.533 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 163' ' ' MET . . . . . 0.446 ' N ' ' SD ' ' A' ' 163' ' ' MET . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.372 0 N-CA-C 109.268 -0.641 . . . . 50.329999999999998 109.268 . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -147.94 132.21 17.47 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.799 0.84 . . . . 64.530000000000001 110.201 176.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -89.2 -38.66 14.1 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.677 0.791 . . . . 51.43 111.972 -169.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -95.31 21.96 41.35 Favored Glycine 0 N--CA 1.476 1.359 0 N-CA-C 112.553 -0.219 . . . . 60.25 112.553 -174.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -153.63 173.24 16.03 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 124.579 1.151 . . . . 51.210000000000001 109.195 175.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.423 HG11 HG22 ' A' ' 221' ' ' VAL . 55.4 t -110.64 152.75 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 123.798 0.839 . . . . 72.519999999999996 110.39 -177.656 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 48.8 mtm -98.29 -176.2 3.33 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.88 1.672 . . . . 64.219999999999999 110.074 -168.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 8.7 p -101.71 88.47 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.026 0 CA-C-O 123.125 1.441 . . . . 72.230000000000004 108.079 161.184 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' MET . . . . . 0.417 ' HG3' ' HA ' ' A' ' 235' ' ' LEU . 0.0 OUTLIER -123.81 -6.03 7.99 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 113.717 -1.583 . . . . 73.200000000000003 110.021 -177.129 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.459 ' HA ' ' HB3' ' A' ' 233' ' ' LEU . 68.5 m -37.64 -64.63 0.37 Allowed 'General case' 0 C--N 1.351 0.643 0 C-N-CA 126.97 2.108 . . . . 44.229999999999997 114.379 -168.68 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' TYR . . . . . 0.43 ' HB2' ' HB3' ' A' ' 224' ' ' PRO . 53.3 t80 -63.51 -53.37 53.02 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 123.661 0.6 . . . . 74.230000000000004 109.639 -174.482 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 64.15 -15.45 0.13 Allowed Glycine 0 CA--C 1.542 1.747 0 N-CA-C 115.937 1.135 . . . . 74.420000000000002 115.937 176.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -78.58 107.76 11.49 Favored 'General case' 0 C--N 1.349 0.566 0 C-N-CA 124.151 0.98 . . . . 72.310000000000002 108.725 -175.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 33.0 m -67.29 123.19 19.65 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 117.69 -1.148 . . . . 75.409999999999997 107.913 169.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -11.24 -46.72 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.806 0 C-N-CA 128.576 2.75 . . . . 65.340000000000003 116.884 -164.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -58.18 168.37 1.06 Allowed 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 124.647 1.179 . . . . 61.020000000000003 111.868 176.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -78.48 -6.16 54.61 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.164 0.585 . . . . 72.010000000000005 112.403 -179.087 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -76.65 -115.36 0.14 Allowed Glycine 0 CA--C 1.534 1.278 0 CA-C-O 119.899 -0.389 . . . . 60.149999999999999 113.691 -176.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 38.5 m 63.06 -83.14 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.904 1.281 . . . . 74.329999999999998 113.058 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 73.45 -88.65 0.61 Allowed Glycine 0 C--N 1.352 1.452 0 N-CA-C 111.64 -0.584 . . . . 23.140000000000001 111.64 -173.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 72.86 75.73 0.69 Allowed Glycine 0 C--N 1.351 1.414 0 C-N-CA 123.025 0.345 . . . . 72.510000000000005 113.275 173.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 34.5 p -138.45 123.1 18.62 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.501 0.72 . . . . 53.109999999999999 109.627 178.059 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -83.54 -77.83 1.1 Allowed Glycine 0 C--N 1.341 0.814 0 N-CA-C 110.757 -0.937 . . . . 41.030000000000001 110.757 177.563 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 86.32 -89.13 1.61 Allowed Glycine 0 C--N 1.342 0.892 0 CA-C-O 119.855 -0.414 . . . . 61.340000000000003 112.738 176.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 32.9 t 68.84 176.8 0.27 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 125.444 1.497 . . . . 53.210000000000001 111.236 -171.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -123.04 37.74 2.7 Favored Glycine 0 C--N 1.348 1.243 0 O-C-N 122.038 -0.414 . . . . 51.409999999999997 112.481 -177.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -120.5 11.97 10.34 Favored Glycine 0 N--CA 1.471 1.002 0 CA-C-O 119.18 -0.789 . . . . 53.200000000000003 113.852 -175.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 19.5 m 63.4 43.72 5.88 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 124.055 0.942 . . . . 62.520000000000003 110.652 -177.382 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -107.2 -37.5 6.25 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.817 1.247 . . . . 65.310000000000002 110.636 -172.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 35.1 p-10 -75.54 172.83 11.88 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-N 115.7 -0.682 . . . . 65.299999999999997 110.578 178.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.414 HD13 ' CE1' ' A' ' 240' ' ' PHE . 33.9 tp -152.96 140.7 20.0 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.878 -0.601 . . . . 73.420000000000002 110.545 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -112.36 137.95 49.78 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.508 -0.769 . . . . 72.420000000000002 108.927 169.507 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.417 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -148.13 158.01 43.83 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 107.919 -1.141 . . . . 73.319999999999993 107.919 170.069 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 25.1 p -89.87 154.11 20.13 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 122.188 0.994 . . . . 65.200000000000003 112.511 169.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.68 HD13 ' HB2' ' A' ' 212' ' ' ALA . 22.2 tp -124.28 132.84 53.59 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 112.997 -1.911 . . . . 61.310000000000002 107.352 164.541 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -94.72 113.7 25.51 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 108.372 -0.973 . . . . 73.530000000000001 108.372 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.637 HG22 HG21 ' A' ' 210' ' ' VAL . 24.8 t -118.0 130.9 24.43 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 114.95 -1.023 . . . . 74.040000000000006 108.578 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.494 ' HG2' ' HB ' ' A' ' 203' ' ' ILE . 59.3 Cg_endo -73.76 149.76 43.5 Favored 'Trans proline' 0 C--N 1.366 1.475 0 C-N-CA 121.47 1.447 . . . . 73.230000000000004 110.833 168.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -53.45 -44.71 98.14 Favored Pre-proline 0 N--CA 1.483 1.202 0 CA-C-O 118.193 -0.908 . . . . 50.140000000000001 112.186 177.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.453 ' HD2' ' HB2' ' A' ' 200' ' ' PRO . 86.0 Cg_exo -50.56 -41.22 53.67 Favored 'Trans proline' 0 C--N 1.399 3.223 0 C-N-CA 122.46 2.107 . . . . 71.519999999999996 113.525 173.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.494 ' HB ' ' HG2' ' A' ' 200' ' ' PRO . 1.8 mp -86.42 -23.07 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 N-CA-C 109.718 -0.475 . . . . 74.310000000000002 109.718 -176.403 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -72.57 -36.71 68.25 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 122.934 0.494 . . . . 73.109999999999999 111.044 177.586 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 25.4 t -89.56 -36.37 8.57 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 125.663 1.585 . . . . 72.230000000000004 112.873 -178.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 50.2 t -98.23 -42.58 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 O-C-N 121.663 -0.648 . . . . 64.0 110.91 -176.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 120.82 153.95 9.19 Favored Glycine 0 C--N 1.341 0.855 0 N-CA-C 110.704 -0.958 . . . . 42.5 110.704 -176.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 161.03 154.94 7.61 Favored Glycine 0 C--O 1.245 0.786 0 N-CA-C 111.57 -0.612 . . . . 41.130000000000003 111.57 177.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 39.3 ttmt -86.54 128.95 35.02 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.905 0.352 . . . . 63.310000000000002 110.655 176.041 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.637 HG21 HG22 ' A' ' 199' ' ' VAL . 13.5 m -130.74 144.51 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.958 1.303 . . . . 74.340000000000003 108.533 -179.394 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 24.2 ttt180 -97.08 141.62 30.0 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.059 0.943 . . . . 73.140000000000001 110.437 -167.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.68 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -133.18 124.75 28.02 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.429 1.491 . . . . 72.030000000000001 110.187 -168.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 33.6 tpp -77.48 114.95 16.83 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 109.024 -0.732 . . . . 73.129999999999995 109.024 174.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 63.0 p -124.16 -176.3 3.46 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.193 0.997 . . . . 61.240000000000002 110.292 -177.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.537 HD21 ' HD3' ' A' ' 241' ' ' PRO . 66.9 tp -47.24 -51.58 18.38 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.623 1.169 . . . . 72.239999999999995 112.657 176.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -72.01 -27.22 62.58 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 114.75 -1.114 . . . . 74.209999999999994 111.085 -172.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 137.14 -165.2 25.22 Favored Glycine 0 C--O 1.244 0.774 0 N-CA-C 110.702 -0.959 . . . . 53.420000000000002 110.702 -173.046 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.79 131.54 24.44 Favored 'Trans proline' 0 CA--C 1.549 1.226 0 C-N-CA 121.979 1.786 . . . . 73.329999999999998 111.187 175.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 25.7 m -129.65 157.25 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 124.087 0.955 . . . . 74.450000000000003 108.742 -179.369 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.538 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 47.0 mt-10 -115.24 117.23 29.91 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-O 121.145 0.498 . . . . 71.120000000000005 111.358 -176.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.423 HG22 HG11 ' A' ' 168' ' ' VAL . 100.0 t -121.86 107.15 19.31 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 125.65 1.58 . . . . 61.43 110.893 -165.697 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.603 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -75.19 118.19 17.84 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.583 0.353 . . . . 71.420000000000002 111.122 176.513 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 26.8 m -89.6 154.4 48.32 Favored Pre-proline 0 N--CA 1.489 1.48 0 C-N-CA 123.71 0.804 . . . . 71.430000000000007 111.693 -176.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 224' ' ' PRO . . . . . 0.566 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 34.2 Cg_endo -63.02 164.04 20.63 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 122.658 2.239 . . . . 74.120000000000005 113.057 174.033 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -87.08 32.13 0.44 Allowed 'Trans proline' 0 C--N 1.37 1.66 0 C-N-CA 122.779 2.319 . . . . 74.219999999999999 113.19 174.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -147.97 1.46 0.66 Allowed 'General case' 0 N--CA 1.485 1.29 0 CA-C-O 118.903 -0.57 . . . . 65.019999999999996 112.333 175.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.566 ' HB ' ' HG2' ' A' ' 224' ' ' PRO . 0.7 OUTLIER -60.57 154.64 20.57 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 123.466 0.479 . . . . 44.43 110.406 -168.144 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 228' ' ' GLN . . . . . 0.48 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 4.9 pt20 -134.38 161.19 35.68 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.27 0.628 . . . . 71.030000000000001 110.698 -174.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -60.29 112.15 1.82 Allowed 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.906 -0.405 . . . . 63.310000000000002 109.906 176.299 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.41 0.75 21.96 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-N 115.083 -0.962 . . . . 63.020000000000003 112.122 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.48 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -72.81 126.05 28.99 Favored 'General case' 0 C--N 1.359 0.98 0 N-CA-C 108.835 -0.802 . . . . 63.109999999999999 108.835 -174.735 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -97.17 98.15 9.78 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 108.255 -1.016 . . . . 71.349999999999994 108.255 -173.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.459 ' HB3' ' HA ' ' A' ' 172' ' ' SER . 30.9 mt -77.96 99.94 6.24 Favored 'General case' 0 C--N 1.343 0.297 0 N-CA-C 106.803 -1.555 . . . . 52.420000000000002 106.803 -179.271 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 234' ' ' ARG . . . . . 0.521 ' HB2' ' HE2' ' A' ' 236' ' ' LYS . 0.0 OUTLIER -81.4 111.42 17.74 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 114.282 -1.326 . . . . 64.420000000000002 111.642 -173.952 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.527 ' O ' ' HB2' ' A' ' 248' ' ' ASP . 7.3 mp -100.28 127.85 46.48 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 106.193 -1.78 . . . . 22.120000000000001 106.193 173.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.521 ' HE2' ' HB2' ' A' ' 234' ' ' ARG . 5.3 mptp? -101.48 119.49 38.85 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.46 0.704 . . . . 73.310000000000002 110.868 -175.308 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 78.19 23.58 65.62 Favored Glycine 0 C--N 1.354 1.546 0 O-C-N 123.89 0.744 . . . . 41.43 112.662 -179.085 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.496 ' HB2' ' HB3' ' A' ' 235' ' ' LEU . 26.8 mmmt -119.06 21.28 12.42 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.297 1.039 . . . . 60.530000000000001 111.052 -175.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -94.12 -128.6 5.19 Favored Glycine 0 C--N 1.345 1.043 0 N-CA-C 110.243 -1.143 . . . . 74.109999999999999 110.243 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 240' ' ' PHE . . . . . 0.436 ' O ' ' HA ' ' A' ' 246' ' ' ARG . 7.3 m-30 -70.98 152.41 94.95 Favored Pre-proline 0 CA--C 1.551 0.985 0 CA-C-N 117.479 0.64 . . . . 70.040000000000006 111.668 178.716 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.537 ' HD3' HD21 ' A' ' 215' ' ' LEU . 48.2 Cg_endo -64.92 171.8 8.15 Favored 'Trans proline' 0 C--N 1.387 2.6 0 C-N-CA 123.182 2.588 . . . . 74.329999999999998 112.166 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -66.19 -41.87 94.62 Favored Glycine 0 CA--C 1.541 1.706 0 CA-C-O 118.489 -1.173 . . . . 55.450000000000003 113.445 -177.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 243' ' ' PRO . . . . . 0.449 ' HD2' ' HB2' ' A' ' 241' ' ' PRO . 81.4 Cg_exo -54.67 -39.9 86.84 Favored 'Trans proline' 0 C--N 1.388 2.632 0 C-N-CA 122.556 2.171 . . . . 61.399999999999999 114.095 168.668 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -76.68 -22.43 54.0 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.479 0.712 . . . . 71.230000000000004 110.646 177.186 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 106.93 111.78 3.61 Favored Glycine 0 C--N 1.343 0.953 0 N-CA-C 108.679 -1.768 . . . . 62.509999999999998 108.679 -172.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.436 ' HA ' ' O ' ' A' ' 240' ' ' PHE . 54.1 ttp180 -73.4 124.66 26.21 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 117.086 0.443 . . . . 62.140000000000001 110.76 -174.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -135.84 -158.8 8.3 Favored Glycine 0 CA--C 1.505 -0.552 0 N-CA-C 110.488 -1.045 . . . . 43.200000000000003 110.488 174.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 248' ' ' ASP . . . . . 0.527 ' HB2' ' O ' ' A' ' 235' ' ' LEU . 34.2 p-10 -123.14 161.96 23.42 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.137 0.575 . . . . 72.219999999999999 110.125 -174.796 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 8.4 tp -132.0 134.89 46.09 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 108.375 -0.972 . . . . 43.520000000000003 108.375 -168.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -115.67 148.96 39.1 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 108.53 -0.915 . . . . 74.329999999999998 108.53 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.417 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 75.0 mt -122.38 112.49 18.15 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 108.594 -0.891 . . . . 71.109999999999999 108.594 179.045 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -89.76 112.28 23.53 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.285 -1.006 . . . . 70.209999999999994 108.285 -173.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.505 HG11 HG23 ' A' ' 227' ' ' THR . 53.8 t -61.6 125.9 18.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 114.969 -1.014 . . . . 72.519999999999996 110.222 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 41.8 mtp180 -115.54 122.51 45.9 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 106.571 -1.64 . . . . 74.319999999999993 106.571 171.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.459 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 46.8 mm -83.76 123.57 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 122.665 0.386 . . . . 62.130000000000003 110.123 -175.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.2 t . . . . . 0 CA--C 1.561 1.4 0 C-N-CA 124.273 1.029 . . . . 75.430000000000007 109.056 -172.275 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 53.8 t . . . . . 0 N--CA 1.471 0.591 0 CA-C-O 121.49 0.662 . . . . 73.12 110.395 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 44.8 mtm -102.64 -175.54 2.85 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.183 1.793 . . . . 65.14 110.132 -166.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 8.3 p -94.25 87.7 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.115 0 CA-C-O 123.196 1.474 . . . . 74.01 108.037 159.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.28 -5.09 7.81 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 113.737 -1.574 . . . . 73.3 110.308 -177.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.51 ' HA ' ' HB3' ' A' ' 233' ' ' LEU . 69.9 m -37.54 -63.48 0.45 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.972 2.109 . . . . 35.41 114.488 -170.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 62.0 t80 . . . . . 0 N--CA 1.477 0.889 0 CA-C-O 121.116 0.484 . . . . 73.12 111.234 -172.517 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 . . . . . 0 N--CA 1.475 0.789 0 N-CA-C 108.071 -1.085 . . . . 63.52 108.071 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -74.39 170.06 16.41 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 114.587 -1.188 . . . . 72.3 110.086 175.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 35.6 tp -152.71 139.08 18.5 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 115.904 -0.589 . . . . 71.44 109.5 176.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -112.5 139.94 47.66 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.53 -0.915 . . . . 74.44 108.53 169.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -147.76 156.35 42.65 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.464 -0.939 . . . . 44.1 108.464 166.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 20.4 p -84.28 150.94 25.08 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 122.446 1.117 . . . . 63.42 112.248 169.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.599 HD13 ' HB2' ' A' ' 212' ' ' ALA . 36.7 tp -126.03 133.66 51.67 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 113.063 -1.881 . . . . 71.34 106.774 170.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.442 ' HB2' HG21 ' A' ' 256' ' ' THR . 12.7 p-10 -94.69 111.55 23.32 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 108.535 -0.913 . . . . 74.13 108.535 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.596 HG22 HG21 ' A' ' 210' ' ' VAL . 58.1 t -115.94 129.48 25.15 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-N 114.783 -1.099 . . . . 73.21 108.884 -179.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -65.73 146.41 83.73 Favored 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 122.398 2.066 . . . . 73.32 111.513 169.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.436 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.62 -45.7 98.56 Favored Pre-proline 0 CA--C 1.565 1.527 0 C-N-CA 123.612 0.765 . . . . 75.24 111.918 174.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 27.6 Cg_endo -61.06 -31.03 90.52 Favored 'Trans proline' 0 C--N 1.404 3.462 0 C-N-CA 122.293 1.996 . . . . 74.32 112.618 176.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -86.25 -24.17 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 N-CA-C 108.962 -0.755 . . . . 70.21 108.962 -177.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -74.25 -37.03 63.88 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 123.079 0.552 . . . . 71.13 110.764 178.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 28.4 t -87.45 -38.71 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 O-C-N 124.68 1.238 . . . . 74.21 112.711 -178.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 54.9 t -98.4 -42.26 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 O-C-N 121.953 -0.467 . . . . 72.35 111.149 -175.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 123.06 155.56 9.34 Favored Glycine 0 C--N 1.339 0.732 0 N-CA-C 111.021 -0.832 . . . . 41.25 111.021 -175.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 161.38 156.09 8.16 Favored Glycine 0 C--O 1.245 0.819 0 N-CA-C 111.29 -0.724 . . . . 74.4 111.29 177.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.618 ' HD3' ' HB3' ' A' ' 220' ' ' GLU . 37.3 ttmt -84.28 136.66 33.83 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 109.437 -0.579 . . . . 44.44 109.437 175.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.596 HG21 HG22 ' A' ' 199' ' ' VAL . 11.4 m -135.16 151.48 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.363 1.065 . . . . 73.4 108.776 175.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . 0.402 ' HD2' ' N ' ' A' ' 212' ' ' ALA . 2.2 tmm_? -96.34 141.79 29.25 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.419 0.688 . . . . 61.43 109.734 -171.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.599 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -131.1 123.88 29.57 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.536 0.734 . . . . 34.0 109.03 -177.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 37.8 tpp -80.36 109.78 15.18 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 107.837 -1.172 . . . . 71.23 107.837 172.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 73.4 p -113.0 -172.64 2.09 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.418 0.687 . . . . 63.3 110.536 -176.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.626 HD21 ' HD3' ' A' ' 241' ' ' PRO . 66.6 tp -46.18 -50.82 15.23 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.439 1.095 . . . . 72.33 111.598 170.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -72.09 -30.05 64.71 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.055 -0.975 . . . . 45.11 111.753 -174.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 132.45 -164.45 23.91 Favored Glycine 0 C--N 1.342 0.871 0 CA-C-O 119.344 -0.698 . . . . 75.52 111.676 -170.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -66.68 129.02 20.1 Favored 'Trans proline' 0 C--N 1.374 1.89 0 C-N-CA 122.437 2.091 . . . . 75.31 111.346 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.445 HG22 ' O ' ' A' ' 212' ' ' ALA . 28.4 m -134.26 164.17 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 123.472 0.709 . . . . 74.22 110.975 -175.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.618 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 41.9 mt-10 -109.07 114.61 28.49 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.257 1.023 . . . . 64.05 108.689 -171.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 34.9 t -125.6 100.81 7.4 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 123.471 0.709 . . . . 74.13 109.665 -174.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.555 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -79.21 117.6 20.38 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 122.556 0.342 . . . . 60.33 110.243 174.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 30.2 m -88.09 152.12 50.18 Favored Pre-proline 0 N--CA 1.49 1.569 0 C-N-CA 123.253 0.621 . . . . 62.41 111.877 -175.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . 0.523 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 33.5 Cg_endo -63.62 163.71 23.46 Favored 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 122.651 2.234 . . . . 72.31 113.432 176.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -84.16 33.73 0.51 Allowed 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 123.237 2.625 . . . . 74.2 113.263 175.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . 0.418 ' HD2' ' HA ' ' A' ' 226' ' ' ARG . 10.0 tpt180 -150.07 -1.61 0.41 Allowed 'General case' 0 N--CA 1.477 0.897 0 O-C-N 121.805 -0.559 . . . . 73.32 112.217 175.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.576 HG23 HG11 ' A' ' 253' ' ' VAL . 0.6 OUTLIER -59.6 152.45 22.18 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 123.683 0.615 . . . . 71.34 109.639 -164.457 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . 0.492 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 5.2 pt20 -132.46 161.42 33.74 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.081 0.553 . . . . 75.25 110.29 -169.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -60.47 112.11 1.84 Allowed 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 109.818 -0.438 . . . . 50.32 109.818 174.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.25 -3.31 22.23 Favored Glycine 0 C--O 1.244 0.774 0 CA-C-N 115.269 -0.878 . . . . 71.02 111.895 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.492 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -67.79 126.85 30.71 Favored 'General case' 0 C--N 1.361 1.078 0 N-CA-C 109.016 -0.735 . . . . 75.22 109.016 -172.114 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -97.27 98.73 10.24 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 108.944 -0.761 . . . . 74.12 108.944 -173.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.51 ' HB3' ' HA ' ' A' ' 172' ' ' SER . 31.5 mt -79.16 100.78 7.59 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.059 -1.46 . . . . 63.51 107.059 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -79.69 124.97 29.06 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 124.381 1.05 . . . . 64.23 110.164 -175.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.583 ' HB3' ' HB2' ' A' ' 238' ' ' LYS . 7.1 mp -111.41 123.94 51.24 Favored 'General case' 0 C--O 1.219 -0.504 0 N-CA-C 104.769 -2.308 . . . . 70.45 104.769 170.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.478 ' HA ' ' HB3' ' A' ' 248' ' ' ASP . 44.2 tptt -103.07 117.34 34.35 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 118.92 0.782 . . . . 72.43 110.58 -171.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 79.03 27.03 57.05 Favored Glycine 0 C--N 1.345 1.045 0 O-C-N 123.429 0.455 . . . . 55.35 112.012 -175.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.583 ' HB2' ' HB3' ' A' ' 235' ' ' LEU . 29.4 mmmt -128.82 24.0 5.72 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.219 1.008 . . . . 72.0 111.68 -176.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . 0.455 ' HA2' ' HB2' ' A' ' 249' ' ' LEU . . . -95.73 -129.47 5.92 Favored Glycine 0 N--CA 1.469 0.876 0 N-CA-C 110.857 -0.897 . . . . 64.33 110.857 178.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . 0.459 ' O ' ' HA ' ' A' ' 246' ' ' ARG . 4.8 m-30 -68.58 153.13 96.16 Favored Pre-proline 0 CA--C 1.548 0.894 0 CA-C-N 117.374 0.587 . . . . 51.34 111.45 177.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.626 ' HD3' HD21 ' A' ' 215' ' ' LEU . 89.3 Cg_endo -69.95 172.64 12.45 Favored 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 123.346 2.697 . . . . 73.43 112.74 -174.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -66.33 -38.19 93.46 Favored Glycine 0 CA--C 1.545 1.943 0 CA-C-O 118.353 -1.248 . . . . 75.02 113.733 -178.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . 0.592 ' HD2' ' HB2' ' A' ' 241' ' ' PRO . 79.3 Cg_exo -52.75 -39.05 78.05 Favored 'Trans proline' 0 C--N 1.392 2.859 0 CA-C-N 120.918 2.359 . . . . 62.2 113.619 167.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -78.73 -23.5 45.43 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.583 0.753 . . . . 71.33 110.635 175.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 102.83 113.3 3.77 Favored Glycine 0 C--N 1.342 0.864 0 N-CA-C 108.4 -1.88 . . . . 40.23 108.4 -168.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.459 ' HA ' ' O ' ' A' ' 240' ' ' PHE . 15.9 ttp180 -70.81 131.22 43.47 Favored 'General case' 0 C--N 1.348 0.526 0 CA-C-N 117.473 0.636 . . . . 72.54 110.033 -172.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -136.23 -157.15 7.7 Favored Glycine 0 CA--C 1.502 -0.775 0 N-CA-C 110.879 -0.888 . . . . 63.42 110.879 176.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . 0.478 ' HB3' ' HA ' ' A' ' 236' ' ' LYS . 0.4 OUTLIER -124.24 159.03 31.08 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.698 0.799 . . . . 71.12 111.081 -175.945 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.455 ' HB2' ' HA2' ' A' ' 239' ' ' GLY . 8.0 tp -130.12 135.35 48.12 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.222 1.009 . . . . 72.35 108.512 -167.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -118.86 146.35 44.94 Favored 'General case' 0 C--O 1.247 0.922 0 N-CA-C 107.137 -1.431 . . . . 75.13 107.137 -174.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.459 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 71.1 mt -123.04 114.21 20.08 Favored 'General case' 0 C--O 1.223 -0.329 0 N-CA-C 108.078 -1.082 . . . . 50.11 108.078 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -88.59 111.71 22.2 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 107.712 -1.218 . . . . 72.25 107.712 -175.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.576 HG11 HG23 ' A' ' 227' ' ' THR . 56.0 t -62.06 127.35 21.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 114.871 -1.058 . . . . 65.11 110.176 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 14.5 mmt85 -117.1 122.24 43.58 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 106.89 -1.522 . . . . 73.43 106.89 173.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 46.3 mm -82.65 118.55 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 115.491 -0.777 . . . . 74.54 110.411 -174.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . 0.442 HG21 ' HB2' ' A' ' 198' ' ' ASP . 1.4 t . . . . . 0 CA--C 1.556 1.188 0 C-N-CA 124.928 1.291 . . . . 74.14 107.697 -175.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.407 HG11 HG22 ' A' ' 221' ' ' VAL . 56.1 t . . . . . 0 N--CA 1.476 0.872 0 CA-C-O 121.761 0.791 . . . . 72.43 111.715 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 46.2 mtm -99.38 -176.72 3.37 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.794 1.638 . . . . 74.32 109.898 -169.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 8.7 p -94.5 87.11 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.027 0 CA-C-O 122.986 1.375 . . . . 75.41 108.324 163.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.57 -4.84 7.68 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 125.552 1.541 . . . . 62.32 110.024 -178.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 68.4 m -41.85 -64.81 0.52 Allowed 'General case' 0 C--O 1.246 0.909 0 C-N-CA 126.369 1.868 . . . . 74.25 113.042 -168.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . 0.623 ' HB2' ' HB3' ' A' ' 224' ' ' PRO . 63.1 t80 . . . . . 0 C--N 1.352 0.696 0 N-CA-C 108.764 -0.828 . . . . 73.4 108.764 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 . . . . . 0 N--CA 1.477 0.915 0 CA-C-O 121.079 0.466 . . . . 73.45 111.076 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.58 171.03 15.32 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-N 115.187 -0.915 . . . . 52.32 109.299 -176.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.423 ' O ' ' HA ' ' A' ' 249' ' ' LEU . 37.1 tp -152.3 131.53 12.78 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.44 -0.948 . . . . 61.21 108.44 174.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -117.26 138.29 51.83 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 123.41 0.684 . . . . 74.55 109.158 171.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -148.14 165.79 29.81 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.49 1.116 . . . . 73.52 108.165 176.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . 0.435 HG21 ' HE ' ' A' ' 254' ' ' ARG . 39.8 p -93.67 154.74 17.65 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 122.395 1.093 . . . . 50.02 112.275 168.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.638 HD13 ' HB2' ' A' ' 212' ' ' ALA . 35.4 tp -125.6 132.16 52.57 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 112.767 -2.015 . . . . 75.34 106.421 165.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -95.27 117.42 30.24 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 107.879 -1.156 . . . . 73.04 107.879 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.592 HG22 HG21 ' A' ' 210' ' ' VAL . 58.0 t -119.57 131.55 24.34 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 124.353 1.061 . . . . 72.34 110.019 -178.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -65.1 144.23 81.03 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.326 2.017 . . . . 61.15 111.418 168.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.451 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.47 -44.94 98.62 Favored Pre-proline 0 CA--C 1.564 1.517 0 C-N-CA 123.799 0.84 . . . . 72.31 112.167 174.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 17.8 Cg_endo -58.72 -33.45 98.35 Favored 'Trans proline' 0 C--N 1.404 3.499 0 C-N-CA 121.784 1.656 . . . . 73.24 112.361 175.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -86.06 -23.61 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 N-CA-C 109.357 -0.609 . . . . 75.12 109.357 -177.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -74.12 -39.33 63.41 Favored 'General case' 0 C--O 1.243 0.729 0 C-N-CA 123.046 0.538 . . . . 40.04 110.897 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 38.6 t -89.42 -36.05 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.818 1.247 . . . . 61.15 112.962 -178.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.436 ' HB ' ' O ' ' A' ' 202' ' ' PRO . 47.6 t -95.98 -41.47 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 O-C-N 121.538 -0.726 . . . . 72.11 110.184 -177.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 121.57 152.12 8.66 Favored Glycine 0 C--N 1.344 0.98 0 N-CA-C 110.57 -1.012 . . . . 63.31 110.57 -178.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.89 155.99 8.77 Favored Glycine 0 C--O 1.242 0.606 0 N-CA-C 112.289 -0.324 . . . . 65.23 112.289 176.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.619 ' HD3' ' HB3' ' A' ' 220' ' ' GLU . 38.3 ttmt -84.25 132.47 34.64 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.049 0.54 . . . . 71.42 109.781 175.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.592 HG21 HG22 ' A' ' 199' ' ' VAL . 8.3 m -131.07 150.62 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.674 1.19 . . . . 61.41 108.225 174.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -95.73 143.62 26.83 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 109.226 -0.657 . . . . 73.55 109.226 -174.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.638 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -130.76 128.02 39.92 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.976 0.91 . . . . 50.14 109.035 -177.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 31.7 tpp -79.39 116.37 19.59 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.642 -0.873 . . . . 61.21 108.642 171.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 68.8 p -121.06 -176.59 3.3 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.787 0.835 . . . . 64.15 110.001 -177.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.53 HD21 ' HD3' ' A' ' 241' ' ' PRO . 66.6 tp -46.72 -51.38 16.27 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.497 1.119 . . . . 54.32 111.894 172.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -72.1 -27.19 62.49 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 114.044 -1.434 . . . . 74.32 111.269 -172.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 131.98 -164.39 23.71 Favored Glycine 0 C--N 1.338 0.677 0 N-CA-C 111.508 -0.637 . . . . 75.43 111.508 -174.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -66.45 129.83 22.29 Favored 'Trans proline' 0 C--N 1.361 1.21 0 C-N-CA 122.407 2.071 . . . . 74.43 111.35 178.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 31.8 m -133.18 161.33 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 123.738 0.815 . . . . 54.13 110.816 -177.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.619 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 53.1 mt-10 -110.32 110.77 21.7 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.559 1.144 . . . . 74.41 109.842 -173.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.407 HG22 HG11 ' A' ' 168' ' ' VAL . 48.8 t -121.15 102.39 12.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 C-N-CA 124.352 1.061 . . . . 73.11 109.228 -172.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.603 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -79.2 117.08 19.89 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 122.796 0.439 . . . . 54.33 110.532 174.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 34.8 m -86.52 153.59 55.93 Favored Pre-proline 0 N--CA 1.487 1.392 0 C-N-CA 123.737 0.815 . . . . 74.22 111.457 -176.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . 0.623 ' HB3' ' HB2' ' A' ' 173' ' ' TYR . 32.7 Cg_endo -63.02 164.94 17.86 Favored 'Trans proline' 0 C--N 1.379 2.155 0 C-N-CA 122.737 2.291 . . . . 74.43 113.189 175.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -84.0 29.53 0.54 Allowed 'Trans proline' 0 C--N 1.369 1.606 0 C-N-CA 123.258 2.639 . . . . 74.22 113.178 172.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -145.9 0.1 0.83 Allowed 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 118.618 -0.706 . . . . 75.12 112.499 177.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.563 HG23 HG11 ' A' ' 253' ' ' VAL . 0.6 OUTLIER -60.95 154.66 21.85 Favored 'General case' 0 CA--C 1.573 1.84 0 O-C-N 123.375 0.422 . . . . 73.13 109.906 -167.117 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . 0.492 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 4.8 pt20 -135.26 161.94 33.98 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.563 0.745 . . . . 70.22 110.948 -169.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -62.75 110.86 1.88 Allowed 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.244 -0.65 . . . . 73.34 109.244 176.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.09 -0.55 22.65 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-N 115.187 -0.915 . . . . 40.14 111.903 178.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.492 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -67.92 123.85 21.75 Favored 'General case' 0 C--N 1.362 1.128 0 N-CA-C 108.824 -0.806 . . . . 75.31 108.824 -171.041 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -100.08 96.72 7.7 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.222 -0.658 . . . . 75.54 109.222 -170.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.464 ' O ' ' HA ' ' A' ' 250' ' ' TYR . 24.4 mt -80.21 98.57 7.41 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 106.378 -1.712 . . . . 73.43 106.378 -177.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . 0.671 ' HD3' ' HE2' ' A' ' 236' ' ' LYS . 0.0 OUTLIER -82.19 125.61 31.11 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.476 0.71 . . . . 52.45 111.501 178.631 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.563 ' HB3' ' HB2' ' A' ' 238' ' ' LYS . 7.2 mp -111.17 128.52 55.93 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 106.627 -1.619 . . . . 74.52 106.627 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.671 ' HE2' ' HD3' ' A' ' 234' ' ' ARG . 5.6 mptp? -97.07 116.84 30.0 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.253 0.621 . . . . 74.21 110.986 -173.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 76.46 29.27 58.31 Favored Glycine 0 C--N 1.35 1.307 0 O-C-N 124.06 0.85 . . . . 41.03 112.047 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.563 ' HB2' ' HB3' ' A' ' 235' ' ' LEU . 29.3 mmmt -127.27 20.38 6.82 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.113 0.965 . . . . 75.45 111.124 -175.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -94.95 -127.84 5.22 Favored Glycine 0 C--N 1.343 0.942 0 N-CA-C 110.059 -1.217 . . . . 43.51 110.059 178.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . 0.431 ' O ' ' HA ' ' A' ' 246' ' ' ARG . 7.3 m-30 -71.53 152.07 93.83 Favored Pre-proline 0 CA--C 1.554 1.098 0 CA-C-N 117.121 0.46 . . . . 72.41 111.767 177.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.53 ' HD3' HD21 ' A' ' 215' ' ' LEU . 59.2 Cg_endo -65.67 172.08 8.67 Favored 'Trans proline' 0 C--N 1.384 2.426 0 C-N-CA 123.468 2.779 . . . . 74.43 112.332 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.416 ' N ' ' HD2' ' A' ' 243' ' ' PRO . . . -66.31 -42.24 94.16 Favored Glycine 0 CA--C 1.541 1.672 0 CA-C-O 118.241 -1.311 . . . . 44.5 114.185 -176.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' A' ' 242' ' ' GLY . 10.2 Cg_endo -51.77 -38.78 67.72 Favored 'Trans proline' 0 C--N 1.392 2.825 0 C-N-CA 122.697 2.265 . . . . 51.22 113.223 168.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -79.19 -23.68 43.7 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.168 0.587 . . . . 31.52 110.839 176.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 105.79 111.33 3.58 Favored Glycine 0 C--N 1.343 0.919 0 N-CA-C 108.757 -1.737 . . . . 74.11 108.757 -170.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.431 ' HA ' ' O ' ' A' ' 240' ' ' PHE . 74.3 mtt180 -63.6 124.54 21.64 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.46 0.704 . . . . 73.53 110.965 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -136.81 -158.15 7.9 Favored Glycine 0 C--O 1.24 0.517 0 CA-C-N 115.582 -0.736 . . . . 52.21 112.253 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -117.32 164.74 14.38 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.839 0.856 . . . . 54.2 109.517 -176.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.423 ' HA ' ' O ' ' A' ' 193' ' ' LEU . 12.3 tp -133.78 132.53 40.61 Favored 'General case' 0 C--O 1.217 -0.654 0 N-CA-C 108.541 -0.911 . . . . 65.55 108.541 -176.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.464 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 0.4 OUTLIER -113.27 145.55 40.84 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 123.48 0.712 . . . . 73.45 109.433 177.803 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 73.5 mt -124.28 112.5 17.08 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.361 -1.348 . . . . 71.54 107.361 176.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -92.19 106.57 18.55 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 107.526 -1.287 . . . . 64.33 107.526 -172.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.563 HG11 HG23 ' A' ' 227' ' ' THR . 56.0 t -61.88 125.86 18.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 115.005 -0.998 . . . . 73.35 110.623 -177.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . 0.435 ' HE ' HG21 ' A' ' 196' ' ' THR . 26.4 mtm180 -113.6 123.77 50.75 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 106.644 -1.613 . . . . 70.03 106.644 171.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 46.5 mm -84.78 130.77 35.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 C-N-CA 123.181 0.592 . . . . 73.43 109.851 -175.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.4 t . . . . . 0 CA--C 1.563 1.471 0 C-N-CA 124.24 1.016 . . . . 72.4 108.355 -172.109 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.46 HG11 HG22 ' A' ' 221' ' ' VAL . 51.1 t . . . . . 0 N--CA 1.476 0.847 0 CA-C-O 121.441 0.639 . . . . 51.13 110.54 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 43.3 mtm -98.35 -177.78 3.82 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 125.544 1.538 . . . . 62.51 109.656 -169.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 9.0 p -100.52 90.4 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 N-CA-C 107.42 -1.326 . . . . 73.43 107.42 162.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . 0.435 ' HG3' ' HA ' ' A' ' 235' ' ' LEU . 0.0 OUTLIER -125.3 -6.14 7.13 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 114.096 -1.411 . . . . 75.31 110.297 -175.863 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.448 ' HA ' ' HB3' ' A' ' 233' ' ' LEU . 67.2 m -40.77 -65.29 0.43 Allowed 'General case' 0 C--N 1.353 0.728 0 C-N-CA 126.461 1.904 . . . . 61.43 113.682 -165.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 72.8 t80 . . . . . 0 C--O 1.238 0.486 0 O-C-N 123.504 0.502 . . . . 74.41 110.187 -177.636 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 . . . . . 0 N--CA 1.472 0.653 0 N-CA-C 108.563 -0.903 . . . . 63.14 108.563 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.428 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 38.5 p-10 -74.72 165.15 25.7 Favored 'General case' 0 C--O 1.247 0.948 0 CA-C-N 115.343 -0.844 . . . . 73.51 109.984 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.411 HD13 ' CE1' ' A' ' 240' ' ' PHE . 53.1 tp -149.94 143.34 25.18 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.902 -0.59 . . . . 62.42 109.548 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -115.52 138.47 51.0 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.969 0.908 . . . . 73.32 108.636 173.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -149.09 158.32 44.09 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.73 -0.841 . . . . 44.41 108.73 170.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 26.5 p -81.3 153.08 27.26 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 122.187 0.994 . . . . 53.34 111.851 166.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.691 HD13 ' HB2' ' A' ' 212' ' ' ALA . 33.5 tp -122.62 134.5 54.51 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 113.053 -1.885 . . . . 74.23 106.911 162.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -94.7 117.47 30.18 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 108.142 -1.058 . . . . 74.11 108.142 177.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.603 HG22 HG21 ' A' ' 210' ' ' VAL . 45.1 t -122.51 132.21 24.29 Favored Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 124.049 0.94 . . . . 65.54 109.153 178.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -69.57 145.55 58.6 Favored 'Trans proline' 0 C--N 1.365 1.433 0 C-N-CA 122.352 2.035 . . . . 63.11 110.52 169.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.458 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -52.91 -43.56 94.36 Favored Pre-proline 0 N--CA 1.486 1.332 0 N-CA-C 112.567 0.58 . . . . 54.01 112.567 173.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 10.6 Cg_endo -55.21 -37.72 94.1 Favored 'Trans proline' 0 C--N 1.399 3.217 0 C-N-CA 122.006 1.804 . . . . 43.2 112.736 174.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -86.55 -23.66 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 N-CA-C 109.841 -0.429 . . . . 71.33 109.841 -175.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -73.48 -38.0 65.56 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 123.146 0.578 . . . . 61.1 111.029 178.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 39.8 t -89.01 -35.43 7.71 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 C-N-CA 125.022 1.329 . . . . 74.51 112.648 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.414 ' HB ' ' O ' ' A' ' 202' ' ' PRO . 51.5 t -97.92 -42.93 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 O-C-N 121.547 -0.721 . . . . 61.34 111.129 -176.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 121.82 152.45 8.7 Favored Glycine 0 C--N 1.339 0.743 0 N-CA-C 110.707 -0.957 . . . . 74.35 110.707 -176.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 161.81 155.55 7.98 Favored Glycine 0 C--O 1.245 0.839 0 N-CA-C 111.307 -0.717 . . . . 71.11 111.307 177.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.62 ' HD3' ' HB3' ' A' ' 220' ' ' GLU . 36.3 ttmt -84.85 133.66 34.31 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 122.998 0.519 . . . . 73.33 110.026 174.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.603 HG21 HG22 ' A' ' 199' ' ' VAL . 15.5 m -131.24 153.4 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.417 1.087 . . . . 75.41 109.665 177.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . 0.667 ' HE ' ' HB3' ' A' ' 218' ' ' PRO . 0.0 OUTLIER -95.14 142.69 27.3 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.266 1.026 . . . . 74.04 109.352 -171.79 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.691 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -132.85 122.35 24.28 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.561 0.745 . . . . 65.31 109.459 -177.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 34.2 tpp -78.9 109.91 13.62 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 108.958 -0.756 . . . . 74.15 108.958 172.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 67.5 p -120.36 -175.08 2.93 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.928 0.891 . . . . 51.34 110.387 -175.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.534 HD21 ' HD3' ' A' ' 241' ' ' PRO . 64.0 tp -44.19 -53.32 6.64 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.298 1.039 . . . . 72.11 112.754 174.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -73.32 -27.89 61.77 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 114.821 -1.081 . . . . 74.34 111.392 -172.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 135.05 -164.45 24.78 Favored Glycine 0 C--N 1.341 0.855 0 N-CA-C 111.687 -0.565 . . . . 44.22 111.687 -171.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . 0.667 ' HB3' ' HE ' ' A' ' 211' ' ' ARG . 41.3 Cg_endo -63.93 130.73 28.45 Favored 'Trans proline' 0 C--N 1.369 1.639 0 C-N-CA 122.848 2.365 . . . . 73.4 111.335 176.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.406 HG22 ' O ' ' A' ' 212' ' ' ALA . 23.2 m -131.84 161.82 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.707 0.803 . . . . 60.54 110.723 -177.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.62 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 43.9 mt-10 -112.0 112.68 24.49 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.445 1.098 . . . . 65.53 109.899 -171.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.46 HG22 HG11 ' A' ' 168' ' ' VAL . 50.5 t -126.39 102.61 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 124.221 1.008 . . . . 74.21 110.174 -171.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.608 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -78.06 118.19 20.09 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.948 0.499 . . . . 63.52 110.391 174.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 36.0 m -90.71 152.33 44.74 Favored Pre-proline 0 N--CA 1.482 1.159 0 C-N-CA 123.445 0.698 . . . . 73.43 111.296 -176.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . 0.528 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 36.1 Cg_endo -63.91 165.4 18.96 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.839 2.359 . . . . 61.04 113.054 175.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -84.78 28.98 0.55 Allowed 'Trans proline' 0 C--N 1.378 2.091 0 C-N-CA 123.222 2.614 . . . . 63.21 113.032 175.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 35.4 mmt180 -145.07 -2.8 0.78 Allowed 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.335 0.654 . . . . 74.2 112.259 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.535 HG23 HG11 ' A' ' 253' ' ' VAL . 0.6 OUTLIER -60.81 149.47 35.77 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.433 -0.58 . . . . 70.32 109.433 -165.864 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . 0.471 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 13.2 pt20 -133.81 162.3 32.38 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.123 0.569 . . . . 74.01 110.417 -173.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -59.73 110.97 1.27 Allowed 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.145 0.498 . . . . 62.44 110.05 178.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.63 -0.66 21.79 Favored Glycine 0 C--N 1.335 0.49 0 CA-C-N 114.675 -1.148 . . . . 74.24 112.095 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -68.18 125.24 25.75 Favored 'General case' 0 C--N 1.359 0.992 0 N-CA-C 108.901 -0.777 . . . . 74.21 108.901 -175.002 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -98.9 97.58 8.75 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.283 0.633 . . . . 72.54 109.571 -168.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.479 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 22.2 mt -82.68 100.01 9.96 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 107.839 -1.171 . . . . 72.14 107.839 -176.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . 0.618 ' H ' ' HD3' ' A' ' 234' ' ' ARG . 0.0 OUTLIER -82.95 113.76 20.77 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.154 -0.93 . . . . 64.41 111.185 -176.964 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.485 ' O ' ' HB2' ' A' ' 248' ' ' ASP . 7.3 mp -100.66 127.25 47.12 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 106.772 -1.566 . . . . 75.14 106.772 173.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -101.74 117.12 34.21 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.342 0.657 . . . . 73.02 110.636 -175.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 79.08 32.35 39.83 Favored Glycine 0 C--N 1.348 1.227 0 O-C-N 124.268 0.98 . . . . 73.23 112.309 -177.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.46 ' HB2' ' HB3' ' A' ' 235' ' ' LEU . 29.3 mmmt -128.7 19.59 6.14 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.607 0.763 . . . . 74.21 111.66 -178.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -98.04 -134.03 8.18 Favored Glycine 0 C--N 1.343 0.953 0 N-CA-C 111.039 -0.824 . . . . 74.3 111.039 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . 0.48 ' O ' ' HA ' ' A' ' 246' ' ' ARG . 5.9 m-30 -66.18 154.91 89.04 Favored Pre-proline 0 CA--C 1.547 0.854 0 N-CA-C 112.699 0.629 . . . . 63.24 112.699 -177.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.534 ' HD3' HD21 ' A' ' 215' ' ' LEU . 86.2 Cg_endo -71.99 171.54 16.47 Favored 'Trans proline' 0 C--N 1.383 2.348 0 C-N-CA 123.285 2.657 . . . . 64.21 112.797 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.465 ' N ' ' HD2' ' A' ' 243' ' ' PRO . . . -67.17 -38.33 91.99 Favored Glycine 0 CA--C 1.545 1.962 0 CA-C-O 118.364 -1.242 . . . . 71.42 114.713 -177.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 242' ' ' GLY . 10.0 Cg_endo -53.72 -37.18 83.94 Favored 'Trans proline' 0 C--N 1.39 2.74 0 CA-C-N 120.974 2.387 . . . . 74.25 112.511 169.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -80.16 -24.6 40.28 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.513 0.725 . . . . 72.21 110.834 175.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 105.95 111.35 3.58 Favored Glycine 0 C--N 1.341 0.819 0 N-CA-C 107.802 -2.119 . . . . 73.2 107.802 -167.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.48 ' HA ' ' O ' ' A' ' 240' ' ' PHE . 1.5 tmm_? -73.12 128.52 35.73 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 109.738 -0.468 . . . . 73.0 109.738 -170.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -137.09 -156.79 7.43 Favored Glycine 0 C--N 1.342 0.911 0 CA-C-N 115.982 -0.554 . . . . 43.4 112.951 -175.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . 0.485 ' HB2' ' O ' ' A' ' 235' ' ' LEU . 32.4 p-10 -123.78 165.23 17.65 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.327 1.051 . . . . 45.12 110.526 -174.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 10.8 tp -135.56 135.37 40.28 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.191 -0.67 . . . . 63.2 109.191 -170.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -115.66 145.81 42.39 Favored 'General case' 0 C--O 1.246 0.88 0 N-CA-C 107.637 -1.246 . . . . 63.1 107.637 -178.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.479 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 82.2 mt -123.82 113.79 19.01 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 108.558 -0.904 . . . . 41.43 108.558 -179.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -89.78 110.49 21.4 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.83 -1.174 . . . . 64.53 107.83 -176.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.535 HG11 HG23 ' A' ' 227' ' ' THR . 51.2 t -61.81 134.16 27.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 115.162 -0.927 . . . . 54.02 110.527 -178.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 18.1 mtp85 -120.73 125.22 47.08 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.337 -1.357 . . . . 63.52 107.337 172.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 48.0 mm -84.92 112.83 22.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 108.948 -0.76 . . . . 74.22 108.948 -179.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 CA--C 1.557 1.248 0 CA-C-O 117.415 -1.279 . . . . 73.34 108.912 -171.734 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.405 HG11 HG22 ' A' ' 221' ' ' VAL . 54.6 t . . . . . 0 N--CA 1.475 0.823 0 CA-C-O 121.731 0.777 . . . . 64.34 111.415 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 43.4 mtm -101.42 -176.05 3.03 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.619 1.968 . . . . 74.53 109.462 -170.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 10.3 p -101.77 88.84 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.079 0 CA-C-O 122.973 1.368 . . . . 72.24 107.791 163.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.72 -5.66 8.61 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 114.05 -1.432 . . . . 53.53 110.587 -174.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.46 ' HA ' ' HB3' ' A' ' 233' ' ' LEU . 69.3 m -36.25 -64.96 0.29 Allowed 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 127.014 2.126 . . . . 72.25 115.617 -167.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . 0.442 ' HB2' ' HG3' ' A' ' 224' ' ' PRO . 66.9 t80 . . . . . 0 N--CA 1.479 1.005 0 C-N-CA 123.165 0.586 . . . . 74.32 111.517 -170.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 . . . . . 0 N--CA 1.478 0.949 0 CA-C-O 121.246 0.546 . . . . 73.11 110.169 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -76.28 164.29 26.2 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-N 115.394 -0.821 . . . . 64.44 110.458 -177.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 40.9 tp -151.1 140.14 21.07 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.344 -0.844 . . . . 62.5 109.846 176.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -114.77 140.04 49.22 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.649 0.78 . . . . 74.12 109.421 168.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -145.16 157.03 44.19 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 108.353 -0.98 . . . . 63.34 108.353 167.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 30.0 p -81.46 154.38 26.37 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 122.139 0.971 . . . . 75.11 111.516 167.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.656 HD13 ' HB2' ' A' ' 212' ' ' ALA . 42.3 tp -121.17 133.32 55.18 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 113.286 -1.779 . . . . 73.22 107.026 168.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -92.55 112.35 24.26 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 106.95 -1.5 . . . . 72.55 106.95 -177.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.551 HG22 HG21 ' A' ' 210' ' ' VAL . 43.3 t -124.55 130.41 24.3 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 123.333 0.653 . . . . 73.32 109.275 -177.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -66.81 144.13 69.95 Favored 'Trans proline' 0 C--N 1.368 1.6 0 C-N-CA 121.984 1.789 . . . . 75.55 110.974 166.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.439 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.16 -45.19 98.41 Favored Pre-proline 0 CA--C 1.562 1.421 0 CA-C-O 118.309 -0.853 . . . . 42.12 112.322 174.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.467 ' O ' ' HB ' ' A' ' 206' ' ' VAL . 22.9 Cg_endo -59.35 -30.98 94.17 Favored 'Trans proline' 0 C--N 1.4 3.252 0 C-N-CA 121.909 1.739 . . . . 62.12 112.537 175.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.7 mp -85.88 -25.97 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 O-C-N 121.645 -0.659 . . . . 74.1 109.68 -178.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -74.25 -38.81 63.37 Favored 'General case' 0 C--O 1.246 0.913 0 CA-C-O 121.13 0.49 . . . . 62.41 111.078 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 41.2 t -88.96 -37.21 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 C-N-CA 124.809 1.244 . . . . 74.31 112.653 -177.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.467 ' HB ' ' O ' ' A' ' 202' ' ' PRO . 53.1 t -96.85 -42.4 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 O-C-N 121.648 -0.658 . . . . 61.01 109.71 -176.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 124.31 148.66 7.48 Favored Glycine 0 C--N 1.349 1.287 0 N-CA-C 111.306 -0.718 . . . . 54.4 111.306 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 165.48 156.07 9.0 Favored Glycine 0 C--N 1.342 0.876 0 N-CA-C 112.259 -0.336 . . . . 52.41 112.259 177.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.606 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 38.1 ttmt -85.01 131.93 34.4 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.284 0.634 . . . . 65.02 110.16 176.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.551 HG21 HG22 ' A' ' 199' ' ' VAL . 13.8 m -131.07 153.22 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 124.023 0.929 . . . . 63.11 110.106 178.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -94.5 142.73 27.1 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.159 0.984 . . . . 65.03 109.468 -171.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.656 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -132.74 119.51 20.43 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.388 0.675 . . . . 74.2 109.774 -176.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 35.5 tpp -78.68 110.13 13.54 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 108.759 -0.83 . . . . 73.1 108.759 171.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 67.1 p -119.17 -175.26 2.89 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.085 0.954 . . . . 73.24 110.706 -174.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.539 HD21 ' HD3' ' A' ' 241' ' ' PRO . 65.5 tp -49.77 -50.66 43.77 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.984 0.914 . . . . 74.13 111.439 169.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -71.86 -26.7 62.46 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 114.567 -1.197 . . . . 74.33 111.84 -173.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 133.09 -165.17 24.08 Favored Glycine 0 C--N 1.344 1.004 0 N-CA-C 111.488 -0.645 . . . . 52.54 111.488 -178.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -67.56 128.08 17.52 Favored 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 121.709 1.606 . . . . 75.15 110.566 174.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 25.1 m -132.98 162.3 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 123.329 0.652 . . . . 65.25 110.397 -174.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.599 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 45.1 mt-10 -111.78 111.64 22.75 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.647 0.779 . . . . 74.33 109.446 -173.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.405 HG22 HG11 ' A' ' 168' ' ' VAL . 57.4 t -122.65 103.81 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 124.812 1.245 . . . . 64.42 109.646 -172.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.606 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -75.34 117.57 17.29 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 110.061 -0.348 . . . . 71.12 110.061 174.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 28.3 m -85.47 153.5 58.8 Favored Pre-proline 0 N--CA 1.489 1.495 0 C-N-CA 122.889 0.475 . . . . 74.5 110.796 -176.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . 0.442 ' HG3' ' HB2' ' A' ' 173' ' ' TYR . 34.2 Cg_exo -59.7 162.36 15.74 Favored 'Trans proline' 0 C--N 1.383 2.373 0 C-N-CA 122.43 2.087 . . . . 73.3 112.757 177.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -91.02 30.12 0.36 Allowed 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 123.219 2.613 . . . . 72.34 112.039 177.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 -145.12 -9.12 0.59 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.061 0.945 . . . . 55.24 111.403 178.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.556 HG23 HG11 ' A' ' 253' ' ' VAL . 0.8 OUTLIER -59.39 156.39 12.96 Favored 'General case' 0 CA--C 1.567 1.633 0 O-C-N 123.885 0.741 . . . . 73.22 111.603 -158.906 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . 0.41 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 19.7 pt20 -130.22 162.55 28.67 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.341 0.657 . . . . 70.42 110.851 -171.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . 0.421 ' HB1' HH21 ' A' ' 254' ' ' ARG . . . -61.4 112.64 2.26 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.903 -0.59 . . . . 30.4 109.438 174.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.44 -3.86 21.74 Favored Glycine 0 N--CA 1.466 0.68 0 CA-C-N 115.642 -0.708 . . . . 72.55 112.067 178.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -68.69 126.24 29.08 Favored 'General case' 0 C--N 1.358 0.948 0 N-CA-C 109.268 -0.641 . . . . 71.44 109.268 -173.065 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -98.39 98.47 9.69 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.373 -0.603 . . . . 74.45 109.373 -171.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.46 ' HB3' ' HA ' ' A' ' 172' ' ' SER . 25.0 mt -79.64 99.77 7.52 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 106.917 -1.512 . . . . 62.22 106.917 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -81.34 115.68 20.81 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-O 121.546 0.689 . . . . 65.24 110.871 -176.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.425 ' HB3' ' HB2' ' A' ' 238' ' ' LYS . 7.3 mp -99.52 124.82 45.04 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 105.458 -2.053 . . . . 64.31 105.458 170.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 41.0 tptt -102.14 117.93 35.83 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 117.909 0.322 . . . . 63.44 110.156 -171.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 77.65 22.02 70.69 Favored Glycine 0 C--N 1.342 0.913 0 O-C-N 123.542 0.526 . . . . 73.14 112.86 -178.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.425 ' HB2' ' HB3' ' A' ' 235' ' ' LEU . 1.5 mmmp? -120.65 20.74 11.7 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.012 0.925 . . . . 55.21 110.035 -177.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -96.75 -135.09 8.38 Favored Glycine 0 C--N 1.349 1.285 0 N-CA-C 111.258 -0.737 . . . . 72.24 111.258 178.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 6.3 m-30 -65.1 150.59 95.21 Favored Pre-proline 0 N--CA 1.48 1.035 0 N-CA-C 112.339 0.496 . . . . 63.01 112.339 -177.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.539 ' HD3' HD21 ' A' ' 215' ' ' LEU . 60.0 Cg_endo -67.37 170.38 13.59 Favored 'Trans proline' 0 C--N 1.383 2.376 0 C-N-CA 123.13 2.553 . . . . 73.41 113.075 -177.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -68.37 -39.58 87.44 Favored Glycine 0 CA--C 1.538 1.509 0 CA-C-O 118.613 -1.104 . . . . 63.32 114.361 -177.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -48.38 -40.27 36.08 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 122.515 2.144 . . . . 32.3 113.871 164.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -77.9 -24.64 48.32 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.51 0.724 . . . . 31.42 110.705 175.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 106.65 111.45 3.58 Favored Glycine 0 C--N 1.336 0.546 0 N-CA-C 108.095 -2.002 . . . . 71.24 108.095 -167.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -71.84 125.23 26.64 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-N 117.458 0.629 . . . . 70.31 110.198 -172.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -138.81 -157.73 7.45 Favored Glycine 0 C--N 1.337 0.599 0 CA-C-N 116.085 -0.507 . . . . 72.24 112.727 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -119.78 165.22 14.84 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.945 0.898 . . . . 74.34 110.085 -173.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 10.5 tp -134.39 133.24 40.35 Favored 'General case' 0 C--O 1.219 -0.523 0 N-CA-C 107.683 -1.228 . . . . 75.52 107.683 -173.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 7.7 m-30 -116.13 147.89 40.88 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 108.063 -1.088 . . . . 73.41 108.063 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 78.2 mt -122.8 114.27 20.29 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 107.89 -1.152 . . . . 74.35 107.89 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -88.05 111.75 21.88 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 107.816 -1.179 . . . . 74.01 107.816 -178.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.556 HG11 HG23 ' A' ' 227' ' ' THR . 53.2 t -60.92 125.74 17.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 O-C-N 123.976 0.797 . . . . 74.13 109.891 178.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . 0.421 HH21 ' HB1' ' A' ' 229' ' ' ALA . 0.2 OUTLIER -112.01 124.28 52.07 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 106.658 -1.608 . . . . 75.25 106.658 174.667 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 51.3 mm -88.51 126.7 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 O-C-N 123.931 0.77 . . . . 63.33 109.527 -177.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 CA--C 1.558 1.278 0 N-CA-C 107.605 -1.257 . . . . 74.3 107.605 -177.07 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 78.9 t . . . . . 0 N--CA 1.481 1.09 0 CA-C-O 121.342 0.591 . . . . 73.15 111.52 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 44.5 mtm -101.97 -174.92 2.7 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.936 1.694 . . . . 73.51 110.059 -168.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 10.9 p -95.3 87.85 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.188 0 CA-C-O 123.195 1.474 . . . . 65.54 108.126 162.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.15 -3.76 8.5 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 114.053 -1.431 . . . . 75.03 110.106 -177.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.519 ' HA ' ' HB3' ' A' ' 233' ' ' LEU . 68.1 m -41.51 -66.52 0.33 Allowed 'General case' 0 C--N 1.353 0.741 0 C-N-CA 126.348 1.859 . . . . 62.54 113.454 -170.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 54.1 t80 . . . . . 0 C--O 1.242 0.702 0 N-CA-C 108.422 -0.955 . . . . 64.24 108.422 178.499 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 . . . . . 0 N--CA 1.481 1.104 0 N-CA-C 109.147 -0.686 . . . . 65.23 109.147 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -75.23 154.78 37.36 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-N 114.717 -1.129 . . . . 72.03 108.849 -177.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 57.6 tp -148.88 132.41 16.73 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.305 -0.628 . . . . 72.43 109.305 -174.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -117.04 140.14 49.85 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.386 0.674 . . . . 65.44 109.213 174.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -147.8 158.19 43.91 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.69 0.796 . . . . 70.41 108.985 174.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 24.0 p -83.86 152.12 24.75 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 122.339 1.066 . . . . 74.45 112.292 167.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.656 HD13 ' HB2' ' A' ' 212' ' ' ALA . 33.3 tp -124.46 134.11 53.16 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 112.695 -2.048 . . . . 75.43 107.008 167.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -93.35 116.77 29.32 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.216 -1.031 . . . . 75.35 108.216 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.589 HG22 HG21 ' A' ' 210' ' ' VAL . 61.7 t -123.14 130.55 24.53 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 124.141 0.976 . . . . 75.12 109.174 178.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -66.09 143.63 72.55 Favored 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 122.161 1.907 . . . . 62.43 111.015 167.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.432 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.47 -43.75 96.22 Favored Pre-proline 0 CA--C 1.566 1.568 0 CA-C-O 118.141 -0.933 . . . . 72.45 112.572 175.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 19.1 Cg_endo -57.65 -31.28 91.48 Favored 'Trans proline' 0 C--N 1.403 3.445 0 C-N-CA 121.876 1.717 . . . . 73.24 112.634 173.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -87.14 -25.64 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 N-CA-C 109.487 -0.56 . . . . 74.31 109.487 -178.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . 0.4 ' HA ' HG22 ' A' ' 227' ' ' THR . . . -73.43 -37.95 65.7 Favored 'General case' 0 C--O 1.244 0.794 0 C-N-CA 122.983 0.513 . . . . 72.14 110.987 178.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 25.4 t -88.29 -38.65 11.93 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 125.368 1.467 . . . . 54.42 112.875 -177.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 79.5 t -98.5 -41.46 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 O-C-N 121.664 -0.647 . . . . 64.34 110.45 -176.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 126.98 152.73 8.09 Favored Glycine 0 N--CA 1.468 0.815 0 N-CA-C 111.287 -0.725 . . . . 53.33 111.287 -178.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.98 154.16 7.84 Favored Glycine 0 C--O 1.244 0.74 0 CA-C-N 116.978 0.389 . . . . 63.31 112.675 175.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.576 ' HD3' ' HB3' ' A' ' 220' ' ' GLU . 36.7 ttmt -85.95 131.29 34.32 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.572 0.749 . . . . 75.33 109.215 175.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.589 HG21 HG22 ' A' ' 199' ' ' VAL . 15.8 m -130.0 154.45 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 123.734 0.814 . . . . 61.2 109.633 -177.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.11 135.91 33.86 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.732 0.813 . . . . 74.25 109.274 -171.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.656 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -132.73 116.49 16.66 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.813 -0.81 . . . . 43.12 108.813 -176.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 36.7 tpp -80.78 109.87 15.75 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 107.819 -1.178 . . . . 60.12 107.819 173.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 64.8 p -113.22 -175.42 2.66 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.125 0.57 . . . . 74.42 110.533 -174.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.456 HD21 ' HD3' ' A' ' 241' ' ' PRO . 60.5 tp -47.67 -51.17 22.61 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 124.323 1.014 . . . . 54.24 110.888 169.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -72.31 -27.03 62.19 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 113.884 -1.507 . . . . 73.31 110.944 -174.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 129.73 -166.14 22.0 Favored Glycine 0 C--N 1.341 0.81 0 CA-C-N 116.133 -0.485 . . . . 74.14 112.007 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -62.67 130.76 30.76 Favored 'Trans proline' 0 CA--C 1.552 1.419 0 C-N-CA 122.649 2.233 . . . . 74.43 111.84 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.436 HG22 ' O ' ' A' ' 212' ' ' ALA . 20.6 m -139.61 160.3 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 123.061 0.544 . . . . 64.45 110.408 -172.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.576 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 40.2 mt-10 -110.88 111.82 23.23 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.738 0.815 . . . . 52.42 109.311 -175.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 60.4 t -120.56 102.96 13.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 124.25 1.02 . . . . 74.01 108.937 -173.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.54 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -76.72 117.2 18.1 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 109.98 -0.378 . . . . 71.54 109.98 175.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 35.5 m -87.85 152.02 50.64 Favored Pre-proline 0 N--CA 1.487 1.399 0 C-N-CA 122.996 0.518 . . . . 61.33 110.562 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . 0.565 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 35.5 Cg_endo -63.48 163.48 23.77 Favored 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 122.213 1.942 . . . . 74.25 113.034 176.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -80.63 29.8 0.52 Allowed 'Trans proline' 0 C--N 1.373 1.864 0 C-N-CA 123.354 2.702 . . . . 71.41 113.416 174.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 -150.7 0.69 0.42 Allowed 'General case' 0 N--CA 1.474 0.738 0 O-C-N 122.113 -0.367 . . . . 55.21 111.839 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.63 HG23 HG11 ' A' ' 253' ' ' VAL . 0.7 OUTLIER -60.82 153.23 25.05 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.497 -0.557 . . . . 72.34 109.497 -169.058 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . 0.446 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 19.6 pt20 -132.73 162.11 32.28 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.403 0.681 . . . . 73.52 110.44 -171.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -61.13 111.46 1.72 Allowed 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 108.946 -0.761 . . . . 72.04 108.946 172.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.69 -1.62 21.68 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-N 115.087 -0.961 . . . . 72.23 112.501 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -68.79 127.08 31.82 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.445 0.698 . . . . 70.1 109.494 -173.971 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -98.21 97.1 8.56 Favored 'General case' 0 C--O 1.244 0.767 0 C-N-CA 123.413 0.685 . . . . 74.32 109.309 -170.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.519 ' HB3' ' HA ' ' A' ' 172' ' ' SER . 24.3 mt -80.23 99.24 7.73 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 107.504 -1.295 . . . . 71.33 107.504 -178.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 2.3 ppt_? -81.51 117.39 21.88 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.761 0.825 . . . . 74.13 112.579 -174.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.456 ' HB2' ' O ' ' A' ' 249' ' ' LEU . 7.6 mp -110.18 126.98 54.67 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 107.035 -1.468 . . . . 45.21 107.035 174.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -103.44 118.06 35.87 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.715 0.806 . . . . 75.21 111.024 -173.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 78.97 22.4 66.05 Favored Glycine 0 C--N 1.347 1.192 0 O-C-N 123.882 0.739 . . . . 13.14 112.304 -178.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -120.5 19.33 12.01 Favored 'General case' 0 C--N 1.347 0.486 0 C-N-CA 123.462 0.705 . . . . 62.43 109.984 -178.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -95.69 -136.61 8.77 Favored Glycine 0 C--N 1.35 1.361 0 N-CA-C 111.06 -0.816 . . . . 64.11 111.06 177.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 6.3 m-30 -68.28 148.27 98.24 Favored Pre-proline 0 CA--C 1.551 0.988 0 CA-C-N 117.559 0.68 . . . . 65.54 111.429 -178.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.456 ' HD3' HD21 ' A' ' 215' ' ' LEU . 65.7 Cg_endo -67.01 172.33 9.96 Favored 'Trans proline' 0 C--N 1.38 2.19 0 C-N-CA 123.399 2.733 . . . . 65.21 112.416 -177.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.451 ' N ' ' HD2' ' A' ' 243' ' ' PRO . . . -66.34 -38.29 93.52 Favored Glycine 0 CA--C 1.545 1.941 0 CA-C-O 117.92 -1.489 . . . . 64.44 114.163 -176.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 242' ' ' GLY . 9.7 Cg_endo -53.19 -35.28 72.83 Favored 'Trans proline' 0 C--N 1.392 2.867 0 CA-C-N 120.892 2.346 . . . . 74.14 113.351 167.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -85.45 -25.11 27.13 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.079 0.552 . . . . 43.21 110.464 176.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 112.52 114.19 3.29 Favored Glycine 0 C--N 1.343 0.962 0 N-CA-C 109.866 -1.294 . . . . 71.22 109.866 -169.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 32.2 ttm180 -66.22 128.44 36.13 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 117.389 0.594 . . . . 74.14 110.591 -176.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -148.1 -156.48 7.08 Favored Glycine 0 C--N 1.336 0.534 0 CA-C-N 115.657 -0.702 . . . . 72.32 112.48 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -118.58 165.86 13.43 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.214 0.605 . . . . 73.53 109.373 -171.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.456 ' O ' ' HB2' ' A' ' 235' ' ' LEU . 11.3 tp -133.83 132.07 39.97 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 107.31 -1.367 . . . . 64.41 107.31 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 9.8 m-30 -122.73 147.22 46.74 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.127 -1.064 . . . . 72.1 108.127 -178.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.413 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 86.0 mt -123.08 115.92 22.63 Favored 'General case' 0 C--O 1.222 -0.364 0 N-CA-C 108.327 -0.99 . . . . 53.11 108.327 -176.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -88.39 111.62 21.96 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 107.574 -1.269 . . . . 73.42 107.574 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.63 HG11 HG23 ' A' ' 227' ' ' THR . 55.6 t -61.35 128.35 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 CA-C-N 115.126 -0.943 . . . . 74.31 110.088 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 8.1 mmt180 -119.89 123.44 43.6 Favored 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 107.809 -1.182 . . . . 70.45 107.809 177.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 47.9 mm -82.76 122.11 36.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 114.718 -1.128 . . . . 65.45 109.945 -174.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.7 t . . . . . 0 CA--C 1.557 1.233 0 N-CA-C 107.229 -1.397 . . . . 72.53 107.229 -179.182 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.577 HG11 HG22 ' A' ' 221' ' ' VAL . 53.2 t . . . . . 0 N--CA 1.475 0.811 0 CA-C-O 121.21 0.528 . . . . 72.32 110.863 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 50.2 mtm -99.43 -176.47 3.3 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 125.8 1.64 . . . . 73.3 110.019 -169.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 8.8 p -99.97 86.48 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 CA-C-O 123.149 1.452 . . . . 74.52 107.94 163.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . 0.503 ' HG3' ' HA ' ' A' ' 235' ' ' LEU . 0.0 OUTLIER -122.63 -5.36 8.67 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 113.675 -1.602 . . . . 63.52 110.041 -176.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.539 ' HA ' ' HB3' ' A' ' 233' ' ' LEU . 69.4 m -40.93 -63.33 0.68 Allowed 'General case' 0 C--N 1.35 0.608 0 C-N-CA 126.818 2.047 . . . . 52.44 114.553 -168.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . 0.598 ' HB2' ' HB3' ' A' ' 224' ' ' PRO . 67.3 t80 . . . . . 0 N--CA 1.474 0.761 0 CA-C-O 121.224 0.535 . . . . 64.04 110.9 -176.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 . . . . . 0 N--CA 1.479 1.008 0 N-CA-C 107.213 -1.403 . . . . 75.12 107.213 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 24.5 p-10 -74.21 172.67 11.36 Favored 'General case' 0 C--O 1.245 0.843 0 CA-C-N 113.425 -1.716 . . . . 63.12 109.724 167.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 33.0 tp -152.06 140.39 20.48 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.847 0.356 . . . . 72.13 110.324 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -115.46 139.69 49.81 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.269 1.028 . . . . 71.31 108.632 168.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.424 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -147.92 158.13 43.89 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.097 -1.075 . . . . 71.24 108.097 168.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 32.3 p -82.89 153.78 24.94 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 122.146 0.974 . . . . 54.34 112.585 167.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.598 HD13 ' HB2' ' A' ' 212' ' ' ALA . 25.8 tp -124.23 132.01 53.57 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 112.88 -1.964 . . . . 75.54 107.09 164.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -94.45 116.78 29.19 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.827 -0.805 . . . . 64.33 108.827 177.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.558 HG22 HG21 ' A' ' 210' ' ' VAL . 57.4 t -117.93 134.62 23.27 Favored Pre-proline 0 CA--C 1.549 0.923 0 CA-C-N 114.573 -1.194 . . . . 64.11 109.214 -177.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -67.5 146.7 75.17 Favored 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 122.185 1.923 . . . . 75.43 111.121 169.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.443 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.66 -45.76 98.58 Favored Pre-proline 0 CA--C 1.567 1.612 0 C-N-CA 123.65 0.78 . . . . 75.4 112.568 174.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 28.0 Cg_endo -60.73 -31.41 91.9 Favored 'Trans proline' 0 C--N 1.393 2.887 0 C-N-CA 122.202 1.934 . . . . 60.11 112.98 176.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -86.19 -24.47 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 109.441 -0.577 . . . . 73.11 109.441 -177.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -73.31 -37.7 66.09 Favored 'General case' 0 C--O 1.244 0.78 0 C-N-CA 123.053 0.541 . . . . 42.43 111.417 178.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 24.9 t -88.99 -36.66 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 CA-C-N 114.348 -1.296 . . . . 71.3 113.506 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 55.7 t -96.92 -42.3 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 O-C-N 121.486 -0.759 . . . . 64.24 111.007 -177.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 123.36 152.87 8.59 Favored Glycine 0 C--N 1.341 0.861 0 N-CA-C 110.727 -0.949 . . . . 55.03 110.727 -175.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.68 151.83 6.74 Favored Glycine 0 C--O 1.246 0.849 0 N-CA-C 111.578 -0.609 . . . . 75.2 111.578 177.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.623 ' HD3' ' HB3' ' A' ' 220' ' ' GLU . 4.2 ttmp? -84.2 130.2 34.84 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 108.667 -0.864 . . . . 73.21 108.667 174.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.558 HG21 HG22 ' A' ' 199' ' ' VAL . 15.8 m -129.9 152.24 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.383 1.073 . . . . 50.34 108.301 178.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 4.8 tmm_? -95.37 141.93 28.35 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 108.466 -0.939 . . . . 72.23 108.466 -172.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.598 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -132.14 124.92 30.06 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.959 0.903 . . . . 63.32 109.065 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 39.8 tpp -79.86 109.98 14.79 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 108.243 -1.021 . . . . 75.11 108.243 171.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 71.0 p -117.96 -175.59 2.87 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.838 0.855 . . . . 75.21 110.684 -177.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 63.0 tp -42.1 -50.65 4.72 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.809 1.244 . . . . 65.31 112.345 174.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -71.57 -27.08 62.91 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 114.552 -1.203 . . . . 74.55 111.595 -173.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 127.9 -163.35 21.58 Favored Glycine 0 C--N 1.34 0.791 0 N-CA-C 110.849 -0.9 . . . . 71.02 110.849 -170.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -65.49 129.84 23.57 Favored 'Trans proline' 0 C--N 1.371 1.741 0 C-N-CA 122.301 2.001 . . . . 75.11 111.594 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.442 HG22 ' O ' ' A' ' 212' ' ' ALA . 27.6 m -134.83 162.04 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 123.456 0.703 . . . . 60.22 111.041 -176.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.623 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 46.6 mt-10 -110.93 113.04 25.31 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.124 0.97 . . . . 75.05 109.77 -173.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.577 HG22 HG11 ' A' ' 168' ' ' VAL . 48.3 t -123.42 102.92 12.18 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 124.429 1.091 . . . . 72.31 109.815 -172.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.6 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -78.96 116.94 19.58 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 122.604 0.361 . . . . 52.22 110.505 175.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 35.3 m -88.79 152.44 48.87 Favored Pre-proline 0 N--CA 1.488 1.446 0 C-N-CA 123.252 0.621 . . . . 71.13 111.478 -175.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . 0.598 ' HB3' ' HB2' ' A' ' 173' ' ' TYR . 36.9 Cg_endo -63.13 166.36 14.77 Favored 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 122.838 2.359 . . . . 72.13 113.147 178.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -84.72 30.19 0.52 Allowed 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 122.838 2.359 . . . . 60.51 112.609 174.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -147.92 -0.72 0.6 Allowed 'General case' 0 N--CA 1.475 0.823 0 O-C-N 121.635 -0.666 . . . . 74.5 111.955 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.58 HG23 HG11 ' A' ' 253' ' ' VAL . 0.6 OUTLIER -61.18 152.53 28.44 Favored 'General case' 0 CA--C 1.567 1.633 0 N-CA-C 109.74 -0.467 . . . . 52.42 109.74 -167.482 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . 0.447 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 20.2 pt20 -135.05 161.47 35.21 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.456 0.703 . . . . 53.34 109.665 -173.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -61.33 111.23 1.68 Allowed 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 109.066 -0.716 . . . . 74.14 109.066 175.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 116.3 -0.47 20.68 Favored Glycine 0 N--CA 1.468 0.806 0 CA-C-N 114.783 -1.099 . . . . 74.34 112.787 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.447 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -70.92 127.36 32.32 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.83 0.852 . . . . 73.13 109.7 -175.671 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -97.62 99.22 10.6 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 109.324 -0.621 . . . . 60.23 109.324 -173.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.539 ' HB3' ' HA ' ' A' ' 172' ' ' SER . 22.8 mt -79.32 98.49 6.71 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.051 -1.463 . . . . 72.14 107.051 179.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 6.3 ppt_? -81.94 114.13 20.33 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-O 121.456 0.646 . . . . 74.13 111.972 -176.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.503 ' HA ' ' HG3' ' A' ' 171' ' ' MET . 7.2 mp -99.39 129.11 45.56 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 106.63 -1.619 . . . . 63.44 106.63 173.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 27.8 tptt -101.7 115.88 31.51 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 117.892 0.315 . . . . 73.45 110.721 -171.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.484 ' H ' ' HB3' ' A' ' 248' ' ' ASP . . . 78.12 29.38 53.98 Favored Glycine 0 C--N 1.344 1.019 0 O-C-N 123.832 0.708 . . . . 40.41 112.872 -178.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -119.31 20.05 12.64 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.841 0.856 . . . . 61.31 110.959 -177.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -95.95 -141.28 11.75 Favored Glycine 0 C--N 1.349 1.28 0 N-CA-C 110.453 -1.059 . . . . 54.2 110.453 178.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 7.2 m-30 -68.63 148.85 98.09 Favored Pre-proline 0 CA--C 1.548 0.881 0 CA-C-N 117.221 0.511 . . . . 63.23 111.592 -175.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -65.59 170.91 10.34 Favored 'Trans proline' 0 C--N 1.384 2.409 0 C-N-CA 123.209 2.606 . . . . 73.04 112.179 177.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -67.28 -39.65 92.07 Favored Glycine 0 CA--C 1.546 1.98 0 CA-C-O 118.719 -1.045 . . . . 33.14 114.186 -175.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_exo -50.39 -39.33 53.96 Favored 'Trans proline' 0 C--N 1.384 2.406 0 C-N-CA 122.601 2.201 . . . . 74.1 113.789 166.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -81.93 -24.22 35.72 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.045 0.538 . . . . 74.53 110.55 177.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 111.36 112.62 3.32 Favored Glycine 0 C--N 1.34 0.781 0 N-CA-C 109.112 -1.595 . . . . 62.24 109.112 -170.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -70.51 129.01 38.11 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 109.091 -0.707 . . . . 75.22 109.091 -172.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -148.9 -161.54 9.74 Favored Glycine 0 C--N 1.341 0.848 0 O-C-N 123.451 0.469 . . . . 72.21 112.751 173.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . 0.484 ' HB3' ' H ' ' A' ' 237' ' ' GLY . 15.8 p-10 -123.9 164.24 19.66 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.562 1.145 . . . . 63.54 110.782 -176.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 8.9 tp -132.0 136.28 47.16 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 109.27 -0.641 . . . . 64.02 109.27 -166.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -121.64 148.11 44.98 Favored 'General case' 0 C--O 1.247 0.939 0 N-CA-C 108.164 -1.05 . . . . 74.24 108.164 -176.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.424 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 71.5 mt -123.59 113.96 19.39 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 108.891 -0.781 . . . . 74.41 108.891 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -88.45 111.79 22.2 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.223 -1.028 . . . . 72.45 108.223 -177.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.58 HG11 HG23 ' A' ' 227' ' ' THR . 55.4 t -61.36 130.18 25.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 114.862 -1.063 . . . . 65.35 110.404 178.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 37.3 mtm180 -116.84 125.47 51.61 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 106.578 -1.638 . . . . 72.32 106.578 169.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 49.8 mm -84.27 127.5 39.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 108.727 -0.842 . . . . 43.12 108.727 -178.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.2 t . . . . . 0 CA--C 1.552 1.049 0 N-CA-C 108.369 -0.975 . . . . 70.3 108.369 -177.165 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 53.0 t . . . . . 0 N--CA 1.479 1.01 0 CA-C-O 121.529 0.681 . . . . 74.14 111.403 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 46.6 mtm -100.66 -176.83 3.3 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.282 1.833 . . . . 73.13 109.271 -173.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 11.2 p -98.97 88.74 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.321 0 CA-C-O 123.092 1.425 . . . . 72.41 107.758 163.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . 0.41 ' HG3' ' HA ' ' A' ' 235' ' ' LEU . 0.0 OUTLIER -123.92 -4.46 8.05 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 113.767 -1.56 . . . . 61.21 110.593 -172.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.532 ' HB3' HD22 ' A' ' 233' ' ' LEU . 70.3 m -40.7 -64.38 0.54 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.421 1.889 . . . . 75.5 114.187 -173.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . 0.624 ' HB2' ' HG3' ' A' ' 224' ' ' PRO . 45.2 t80 . . . . . 0 C--O 1.242 0.692 0 N-CA-C 108.321 -0.992 . . . . 72.13 108.321 -178.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.403 ' HG2' ' HA3' ' A' ' 245' ' ' GLY . 73.4 mt-30 . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 121.934 0.873 . . . . 62.22 109.625 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -74.33 169.59 17.34 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 114.209 -1.359 . . . . 62.42 110.645 172.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 57.7 tp -150.63 141.12 22.48 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.995 0.518 . . . . 72.25 109.803 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -116.6 138.68 51.24 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 123.996 0.918 . . . . 74.44 109.231 172.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -149.32 159.23 44.45 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 108.703 -0.851 . . . . 33.45 108.703 169.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 31.1 p -85.88 153.07 22.48 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.931 0.872 . . . . 74.33 112.322 166.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.638 HD13 ' HB2' ' A' ' 212' ' ' ALA . 31.6 tp -124.58 132.76 53.43 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 113.086 -1.87 . . . . 75.13 107.245 166.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -95.1 113.26 24.93 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.953 0.882 . . . . 73.51 109.467 -176.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.582 HG22 HG21 ' A' ' 210' ' ' VAL . 60.9 t -118.62 132.09 24.0 Favored Pre-proline 0 CA--C 1.55 0.966 0 CA-C-N 114.711 -1.131 . . . . 55.3 109.967 -177.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -66.66 144.64 72.91 Favored 'Trans proline' 0 C--N 1.37 1.691 0 C-N-CA 122.281 1.987 . . . . 73.52 111.298 166.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.434 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.08 -43.75 95.45 Favored Pre-proline 0 CA--C 1.561 1.379 0 C-N-CA 124.245 1.018 . . . . 63.42 112.586 173.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.434 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 18.8 Cg_endo -57.89 -33.01 96.5 Favored 'Trans proline' 0 C--N 1.397 3.127 0 C-N-CA 121.681 1.588 . . . . 61.32 112.702 173.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -86.42 -23.69 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 N-CA-C 109.303 -0.628 . . . . 74.33 109.303 -177.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -76.0 -36.87 59.0 Favored 'General case' 0 C--O 1.248 0.982 0 C-N-CA 123.094 0.558 . . . . 24.14 111.691 178.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 31.9 t -88.89 -36.51 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 125.161 1.384 . . . . 71.42 112.555 -179.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.409 ' HB ' ' O ' ' A' ' 202' ' ' PRO . 60.3 t -98.21 -42.14 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 O-C-N 121.659 -0.651 . . . . 63.22 109.981 -176.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 122.85 153.86 8.91 Favored Glycine 0 C--N 1.342 0.901 0 N-CA-C 110.666 -0.974 . . . . 51.52 110.666 -175.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.81 149.32 5.77 Favored Glycine 0 C--O 1.241 0.567 0 N-CA-C 112.058 -0.417 . . . . 70.45 112.058 175.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.618 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 36.8 ttmt -85.24 128.46 34.69 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.491 -0.559 . . . . 74.5 109.491 176.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.582 HG21 HG22 ' A' ' 199' ' ' VAL . 15.4 m -129.81 149.51 33.7 Favored 'Isoleucine or valine' 0 C--O 1.245 0.847 0 N-CA-C 108.036 -1.098 . . . . 75.11 108.036 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 7.0 tmm_? -96.78 143.87 27.3 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.169 0.587 . . . . 73.22 109.716 -170.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.638 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -132.28 124.58 29.15 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.551 0.74 . . . . 52.02 109.163 -177.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 36.1 tpp -79.84 109.49 14.31 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.155 -1.054 . . . . 63.13 108.155 174.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 53.2 p -111.24 -177.59 3.24 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 123.324 0.65 . . . . 74.33 109.924 -176.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.571 HD21 ' HD3' ' A' ' 241' ' ' PRO . 62.1 tp -46.56 -52.82 12.65 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.292 1.037 . . . . 70.42 111.433 174.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -73.46 -27.69 61.54 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 113.674 -1.603 . . . . 72.31 111.554 -173.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 138.5 -166.99 25.16 Favored Glycine 0 C--N 1.35 1.308 0 CA-C-O 119.693 -0.504 . . . . 54.32 112.437 -176.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -65.47 130.1 24.27 Favored 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 122.454 2.103 . . . . 70.1 111.56 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 22.8 m -129.16 158.24 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 123.222 0.609 . . . . 74.24 110.055 -179.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.521 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 46.6 mt-10 -112.8 111.95 23.09 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.708 -0.849 . . . . 71.41 108.708 -174.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 99.3 t -124.84 104.13 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.207 1.003 . . . . 60.01 110.542 -169.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.618 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -77.31 117.61 18.98 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 122.658 0.383 . . . . 71.25 110.373 175.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.453 HG11 HG21 ' A' ' 199' ' ' VAL . 27.7 m -85.81 154.4 58.43 Favored Pre-proline 0 N--CA 1.479 1.012 0 C-N-CA 123.433 0.693 . . . . 75.32 111.329 -175.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . 0.624 ' HG3' ' HB2' ' A' ' 173' ' ' TYR . 36.7 Cg_exo -59.17 161.98 15.08 Favored 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 122.669 2.246 . . . . 70.5 113.231 178.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -89.28 25.99 0.57 Allowed 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 123.231 2.62 . . . . 74.2 112.632 173.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 14.4 mmt180 -146.04 0.76 0.84 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.74 0.816 . . . . 72.31 111.384 176.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.531 HG23 HG11 ' A' ' 253' ' ' VAL . 0.7 OUTLIER -62.05 153.38 29.9 Favored 'General case' 0 CA--C 1.568 1.647 0 O-C-N 123.382 0.426 . . . . 53.32 110.207 -167.56 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -133.8 162.03 33.1 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.634 0.774 . . . . 71.52 110.237 -176.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -60.23 110.63 1.28 Allowed 'General case' 0 C--N 1.351 0.672 0 O-C-N 123.446 0.466 . . . . 33.03 109.909 177.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 116.1 1.14 20.76 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-N 115.158 -0.928 . . . . 65.54 111.984 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.83 125.39 26.61 Favored 'General case' 0 C--N 1.359 1.004 0 N-CA-C 108.683 -0.858 . . . . 75.32 108.683 -177.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -97.39 97.56 9.22 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.35 -0.981 . . . . 74.01 108.35 -171.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.532 HD22 ' HB3' ' A' ' 172' ' ' SER . 25.0 mt -78.33 97.63 5.66 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 106.429 -1.693 . . . . 52.14 106.429 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 7.8 ppt_? -81.81 125.07 30.23 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 122.909 0.483 . . . . 74.43 110.862 -177.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.41 ' HA ' ' HG3' ' A' ' 171' ' ' MET . 8.9 mp -108.78 130.05 55.38 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 106.697 -1.594 . . . . 75.44 106.697 175.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.51 113.62 25.21 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 122.734 0.413 . . . . 53.31 109.905 -170.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 76.71 24.69 66.71 Favored Glycine 0 C--N 1.343 0.954 0 O-C-N 123.596 0.56 . . . . 53.14 113.644 177.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -117.86 23.79 11.45 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.24 0.616 . . . . 74.4 110.547 -176.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -96.43 -131.21 6.74 Favored Glycine 0 C--N 1.346 1.089 0 CA-C-O 119.62 -0.545 . . . . 74.0 111.882 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 6.7 m-30 -72.15 154.68 92.19 Favored Pre-proline 0 CA--C 1.55 0.953 0 N-CA-C 112.746 0.647 . . . . 71.43 112.746 -176.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.571 ' HD3' HD21 ' A' ' 215' ' ' LEU . 73.7 Cg_endo -69.7 172.43 12.59 Favored 'Trans proline' 0 C--N 1.389 2.706 0 C-N-CA 123.428 2.752 . . . . 72.5 112.265 -179.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.411 ' N ' ' HD2' ' A' ' 243' ' ' PRO . . . -68.07 -39.33 88.81 Favored Glycine 0 CA--C 1.544 1.877 0 CA-C-O 118.257 -1.302 . . . . 50.15 114.395 -175.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . 0.411 ' HD2' ' N ' ' A' ' 242' ' ' GLY . 9.7 Cg_endo -55.14 -36.39 92.96 Favored 'Trans proline' 0 C--N 1.385 2.448 0 CA-C-N 120.725 2.263 . . . . 72.32 113.677 167.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -79.01 -24.04 43.97 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.053 0.541 . . . . 61.13 110.39 174.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . 0.403 ' HA3' ' HG2' ' A' ' 191' ' ' GLN . . . 107.69 112.38 3.62 Favored Glycine 0 C--N 1.344 1.023 0 N-CA-C 108.752 -1.739 . . . . 72.23 108.752 -169.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -69.7 122.18 18.64 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.614 -0.884 . . . . 75.24 108.614 -173.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -137.5 -159.51 8.24 Favored Glycine 0 C--N 1.342 0.878 0 O-C-N 123.551 0.532 . . . . 32.11 112.907 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -121.44 163.95 17.93 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.099 1.36 . . . . 72.14 110.549 -173.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 9.8 tp -134.89 134.21 40.45 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 109.628 -0.508 . . . . 71.05 109.628 -169.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -115.09 146.74 41.01 Favored 'General case' 0 C--O 1.244 0.766 0 N-CA-C 108.931 -0.766 . . . . 75.33 108.931 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 82.5 mt -123.86 113.81 19.02 Favored 'General case' 0 C--O 1.224 -0.241 0 N-CA-C 107.557 -1.275 . . . . 74.32 107.557 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -91.03 111.86 23.51 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.251 -1.018 . . . . 64.45 108.251 -173.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.531 HG11 HG23 ' A' ' 227' ' ' THR . 53.8 t -60.04 126.75 18.34 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.423 0 O-C-N 124.238 0.961 . . . . 62.13 109.811 179.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 16.2 mtt180 -116.24 125.24 51.94 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.012 -1.477 . . . . 75.34 107.012 172.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 49.6 mm -86.33 123.06 39.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 108.718 -0.845 . . . . 71.42 108.718 -178.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.3 t . . . . . 0 CA--C 1.555 1.144 0 N-CA-C 109.271 -0.64 . . . . 65.41 109.271 -173.558 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.431 HG11 HG22 ' A' ' 221' ' ' VAL . 53.0 t . . . . . 0 CA--C 1.544 0.72 0 CA-C-O 121.213 0.53 . . . . 63.31 110.858 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 42.1 mtm -99.32 -176.91 3.43 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.825 1.65 . . . . 71.31 109.032 -171.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 14.5 p -95.57 86.5 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 CA-C-O 123.457 1.599 . . . . 61.53 107.585 163.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . 0.529 ' HG3' ' HA ' ' A' ' 235' ' ' LEU . 0.0 OUTLIER -122.62 -4.2 8.74 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 113.348 -1.751 . . . . 71.33 109.728 -175.912 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.488 ' HA ' ' HB3' ' A' ' 233' ' ' LEU . 66.3 m -41.95 -66.52 0.34 Allowed 'General case' 0 C--N 1.353 0.729 0 C-N-CA 126.202 1.801 . . . . 43.2 112.933 -169.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 43.0 t80 . . . . . 0 CA--C 1.541 0.63 0 N-CA-C 108.925 -0.769 . . . . 64.04 108.925 -176.91 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 . . . . . 0 N--CA 1.479 1.014 0 N-CA-C 108.579 -0.897 . . . . 72.21 108.579 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 30.2 p-10 -75.26 175.74 8.04 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-N 113.869 -1.514 . . . . 71.31 110.443 170.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 32.2 tp -152.31 138.64 18.46 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.597 -0.729 . . . . 51.13 109.246 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -116.01 139.29 50.41 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.581 0.753 . . . . 74.41 109.51 173.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -147.91 157.3 43.45 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.426 -0.953 . . . . 53.21 108.426 169.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 26.6 p -81.44 153.45 26.89 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 121.887 0.851 . . . . 71.41 111.272 164.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.636 HD13 ' HB2' ' A' ' 212' ' ' ALA . 37.3 tp -125.31 131.54 53.03 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 113.345 -1.752 . . . . 74.44 106.755 167.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.428 ' HB2' HG21 ' A' ' 256' ' ' THR . 5.7 p-10 -93.43 114.65 27.1 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 107.554 -1.276 . . . . 65.42 107.554 -178.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.561 HG22 HG21 ' A' ' 210' ' ' VAL . 55.0 t -121.05 131.04 24.59 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 114.85 -1.068 . . . . 52.22 109.198 -177.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -66.97 148.25 81.57 Favored 'Trans proline' 0 C--N 1.369 1.63 0 C-N-CA 122.321 2.014 . . . . 63.33 110.951 169.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.44 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.62 -45.88 98.48 Favored Pre-proline 0 CA--C 1.562 1.423 0 CA-C-O 118.38 -0.819 . . . . 63.43 112.205 172.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.44 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 20.6 Cg_endo -59.6 -31.14 93.93 Favored 'Trans proline' 0 C--N 1.396 3.053 0 C-N-CA 122.096 1.864 . . . . 74.0 112.814 176.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -87.71 -24.55 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 109.52 -0.548 . . . . 74.21 109.52 -177.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -76.14 -37.3 58.15 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-O 121.064 0.459 . . . . 65.52 110.806 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 23.6 t -88.52 -38.52 11.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 CA-C-N 114.156 -1.384 . . . . 73.11 112.124 -177.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.413 ' HB ' ' O ' ' A' ' 202' ' ' PRO . 72.3 t -98.76 -40.44 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 O-C-N 121.959 -0.463 . . . . 75.25 110.89 -178.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 121.33 150.41 8.32 Favored Glycine 0 N--CA 1.472 1.072 0 N-CA-C 111.311 -0.715 . . . . 71.32 111.311 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 165.65 155.6 8.77 Favored Glycine 0 C--O 1.244 0.773 0 CA-C-N 116.869 0.334 . . . . 62.54 112.473 177.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.584 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 34.6 ttmt -86.33 129.76 34.74 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.106 0.562 . . . . 75.01 109.878 179.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.561 HG21 HG22 ' A' ' 199' ' ' VAL . 10.8 m -131.96 151.94 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 124.467 1.107 . . . . 74.33 108.863 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -93.96 144.14 25.72 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.409 -0.589 . . . . 75.3 109.409 -171.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.636 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -133.05 125.27 29.26 Favored 'General case' 0 C--N 1.349 0.56 0 N-CA-C 108.907 -0.775 . . . . 75.04 108.907 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 36.5 tpp -78.68 112.74 16.09 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 108.706 -0.85 . . . . 70.42 108.706 171.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 64.1 p -119.59 -175.01 2.86 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 123.71 0.804 . . . . 52.33 110.222 -176.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.54 HD21 ' HD3' ' A' ' 241' ' ' PRO . 67.2 tp -47.08 -52.93 13.93 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.239 1.016 . . . . 75.23 112.456 175.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -72.51 -27.85 62.51 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.178 -0.919 . . . . 62.44 110.977 -172.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 138.22 -165.26 25.48 Favored Glycine 0 C--N 1.34 0.794 0 N-CA-C 111.581 -0.608 . . . . 32.14 111.581 -172.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -66.18 131.15 25.96 Favored 'Trans proline' 0 C--N 1.37 1.707 0 C-N-CA 122.347 2.031 . . . . 63.2 110.779 177.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 29.4 m -130.93 161.12 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.642 0.777 . . . . 71.34 110.148 -178.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.519 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 43.7 mt-10 -111.65 111.94 23.29 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.742 0.817 . . . . 62.34 108.906 -175.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.431 HG22 HG11 ' A' ' 168' ' ' VAL . 57.4 t -121.75 103.76 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 124.164 0.986 . . . . 74.1 110.11 -171.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.584 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -78.32 118.29 20.37 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.437 0.695 . . . . 74.23 110.666 176.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 35.7 m -89.09 151.29 46.65 Favored Pre-proline 0 N--CA 1.481 1.093 0 C-N-CA 122.869 0.468 . . . . 72.21 110.975 -176.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . 0.625 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 28.6 Cg_endo -61.38 164.54 14.95 Favored 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 122.724 2.283 . . . . 63.21 113.102 176.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -91.75 37.65 0.28 Allowed 'Trans proline' 0 C--N 1.373 1.85 0 C-N-CA 123.427 2.751 . . . . 74.52 112.066 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 -148.37 -9.58 0.37 Allowed 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 116.579 -0.282 . . . . 74.45 111.356 176.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.625 ' HB ' ' HG2' ' A' ' 224' ' ' PRO . 0.7 OUTLIER -59.62 154.15 18.34 Favored 'General case' 0 CA--C 1.559 1.318 0 O-C-N 124.102 0.876 . . . . 74.44 110.633 -161.665 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . 0.468 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 4.5 pt20 -134.53 162.28 32.7 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.317 0.647 . . . . 73.23 110.371 -172.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -58.6 112.81 1.74 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 122.985 0.514 . . . . 51.22 110.841 177.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.52 1.6 21.53 Favored Glycine 0 CA--C 1.522 0.492 0 CA-C-N 115.135 -0.938 . . . . 61.22 111.877 178.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.468 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -69.82 125.52 26.97 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.121 0.569 . . . . 73.42 109.698 -175.769 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -97.09 100.6 12.09 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 109.241 -0.652 . . . . 72.42 109.241 -176.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.488 ' HB3' ' HA ' ' A' ' 172' ' ' SER . 39.7 mt -78.4 102.22 7.66 Favored 'General case' 0 C--N 1.341 0.236 0 N-CA-C 108.208 -1.034 . . . . 62.43 108.208 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . 0.684 ' HD2' ' H ' ' A' ' 234' ' ' ARG . 0.0 OUTLIER -79.98 117.73 21.09 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 124.733 1.271 . . . . 75.13 111.836 -174.773 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.62 ' HB3' ' HB2' ' A' ' 238' ' ' LYS . 8.2 mp -107.68 128.08 54.24 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 106.907 -1.516 . . . . 72.0 106.907 173.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -101.52 116.81 33.61 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.753 0.821 . . . . 62.54 111.441 -174.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 74.63 27.72 64.66 Favored Glycine 0 C--N 1.351 1.401 0 O-C-N 123.895 0.747 . . . . 53.34 111.857 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.62 ' HB2' ' HB3' ' A' ' 235' ' ' LEU . 28.7 mmmt -126.29 22.11 7.2 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.365 1.066 . . . . 72.02 111.134 -175.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -93.93 -128.31 5.04 Favored Glycine 0 C--N 1.341 0.815 0 N-CA-C 110.22 -1.152 . . . . 64.52 110.22 176.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . 0.454 ' O ' ' HA ' ' A' ' 246' ' ' ARG . 6.6 m-30 -70.08 153.81 95.06 Favored Pre-proline 0 CA--C 1.551 0.992 0 CA-C-N 117.65 0.725 . . . . 60.41 111.714 176.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.54 ' HD3' HD21 ' A' ' 215' ' ' LEU . 60.4 Cg_endo -68.35 171.73 12.38 Favored 'Trans proline' 0 C--N 1.381 2.239 0 C-N-CA 123.38 2.72 . . . . 63.42 112.078 178.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.429 ' N ' ' HD2' ' A' ' 243' ' ' PRO . . . -67.59 -39.55 90.75 Favored Glycine 0 CA--C 1.543 1.834 0 CA-C-O 118.4 -1.222 . . . . 73.43 114.634 -176.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' A' ' 242' ' ' GLY . 9.1 Cg_endo -51.88 -38.81 68.94 Favored 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 122.698 2.265 . . . . 71.41 113.225 167.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -78.68 -25.29 44.81 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.449 0.699 . . . . 74.23 110.66 175.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 106.1 112.77 3.73 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 109.084 -1.606 . . . . 74.05 109.084 -168.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.454 ' HA ' ' O ' ' A' ' 240' ' ' PHE . 52.7 ttp180 -72.22 127.06 31.37 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 117.266 0.533 . . . . 72.22 110.977 -175.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -136.56 -157.18 7.65 Favored Glycine 0 C--O 1.239 0.452 0 CA-C-N 115.575 -0.739 . . . . 44.33 111.718 178.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -116.29 166.14 12.38 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.872 0.869 . . . . 72.41 109.028 -174.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 10.6 tp -134.78 134.14 40.6 Favored 'General case' 0 C--O 1.213 -0.827 0 N-CA-C 108.333 -0.988 . . . . 75.11 108.333 -176.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.445 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 8.1 m-85 -121.97 146.23 47.35 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 108.943 -0.762 . . . . 72.32 108.943 -177.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.419 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 77.6 mt -124.64 115.52 20.93 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.917 -0.772 . . . . 74.23 108.917 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -88.94 106.71 18.59 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 107.873 -1.158 . . . . 72.4 107.873 -173.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.599 HG11 HG23 ' A' ' 227' ' ' THR . 52.7 t -59.93 125.26 15.74 Favored 'Isoleucine or valine' 0 C--N 1.34 0.184 0 O-C-N 124.09 0.869 . . . . 75.1 109.439 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -120.78 124.35 44.87 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.212 -1.403 . . . . 74.22 107.212 176.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 51.1 mm -85.75 118.45 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 O-C-N 124.124 0.89 . . . . 74.21 109.414 -173.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . 0.428 HG21 ' HB2' ' A' ' 198' ' ' ASP . 1.0 OUTLIER . . . . . 0 CA--C 1.554 1.107 0 N-CA-C 108.582 -0.896 . . . . 70.21 108.582 -171.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.465 HG11 HG22 ' A' ' 221' ' ' VAL . 54.9 t . . . . . 0 N--CA 1.475 0.787 0 CA-C-O 121.323 0.582 . . . . 53.43 111.765 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 44.1 mtm -98.75 -176.75 3.44 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.651 1.581 . . . . 65.15 109.651 -174.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 8.3 p -99.98 89.04 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 CA-C-O 122.964 1.364 . . . . 73.21 108.592 163.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . 0.457 ' HG3' ' HA ' ' A' ' 235' ' ' LEU . 0.0 OUTLIER -123.76 -6.09 8.01 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 113.946 -1.479 . . . . 63.43 110.789 -174.478 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.472 ' HB3' HD22 ' A' ' 233' ' ' LEU . 66.1 m -39.64 -66.45 0.3 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.545 1.938 . . . . 75.02 114.638 -167.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 57.5 t80 . . . . . 0 N--CA 1.472 0.625 0 C-N-CA 122.603 0.361 . . . . 74.24 110.068 -175.386 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.518 ' HG2' ' HA3' ' A' ' 245' ' ' GLY . 45.2 mt-30 . . . . . 0 N--CA 1.477 0.916 0 CA-C-O 121.338 0.59 . . . . 63.31 110.47 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -75.4 162.08 28.68 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 114.806 -1.088 . . . . 73.23 109.182 176.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.444 HD23 HD13 ' A' ' 249' ' ' LEU . 52.7 tp -149.96 136.52 19.14 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.128 -0.693 . . . . 71.53 109.128 171.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -113.17 139.58 48.64 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.011 -0.737 . . . . 74.54 109.011 170.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.456 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -148.38 155.05 40.76 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.491 0.716 . . . . 73.1 109.338 173.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 25.2 p -82.0 153.62 26.11 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 122.085 0.945 . . . . 75.45 112.774 171.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.656 HD13 ' HB2' ' A' ' 212' ' ' ALA . 39.3 tp -126.97 132.26 50.86 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 113.108 -1.86 . . . . 72.21 106.642 169.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -95.13 111.59 23.39 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.068 -1.086 . . . . 73.24 108.068 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.516 HG22 HG21 ' A' ' 210' ' ' VAL . 46.8 t -114.84 131.91 23.22 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-N 114.663 -1.153 . . . . 71.35 109.299 -178.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -68.59 145.3 63.61 Favored 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 122.229 1.953 . . . . 62.42 110.934 168.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.432 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.86 -45.56 98.82 Favored Pre-proline 0 CA--C 1.564 1.493 0 O-C-N 123.961 0.788 . . . . 53.45 111.845 174.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 19.6 Cg_endo -58.97 -32.9 98.38 Favored 'Trans proline' 0 C--N 1.403 3.442 0 C-N-CA 122.155 1.903 . . . . 71.52 112.777 175.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.7 mp -86.0 -24.85 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 109.509 -0.552 . . . . 75.42 109.509 -176.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -73.22 -37.71 66.32 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 122.942 0.497 . . . . 64.44 110.943 178.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 21.0 t -87.78 -37.28 10.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-N 114.426 -1.261 . . . . 70.11 112.981 -178.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 53.4 t -96.62 -42.2 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 O-C-N 122.203 -0.311 . . . . 62.44 110.484 -175.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 121.2 145.46 7.22 Favored Glycine 0 C--N 1.339 0.743 0 N-CA-C 110.76 -0.936 . . . . 73.11 110.76 -176.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 166.13 155.72 8.98 Favored Glycine 0 C--O 1.246 0.906 0 CA-C-O 121.29 0.383 . . . . 63.03 112.538 178.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.58 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 36.8 ttmt -86.32 131.73 34.14 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.564 0.745 . . . . 72.04 109.685 178.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.516 HG21 HG22 ' A' ' 199' ' ' VAL . 14.2 m -129.2 149.23 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 124.165 0.986 . . . . 71.22 109.197 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 4.4 tmm_? -95.98 141.55 29.26 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 108.918 -0.771 . . . . 72.31 108.918 -170.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.656 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -132.64 116.17 16.32 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.501 1.12 . . . . 61.35 109.223 -175.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 38.1 tpp -78.85 108.7 12.49 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 107.612 -1.255 . . . . 63.34 107.612 172.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 71.3 p -114.48 -175.17 2.62 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.811 0.844 . . . . 75.42 110.611 -175.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.614 HD21 ' HD3' ' A' ' 241' ' ' PRO . 61.8 tp -45.01 -52.4 8.9 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.757 1.223 . . . . 65.52 112.091 173.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -72.11 -28.08 63.06 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 114.189 -1.369 . . . . 63.25 111.031 -171.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 135.02 -166.23 24.43 Favored Glycine 0 C--O 1.243 0.717 0 CA-C-N 115.509 -0.769 . . . . 25.22 111.304 -173.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.0 131.43 23.83 Favored 'Trans proline' 0 C--N 1.363 1.3 0 C-N-CA 122.352 2.035 . . . . 72.25 111.672 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 28.9 m -134.26 157.76 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.749 0.82 . . . . 61.14 109.981 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.504 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 38.7 mt-10 -114.28 115.56 27.61 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.641 0.776 . . . . 73.51 110.568 -176.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.465 HG22 HG11 ' A' ' 168' ' ' VAL . 98.3 t -121.74 105.29 16.22 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 125.366 1.466 . . . . 75.21 110.245 -168.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.58 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -76.3 118.47 19.05 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 122.425 0.29 . . . . 72.42 110.621 176.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 35.0 m -87.25 151.72 51.67 Favored Pre-proline 0 N--CA 1.489 1.496 0 C-N-CA 123.178 0.591 . . . . 64.22 110.673 -178.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . 0.658 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 26.1 Cg_endo -61.06 163.59 16.31 Favored 'Trans proline' 0 C--N 1.38 2.215 0 C-N-CA 122.706 2.271 . . . . 64.4 113.193 177.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -87.27 34.02 0.43 Allowed 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 122.951 2.434 . . . . 63.32 112.572 178.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -149.73 -3.35 0.4 Allowed 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 112.321 0.489 . . . . 73.05 112.321 177.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.658 ' HB ' ' HG2' ' A' ' 224' ' ' PRO . 0.7 OUTLIER -61.97 154.34 26.75 Favored 'General case' 0 CA--C 1.563 1.461 0 O-C-N 123.304 0.377 . . . . 73.42 111.788 -165.099 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -136.82 161.04 37.08 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.472 0.709 . . . . 73.54 110.193 -178.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -58.56 113.12 1.85 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.45 0.7 . . . . 75.15 111.175 -177.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 116.69 0.31 19.96 Favored Glycine 0 CA--C 1.524 0.616 0 CA-C-N 115.064 -0.971 . . . . 71.1 112.395 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.434 ' HE ' HD23 ' A' ' 233' ' ' LEU . 0.0 OUTLIER -68.97 130.76 43.69 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 109.076 -0.713 . . . . 71.31 109.076 -176.396 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -97.76 96.18 8.06 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 109.018 -0.734 . . . . 74.11 109.018 -168.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.472 HD22 ' HB3' ' A' ' 172' ' ' SER . 24.4 mt -82.6 97.62 8.58 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 106.694 -1.595 . . . . 72.2 106.694 -178.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 3.5 ppt_? -83.23 125.29 31.42 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 123.97 0.794 . . . . 71.3 110.988 -179.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.457 ' HA ' ' HG3' ' A' ' 171' ' ' MET . 7.3 mp -110.02 126.65 54.2 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 106.286 -1.746 . . . . 74.24 106.286 177.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 11.3 tptp -98.6 115.28 28.29 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 110.048 -0.353 . . . . 75.4 110.048 -170.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.621 ' HA2' HH11 ' A' ' 246' ' ' ARG . . . 79.66 23.35 62.48 Favored Glycine 0 C--N 1.343 0.951 0 O-C-N 123.836 0.71 . . . . 33.14 113.65 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? -122.72 23.93 9.31 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.296 0.638 . . . . 53.14 111.292 -177.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . 0.444 ' HA2' ' HB2' ' A' ' 249' ' ' LEU . . . -93.79 -130.96 5.86 Favored Glycine 0 C--N 1.349 1.261 0 CA-C-O 119.296 -0.725 . . . . 63.15 111.919 -178.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -69.29 149.21 97.44 Favored Pre-proline 0 CA--C 1.553 1.093 0 CA-C-N 117.366 0.583 . . . . 74.15 111.53 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.614 ' HD3' HD21 ' A' ' 215' ' ' LEU . 44.1 Cg_endo -63.62 171.78 6.51 Favored 'Trans proline' 0 C--N 1.391 2.764 0 C-N-CA 123.574 2.849 . . . . 63.51 112.565 -178.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -66.02 -42.95 94.38 Favored Glycine 0 CA--C 1.544 1.849 0 CA-C-O 118.223 -1.321 . . . . 73.43 114.098 -173.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -58.92 -34.75 99.24 Favored 'Trans proline' 0 C--N 1.388 2.644 0 CA-C-N 120.812 2.306 . . . . 73.21 113.785 170.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -77.14 -24.54 51.61 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.18 0.592 . . . . 64.53 110.37 173.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . 0.518 ' HA3' ' HG2' ' A' ' 191' ' ' GLN . . . 110.51 117.74 3.84 Favored Glycine 0 C--N 1.344 0.973 0 N-CA-C 110.532 -1.027 . . . . 70.11 110.532 -172.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.621 HH11 ' HA2' ' A' ' 237' ' ' GLY . 2.3 tmm_? -68.6 124.74 24.43 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.18 -0.674 . . . . 60.03 109.18 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -143.12 -156.2 6.7 Favored Glycine 0 N--CA 1.47 0.943 0 O-C-N 123.517 0.511 . . . . 63.31 112.109 176.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -115.53 167.05 11.23 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 109.112 -0.699 . . . . 62.32 109.112 -176.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.444 ' HB2' ' HA2' ' A' ' 239' ' ' GLY . 17.9 tp -134.48 133.07 39.99 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 108.499 -0.926 . . . . 73.31 108.499 -175.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -114.06 147.6 38.45 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 123.598 0.759 . . . . 73.22 110.245 178.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.456 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 88.9 mt -125.65 113.85 17.91 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 114.017 -1.447 . . . . 64.24 107.511 174.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -89.73 112.64 23.98 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 107.671 -1.233 . . . . 75.42 107.671 -176.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.515 HG11 HG23 ' A' ' 227' ' ' THR . 54.6 t -59.65 127.31 18.79 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.117 0 O-C-N 124.46 1.1 . . . . 70.31 109.75 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 8.3 mmt180 -123.96 123.45 40.41 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.251 -1.018 . . . . 55.05 108.251 175.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 46.2 mm -87.15 118.73 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 123.258 0.623 . . . . 52.22 110.033 -174.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.4 t . . . . . 0 CA--C 1.56 1.357 0 C-N-CA 123.546 0.738 . . . . 44.04 109.251 -171.555 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 47.5 t . . . . . 0 CA--C 1.545 0.76 0 CA-C-O 121.12 0.486 . . . . 65.12 111.596 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 47.9 mtm -99.11 -175.62 3.08 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 126.183 1.793 . . . . 75.42 109.703 -171.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 14.3 p -95.63 87.81 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.351 0 N-CA-C 107.107 -1.442 . . . . 74.34 107.107 161.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . 0.411 ' SD ' ' HG ' ' A' ' 235' ' ' LEU . 0.0 OUTLIER -129.96 -4.79 4.52 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 114.211 -1.359 . . . . 71.25 110.9 -174.203 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.468 ' HA ' ' HB3' ' A' ' 233' ' ' LEU . 70.9 m -40.17 -65.13 0.43 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.666 1.986 . . . . 64.42 113.049 -171.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 55.4 t80 . . . . . 0 CA--C 1.543 0.677 0 N-CA-C 107.518 -1.29 . . . . 72.33 107.518 179.542 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.423 ' HA ' ' O ' ' A' ' 245' ' ' GLY . 21.9 mt-30 . . . . . 0 C--O 1.245 0.819 0 N-CA-C 108.252 -1.018 . . . . 75.31 108.252 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 29.2 p-10 -74.17 167.64 21.17 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 114.722 -1.126 . . . . 44.35 110.548 174.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 52.8 tp -150.65 139.64 21.0 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.449 -0.796 . . . . 64.53 109.821 177.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -110.03 138.77 45.94 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 123.869 0.867 . . . . 74.34 109.509 171.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -148.05 157.78 43.7 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 108.185 -1.043 . . . . 63.12 108.185 168.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . 0.439 HG22 ' HB3' ' A' ' 252' ' ' GLU . 27.8 p -92.87 152.58 19.32 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.957 0.884 . . . . 74.43 112.242 168.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.671 HD13 ' HB2' ' A' ' 212' ' ' ALA . 41.1 tp -123.86 130.79 53.17 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 113.073 -1.876 . . . . 73.22 106.826 167.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.431 ' HB2' HG21 ' A' ' 256' ' ' THR . 10.0 p-10 -94.63 112.39 24.14 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 121.951 0.881 . . . . 72.34 109.047 -178.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.594 HG22 HG21 ' A' ' 210' ' ' VAL . 61.0 t -119.35 132.81 23.85 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 124.119 0.968 . . . . 61.12 109.903 -175.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -68.46 144.35 60.96 Favored 'Trans proline' 0 C--N 1.369 1.608 0 C-N-CA 121.999 1.799 . . . . 70.1 111.337 167.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.431 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.0 -43.62 94.97 Favored Pre-proline 0 CA--C 1.559 1.301 0 CA-C-O 118.104 -0.95 . . . . 72.41 112.601 173.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 19.3 Cg_endo -56.86 -33.61 95.1 Favored 'Trans proline' 0 C--N 1.399 3.237 0 C-N-CA 121.728 1.618 . . . . 73.22 112.631 173.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -86.71 -24.25 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 N-CA-C 109.623 -0.51 . . . . 55.34 109.623 -177.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . 0.417 ' HA ' HG22 ' A' ' 227' ' ' THR . . . -73.5 -37.59 65.63 Favored 'General case' 0 C--O 1.246 0.89 0 C-N-CA 123.335 0.654 . . . . 62.32 110.866 178.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 41.4 t -90.04 -34.67 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.224 0 CA-C-N 113.498 -1.683 . . . . 74.32 113.414 -177.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 54.6 t -101.39 -42.39 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 O-C-N 121.479 -0.763 . . . . 73.41 111.096 -178.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 126.12 155.24 8.89 Favored Glycine 0 C--N 1.34 0.773 0 N-CA-C 110.941 -0.863 . . . . 34.4 110.941 -176.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.64 149.1 5.68 Favored Glycine 0 C--O 1.246 0.894 0 N-CA-C 111.48 -0.648 . . . . 62.41 111.48 176.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.579 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 34.3 ttpt -84.71 129.83 34.78 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 109.267 -0.642 . . . . 70.44 109.267 174.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.594 HG21 HG22 ' A' ' 199' ' ' VAL . 9.7 m -133.37 147.93 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 124.013 0.925 . . . . 61.43 108.77 -178.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . 0.419 ' HD2' ' N ' ' A' ' 212' ' ' ALA . 6.4 tmm_? -94.77 141.79 28.21 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.218 0.607 . . . . 73.01 109.429 -170.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.671 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -131.18 126.22 35.04 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.495 1.118 . . . . 73.52 108.498 -176.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 37.3 tpp -80.05 108.5 13.69 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 108.083 -1.08 . . . . 75.13 108.083 173.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 71.4 p -117.23 178.8 4.23 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.692 0.797 . . . . 75.02 110.741 -176.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 69.0 tp -45.33 -50.71 11.86 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.17 1.388 . . . . 62.22 112.276 176.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -71.96 -26.69 62.37 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 114.551 -1.204 . . . . 71.34 111.288 -173.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 138.6 -166.53 25.29 Favored Glycine 0 C--N 1.341 0.861 0 N-CA-C 111.389 -0.684 . . . . 52.02 111.389 -177.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -65.33 130.27 24.92 Favored 'Trans proline' 0 C--N 1.368 1.555 0 C-N-CA 121.9 1.733 . . . . 73.12 110.771 174.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 30.2 m -134.74 159.72 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 123.312 0.645 . . . . 72.33 110.532 -174.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.555 ' HB3' ' HD2' ' A' ' 209' ' ' LYS . 44.6 mt-10 -113.42 114.7 26.95 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.344 0.658 . . . . 53.21 109.764 -174.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 54.9 t -122.01 103.74 13.87 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 C-N-CA 125.009 1.324 . . . . 72.54 109.667 -169.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.579 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -77.48 117.88 19.37 Favored 'General case' 0 N--CA 1.478 0.943 0 O-C-N 122.167 -0.333 . . . . 52.12 110.478 175.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.416 HG11 HG21 ' A' ' 199' ' ' VAL . 27.5 m -85.23 152.8 58.85 Favored Pre-proline 0 N--CA 1.492 1.66 0 C-N-CA 123.202 0.601 . . . . 73.2 111.157 -176.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . 0.543 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 33.6 Cg_endo -65.99 163.03 32.71 Favored 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 121.75 1.633 . . . . 52.01 112.541 177.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -85.34 27.42 0.6 Allowed 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 122.854 2.369 . . . . 33.41 112.94 178.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 41.5 mmt-85 -144.93 0.11 0.93 Allowed 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.382 0.673 . . . . 70.32 111.447 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.594 HG23 HG11 ' A' ' 253' ' ' VAL . 0.7 OUTLIER -61.65 155.71 21.84 Favored 'General case' 0 CA--C 1.573 1.859 0 O-C-N 123.88 0.738 . . . . 65.25 109.529 -169.191 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . 0.429 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 4.8 pt20 -133.07 162.86 30.59 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.541 0.736 . . . . 73.4 110.844 -174.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -59.38 110.75 1.16 Allowed 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 109.444 -0.576 . . . . 75.34 109.444 171.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 114.35 0.36 23.6 Favored Glycine 0 CA--C 1.524 0.61 0 CA-C-N 115.379 -0.828 . . . . 43.43 111.686 178.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.429 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -72.04 125.5 27.4 Favored 'General case' 0 C--N 1.359 0.99 0 N-CA-C 109.022 -0.733 . . . . 75.21 109.022 -174.141 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -98.98 97.7 8.83 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 123.508 0.723 . . . . 72.0 109.457 -169.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.468 ' HB3' ' HA ' ' A' ' 172' ' ' SER . 30.7 mt -80.38 98.0 7.29 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 107.008 -1.479 . . . . 64.43 107.008 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 2.0 ppt_? -83.61 117.37 23.12 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 121.493 0.663 . . . . 73.2 111.417 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.411 ' HG ' ' SD ' ' A' ' 171' ' ' MET . 6.3 mp -99.17 125.8 44.82 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 105.479 -2.045 . . . . 74.11 105.479 174.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.406 ' HA ' ' HB3' ' A' ' 248' ' ' ASP . 18.3 tptt -101.79 117.43 34.84 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 118.657 0.662 . . . . 73.14 111.234 -168.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.49 ' H ' ' HB3' ' A' ' 248' ' ' ASP . . . 78.03 24.6 63.75 Favored Glycine 0 C--N 1.354 1.583 0 O-C-N 123.837 0.711 . . . . 61.24 112.549 -174.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.406 ' HB2' ' HB3' ' A' ' 235' ' ' LEU . 30.1 mmmt -119.1 20.67 12.61 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.571 0.748 . . . . 75.42 110.943 -175.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -96.83 -139.56 10.69 Favored Glycine 0 C--N 1.346 1.097 0 N-CA-C 111.124 -0.79 . . . . 71.42 111.124 177.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 7.1 m-30 -68.89 149.53 97.85 Favored Pre-proline 0 N--CA 1.478 0.955 0 N-CA-C 112.372 0.508 . . . . 65.42 112.372 -174.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -63.12 170.87 7.02 Favored 'Trans proline' 0 C--N 1.386 2.549 0 C-N-CA 123.488 2.792 . . . . 64.11 112.65 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.43 ' N ' ' HD2' ' A' ' 243' ' ' PRO . . . -66.55 -40.03 94.1 Favored Glycine 0 CA--C 1.551 2.306 0 CA-C-O 118.244 -1.309 . . . . 64.44 114.695 -174.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 242' ' ' GLY . 13.1 Cg_endo -56.64 -36.61 98.24 Favored 'Trans proline' 0 C--N 1.391 2.763 0 CA-C-N 120.792 2.296 . . . . 62.43 113.219 169.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -78.28 -25.36 46.67 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.148 0.579 . . . . 63.13 110.414 175.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 191' ' ' GLN . . . 113.18 117.08 3.39 Favored Glycine 0 C--N 1.344 1.007 0 N-CA-C 109.543 -1.423 . . . . 75.54 109.543 -169.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 45.9 ttm105 -72.11 125.98 28.64 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 117.283 0.541 . . . . 75.31 110.4 -178.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -148.54 -158.18 7.89 Favored Glycine 0 C--N 1.331 0.287 0 CA-C-N 116.008 -0.542 . . . . 74.2 112.094 175.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . 0.49 ' HB3' ' H ' ' A' ' 237' ' ' GLY . 0.1 OUTLIER -126.72 166.26 17.71 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.261 1.024 . . . . 72.12 110.526 -174.465 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 7.2 tp -132.86 134.66 44.91 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.667 -0.864 . . . . 63.34 108.667 -167.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -115.18 146.95 40.89 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 108.352 -0.981 . . . . 71.12 108.352 -175.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.413 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 84.6 mt -124.22 113.87 18.86 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 107.94 -1.133 . . . . 73.05 107.94 179.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . 0.439 ' HB3' HG22 ' A' ' 196' ' ' THR . 24.1 tt0 -88.74 110.39 20.96 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 107.698 -1.223 . . . . 71.12 107.698 -176.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.594 HG11 HG23 ' A' ' 227' ' ' THR . 55.5 t -60.77 125.63 17.26 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.263 0 O-C-N 124.116 0.885 . . . . 53.31 109.186 176.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 24.4 mtp85 -122.29 122.97 40.34 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 107.919 -1.141 . . . . 74.24 107.919 178.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.427 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 47.2 mm -85.84 118.67 32.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 O-C-N 123.635 0.584 . . . . 72.14 109.89 -171.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . 0.431 HG21 ' HB2' ' A' ' 198' ' ' ASP . 1.7 t . . . . . 0 CA--C 1.551 1.008 0 C-N-CA 124.329 1.052 . . . . 74.44 109.357 -171.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 53.7 t . . . . . 0 N--CA 1.478 0.925 0 CA-C-O 121.885 0.85 . . . . 55.3 111.908 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 43.3 mtm -101.62 -176.06 3.03 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 126.625 1.97 . . . . 64.51 109.862 -168.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 10.2 p -99.23 87.14 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 CA-C-O 123.066 1.413 . . . . 73.52 107.534 162.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.43 -4.45 8.83 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 113.883 -1.508 . . . . 70.34 110.285 -174.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.449 ' O ' ' HA ' ' A' ' 233' ' ' LEU . 69.6 m -39.0 -68.3 0.17 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.775 2.03 . . . . 63.34 113.839 -166.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . 0.474 ' HB2' ' HG3' ' A' ' 224' ' ' PRO . 67.2 t80 . . . . . 0 CA--C 1.538 0.494 0 N-CA-C 109.372 -0.603 . . . . 75.22 109.372 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 . . . . . 0 N--CA 1.468 0.428 0 CA-C-O 121.369 0.604 . . . . 74.31 109.439 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -82.95 167.62 17.8 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 114.844 -1.071 . . . . 52.33 109.925 175.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 50.3 tp -150.55 138.73 20.24 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.161 -0.472 . . . . 71.25 109.766 -177.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -117.33 139.45 50.83 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.035 0.934 . . . . 54.03 109.207 172.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -148.39 158.65 44.24 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.737 -0.838 . . . . 45.12 108.737 171.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 33.2 p -80.95 153.63 27.4 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 122.13 0.967 . . . . 74.43 111.802 168.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.66 HD13 ' HB2' ' A' ' 212' ' ' ALA . 38.8 tp -124.09 133.42 53.62 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 112.961 -1.927 . . . . 73.42 106.402 166.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -93.05 114.76 27.39 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.785 -1.191 . . . . 72.25 107.785 178.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.607 HG22 HG21 ' A' ' 210' ' ' VAL . 61.0 t -122.93 130.51 24.58 Favored Pre-proline 0 CA--C 1.542 0.673 0 C-N-CA 124.202 1.001 . . . . 52.33 108.832 179.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -68.48 146.72 69.04 Favored 'Trans proline' 0 C--N 1.363 1.29 0 C-N-CA 122.402 2.068 . . . . 63.04 111.76 168.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.449 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.23 -44.79 98.08 Favored Pre-proline 0 CA--C 1.564 1.507 0 C-N-CA 124.178 0.991 . . . . 61.43 112.25 172.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 19.8 Cg_endo -58.11 -34.68 98.74 Favored 'Trans proline' 0 C--N 1.401 3.294 0 C-N-CA 122.127 1.885 . . . . 72.1 112.58 174.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -85.43 -23.37 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 N-CA-C 109.138 -0.69 . . . . 74.33 109.138 -177.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -74.25 -37.98 63.62 Favored 'General case' 0 C--O 1.247 0.95 0 C-N-CA 123.108 0.563 . . . . 73.22 111.589 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 35.0 t -88.89 -37.88 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 CA-C-N 114.443 -1.253 . . . . 65.15 112.798 -179.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 54.5 t -95.82 -41.63 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 O-C-N 121.834 -0.541 . . . . 63.34 110.463 -175.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 121.59 151.1 8.43 Favored Glycine 0 C--N 1.344 1.012 0 N-CA-C 111.044 -0.822 . . . . 44.3 111.044 -177.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.77 154.48 7.96 Favored Glycine 0 C--O 1.246 0.862 0 N-CA-C 112.253 -0.339 . . . . 62.4 112.253 176.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.588 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 39.1 ttmt -85.32 132.68 34.21 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 123.472 0.709 . . . . 73.32 109.901 175.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.607 HG21 HG22 ' A' ' 199' ' ' VAL . 12.9 m -130.79 153.5 39.24 Favored 'Isoleucine or valine' 0 C--O 1.244 0.807 0 C-N-CA 124.713 1.205 . . . . 52.35 108.607 176.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -93.4 145.05 24.76 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.544 0.737 . . . . 74.31 110.239 -176.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.66 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -131.06 117.96 19.87 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 107.726 -1.213 . . . . 31.25 107.726 177.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 34.3 tpp -79.66 109.1 13.73 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 107.399 -1.334 . . . . 55.45 107.399 177.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 62.3 p -113.46 -172.38 2.06 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.253 0.621 . . . . 74.21 110.858 -172.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.653 HD21 ' HD3' ' A' ' 241' ' ' PRO . 63.1 tp -46.63 -52.1 14.4 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.561 1.144 . . . . 65.33 111.223 171.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -74.08 -28.96 61.63 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 114.294 -1.321 . . . . 73.31 112.3 -174.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 134.43 -166.72 24.1 Favored Glycine 0 C--N 1.346 1.102 0 CA-C-O 119.33 -0.706 . . . . 71.34 111.589 -173.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -62.32 136.06 57.57 Favored 'Trans proline' 0 C--N 1.372 1.766 0 C-N-CA 122.869 2.379 . . . . 53.11 111.301 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 212' ' ' ALA . 24.3 m -135.34 157.91 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 109.922 -0.399 . . . . 71.32 109.922 -176.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.555 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 44.6 mt-10 -110.01 105.44 14.58 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.773 0.829 . . . . 65.13 109.147 -167.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 58.7 t -122.11 101.98 10.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 115.198 -0.91 . . . . 75.2 109.335 -172.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.588 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -79.21 118.35 21.07 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 109.361 -0.607 . . . . 41.53 109.361 172.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 34.1 m -85.23 152.09 57.75 Favored Pre-proline 0 N--CA 1.482 1.164 0 C-N-CA 123.124 0.57 . . . . 33.45 110.363 -176.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . 0.474 ' HG3' ' HB2' ' A' ' 173' ' ' TYR . 36.2 Cg_endo -62.82 163.37 22.13 Favored 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 122.227 1.951 . . . . 65.41 112.362 176.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -85.37 32.96 0.47 Allowed 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 122.899 2.4 . . . . 72.54 112.729 175.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . 0.42 ' HA ' ' HD2' ' A' ' 226' ' ' ARG . 13.2 tpt180 -149.41 4.32 0.6 Allowed 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 116.095 -0.502 . . . . 75.42 110.731 175.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.506 HG23 HG11 ' A' ' 253' ' ' VAL . 0.6 OUTLIER -59.94 154.35 19.05 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.896 -0.779 . . . . 74.43 108.896 -169.855 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -131.7 161.39 32.9 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.291 0.636 . . . . 72.44 110.384 -168.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -62.33 109.37 1.32 Allowed 'General case' 0 C--O 1.241 0.62 0 N-CA-C 107.922 -1.14 . . . . 45.55 107.922 167.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 113.85 2.76 23.74 Favored Glycine 0 C--N 1.337 0.589 0 CA-C-N 115.309 -0.859 . . . . 61.33 112.428 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.14 127.08 31.58 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.046 -0.724 . . . . 72.01 109.046 -175.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -99.73 98.19 9.04 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 123.466 0.706 . . . . 73.43 109.353 -171.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.466 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 20.3 mt -82.63 98.62 9.11 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 106.928 -1.508 . . . . 75.42 106.928 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 7.1 ppt_? -83.06 114.0 20.99 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-O 121.349 0.595 . . . . 74.15 111.374 -179.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.483 ' O ' ' HB2' ' A' ' 248' ' ' ASP . 8.0 mp -104.11 126.67 51.41 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 106.52 -1.659 . . . . 74.51 106.52 174.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -102.92 119.05 38.16 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.476 0.71 . . . . 72.34 111.35 -174.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 79.0 31.42 43.33 Favored Glycine 0 C--N 1.354 1.564 0 O-C-N 123.969 0.793 . . . . 51.43 112.309 -175.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -127.98 20.33 6.45 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.389 0.676 . . . . 71.32 111.053 -178.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -98.01 -131.27 7.08 Favored Glycine 0 C--N 1.349 1.267 0 CA-C-O 119.576 -0.569 . . . . 53.22 112.407 -177.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -71.16 155.18 93.45 Favored Pre-proline 0 CA--C 1.55 0.98 0 CA-C-N 117.453 0.627 . . . . 74.34 112.453 -178.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.653 ' HD3' HD21 ' A' ' 215' ' ' LEU . 88.8 Cg_endo -72.99 171.67 17.05 Favored 'Trans proline' 0 C--N 1.387 2.603 0 C-N-CA 123.502 2.801 . . . . 75.51 112.67 -174.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -66.41 -38.72 93.79 Favored Glycine 0 CA--C 1.545 1.958 0 CA-C-O 118.382 -1.232 . . . . 75.43 113.575 -179.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . 0.447 ' HD2' ' HB2' ' A' ' 241' ' ' PRO . 53.5 Cg_exo -46.3 -44.47 20.11 Favored 'Trans proline' 0 C--N 1.385 2.464 0 C-N-CA 123.047 2.498 . . . . 73.21 114.041 163.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -78.73 -23.81 45.22 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.675 0.79 . . . . 72.14 110.765 177.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 105.27 114.49 3.96 Favored Glycine 0 C--N 1.341 0.861 0 N-CA-C 108.458 -1.857 . . . . 44.31 108.458 -165.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.61 124.0 23.74 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.163 0.585 . . . . 72.33 109.53 -172.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -137.8 -156.69 7.28 Favored Glycine 0 N--CA 1.477 1.432 0 CA-C-O 119.886 -0.397 . . . . 24.21 112.305 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . 0.483 ' HB2' ' O ' ' A' ' 235' ' ' LEU . 6.5 p30 -123.0 167.54 13.47 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.178 0.591 . . . . 64.32 111.706 -175.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 11.7 tp -134.67 134.41 41.09 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.634 0.774 . . . . 62.11 109.265 -170.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 4.2 m-30 -118.94 148.94 42.41 Favored 'General case' 0 C--O 1.25 1.114 0 N-CA-C 108.708 -0.849 . . . . 74.35 108.708 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.466 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 88.4 mt -120.72 124.42 45.12 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.446 -0.576 . . . . 61.4 109.446 -177.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -91.51 100.82 13.51 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 107.197 -1.408 . . . . 74.45 107.197 -177.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.506 HG11 HG23 ' A' ' 227' ' ' THR . 55.7 t -63.15 123.58 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-O 121.488 0.661 . . . . 62.54 110.7 -178.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -114.66 123.5 49.46 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 107.606 -1.257 . . . . 70.51 107.606 177.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 47.0 mm -88.21 111.57 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 O-C-N 123.981 0.801 . . . . 74.22 110.181 -175.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.6 t . . . . . 0 C--O 1.255 1.376 0 C-N-CA 124.143 0.977 . . . . 42.04 110.196 -173.526 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 45.7 t . . . . . 0 N--CA 1.478 0.946 0 CA-C-O 121.196 0.522 . . . . 73.34 110.61 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 50.6 mtm -98.8 -177.69 3.73 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 125.226 1.41 . . . . 71.51 110.212 -169.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 7.7 p -99.05 87.79 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.065 0 CA-C-O 122.989 1.376 . . . . 53.14 107.49 162.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.1 -4.97 8.97 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 125.495 1.518 . . . . 63.14 109.979 -176.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 69.9 m -36.36 -66.15 0.23 Allowed 'General case' 0 C--N 1.35 0.612 0 C-N-CA 126.906 2.082 . . . . 74.1 114.559 -167.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . 0.409 ' HB2' ' HG3' ' A' ' 224' ' ' PRO . 77.2 t80 . . . . . 0 CA--C 1.54 0.579 0 N-CA-C 110.1 -0.333 . . . . 73.52 110.1 -177.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.431 ' HG2' ' HA3' ' A' ' 245' ' ' GLY . 70.9 mt-30 . . . . . 0 N--CA 1.477 0.907 0 CA-C-O 121.301 0.572 . . . . 61.41 109.675 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -77.0 165.09 25.11 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-N 115.051 -0.977 . . . . 55.14 109.625 177.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 35.2 tp -151.47 139.14 19.71 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.933 -0.576 . . . . 71.25 109.841 178.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -116.55 140.21 49.64 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.411 1.084 . . . . 74.33 109.555 174.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -149.59 160.87 43.13 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 123.908 0.883 . . . . 54.34 108.781 168.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 34.7 p -83.91 154.4 23.43 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 121.757 0.789 . . . . 75.33 111.458 163.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.662 HD13 ' HB2' ' A' ' 212' ' ' ALA . 37.4 tp -121.11 132.05 54.63 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 113.768 -1.56 . . . . 62.34 107.152 162.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -93.18 111.36 22.97 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 108.248 -1.019 . . . . 63.41 108.248 -178.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.578 HG22 HG21 ' A' ' 210' ' ' VAL . 56.4 t -120.36 131.73 24.34 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 123.87 0.868 . . . . 72.32 108.892 -178.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -66.49 148.19 83.45 Favored 'Trans proline' 0 C--N 1.369 1.631 0 C-N-CA 121.957 1.771 . . . . 64.32 111.253 168.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.433 ' HB3' ' HD3' ' A' ' 202' ' ' PRO . . . -53.77 -46.78 98.27 Favored Pre-proline 0 CA--C 1.56 1.336 0 CA-C-O 118.609 -0.71 . . . . 41.11 111.523 174.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.433 ' HD3' ' HB3' ' A' ' 201' ' ' ALA . 73.0 Cg_exo -51.37 -39.62 63.14 Favored 'Trans proline' 0 C--N 1.396 3.061 0 C-N-CA 122.744 2.296 . . . . 73.24 114.08 172.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -84.99 -24.73 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 N-CA-C 109.525 -0.546 . . . . 73.44 109.525 -174.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . 0.433 ' HA ' HG22 ' A' ' 227' ' ' THR . . . -74.21 -37.95 63.73 Favored 'General case' 0 C--O 1.247 0.955 0 CA-C-O 121.548 0.69 . . . . 73.42 111.552 179.052 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 14.1 t -88.14 -38.49 11.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 113.798 -1.547 . . . . 70.43 112.008 -177.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 90.3 t -97.15 -41.73 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 122.931 0.493 . . . . 53.41 110.37 -174.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 120.85 145.97 7.42 Favored Glycine 0 C--N 1.35 1.311 0 N-CA-C 110.803 -0.919 . . . . 73.14 110.803 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 166.96 154.66 8.55 Favored Glycine 0 C--O 1.247 0.959 0 CA-C-N 117.202 0.501 . . . . 52.45 112.715 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.626 ' HD3' ' HB3' ' A' ' 220' ' ' GLU . 38.8 ttmt -85.65 129.84 34.72 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.627 0.771 . . . . 70.32 110.09 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.578 HG21 HG22 ' A' ' 199' ' ' VAL . 14.0 m -131.05 151.46 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 123.917 0.887 . . . . 72.31 109.753 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -95.02 141.51 28.59 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 109.034 -0.728 . . . . 62.21 109.034 -172.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.662 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -132.37 120.96 22.74 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.841 0.856 . . . . 63.32 108.831 -176.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 34.6 tpp -77.79 110.16 12.42 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 108.625 -0.88 . . . . 73.03 108.625 173.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 61.0 p -116.92 -179.55 3.72 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.827 0.851 . . . . 73.11 110.068 -177.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.541 HD21 ' HD3' ' A' ' 241' ' ' PRO . 65.7 tp -46.03 -52.05 12.57 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.544 1.138 . . . . 64.33 112.159 175.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -72.97 -26.81 61.5 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.533 1.133 . . . . 62.41 111.738 -174.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 139.19 -166.61 25.42 Favored Glycine 0 C--N 1.343 0.941 0 CA-C-O 119.437 -0.646 . . . . 63.51 111.981 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.28 129.73 23.56 Favored 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 122.026 1.817 . . . . 73.24 111.021 175.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 24.7 m -130.37 160.84 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 123.363 0.665 . . . . 45.54 110.227 -177.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.626 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 45.2 mt-10 -112.81 111.42 22.18 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.393 0.677 . . . . 72.1 109.684 -173.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 62.7 t -121.63 103.18 13.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 124.887 1.275 . . . . 71.41 109.43 -173.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.618 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -78.95 118.12 20.67 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 110.004 -0.369 . . . . 42.44 110.004 175.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 33.7 m -86.18 150.08 51.39 Favored Pre-proline 0 N--CA 1.485 1.298 0 C-N-CA 122.936 0.494 . . . . 72.21 110.516 -177.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . 0.467 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 24.1 Cg_endo -62.66 163.1 22.46 Favored 'Trans proline' 0 C--N 1.384 2.411 0 C-N-CA 122.431 2.088 . . . . 73.15 112.912 178.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -83.85 35.58 0.56 Allowed 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 123.225 2.617 . . . . 55.51 112.945 177.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -150.6 -4.93 0.32 Allowed 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.06 0.544 . . . . 73.13 111.549 176.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.583 HG23 HG11 ' A' ' 253' ' ' VAL . 0.6 OUTLIER -60.59 151.14 29.61 Favored 'General case' 0 CA--C 1.57 1.735 0 N-CA-C 109.266 -0.642 . . . . 74.4 109.266 -165.529 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . 0.438 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 20.6 pt20 -134.2 162.43 32.16 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.025 0.53 . . . . 74.15 110.368 -170.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -56.53 111.33 0.97 Allowed 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 109.824 -0.436 . . . . 74.13 109.824 175.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 114.82 -0.29 23.01 Favored Glycine 0 C--N 1.337 0.615 0 CA-C-N 115.564 -0.744 . . . . 65.32 112.094 178.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.438 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -72.45 122.72 21.73 Favored 'General case' 0 C--N 1.354 0.782 0 N-CA-C 108.661 -0.866 . . . . 73.0 108.661 -173.808 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 10.8 mmmm -98.35 97.57 8.92 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 109.307 -0.627 . . . . 70.03 109.307 -168.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 22.2 mt -80.5 97.06 6.97 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.14 -1.43 . . . . 74.42 107.14 -177.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.07 117.26 23.31 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.772 -0.649 . . . . 74.42 111.328 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 7.5 mp -97.69 127.55 43.73 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 105.807 -1.923 . . . . 70.35 105.807 171.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 15.3 tptt -101.23 115.45 30.53 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.525 0.33 . . . . 61.41 110.478 -167.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 77.84 32.49 45.11 Favored Glycine 0 C--N 1.349 1.281 0 O-C-N 123.922 0.764 . . . . 62.44 112.144 -175.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -125.98 23.41 7.19 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.796 0.838 . . . . 73.04 111.611 -174.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -93.8 -129.44 5.37 Favored Glycine 0 C--N 1.342 0.891 0 N-CA-C 110.916 -0.874 . . . . 3.41 110.916 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 6.9 m-30 -70.89 151.19 95.15 Favored Pre-proline 0 CA--C 1.551 1.011 0 CA-C-N 117.72 0.76 . . . . 64.03 111.678 177.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.541 ' HD3' HD21 ' A' ' 215' ' ' LEU . 60.3 Cg_endo -66.27 172.69 8.5 Favored 'Trans proline' 0 C--N 1.385 2.469 0 C-N-CA 123.561 2.841 . . . . 52.04 112.157 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.422 ' N ' ' HD2' ' A' ' 243' ' ' PRO . . . -66.35 -42.18 94.12 Favored Glycine 0 CA--C 1.545 1.964 0 CA-C-O 118.311 -1.272 . . . . 64.35 114.067 -174.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . 0.422 ' HD2' ' N ' ' A' ' 242' ' ' GLY . 9.3 Cg_endo -53.76 -36.44 82.2 Favored 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 122.74 2.293 . . . . 74.45 113.441 169.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -78.98 -24.07 44.03 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.318 0.647 . . . . 44.01 110.692 174.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . 0.431 ' HA3' ' HG2' ' A' ' 191' ' ' GLN . . . 109.33 116.05 3.84 Favored Glycine 0 C--N 1.344 1.018 0 N-CA-C 109.599 -1.4 . . . . 73.22 109.599 -170.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -72.36 124.48 25.21 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 117.355 0.577 . . . . 71.31 110.402 -178.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -140.07 -157.46 7.25 Favored Glycine 0 N--CA 1.466 0.639 0 N-CA-C 111.044 -0.823 . . . . 70.51 111.044 174.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 8.4 p30 -119.86 167.56 11.99 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 117.515 0.657 . . . . 71.42 110.708 -177.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 9.8 tp -133.53 133.92 42.76 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 108.923 -0.769 . . . . 61.05 108.923 -172.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -115.46 146.05 42.01 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 109.105 -0.702 . . . . 74.5 109.105 -177.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 81.2 mt -125.79 113.09 16.82 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 107.896 -1.15 . . . . 74.34 107.896 178.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -89.6 113.36 24.79 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.846 -0.798 . . . . 74.23 108.846 -177.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.583 HG11 HG23 ' A' ' 227' ' ' THR . 55.8 t -59.36 124.28 13.3 Favored 'Isoleucine or valine' 0 C--N 1.344 0.365 0 O-C-N 124.089 0.868 . . . . 71.24 109.479 178.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 8.4 mmt180 -122.9 122.79 39.47 Favored 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 107.376 -1.342 . . . . 64.01 107.376 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 48.9 mm -84.17 120.67 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 O-C-N 124.216 0.948 . . . . 63.2 110.603 -170.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.4 t . . . . . 0 CA--C 1.558 1.267 0 CA-C-O 118.038 -0.982 . . . . 51.2 109.691 -169.794 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.46 HG11 HG22 ' A' ' 221' ' ' VAL . 52.9 t . . . . . 0 N--CA 1.471 0.62 0 CA-C-O 121.806 0.812 . . . . 74.11 111.25 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 43.2 mtm -100.48 -175.49 2.93 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 126.362 1.865 . . . . 73.05 109.433 -166.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 9.1 p -99.28 87.97 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.147 0 CA-C-O 123.022 1.391 . . . . 65.43 107.856 163.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.51 -6.46 8.13 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 113.851 -1.522 . . . . 64.43 110.637 -175.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.54 ' HA ' ' HB3' ' A' ' 233' ' ' LEU . 68.5 m -44.36 -65.25 0.54 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.272 1.829 . . . . 75.35 113.586 -172.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . 0.42 ' HB2' ' HB3' ' A' ' 224' ' ' PRO . 42.6 t80 . . . . . 0 CA--C 1.536 0.44 0 C-N-CA 123.776 0.83 . . . . 73.0 109.588 -177.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 121.1 0.476 . . . . 74.43 109.931 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.4 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 61.1 t0 -75.37 153.9 37.51 Favored 'General case' 0 C--O 1.244 0.791 0 CA-C-N 114.489 -1.232 . . . . 72.42 107.923 174.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 46.7 tp -147.54 141.42 25.82 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 122.802 0.441 . . . . 71.23 110.123 -170.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -116.69 139.44 50.55 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.322 0.649 . . . . 75.2 109.849 172.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -141.17 156.84 45.88 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 108.078 -1.082 . . . . 54.43 108.078 167.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 35.3 p -86.51 152.63 22.48 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-O 121.95 0.881 . . . . 64.55 111.656 168.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.674 HD13 ' HB2' ' A' ' 212' ' ' ALA . 42.4 tp -121.62 131.08 53.91 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 113.264 -1.789 . . . . 75.21 107.3 167.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -94.43 111.77 23.53 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 122.023 0.916 . . . . 53.43 108.982 -177.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.6 HG22 HG21 ' A' ' 210' ' ' VAL . 53.4 t -120.09 132.32 24.13 Favored Pre-proline 0 CA--C 1.546 0.789 0 CA-C-N 114.707 -1.133 . . . . 65.13 109.964 -176.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -68.96 147.28 67.65 Favored 'Trans proline' 0 C--N 1.372 1.807 0 C-N-CA 122.326 2.018 . . . . 52.33 111.269 167.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.418 ' HB3' ' HD3' ' A' ' 202' ' ' PRO . . . -53.2 -46.67 97.71 Favored Pre-proline 0 CA--C 1.569 1.686 0 C-N-CA 123.447 0.699 . . . . 75.2 111.945 174.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.418 ' HD3' ' HB3' ' A' ' 201' ' ' ALA . 78.2 Cg_exo -51.13 -39.97 60.49 Favored 'Trans proline' 0 C--N 1.396 3.033 0 C-N-CA 122.638 2.225 . . . . 61.53 113.817 172.092 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.7 mp -84.68 -23.13 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 N-CA-C 109.327 -0.62 . . . . 73.12 109.327 -174.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -73.32 -39.28 65.4 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 123.143 0.577 . . . . 53.31 111.897 178.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 39.7 t -88.93 -34.32 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 CA-C-N 114.787 -1.097 . . . . 75.34 113.201 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 54.5 t -97.96 -42.17 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 O-C-N 121.514 -0.741 . . . . 75.32 110.636 -175.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 123.52 152.36 8.45 Favored Glycine 0 C--N 1.341 0.836 0 N-CA-C 111.05 -0.82 . . . . 34.44 111.05 -176.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.45 149.21 5.71 Favored Glycine 0 C--O 1.242 0.647 0 N-CA-C 111.476 -0.65 . . . . 74.32 111.476 176.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.64 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 36.0 ttmt -85.62 130.0 34.68 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 109.444 -0.576 . . . . 73.12 109.444 174.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.6 HG21 HG22 ' A' ' 199' ' ' VAL . 8.7 m -130.64 151.4 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.46 1.104 . . . . 72.3 108.693 -178.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 47.7 ttt180 -94.68 140.38 29.96 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.188 -0.914 . . . . 75.54 109.558 -167.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.674 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -132.23 115.35 15.56 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.028 0.931 . . . . 73.43 109.097 -171.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 32.5 tpp -78.78 110.9 14.38 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 108.167 -1.049 . . . . 75.24 108.167 175.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 69.6 p -115.28 -176.25 2.87 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.56 0.744 . . . . 73.43 110.456 -176.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.598 HD21 ' HD3' ' A' ' 241' ' ' PRO . 66.3 tp -47.57 -51.68 20.22 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.624 1.169 . . . . 45.31 111.998 177.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -72.17 -27.95 62.91 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 114.507 -1.224 . . . . 70.13 111.078 -174.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 136.64 -165.91 24.93 Favored Glycine 0 C--N 1.34 0.79 0 N-CA-C 111.464 -0.654 . . . . 44.4 111.464 -175.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -65.9 132.62 30.9 Favored 'Trans proline' 0 C--N 1.368 1.59 0 C-N-CA 122.565 2.176 . . . . 73.33 112.024 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 31.5 m -132.6 160.82 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.432 1.093 . . . . 72.5 109.333 177.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.403 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 47.9 mt-10 -113.16 115.73 28.71 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 122.959 0.504 . . . . 63.22 110.035 -176.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.46 HG22 HG11 ' A' ' 168' ' ' VAL . 59.0 t -121.77 105.73 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.16 1.384 . . . . 73.25 110.705 -168.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.64 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -73.82 118.52 16.88 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.889 0.476 . . . . 71.55 110.946 176.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 27.1 m -88.66 150.59 46.4 Favored Pre-proline 0 N--CA 1.483 1.184 0 C-N-CA 122.566 0.346 . . . . 73.3 110.776 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . 0.491 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 33.1 Cg_endo -64.97 165.57 21.1 Favored 'Trans proline' 0 C--N 1.373 1.829 0 C-N-CA 122.625 2.217 . . . . 73.1 113.653 176.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -83.68 29.1 0.55 Allowed 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 123.167 2.578 . . . . 74.13 113.664 172.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 35.4 mmt180 -143.97 -1.44 0.97 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.099 0.56 . . . . 73.41 111.505 177.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.544 HG23 HG11 ' A' ' 253' ' ' VAL . 0.6 OUTLIER -61.17 152.12 29.5 Favored 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 108.919 -0.771 . . . . 53.51 108.919 -166.27 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . 0.512 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 4.5 pt20 -135.31 163.03 30.91 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.314 0.645 . . . . 65.31 110.407 -174.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -61.1 110.76 1.46 Allowed 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 109.288 -0.634 . . . . 73.31 109.288 175.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.74 -0.25 21.57 Favored Glycine 0 CA--C 1.525 0.683 0 CA-C-N 115.369 -0.832 . . . . 75.44 112.308 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.512 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -68.26 125.45 26.45 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.737 0.815 . . . . 71.11 109.605 -174.189 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 49.2 mmtm -99.4 98.23 9.18 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.232 0.613 . . . . 74.4 109.504 -172.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.54 ' HB3' ' HA ' ' A' ' 172' ' ' SER . 22.5 mt -82.25 99.96 9.61 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 107.048 -1.464 . . . . 72.33 107.048 178.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -79.77 125.89 30.26 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 121.169 0.509 . . . . 75.25 110.99 -177.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 7.7 mp -111.13 127.91 55.72 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 105.999 -1.852 . . . . 74.35 105.999 172.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 41.4 tptt -101.75 117.89 35.81 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 118.054 0.388 . . . . 63.04 110.84 -173.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 79.22 30.69 45.08 Favored Glycine 0 C--N 1.347 1.159 0 O-C-N 123.481 0.488 . . . . 74.13 111.98 -178.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -127.43 20.51 6.72 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.007 0.923 . . . . 62.11 110.424 -176.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -96.92 -130.5 6.6 Favored Glycine 0 C--N 1.347 1.155 0 N-CA-C 111.19 -0.764 . . . . 45.34 111.19 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . 0.47 ' O ' ' HA ' ' A' ' 246' ' ' ARG . 4.8 m-30 -71.16 155.53 93.0 Favored Pre-proline 0 N--CA 1.478 0.931 0 N-CA-C 112.479 0.548 . . . . 62.41 112.479 -178.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.598 ' HD3' HD21 ' A' ' 215' ' ' LEU . 73.2 Cg_endo -69.35 171.81 13.35 Favored 'Trans proline' 0 C--N 1.388 2.633 0 C-N-CA 123.297 2.665 . . . . 74.25 112.396 -174.067 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.436 ' N ' ' HD2' ' A' ' 243' ' ' PRO . . . -66.81 -38.05 92.73 Favored Glycine 0 CA--C 1.544 1.851 0 CA-C-O 118.204 -1.331 . . . . 75.43 114.424 -176.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 242' ' ' GLY . 10.2 Cg_endo -52.27 -42.1 62.18 Favored 'Trans proline' 0 C--N 1.383 2.391 0 CA-C-N 120.696 2.248 . . . . 60.45 113.237 166.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -77.32 -23.04 51.06 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.546 0.738 . . . . 51.54 110.256 174.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 104.37 115.46 4.08 Favored Glycine 0 C--N 1.342 0.888 0 N-CA-C 109.33 -1.508 . . . . 74.33 109.33 -169.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 240' ' ' PHE . 38.4 ttp180 -69.04 124.08 22.79 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 117.663 0.731 . . . . 73.44 110.681 -178.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -133.93 -157.05 8.12 Favored Glycine 0 C--N 1.337 0.615 0 CA-C-N 115.193 -0.912 . . . . 72.01 111.003 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . 0.4 ' O ' ' HA ' ' A' ' 192' ' ' ASP . 0.2 OUTLIER -121.04 160.62 23.22 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.412 0.685 . . . . 73.12 110.764 -171.259 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 11.6 tp -135.32 133.79 39.18 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.729 0.811 . . . . 70.23 108.994 -172.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -114.7 150.38 35.33 Favored 'General case' 0 C--O 1.245 0.867 0 N-CA-C 108.527 -0.916 . . . . 72.02 108.527 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 64.6 mt -121.13 113.4 19.96 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.548 -1.278 . . . . 64.45 107.548 178.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -88.61 112.16 22.74 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 107.556 -1.276 . . . . 72.12 107.556 -179.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.544 HG11 HG23 ' A' ' 227' ' ' THR . 55.7 t -62.28 128.69 24.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 115.085 -0.961 . . . . 63.22 110.509 177.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 42.5 mtp180 -115.08 125.27 53.32 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 106.805 -1.554 . . . . 64.13 106.805 171.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 48.3 mm -87.3 127.03 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 N-CA-C 109.576 -0.527 . . . . 73.35 109.576 -176.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.7 t . . . . . 0 CA--C 1.56 1.355 0 N-CA-C 108.275 -1.009 . . . . 64.3 108.275 -174.078 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 55.5 t . . . . . 0 N--CA 1.482 1.135 0 CA-C-O 121.822 0.82 . . . . 51.13 112.22 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 39.4 mtm -100.97 -176.18 3.09 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.526 1.931 . . . . 62.51 110.17 -165.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 9.4 p -96.88 88.13 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 CA-C-O 122.939 1.352 . . . . 73.43 108.238 163.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.71 -4.8 8.14 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 114.418 -1.265 . . . . 75.31 110.64 -176.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.514 ' HA ' ' HB3' ' A' ' 233' ' ' LEU . 69.9 m -41.29 -66.12 0.37 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.493 1.917 . . . . 61.43 114.508 -169.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 70.9 t80 . . . . . 0 CA--C 1.536 0.404 0 CA-C-O 121.031 0.443 . . . . 74.41 110.829 -173.115 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.421 ' HA ' ' O ' ' A' ' 245' ' ' GLY . 23.1 mt-30 . . . . . 0 N--CA 1.479 0.997 0 CA-C-O 121.83 0.824 . . . . 63.14 109.085 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 29.3 p-10 -74.27 160.97 30.39 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 114.016 -1.447 . . . . 73.51 110.8 -177.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 48.5 tp -150.63 135.05 17.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.159 -0.928 . . . . 62.42 108.628 173.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -116.27 138.84 50.96 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.663 -0.866 . . . . 73.32 108.663 176.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -149.15 158.58 44.29 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.399 0.679 . . . . 44.41 109.406 171.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 37.0 p -81.33 154.37 26.54 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.924 0.869 . . . . 53.34 111.842 165.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.695 HD13 ' HB2' ' A' ' 212' ' ' ALA . 34.9 tp -125.74 133.48 52.07 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 113.52 -1.673 . . . . 74.23 106.924 170.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -94.68 111.7 23.47 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.79 -0.818 . . . . 74.11 108.79 -175.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.611 HG22 HG21 ' A' ' 210' ' ' VAL . 46.4 t -123.18 129.78 24.81 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 124.328 1.051 . . . . 65.54 109.813 -177.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -67.52 149.03 79.78 Favored 'Trans proline' 0 C--N 1.365 1.429 0 C-N-CA 122.586 2.191 . . . . 63.11 112.079 169.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.426 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.3 -46.96 97.67 Favored Pre-proline 0 CA--C 1.562 1.432 0 CA-C-O 118.353 -0.832 . . . . 54.01 112.446 173.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.459 ' O ' ' HB ' ' A' ' 206' ' ' VAL . 24.2 Cg_endo -60.43 -31.77 93.0 Favored 'Trans proline' 0 C--N 1.395 3.017 0 C-N-CA 121.719 1.613 . . . . 43.2 112.461 177.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.7 mp -86.2 -22.96 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 N-CA-C 109.475 -0.565 . . . . 71.33 109.475 -178.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . 0.407 ' HA ' HG22 ' A' ' 227' ' ' THR . . . -73.31 -37.96 65.99 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 122.989 0.516 . . . . 61.1 111.098 176.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 19.5 t -89.2 -33.18 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.977 1.311 . . . . 74.51 113.011 -178.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.459 ' HB ' ' O ' ' A' ' 202' ' ' PRO . 51.2 t -100.49 -43.18 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 O-C-N 121.611 -0.68 . . . . 61.34 110.726 -176.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 121.22 152.18 8.73 Favored Glycine 0 N--CA 1.466 0.699 0 N-CA-C 110.811 -0.916 . . . . 74.35 110.811 -176.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.71 152.98 7.25 Favored Glycine 0 C--O 1.243 0.658 0 N-CA-C 111.671 -0.572 . . . . 71.11 111.671 177.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.572 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 30.2 tttt -85.62 130.41 34.58 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.747 -0.834 . . . . 73.33 108.747 176.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.611 HG21 HG22 ' A' ' 199' ' ' VAL . 13.1 m -129.1 151.83 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 N-CA-C 108.632 -0.877 . . . . 75.41 108.632 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . 0.409 ' HD2' ' N ' ' A' ' 212' ' ' ALA . 6.2 tmm_? -94.09 142.14 27.73 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 109.322 -0.622 . . . . 74.04 109.322 -169.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.695 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -132.73 119.24 20.08 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.083 0.953 . . . . 65.31 108.612 -177.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 37.4 tpp -79.68 107.66 12.63 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 107.756 -1.201 . . . . 74.15 107.756 173.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 63.9 p -117.03 -174.8 2.66 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.24 0.616 . . . . 51.34 110.77 -172.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.519 HD21 ' HD3' ' A' ' 241' ' ' PRO . 64.9 tp -48.73 -51.94 26.19 Favored 'General case' 0 C--N 1.358 0.963 0 C-N-CA 123.896 0.879 . . . . 72.11 111.872 175.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -72.46 -28.31 62.84 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.234 -0.894 . . . . 74.34 110.701 -173.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 138.4 -166.58 25.23 Favored Glycine 0 C--N 1.341 0.829 0 CA-C-O 119.648 -0.529 . . . . 44.22 112.186 -174.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -64.92 129.56 23.56 Favored 'Trans proline' 0 C--N 1.369 1.609 0 C-N-CA 122.454 2.103 . . . . 73.4 111.286 176.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.437 HG22 ' O ' ' A' ' 212' ' ' ALA . 21.0 m -133.28 160.66 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 123.445 0.698 . . . . 60.54 110.558 -176.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -113.12 115.43 28.28 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.893 0.877 . . . . 65.53 109.746 -176.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 58.5 t -121.96 103.55 13.62 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.887 0 C-N-CA 124.866 1.266 . . . . 74.21 110.103 -170.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.572 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -77.88 118.22 19.99 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.605 0.362 . . . . 63.52 110.673 177.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 34.0 m -89.01 152.33 48.17 Favored Pre-proline 0 N--CA 1.48 1.064 0 C-N-CA 123.27 0.628 . . . . 73.43 111.225 -177.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . 0.584 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 32.0 Cg_endo -63.73 164.08 22.55 Favored 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 122.593 2.195 . . . . 61.04 113.094 175.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -86.74 28.73 0.53 Allowed 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 123.137 2.558 . . . . 63.21 113.393 177.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 60.1 mmt-85 -145.64 1.21 0.9 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.335 0.654 . . . . 74.2 111.705 176.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.637 HG23 HG11 ' A' ' 253' ' ' VAL . 0.7 OUTLIER -61.26 154.97 22.19 Favored 'General case' 0 CA--C 1.57 1.747 0 O-C-N 123.383 0.427 . . . . 70.32 110.116 -168.986 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . 0.465 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 13.8 pt20 -140.7 162.62 34.98 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.318 0.647 . . . . 74.01 110.63 -174.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -59.27 111.56 1.4 Allowed 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 121.14 0.495 . . . . 62.44 110.527 -178.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.44 0.56 21.94 Favored Glycine 0 CA--C 1.519 0.324 0 CA-C-N 114.882 -1.053 . . . . 74.24 111.823 179.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -69.12 125.12 25.69 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 109.051 -0.722 . . . . 74.21 109.051 -175.065 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -98.55 98.44 9.62 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.146 0.578 . . . . 72.54 109.7 -169.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.514 ' HB3' ' HA ' ' A' ' 172' ' ' SER . 21.5 mt -81.87 100.31 9.54 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.253 -1.388 . . . . 72.14 107.253 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.61 126.11 30.84 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.245 0.545 . . . . 64.41 111.205 -178.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.546 ' HB3' ' HB2' ' A' ' 238' ' ' LYS . 7.3 mp -110.07 124.93 52.38 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 105.948 -1.871 . . . . 75.14 105.948 173.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.32 115.34 30.36 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.079 0.552 . . . . 73.02 111.652 -172.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 76.99 31.82 51.7 Favored Glycine 0 C--N 1.351 1.375 0 CA-C-N 115.05 -0.977 . . . . 73.23 111.92 -175.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.546 ' HB2' ' HB3' ' A' ' 235' ' ' LEU . 30.5 mmmt -128.91 19.96 5.99 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.833 0.853 . . . . 74.21 111.204 -176.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -96.93 -134.56 8.21 Favored Glycine 0 C--N 1.343 0.943 0 N-CA-C 111.633 -0.587 . . . . 74.3 111.633 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 4.6 m-30 -70.09 151.78 95.95 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 122.676 0.39 . . . . 63.24 111.754 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.519 ' HD3' HD21 ' A' ' 215' ' ' LEU . 60.8 Cg_endo -66.97 172.14 10.19 Favored 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 123.532 2.821 . . . . 64.21 112.373 -177.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -66.36 -38.68 93.82 Favored Glycine 0 CA--C 1.539 1.56 0 CA-C-O 118.158 -1.356 . . . . 71.42 114.012 -177.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . 0.463 ' HD2' ' HB2' ' A' ' 241' ' ' PRO . 73.8 Cg_exo -45.73 -45.99 15.87 Favored 'Trans proline' 0 C--N 1.385 2.475 0 C-N-CA 122.771 2.314 . . . . 74.25 114.033 165.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -80.34 -24.45 39.86 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.535 0.734 . . . . 72.21 111.05 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 191' ' ' GLN . . . 113.34 112.29 3.07 Favored Glycine 0 C--N 1.337 0.63 0 N-CA-C 109.617 -1.393 . . . . 73.2 109.617 -169.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.93 123.09 17.63 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.7 0.8 . . . . 73.0 110.457 -179.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -147.67 -155.63 6.68 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-N 116.236 -0.438 . . . . 43.4 113.319 -175.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -119.91 164.17 16.46 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.745 0.818 . . . . 45.12 110.197 -170.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 10.3 tp -134.02 133.53 41.36 Favored 'General case' 0 C--O 1.214 -0.815 0 N-CA-C 107.634 -1.247 . . . . 63.2 107.634 -178.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -122.11 146.18 47.45 Favored 'General case' 0 C--O 1.246 0.908 0 N-CA-C 108.389 -0.967 . . . . 63.1 108.389 -177.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 88.1 mt -124.82 115.91 21.42 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.807 0.843 . . . . 41.43 108.857 -176.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -89.09 110.16 20.92 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.815 -1.18 . . . . 64.53 107.815 -176.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.637 HG11 HG23 ' A' ' 227' ' ' THR . 45.4 t -60.04 128.54 21.21 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.365 0 O-C-N 123.872 0.733 . . . . 54.02 109.73 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.84 123.35 45.69 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 105.981 -1.859 . . . . 63.52 105.981 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 48.8 mm -86.38 117.95 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 109.006 -0.739 . . . . 74.22 109.006 -177.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.2 t . . . . . 0 CA--C 1.557 1.245 0 N-CA-C 107.687 -1.227 . . . . 73.34 107.687 -174.0 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.435 HG11 HG22 ' A' ' 221' ' ' VAL . 53.6 t . . . . . 0 N--CA 1.475 0.799 0 CA-C-O 121.906 0.86 . . . . 54.44 112.139 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 40.6 mtm -99.69 -175.68 3.05 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 126.051 1.74 . . . . 63.32 109.263 -169.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 10.3 p -97.28 88.12 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.184 0 CA-C-O 122.858 1.313 . . . . 74.41 108.275 164.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.27 -5.16 8.34 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 113.771 -1.559 . . . . 73.42 109.945 -178.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.426 ' HA ' ' HB3' ' A' ' 233' ' ' LEU . 67.0 m -39.22 -64.93 0.42 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 127.029 2.132 . . . . 62.04 114.578 -169.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . 0.419 ' HB2' ' HB3' ' A' ' 224' ' ' PRO . 72.6 t80 . . . . . 0 N--CA 1.471 0.6 0 C-N-CA 123.462 0.705 . . . . 73.43 110.901 -176.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 . . . . . 0 N--CA 1.473 0.698 0 N-CA-C 107.482 -1.303 . . . . 74.04 107.482 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.444 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 17.9 p-10 -74.3 160.7 30.74 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 113.08 -1.873 . . . . 72.13 110.411 170.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.456 HD23 HD13 ' A' ' 249' ' ' LEU . 57.6 tp -149.22 143.74 26.11 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.779 -0.646 . . . . 72.35 109.749 -174.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -116.25 139.13 50.69 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.911 0.885 . . . . 70.05 110.169 174.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -148.59 157.39 43.43 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.257 1.023 . . . . 33.12 108.979 173.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 24.9 p -83.75 153.43 24.14 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 122.091 0.948 . . . . 72.52 112.663 168.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.669 HD13 ' HB2' ' A' ' 212' ' ' ALA . 31.6 tp -126.29 133.67 51.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 112.909 -1.951 . . . . 64.05 106.971 167.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -94.3 114.03 26.04 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.206 -1.035 . . . . 75.21 108.206 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.621 HG22 HG21 ' A' ' 210' ' ' VAL . 48.9 t -121.56 132.0 24.32 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 124.186 0.994 . . . . 62.43 109.688 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -69.24 144.21 56.0 Favored 'Trans proline' 0 C--N 1.37 1.703 0 C-N-CA 122.289 1.993 . . . . 74.43 111.014 166.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.435 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -54.48 -42.21 93.31 Favored Pre-proline 0 CA--C 1.565 1.54 0 CA-C-O 118.059 -0.972 . . . . 73.34 112.544 173.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 11.5 Cg_endo -55.22 -36.63 93.79 Favored 'Trans proline' 0 C--N 1.404 3.465 0 C-N-CA 121.885 1.723 . . . . 74.55 112.83 172.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -85.46 -23.89 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 N-CA-C 109.14 -0.689 . . . . 71.41 109.14 -177.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . 0.461 ' HA ' HG22 ' A' ' 227' ' ' THR . . . -73.83 -37.33 64.88 Favored 'General case' 0 C--O 1.247 0.934 0 CA-C-O 121.44 0.638 . . . . 75.21 111.299 179.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 25.2 t -88.71 -38.0 10.93 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-N 113.72 -1.582 . . . . 63.41 112.435 -177.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 76.1 t -97.51 -42.59 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 O-C-N 122.13 -0.356 . . . . 73.11 110.341 -176.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 121.1 148.95 8.06 Favored Glycine 0 C--N 1.341 0.855 0 N-CA-C 110.612 -0.995 . . . . 63.34 110.612 -176.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 165.73 155.39 8.66 Favored Glycine 0 C--O 1.246 0.876 0 N-CA-C 111.856 -0.497 . . . . 63.34 111.856 178.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.648 ' HD3' ' HB3' ' A' ' 220' ' ' GLU . 3.5 ttmp? -84.94 131.22 34.52 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.373 0.669 . . . . 75.43 109.701 178.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.621 HG21 HG22 ' A' ' 199' ' ' VAL . 9.5 m -130.04 151.76 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.444 1.098 . . . . 75.14 108.642 177.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? -95.5 140.84 29.78 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 108.976 -0.75 . . . . 74.31 108.976 -172.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.669 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -131.25 119.8 22.32 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.719 -0.845 . . . . 74.14 108.719 -177.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 37.3 tpp -79.35 107.35 12.05 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 107.592 -1.262 . . . . 74.53 107.592 172.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . 0.42 HG22 HD21 ' A' ' 251' ' ' LEU . 71.5 p -112.43 -173.55 2.27 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.836 0.854 . . . . 62.32 110.878 -174.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 61.7 tp -44.98 -52.63 8.59 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.314 1.046 . . . . 64.53 112.063 167.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -71.81 -26.53 62.44 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 114.263 -1.335 . . . . 62.2 111.46 -169.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 131.09 -165.77 22.95 Favored Glycine 0 C--N 1.34 0.777 0 N-CA-C 110.661 -0.976 . . . . 52.5 110.661 -171.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -65.78 131.02 26.17 Favored 'Trans proline' 0 C--N 1.37 1.67 0 C-N-CA 121.89 1.727 . . . . 64.42 110.715 175.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 212' ' ' ALA . 26.6 m -133.36 162.82 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 123.754 0.821 . . . . 62.41 110.495 -178.283 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.648 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 38.3 mt-10 -112.02 116.07 29.96 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.395 1.078 . . . . 72.23 109.307 -175.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.435 HG22 HG11 ' A' ' 168' ' ' VAL . 44.5 t -124.32 103.28 12.31 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 C-N-CA 124.233 1.013 . . . . 75.33 109.635 -173.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.534 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -78.1 118.4 20.32 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.552 -0.536 . . . . 74.1 109.552 173.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 34.7 m -89.03 151.43 46.95 Favored Pre-proline 0 N--CA 1.483 1.182 0 C-N-CA 123.031 0.532 . . . . 52.43 110.54 -178.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . 0.468 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 41.4 Cg_endo -65.22 165.83 20.88 Favored 'Trans proline' 0 C--N 1.38 2.189 0 C-N-CA 122.939 2.426 . . . . 54.44 113.412 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -80.27 31.97 0.5 Allowed 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 123.163 2.575 . . . . 54.4 113.1 172.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -150.17 -2.32 0.39 Allowed 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 112.275 0.472 . . . . 74.4 112.275 178.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.569 HG23 HG11 ' A' ' 253' ' ' VAL . 0.6 OUTLIER -59.95 150.48 28.75 Favored 'General case' 0 CA--C 1.566 1.596 0 N-CA-C 108.901 -0.778 . . . . 74.34 108.901 -168.423 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . 0.441 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 4.5 pt20 -133.36 162.2 32.47 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.039 0.535 . . . . 74.21 109.876 -171.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . 0.589 ' HB1' HH21 ' A' ' 254' ' ' ARG . . . -59.18 111.52 1.37 Allowed 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 109.318 -0.623 . . . . 71.01 109.318 174.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 114.89 1.16 22.71 Favored Glycine 0 C--N 1.338 0.641 0 CA-C-N 115.696 -0.684 . . . . 71.04 112.013 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.441 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -69.66 123.76 22.21 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 108.967 -0.753 . . . . 72.54 108.967 -174.098 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.439 ' HB3' ' HD1' ' A' ' 250' ' ' TYR . 30.7 mmmt -100.15 97.21 8.05 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 108.767 -0.827 . . . . 73.34 108.767 -172.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 250' ' ' TYR . 20.3 mt -81.51 99.07 8.58 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 106.406 -1.701 . . . . 64.22 106.406 -176.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . 0.696 ' HD3' ' HE2' ' A' ' 236' ' ' LYS . 0.5 OUTLIER -83.02 126.16 32.24 Favored 'General case' 0 CA--C 1.561 1.401 0 C-N-CA 123.854 0.862 . . . . 71.43 112.262 179.803 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.442 ' HB3' ' HB2' ' A' ' 238' ' ' LYS . 7.6 mp -113.72 124.44 52.3 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.964 1.306 . . . . 72.14 108.697 -176.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.696 ' HE2' ' HD3' ' A' ' 234' ' ' ARG . 5.2 mptp? -94.31 115.11 27.29 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 118.537 0.608 . . . . 73.41 110.942 -169.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 77.48 20.48 74.48 Favored Glycine 0 C--N 1.349 1.283 0 O-C-N 124.236 0.96 . . . . 72.44 112.305 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.442 ' HB2' ' HB3' ' A' ' 235' ' ' LEU . 1.0 OUTLIER -117.45 19.46 14.0 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.814 0.846 . . . . 62.12 110.037 -178.575 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -95.85 -139.98 10.72 Favored Glycine 0 C--N 1.35 1.338 0 N-CA-C 110.951 -0.86 . . . . 53.21 110.951 176.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . 0.435 ' O ' ' HA ' ' A' ' 246' ' ' ARG . 6.1 m-30 -61.11 146.94 87.32 Favored Pre-proline 0 N--CA 1.477 0.878 0 N-CA-C 112.645 0.609 . . . . 72.4 112.645 -175.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -59.71 171.08 2.96 Favored 'Trans proline' 0 C--N 1.385 2.497 0 C-N-CA 123.486 2.791 . . . . 75.24 112.524 -178.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.42 ' N ' ' HD2' ' A' ' 243' ' ' PRO . . . -67.64 -41.34 89.74 Favored Glycine 0 CA--C 1.552 2.392 0 CA-C-O 118.284 -1.287 . . . . 73.11 114.237 -174.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' A' ' 242' ' ' GLY . 10.8 Cg_endo -55.57 -36.5 94.63 Favored 'Trans proline' 0 C--N 1.392 2.843 0 C-N-CA 122.749 2.299 . . . . 70.54 112.914 168.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -77.47 -24.67 50.17 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.24 0.616 . . . . 65.51 110.688 174.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 106.68 115.59 4.03 Favored Glycine 0 C--N 1.341 0.821 0 N-CA-C 109.34 -1.504 . . . . 42.42 109.34 -172.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.435 ' HA ' ' O ' ' A' ' 240' ' ' PHE . 29.0 ttm180 -72.87 123.9 24.32 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 117.603 0.702 . . . . 71.3 111.274 -177.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -139.65 -152.74 5.92 Favored Glycine 0 C--N 1.341 0.83 0 CA-C-N 114.808 -1.087 . . . . 73.0 112.304 -177.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . 0.444 ' O ' ' HA ' ' A' ' 192' ' ' ASP . 11.0 t70 -114.69 163.01 16.06 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.403 1.081 . . . . 71.12 108.705 -168.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.456 HD13 HD23 ' A' ' 193' ' ' LEU . 18.8 tp -134.84 132.77 39.01 Favored 'General case' 0 C--O 1.214 -0.804 0 N-CA-C 109.209 -0.663 . . . . 71.25 109.209 -177.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.471 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 0.4 OUTLIER -112.04 145.27 39.99 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-O 121.688 0.756 . . . . 73.21 109.691 178.856 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.42 HD21 HG22 ' A' ' 214' ' ' THR . 72.5 mt -125.65 113.85 17.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 113.909 -1.496 . . . . 74.51 107.602 174.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -91.54 109.55 20.86 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 107.774 -1.195 . . . . 52.15 107.774 -173.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.569 HG11 HG23 ' A' ' 227' ' ' THR . 52.1 t -61.53 122.77 12.94 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 O-C-N 124.301 1.0 . . . . 72.31 109.988 -179.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . 0.589 HH21 ' HB1' ' A' ' 229' ' ' ALA . 0.3 OUTLIER -115.2 122.89 47.41 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 106.872 -1.529 . . . . 74.45 106.872 176.878 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 44.9 mm -87.62 114.97 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 O-C-N 123.918 0.761 . . . . 63.33 110.108 -174.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 CA--C 1.56 1.362 0 C-N-CA 124.09 0.956 . . . . 75.35 109.516 -172.057 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.422 HG11 HG22 ' A' ' 221' ' ' VAL . 54.4 t . . . . . 0 N--CA 1.472 0.67 0 CA-C-O 121.68 0.752 . . . . 72.24 110.119 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 42.9 mtm -99.17 -176.91 3.45 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 125.552 1.541 . . . . 73.14 109.515 -167.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 12.6 p -100.53 86.32 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 CA-C-O 123.428 1.585 . . . . 73.31 107.453 165.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . 0.485 ' HG3' ' HA ' ' A' ' 235' ' ' LEU . 0.0 OUTLIER -124.07 -3.86 8.03 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 113.394 -1.73 . . . . 54.32 110.263 -173.554 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.559 ' HB3' HD22 ' A' ' 233' ' ' LEU . 66.7 m -44.74 -69.84 0.12 Allowed 'General case' 0 C--N 1.351 0.65 0 C-N-CA 125.856 1.662 . . . . 74.41 113.542 -166.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . 0.516 ' HB2' ' HG3' ' A' ' 224' ' ' PRO . 50.8 t80 . . . . . 0 CA--C 1.541 0.614 0 N-CA-C 108.215 -1.031 . . . . 74.42 108.215 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.435 ' HG2' ' HA3' ' A' ' 245' ' ' GLY . 75.0 mt-30 . . . . . 0 N--CA 1.475 0.816 0 CA-C-O 121.599 0.714 . . . . 62.51 110.752 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -85.35 158.8 20.17 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 114.908 -1.042 . . . . 72.41 110.081 -174.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 53.6 tp -150.31 142.48 24.1 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.04 0.536 . . . . 62.23 110.042 -176.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -114.1 142.07 46.68 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.677 0.791 . . . . 74.32 109.286 173.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -148.62 162.4 39.77 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.936 0.894 . . . . 73.21 108.916 173.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 34.6 p -85.95 154.6 21.36 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 122.015 0.912 . . . . 65.15 111.984 166.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.678 HD13 ' HB2' ' A' ' 212' ' ' ALA . 29.2 tp -124.55 133.63 53.24 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 113.404 -1.725 . . . . 73.41 107.172 160.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -93.33 114.03 26.37 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 108.205 -1.035 . . . . 74.42 108.205 178.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.611 HG22 HG21 ' A' ' 210' ' ' VAL . 46.1 t -121.56 131.15 24.51 Favored Pre-proline 0 CA--C 1.546 0.803 0 CA-C-N 115.049 -0.978 . . . . 74.52 109.018 -178.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -68.59 148.27 72.07 Favored 'Trans proline' 0 C--N 1.364 1.391 0 C-N-CA 122.522 2.148 . . . . 61.43 111.379 169.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.411 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.28 -45.75 98.24 Favored Pre-proline 0 CA--C 1.558 1.262 0 CA-C-O 118.597 -0.716 . . . . 53.54 112.887 174.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.432 ' O ' ' HB ' ' A' ' 206' ' ' VAL . 30.1 Cg_endo -61.16 -30.15 88.22 Favored 'Trans proline' 0 C--N 1.395 2.998 0 C-N-CA 121.685 1.59 . . . . 74.43 112.193 178.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -86.47 -25.37 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 N-CA-C 109.482 -0.562 . . . . 74.42 109.482 -177.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -73.4 -37.67 65.87 Favored 'General case' 0 C--O 1.247 0.936 0 C-N-CA 122.89 0.476 . . . . 74.04 111.18 178.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 25.6 t -88.36 -38.0 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 C-N-CA 124.884 1.274 . . . . 73.41 112.869 -178.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.432 ' HB ' ' O ' ' A' ' 202' ' ' PRO . 54.5 t -97.26 -41.47 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 O-C-N 121.841 -0.537 . . . . 74.24 110.545 -175.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 121.61 148.15 7.79 Favored Glycine 0 C--N 1.341 0.847 0 N-CA-C 110.789 -0.925 . . . . 73.41 110.789 -177.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 166.51 151.41 6.8 Favored Glycine 0 C--O 1.245 0.792 0 N-CA-C 112.098 -0.401 . . . . 44.4 112.098 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.664 ' HD3' ' HB3' ' A' ' 220' ' ' GLU . 37.5 ttmt -85.06 132.39 34.33 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.781 0.832 . . . . 71.15 109.615 175.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.611 HG21 HG22 ' A' ' 199' ' ' VAL . 11.2 m -136.11 152.18 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.365 1.066 . . . . 75.54 109.407 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 8.8 tmm_? -94.59 142.83 26.99 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.581 0.752 . . . . 70.1 110.711 -170.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.678 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -131.17 123.12 27.83 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.912 0.885 . . . . 63.2 109.366 -176.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 33.8 tpp -78.6 109.05 12.45 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 108.52 -0.918 . . . . 32.12 108.52 175.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 51.6 p -113.73 -178.35 3.36 Favored 'General case' 0 C--O 1.244 0.8 0 C-N-CA 123.242 0.617 . . . . 72.43 111.132 -174.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.531 HD21 ' HD3' ' A' ' 241' ' ' PRO . 65.5 tp -45.83 -51.66 12.55 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 124.278 0.986 . . . . 73.35 111.33 170.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -73.56 -29.4 62.4 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 114.05 -1.432 . . . . 74.54 111.442 -174.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 136.68 -167.18 24.64 Favored Glycine 0 C--N 1.348 1.211 0 CA-C-O 119.558 -0.579 . . . . 61.42 112.407 -177.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.91 129.47 24.71 Favored 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 122.329 2.019 . . . . 43.25 111.046 176.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.408 HG22 ' O ' ' A' ' 212' ' ' ALA . 28.1 m -132.8 161.55 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 123.573 0.749 . . . . 74.45 110.138 -176.297 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.664 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 51.8 mt-10 -111.54 115.56 29.38 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.711 0.804 . . . . 75.22 109.416 -173.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.422 HG22 HG11 ' A' ' 168' ' ' VAL . 59.8 t -126.63 104.66 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 124.451 1.1 . . . . 72.33 110.102 -169.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.574 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -76.89 117.99 19.04 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 110.066 -0.346 . . . . 54.12 110.066 176.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 34.0 m -88.07 152.36 50.55 Favored Pre-proline 0 N--CA 1.48 1.034 0 C-N-CA 123.002 0.521 . . . . 70.32 110.765 -178.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . 0.548 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 34.6 Cg_endo -62.55 163.69 20.39 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.242 1.961 . . . . 64.31 112.231 174.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -86.76 32.94 0.44 Allowed 'Trans proline' 0 C--N 1.371 1.75 0 C-N-CA 123.249 2.633 . . . . 75.52 112.074 176.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 5.2 tpt180 -148.99 -0.71 0.5 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 122.764 0.426 . . . . 74.34 111.324 178.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.585 HG23 HG11 ' A' ' 253' ' ' VAL . 0.6 OUTLIER -61.12 153.01 26.84 Favored 'General case' 0 CA--C 1.563 1.476 0 N-CA-C 109.519 -0.549 . . . . 41.33 109.519 -167.242 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . 0.464 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 19.5 pt20 -132.77 161.56 33.75 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.182 0.593 . . . . 70.23 110.41 -170.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . 0.461 ' HB1' ' NH2' ' A' ' 254' ' ' ARG . . . -61.27 110.84 1.52 Allowed 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 109.509 -0.552 . . . . 71.25 109.509 174.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 113.92 0.46 24.21 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 111.28 -0.728 . . . . 64.11 111.28 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.464 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -68.84 126.93 31.31 Favored 'General case' 0 C--N 1.362 1.152 0 N-CA-C 109.187 -0.671 . . . . 74.25 109.187 -173.513 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -97.71 97.7 9.24 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 108.947 -0.76 . . . . 64.44 108.947 -169.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.559 HD22 ' HB3' ' A' ' 172' ' ' SER . 25.8 mt -81.11 99.56 8.57 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.696 -1.224 . . . . 61.22 107.696 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.44 113.32 17.49 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.733 -0.667 . . . . 71.33 110.363 -178.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.555 ' HB3' ' HB2' ' A' ' 238' ' ' LYS . 7.5 mp -99.55 124.73 45.01 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 105.943 -1.873 . . . . 62.02 105.943 169.268 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -102.68 118.05 36.0 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.563 0.745 . . . . 64.31 109.777 -176.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 78.42 31.2 46.96 Favored Glycine 0 C--N 1.349 1.264 0 O-C-N 124.103 0.877 . . . . 53.23 112.735 -177.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.555 ' HB2' ' HB3' ' A' ' 235' ' ' LEU . 29.9 mmmt -129.94 21.25 5.4 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.028 0.931 . . . . 74.32 111.042 -179.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -96.81 -131.1 6.8 Favored Glycine 0 C--N 1.346 1.089 0 N-CA-C 111.468 -0.653 . . . . 75.35 111.468 -179.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 7.1 m-30 -70.8 151.77 95.19 Favored Pre-proline 0 CA--C 1.553 1.093 0 C-N-CA 123.458 0.703 . . . . 73.24 112.321 -178.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.531 ' HD3' HD21 ' A' ' 215' ' ' LEU . 58.8 Cg_endo -66.3 171.36 10.51 Favored 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 124.142 3.228 . . . . 73.11 112.977 179.08 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -66.35 -40.5 94.6 Favored Glycine 0 CA--C 1.543 1.84 0 CA-C-O 118.233 -1.315 . . . . 74.01 115.604 -175.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -53.9 -36.86 84.77 Favored 'Trans proline' 0 C--N 1.379 2.18 0 CA-C-N 120.827 2.313 . . . . 64.24 113.029 168.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -79.56 -26.61 41.34 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 122.987 0.515 . . . . 42.04 110.398 174.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . 0.435 ' HA3' ' HG2' ' A' ' 191' ' ' GLN . . . 110.65 115.67 3.63 Favored Glycine 0 C--N 1.345 1.083 0 N-CA-C 109.413 -1.475 . . . . 60.3 109.413 -170.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 11.1 mmm-85 -67.91 121.98 17.2 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.02 0.528 . . . . 61.13 110.292 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -143.73 -156.15 6.69 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-N 115.823 -0.626 . . . . 72.14 112.131 -177.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -120.64 165.53 14.92 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 123.675 0.79 . . . . 61.22 110.749 -172.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 16.1 tp -135.46 134.49 39.64 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 107.828 -1.175 . . . . 73.35 107.828 -173.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 8.9 m-30 -114.39 148.48 37.62 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 109.144 -0.687 . . . . 72.31 109.144 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.448 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 69.9 mt -122.93 113.94 19.78 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.24 -1.393 . . . . 74.22 107.24 178.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -89.65 111.68 22.71 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 106.986 -1.487 . . . . 72.31 106.986 -176.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.585 HG11 HG23 ' A' ' 227' ' ' THR . 54.7 t -62.21 125.82 19.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 O-C-N 123.977 0.798 . . . . 73.05 110.278 -178.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . 0.461 ' NH2' ' HB1' ' A' ' 229' ' ' ALA . 3.8 mmp_? -117.0 122.53 44.49 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.036 -1.468 . . . . 74.22 107.036 176.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 48.7 mm -88.37 115.42 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 O-C-N 123.799 0.687 . . . . 62.41 110.273 -172.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.0 t . . . . . 0 CA--C 1.562 1.413 0 C-N-CA 124.389 1.076 . . . . 54.24 109.23 -169.377 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.526 HG11 HG22 ' A' ' 221' ' ' VAL . 60.7 t . . . . . 0 N--CA 1.473 0.722 0 CA-C-O 121.62 0.724 . . . . 75.52 112.301 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 42.6 mtm -99.51 -176.05 3.17 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.618 1.967 . . . . 64.2 108.813 -171.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 9.9 p -101.57 86.58 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.179 0 CA-C-O 123.067 1.413 . . . . 72.22 108.642 166.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.7 -4.76 9.2 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 113.933 -1.485 . . . . 75.1 110.232 -174.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 68.9 m -39.92 -67.31 0.24 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.778 2.031 . . . . 42.24 114.661 -164.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 51.1 t80 . . . . . 0 N--CA 1.469 0.498 0 C-N-CA 122.482 0.313 . . . . 73.31 110.537 -169.271 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.406 ' HB3' ' HA3' ' A' ' 247' ' ' GLY . 15.9 mt-30 . . . . . 0 N--CA 1.478 0.952 0 CA-C-O 120.952 0.406 . . . . 65.22 110.724 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -76.04 154.93 35.31 Favored 'General case' 0 N--CA 1.481 1.125 0 CA-C-N 115.342 -0.845 . . . . 72.24 109.547 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 56.9 tp -148.23 140.39 24.14 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.028 0.531 . . . . 74.24 110.34 175.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -114.55 138.76 50.24 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.089 0.955 . . . . 73.02 110.097 173.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -147.8 156.59 42.89 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.792 -0.818 . . . . 74.51 108.792 167.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 30.0 p -81.85 151.46 27.32 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 122.113 0.959 . . . . 75.03 112.14 168.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.634 HD13 ' HB2' ' A' ' 212' ' ' ALA . 27.2 tp -120.74 132.38 55.02 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 112.977 -1.92 . . . . 71.33 107.155 164.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -94.93 114.53 26.38 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 107.973 -1.121 . . . . 64.32 107.973 178.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.59 HG22 HG21 ' A' ' 210' ' ' VAL . 46.4 t -113.52 130.23 23.91 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 114.866 -1.061 . . . . 52.22 108.649 178.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -66.01 146.22 81.78 Favored 'Trans proline' 0 C--N 1.373 1.83 0 C-N-CA 122.287 1.992 . . . . 74.14 110.924 169.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.421 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.64 -46.21 98.36 Favored Pre-proline 0 CA--C 1.568 1.672 0 CA-C-O 118.334 -0.841 . . . . 45.22 112.304 175.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.421 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 26.0 Cg_endo -60.82 -31.48 91.77 Favored 'Trans proline' 0 C--N 1.403 3.446 0 C-N-CA 121.697 1.598 . . . . 62.43 112.549 176.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -86.44 -23.69 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 N-CA-C 109.153 -0.684 . . . . 74.31 109.153 -177.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -74.17 -38.53 63.65 Favored 'General case' 0 C--O 1.247 0.931 0 C-N-CA 122.938 0.495 . . . . 73.24 110.933 179.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 22.1 t -88.64 -36.45 9.05 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 CA-C-N 113.532 -1.667 . . . . 73.2 112.504 -177.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 55.5 t -98.61 -42.81 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 O-C-N 122.163 -0.335 . . . . 74.31 110.782 -177.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 122.26 152.14 8.57 Favored Glycine 0 N--CA 1.466 0.651 0 N-CA-C 110.919 -0.873 . . . . 72.1 110.919 -176.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.72 155.68 8.57 Favored Glycine 0 C--O 1.241 0.538 0 N-CA-C 111.444 -0.662 . . . . 63.3 111.444 178.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.571 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 35.4 ttmt -84.45 129.67 34.84 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 109.128 -0.693 . . . . 53.04 109.128 177.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.59 HG21 HG22 ' A' ' 199' ' ' VAL . 15.9 m -132.08 147.84 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.425 0.69 . . . . 65.01 109.594 179.062 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 14.4 ttp-105 -96.84 139.98 32.08 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.901 -1.045 . . . . 73.01 110.258 -167.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.634 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -132.24 120.59 22.39 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.001 0.92 . . . . 60.32 108.87 -174.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 33.5 tpp -78.04 110.02 12.62 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 108.826 -0.805 . . . . 74.44 108.826 174.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 56.4 p -112.33 -176.11 2.84 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 123.865 0.866 . . . . 72.3 109.971 -176.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.584 HD21 ' HD3' ' A' ' 241' ' ' PRO . 65.1 tp -47.9 -52.1 20.66 Favored 'General case' 0 C--N 1.354 0.782 0 C-N-CA 124.003 0.921 . . . . 74.22 111.55 173.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -72.84 -26.95 61.66 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 114.661 -1.154 . . . . 73.31 111.811 -171.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 137.85 -165.56 25.32 Favored Glycine 0 C--N 1.34 0.78 0 N-CA-C 111.299 -0.72 . . . . 23.13 111.299 -173.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.36 131.69 23.9 Favored 'Trans proline' 0 C--N 1.37 1.699 0 C-N-CA 122.081 1.854 . . . . 71.4 110.741 178.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 19.3 m -126.56 157.31 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 108.778 -0.823 . . . . 73.54 108.778 177.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.529 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 43.1 mt-10 -114.56 114.45 25.76 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 123.105 0.562 . . . . 60.32 109.511 -178.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.526 HG22 HG11 ' A' ' 168' ' ' VAL . 89.2 t -120.26 104.79 16.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 C-N-CA 125.474 1.51 . . . . 53.14 109.16 -169.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.571 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -76.11 117.63 18.01 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 122.836 0.454 . . . . 74.4 110.167 177.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 35.3 m -90.35 152.63 45.81 Favored Pre-proline 0 N--CA 1.478 0.927 0 C-N-CA 123.43 0.692 . . . . 64.24 111.289 -175.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . 0.539 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 45.2 Cg_endo -63.4 166.74 14.42 Favored 'Trans proline' 0 C--N 1.376 2.001 0 C-N-CA 123.507 2.805 . . . . 71.23 113.425 176.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -84.51 32.13 0.5 Allowed 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 122.83 2.353 . . . . 64.32 112.503 173.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 -150.51 -1.19 0.39 Allowed 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 112.561 0.578 . . . . 75.14 112.561 -179.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.539 ' HB ' ' HG2' ' A' ' 224' ' ' PRO . 0.6 OUTLIER -60.05 153.13 22.34 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 109.762 -0.458 . . . . 72.13 109.762 -167.101 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . 0.462 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 4.1 pt20 -133.08 161.51 34.21 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.55 0.74 . . . . 64.21 110.028 -174.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -63.46 110.66 2.02 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 109.024 -0.732 . . . . 64.13 109.024 174.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 114.72 3.74 21.87 Favored Glycine 0 C--O 1.241 0.545 0 CA-C-N 115.031 -0.986 . . . . 72.41 112.148 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.462 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -68.46 127.93 34.78 Favored 'General case' 0 CA--C 1.553 1.094 0 N-CA-C 109.288 -0.634 . . . . 74.43 109.288 -179.806 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -97.24 96.99 8.79 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.113 0.565 . . . . 74.02 109.776 -173.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.493 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 19.3 mt -81.83 99.21 8.88 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 106.558 -1.645 . . . . 61.51 106.558 179.092 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 5.0 ppt_? -82.56 116.2 21.87 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.832 -0.622 . . . . 72.44 111.396 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 7.3 mp -105.1 126.99 52.68 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 106.56 -1.645 . . . . 72.4 106.56 173.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 15.9 tptm -101.61 117.1 34.21 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 122.612 0.365 . . . . 72.31 110.668 -171.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 78.89 24.18 62.56 Favored Glycine 0 C--N 1.342 0.863 0 O-C-N 124.004 0.815 . . . . 64.34 112.907 -177.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 1.9 mmmp? -117.21 21.24 13.28 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 122.836 0.454 . . . . 72.22 111.144 -177.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -96.95 -129.95 6.4 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-O 119.406 -0.663 . . . . 64.54 112.095 -178.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 6.0 m-30 -71.04 152.76 94.82 Favored Pre-proline 0 CA--C 1.557 1.229 0 C-N-CA 123.264 0.626 . . . . 75.52 112.427 -177.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.584 ' HD3' HD21 ' A' ' 215' ' ' LEU . 74.3 Cg_endo -69.29 172.83 11.48 Favored 'Trans proline' 0 C--N 1.392 2.825 0 C-N-CA 123.837 3.025 . . . . 73.13 112.72 -179.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.4 ' N ' ' HD2' ' A' ' 243' ' ' PRO . . . -67.52 -39.73 91.04 Favored Glycine 0 CA--C 1.542 1.753 0 CA-C-O 118.058 -1.412 . . . . 61.14 114.671 -174.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . 0.4 ' HD2' ' N ' ' A' ' 242' ' ' GLY . 8.7 Cg_endo -52.28 -41.14 67.99 Favored 'Trans proline' 0 C--N 1.386 2.547 0 CA-C-N 121.071 2.435 . . . . 72.03 112.72 167.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -76.72 -25.21 53.28 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.16 0.584 . . . . 73.32 110.679 176.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 109.02 115.73 3.84 Favored Glycine 0 C--N 1.342 0.869 0 N-CA-C 109.354 -1.498 . . . . 73.22 109.354 -168.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -70.1 122.4 19.34 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 108.732 -0.84 . . . . 74.05 108.732 -178.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . 0.406 ' HA3' ' HB3' ' A' ' 191' ' ' GLN . . . -142.82 -156.16 6.68 Favored Glycine 0 N--CA 1.465 0.596 0 N-CA-C 111.445 -0.662 . . . . 55.14 111.445 177.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 12.2 p30 -120.13 168.48 11.16 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-O 121.753 0.787 . . . . 71.54 111.357 -171.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 14.7 tp -135.5 133.46 38.49 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 107.84 -1.171 . . . . 74.43 107.84 -171.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -118.53 148.49 42.58 Favored 'General case' 0 C--O 1.253 1.28 0 N-CA-C 108.63 -0.878 . . . . 74.22 108.63 -178.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.493 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 91.6 mt -121.25 119.62 32.8 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.514 0.725 . . . . 71.2 109.162 -178.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -89.25 104.6 17.13 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 107.287 -1.375 . . . . 64.1 107.287 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.484 HG11 HG23 ' A' ' 227' ' ' THR . 55.4 t -62.89 128.43 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 121.271 0.558 . . . . 52.33 110.294 178.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 21.5 mtm105 -117.16 126.08 52.24 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.135 -1.432 . . . . 73.24 107.135 172.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 40.9 mm -88.5 127.28 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 109.751 -0.463 . . . . 64.05 109.751 -178.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.7 t . . . . . 0 CA--C 1.559 1.318 0 N-CA-C 107.775 -1.195 . . . . 72.53 107.775 -177.856 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.475 HG11 HG22 ' A' ' 221' ' ' VAL . 55.9 t . . . . . 0 N--CA 1.473 0.676 0 CA-C-O 121.36 0.6 . . . . 42.2 110.075 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 46.5 mtm -99.28 -178.78 4.02 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.099 1.36 . . . . 73.1 109.212 -169.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 10.0 p -97.71 85.73 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 CA-C-O 123.429 1.585 . . . . 71.32 107.318 164.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.65 -4.7 9.23 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 113.608 -1.633 . . . . 70.21 109.846 -174.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.537 ' HA ' ' HB3' ' A' ' 233' ' ' LEU . 67.5 m -43.1 -64.11 0.69 Allowed 'General case' 0 C--O 1.241 0.608 0 C-N-CA 126.681 1.992 . . . . 64.32 113.425 -176.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . 0.419 ' HB2' ' HB3' ' A' ' 224' ' ' PRO . 45.5 t80 . . . . . 0 CA--C 1.536 0.427 0 C-N-CA 123.535 0.734 . . . . 63.03 109.355 -178.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . 0.579 ' HB3' ' HA3' ' A' ' 247' ' ' GLY . 91.4 mt-30 . . . . . 0 C--O 1.247 0.932 0 CA-C-O 121.279 0.561 . . . . 71.22 110.721 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -73.53 153.8 40.13 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 114.407 -1.269 . . . . 70.2 108.978 -177.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 60.5 tp -148.89 138.91 22.18 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 123.841 0.856 . . . . 72.54 108.994 174.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -111.56 142.14 44.23 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.861 0.864 . . . . 71.53 108.74 171.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -147.67 156.37 42.71 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 108.734 -0.839 . . . . 72.23 108.734 167.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 33.0 p -84.69 153.01 23.36 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-O 122.368 1.08 . . . . 65.53 112.127 168.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.593 HD13 ' HB2' ' A' ' 212' ' ' ALA . 20.5 tp -125.52 132.86 52.53 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 112.507 -2.133 . . . . 73.23 106.361 167.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -95.26 112.24 23.98 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.875 0.845 . . . . 75.42 108.772 -179.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.649 HG22 HG21 ' A' ' 210' ' ' VAL . 41.1 t -117.18 132.13 23.65 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 124.589 1.156 . . . . 63.23 108.882 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -68.79 147.55 69.33 Favored 'Trans proline' 0 C--N 1.369 1.647 0 C-N-CA 122.108 1.872 . . . . 74.41 111.159 167.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -54.43 -45.69 99.28 Favored Pre-proline 0 N--CA 1.487 1.38 0 CA-C-O 118.3 -0.857 . . . . 55.41 111.784 174.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -50.85 -40.43 57.48 Favored 'Trans proline' 0 C--N 1.405 3.536 0 C-N-CA 122.172 1.915 . . . . 54.03 113.169 172.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -84.64 -23.25 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 109.398 -0.593 . . . . 75.12 109.398 -175.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . 0.498 ' HA ' HG22 ' A' ' 227' ' ' THR . . . -74.2 -39.57 63.07 Favored 'General case' 0 C--O 1.246 0.902 0 C-N-CA 123.06 0.544 . . . . 61.12 111.515 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 25.1 t -88.73 -36.92 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-N 114.558 -1.201 . . . . 75.2 112.598 -178.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 73.4 t -98.72 -41.02 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 O-C-N 122.136 -0.352 . . . . 73.3 110.807 -176.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 123.13 150.38 8.04 Favored Glycine 0 N--CA 1.475 1.236 0 CA-C-N 118.248 0.476 . . . . 55.33 112.068 177.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.91 153.6 7.57 Favored Glycine 0 C--N 1.343 0.946 0 N-CA-C 112.356 -0.297 . . . . 42.22 112.356 177.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 37.1 ttmt -84.63 131.95 34.54 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 122.945 0.498 . . . . 71.31 110.026 175.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.649 HG21 HG22 ' A' ' 199' ' ' VAL . 12.6 m -135.44 150.56 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.78 1.232 . . . . 72.32 108.639 -177.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -95.81 142.52 27.98 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.032 0.533 . . . . 74.32 110.563 -169.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.593 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -130.74 123.62 29.63 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.728 0.811 . . . . 53.3 109.301 -176.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 35.7 tpp -78.78 111.01 14.48 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 115.621 -0.718 . . . . 73.41 109.502 174.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 46.0 p -119.59 -177.05 3.29 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.955 0.902 . . . . 75.3 110.998 -174.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.571 HD21 ' HD3' ' A' ' 241' ' ' PRO . 59.6 tp -49.4 -51.16 36.93 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.465 1.106 . . . . 51.33 111.114 167.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -71.84 -25.75 62.1 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 113.444 -1.707 . . . . 74.43 111.002 -171.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 135.14 -166.6 24.37 Favored Glycine 0 C--N 1.342 0.897 0 N-CA-C 111.136 -0.786 . . . . 72.04 111.136 178.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -66.79 128.79 19.57 Favored 'Trans proline' 0 C--N 1.364 1.357 0 C-N-CA 121.44 1.427 . . . . 63.51 109.852 171.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.4 HG22 ' O ' ' A' ' 212' ' ' ALA . 27.3 m -130.19 160.2 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.159 0.584 . . . . 73.54 110.143 -176.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.557 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 44.2 mt-10 -111.72 115.8 29.68 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.868 0.867 . . . . 65.52 109.016 -174.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.475 HG22 HG11 ' A' ' 168' ' ' VAL . 60.2 t -125.34 104.14 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 124.633 1.173 . . . . 61.24 110.414 -168.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.562 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -74.59 117.26 16.21 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.846 -0.427 . . . . 63.04 109.846 175.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 32.9 m -90.93 151.74 43.69 Favored Pre-proline 0 N--CA 1.482 1.168 0 C-N-CA 122.803 0.441 . . . . 71.11 109.96 179.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . 0.528 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 39.3 Cg_endo -65.17 166.03 20.19 Favored 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 122.535 2.157 . . . . 45.21 113.284 178.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -79.2 35.5 0.56 Allowed 'Trans proline' 0 C--N 1.37 1.673 0 C-N-CA 122.803 2.336 . . . . 62.43 112.626 167.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 19.3 tpt180 -147.88 -10.65 0.39 Allowed 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.339 0.496 . . . . 71.01 112.339 -178.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.554 HG23 HG11 ' A' ' 253' ' ' VAL . 0.6 OUTLIER -61.16 150.15 35.18 Favored 'General case' 0 CA--C 1.565 1.547 0 N-CA-C 109.226 -0.657 . . . . 73.04 109.226 -164.66 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . 0.503 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 10.7 pt20 -132.52 162.5 31.07 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 122.991 0.517 . . . . 60.31 109.917 -174.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . 0.659 ' HB1' HH21 ' A' ' 254' ' ' ARG . . . -56.91 111.47 1.04 Allowed 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 109.601 -0.518 . . . . 54.5 109.601 174.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.14 -0.83 22.59 Favored Glycine 0 C--N 1.336 0.553 0 CA-C-N 115.268 -0.878 . . . . 60.54 112.418 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.503 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -70.37 124.65 24.7 Favored 'General case' 0 C--N 1.358 0.939 0 N-CA-C 109.262 -0.644 . . . . 72.44 109.262 -171.129 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -98.87 96.62 7.98 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 109.599 -0.519 . . . . 74.34 109.599 -168.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.537 ' HB3' ' HA ' ' A' ' 172' ' ' SER . 19.7 mt -81.88 99.52 9.09 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 106.822 -1.547 . . . . 64.42 106.822 -175.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . 0.46 ' HD2' ' O ' ' A' ' 234' ' ' ARG . 5.1 ppt_? -79.84 121.52 25.5 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 123.645 0.591 . . . . 73.13 110.899 -176.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 8.1 mp -108.55 125.74 52.16 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 105.861 -1.903 . . . . 54.22 105.861 172.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 17.5 tptt -101.87 116.3 32.4 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 118.138 0.426 . . . . 73.44 109.929 -171.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 79.35 21.71 66.6 Favored Glycine 0 C--N 1.349 1.278 0 O-C-N 123.763 0.664 . . . . 40.01 113.834 -178.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -117.54 20.81 13.37 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.736 0.814 . . . . 71.44 109.884 -178.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -98.94 -132.61 7.75 Favored Glycine 0 C--N 1.349 1.303 0 CA-C-O 119.097 -0.835 . . . . 72.44 111.82 -178.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -70.29 152.1 95.67 Favored Pre-proline 0 N--CA 1.481 1.079 0 N-CA-C 112.943 0.72 . . . . 70.53 112.943 -172.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.571 ' HD3' HD21 ' A' ' 215' ' ' LEU . 61.0 Cg_endo -67.2 170.56 13.01 Favored 'Trans proline' 0 C--N 1.392 2.859 0 C-N-CA 122.928 2.419 . . . . 74.02 112.526 -178.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.432 ' N ' ' HD2' ' A' ' 243' ' ' PRO . . . -67.71 -38.58 89.95 Favored Glycine 0 CA--C 1.544 1.874 0 CA-C-O 117.973 -1.459 . . . . 75.23 114.357 -175.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 242' ' ' GLY . 10.1 Cg_endo -54.02 -36.28 83.87 Favored 'Trans proline' 0 C--N 1.388 2.644 0 CA-C-N 120.998 2.399 . . . . 55.54 113.438 167.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -81.33 -25.06 36.71 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-O 121.136 0.493 . . . . 63.51 110.125 174.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 112.22 114.8 3.37 Favored Glycine 0 C--N 1.341 0.82 0 N-CA-C 109.66 -1.376 . . . . 74.5 109.66 -168.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -72.38 122.64 21.53 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 117.825 0.812 . . . . 72.52 109.639 -177.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . 0.579 ' HA3' ' HB3' ' A' ' 191' ' ' GLN . . . -148.34 -154.61 6.35 Favored Glycine 0 CA--C 1.503 -0.713 0 CA-C-N 116.003 -0.544 . . . . 45.14 112.315 -176.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 38.5 p-10 -121.46 163.54 18.61 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.507 0.723 . . . . 74.31 111.125 -167.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 9.5 tp -134.71 134.5 41.12 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.365 -0.976 . . . . 72.22 108.365 -171.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -115.81 148.46 39.87 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.471 -0.937 . . . . 71.42 108.471 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 67.7 mt -123.17 115.15 21.3 Favored 'General case' 0 C--O 1.22 -0.474 0 N-CA-C 108.29 -1.004 . . . . 53.25 108.29 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -89.38 113.54 24.87 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.618 -0.882 . . . . 73.03 108.618 -177.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.554 HG11 HG23 ' A' ' 227' ' ' THR . 50.3 t -60.75 124.79 15.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 O-C-N 124.019 0.824 . . . . 71.45 110.335 176.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . 0.659 HH21 ' HB1' ' A' ' 229' ' ' ALA . 0.5 OUTLIER -120.08 122.31 40.79 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 107.356 -1.35 . . . . 71.12 107.356 176.195 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.433 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 49.1 mm -83.8 122.36 37.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 O-C-N 123.984 0.803 . . . . 54.14 109.835 -173.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.2 t . . . . . 0 CA--C 1.565 1.549 0 C-N-CA 124.23 1.012 . . . . 64.45 108.822 -172.622 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 52.4 t . . . . . 0 N--CA 1.48 1.053 0 CA-C-O 121.385 0.612 . . . . 72.22 110.992 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . 0.402 ' HB2' ' SD ' ' A' ' 171' ' ' MET . 53.4 mtm -99.4 -176.68 3.36 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 125.915 1.686 . . . . 75.45 110.894 -164.121 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 8.5 p -101.88 86.17 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.073 0 N-CA-C 107.195 -1.409 . . . . 72.41 107.195 160.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . 0.402 ' SD ' ' HB2' ' A' ' 169' ' ' MET . 0.0 OUTLIER -124.17 -4.25 7.95 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 114.148 -1.387 . . . . 75.01 110.76 -173.365 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.477 ' HA ' ' HB3' ' A' ' 233' ' ' LEU . 67.2 m -44.1 -65.82 0.46 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.995 1.718 . . . . 65.34 114.046 -168.23 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 55.3 t80 . . . . . 0 C--O 1.243 0.754 0 N-CA-C 108.601 -0.889 . . . . 62.01 108.601 -176.614 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 . . . . . 0 N--CA 1.477 0.895 0 N-CA-C 108.908 -0.775 . . . . 72.33 108.908 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -76.57 168.57 19.84 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-N 114.638 -1.165 . . . . 75.15 109.958 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 39.1 tp -152.44 142.97 22.72 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.269 -0.423 . . . . 74.41 110.104 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -116.13 138.14 51.51 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.797 0.839 . . . . 72.53 109.107 171.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -148.77 160.14 43.48 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.628 0.771 . . . . 73.51 109.42 174.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 37.9 p -84.42 154.54 22.74 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 122.276 1.036 . . . . 72.13 112.195 167.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.766 HD13 ' HB2' ' A' ' 212' ' ' ALA . 30.8 tp -120.47 134.4 55.28 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 112.844 -1.98 . . . . 53.43 106.789 165.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -97.52 111.72 23.87 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 109.107 -0.701 . . . . 74.34 109.107 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.65 HG22 HG21 ' A' ' 210' ' ' VAL . 28.1 t -123.01 130.98 24.39 Favored Pre-proline 0 N--CA 1.479 0.979 0 C-N-CA 124.549 1.139 . . . . 75.44 109.579 -177.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -69.95 144.93 54.55 Favored 'Trans proline' 0 C--N 1.366 1.489 0 C-N-CA 122.22 1.947 . . . . 43.11 111.232 165.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -53.13 -44.63 97.61 Favored Pre-proline 0 N--CA 1.487 1.413 0 CA-C-O 118.348 -0.834 . . . . 74.11 111.953 174.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -47.55 -41.49 29.87 Favored 'Trans proline' 0 C--N 1.401 3.317 0 C-N-CA 122.556 2.171 . . . . 73.53 113.416 171.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -85.91 -23.29 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 109.716 -0.476 . . . . 70.11 109.716 -175.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . 0.417 ' HA ' HG22 ' A' ' 227' ' ' THR . . . -72.45 -37.76 68.45 Favored 'General case' 0 C--O 1.249 1.051 0 CA-C-O 121.05 0.452 . . . . 63.21 111.535 178.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 20.3 t -89.73 -36.05 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.987 0 C-N-CA 125.444 1.497 . . . . 34.03 113.168 -178.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 54.4 t -97.12 -43.14 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 O-C-N 121.998 -0.438 . . . . 72.24 110.268 -176.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 120.95 151.51 8.62 Favored Glycine 0 C--N 1.339 0.744 0 N-CA-C 110.89 -0.884 . . . . 70.35 110.89 -176.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.6 155.89 8.65 Favored Glycine 0 C--O 1.246 0.886 0 N-CA-C 112.048 -0.421 . . . . 64.34 112.048 177.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.594 ' HD3' ' HB3' ' A' ' 220' ' ' GLU . 38.5 ttmt -84.54 131.6 34.62 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.319 0.648 . . . . 74.51 109.519 174.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.65 HG21 HG22 ' A' ' 199' ' ' VAL . 6.7 m -134.42 154.4 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.4 1.08 . . . . 61.44 110.581 -175.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 2.5 tmm_? -93.32 139.92 30.13 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.569 1.147 . . . . 64.33 109.751 -171.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.766 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -132.42 122.6 25.23 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.145 0.978 . . . . 73.01 108.734 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 31.3 tpp -77.68 110.2 12.32 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.679 -0.86 . . . . 61.33 108.679 173.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 62.2 p -121.25 -179.28 4.0 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.998 0.919 . . . . 73.22 110.221 -176.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.503 HD21 ' HD3' ' A' ' 241' ' ' PRO . 61.2 tp -45.09 -52.9 8.59 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.686 1.195 . . . . 75.22 112.485 176.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -72.39 -27.48 62.39 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 114.218 -1.355 . . . . 73.24 111.385 -173.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 138.02 -165.11 25.47 Favored Glycine 0 C--N 1.345 1.055 0 N-CA-C 111.561 -0.616 . . . . 54.21 111.561 -176.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -67.01 129.25 20.27 Favored 'Trans proline' 0 C--N 1.369 1.62 0 C-N-CA 122.147 1.898 . . . . 61.31 111.011 175.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 30.2 m -129.72 160.23 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 123.528 0.731 . . . . 73.41 110.659 -175.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.594 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 44.4 mt-10 -113.01 114.53 27.02 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.835 0.854 . . . . 72.22 109.655 -168.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 61.9 t -127.34 103.43 10.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 124.87 1.268 . . . . 74.03 109.39 -166.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.511 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -77.82 116.79 18.61 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.892 -0.41 . . . . 73.4 109.892 175.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 29.8 m -89.35 152.04 47.12 Favored Pre-proline 0 N--CA 1.492 1.626 0 C-N-CA 123.222 0.609 . . . . 63.21 111.116 -176.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . 0.57 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 29.7 Cg_endo -62.21 162.47 23.16 Favored 'Trans proline' 0 C--N 1.382 2.307 0 C-N-CA 122.197 1.931 . . . . 73.24 112.517 175.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -85.4 30.97 0.49 Allowed 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 123.115 2.543 . . . . 73.52 112.519 176.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -149.06 3.17 0.6 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 122.747 0.419 . . . . 75.11 111.447 176.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.57 ' HB ' ' HG2' ' A' ' 224' ' ' PRO . 0.7 OUTLIER -61.85 155.64 22.74 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 109.829 -0.434 . . . . 64.25 109.829 -171.776 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -136.55 162.41 33.19 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.078 0.551 . . . . 74.3 110.097 -176.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . 0.567 ' HB1' HH21 ' A' ' 254' ' ' ARG . . . -56.15 112.25 1.17 Allowed 'General case' 0 CA--C 1.538 0.505 0 O-C-N 123.471 0.482 . . . . 44.22 109.915 174.017 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.29 -1.07 22.37 Favored Glycine 0 C--O 1.239 0.418 0 CA-C-N 114.968 -1.014 . . . . 71.14 111.982 176.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.62 129.72 40.75 Favored 'General case' 0 C--N 1.361 1.108 0 N-CA-C 109.179 -0.674 . . . . 70.04 109.179 -174.071 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm -98.67 97.69 8.92 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.977 0.911 . . . . 74.42 110.065 -170.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.477 ' HB3' ' HA ' ' A' ' 172' ' ' SER . 17.3 mt -88.09 101.04 13.41 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 107.65 -1.241 . . . . 71.41 107.65 -178.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.48 125.53 29.69 Favored 'General case' 0 CA--C 1.551 1.009 0 CA-C-O 121.164 0.507 . . . . 71.53 110.213 178.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.4 ' HB3' ' HB2' ' A' ' 238' ' ' LYS . 6.9 mp -106.04 126.77 52.6 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 105.879 -1.897 . . . . 53.14 105.879 171.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 8.1 tptp -101.32 115.75 31.23 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 109.994 -0.373 . . . . 72.12 109.994 -168.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 77.5 29.25 56.03 Favored Glycine 0 C--N 1.354 1.574 0 O-C-N 123.676 0.61 . . . . 70.14 112.676 -178.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.4 ' HB2' ' HB3' ' A' ' 235' ' ' LEU . 30.8 mmmt -124.53 23.85 8.04 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.807 0.843 . . . . 73.54 110.715 -177.098 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -94.41 -132.04 6.47 Favored Glycine 0 C--N 1.353 1.523 0 N-CA-C 111.167 -0.773 . . . . 74.14 111.167 178.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 6.2 m-30 -69.48 154.36 94.93 Favored Pre-proline 0 N--CA 1.481 1.08 0 CA-C-N 117.47 0.635 . . . . 62.52 112.043 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.503 ' HD3' HD21 ' A' ' 215' ' ' LEU . 72.8 Cg_endo -70.13 171.26 15.2 Favored 'Trans proline' 0 C--N 1.387 2.565 0 C-N-CA 122.826 2.351 . . . . 75.21 111.909 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -67.68 -38.96 90.43 Favored Glycine 0 CA--C 1.542 1.774 0 CA-C-O 118.479 -1.178 . . . . 75.23 114.078 -178.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . 0.424 ' HD2' ' HB2' ' A' ' 241' ' ' PRO . 87.8 Cg_exo -48.72 -35.19 29.56 Favored 'Trans proline' 0 C--N 1.383 2.36 0 C-N-CA 123.054 2.503 . . . . 70.43 114.09 165.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -88.3 -24.62 23.13 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.457 0.703 . . . . 51.31 110.998 174.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 105.76 115.23 4.03 Favored Glycine 0 C--N 1.345 1.06 0 N-CA-C 109.192 -1.563 . . . . 73.42 109.192 -169.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 35.3 mtt180 -73.1 134.07 44.38 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 122.988 0.515 . . . . 62.15 112.145 -178.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -145.75 -155.91 6.67 Favored Glycine 0 C--O 1.242 0.606 0 CA-C-N 114.654 -1.157 . . . . 53.53 110.304 174.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 12.6 p30 -118.01 168.03 10.91 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 122.949 0.5 . . . . 50.41 110.083 -175.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 9.7 tp -134.42 133.3 40.37 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 107.862 -1.162 . . . . 74.41 107.862 -172.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 10.0 m-30 -114.26 149.46 35.86 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.761 -0.829 . . . . 64.04 108.761 -177.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.403 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 92.1 mt -123.76 121.94 36.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.546 -0.752 . . . . 74.34 109.038 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -88.76 112.55 23.31 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 107.289 -1.375 . . . . 71.11 107.289 174.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.497 HG11 HG23 ' A' ' 227' ' ' THR . 54.1 t -60.8 123.47 13.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 108.868 -0.789 . . . . 62.12 108.868 173.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . 0.567 HH21 ' HB1' ' A' ' 229' ' ' ALA . 0.4 OUTLIER -114.65 123.29 48.92 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 106.71 -1.589 . . . . 73.04 106.71 176.411 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 38.1 mm -86.78 119.99 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 O-C-N 123.783 0.677 . . . . 74.32 109.721 -176.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.3 t . . . . . 0 CA--C 1.562 1.413 0 C-N-CA 125.292 1.437 . . . . 63.01 107.669 -170.533 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.423 HG11 HG22 ' A' ' 221' ' ' VAL . 55.4 t . . . . . 0 N--CA 1.473 0.686 0 CA-C-O 121.474 0.654 . . . . 72.52 110.39 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 48.8 mtm -98.29 -176.2 3.33 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.88 1.672 . . . . 64.22 110.074 -168.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 8.7 p -101.71 88.47 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.026 0 CA-C-O 123.125 1.441 . . . . 72.23 108.079 161.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . 0.417 ' HG3' ' HA ' ' A' ' 235' ' ' LEU . 0.0 OUTLIER -123.81 -6.03 7.99 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 113.717 -1.583 . . . . 73.2 110.021 -177.129 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.459 ' HA ' ' HB3' ' A' ' 233' ' ' LEU . 68.5 m -37.64 -64.63 0.37 Allowed 'General case' 0 C--N 1.351 0.643 0 C-N-CA 126.97 2.108 . . . . 44.23 114.379 -168.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . 0.43 ' HB2' ' HB3' ' A' ' 224' ' ' PRO . 53.3 t80 . . . . . 0 CA--C 1.538 0.488 0 O-C-N 123.661 0.6 . . . . 74.23 109.639 -174.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 . . . . . 0 N--CA 1.478 0.971 0 CA-C-O 120.938 0.399 . . . . 65.31 110.636 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 35.1 p-10 -75.54 172.83 11.88 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-N 115.7 -0.682 . . . . 65.3 110.578 178.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.414 HD13 ' CE1' ' A' ' 240' ' ' PHE . 33.9 tp -152.96 140.7 20.0 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.878 -0.601 . . . . 73.42 110.545 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -112.36 137.95 49.78 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.508 -0.769 . . . . 72.42 108.927 169.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.417 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -148.13 158.01 43.83 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 107.919 -1.141 . . . . 73.32 107.919 170.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 25.1 p -89.87 154.11 20.13 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 122.188 0.994 . . . . 65.2 112.511 169.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.68 HD13 ' HB2' ' A' ' 212' ' ' ALA . 22.2 tp -124.28 132.84 53.59 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 112.997 -1.911 . . . . 61.31 107.352 164.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -94.72 113.7 25.51 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 108.372 -0.973 . . . . 73.53 108.372 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.637 HG22 HG21 ' A' ' 210' ' ' VAL . 24.8 t -118.0 130.9 24.43 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 114.95 -1.023 . . . . 74.04 108.578 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . 0.494 ' HG2' ' HB ' ' A' ' 203' ' ' ILE . 59.3 Cg_endo -73.76 149.76 43.5 Favored 'Trans proline' 0 C--N 1.366 1.475 0 C-N-CA 121.47 1.447 . . . . 73.23 110.833 168.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -53.45 -44.71 98.14 Favored Pre-proline 0 N--CA 1.483 1.202 0 CA-C-O 118.193 -0.908 . . . . 50.14 112.186 177.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.453 ' HD2' ' HB2' ' A' ' 200' ' ' PRO . 86.0 Cg_exo -50.56 -41.22 53.67 Favored 'Trans proline' 0 C--N 1.399 3.223 0 C-N-CA 122.46 2.107 . . . . 71.52 113.525 173.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.494 ' HB ' ' HG2' ' A' ' 200' ' ' PRO . 1.8 mp -86.42 -23.07 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 N-CA-C 109.718 -0.475 . . . . 74.31 109.718 -176.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -72.57 -36.71 68.25 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 122.934 0.494 . . . . 73.11 111.044 177.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 25.4 t -89.56 -36.37 8.57 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 125.663 1.585 . . . . 72.23 112.873 -178.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 50.2 t -98.23 -42.58 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 O-C-N 121.663 -0.648 . . . . 64.0 110.91 -176.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 120.82 153.95 9.19 Favored Glycine 0 C--N 1.341 0.855 0 N-CA-C 110.704 -0.958 . . . . 42.5 110.704 -176.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 161.03 154.94 7.61 Favored Glycine 0 C--O 1.245 0.786 0 N-CA-C 111.57 -0.612 . . . . 41.13 111.57 177.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 39.3 ttmt -86.54 128.95 35.02 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.905 0.352 . . . . 63.31 110.655 176.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.637 HG21 HG22 ' A' ' 199' ' ' VAL . 13.5 m -130.74 144.51 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.958 1.303 . . . . 74.34 108.533 -179.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 24.2 ttt180 -97.08 141.62 30.0 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.059 0.943 . . . . 73.14 110.437 -167.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.68 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -133.18 124.75 28.02 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.429 1.491 . . . . 72.03 110.187 -168.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 33.6 tpp -77.48 114.95 16.83 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 109.024 -0.732 . . . . 73.13 109.024 174.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 63.0 p -124.16 -176.3 3.46 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.193 0.997 . . . . 61.24 110.292 -177.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.537 HD21 ' HD3' ' A' ' 241' ' ' PRO . 66.9 tp -47.24 -51.58 18.38 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.623 1.169 . . . . 72.24 112.657 176.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -72.01 -27.22 62.58 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 114.75 -1.114 . . . . 74.21 111.085 -172.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 137.14 -165.2 25.22 Favored Glycine 0 C--O 1.244 0.774 0 N-CA-C 110.702 -0.959 . . . . 53.42 110.702 -173.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.79 131.54 24.44 Favored 'Trans proline' 0 CA--C 1.549 1.226 0 C-N-CA 121.979 1.786 . . . . 73.33 111.187 175.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 25.7 m -129.65 157.25 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 124.087 0.955 . . . . 74.45 108.742 -179.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.538 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 47.0 mt-10 -115.24 117.23 29.91 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-O 121.145 0.498 . . . . 71.12 111.358 -176.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.423 HG22 HG11 ' A' ' 168' ' ' VAL . 100.0 t -121.86 107.15 19.31 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 125.65 1.58 . . . . 61.43 110.893 -165.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.603 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -75.19 118.19 17.84 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.583 0.353 . . . . 71.42 111.122 176.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 26.8 m -89.6 154.4 48.32 Favored Pre-proline 0 N--CA 1.489 1.48 0 C-N-CA 123.71 0.804 . . . . 71.43 111.693 -176.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . 0.566 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 34.2 Cg_endo -63.02 164.04 20.63 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 122.658 2.239 . . . . 74.12 113.057 174.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -87.08 32.13 0.44 Allowed 'Trans proline' 0 C--N 1.37 1.66 0 C-N-CA 122.779 2.319 . . . . 74.22 113.19 174.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -147.97 1.46 0.66 Allowed 'General case' 0 N--CA 1.485 1.29 0 CA-C-O 118.903 -0.57 . . . . 65.02 112.333 175.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.566 ' HB ' ' HG2' ' A' ' 224' ' ' PRO . 0.7 OUTLIER -60.57 154.64 20.57 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 123.466 0.479 . . . . 44.43 110.406 -168.144 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . 0.48 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 4.9 pt20 -134.38 161.19 35.68 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.27 0.628 . . . . 71.03 110.698 -174.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -60.29 112.15 1.82 Allowed 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.906 -0.405 . . . . 63.31 109.906 176.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.41 0.75 21.96 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-N 115.083 -0.962 . . . . 63.02 112.122 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.48 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -72.81 126.05 28.99 Favored 'General case' 0 C--N 1.359 0.98 0 N-CA-C 108.835 -0.802 . . . . 63.11 108.835 -174.735 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -97.17 98.15 9.78 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 108.255 -1.016 . . . . 71.35 108.255 -173.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.459 ' HB3' ' HA ' ' A' ' 172' ' ' SER . 30.9 mt -77.96 99.94 6.24 Favored 'General case' 0 C--N 1.343 0.297 0 N-CA-C 106.803 -1.555 . . . . 52.42 106.803 -179.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . 0.521 ' HB2' ' HE2' ' A' ' 236' ' ' LYS . 0.0 OUTLIER -81.4 111.42 17.74 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 114.282 -1.326 . . . . 64.42 111.642 -173.952 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.527 ' O ' ' HB2' ' A' ' 248' ' ' ASP . 7.3 mp -100.28 127.85 46.48 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 106.193 -1.78 . . . . 22.12 106.193 173.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.521 ' HE2' ' HB2' ' A' ' 234' ' ' ARG . 5.3 mptp? -101.48 119.49 38.85 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.46 0.704 . . . . 73.31 110.868 -175.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 78.19 23.58 65.62 Favored Glycine 0 C--N 1.354 1.546 0 O-C-N 123.89 0.744 . . . . 41.43 112.662 -179.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.496 ' HB2' ' HB3' ' A' ' 235' ' ' LEU . 26.8 mmmt -119.06 21.28 12.42 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.297 1.039 . . . . 60.53 111.052 -175.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -94.12 -128.6 5.19 Favored Glycine 0 C--N 1.345 1.043 0 N-CA-C 110.243 -1.143 . . . . 74.11 110.243 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . 0.436 ' O ' ' HA ' ' A' ' 246' ' ' ARG . 7.3 m-30 -70.98 152.41 94.95 Favored Pre-proline 0 CA--C 1.551 0.985 0 CA-C-N 117.479 0.64 . . . . 70.04 111.668 178.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.537 ' HD3' HD21 ' A' ' 215' ' ' LEU . 48.2 Cg_endo -64.92 171.8 8.15 Favored 'Trans proline' 0 C--N 1.387 2.6 0 C-N-CA 123.182 2.588 . . . . 74.33 112.166 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -66.19 -41.87 94.62 Favored Glycine 0 CA--C 1.541 1.706 0 CA-C-O 118.489 -1.173 . . . . 55.45 113.445 -177.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . 0.449 ' HD2' ' HB2' ' A' ' 241' ' ' PRO . 81.4 Cg_exo -54.67 -39.9 86.84 Favored 'Trans proline' 0 C--N 1.388 2.632 0 C-N-CA 122.556 2.171 . . . . 61.4 114.095 168.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -76.68 -22.43 54.0 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.479 0.712 . . . . 71.23 110.646 177.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 106.93 111.78 3.61 Favored Glycine 0 C--N 1.343 0.953 0 N-CA-C 108.679 -1.768 . . . . 62.51 108.679 -172.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.436 ' HA ' ' O ' ' A' ' 240' ' ' PHE . 54.1 ttp180 -73.4 124.66 26.21 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 117.086 0.443 . . . . 62.14 110.76 -174.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -135.84 -158.8 8.3 Favored Glycine 0 CA--C 1.505 -0.552 0 N-CA-C 110.488 -1.045 . . . . 43.2 110.488 174.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . 0.527 ' HB2' ' O ' ' A' ' 235' ' ' LEU . 34.2 p-10 -123.14 161.96 23.42 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.137 0.575 . . . . 72.22 110.125 -174.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 8.4 tp -132.0 134.89 46.09 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 108.375 -0.972 . . . . 43.52 108.375 -168.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -115.67 148.96 39.1 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 108.53 -0.915 . . . . 74.33 108.53 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.417 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 75.0 mt -122.38 112.49 18.15 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 108.594 -0.891 . . . . 71.11 108.594 179.045 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -89.76 112.28 23.53 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.285 -1.006 . . . . 70.21 108.285 -173.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.505 HG11 HG23 ' A' ' 227' ' ' THR . 53.8 t -61.6 125.9 18.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 114.969 -1.014 . . . . 72.52 110.222 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 41.8 mtp180 -115.54 122.51 45.9 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 106.571 -1.64 . . . . 74.32 106.571 171.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.459 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 46.8 mm -83.76 123.57 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 122.665 0.386 . . . . 62.13 110.123 -175.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.2 t . . . . . 0 CA--C 1.561 1.4 0 C-N-CA 124.273 1.029 . . . . 75.43 109.056 -172.275 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 12.5 tmm? . . . . . 0 N--CA 1.478 0.969 0 N-CA-C 108.894 -0.78 . . . . 63.51 108.894 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.494 ' HB2' ' HB3' ' A' ' 167' ' ' ALA . 0.0 OUTLIER -126.61 85.43 2.38 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.2 1.0 . . . . 72.04 110.442 -174.863 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -71.7 -33.49 68.82 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.898 0.879 . . . . 45.22 111.538 -178.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -96.26 37.45 3.43 Favored Glycine 0 N--CA 1.472 1.039 0 N-CA-C 111.894 -0.482 . . . . 41.02 111.894 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.494 ' HB3' ' HB2' ' A' ' 164' ' ' LYS . . . -153.39 172.91 16.34 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.491 1.117 . . . . 62.35 109.133 178.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 53.8 t -108.9 147.06 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 123.572 0.749 . . . . 73.12 110.395 -173.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 44.8 mtm -102.64 -175.54 2.85 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.183 1.793 . . . . 65.14 110.132 -166.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 8.3 p -94.25 87.7 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.115 0 CA-C-O 123.196 1.474 . . . . 74.01 108.037 159.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.28 -5.09 7.81 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 113.737 -1.574 . . . . 73.3 110.308 -177.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.51 ' HA ' ' HB3' ' A' ' 233' ' ' LEU . 69.9 m -37.54 -63.48 0.45 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.972 2.109 . . . . 35.41 114.488 -170.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -58.7 -34.02 70.84 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 121.116 0.484 . . . . 73.12 111.234 -172.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 92.55 75.97 1.32 Allowed Glycine 0 C--N 1.341 0.818 0 N-CA-C 108.429 -1.868 . . . . 54.44 108.429 -172.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -60.0 88.71 0.01 OUTLIER 'General case' 0 C--N 1.354 0.774 0 C-N-CA 124.242 1.017 . . . . 71.43 110.09 -177.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 47.1 m -120.69 124.76 45.97 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 113.828 -1.533 . . . . 51.53 108.605 -176.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -57.66 -21.91 42.69 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.525 0.73 . . . . 75.04 111.398 173.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -67.66 171.61 6.16 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 124.871 1.268 . . . . 75.52 111.903 170.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -61.81 -40.96 97.08 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.843 0.857 . . . . 71.33 110.887 176.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -170.73 115.06 0.57 Allowed Glycine 0 C--N 1.328 0.121 0 CA-C-N 115.033 -0.985 . . . . 53.22 110.989 178.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 50.5 m -147.36 169.99 18.28 Favored 'General case' 0 C--O 1.244 0.784 0 C-N-CA 123.366 0.666 . . . . 75.33 110.524 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -148.1 -42.97 0.03 OUTLIER Glycine 0 C--N 1.341 0.83 0 CA-C-N 115.737 -0.665 . . . . 54.13 111.787 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 69.12 66.41 2.27 Favored Glycine 0 C--N 1.346 1.11 0 N-CA-C 111.945 -0.462 . . . . 51.12 111.945 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 71.4 p -71.89 147.06 47.44 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 123.132 0.573 . . . . 73.31 110.596 177.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -160.37 175.38 37.13 Favored Glycine 0 C--N 1.341 0.849 0 N-CA-C 111.942 -0.463 . . . . 75.13 111.942 -177.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 72.91 14.15 78.64 Favored Glycine 0 C--N 1.35 1.316 0 C-N-CA 122.591 0.139 . . . . 55.43 112.979 -175.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 63.2 p -73.9 145.96 44.39 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.085 0.954 . . . . 72.42 111.342 -176.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.71 -57.88 2.97 Favored Glycine 0 C--N 1.345 1.079 0 CA-C-N 116.255 -0.429 . . . . 65.15 112.082 177.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -82.34 6.64 67.34 Favored Glycine 0 C--N 1.348 1.248 0 CA-C-O 119.5 -0.611 . . . . 62.24 114.157 -177.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 38.9 t 62.9 52.29 2.7 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.912 0.885 . . . . 75.13 111.253 175.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -105.88 -31.9 8.6 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 114.768 -1.105 . . . . 63.52 108.071 170.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -74.39 170.06 16.41 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 114.587 -1.188 . . . . 72.3 110.086 175.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 35.6 tp -152.71 139.08 18.5 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 115.904 -0.589 . . . . 71.44 109.5 176.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -112.5 139.94 47.66 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.53 -0.915 . . . . 74.44 108.53 169.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -147.76 156.35 42.65 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.464 -0.939 . . . . 44.1 108.464 166.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 20.4 p -84.28 150.94 25.08 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 122.446 1.117 . . . . 63.42 112.248 169.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.599 HD13 ' HB2' ' A' ' 212' ' ' ALA . 36.7 tp -126.03 133.66 51.67 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 113.063 -1.881 . . . . 71.34 106.774 170.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.442 ' HB2' HG21 ' A' ' 256' ' ' THR . 12.7 p-10 -94.69 111.55 23.32 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 108.535 -0.913 . . . . 74.13 108.535 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.596 HG22 HG21 ' A' ' 210' ' ' VAL . 58.1 t -115.94 129.48 25.15 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-N 114.783 -1.099 . . . . 73.21 108.884 -179.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -65.73 146.41 83.73 Favored 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 122.398 2.066 . . . . 73.32 111.513 169.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.436 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.62 -45.7 98.56 Favored Pre-proline 0 CA--C 1.565 1.527 0 C-N-CA 123.612 0.765 . . . . 75.24 111.918 174.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 27.6 Cg_endo -61.06 -31.03 90.52 Favored 'Trans proline' 0 C--N 1.404 3.462 0 C-N-CA 122.293 1.996 . . . . 74.32 112.618 176.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -86.25 -24.17 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 N-CA-C 108.962 -0.755 . . . . 70.21 108.962 -177.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -74.25 -37.03 63.88 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 123.079 0.552 . . . . 71.13 110.764 178.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 28.4 t -87.45 -38.71 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 O-C-N 124.68 1.238 . . . . 74.21 112.711 -178.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 54.9 t -98.4 -42.26 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 O-C-N 121.953 -0.467 . . . . 72.35 111.149 -175.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 123.06 155.56 9.34 Favored Glycine 0 C--N 1.339 0.732 0 N-CA-C 111.021 -0.832 . . . . 41.25 111.021 -175.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 161.38 156.09 8.16 Favored Glycine 0 C--O 1.245 0.819 0 N-CA-C 111.29 -0.724 . . . . 74.4 111.29 177.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.618 ' HD3' ' HB3' ' A' ' 220' ' ' GLU . 37.3 ttmt -84.28 136.66 33.83 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 109.437 -0.579 . . . . 44.44 109.437 175.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.596 HG21 HG22 ' A' ' 199' ' ' VAL . 11.4 m -135.16 151.48 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.363 1.065 . . . . 73.4 108.776 175.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . 0.402 ' HD2' ' N ' ' A' ' 212' ' ' ALA . 2.2 tmm_? -96.34 141.79 29.25 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.419 0.688 . . . . 61.43 109.734 -171.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.599 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -131.1 123.88 29.57 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.536 0.734 . . . . 34.0 109.03 -177.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 37.8 tpp -80.36 109.78 15.18 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 107.837 -1.172 . . . . 71.23 107.837 172.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 73.4 p -113.0 -172.64 2.09 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.418 0.687 . . . . 63.3 110.536 -176.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.626 HD21 ' HD3' ' A' ' 241' ' ' PRO . 66.6 tp -46.18 -50.82 15.23 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.439 1.095 . . . . 72.33 111.598 170.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -72.09 -30.05 64.71 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.055 -0.975 . . . . 45.11 111.753 -174.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 132.45 -164.45 23.91 Favored Glycine 0 C--N 1.342 0.871 0 CA-C-O 119.344 -0.698 . . . . 75.52 111.676 -170.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -66.68 129.02 20.1 Favored 'Trans proline' 0 C--N 1.374 1.89 0 C-N-CA 122.437 2.091 . . . . 75.31 111.346 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.445 HG22 ' O ' ' A' ' 212' ' ' ALA . 28.4 m -134.26 164.17 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 123.472 0.709 . . . . 74.22 110.975 -175.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.618 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 41.9 mt-10 -109.07 114.61 28.49 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.257 1.023 . . . . 64.05 108.689 -171.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 34.9 t -125.6 100.81 7.4 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 123.471 0.709 . . . . 74.13 109.665 -174.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.555 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -79.21 117.6 20.38 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 122.556 0.342 . . . . 60.33 110.243 174.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 30.2 m -88.09 152.12 50.18 Favored Pre-proline 0 N--CA 1.49 1.569 0 C-N-CA 123.253 0.621 . . . . 62.41 111.877 -175.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . 0.523 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 33.5 Cg_endo -63.62 163.71 23.46 Favored 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 122.651 2.234 . . . . 72.31 113.432 176.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -84.16 33.73 0.51 Allowed 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 123.237 2.625 . . . . 74.2 113.263 175.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . 0.418 ' HD2' ' HA ' ' A' ' 226' ' ' ARG . 10.0 tpt180 -150.07 -1.61 0.41 Allowed 'General case' 0 N--CA 1.477 0.897 0 O-C-N 121.805 -0.559 . . . . 73.32 112.217 175.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.576 HG23 HG11 ' A' ' 253' ' ' VAL . 0.6 OUTLIER -59.6 152.45 22.18 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 123.683 0.615 . . . . 71.34 109.639 -164.457 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . 0.492 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 5.2 pt20 -132.46 161.42 33.74 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.081 0.553 . . . . 75.25 110.29 -169.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -60.47 112.11 1.84 Allowed 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 109.818 -0.438 . . . . 50.32 109.818 174.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.25 -3.31 22.23 Favored Glycine 0 C--O 1.244 0.774 0 CA-C-N 115.269 -0.878 . . . . 71.02 111.895 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.492 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -67.79 126.85 30.71 Favored 'General case' 0 C--N 1.361 1.078 0 N-CA-C 109.016 -0.735 . . . . 75.22 109.016 -172.114 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -97.27 98.73 10.24 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 108.944 -0.761 . . . . 74.12 108.944 -173.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.51 ' HB3' ' HA ' ' A' ' 172' ' ' SER . 31.5 mt -79.16 100.78 7.59 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.059 -1.46 . . . . 63.51 107.059 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -79.69 124.97 29.06 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 124.381 1.05 . . . . 64.23 110.164 -175.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.583 ' HB3' ' HB2' ' A' ' 238' ' ' LYS . 7.1 mp -111.41 123.94 51.24 Favored 'General case' 0 C--O 1.219 -0.504 0 N-CA-C 104.769 -2.308 . . . . 70.45 104.769 170.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.478 ' HA ' ' HB3' ' A' ' 248' ' ' ASP . 44.2 tptt -103.07 117.34 34.35 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 118.92 0.782 . . . . 72.43 110.58 -171.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 79.03 27.03 57.05 Favored Glycine 0 C--N 1.345 1.045 0 O-C-N 123.429 0.455 . . . . 55.35 112.012 -175.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.583 ' HB2' ' HB3' ' A' ' 235' ' ' LEU . 29.4 mmmt -128.82 24.0 5.72 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.219 1.008 . . . . 72.0 111.68 -176.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . 0.455 ' HA2' ' HB2' ' A' ' 249' ' ' LEU . . . -95.73 -129.47 5.92 Favored Glycine 0 N--CA 1.469 0.876 0 N-CA-C 110.857 -0.897 . . . . 64.33 110.857 178.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . 0.459 ' O ' ' HA ' ' A' ' 246' ' ' ARG . 4.8 m-30 -68.58 153.13 96.16 Favored Pre-proline 0 CA--C 1.548 0.894 0 CA-C-N 117.374 0.587 . . . . 51.34 111.45 177.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.626 ' HD3' HD21 ' A' ' 215' ' ' LEU . 89.3 Cg_endo -69.95 172.64 12.45 Favored 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 123.346 2.697 . . . . 73.43 112.74 -174.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -66.33 -38.19 93.46 Favored Glycine 0 CA--C 1.545 1.943 0 CA-C-O 118.353 -1.248 . . . . 75.02 113.733 -178.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . 0.592 ' HD2' ' HB2' ' A' ' 241' ' ' PRO . 79.3 Cg_exo -52.75 -39.05 78.05 Favored 'Trans proline' 0 C--N 1.392 2.859 0 CA-C-N 120.918 2.359 . . . . 62.2 113.619 167.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -78.73 -23.5 45.43 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.583 0.753 . . . . 71.33 110.635 175.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 102.83 113.3 3.77 Favored Glycine 0 C--N 1.342 0.864 0 N-CA-C 108.4 -1.88 . . . . 40.23 108.4 -168.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.459 ' HA ' ' O ' ' A' ' 240' ' ' PHE . 15.9 ttp180 -70.81 131.22 43.47 Favored 'General case' 0 C--N 1.348 0.526 0 CA-C-N 117.473 0.636 . . . . 72.54 110.033 -172.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -136.23 -157.15 7.7 Favored Glycine 0 CA--C 1.502 -0.775 0 N-CA-C 110.879 -0.888 . . . . 63.42 110.879 176.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . 0.478 ' HB3' ' HA ' ' A' ' 236' ' ' LYS . 0.4 OUTLIER -124.24 159.03 31.08 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.698 0.799 . . . . 71.12 111.081 -175.945 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.455 ' HB2' ' HA2' ' A' ' 239' ' ' GLY . 8.0 tp -130.12 135.35 48.12 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.222 1.009 . . . . 72.35 108.512 -167.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -118.86 146.35 44.94 Favored 'General case' 0 C--O 1.247 0.922 0 N-CA-C 107.137 -1.431 . . . . 75.13 107.137 -174.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.459 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 71.1 mt -123.04 114.21 20.08 Favored 'General case' 0 C--O 1.223 -0.329 0 N-CA-C 108.078 -1.082 . . . . 50.11 108.078 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -88.59 111.71 22.2 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 107.712 -1.218 . . . . 72.25 107.712 -175.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.576 HG11 HG23 ' A' ' 227' ' ' THR . 56.0 t -62.06 127.35 21.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 114.871 -1.058 . . . . 65.11 110.176 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 14.5 mmt85 -117.1 122.24 43.58 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 106.89 -1.522 . . . . 73.43 106.89 173.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 46.3 mm -82.65 118.55 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 115.491 -0.777 . . . . 74.54 110.411 -174.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . 0.442 HG21 ' HB2' ' A' ' 198' ' ' ASP . 1.4 t . . . . . 0 CA--C 1.556 1.188 0 C-N-CA 124.928 1.291 . . . . 74.14 107.697 -175.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 19.7 mmt . . . . . 0 N--CA 1.482 1.14 0 CA-C-O 120.72 0.295 . . . . 53.33 110.501 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 22.8 pttm -79.83 87.84 5.28 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.411 -0.813 . . . . 73.53 109.118 171.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -81.19 -14.47 57.53 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-N 115.716 -0.675 . . . . 73.1 112.129 -174.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -101.41 9.11 57.31 Favored Glycine 0 N--CA 1.472 1.096 0 O-C-N 123.433 0.458 . . . . 72.3 112.945 174.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -142.29 168.92 18.59 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.027 0.931 . . . . 61.33 109.798 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.407 HG11 HG22 ' A' ' 221' ' ' VAL . 56.1 t -110.33 151.08 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-O 121.761 0.791 . . . . 72.43 111.715 -168.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 46.2 mtm -99.38 -176.72 3.37 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.794 1.638 . . . . 74.32 109.898 -169.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 8.7 p -94.5 87.11 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.027 0 CA-C-O 122.986 1.375 . . . . 75.41 108.324 163.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.57 -4.84 7.68 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 125.552 1.541 . . . . 62.32 110.024 -178.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 68.4 m -41.85 -64.81 0.52 Allowed 'General case' 0 C--O 1.246 0.909 0 C-N-CA 126.369 1.868 . . . . 74.25 113.042 -168.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . 0.623 ' HB2' ' HB3' ' A' ' 224' ' ' PRO . 63.1 t80 -67.36 -49.94 61.9 Favored 'General case' 0 C--N 1.352 0.696 0 N-CA-C 108.764 -0.828 . . . . 73.4 108.764 178.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 56.87 90.84 0.01 OUTLIER Glycine 0 C--N 1.363 2.045 0 O-C-N 125.09 1.494 . . . . 73.32 111.028 -173.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -52.44 85.7 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.936 1.294 . . . . 65.25 112.233 -172.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 31.5 m -78.07 121.46 24.3 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.06 -0.973 . . . . 63.1 108.737 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -64.1 -25.22 68.0 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 116.186 -0.461 . . . . 74.14 110.328 171.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -64.49 157.78 25.74 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.987 0.915 . . . . 74.14 110.599 168.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -71.39 -24.02 61.99 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.114 0.566 . . . . 72.44 110.561 176.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -118.7 173.34 14.87 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-N 115.385 -0.825 . . . . 55.31 112.331 177.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 46.6 m -83.17 135.25 34.86 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.581 0.752 . . . . 52.42 110.224 178.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -58.14 96.22 0.06 OUTLIER Glycine 0 C--N 1.347 1.164 0 O-C-N 123.935 0.772 . . . . 62.41 112.201 176.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -78.23 77.51 1.68 Allowed Glycine 0 C--N 1.349 1.3 0 C-N-CA 123.292 0.472 . . . . 52.12 111.929 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 23.0 t -160.5 136.07 8.14 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 107.897 -1.149 . . . . 41.33 107.897 -177.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -169.84 140.1 5.9 Favored Glycine 0 C--N 1.342 0.863 0 C-N-CA 121.359 -0.448 . . . . 70.21 113.599 -176.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 65.46 -87.49 0.09 OUTLIER Glycine 0 C--N 1.351 1.363 0 O-C-N 124.521 0.777 . . . . 64.34 114.26 173.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 33.5 t -175.33 -40.32 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.403 1.081 . . . . 73.23 109.92 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 118.46 -18.17 11.05 Favored Glycine 0 C--N 1.354 1.536 0 N-CA-C 114.678 0.631 . . . . 44.54 114.678 176.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -78.19 -71.43 1.23 Allowed Glycine 0 N--CA 1.471 1.01 0 CA-C-N 117.557 0.678 . . . . 71.22 113.362 -172.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 58.1 m -150.21 20.75 0.86 Allowed 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.43 0.692 . . . . 65.12 110.602 -177.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -106.95 -31.54 8.28 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.702 0.801 . . . . 73.45 111.076 -170.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.58 171.03 15.32 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-N 115.187 -0.915 . . . . 52.32 109.299 -176.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.423 ' O ' ' HA ' ' A' ' 249' ' ' LEU . 37.1 tp -152.3 131.53 12.78 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.44 -0.948 . . . . 61.21 108.44 174.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -117.26 138.29 51.83 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 123.41 0.684 . . . . 74.55 109.158 171.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -148.14 165.79 29.81 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.49 1.116 . . . . 73.52 108.165 176.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . 0.435 HG21 ' HE ' ' A' ' 254' ' ' ARG . 39.8 p -93.67 154.74 17.65 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 122.395 1.093 . . . . 50.02 112.275 168.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.638 HD13 ' HB2' ' A' ' 212' ' ' ALA . 35.4 tp -125.6 132.16 52.57 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 112.767 -2.015 . . . . 75.34 106.421 165.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -95.27 117.42 30.24 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 107.879 -1.156 . . . . 73.04 107.879 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.592 HG22 HG21 ' A' ' 210' ' ' VAL . 58.0 t -119.57 131.55 24.34 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 124.353 1.061 . . . . 72.34 110.019 -178.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -65.1 144.23 81.03 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.326 2.017 . . . . 61.15 111.418 168.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.451 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.47 -44.94 98.62 Favored Pre-proline 0 CA--C 1.564 1.517 0 C-N-CA 123.799 0.84 . . . . 72.31 112.167 174.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 17.8 Cg_endo -58.72 -33.45 98.35 Favored 'Trans proline' 0 C--N 1.404 3.499 0 C-N-CA 121.784 1.656 . . . . 73.24 112.361 175.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -86.06 -23.61 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 N-CA-C 109.357 -0.609 . . . . 75.12 109.357 -177.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -74.12 -39.33 63.41 Favored 'General case' 0 C--O 1.243 0.729 0 C-N-CA 123.046 0.538 . . . . 40.04 110.897 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 38.6 t -89.42 -36.05 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.818 1.247 . . . . 61.15 112.962 -178.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.436 ' HB ' ' O ' ' A' ' 202' ' ' PRO . 47.6 t -95.98 -41.47 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 O-C-N 121.538 -0.726 . . . . 72.11 110.184 -177.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 121.57 152.12 8.66 Favored Glycine 0 C--N 1.344 0.98 0 N-CA-C 110.57 -1.012 . . . . 63.31 110.57 -178.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.89 155.99 8.77 Favored Glycine 0 C--O 1.242 0.606 0 N-CA-C 112.289 -0.324 . . . . 65.23 112.289 176.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.619 ' HD3' ' HB3' ' A' ' 220' ' ' GLU . 38.3 ttmt -84.25 132.47 34.64 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.049 0.54 . . . . 71.42 109.781 175.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.592 HG21 HG22 ' A' ' 199' ' ' VAL . 8.3 m -131.07 150.62 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.674 1.19 . . . . 61.41 108.225 174.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -95.73 143.62 26.83 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 109.226 -0.657 . . . . 73.55 109.226 -174.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.638 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -130.76 128.02 39.92 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.976 0.91 . . . . 50.14 109.035 -177.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 31.7 tpp -79.39 116.37 19.59 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.642 -0.873 . . . . 61.21 108.642 171.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 68.8 p -121.06 -176.59 3.3 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.787 0.835 . . . . 64.15 110.001 -177.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.53 HD21 ' HD3' ' A' ' 241' ' ' PRO . 66.6 tp -46.72 -51.38 16.27 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.497 1.119 . . . . 54.32 111.894 172.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -72.1 -27.19 62.49 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 114.044 -1.434 . . . . 74.32 111.269 -172.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 131.98 -164.39 23.71 Favored Glycine 0 C--N 1.338 0.677 0 N-CA-C 111.508 -0.637 . . . . 75.43 111.508 -174.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -66.45 129.83 22.29 Favored 'Trans proline' 0 C--N 1.361 1.21 0 C-N-CA 122.407 2.071 . . . . 74.43 111.35 178.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 31.8 m -133.18 161.33 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 123.738 0.815 . . . . 54.13 110.816 -177.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.619 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 53.1 mt-10 -110.32 110.77 21.7 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.559 1.144 . . . . 74.41 109.842 -173.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.407 HG22 HG11 ' A' ' 168' ' ' VAL . 48.8 t -121.15 102.39 12.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 C-N-CA 124.352 1.061 . . . . 73.11 109.228 -172.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.603 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -79.2 117.08 19.89 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 122.796 0.439 . . . . 54.33 110.532 174.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 34.8 m -86.52 153.59 55.93 Favored Pre-proline 0 N--CA 1.487 1.392 0 C-N-CA 123.737 0.815 . . . . 74.22 111.457 -176.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . 0.623 ' HB3' ' HB2' ' A' ' 173' ' ' TYR . 32.7 Cg_endo -63.02 164.94 17.86 Favored 'Trans proline' 0 C--N 1.379 2.155 0 C-N-CA 122.737 2.291 . . . . 74.43 113.189 175.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -84.0 29.53 0.54 Allowed 'Trans proline' 0 C--N 1.369 1.606 0 C-N-CA 123.258 2.639 . . . . 74.22 113.178 172.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -145.9 0.1 0.83 Allowed 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 118.618 -0.706 . . . . 75.12 112.499 177.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.563 HG23 HG11 ' A' ' 253' ' ' VAL . 0.6 OUTLIER -60.95 154.66 21.85 Favored 'General case' 0 CA--C 1.573 1.84 0 O-C-N 123.375 0.422 . . . . 73.13 109.906 -167.117 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . 0.492 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 4.8 pt20 -135.26 161.94 33.98 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.563 0.745 . . . . 70.22 110.948 -169.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -62.75 110.86 1.88 Allowed 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.244 -0.65 . . . . 73.34 109.244 176.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.09 -0.55 22.65 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-N 115.187 -0.915 . . . . 40.14 111.903 178.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.492 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -67.92 123.85 21.75 Favored 'General case' 0 C--N 1.362 1.128 0 N-CA-C 108.824 -0.806 . . . . 75.31 108.824 -171.041 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -100.08 96.72 7.7 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.222 -0.658 . . . . 75.54 109.222 -170.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.464 ' O ' ' HA ' ' A' ' 250' ' ' TYR . 24.4 mt -80.21 98.57 7.41 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 106.378 -1.712 . . . . 73.43 106.378 -177.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . 0.671 ' HD3' ' HE2' ' A' ' 236' ' ' LYS . 0.0 OUTLIER -82.19 125.61 31.11 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.476 0.71 . . . . 52.45 111.501 178.631 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.563 ' HB3' ' HB2' ' A' ' 238' ' ' LYS . 7.2 mp -111.17 128.52 55.93 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 106.627 -1.619 . . . . 74.52 106.627 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.671 ' HE2' ' HD3' ' A' ' 234' ' ' ARG . 5.6 mptp? -97.07 116.84 30.0 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.253 0.621 . . . . 74.21 110.986 -173.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 76.46 29.27 58.31 Favored Glycine 0 C--N 1.35 1.307 0 O-C-N 124.06 0.85 . . . . 41.03 112.047 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.563 ' HB2' ' HB3' ' A' ' 235' ' ' LEU . 29.3 mmmt -127.27 20.38 6.82 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.113 0.965 . . . . 75.45 111.124 -175.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -94.95 -127.84 5.22 Favored Glycine 0 C--N 1.343 0.942 0 N-CA-C 110.059 -1.217 . . . . 43.51 110.059 178.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . 0.431 ' O ' ' HA ' ' A' ' 246' ' ' ARG . 7.3 m-30 -71.53 152.07 93.83 Favored Pre-proline 0 CA--C 1.554 1.098 0 CA-C-N 117.121 0.46 . . . . 72.41 111.767 177.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.53 ' HD3' HD21 ' A' ' 215' ' ' LEU . 59.2 Cg_endo -65.67 172.08 8.67 Favored 'Trans proline' 0 C--N 1.384 2.426 0 C-N-CA 123.468 2.779 . . . . 74.43 112.332 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.416 ' N ' ' HD2' ' A' ' 243' ' ' PRO . . . -66.31 -42.24 94.16 Favored Glycine 0 CA--C 1.541 1.672 0 CA-C-O 118.241 -1.311 . . . . 44.5 114.185 -176.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' A' ' 242' ' ' GLY . 10.2 Cg_endo -51.77 -38.78 67.72 Favored 'Trans proline' 0 C--N 1.392 2.825 0 C-N-CA 122.697 2.265 . . . . 51.22 113.223 168.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -79.19 -23.68 43.7 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.168 0.587 . . . . 31.52 110.839 176.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 105.79 111.33 3.58 Favored Glycine 0 C--N 1.343 0.919 0 N-CA-C 108.757 -1.737 . . . . 74.11 108.757 -170.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.431 ' HA ' ' O ' ' A' ' 240' ' ' PHE . 74.3 mtt180 -63.6 124.54 21.64 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.46 0.704 . . . . 73.53 110.965 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -136.81 -158.15 7.9 Favored Glycine 0 C--O 1.24 0.517 0 CA-C-N 115.582 -0.736 . . . . 52.21 112.253 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -117.32 164.74 14.38 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.839 0.856 . . . . 54.2 109.517 -176.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.423 ' HA ' ' O ' ' A' ' 193' ' ' LEU . 12.3 tp -133.78 132.53 40.61 Favored 'General case' 0 C--O 1.217 -0.654 0 N-CA-C 108.541 -0.911 . . . . 65.55 108.541 -176.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.464 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 0.4 OUTLIER -113.27 145.55 40.84 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 123.48 0.712 . . . . 73.45 109.433 177.803 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 73.5 mt -124.28 112.5 17.08 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.361 -1.348 . . . . 71.54 107.361 176.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -92.19 106.57 18.55 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 107.526 -1.287 . . . . 64.33 107.526 -172.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.563 HG11 HG23 ' A' ' 227' ' ' THR . 56.0 t -61.88 125.86 18.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 115.005 -0.998 . . . . 73.35 110.623 -177.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . 0.435 ' HE ' HG21 ' A' ' 196' ' ' THR . 26.4 mtm180 -113.6 123.77 50.75 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 106.644 -1.613 . . . . 70.03 106.644 171.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 46.5 mm -84.78 130.77 35.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 C-N-CA 123.181 0.592 . . . . 73.43 109.851 -175.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.4 t . . . . . 0 CA--C 1.563 1.471 0 C-N-CA 124.24 1.016 . . . . 72.4 108.355 -172.109 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . 0.503 ' HA ' ' SD ' ' A' ' 169' ' ' MET . 1.0 OUTLIER . . . . . 0 N--CA 1.482 1.158 0 N-CA-C 109.31 -0.626 . . . . 72.15 109.31 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 32.6 mtmm -84.69 131.43 34.58 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 122.944 0.498 . . . . 73.25 109.809 173.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -86.62 -52.76 5.35 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.855 0.862 . . . . 71.44 111.477 -173.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -98.19 17.35 58.75 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-N 115.878 -0.601 . . . . 63.54 112.954 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -151.95 172.14 16.7 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.226 1.01 . . . . 42.14 109.405 176.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.46 HG11 HG22 ' A' ' 221' ' ' VAL . 51.1 t -111.05 149.96 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.999 0.919 . . . . 51.13 110.54 -178.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.503 ' SD ' ' HA ' ' A' ' 163' ' ' MET . 43.3 mtm -98.35 -177.78 3.82 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 125.544 1.538 . . . . 62.51 109.656 -169.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 9.0 p -100.52 90.4 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 N-CA-C 107.42 -1.326 . . . . 73.43 107.42 162.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . 0.435 ' HG3' ' HA ' ' A' ' 235' ' ' LEU . 0.0 OUTLIER -125.3 -6.14 7.13 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 114.096 -1.411 . . . . 75.31 110.297 -175.863 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.448 ' HA ' ' HB3' ' A' ' 233' ' ' LEU . 67.2 m -40.77 -65.29 0.43 Allowed 'General case' 0 C--N 1.353 0.728 0 C-N-CA 126.461 1.904 . . . . 61.43 113.682 -165.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -63.54 -48.53 77.14 Favored 'General case' 0 C--O 1.238 0.486 0 O-C-N 123.504 0.502 . . . . 74.41 110.187 -177.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 60.91 93.03 0.01 OUTLIER Glycine 0 C--N 1.346 1.11 0 N-CA-C 109.715 -1.354 . . . . 64.04 109.715 -167.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -55.82 95.34 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.86 0.864 . . . . 70.42 110.215 -177.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 51.1 m -82.52 120.71 25.85 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-N 114.688 -1.142 . . . . 61.25 109.869 -174.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -70.43 -20.9 62.87 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 115.52 -0.764 . . . . 73.42 109.763 170.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -72.3 161.8 30.35 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.459 1.104 . . . . 60.05 110.933 173.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -81.9 2.96 28.07 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.185 0.594 . . . . 61.32 111.576 176.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -143.16 139.71 9.14 Favored Glycine 0 C--N 1.346 1.118 0 N-CA-C 111.069 -0.812 . . . . 64.11 111.069 173.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 23.0 t -106.4 106.3 16.75 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.746 0.818 . . . . 72.12 109.459 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -99.02 -123.35 4.91 Favored Glycine 0 C--N 1.347 1.166 0 O-C-N 123.16 0.288 . . . . 33.3 112.555 -178.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 146.02 82.9 0.05 OUTLIER Glycine 0 C--N 1.347 1.15 0 CA-C-N 116.606 0.203 . . . . 61.21 112.874 175.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 62.0 p -131.13 162.42 29.92 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.865 0.866 . . . . 70.43 109.673 177.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -172.42 -84.91 0.06 OUTLIER Glycine 0 C--N 1.346 1.12 0 C-N-CA 121.665 -0.302 . . . . 43.01 113.253 175.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.421 ' O ' ' HB2' ' A' ' 191' ' ' GLN . . . -87.01 50.23 4.12 Favored Glycine 0 C--N 1.347 1.192 0 C-N-CA 123.118 0.39 . . . . 41.05 113.289 -172.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 9.6 t -97.27 93.56 6.59 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 123.516 0.726 . . . . 73.22 109.936 -173.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -136.28 -83.1 0.14 Allowed Glycine 0 C--N 1.346 1.108 0 CA-C-N 116.232 -0.44 . . . . 72.31 112.473 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -106.27 -72.41 0.82 Allowed Glycine 0 C--N 1.351 1.399 0 N-CA-C 110.358 -1.097 . . . . 51.54 110.358 178.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 67.1 m -154.57 76.54 1.02 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.778 0.831 . . . . 53.42 109.38 174.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.421 ' HB2' ' O ' ' A' ' 186' ' ' GLY . 27.5 mt-30 -117.39 -48.21 2.62 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 114.575 -1.193 . . . . 63.14 108.563 172.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.428 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 38.5 p-10 -74.72 165.15 25.7 Favored 'General case' 0 C--O 1.247 0.948 0 CA-C-N 115.343 -0.844 . . . . 73.51 109.984 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.411 HD13 ' CE1' ' A' ' 240' ' ' PHE . 53.1 tp -149.94 143.34 25.18 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.902 -0.59 . . . . 62.42 109.548 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -115.52 138.47 51.0 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.969 0.908 . . . . 73.32 108.636 173.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -149.09 158.32 44.09 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.73 -0.841 . . . . 44.41 108.73 170.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 26.5 p -81.3 153.08 27.26 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 122.187 0.994 . . . . 53.34 111.851 166.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.691 HD13 ' HB2' ' A' ' 212' ' ' ALA . 33.5 tp -122.62 134.5 54.51 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 113.053 -1.885 . . . . 74.23 106.911 162.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -94.7 117.47 30.18 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 108.142 -1.058 . . . . 74.11 108.142 177.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.603 HG22 HG21 ' A' ' 210' ' ' VAL . 45.1 t -122.51 132.21 24.29 Favored Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 124.049 0.94 . . . . 65.54 109.153 178.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -69.57 145.55 58.6 Favored 'Trans proline' 0 C--N 1.365 1.433 0 C-N-CA 122.352 2.035 . . . . 63.11 110.52 169.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.458 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -52.91 -43.56 94.36 Favored Pre-proline 0 N--CA 1.486 1.332 0 N-CA-C 112.567 0.58 . . . . 54.01 112.567 173.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 10.6 Cg_endo -55.21 -37.72 94.1 Favored 'Trans proline' 0 C--N 1.399 3.217 0 C-N-CA 122.006 1.804 . . . . 43.2 112.736 174.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -86.55 -23.66 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 N-CA-C 109.841 -0.429 . . . . 71.33 109.841 -175.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -73.48 -38.0 65.56 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 123.146 0.578 . . . . 61.1 111.029 178.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 39.8 t -89.01 -35.43 7.71 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 C-N-CA 125.022 1.329 . . . . 74.51 112.648 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.414 ' HB ' ' O ' ' A' ' 202' ' ' PRO . 51.5 t -97.92 -42.93 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 O-C-N 121.547 -0.721 . . . . 61.34 111.129 -176.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 121.82 152.45 8.7 Favored Glycine 0 C--N 1.339 0.743 0 N-CA-C 110.707 -0.957 . . . . 74.35 110.707 -176.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 161.81 155.55 7.98 Favored Glycine 0 C--O 1.245 0.839 0 N-CA-C 111.307 -0.717 . . . . 71.11 111.307 177.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.62 ' HD3' ' HB3' ' A' ' 220' ' ' GLU . 36.3 ttmt -84.85 133.66 34.31 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 122.998 0.519 . . . . 73.33 110.026 174.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.603 HG21 HG22 ' A' ' 199' ' ' VAL . 15.5 m -131.24 153.4 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.417 1.087 . . . . 75.41 109.665 177.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . 0.667 ' HE ' ' HB3' ' A' ' 218' ' ' PRO . 0.0 OUTLIER -95.14 142.69 27.3 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.266 1.026 . . . . 74.04 109.352 -171.79 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.691 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -132.85 122.35 24.28 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.561 0.745 . . . . 65.31 109.459 -177.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 34.2 tpp -78.9 109.91 13.62 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 108.958 -0.756 . . . . 74.15 108.958 172.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 67.5 p -120.36 -175.08 2.93 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.928 0.891 . . . . 51.34 110.387 -175.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.534 HD21 ' HD3' ' A' ' 241' ' ' PRO . 64.0 tp -44.19 -53.32 6.64 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.298 1.039 . . . . 72.11 112.754 174.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -73.32 -27.89 61.77 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 114.821 -1.081 . . . . 74.34 111.392 -172.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 135.05 -164.45 24.78 Favored Glycine 0 C--N 1.341 0.855 0 N-CA-C 111.687 -0.565 . . . . 44.22 111.687 -171.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . 0.667 ' HB3' ' HE ' ' A' ' 211' ' ' ARG . 41.3 Cg_endo -63.93 130.73 28.45 Favored 'Trans proline' 0 C--N 1.369 1.639 0 C-N-CA 122.848 2.365 . . . . 73.4 111.335 176.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.406 HG22 ' O ' ' A' ' 212' ' ' ALA . 23.2 m -131.84 161.82 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.707 0.803 . . . . 60.54 110.723 -177.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.62 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 43.9 mt-10 -112.0 112.68 24.49 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.445 1.098 . . . . 65.53 109.899 -171.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.46 HG22 HG11 ' A' ' 168' ' ' VAL . 50.5 t -126.39 102.61 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 124.221 1.008 . . . . 74.21 110.174 -171.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.608 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -78.06 118.19 20.09 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.948 0.499 . . . . 63.52 110.391 174.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 36.0 m -90.71 152.33 44.74 Favored Pre-proline 0 N--CA 1.482 1.159 0 C-N-CA 123.445 0.698 . . . . 73.43 111.296 -176.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . 0.528 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 36.1 Cg_endo -63.91 165.4 18.96 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.839 2.359 . . . . 61.04 113.054 175.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -84.78 28.98 0.55 Allowed 'Trans proline' 0 C--N 1.378 2.091 0 C-N-CA 123.222 2.614 . . . . 63.21 113.032 175.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 35.4 mmt180 -145.07 -2.8 0.78 Allowed 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.335 0.654 . . . . 74.2 112.259 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.535 HG23 HG11 ' A' ' 253' ' ' VAL . 0.6 OUTLIER -60.81 149.47 35.77 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.433 -0.58 . . . . 70.32 109.433 -165.864 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . 0.471 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 13.2 pt20 -133.81 162.3 32.38 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.123 0.569 . . . . 74.01 110.417 -173.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -59.73 110.97 1.27 Allowed 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.145 0.498 . . . . 62.44 110.05 178.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.63 -0.66 21.79 Favored Glycine 0 C--N 1.335 0.49 0 CA-C-N 114.675 -1.148 . . . . 74.24 112.095 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -68.18 125.24 25.75 Favored 'General case' 0 C--N 1.359 0.992 0 N-CA-C 108.901 -0.777 . . . . 74.21 108.901 -175.002 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -98.9 97.58 8.75 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.283 0.633 . . . . 72.54 109.571 -168.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.479 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 22.2 mt -82.68 100.01 9.96 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 107.839 -1.171 . . . . 72.14 107.839 -176.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . 0.618 ' H ' ' HD3' ' A' ' 234' ' ' ARG . 0.0 OUTLIER -82.95 113.76 20.77 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.154 -0.93 . . . . 64.41 111.185 -176.964 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.485 ' O ' ' HB2' ' A' ' 248' ' ' ASP . 7.3 mp -100.66 127.25 47.12 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 106.772 -1.566 . . . . 75.14 106.772 173.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -101.74 117.12 34.21 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.342 0.657 . . . . 73.02 110.636 -175.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 79.08 32.35 39.83 Favored Glycine 0 C--N 1.348 1.227 0 O-C-N 124.268 0.98 . . . . 73.23 112.309 -177.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.46 ' HB2' ' HB3' ' A' ' 235' ' ' LEU . 29.3 mmmt -128.7 19.59 6.14 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.607 0.763 . . . . 74.21 111.66 -178.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -98.04 -134.03 8.18 Favored Glycine 0 C--N 1.343 0.953 0 N-CA-C 111.039 -0.824 . . . . 74.3 111.039 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . 0.48 ' O ' ' HA ' ' A' ' 246' ' ' ARG . 5.9 m-30 -66.18 154.91 89.04 Favored Pre-proline 0 CA--C 1.547 0.854 0 N-CA-C 112.699 0.629 . . . . 63.24 112.699 -177.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.534 ' HD3' HD21 ' A' ' 215' ' ' LEU . 86.2 Cg_endo -71.99 171.54 16.47 Favored 'Trans proline' 0 C--N 1.383 2.348 0 C-N-CA 123.285 2.657 . . . . 64.21 112.797 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.465 ' N ' ' HD2' ' A' ' 243' ' ' PRO . . . -67.17 -38.33 91.99 Favored Glycine 0 CA--C 1.545 1.962 0 CA-C-O 118.364 -1.242 . . . . 71.42 114.713 -177.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 242' ' ' GLY . 10.0 Cg_endo -53.72 -37.18 83.94 Favored 'Trans proline' 0 C--N 1.39 2.74 0 CA-C-N 120.974 2.387 . . . . 74.25 112.511 169.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -80.16 -24.6 40.28 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.513 0.725 . . . . 72.21 110.834 175.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 105.95 111.35 3.58 Favored Glycine 0 C--N 1.341 0.819 0 N-CA-C 107.802 -2.119 . . . . 73.2 107.802 -167.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.48 ' HA ' ' O ' ' A' ' 240' ' ' PHE . 1.5 tmm_? -73.12 128.52 35.73 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 109.738 -0.468 . . . . 73.0 109.738 -170.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -137.09 -156.79 7.43 Favored Glycine 0 C--N 1.342 0.911 0 CA-C-N 115.982 -0.554 . . . . 43.4 112.951 -175.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . 0.485 ' HB2' ' O ' ' A' ' 235' ' ' LEU . 32.4 p-10 -123.78 165.23 17.65 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.327 1.051 . . . . 45.12 110.526 -174.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 10.8 tp -135.56 135.37 40.28 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.191 -0.67 . . . . 63.2 109.191 -170.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -115.66 145.81 42.39 Favored 'General case' 0 C--O 1.246 0.88 0 N-CA-C 107.637 -1.246 . . . . 63.1 107.637 -178.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.479 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 82.2 mt -123.82 113.79 19.01 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 108.558 -0.904 . . . . 41.43 108.558 -179.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -89.78 110.49 21.4 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.83 -1.174 . . . . 64.53 107.83 -176.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.535 HG11 HG23 ' A' ' 227' ' ' THR . 51.2 t -61.81 134.16 27.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 115.162 -0.927 . . . . 54.02 110.527 -178.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 18.1 mtp85 -120.73 125.22 47.08 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.337 -1.357 . . . . 63.52 107.337 172.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 48.0 mm -84.92 112.83 22.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 108.948 -0.76 . . . . 74.22 108.948 -179.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 CA--C 1.557 1.248 0 CA-C-O 117.415 -1.279 . . . . 73.34 108.912 -171.734 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 50.6 ttm . . . . . 0 N--CA 1.473 0.704 0 N-CA-C 109.576 -0.528 . . . . 75.3 109.576 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.475 ' HB2' ' HB3' ' A' ' 167' ' ' ALA . 0.0 OUTLIER -77.69 93.05 4.2 Favored 'General case' 0 CA--C 1.555 1.168 0 CA-C-O 121.823 0.82 . . . . 71.31 111.711 -179.734 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -78.18 -21.4 50.22 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.554 0.741 . . . . 71.44 111.457 176.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -97.48 17.07 59.61 Favored Glycine 0 C--N 1.345 1.059 0 O-C-N 123.555 0.534 . . . . 74.24 112.625 178.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.475 ' HB3' ' HB2' ' A' ' 164' ' ' LYS . . . -148.08 172.84 13.62 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.58 1.152 . . . . 62.11 108.837 176.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.405 HG11 HG22 ' A' ' 221' ' ' VAL . 54.6 t -110.22 152.3 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-O 121.731 0.777 . . . . 64.34 111.415 -170.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 43.4 mtm -101.42 -176.05 3.03 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.619 1.968 . . . . 74.53 109.462 -170.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 10.3 p -101.77 88.84 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.079 0 CA-C-O 122.973 1.368 . . . . 72.24 107.791 163.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.72 -5.66 8.61 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 114.05 -1.432 . . . . 53.53 110.587 -174.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.46 ' HA ' ' HB3' ' A' ' 233' ' ' LEU . 69.3 m -36.25 -64.96 0.29 Allowed 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 127.014 2.126 . . . . 72.25 115.617 -167.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . 0.442 ' HB2' ' HG3' ' A' ' 224' ' ' PRO . 66.9 t80 -61.4 -33.42 73.65 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.165 0.586 . . . . 74.32 111.517 -170.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 79.39 39.85 17.5 Favored Glycine 0 C--N 1.343 0.919 0 N-CA-C 110.191 -1.164 . . . . 75.41 110.191 -173.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -70.07 102.15 1.98 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.353 1.061 . . . . 53.04 110.494 -173.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 58.3 p -110.12 124.94 52.43 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.937 1.295 . . . . 54.55 108.995 176.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -65.52 -13.09 58.15 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.922 0.489 . . . . 64.12 112.315 176.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -90.51 161.7 15.38 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.539 1.136 . . . . 61.23 109.071 168.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -59.81 -36.52 76.93 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 112.168 0.433 . . . . 73.34 112.168 -175.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -159.7 -176.53 31.87 Favored Glycine 0 CA--C 1.522 0.527 0 CA-C-N 115.302 -0.863 . . . . 72.24 111.999 177.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 36.2 m -110.92 7.38 21.71 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.559 0.744 . . . . 74.13 111.169 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 84.63 -57.75 5.01 Favored Glycine 0 C--N 1.354 1.565 0 N-CA-C 112.03 -0.428 . . . . 74.03 112.03 -178.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -169.3 -128.83 1.04 Allowed Glycine 0 C--N 1.34 0.77 0 N-CA-C 111.035 -0.826 . . . . 71.13 111.035 177.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 46.6 t -143.28 125.15 15.13 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 123.601 0.76 . . . . 54.22 109.931 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -78.41 68.17 2.98 Favored Glycine 0 C--N 1.35 1.352 0 N-CA-C 111.347 -0.701 . . . . 73.44 111.347 169.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -157.58 -97.14 0.12 Allowed Glycine 0 C--O 1.241 0.541 0 N-CA-C 109.304 -1.518 . . . . 73.22 109.304 -178.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 23.7 m 57.72 26.28 12.84 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 124.76 1.224 . . . . 72.14 112.53 171.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -102.33 147.03 17.07 Favored Glycine 0 C--N 1.343 0.954 0 CA-C-N 115.599 -0.728 . . . . 64.0 112.549 -176.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -64.82 -62.32 5.1 Favored Glycine 0 C--N 1.346 1.119 0 N-CA-C 111.696 -0.562 . . . . 43.32 111.696 178.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 67.8 p -89.47 22.31 3.01 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.705 0.802 . . . . 62.31 111.439 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -117.59 -56.11 2.24 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.19 0.596 . . . . 73.11 110.169 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -76.28 164.29 26.2 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-N 115.394 -0.821 . . . . 64.44 110.458 -177.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 40.9 tp -151.1 140.14 21.07 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.344 -0.844 . . . . 62.5 109.846 176.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -114.77 140.04 49.22 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.649 0.78 . . . . 74.12 109.421 168.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -145.16 157.03 44.19 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 108.353 -0.98 . . . . 63.34 108.353 167.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 30.0 p -81.46 154.38 26.37 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 122.139 0.971 . . . . 75.11 111.516 167.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.656 HD13 ' HB2' ' A' ' 212' ' ' ALA . 42.3 tp -121.17 133.32 55.18 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 113.286 -1.779 . . . . 73.22 107.026 168.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -92.55 112.35 24.26 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 106.95 -1.5 . . . . 72.55 106.95 -177.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.551 HG22 HG21 ' A' ' 210' ' ' VAL . 43.3 t -124.55 130.41 24.3 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 123.333 0.653 . . . . 73.32 109.275 -177.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -66.81 144.13 69.95 Favored 'Trans proline' 0 C--N 1.368 1.6 0 C-N-CA 121.984 1.789 . . . . 75.55 110.974 166.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.439 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.16 -45.19 98.41 Favored Pre-proline 0 CA--C 1.562 1.421 0 CA-C-O 118.309 -0.853 . . . . 42.12 112.322 174.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.467 ' O ' ' HB ' ' A' ' 206' ' ' VAL . 22.9 Cg_endo -59.35 -30.98 94.17 Favored 'Trans proline' 0 C--N 1.4 3.252 0 C-N-CA 121.909 1.739 . . . . 62.12 112.537 175.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.7 mp -85.88 -25.97 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 O-C-N 121.645 -0.659 . . . . 74.1 109.68 -178.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -74.25 -38.81 63.37 Favored 'General case' 0 C--O 1.246 0.913 0 CA-C-O 121.13 0.49 . . . . 62.41 111.078 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 41.2 t -88.96 -37.21 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 C-N-CA 124.809 1.244 . . . . 74.31 112.653 -177.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.467 ' HB ' ' O ' ' A' ' 202' ' ' PRO . 53.1 t -96.85 -42.4 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 O-C-N 121.648 -0.658 . . . . 61.01 109.71 -176.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 124.31 148.66 7.48 Favored Glycine 0 C--N 1.349 1.287 0 N-CA-C 111.306 -0.718 . . . . 54.4 111.306 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 165.48 156.07 9.0 Favored Glycine 0 C--N 1.342 0.876 0 N-CA-C 112.259 -0.336 . . . . 52.41 112.259 177.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.606 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 38.1 ttmt -85.01 131.93 34.4 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.284 0.634 . . . . 65.02 110.16 176.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.551 HG21 HG22 ' A' ' 199' ' ' VAL . 13.8 m -131.07 153.22 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 124.023 0.929 . . . . 63.11 110.106 178.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -94.5 142.73 27.1 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.159 0.984 . . . . 65.03 109.468 -171.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.656 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -132.74 119.51 20.43 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.388 0.675 . . . . 74.2 109.774 -176.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 35.5 tpp -78.68 110.13 13.54 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 108.759 -0.83 . . . . 73.1 108.759 171.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 67.1 p -119.17 -175.26 2.89 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.085 0.954 . . . . 73.24 110.706 -174.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.539 HD21 ' HD3' ' A' ' 241' ' ' PRO . 65.5 tp -49.77 -50.66 43.77 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.984 0.914 . . . . 74.13 111.439 169.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -71.86 -26.7 62.46 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 114.567 -1.197 . . . . 74.33 111.84 -173.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 133.09 -165.17 24.08 Favored Glycine 0 C--N 1.344 1.004 0 N-CA-C 111.488 -0.645 . . . . 52.54 111.488 -178.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -67.56 128.08 17.52 Favored 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 121.709 1.606 . . . . 75.15 110.566 174.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 25.1 m -132.98 162.3 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 123.329 0.652 . . . . 65.25 110.397 -174.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.599 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 45.1 mt-10 -111.78 111.64 22.75 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.647 0.779 . . . . 74.33 109.446 -173.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.405 HG22 HG11 ' A' ' 168' ' ' VAL . 57.4 t -122.65 103.81 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 124.812 1.245 . . . . 64.42 109.646 -172.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.606 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -75.34 117.57 17.29 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 110.061 -0.348 . . . . 71.12 110.061 174.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 28.3 m -85.47 153.5 58.8 Favored Pre-proline 0 N--CA 1.489 1.495 0 C-N-CA 122.889 0.475 . . . . 74.5 110.796 -176.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . 0.442 ' HG3' ' HB2' ' A' ' 173' ' ' TYR . 34.2 Cg_exo -59.7 162.36 15.74 Favored 'Trans proline' 0 C--N 1.383 2.373 0 C-N-CA 122.43 2.087 . . . . 73.3 112.757 177.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -91.02 30.12 0.36 Allowed 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 123.219 2.613 . . . . 72.34 112.039 177.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 -145.12 -9.12 0.59 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.061 0.945 . . . . 55.24 111.403 178.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.556 HG23 HG11 ' A' ' 253' ' ' VAL . 0.8 OUTLIER -59.39 156.39 12.96 Favored 'General case' 0 CA--C 1.567 1.633 0 O-C-N 123.885 0.741 . . . . 73.22 111.603 -158.906 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . 0.41 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 19.7 pt20 -130.22 162.55 28.67 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.341 0.657 . . . . 70.42 110.851 -171.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . 0.421 ' HB1' HH21 ' A' ' 254' ' ' ARG . . . -61.4 112.64 2.26 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.903 -0.59 . . . . 30.4 109.438 174.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.44 -3.86 21.74 Favored Glycine 0 N--CA 1.466 0.68 0 CA-C-N 115.642 -0.708 . . . . 72.55 112.067 178.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -68.69 126.24 29.08 Favored 'General case' 0 C--N 1.358 0.948 0 N-CA-C 109.268 -0.641 . . . . 71.44 109.268 -173.065 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -98.39 98.47 9.69 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.373 -0.603 . . . . 74.45 109.373 -171.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.46 ' HB3' ' HA ' ' A' ' 172' ' ' SER . 25.0 mt -79.64 99.77 7.52 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 106.917 -1.512 . . . . 62.22 106.917 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -81.34 115.68 20.81 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-O 121.546 0.689 . . . . 65.24 110.871 -176.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.425 ' HB3' ' HB2' ' A' ' 238' ' ' LYS . 7.3 mp -99.52 124.82 45.04 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 105.458 -2.053 . . . . 64.31 105.458 170.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 41.0 tptt -102.14 117.93 35.83 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 117.909 0.322 . . . . 63.44 110.156 -171.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 77.65 22.02 70.69 Favored Glycine 0 C--N 1.342 0.913 0 O-C-N 123.542 0.526 . . . . 73.14 112.86 -178.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.425 ' HB2' ' HB3' ' A' ' 235' ' ' LEU . 1.5 mmmp? -120.65 20.74 11.7 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.012 0.925 . . . . 55.21 110.035 -177.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -96.75 -135.09 8.38 Favored Glycine 0 C--N 1.349 1.285 0 N-CA-C 111.258 -0.737 . . . . 72.24 111.258 178.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 6.3 m-30 -65.1 150.59 95.21 Favored Pre-proline 0 N--CA 1.48 1.035 0 N-CA-C 112.339 0.496 . . . . 63.01 112.339 -177.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.539 ' HD3' HD21 ' A' ' 215' ' ' LEU . 60.0 Cg_endo -67.37 170.38 13.59 Favored 'Trans proline' 0 C--N 1.383 2.376 0 C-N-CA 123.13 2.553 . . . . 73.41 113.075 -177.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -68.37 -39.58 87.44 Favored Glycine 0 CA--C 1.538 1.509 0 CA-C-O 118.613 -1.104 . . . . 63.32 114.361 -177.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -48.38 -40.27 36.08 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 122.515 2.144 . . . . 32.3 113.871 164.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -77.9 -24.64 48.32 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.51 0.724 . . . . 31.42 110.705 175.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 106.65 111.45 3.58 Favored Glycine 0 C--N 1.336 0.546 0 N-CA-C 108.095 -2.002 . . . . 71.24 108.095 -167.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -71.84 125.23 26.64 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-N 117.458 0.629 . . . . 70.31 110.198 -172.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -138.81 -157.73 7.45 Favored Glycine 0 C--N 1.337 0.599 0 CA-C-N 116.085 -0.507 . . . . 72.24 112.727 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -119.78 165.22 14.84 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.945 0.898 . . . . 74.34 110.085 -173.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 10.5 tp -134.39 133.24 40.35 Favored 'General case' 0 C--O 1.219 -0.523 0 N-CA-C 107.683 -1.228 . . . . 75.52 107.683 -173.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 7.7 m-30 -116.13 147.89 40.88 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 108.063 -1.088 . . . . 73.41 108.063 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 78.2 mt -122.8 114.27 20.29 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 107.89 -1.152 . . . . 74.35 107.89 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -88.05 111.75 21.88 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 107.816 -1.179 . . . . 74.01 107.816 -178.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.556 HG11 HG23 ' A' ' 227' ' ' THR . 53.2 t -60.92 125.74 17.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 O-C-N 123.976 0.797 . . . . 74.13 109.891 178.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . 0.421 HH21 ' HB1' ' A' ' 229' ' ' ALA . 0.2 OUTLIER -112.01 124.28 52.07 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 106.658 -1.608 . . . . 75.25 106.658 174.667 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 51.3 mm -88.51 126.7 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 O-C-N 123.931 0.77 . . . . 63.33 109.527 -177.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 CA--C 1.558 1.278 0 N-CA-C 107.605 -1.257 . . . . 74.3 107.605 -177.07 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 57.9 ttp . . . . . 0 N--CA 1.484 1.24 0 N-CA-C 109.675 -0.491 . . . . 64.14 109.675 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.52 153.05 35.82 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.084 0.554 . . . . 55.34 110.416 172.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -105.17 -36.42 7.26 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.885 0.874 . . . . 74.33 111.165 -172.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -98.72 24.55 31.67 Favored Glycine 0 C--N 1.343 0.918 0 CA-C-N 115.972 -0.558 . . . . 70.03 113.07 -177.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -147.87 165.83 29.43 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.681 0.793 . . . . 64.33 109.978 178.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 78.9 t -109.19 146.07 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 123.598 0.759 . . . . 73.15 111.52 -169.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 44.5 mtm -101.97 -174.92 2.7 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.936 1.694 . . . . 73.51 110.059 -168.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 10.9 p -95.3 87.85 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.188 0 CA-C-O 123.195 1.474 . . . . 65.54 108.126 162.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.15 -3.76 8.5 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 114.053 -1.431 . . . . 75.03 110.106 -177.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.519 ' HA ' ' HB3' ' A' ' 233' ' ' LEU . 68.1 m -41.51 -66.52 0.33 Allowed 'General case' 0 C--N 1.353 0.741 0 C-N-CA 126.348 1.859 . . . . 62.54 113.454 -170.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -71.62 -43.26 66.48 Favored 'General case' 0 C--O 1.242 0.702 0 N-CA-C 108.422 -0.955 . . . . 64.24 108.422 178.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 57.12 67.1 2.39 Favored Glycine 0 C--N 1.359 1.824 0 O-C-N 124.683 1.239 . . . . 73.01 110.192 -176.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -62.29 88.14 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.007 0 CA-C-O 122.13 0.967 . . . . 73.32 112.725 -169.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 17.1 p -87.91 117.86 27.05 Favored 'General case' 0 C--O 1.245 0.821 0 N-CA-C 106.876 -1.527 . . . . 63.34 106.876 166.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -59.85 -29.77 68.51 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.531 0.732 . . . . 75.12 111.564 -173.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -97.49 129.65 44.65 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 107.758 -1.201 . . . . 70.45 107.758 163.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -68.66 -37.31 79.54 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.761 0.824 . . . . 74.53 111.255 -171.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -73.8 -8.37 77.25 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-N 115.053 -0.976 . . . . 42.33 113.688 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 34.8 m -82.84 146.7 28.77 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.357 0.663 . . . . 74.23 110.443 176.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 82.0 29.24 38.69 Favored Glycine 0 C--N 1.347 1.173 0 O-C-N 123.503 0.502 . . . . 63.41 112.601 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -86.92 9.72 70.98 Favored Glycine 0 C--N 1.349 1.299 0 C-N-CA 123.101 0.381 . . . . 62.43 113.195 177.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 39.8 p -66.7 157.98 31.29 Favored 'General case' 0 C--O 1.246 0.872 0 C-N-CA 123.862 0.865 . . . . 73.13 111.014 174.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -179.0 141.13 4.73 Favored Glycine 0 C--N 1.336 0.538 0 CA-C-N 116.062 -0.517 . . . . 51.42 112.462 -178.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -90.51 59.37 3.36 Favored Glycine 0 C--N 1.347 1.186 0 N-CA-C 111.948 -0.461 . . . . 64.43 111.948 178.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.411 ' HA ' ' HB2' ' A' ' 192' ' ' ASP . 49.3 m -63.08 109.19 1.42 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.142 0.577 . . . . 72.43 111.04 -177.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -154.79 157.86 27.89 Favored Glycine 0 C--O 1.243 0.68 0 N-CA-C 110.651 -0.979 . . . . 72.44 110.651 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -57.29 -36.41 75.76 Favored Glycine 0 C--N 1.349 1.251 0 O-C-N 124.284 0.638 . . . . 52.43 113.873 -174.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 43.5 m -135.61 42.84 2.65 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.279 0.632 . . . . 54.32 110.374 173.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -118.64 -66.8 1.04 Allowed 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 109.147 -0.686 . . . . 65.23 109.147 172.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.411 ' HB2' ' HA ' ' A' ' 187' ' ' SER . 31.0 t0 -75.23 154.78 37.36 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-N 114.717 -1.129 . . . . 72.03 108.849 -177.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 57.6 tp -148.88 132.41 16.73 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.305 -0.628 . . . . 72.43 109.305 -174.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -117.04 140.14 49.85 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.386 0.674 . . . . 65.44 109.213 174.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -147.8 158.19 43.91 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.69 0.796 . . . . 70.41 108.985 174.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 24.0 p -83.86 152.12 24.75 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 122.339 1.066 . . . . 74.45 112.292 167.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.656 HD13 ' HB2' ' A' ' 212' ' ' ALA . 33.3 tp -124.46 134.11 53.16 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 112.695 -2.048 . . . . 75.43 107.008 167.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -93.35 116.77 29.32 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.216 -1.031 . . . . 75.35 108.216 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.589 HG22 HG21 ' A' ' 210' ' ' VAL . 61.7 t -123.14 130.55 24.53 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 124.141 0.976 . . . . 75.12 109.174 178.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -66.09 143.63 72.55 Favored 'Trans proline' 0 C--N 1.373 1.861 0 C-N-CA 122.161 1.907 . . . . 62.43 111.015 167.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.432 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.47 -43.75 96.22 Favored Pre-proline 0 CA--C 1.566 1.568 0 CA-C-O 118.141 -0.933 . . . . 72.45 112.572 175.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 19.1 Cg_endo -57.65 -31.28 91.48 Favored 'Trans proline' 0 C--N 1.403 3.445 0 C-N-CA 121.876 1.717 . . . . 73.24 112.634 173.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -87.14 -25.64 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 N-CA-C 109.487 -0.56 . . . . 74.31 109.487 -178.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.4 ' HA ' HG22 ' A' ' 227' ' ' THR . . . -73.43 -37.95 65.7 Favored 'General case' 0 C--O 1.244 0.794 0 C-N-CA 122.983 0.513 . . . . 72.14 110.987 178.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 25.4 t -88.29 -38.65 11.93 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 125.368 1.467 . . . . 54.42 112.875 -177.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 79.5 t -98.5 -41.46 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 O-C-N 121.664 -0.647 . . . . 64.34 110.45 -176.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 126.98 152.73 8.09 Favored Glycine 0 N--CA 1.468 0.815 0 N-CA-C 111.287 -0.725 . . . . 53.33 111.287 -178.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.98 154.16 7.84 Favored Glycine 0 C--O 1.244 0.74 0 CA-C-N 116.978 0.389 . . . . 63.31 112.675 175.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.576 ' HD3' ' HB3' ' A' ' 220' ' ' GLU . 36.7 ttmt -85.95 131.29 34.32 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.572 0.749 . . . . 75.33 109.215 175.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.589 HG21 HG22 ' A' ' 199' ' ' VAL . 15.8 m -130.0 154.45 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 123.734 0.814 . . . . 61.2 109.633 -177.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.11 135.91 33.86 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.732 0.813 . . . . 74.25 109.274 -171.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.656 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -132.73 116.49 16.66 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 108.813 -0.81 . . . . 43.12 108.813 -176.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 36.7 tpp -80.78 109.87 15.75 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 107.819 -1.178 . . . . 60.12 107.819 173.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 64.8 p -113.22 -175.42 2.66 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.125 0.57 . . . . 74.42 110.533 -174.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.456 HD21 ' HD3' ' A' ' 241' ' ' PRO . 60.5 tp -47.67 -51.17 22.61 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 124.323 1.014 . . . . 54.24 110.888 169.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -72.31 -27.03 62.19 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 113.884 -1.507 . . . . 73.31 110.944 -174.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 129.73 -166.14 22.0 Favored Glycine 0 C--N 1.341 0.81 0 CA-C-N 116.133 -0.485 . . . . 74.14 112.007 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -62.67 130.76 30.76 Favored 'Trans proline' 0 CA--C 1.552 1.419 0 C-N-CA 122.649 2.233 . . . . 74.43 111.84 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.436 HG22 ' O ' ' A' ' 212' ' ' ALA . 20.6 m -139.61 160.3 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 123.061 0.544 . . . . 64.45 110.408 -172.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.576 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 40.2 mt-10 -110.88 111.82 23.23 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.738 0.815 . . . . 52.42 109.311 -175.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 60.4 t -120.56 102.96 13.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 124.25 1.02 . . . . 74.01 108.937 -173.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.54 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -76.72 117.2 18.1 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 109.98 -0.378 . . . . 71.54 109.98 175.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 35.5 m -87.85 152.02 50.64 Favored Pre-proline 0 N--CA 1.487 1.399 0 C-N-CA 122.996 0.518 . . . . 61.33 110.562 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . 0.565 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 35.5 Cg_endo -63.48 163.48 23.77 Favored 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 122.213 1.942 . . . . 74.25 113.034 176.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -80.63 29.8 0.52 Allowed 'Trans proline' 0 C--N 1.373 1.864 0 C-N-CA 123.354 2.702 . . . . 71.41 113.416 174.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 22.8 tpt180 -150.7 0.69 0.42 Allowed 'General case' 0 N--CA 1.474 0.738 0 O-C-N 122.113 -0.367 . . . . 55.21 111.839 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.63 HG23 HG11 ' A' ' 253' ' ' VAL . 0.7 OUTLIER -60.82 153.23 25.05 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.497 -0.557 . . . . 72.34 109.497 -169.058 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . 0.446 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 19.6 pt20 -132.73 162.11 32.28 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 123.403 0.681 . . . . 73.52 110.44 -171.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -61.13 111.46 1.72 Allowed 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 108.946 -0.761 . . . . 72.04 108.946 172.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.69 -1.62 21.68 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-N 115.087 -0.961 . . . . 72.23 112.501 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -68.79 127.08 31.82 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.445 0.698 . . . . 70.1 109.494 -173.971 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -98.21 97.1 8.56 Favored 'General case' 0 C--O 1.244 0.767 0 C-N-CA 123.413 0.685 . . . . 74.32 109.309 -170.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.519 ' HB3' ' HA ' ' A' ' 172' ' ' SER . 24.3 mt -80.23 99.24 7.73 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 107.504 -1.295 . . . . 71.33 107.504 -178.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 2.3 ppt_? -81.51 117.39 21.88 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.761 0.825 . . . . 74.13 112.579 -174.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.456 ' HB2' ' O ' ' A' ' 249' ' ' LEU . 7.6 mp -110.18 126.98 54.67 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 107.035 -1.468 . . . . 45.21 107.035 174.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -103.44 118.06 35.87 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.715 0.806 . . . . 75.21 111.024 -173.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 78.97 22.4 66.05 Favored Glycine 0 C--N 1.347 1.192 0 O-C-N 123.882 0.739 . . . . 13.14 112.304 -178.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -120.5 19.33 12.01 Favored 'General case' 0 C--N 1.347 0.486 0 C-N-CA 123.462 0.705 . . . . 62.43 109.984 -178.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -95.69 -136.61 8.77 Favored Glycine 0 C--N 1.35 1.361 0 N-CA-C 111.06 -0.816 . . . . 64.11 111.06 177.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 6.3 m-30 -68.28 148.27 98.24 Favored Pre-proline 0 CA--C 1.551 0.988 0 CA-C-N 117.559 0.68 . . . . 65.54 111.429 -178.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.456 ' HD3' HD21 ' A' ' 215' ' ' LEU . 65.7 Cg_endo -67.01 172.33 9.96 Favored 'Trans proline' 0 C--N 1.38 2.19 0 C-N-CA 123.399 2.733 . . . . 65.21 112.416 -177.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.451 ' N ' ' HD2' ' A' ' 243' ' ' PRO . . . -66.34 -38.29 93.52 Favored Glycine 0 CA--C 1.545 1.941 0 CA-C-O 117.92 -1.489 . . . . 64.44 114.163 -176.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 242' ' ' GLY . 9.7 Cg_endo -53.19 -35.28 72.83 Favored 'Trans proline' 0 C--N 1.392 2.867 0 CA-C-N 120.892 2.346 . . . . 74.14 113.351 167.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -85.45 -25.11 27.13 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.079 0.552 . . . . 43.21 110.464 176.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 112.52 114.19 3.29 Favored Glycine 0 C--N 1.343 0.962 0 N-CA-C 109.866 -1.294 . . . . 71.22 109.866 -169.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 32.2 ttm180 -66.22 128.44 36.13 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 117.389 0.594 . . . . 74.14 110.591 -176.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -148.1 -156.48 7.08 Favored Glycine 0 C--N 1.336 0.534 0 CA-C-N 115.657 -0.702 . . . . 72.32 112.48 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -118.58 165.86 13.43 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.214 0.605 . . . . 73.53 109.373 -171.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.456 ' O ' ' HB2' ' A' ' 235' ' ' LEU . 11.3 tp -133.83 132.07 39.97 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 107.31 -1.367 . . . . 64.41 107.31 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 9.8 m-30 -122.73 147.22 46.74 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.127 -1.064 . . . . 72.1 108.127 -178.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.413 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 86.0 mt -123.08 115.92 22.63 Favored 'General case' 0 C--O 1.222 -0.364 0 N-CA-C 108.327 -0.99 . . . . 53.11 108.327 -176.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -88.39 111.62 21.96 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 107.574 -1.269 . . . . 73.42 107.574 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.63 HG11 HG23 ' A' ' 227' ' ' THR . 55.6 t -61.35 128.35 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 CA-C-N 115.126 -0.943 . . . . 74.31 110.088 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 8.1 mmt180 -119.89 123.44 43.6 Favored 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 107.809 -1.182 . . . . 70.45 107.809 177.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 47.9 mm -82.76 122.11 36.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 114.718 -1.128 . . . . 65.45 109.945 -174.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.7 t . . . . . 0 CA--C 1.557 1.233 0 N-CA-C 107.229 -1.397 . . . . 72.53 107.229 -179.182 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 27.3 ttt . . . . . 0 N--CA 1.479 0.997 0 N-CA-C 109.039 -0.726 . . . . 71.32 109.039 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.495 ' HB2' ' HB3' ' A' ' 167' ' ' ALA . 0.0 OUTLIER -65.8 93.81 0.19 Allowed 'General case' 0 CA--C 1.557 1.25 0 C-N-CA 123.53 0.732 . . . . 74.15 111.559 -179.925 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -72.71 -24.93 61.06 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.444 0.698 . . . . 72.32 110.987 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -98.69 25.59 27.39 Favored Glycine 0 C--N 1.349 1.279 0 CA-C-N 116.158 -0.474 . . . . 64.1 112.63 176.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.495 ' HB3' ' HB2' ' A' ' 164' ' ' LYS . . . -152.66 173.2 15.53 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.939 0.896 . . . . 63.23 108.876 173.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.577 HG11 HG22 ' A' ' 221' ' ' VAL . 53.2 t -109.41 151.07 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.107 0.563 . . . . 72.32 110.863 -172.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 50.2 mtm -99.43 -176.47 3.3 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 125.8 1.64 . . . . 73.3 110.019 -169.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 8.8 p -99.97 86.48 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 CA-C-O 123.149 1.452 . . . . 74.52 107.94 163.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . 0.503 ' HG3' ' HA ' ' A' ' 235' ' ' LEU . 0.0 OUTLIER -122.63 -5.36 8.67 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 113.675 -1.602 . . . . 63.52 110.041 -176.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.539 ' HA ' ' HB3' ' A' ' 233' ' ' LEU . 69.4 m -40.93 -63.33 0.68 Allowed 'General case' 0 C--N 1.35 0.608 0 C-N-CA 126.818 2.047 . . . . 52.44 114.553 -168.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . 0.598 ' HB2' ' HB3' ' A' ' 224' ' ' PRO . 67.3 t80 -59.03 -35.76 73.83 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.224 0.535 . . . . 64.04 110.9 -176.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 106.94 63.82 0.59 Allowed Glycine 0 N--CA 1.439 -1.114 0 N-CA-C 108.032 -2.027 . . . . 71.12 108.032 -167.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -60.62 98.22 0.06 Allowed 'General case' 0 C--O 1.241 0.62 0 C-N-CA 124.493 1.117 . . . . 71.34 110.023 -176.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 48.5 m -120.87 120.79 36.55 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.843 0.857 . . . . 61.32 111.01 -175.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -78.18 -8.77 58.72 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 109.259 -0.645 . . . . 74.34 109.259 160.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -75.4 174.07 10.09 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.525 1.53 . . . . 74.13 110.777 165.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -56.11 -37.99 70.16 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.464 0.706 . . . . 62.12 111.449 172.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 160.63 54.6 0.01 OUTLIER Glycine 0 C--N 1.338 0.677 0 CA-C-N 115.256 -0.884 . . . . 72.21 111.401 176.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 14.6 m -93.83 117.32 29.93 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.281 0.632 . . . . 61.51 110.845 -173.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -121.52 -72.69 0.3 Allowed Glycine 0 C--N 1.349 1.285 0 N-CA-C 111.633 -0.587 . . . . 54.45 111.633 177.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 72.09 174.0 21.67 Favored Glycine 0 C--N 1.351 1.372 0 CA-C-O 121.375 0.431 . . . . 71.11 114.055 175.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.597 ' HB3' ' HB2' ' A' ' 187' ' ' SER . 73.2 m -113.38 126.96 55.93 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.97 0.908 . . . . 71.13 109.838 177.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -85.1 -75.66 1.22 Allowed Glycine 0 C--N 1.344 0.999 0 O-C-N 123.631 0.582 . . . . 74.34 111.87 -176.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 191' ' ' GLN . . . -94.32 52.95 2.12 Favored Glycine 0 C--N 1.342 0.877 0 N-CA-C 111.728 -0.549 . . . . 71.5 111.728 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.597 ' HB2' ' HB3' ' A' ' 184' ' ' SER . 23.1 t -77.23 119.3 20.7 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 122.424 0.29 . . . . 70.13 110.409 -177.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -167.65 -131.22 1.25 Allowed Glycine 0 C--N 1.342 0.872 0 N-CA-C 111.865 -0.494 . . . . 53.21 111.865 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -83.33 -56.96 2.57 Favored Glycine 0 C--N 1.347 1.167 0 N-CA-C 112.14 -0.384 . . . . 42.24 112.14 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 17.7 m -152.93 60.69 0.79 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.144 0.978 . . . . 73.4 109.182 -175.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.479 ' HB2' ' O ' ' A' ' 186' ' ' GLY . 20.8 mt-30 -119.17 -52.47 2.29 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 107.213 -1.403 . . . . 75.12 107.213 172.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 24.5 p-10 -74.21 172.67 11.36 Favored 'General case' 0 C--O 1.245 0.843 0 CA-C-N 113.425 -1.716 . . . . 63.12 109.724 167.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 33.0 tp -152.06 140.39 20.48 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.847 0.356 . . . . 72.13 110.324 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -115.46 139.69 49.81 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.269 1.028 . . . . 71.31 108.632 168.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.424 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -147.92 158.13 43.89 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.097 -1.075 . . . . 71.24 108.097 168.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 32.3 p -82.89 153.78 24.94 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 122.146 0.974 . . . . 54.34 112.585 167.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.598 HD13 ' HB2' ' A' ' 212' ' ' ALA . 25.8 tp -124.23 132.01 53.57 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 112.88 -1.964 . . . . 75.54 107.09 164.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -94.45 116.78 29.19 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.827 -0.805 . . . . 64.33 108.827 177.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.558 HG22 HG21 ' A' ' 210' ' ' VAL . 57.4 t -117.93 134.62 23.27 Favored Pre-proline 0 CA--C 1.549 0.923 0 CA-C-N 114.573 -1.194 . . . . 64.11 109.214 -177.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -67.5 146.7 75.17 Favored 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 122.185 1.923 . . . . 75.43 111.121 169.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.443 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.66 -45.76 98.58 Favored Pre-proline 0 CA--C 1.567 1.612 0 C-N-CA 123.65 0.78 . . . . 75.4 112.568 174.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 28.0 Cg_endo -60.73 -31.41 91.9 Favored 'Trans proline' 0 C--N 1.393 2.887 0 C-N-CA 122.202 1.934 . . . . 60.11 112.98 176.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -86.19 -24.47 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 109.441 -0.577 . . . . 73.11 109.441 -177.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -73.31 -37.7 66.09 Favored 'General case' 0 C--O 1.244 0.78 0 C-N-CA 123.053 0.541 . . . . 42.43 111.417 178.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 24.9 t -88.99 -36.66 9.09 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 CA-C-N 114.348 -1.296 . . . . 71.3 113.506 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 55.7 t -96.92 -42.3 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 O-C-N 121.486 -0.759 . . . . 64.24 111.007 -177.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 123.36 152.87 8.59 Favored Glycine 0 C--N 1.341 0.861 0 N-CA-C 110.727 -0.949 . . . . 55.03 110.727 -175.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.68 151.83 6.74 Favored Glycine 0 C--O 1.246 0.849 0 N-CA-C 111.578 -0.609 . . . . 75.2 111.578 177.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.623 ' HD3' ' HB3' ' A' ' 220' ' ' GLU . 4.2 ttmp? -84.2 130.2 34.84 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 108.667 -0.864 . . . . 73.21 108.667 174.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.558 HG21 HG22 ' A' ' 199' ' ' VAL . 15.8 m -129.9 152.24 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.383 1.073 . . . . 50.34 108.301 178.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 4.8 tmm_? -95.37 141.93 28.35 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 108.466 -0.939 . . . . 72.23 108.466 -172.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.598 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -132.14 124.92 30.06 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.959 0.903 . . . . 63.32 109.065 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 39.8 tpp -79.86 109.98 14.79 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 108.243 -1.021 . . . . 75.11 108.243 171.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 71.0 p -117.96 -175.59 2.87 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.838 0.855 . . . . 75.21 110.684 -177.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 63.0 tp -42.1 -50.65 4.72 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.809 1.244 . . . . 65.31 112.345 174.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -71.57 -27.08 62.91 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 114.552 -1.203 . . . . 74.55 111.595 -173.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 127.9 -163.35 21.58 Favored Glycine 0 C--N 1.34 0.791 0 N-CA-C 110.849 -0.9 . . . . 71.02 110.849 -170.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -65.49 129.84 23.57 Favored 'Trans proline' 0 C--N 1.371 1.741 0 C-N-CA 122.301 2.001 . . . . 75.11 111.594 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.442 HG22 ' O ' ' A' ' 212' ' ' ALA . 27.6 m -134.83 162.04 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 123.456 0.703 . . . . 60.22 111.041 -176.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.623 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 46.6 mt-10 -110.93 113.04 25.31 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.124 0.97 . . . . 75.05 109.77 -173.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.577 HG22 HG11 ' A' ' 168' ' ' VAL . 48.3 t -123.42 102.92 12.18 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 124.429 1.091 . . . . 72.31 109.815 -172.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.6 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -78.96 116.94 19.58 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 122.604 0.361 . . . . 52.22 110.505 175.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 35.3 m -88.79 152.44 48.87 Favored Pre-proline 0 N--CA 1.488 1.446 0 C-N-CA 123.252 0.621 . . . . 71.13 111.478 -175.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . 0.598 ' HB3' ' HB2' ' A' ' 173' ' ' TYR . 36.9 Cg_endo -63.13 166.36 14.77 Favored 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 122.838 2.359 . . . . 72.13 113.147 178.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -84.72 30.19 0.52 Allowed 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 122.838 2.359 . . . . 60.51 112.609 174.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -147.92 -0.72 0.6 Allowed 'General case' 0 N--CA 1.475 0.823 0 O-C-N 121.635 -0.666 . . . . 74.5 111.955 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.58 HG23 HG11 ' A' ' 253' ' ' VAL . 0.6 OUTLIER -61.18 152.53 28.44 Favored 'General case' 0 CA--C 1.567 1.633 0 N-CA-C 109.74 -0.467 . . . . 52.42 109.74 -167.482 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . 0.447 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 20.2 pt20 -135.05 161.47 35.21 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.456 0.703 . . . . 53.34 109.665 -173.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -61.33 111.23 1.68 Allowed 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 109.066 -0.716 . . . . 74.14 109.066 175.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 116.3 -0.47 20.68 Favored Glycine 0 N--CA 1.468 0.806 0 CA-C-N 114.783 -1.099 . . . . 74.34 112.787 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.447 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -70.92 127.36 32.32 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.83 0.852 . . . . 73.13 109.7 -175.671 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm -97.62 99.22 10.6 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 109.324 -0.621 . . . . 60.23 109.324 -173.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.539 ' HB3' ' HA ' ' A' ' 172' ' ' SER . 22.8 mt -79.32 98.49 6.71 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.051 -1.463 . . . . 72.14 107.051 179.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 6.3 ppt_? -81.94 114.13 20.33 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-O 121.456 0.646 . . . . 74.13 111.972 -176.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.503 ' HA ' ' HG3' ' A' ' 171' ' ' MET . 7.2 mp -99.39 129.11 45.56 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 106.63 -1.619 . . . . 63.44 106.63 173.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 27.8 tptt -101.7 115.88 31.51 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 117.892 0.315 . . . . 73.45 110.721 -171.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.484 ' H ' ' HB3' ' A' ' 248' ' ' ASP . . . 78.12 29.38 53.98 Favored Glycine 0 C--N 1.344 1.019 0 O-C-N 123.832 0.708 . . . . 40.41 112.872 -178.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -119.31 20.05 12.64 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.841 0.856 . . . . 61.31 110.959 -177.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -95.95 -141.28 11.75 Favored Glycine 0 C--N 1.349 1.28 0 N-CA-C 110.453 -1.059 . . . . 54.2 110.453 178.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 7.2 m-30 -68.63 148.85 98.09 Favored Pre-proline 0 CA--C 1.548 0.881 0 CA-C-N 117.221 0.511 . . . . 63.23 111.592 -175.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -65.59 170.91 10.34 Favored 'Trans proline' 0 C--N 1.384 2.409 0 C-N-CA 123.209 2.606 . . . . 73.04 112.179 177.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -67.28 -39.65 92.07 Favored Glycine 0 CA--C 1.546 1.98 0 CA-C-O 118.719 -1.045 . . . . 33.14 114.186 -175.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_exo -50.39 -39.33 53.96 Favored 'Trans proline' 0 C--N 1.384 2.406 0 C-N-CA 122.601 2.201 . . . . 74.1 113.789 166.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -81.93 -24.22 35.72 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.045 0.538 . . . . 74.53 110.55 177.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 111.36 112.62 3.32 Favored Glycine 0 C--N 1.34 0.781 0 N-CA-C 109.112 -1.595 . . . . 62.24 109.112 -170.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -70.51 129.01 38.11 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 109.091 -0.707 . . . . 75.22 109.091 -172.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -148.9 -161.54 9.74 Favored Glycine 0 C--N 1.341 0.848 0 O-C-N 123.451 0.469 . . . . 72.21 112.751 173.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . 0.484 ' HB3' ' H ' ' A' ' 237' ' ' GLY . 15.8 p-10 -123.9 164.24 19.66 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.562 1.145 . . . . 63.54 110.782 -176.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 8.9 tp -132.0 136.28 47.16 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 109.27 -0.641 . . . . 64.02 109.27 -166.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -121.64 148.11 44.98 Favored 'General case' 0 C--O 1.247 0.939 0 N-CA-C 108.164 -1.05 . . . . 74.24 108.164 -176.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.424 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 71.5 mt -123.59 113.96 19.39 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 108.891 -0.781 . . . . 74.41 108.891 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -88.45 111.79 22.2 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.223 -1.028 . . . . 72.45 108.223 -177.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.58 HG11 HG23 ' A' ' 227' ' ' THR . 55.4 t -61.36 130.18 25.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 114.862 -1.063 . . . . 65.35 110.404 178.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 37.3 mtm180 -116.84 125.47 51.61 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 106.578 -1.638 . . . . 72.32 106.578 169.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 49.8 mm -84.27 127.5 39.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 108.727 -0.842 . . . . 43.12 108.727 -178.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.2 t . . . . . 0 CA--C 1.552 1.049 0 N-CA-C 108.369 -0.975 . . . . 70.3 108.369 -177.165 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 26.1 ptt? . . . . . 0 N--CA 1.474 0.748 0 N-CA-C 109.823 -0.436 . . . . 74.34 109.823 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.53 84.69 3.91 Favored 'General case' 0 CA--C 1.552 1.027 0 CA-C-O 121.915 0.864 . . . . 75.43 110.133 175.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -65.28 -15.0 62.05 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.903 1.281 . . . . 64.13 112.477 178.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -98.16 17.17 59.04 Favored Glycine 0 C--N 1.349 1.293 0 CA-C-N 116.588 -0.278 . . . . 72.1 112.575 175.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -153.13 171.25 18.74 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.249 1.02 . . . . 71.4 109.506 178.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 53.0 t -112.52 153.04 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-O 121.529 0.681 . . . . 74.14 111.403 -177.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 46.6 mtm -100.66 -176.83 3.3 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.282 1.833 . . . . 73.13 109.271 -173.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 11.2 p -98.97 88.74 1.68 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.321 0 CA-C-O 123.092 1.425 . . . . 72.41 107.758 163.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . 0.41 ' HG3' ' HA ' ' A' ' 235' ' ' LEU . 0.0 OUTLIER -123.92 -4.46 8.05 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 113.767 -1.56 . . . . 61.21 110.593 -172.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.532 ' HB3' HD22 ' A' ' 233' ' ' LEU . 70.3 m -40.7 -64.38 0.54 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.421 1.889 . . . . 75.5 114.187 -173.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . 0.624 ' HB2' ' HG3' ' A' ' 224' ' ' PRO . 45.2 t80 -69.64 -50.02 48.2 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 108.321 -0.992 . . . . 72.13 108.321 -178.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 39.6 48.73 3.11 Favored Glycine 0 C--N 1.364 2.132 0 O-C-N 125.491 1.744 . . . . 33.33 115.186 170.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 -75.44 -61.12 2.02 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 116.942 0.371 . . . . 51.24 110.25 -176.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 31.0 m -122.86 83.24 2.09 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.281 0.562 . . . . 73.44 109.675 -177.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -98.37 -28.01 13.84 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 107.925 -1.139 . . . . 65.25 107.925 168.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -80.3 172.71 13.41 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.613 1.565 . . . . 40.42 109.208 172.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -52.93 -36.47 59.73 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 123.551 0.741 . . . . 72.31 112.257 178.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -126.1 -88.79 0.71 Allowed Glycine 0 N--CA 1.454 -0.115 0 N-CA-C 109.044 -1.623 . . . . 43.03 109.044 170.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 42.3 t -170.43 114.46 0.46 Allowed 'General case' 0 C--O 1.242 0.665 0 N-CA-C 108.601 -0.889 . . . . 62.44 108.601 174.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -94.98 -58.16 1.18 Allowed Glycine 0 C--N 1.339 0.719 0 N-CA-C 111.313 -0.715 . . . . 73.13 111.313 174.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 60.69 42.87 99.51 Favored Glycine 0 C--N 1.35 1.316 0 N-CA-C 111.393 -0.683 . . . . 63.23 111.393 -171.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 59.0 m -62.48 110.98 1.85 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.697 0.799 . . . . 34.43 111.703 -172.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -86.27 128.53 8.9 Favored Glycine 0 C--N 1.34 0.797 0 CA-C-N 115.347 -0.842 . . . . 75.42 111.576 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -89.33 61.16 3.64 Favored Glycine 0 C--N 1.341 0.826 0 N-CA-C 111.669 -0.572 . . . . 74.32 111.669 178.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 30.3 p -68.32 132.93 47.96 Favored 'General case' 0 C--O 1.244 0.808 0 C-N-CA 123.223 0.609 . . . . 65.42 110.568 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -154.54 -164.65 13.09 Favored Glycine 0 C--O 1.242 0.618 0 CA-C-N 115.467 -0.788 . . . . 74.11 111.279 178.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -57.8 -42.31 94.46 Favored Glycine 0 C--N 1.348 1.219 0 N-CA-C 111.363 -0.695 . . . . 70.2 111.363 175.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 10.5 t -173.41 70.04 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.639 1.175 . . . . 75.0 107.865 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.403 ' HG2' ' HA3' ' A' ' 245' ' ' GLY . 73.4 mt-30 -116.71 -52.25 2.55 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 121.934 0.873 . . . . 62.22 109.625 -177.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -74.33 169.59 17.34 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 114.209 -1.359 . . . . 62.42 110.645 172.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 57.7 tp -150.63 141.12 22.48 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.995 0.518 . . . . 72.25 109.803 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -116.6 138.68 51.24 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 123.996 0.918 . . . . 74.44 109.231 172.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -149.32 159.23 44.45 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 108.703 -0.851 . . . . 33.45 108.703 169.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 31.1 p -85.88 153.07 22.48 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.931 0.872 . . . . 74.33 112.322 166.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.638 HD13 ' HB2' ' A' ' 212' ' ' ALA . 31.6 tp -124.58 132.76 53.43 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 113.086 -1.87 . . . . 75.13 107.245 166.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -95.1 113.26 24.93 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.953 0.882 . . . . 73.51 109.467 -176.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.582 HG22 HG21 ' A' ' 210' ' ' VAL . 60.9 t -118.62 132.09 24.0 Favored Pre-proline 0 CA--C 1.55 0.966 0 CA-C-N 114.711 -1.131 . . . . 55.3 109.967 -177.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -66.66 144.64 72.91 Favored 'Trans proline' 0 C--N 1.37 1.691 0 C-N-CA 122.281 1.987 . . . . 73.52 111.298 166.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.434 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.08 -43.75 95.45 Favored Pre-proline 0 CA--C 1.561 1.379 0 C-N-CA 124.245 1.018 . . . . 63.42 112.586 173.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.434 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 18.8 Cg_endo -57.89 -33.01 96.5 Favored 'Trans proline' 0 C--N 1.397 3.127 0 C-N-CA 121.681 1.588 . . . . 61.32 112.702 173.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -86.42 -23.69 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 N-CA-C 109.303 -0.628 . . . . 74.33 109.303 -177.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -76.0 -36.87 59.0 Favored 'General case' 0 C--O 1.248 0.982 0 C-N-CA 123.094 0.558 . . . . 24.14 111.691 178.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 31.9 t -88.89 -36.51 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 125.161 1.384 . . . . 71.42 112.555 -179.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.409 ' HB ' ' O ' ' A' ' 202' ' ' PRO . 60.3 t -98.21 -42.14 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 O-C-N 121.659 -0.651 . . . . 63.22 109.981 -176.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 122.85 153.86 8.91 Favored Glycine 0 C--N 1.342 0.901 0 N-CA-C 110.666 -0.974 . . . . 51.52 110.666 -175.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.81 149.32 5.77 Favored Glycine 0 C--O 1.241 0.567 0 N-CA-C 112.058 -0.417 . . . . 70.45 112.058 175.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.618 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 36.8 ttmt -85.24 128.46 34.69 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.491 -0.559 . . . . 74.5 109.491 176.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.582 HG21 HG22 ' A' ' 199' ' ' VAL . 15.4 m -129.81 149.51 33.7 Favored 'Isoleucine or valine' 0 C--O 1.245 0.847 0 N-CA-C 108.036 -1.098 . . . . 75.11 108.036 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 7.0 tmm_? -96.78 143.87 27.3 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.169 0.587 . . . . 73.22 109.716 -170.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.638 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -132.28 124.58 29.15 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.551 0.74 . . . . 52.02 109.163 -177.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 36.1 tpp -79.84 109.49 14.31 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 108.155 -1.054 . . . . 63.13 108.155 174.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 53.2 p -111.24 -177.59 3.24 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 123.324 0.65 . . . . 74.33 109.924 -176.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.571 HD21 ' HD3' ' A' ' 241' ' ' PRO . 62.1 tp -46.56 -52.82 12.65 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.292 1.037 . . . . 70.42 111.433 174.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -73.46 -27.69 61.54 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 113.674 -1.603 . . . . 72.31 111.554 -173.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 138.5 -166.99 25.16 Favored Glycine 0 C--N 1.35 1.308 0 CA-C-O 119.693 -0.504 . . . . 54.32 112.437 -176.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -65.47 130.1 24.27 Favored 'Trans proline' 0 C--N 1.372 1.768 0 C-N-CA 122.454 2.103 . . . . 70.1 111.56 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 22.8 m -129.16 158.24 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 123.222 0.609 . . . . 74.24 110.055 -179.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.521 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 46.6 mt-10 -112.8 111.95 23.09 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.708 -0.849 . . . . 71.41 108.708 -174.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 99.3 t -124.84 104.13 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.207 1.003 . . . . 60.01 110.542 -169.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.618 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -77.31 117.61 18.98 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 122.658 0.383 . . . . 71.25 110.373 175.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.453 HG11 HG21 ' A' ' 199' ' ' VAL . 27.7 m -85.81 154.4 58.43 Favored Pre-proline 0 N--CA 1.479 1.012 0 C-N-CA 123.433 0.693 . . . . 75.32 111.329 -175.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . 0.624 ' HG3' ' HB2' ' A' ' 173' ' ' TYR . 36.7 Cg_exo -59.17 161.98 15.08 Favored 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 122.669 2.246 . . . . 70.5 113.231 178.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -89.28 25.99 0.57 Allowed 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 123.231 2.62 . . . . 74.2 112.632 173.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 14.4 mmt180 -146.04 0.76 0.84 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.74 0.816 . . . . 72.31 111.384 176.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.531 HG23 HG11 ' A' ' 253' ' ' VAL . 0.7 OUTLIER -62.05 153.38 29.9 Favored 'General case' 0 CA--C 1.568 1.647 0 O-C-N 123.382 0.426 . . . . 53.32 110.207 -167.56 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -133.8 162.03 33.1 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.634 0.774 . . . . 71.52 110.237 -176.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -60.23 110.63 1.28 Allowed 'General case' 0 C--N 1.351 0.672 0 O-C-N 123.446 0.466 . . . . 33.03 109.909 177.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 116.1 1.14 20.76 Favored Glycine 0 CA--C 1.525 0.702 0 CA-C-N 115.158 -0.928 . . . . 65.54 111.984 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.83 125.39 26.61 Favored 'General case' 0 C--N 1.359 1.004 0 N-CA-C 108.683 -0.858 . . . . 75.32 108.683 -177.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -97.39 97.56 9.22 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.35 -0.981 . . . . 74.01 108.35 -171.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.532 HD22 ' HB3' ' A' ' 172' ' ' SER . 25.0 mt -78.33 97.63 5.66 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 106.429 -1.693 . . . . 52.14 106.429 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 7.8 ppt_? -81.81 125.07 30.23 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 122.909 0.483 . . . . 74.43 110.862 -177.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.41 ' HA ' ' HG3' ' A' ' 171' ' ' MET . 8.9 mp -108.78 130.05 55.38 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 106.697 -1.594 . . . . 75.44 106.697 175.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.51 113.62 25.21 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 122.734 0.413 . . . . 53.31 109.905 -170.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 76.71 24.69 66.71 Favored Glycine 0 C--N 1.343 0.954 0 O-C-N 123.596 0.56 . . . . 53.14 113.644 177.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -117.86 23.79 11.45 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.24 0.616 . . . . 74.4 110.547 -176.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -96.43 -131.21 6.74 Favored Glycine 0 C--N 1.346 1.089 0 CA-C-O 119.62 -0.545 . . . . 74.0 111.882 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 6.7 m-30 -72.15 154.68 92.19 Favored Pre-proline 0 CA--C 1.55 0.953 0 N-CA-C 112.746 0.647 . . . . 71.43 112.746 -176.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.571 ' HD3' HD21 ' A' ' 215' ' ' LEU . 73.7 Cg_endo -69.7 172.43 12.59 Favored 'Trans proline' 0 C--N 1.389 2.706 0 C-N-CA 123.428 2.752 . . . . 72.5 112.265 -179.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.411 ' N ' ' HD2' ' A' ' 243' ' ' PRO . . . -68.07 -39.33 88.81 Favored Glycine 0 CA--C 1.544 1.877 0 CA-C-O 118.257 -1.302 . . . . 50.15 114.395 -175.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . 0.411 ' HD2' ' N ' ' A' ' 242' ' ' GLY . 9.7 Cg_endo -55.14 -36.39 92.96 Favored 'Trans proline' 0 C--N 1.385 2.448 0 CA-C-N 120.725 2.263 . . . . 72.32 113.677 167.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -79.01 -24.04 43.97 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.053 0.541 . . . . 61.13 110.39 174.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . 0.403 ' HA3' ' HG2' ' A' ' 191' ' ' GLN . . . 107.69 112.38 3.62 Favored Glycine 0 C--N 1.344 1.023 0 N-CA-C 108.752 -1.739 . . . . 72.23 108.752 -169.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -69.7 122.18 18.64 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.614 -0.884 . . . . 75.24 108.614 -173.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -137.5 -159.51 8.24 Favored Glycine 0 C--N 1.342 0.878 0 O-C-N 123.551 0.532 . . . . 32.11 112.907 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -121.44 163.95 17.93 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.099 1.36 . . . . 72.14 110.549 -173.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 9.8 tp -134.89 134.21 40.45 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 109.628 -0.508 . . . . 71.05 109.628 -169.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -115.09 146.74 41.01 Favored 'General case' 0 C--O 1.244 0.766 0 N-CA-C 108.931 -0.766 . . . . 75.33 108.931 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 82.5 mt -123.86 113.81 19.02 Favored 'General case' 0 C--O 1.224 -0.241 0 N-CA-C 107.557 -1.275 . . . . 74.32 107.557 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -91.03 111.86 23.51 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.251 -1.018 . . . . 64.45 108.251 -173.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.531 HG11 HG23 ' A' ' 227' ' ' THR . 53.8 t -60.04 126.75 18.34 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.423 0 O-C-N 124.238 0.961 . . . . 62.13 109.811 179.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 16.2 mtt180 -116.24 125.24 51.94 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.012 -1.477 . . . . 75.34 107.012 172.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 49.6 mm -86.33 123.06 39.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 108.718 -0.845 . . . . 71.42 108.718 -178.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.3 t . . . . . 0 CA--C 1.555 1.144 0 N-CA-C 109.271 -0.64 . . . . 65.41 109.271 -173.558 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 25.3 ptp . . . . . 0 N--CA 1.477 0.889 0 N-CA-C 110.229 -0.286 . . . . 73.12 110.229 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.43 149.23 22.33 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.278 0.631 . . . . 64.12 109.739 175.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -122.16 -37.82 2.78 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.18 0.992 . . . . 75.22 110.523 -173.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -97.68 33.55 5.8 Favored Glycine 0 C--N 1.344 0.988 0 CA-C-N 115.997 -0.547 . . . . 70.15 111.787 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -150.85 168.49 24.3 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 123.739 0.816 . . . . 73.45 110.37 -176.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.431 HG11 HG22 ' A' ' 221' ' ' VAL . 53.0 t -111.98 152.87 13.75 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 C-N-CA 124.734 1.213 . . . . 63.31 110.858 -170.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 42.1 mtm -99.32 -176.91 3.43 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.825 1.65 . . . . 71.31 109.032 -171.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 14.5 p -95.57 86.5 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 CA-C-O 123.457 1.599 . . . . 61.53 107.585 163.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . 0.529 ' HG3' ' HA ' ' A' ' 235' ' ' LEU . 0.0 OUTLIER -122.62 -4.2 8.74 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 113.348 -1.751 . . . . 71.33 109.728 -175.912 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.488 ' HA ' ' HB3' ' A' ' 233' ' ' LEU . 66.3 m -41.95 -66.52 0.34 Allowed 'General case' 0 C--N 1.353 0.729 0 C-N-CA 126.202 1.801 . . . . 43.2 112.933 -169.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -70.46 -43.01 70.72 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 108.925 -0.769 . . . . 64.04 108.925 -176.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 47.42 46.21 22.61 Favored Glycine 0 C--N 1.365 2.147 0 O-C-N 124.638 1.211 . . . . 23.41 114.041 172.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -163.26 139.86 7.2 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.267 1.027 . . . . 70.12 108.864 -170.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 50.2 m -71.5 122.89 21.24 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 107.359 -1.348 . . . . 44.3 107.359 167.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -17.85 -46.97 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 128.141 2.576 . . . . 73.14 117.51 -166.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -63.98 142.05 58.55 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 118.471 0.578 . . . . 72.31 109.972 175.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -57.03 -38.26 72.91 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 114.309 1.226 . . . . 73.53 114.309 -159.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -56.15 100.73 0.11 Allowed Glycine 0 N--CA 1.475 1.242 0 O-C-N 123.846 0.716 . . . . 60.1 112.881 -177.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 51.1 m -89.86 176.33 6.87 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.002 0.921 . . . . 73.24 112.019 -173.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -81.48 -144.9 4.54 Favored Glycine 0 C--N 1.349 1.263 0 CA-C-N 115.075 -0.966 . . . . 74.34 112.323 176.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -114.31 -152.84 10.65 Favored Glycine 0 C--N 1.343 0.95 0 CA-C-N 117.085 0.443 . . . . 71.33 113.23 -176.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 47.0 t -142.61 163.78 31.91 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.423 1.089 . . . . 62.21 109.267 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -97.11 -56.97 1.1 Allowed Glycine 0 C--N 1.348 1.207 0 CA-C-N 116.592 -0.276 . . . . 53.14 113.234 -176.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.4 ' HA3' ' HA2' ' A' ' 247' ' ' GLY . . . -131.29 105.96 0.65 Allowed Glycine 0 C--N 1.341 0.851 0 N-CA-C 111.308 -0.717 . . . . 61.11 111.308 -179.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.513 ' HA ' ' HB3' ' A' ' 192' ' ' ASP . 17.1 t -149.44 153.69 37.69 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 122.626 0.37 . . . . 71.14 110.712 -176.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 88.02 -33.5 4.01 Favored Glycine 0 C--N 1.353 1.491 0 CA-C-N 116.062 -0.517 . . . . 33.11 113.931 177.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -81.34 12.31 39.62 Favored Glycine 0 C--N 1.35 1.338 0 CA-C-O 119.235 -0.758 . . . . 63.4 114.268 -176.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 13.0 t 67.67 21.35 9.35 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.932 1.293 . . . . 73.21 110.989 -176.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -102.58 -23.04 13.91 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.349 1.46 . . . . 72.21 108.579 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.513 ' HB3' ' HA ' ' A' ' 187' ' ' SER . 30.2 p-10 -75.26 175.74 8.04 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-N 113.869 -1.514 . . . . 71.31 110.443 170.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 32.2 tp -152.31 138.64 18.46 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.597 -0.729 . . . . 51.13 109.246 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -116.01 139.29 50.41 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.581 0.753 . . . . 74.41 109.51 173.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -147.91 157.3 43.45 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.426 -0.953 . . . . 53.21 108.426 169.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 26.6 p -81.44 153.45 26.89 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 121.887 0.851 . . . . 71.41 111.272 164.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.636 HD13 ' HB2' ' A' ' 212' ' ' ALA . 37.3 tp -125.31 131.54 53.03 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 113.345 -1.752 . . . . 74.44 106.755 167.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.428 ' HB2' HG21 ' A' ' 256' ' ' THR . 5.7 p-10 -93.43 114.65 27.1 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 107.554 -1.276 . . . . 65.42 107.554 -178.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.561 HG22 HG21 ' A' ' 210' ' ' VAL . 55.0 t -121.05 131.04 24.59 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 114.85 -1.068 . . . . 52.22 109.198 -177.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -66.97 148.25 81.57 Favored 'Trans proline' 0 C--N 1.369 1.63 0 C-N-CA 122.321 2.014 . . . . 63.33 110.951 169.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.44 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.62 -45.88 98.48 Favored Pre-proline 0 CA--C 1.562 1.423 0 CA-C-O 118.38 -0.819 . . . . 63.43 112.205 172.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.44 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 20.6 Cg_endo -59.6 -31.14 93.93 Favored 'Trans proline' 0 C--N 1.396 3.053 0 C-N-CA 122.096 1.864 . . . . 74.0 112.814 176.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -87.71 -24.55 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 109.52 -0.548 . . . . 74.21 109.52 -177.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -76.14 -37.3 58.15 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-O 121.064 0.459 . . . . 65.52 110.806 178.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 23.6 t -88.52 -38.52 11.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 CA-C-N 114.156 -1.384 . . . . 73.11 112.124 -177.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.413 ' HB ' ' O ' ' A' ' 202' ' ' PRO . 72.3 t -98.76 -40.44 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 O-C-N 121.959 -0.463 . . . . 75.25 110.89 -178.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 121.33 150.41 8.32 Favored Glycine 0 N--CA 1.472 1.072 0 N-CA-C 111.311 -0.715 . . . . 71.32 111.311 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 165.65 155.6 8.77 Favored Glycine 0 C--O 1.244 0.773 0 CA-C-N 116.869 0.334 . . . . 62.54 112.473 177.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.584 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 34.6 ttmt -86.33 129.76 34.74 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.106 0.562 . . . . 75.01 109.878 179.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.561 HG21 HG22 ' A' ' 199' ' ' VAL . 10.8 m -131.96 151.94 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 124.467 1.107 . . . . 74.33 108.863 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -93.96 144.14 25.72 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 109.409 -0.589 . . . . 75.3 109.409 -171.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.636 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -133.05 125.27 29.26 Favored 'General case' 0 C--N 1.349 0.56 0 N-CA-C 108.907 -0.775 . . . . 75.04 108.907 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 36.5 tpp -78.68 112.74 16.09 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 108.706 -0.85 . . . . 70.42 108.706 171.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 64.1 p -119.59 -175.01 2.86 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 123.71 0.804 . . . . 52.33 110.222 -176.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.54 HD21 ' HD3' ' A' ' 241' ' ' PRO . 67.2 tp -47.08 -52.93 13.93 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.239 1.016 . . . . 75.23 112.456 175.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -72.51 -27.85 62.51 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.178 -0.919 . . . . 62.44 110.977 -172.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 138.22 -165.26 25.48 Favored Glycine 0 C--N 1.34 0.794 0 N-CA-C 111.581 -0.608 . . . . 32.14 111.581 -172.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -66.18 131.15 25.96 Favored 'Trans proline' 0 C--N 1.37 1.707 0 C-N-CA 122.347 2.031 . . . . 63.2 110.779 177.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 29.4 m -130.93 161.12 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.642 0.777 . . . . 71.34 110.148 -178.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.519 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 43.7 mt-10 -111.65 111.94 23.29 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.742 0.817 . . . . 62.34 108.906 -175.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.431 HG22 HG11 ' A' ' 168' ' ' VAL . 57.4 t -121.75 103.76 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 124.164 0.986 . . . . 74.1 110.11 -171.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.584 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -78.32 118.29 20.37 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.437 0.695 . . . . 74.23 110.666 176.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 35.7 m -89.09 151.29 46.65 Favored Pre-proline 0 N--CA 1.481 1.093 0 C-N-CA 122.869 0.468 . . . . 72.21 110.975 -176.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . 0.625 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 28.6 Cg_endo -61.38 164.54 14.95 Favored 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 122.724 2.283 . . . . 63.21 113.102 176.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -91.75 37.65 0.28 Allowed 'Trans proline' 0 C--N 1.373 1.85 0 C-N-CA 123.427 2.751 . . . . 74.52 112.066 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 -148.37 -9.58 0.37 Allowed 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 116.579 -0.282 . . . . 74.45 111.356 176.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.625 ' HB ' ' HG2' ' A' ' 224' ' ' PRO . 0.7 OUTLIER -59.62 154.15 18.34 Favored 'General case' 0 CA--C 1.559 1.318 0 O-C-N 124.102 0.876 . . . . 74.44 110.633 -161.665 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . 0.468 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 4.5 pt20 -134.53 162.28 32.7 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.317 0.647 . . . . 73.23 110.371 -172.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -58.6 112.81 1.74 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 122.985 0.514 . . . . 51.22 110.841 177.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.52 1.6 21.53 Favored Glycine 0 CA--C 1.522 0.492 0 CA-C-N 115.135 -0.938 . . . . 61.22 111.877 178.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.468 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -69.82 125.52 26.97 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.121 0.569 . . . . 73.42 109.698 -175.769 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -97.09 100.6 12.09 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 109.241 -0.652 . . . . 72.42 109.241 -176.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.488 ' HB3' ' HA ' ' A' ' 172' ' ' SER . 39.7 mt -78.4 102.22 7.66 Favored 'General case' 0 C--N 1.341 0.236 0 N-CA-C 108.208 -1.034 . . . . 62.43 108.208 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . 0.684 ' HD2' ' H ' ' A' ' 234' ' ' ARG . 0.0 OUTLIER -79.98 117.73 21.09 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 124.733 1.271 . . . . 75.13 111.836 -174.773 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.62 ' HB3' ' HB2' ' A' ' 238' ' ' LYS . 8.2 mp -107.68 128.08 54.24 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 106.907 -1.516 . . . . 72.0 106.907 173.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -101.52 116.81 33.61 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.753 0.821 . . . . 62.54 111.441 -174.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 74.63 27.72 64.66 Favored Glycine 0 C--N 1.351 1.401 0 O-C-N 123.895 0.747 . . . . 53.34 111.857 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.62 ' HB2' ' HB3' ' A' ' 235' ' ' LEU . 28.7 mmmt -126.29 22.11 7.2 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.365 1.066 . . . . 72.02 111.134 -175.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -93.93 -128.31 5.04 Favored Glycine 0 C--N 1.341 0.815 0 N-CA-C 110.22 -1.152 . . . . 64.52 110.22 176.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . 0.454 ' O ' ' HA ' ' A' ' 246' ' ' ARG . 6.6 m-30 -70.08 153.81 95.06 Favored Pre-proline 0 CA--C 1.551 0.992 0 CA-C-N 117.65 0.725 . . . . 60.41 111.714 176.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.54 ' HD3' HD21 ' A' ' 215' ' ' LEU . 60.4 Cg_endo -68.35 171.73 12.38 Favored 'Trans proline' 0 C--N 1.381 2.239 0 C-N-CA 123.38 2.72 . . . . 63.42 112.078 178.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.429 ' N ' ' HD2' ' A' ' 243' ' ' PRO . . . -67.59 -39.55 90.75 Favored Glycine 0 CA--C 1.543 1.834 0 CA-C-O 118.4 -1.222 . . . . 73.43 114.634 -176.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' A' ' 242' ' ' GLY . 9.1 Cg_endo -51.88 -38.81 68.94 Favored 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 122.698 2.265 . . . . 71.41 113.225 167.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -78.68 -25.29 44.81 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.449 0.699 . . . . 74.23 110.66 175.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 106.1 112.77 3.73 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 109.084 -1.606 . . . . 74.05 109.084 -168.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.454 ' HA ' ' O ' ' A' ' 240' ' ' PHE . 52.7 ttp180 -72.22 127.06 31.37 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 117.266 0.533 . . . . 72.22 110.977 -175.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.4 ' HA2' ' HA3' ' A' ' 186' ' ' GLY . . . -136.56 -157.18 7.65 Favored Glycine 0 C--O 1.239 0.452 0 CA-C-N 115.575 -0.739 . . . . 44.33 111.718 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -116.29 166.14 12.38 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.872 0.869 . . . . 72.41 109.028 -174.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 10.6 tp -134.78 134.14 40.6 Favored 'General case' 0 C--O 1.213 -0.827 0 N-CA-C 108.333 -0.988 . . . . 75.11 108.333 -176.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.445 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 8.1 m-85 -121.97 146.23 47.35 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 108.943 -0.762 . . . . 72.32 108.943 -177.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.419 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 77.6 mt -124.64 115.52 20.93 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.917 -0.772 . . . . 74.23 108.917 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -88.94 106.71 18.59 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 107.873 -1.158 . . . . 72.4 107.873 -173.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.599 HG11 HG23 ' A' ' 227' ' ' THR . 52.7 t -59.93 125.26 15.74 Favored 'Isoleucine or valine' 0 C--N 1.34 0.184 0 O-C-N 124.09 0.869 . . . . 75.1 109.439 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 22.1 mmt180 -120.78 124.35 44.87 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.212 -1.403 . . . . 74.22 107.212 176.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 51.1 mm -85.75 118.45 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 O-C-N 124.124 0.89 . . . . 74.21 109.414 -173.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . 0.428 HG21 ' HB2' ' A' ' 198' ' ' ASP . 1.0 OUTLIER . . . . . 0 CA--C 1.554 1.107 0 N-CA-C 108.582 -0.896 . . . . 70.21 108.582 -171.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . 0.616 ' HG2' ' HG3' ' A' ' 164' ' ' LYS . 1.3 pmm? . . . . . 0 CA--C 1.545 0.768 0 N-CA-C 109.397 -0.594 . . . . 53.53 109.397 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.616 ' HG3' ' HG2' ' A' ' 163' ' ' MET . 0.0 OUTLIER -159.74 103.68 1.54 Allowed 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 124.132 0.973 . . . . 63.42 109.522 176.877 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -85.94 -41.01 15.28 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.911 0.884 . . . . 70.44 110.677 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -97.24 37.8 3.32 Favored Glycine 0 N--CA 1.471 0.986 0 CA-C-N 115.587 -0.733 . . . . 65.14 111.98 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.612 ' HB3' ' HB2' ' A' ' 164' ' ' LYS . . . -152.9 166.07 33.47 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.744 0.817 . . . . 75.14 110.124 177.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.465 HG11 HG22 ' A' ' 221' ' ' VAL . 54.9 t -111.23 156.45 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 124.701 1.201 . . . . 53.43 111.765 -167.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 44.1 mtm -98.75 -176.75 3.44 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.651 1.581 . . . . 65.15 109.651 -174.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 8.3 p -99.98 89.04 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 CA-C-O 122.964 1.364 . . . . 73.21 108.592 163.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . 0.457 ' HG3' ' HA ' ' A' ' 235' ' ' LEU . 0.0 OUTLIER -123.76 -6.09 8.01 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 113.946 -1.479 . . . . 63.43 110.789 -174.478 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.472 ' HB3' HD22 ' A' ' 233' ' ' LEU . 66.1 m -39.64 -66.45 0.3 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.545 1.938 . . . . 75.02 114.638 -167.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -66.72 -48.45 69.15 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 122.603 0.361 . . . . 74.24 110.068 -175.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 49.4 59.77 6.84 Favored Glycine 0 C--N 1.357 1.704 0 O-C-N 124.377 1.048 . . . . 74.33 113.181 176.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -54.66 96.82 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.043 0.937 . . . . 62.22 111.535 -171.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 43.4 m -82.64 87.97 6.71 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 109.305 -0.628 . . . . 31.4 109.305 178.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -78.13 -30.43 49.32 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 122.067 0.937 . . . . 70.51 108.854 172.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -80.48 173.56 12.48 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 113.939 -1.482 . . . . 61.12 111.243 178.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -58.33 -26.93 63.67 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.323 1.049 . . . . 74.21 112.624 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -65.5 76.0 0.1 OUTLIER Glycine 0 N--CA 1.473 1.13 0 O-C-N 123.896 0.747 . . . . 72.11 113.265 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 31.8 m -129.27 -2.26 5.03 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.293 1.037 . . . . 53.24 111.371 -174.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -74.02 113.3 4.1 Favored Glycine 0 CA--C 1.533 1.18 0 CA-C-O 119.484 -0.62 . . . . 35.1 112.053 -178.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -69.43 78.4 0.33 Allowed Glycine 0 C--N 1.355 1.613 0 C-N-CA 123.454 0.55 . . . . 62.45 112.115 178.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 22.7 p -142.29 100.59 3.74 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.998 0.919 . . . . 72.12 108.949 -174.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -76.28 105.67 2.03 Favored Glycine 0 C--N 1.345 1.029 0 CA-C-N 116.582 -0.281 . . . . 64.04 112.642 -176.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 63.12 -118.68 14.59 Favored Glycine 0 C--N 1.343 0.967 0 N-CA-C 111.977 -0.449 . . . . 72.02 111.977 -176.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 33.7 t -95.3 -18.67 20.61 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.597 0.759 . . . . 73.44 110.033 173.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.437 ' HA2' ' HB2' ' A' ' 192' ' ' ASP . . . 70.9 19.22 76.8 Favored Glycine 0 C--N 1.351 1.377 0 N-CA-C 114.703 0.641 . . . . 74.44 114.703 176.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -77.99 -71.77 1.2 Allowed Glycine 0 C--N 1.353 1.485 0 CA-C-N 117.336 0.568 . . . . 61.3 112.037 179.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 29.0 m -142.34 29.41 1.61 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.167 0.987 . . . . 71.23 108.629 173.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.518 ' HG2' ' HA3' ' A' ' 245' ' ' GLY . 45.2 mt-30 -113.74 -32.93 5.98 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 114.817 -1.083 . . . . 63.31 110.47 -172.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.437 ' HB2' ' HA2' ' A' ' 188' ' ' GLY . 44.9 t0 -75.4 162.08 28.68 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 114.806 -1.088 . . . . 73.23 109.182 176.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.444 HD23 HD13 ' A' ' 249' ' ' LEU . 52.7 tp -149.96 136.52 19.14 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.128 -0.693 . . . . 71.53 109.128 171.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -113.17 139.58 48.64 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.011 -0.737 . . . . 74.54 109.011 170.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.456 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -148.38 155.05 40.76 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.491 0.716 . . . . 73.1 109.338 173.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 25.2 p -82.0 153.62 26.11 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 122.085 0.945 . . . . 75.45 112.774 171.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.656 HD13 ' HB2' ' A' ' 212' ' ' ALA . 39.3 tp -126.97 132.26 50.86 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 113.108 -1.86 . . . . 72.21 106.642 169.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -95.13 111.59 23.39 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.068 -1.086 . . . . 73.24 108.068 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.516 HG22 HG21 ' A' ' 210' ' ' VAL . 46.8 t -114.84 131.91 23.22 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-N 114.663 -1.153 . . . . 71.35 109.299 -178.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -68.59 145.3 63.61 Favored 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 122.229 1.953 . . . . 62.42 110.934 168.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.432 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.86 -45.56 98.82 Favored Pre-proline 0 CA--C 1.564 1.493 0 O-C-N 123.961 0.788 . . . . 53.45 111.845 174.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 19.6 Cg_endo -58.97 -32.9 98.38 Favored 'Trans proline' 0 C--N 1.403 3.442 0 C-N-CA 122.155 1.903 . . . . 71.52 112.777 175.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.7 mp -86.0 -24.85 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 109.509 -0.552 . . . . 75.42 109.509 -176.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -73.22 -37.71 66.32 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 122.942 0.497 . . . . 64.44 110.943 178.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 21.0 t -87.78 -37.28 10.56 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-N 114.426 -1.261 . . . . 70.11 112.981 -178.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 53.4 t -96.62 -42.2 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 O-C-N 122.203 -0.311 . . . . 62.44 110.484 -175.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 121.2 145.46 7.22 Favored Glycine 0 C--N 1.339 0.743 0 N-CA-C 110.76 -0.936 . . . . 73.11 110.76 -176.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 166.13 155.72 8.98 Favored Glycine 0 C--O 1.246 0.906 0 CA-C-O 121.29 0.383 . . . . 63.03 112.538 178.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.58 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 36.8 ttmt -86.32 131.73 34.14 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.564 0.745 . . . . 72.04 109.685 178.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.516 HG21 HG22 ' A' ' 199' ' ' VAL . 14.2 m -129.2 149.23 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 124.165 0.986 . . . . 71.22 109.197 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 4.4 tmm_? -95.98 141.55 29.26 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 108.918 -0.771 . . . . 72.31 108.918 -170.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.656 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -132.64 116.17 16.32 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.501 1.12 . . . . 61.35 109.223 -175.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 38.1 tpp -78.85 108.7 12.49 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 107.612 -1.255 . . . . 63.34 107.612 172.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 71.3 p -114.48 -175.17 2.62 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.811 0.844 . . . . 75.42 110.611 -175.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.614 HD21 ' HD3' ' A' ' 241' ' ' PRO . 61.8 tp -45.01 -52.4 8.9 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.757 1.223 . . . . 65.52 112.091 173.288 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -72.11 -28.08 63.06 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 114.189 -1.369 . . . . 63.25 111.031 -171.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 135.02 -166.23 24.43 Favored Glycine 0 C--O 1.243 0.717 0 CA-C-N 115.509 -0.769 . . . . 25.22 111.304 -173.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.0 131.43 23.83 Favored 'Trans proline' 0 C--N 1.363 1.3 0 C-N-CA 122.352 2.035 . . . . 72.25 111.672 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 28.9 m -134.26 157.76 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.749 0.82 . . . . 61.14 109.981 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.504 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 38.7 mt-10 -114.28 115.56 27.61 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.641 0.776 . . . . 73.51 110.568 -176.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.465 HG22 HG11 ' A' ' 168' ' ' VAL . 98.3 t -121.74 105.29 16.22 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 C-N-CA 125.366 1.466 . . . . 75.21 110.245 -168.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.58 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -76.3 118.47 19.05 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 122.425 0.29 . . . . 72.42 110.621 176.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 35.0 m -87.25 151.72 51.67 Favored Pre-proline 0 N--CA 1.489 1.496 0 C-N-CA 123.178 0.591 . . . . 64.22 110.673 -178.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . 0.658 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 26.1 Cg_endo -61.06 163.59 16.31 Favored 'Trans proline' 0 C--N 1.38 2.215 0 C-N-CA 122.706 2.271 . . . . 64.4 113.193 177.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -87.27 34.02 0.43 Allowed 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 122.951 2.434 . . . . 63.32 112.572 178.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -149.73 -3.35 0.4 Allowed 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 112.321 0.489 . . . . 73.05 112.321 177.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.658 ' HB ' ' HG2' ' A' ' 224' ' ' PRO . 0.7 OUTLIER -61.97 154.34 26.75 Favored 'General case' 0 CA--C 1.563 1.461 0 O-C-N 123.304 0.377 . . . . 73.42 111.788 -165.099 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -136.82 161.04 37.08 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.472 0.709 . . . . 73.54 110.193 -178.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -58.56 113.12 1.85 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.45 0.7 . . . . 75.15 111.175 -177.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 116.69 0.31 19.96 Favored Glycine 0 CA--C 1.524 0.616 0 CA-C-N 115.064 -0.971 . . . . 71.1 112.395 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.434 ' HE ' HD23 ' A' ' 233' ' ' LEU . 0.0 OUTLIER -68.97 130.76 43.69 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 109.076 -0.713 . . . . 71.31 109.076 -176.396 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -97.76 96.18 8.06 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 109.018 -0.734 . . . . 74.11 109.018 -168.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.472 HD22 ' HB3' ' A' ' 172' ' ' SER . 24.4 mt -82.6 97.62 8.58 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 106.694 -1.595 . . . . 72.2 106.694 -178.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 3.5 ppt_? -83.23 125.29 31.42 Favored 'General case' 0 CA--C 1.546 0.789 0 O-C-N 123.97 0.794 . . . . 71.3 110.988 -179.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.457 ' HA ' ' HG3' ' A' ' 171' ' ' MET . 7.3 mp -110.02 126.65 54.2 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 106.286 -1.746 . . . . 74.24 106.286 177.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 11.3 tptp -98.6 115.28 28.29 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 110.048 -0.353 . . . . 75.4 110.048 -170.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.621 ' HA2' HH11 ' A' ' 246' ' ' ARG . . . 79.66 23.35 62.48 Favored Glycine 0 C--N 1.343 0.951 0 O-C-N 123.836 0.71 . . . . 33.14 113.65 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? -122.72 23.93 9.31 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.296 0.638 . . . . 53.14 111.292 -177.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . 0.444 ' HA2' ' HB2' ' A' ' 249' ' ' LEU . . . -93.79 -130.96 5.86 Favored Glycine 0 C--N 1.349 1.261 0 CA-C-O 119.296 -0.725 . . . . 63.15 111.919 -178.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -69.29 149.21 97.44 Favored Pre-proline 0 CA--C 1.553 1.093 0 CA-C-N 117.366 0.583 . . . . 74.15 111.53 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.614 ' HD3' HD21 ' A' ' 215' ' ' LEU . 44.1 Cg_endo -63.62 171.78 6.51 Favored 'Trans proline' 0 C--N 1.391 2.764 0 C-N-CA 123.574 2.849 . . . . 63.51 112.565 -178.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -66.02 -42.95 94.38 Favored Glycine 0 CA--C 1.544 1.849 0 CA-C-O 118.223 -1.321 . . . . 73.43 114.098 -173.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -58.92 -34.75 99.24 Favored 'Trans proline' 0 C--N 1.388 2.644 0 CA-C-N 120.812 2.306 . . . . 73.21 113.785 170.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -77.14 -24.54 51.61 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.18 0.592 . . . . 64.53 110.37 173.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . 0.518 ' HA3' ' HG2' ' A' ' 191' ' ' GLN . . . 110.51 117.74 3.84 Favored Glycine 0 C--N 1.344 0.973 0 N-CA-C 110.532 -1.027 . . . . 70.11 110.532 -172.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.621 HH11 ' HA2' ' A' ' 237' ' ' GLY . 2.3 tmm_? -68.6 124.74 24.43 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.18 -0.674 . . . . 60.03 109.18 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -143.12 -156.2 6.7 Favored Glycine 0 N--CA 1.47 0.943 0 O-C-N 123.517 0.511 . . . . 63.31 112.109 176.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -115.53 167.05 11.23 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 109.112 -0.699 . . . . 62.32 109.112 -176.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.444 HD13 HD23 ' A' ' 193' ' ' LEU . 17.9 tp -134.48 133.07 39.99 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 108.499 -0.926 . . . . 73.31 108.499 -175.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -114.06 147.6 38.45 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 123.598 0.759 . . . . 73.22 110.245 178.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.456 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 88.9 mt -125.65 113.85 17.91 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 114.017 -1.447 . . . . 64.24 107.511 174.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -89.73 112.64 23.98 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 107.671 -1.233 . . . . 75.42 107.671 -176.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.515 HG11 HG23 ' A' ' 227' ' ' THR . 54.6 t -59.65 127.31 18.79 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.117 0 O-C-N 124.46 1.1 . . . . 70.31 109.75 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 8.3 mmt180 -123.96 123.45 40.41 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.251 -1.018 . . . . 55.05 108.251 175.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 46.2 mm -87.15 118.73 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 123.258 0.623 . . . . 52.22 110.033 -174.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.4 t . . . . . 0 CA--C 1.56 1.357 0 C-N-CA 123.546 0.738 . . . . 44.04 109.251 -171.555 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.485 1.282 0 N-CA-C 110.323 -0.251 . . . . 65.12 110.323 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -67.1 96.5 0.45 Allowed 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 109.135 -0.691 . . . . 72.44 109.135 179.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -77.72 -69.46 0.54 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.572 0.749 . . . . 75.42 111.414 -168.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -98.66 30.47 9.62 Favored Glycine 0 N--CA 1.473 1.149 0 N-CA-C 111.281 -0.727 . . . . 73.11 111.281 173.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -142.92 167.4 22.17 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.942 1.297 . . . . 63.51 108.714 -178.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 47.5 t -113.2 155.61 14.36 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 123.748 0.819 . . . . 65.12 111.596 -173.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 47.9 mtm -99.11 -175.62 3.08 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 126.183 1.793 . . . . 75.42 109.703 -171.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 14.3 p -95.63 87.81 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.351 0 N-CA-C 107.107 -1.442 . . . . 74.34 107.107 161.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . 0.411 ' SD ' ' HG ' ' A' ' 235' ' ' LEU . 0.0 OUTLIER -129.96 -4.79 4.52 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 114.211 -1.359 . . . . 71.25 110.9 -174.203 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.468 ' HA ' ' HB3' ' A' ' 233' ' ' LEU . 70.9 m -40.17 -65.13 0.43 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.666 1.986 . . . . 64.42 113.049 -171.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -73.45 -50.22 22.8 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 107.518 -1.29 . . . . 72.33 107.518 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 54.87 20.29 18.43 Favored Glycine 0 C--N 1.365 2.189 0 O-C-N 124.636 1.21 . . . . 73.23 115.494 172.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -132.33 156.24 46.96 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.81 0.844 . . . . 72.21 109.615 -167.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 51.0 m -68.65 127.15 32.02 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 108.401 -0.962 . . . . 62.33 108.401 169.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -24.11 -34.42 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 C-N-CA 128.227 2.611 . . . . 74.34 117.678 -171.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -62.38 173.1 1.28 Allowed 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.785 0.834 . . . . 74.11 111.765 171.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -55.76 -35.74 66.55 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 120.809 0.338 . . . . 72.34 111.478 177.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 56.79 -129.45 49.06 Favored Glycine 0 C--N 1.338 0.666 0 CA-C-N 114.805 -1.089 . . . . 72.15 113.825 171.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 21.5 t -170.9 -158.13 0.14 Allowed 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 124.764 1.226 . . . . 34.42 107.95 177.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 96.88 112.3 2.9 Favored Glycine 0 C--N 1.347 1.184 0 N-CA-C 111.156 -0.778 . . . . 61.13 111.156 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.604 ' HA2' ' HG2' ' A' ' 234' ' ' ARG . . . -167.71 -96.84 0.11 Allowed Glycine 0 C--N 1.346 1.088 0 CA-C-O 119.966 -0.352 . . . . 33.23 112.457 -177.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 15.7 m -66.27 122.58 17.81 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.942 0.897 . . . . 73.21 111.461 -173.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -156.99 155.17 26.15 Favored Glycine 0 C--N 1.336 0.549 0 N-CA-C 110.755 -0.938 . . . . 74.31 110.755 175.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.419 ' O ' ' HB2' ' A' ' 191' ' ' GLN . . . 49.16 33.77 15.62 Favored Glycine 0 C--N 1.352 1.438 0 O-C-N 123.827 0.369 . . . . 41.32 112.893 -178.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 54.1 p -86.01 130.83 34.42 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 122.987 0.515 . . . . 74.33 110.189 -173.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -174.58 -140.65 3.36 Favored Glycine 0 C--N 1.345 1.071 0 CA-C-O 119.712 -0.493 . . . . 53.23 112.442 -178.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -65.64 -49.89 57.36 Favored Glycine 0 C--N 1.35 1.327 0 O-C-N 123.753 0.325 . . . . 52.51 113.379 -174.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 78.5 p -162.74 58.84 0.21 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.635 0.774 . . . . 72.15 109.813 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.423 ' HA ' ' O ' ' A' ' 245' ' ' GLY . 21.9 mt-30 -114.53 -57.3 2.29 Favored 'General case' 0 C--O 1.245 0.819 0 N-CA-C 108.252 -1.018 . . . . 75.31 108.252 175.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 29.2 p-10 -74.17 167.64 21.17 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 114.722 -1.126 . . . . 44.35 110.548 174.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 52.8 tp -150.65 139.64 21.0 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.449 -0.796 . . . . 64.53 109.821 177.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -110.03 138.77 45.94 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 123.869 0.867 . . . . 74.34 109.509 171.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -148.05 157.78 43.7 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 108.185 -1.043 . . . . 63.12 108.185 168.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . 0.439 HG22 ' HB3' ' A' ' 252' ' ' GLU . 27.8 p -92.87 152.58 19.32 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.957 0.884 . . . . 74.43 112.242 168.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.671 HD13 ' HB2' ' A' ' 212' ' ' ALA . 41.1 tp -123.86 130.79 53.17 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 113.073 -1.876 . . . . 73.22 106.826 167.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.431 ' HB2' HG21 ' A' ' 256' ' ' THR . 10.0 p-10 -94.63 112.39 24.14 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 121.951 0.881 . . . . 72.34 109.047 -178.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.594 HG22 HG21 ' A' ' 210' ' ' VAL . 61.0 t -119.35 132.81 23.85 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 124.119 0.968 . . . . 61.12 109.903 -175.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -68.46 144.35 60.96 Favored 'Trans proline' 0 C--N 1.369 1.608 0 C-N-CA 121.999 1.799 . . . . 70.1 111.337 167.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.431 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.0 -43.62 94.97 Favored Pre-proline 0 CA--C 1.559 1.301 0 CA-C-O 118.104 -0.95 . . . . 72.41 112.601 173.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 19.3 Cg_endo -56.86 -33.61 95.1 Favored 'Trans proline' 0 C--N 1.399 3.237 0 C-N-CA 121.728 1.618 . . . . 73.22 112.631 173.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -86.71 -24.25 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 N-CA-C 109.623 -0.51 . . . . 55.34 109.623 -177.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.417 ' HA ' HG22 ' A' ' 227' ' ' THR . . . -73.5 -37.59 65.63 Favored 'General case' 0 C--O 1.246 0.89 0 C-N-CA 123.335 0.654 . . . . 62.32 110.866 178.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 41.4 t -90.04 -34.67 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.224 0 CA-C-N 113.498 -1.683 . . . . 74.32 113.414 -177.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 54.6 t -101.39 -42.39 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 O-C-N 121.479 -0.763 . . . . 73.41 111.096 -178.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 126.12 155.24 8.89 Favored Glycine 0 C--N 1.34 0.773 0 N-CA-C 110.941 -0.863 . . . . 34.4 110.941 -176.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.64 149.1 5.68 Favored Glycine 0 C--O 1.246 0.894 0 N-CA-C 111.48 -0.648 . . . . 62.41 111.48 176.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.579 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 34.3 ttpt -84.71 129.83 34.78 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 109.267 -0.642 . . . . 70.44 109.267 174.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.594 HG21 HG22 ' A' ' 199' ' ' VAL . 9.7 m -133.37 147.93 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 124.013 0.925 . . . . 61.43 108.77 -178.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . 0.419 ' HD2' ' N ' ' A' ' 212' ' ' ALA . 6.4 tmm_? -94.77 141.79 28.21 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.218 0.607 . . . . 73.01 109.429 -170.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.671 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -131.18 126.22 35.04 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.495 1.118 . . . . 73.52 108.498 -176.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 37.3 tpp -80.05 108.5 13.69 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 108.083 -1.08 . . . . 75.13 108.083 173.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 71.4 p -117.23 178.8 4.23 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.692 0.797 . . . . 75.02 110.741 -176.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 69.0 tp -45.33 -50.71 11.86 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.17 1.388 . . . . 62.22 112.276 176.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -71.96 -26.69 62.37 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 114.551 -1.204 . . . . 71.34 111.288 -173.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 138.6 -166.53 25.29 Favored Glycine 0 C--N 1.341 0.861 0 N-CA-C 111.389 -0.684 . . . . 52.02 111.389 -177.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -65.33 130.27 24.92 Favored 'Trans proline' 0 C--N 1.368 1.555 0 C-N-CA 121.9 1.733 . . . . 73.12 110.771 174.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 30.2 m -134.74 159.72 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 123.312 0.645 . . . . 72.33 110.532 -174.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.555 ' HB3' ' HD2' ' A' ' 209' ' ' LYS . 44.6 mt-10 -113.42 114.7 26.95 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.344 0.658 . . . . 53.21 109.764 -174.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 54.9 t -122.01 103.74 13.87 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 C-N-CA 125.009 1.324 . . . . 72.54 109.667 -169.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.579 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -77.48 117.88 19.37 Favored 'General case' 0 N--CA 1.478 0.943 0 O-C-N 122.167 -0.333 . . . . 52.12 110.478 175.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.416 HG11 HG21 ' A' ' 199' ' ' VAL . 27.5 m -85.23 152.8 58.85 Favored Pre-proline 0 N--CA 1.492 1.66 0 C-N-CA 123.202 0.601 . . . . 73.2 111.157 -176.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . 0.543 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 33.6 Cg_endo -65.99 163.03 32.71 Favored 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 121.75 1.633 . . . . 52.01 112.541 177.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -85.34 27.42 0.6 Allowed 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 122.854 2.369 . . . . 33.41 112.94 178.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 41.5 mmt-85 -144.93 0.11 0.93 Allowed 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.382 0.673 . . . . 70.32 111.447 179.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.594 HG23 HG11 ' A' ' 253' ' ' VAL . 0.7 OUTLIER -61.65 155.71 21.84 Favored 'General case' 0 CA--C 1.573 1.859 0 O-C-N 123.88 0.738 . . . . 65.25 109.529 -169.191 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . 0.429 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 4.8 pt20 -133.07 162.86 30.59 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.541 0.736 . . . . 73.4 110.844 -174.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -59.38 110.75 1.16 Allowed 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 109.444 -0.576 . . . . 75.34 109.444 171.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 114.35 0.36 23.6 Favored Glycine 0 CA--C 1.524 0.61 0 CA-C-N 115.379 -0.828 . . . . 43.43 111.686 178.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.429 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -72.04 125.5 27.4 Favored 'General case' 0 C--N 1.359 0.99 0 N-CA-C 109.022 -0.733 . . . . 75.21 109.022 -174.141 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -98.98 97.7 8.83 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 123.508 0.723 . . . . 72.0 109.457 -169.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.468 ' HB3' ' HA ' ' A' ' 172' ' ' SER . 30.7 mt -80.38 98.0 7.29 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 107.008 -1.479 . . . . 64.43 107.008 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . 0.604 ' HG2' ' HA2' ' A' ' 183' ' ' GLY . 2.0 ppt_? -83.61 117.37 23.12 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 121.493 0.663 . . . . 73.2 111.417 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.411 ' HG ' ' SD ' ' A' ' 171' ' ' MET . 6.3 mp -99.17 125.8 44.82 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 105.479 -2.045 . . . . 74.11 105.479 174.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.406 ' HA ' ' HB3' ' A' ' 248' ' ' ASP . 18.3 tptt -101.79 117.43 34.84 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 118.657 0.662 . . . . 73.14 111.234 -168.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.49 ' H ' ' HB3' ' A' ' 248' ' ' ASP . . . 78.03 24.6 63.75 Favored Glycine 0 C--N 1.354 1.583 0 O-C-N 123.837 0.711 . . . . 61.24 112.549 -174.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.406 ' HB2' ' HB3' ' A' ' 235' ' ' LEU . 30.1 mmmt -119.1 20.67 12.61 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.571 0.748 . . . . 75.42 110.943 -175.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -96.83 -139.56 10.69 Favored Glycine 0 C--N 1.346 1.097 0 N-CA-C 111.124 -0.79 . . . . 71.42 111.124 177.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 7.1 m-30 -68.89 149.53 97.85 Favored Pre-proline 0 N--CA 1.478 0.955 0 N-CA-C 112.372 0.508 . . . . 65.42 112.372 -174.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -63.12 170.87 7.02 Favored 'Trans proline' 0 C--N 1.386 2.549 0 C-N-CA 123.488 2.792 . . . . 64.11 112.65 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.43 ' N ' ' HD2' ' A' ' 243' ' ' PRO . . . -66.55 -40.03 94.1 Favored Glycine 0 CA--C 1.551 2.306 0 CA-C-O 118.244 -1.309 . . . . 64.44 114.695 -174.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 242' ' ' GLY . 13.1 Cg_endo -56.64 -36.61 98.24 Favored 'Trans proline' 0 C--N 1.391 2.763 0 CA-C-N 120.792 2.296 . . . . 62.43 113.219 169.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -78.28 -25.36 46.67 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.148 0.579 . . . . 63.13 110.414 175.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 191' ' ' GLN . . . 113.18 117.08 3.39 Favored Glycine 0 C--N 1.344 1.007 0 N-CA-C 109.543 -1.423 . . . . 75.54 109.543 -169.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 45.9 ttm105 -72.11 125.98 28.64 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 117.283 0.541 . . . . 75.31 110.4 -178.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -148.54 -158.18 7.89 Favored Glycine 0 C--N 1.331 0.287 0 CA-C-N 116.008 -0.542 . . . . 74.2 112.094 175.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . 0.49 ' HB3' ' H ' ' A' ' 237' ' ' GLY . 0.1 OUTLIER -126.72 166.26 17.71 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.261 1.024 . . . . 72.12 110.526 -174.465 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 7.2 tp -132.86 134.66 44.91 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.667 -0.864 . . . . 63.34 108.667 -167.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -115.18 146.95 40.89 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 108.352 -0.981 . . . . 71.12 108.352 -175.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.413 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 84.6 mt -124.22 113.87 18.86 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 107.94 -1.133 . . . . 73.05 107.94 179.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.439 ' HB3' HG22 ' A' ' 196' ' ' THR . 24.1 tt0 -88.74 110.39 20.96 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 107.698 -1.223 . . . . 71.12 107.698 -176.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.594 HG11 HG23 ' A' ' 227' ' ' THR . 55.5 t -60.77 125.63 17.26 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.263 0 O-C-N 124.116 0.885 . . . . 53.31 109.186 176.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 24.4 mtp85 -122.29 122.97 40.34 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 107.919 -1.141 . . . . 74.24 107.919 178.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.427 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 47.2 mm -85.84 118.67 32.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 O-C-N 123.635 0.584 . . . . 72.14 109.89 -171.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . 0.431 HG21 ' HB2' ' A' ' 198' ' ' ASP . 1.7 t . . . . . 0 CA--C 1.551 1.008 0 C-N-CA 124.329 1.052 . . . . 74.44 109.357 -171.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . 0.585 ' HA ' ' SD ' ' A' ' 169' ' ' MET . 21.9 mmt . . . . . 0 N--CA 1.486 1.35 0 N-CA-C 109.087 -0.708 . . . . 72.34 109.087 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -104.13 142.24 34.83 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 109.535 -0.543 . . . . 74.54 109.535 170.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -91.14 -56.01 3.32 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.354 1.062 . . . . 70.15 110.614 -170.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -98.69 16.8 59.22 Favored Glycine 0 C--N 1.343 0.958 0 CA-C-N 116.142 -0.481 . . . . 63.42 113.323 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -152.53 161.26 42.83 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.681 0.792 . . . . 65.15 109.526 -177.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 53.7 t -110.52 147.97 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 CA-C-O 121.885 0.85 . . . . 55.3 111.908 -171.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.585 ' SD ' ' HA ' ' A' ' 163' ' ' MET . 43.3 mtm -101.62 -176.06 3.03 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 126.625 1.97 . . . . 64.51 109.862 -168.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 10.2 p -99.23 87.14 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.038 0 CA-C-O 123.066 1.413 . . . . 73.52 107.534 162.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.43 -4.45 8.83 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 113.883 -1.508 . . . . 70.34 110.285 -174.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.449 ' O ' ' HA ' ' A' ' 233' ' ' LEU . 69.6 m -39.0 -68.3 0.17 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.775 2.03 . . . . 63.34 113.839 -166.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . 0.474 ' HB2' ' HG3' ' A' ' 224' ' ' PRO . 67.2 t80 -69.99 -44.55 69.16 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 109.372 -0.603 . . . . 75.22 109.372 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 64.92 61.37 5.89 Favored Glycine 0 C--N 1.355 1.625 0 CA-C-N 114.807 -1.088 . . . . 73.03 112.206 -177.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . 0.455 ' HB3' ' HD2' ' A' ' 173' ' ' TYR . 4.5 p-10 -79.5 128.96 34.01 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.75 0.786 . . . . 71.13 111.406 -176.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 68.9 p -121.08 124.8 45.68 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 106.869 -1.53 . . . . 73.15 106.869 167.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -63.42 -9.09 10.84 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 113.017 0.747 . . . . 71.04 113.017 -177.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -78.17 170.61 16.34 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.192 0.997 . . . . 74.15 110.069 166.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -70.82 -19.82 62.63 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 112.123 0.416 . . . . 64.42 112.123 -174.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -84.53 -150.59 11.89 Favored Glycine 0 CA--C 1.532 1.139 0 O-C-N 123.434 0.459 . . . . 55.51 113.215 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 37.5 t -159.9 -50.51 0.05 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.97 0.908 . . . . 50.4 109.25 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 107.76 114.23 3.8 Favored Glycine 0 C--N 1.344 0.977 0 N-CA-C 110.358 -1.097 . . . . 73.32 110.358 -172.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -153.26 87.61 0.13 Allowed Glycine 0 C--N 1.339 0.708 0 N-CA-C 112.077 -0.409 . . . . 62.32 112.077 -175.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 67.9 m -91.66 179.81 5.55 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.545 0.738 . . . . 74.15 110.357 172.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 177.47 134.33 2.0 Favored Glycine 0 C--N 1.345 1.082 0 N-CA-C 111.716 -0.553 . . . . 74.21 111.716 178.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -78.69 73.93 2.2 Favored Glycine 0 C--N 1.35 1.352 0 C-N-CA 123.435 0.541 . . . . 43.41 112.242 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 14.6 m -63.36 142.06 58.53 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.508 1.123 . . . . 74.12 111.445 -176.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 116.65 -71.11 0.28 Allowed Glycine 0 C--N 1.346 1.131 0 N-CA-C 113.619 0.208 . . . . 62.2 113.619 173.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -87.28 11.59 65.07 Favored Glycine 0 C--N 1.345 1.051 0 CA-C-O 118.726 -1.041 . . . . 62.11 115.166 -168.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 68.1 m 55.73 66.4 1.22 Allowed 'General case' 0 N--CA 1.484 1.244 0 CA-C-O 122.23 1.014 . . . . 75.3 110.489 -173.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -104.92 -24.54 12.84 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 113.767 -1.561 . . . . 74.31 109.439 -178.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -82.95 167.62 17.8 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 114.844 -1.071 . . . . 52.33 109.925 175.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 50.3 tp -150.55 138.73 20.24 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.161 -0.472 . . . . 71.25 109.766 -177.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -117.33 139.45 50.83 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.035 0.934 . . . . 54.03 109.207 172.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -148.39 158.65 44.24 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.737 -0.838 . . . . 45.12 108.737 171.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 33.2 p -80.95 153.63 27.4 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 122.13 0.967 . . . . 74.43 111.802 168.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.66 HD13 ' HB2' ' A' ' 212' ' ' ALA . 38.8 tp -124.09 133.42 53.62 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 112.961 -1.927 . . . . 73.42 106.402 166.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -93.05 114.76 27.39 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.785 -1.191 . . . . 72.25 107.785 178.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.607 HG22 HG21 ' A' ' 210' ' ' VAL . 61.0 t -122.93 130.51 24.58 Favored Pre-proline 0 CA--C 1.542 0.673 0 C-N-CA 124.202 1.001 . . . . 52.33 108.832 179.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -68.48 146.72 69.04 Favored 'Trans proline' 0 C--N 1.363 1.29 0 C-N-CA 122.402 2.068 . . . . 63.04 111.76 168.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.449 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.23 -44.79 98.08 Favored Pre-proline 0 CA--C 1.564 1.507 0 C-N-CA 124.178 0.991 . . . . 61.43 112.25 172.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 19.8 Cg_endo -58.11 -34.68 98.74 Favored 'Trans proline' 0 C--N 1.401 3.294 0 C-N-CA 122.127 1.885 . . . . 72.1 112.58 174.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -85.43 -23.37 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 N-CA-C 109.138 -0.69 . . . . 74.33 109.138 -177.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -74.25 -37.98 63.62 Favored 'General case' 0 C--O 1.247 0.95 0 C-N-CA 123.108 0.563 . . . . 73.22 111.589 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 35.0 t -88.89 -37.88 10.69 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 CA-C-N 114.443 -1.253 . . . . 65.15 112.798 -179.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 54.5 t -95.82 -41.63 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 O-C-N 121.834 -0.541 . . . . 63.34 110.463 -175.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 121.59 151.1 8.43 Favored Glycine 0 C--N 1.344 1.012 0 N-CA-C 111.044 -0.822 . . . . 44.3 111.044 -177.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.77 154.48 7.96 Favored Glycine 0 C--O 1.246 0.862 0 N-CA-C 112.253 -0.339 . . . . 62.4 112.253 176.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.588 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 39.1 ttmt -85.32 132.68 34.21 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 123.472 0.709 . . . . 73.32 109.901 175.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.607 HG21 HG22 ' A' ' 199' ' ' VAL . 12.9 m -130.79 153.5 39.24 Favored 'Isoleucine or valine' 0 C--O 1.244 0.807 0 C-N-CA 124.713 1.205 . . . . 52.35 108.607 176.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -93.4 145.05 24.76 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.544 0.737 . . . . 74.31 110.239 -176.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.66 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -131.06 117.96 19.87 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 107.726 -1.213 . . . . 31.25 107.726 177.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 34.3 tpp -79.66 109.1 13.73 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 107.399 -1.334 . . . . 55.45 107.399 177.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 62.3 p -113.46 -172.38 2.06 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.253 0.621 . . . . 74.21 110.858 -172.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.653 HD21 ' HD3' ' A' ' 241' ' ' PRO . 63.1 tp -46.63 -52.1 14.4 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.561 1.144 . . . . 65.33 111.223 171.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -74.08 -28.96 61.63 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 114.294 -1.321 . . . . 73.31 112.3 -174.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 134.43 -166.72 24.1 Favored Glycine 0 C--N 1.346 1.102 0 CA-C-O 119.33 -0.706 . . . . 71.34 111.589 -173.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -62.32 136.06 57.57 Favored 'Trans proline' 0 C--N 1.372 1.766 0 C-N-CA 122.869 2.379 . . . . 53.11 111.301 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 212' ' ' ALA . 24.3 m -135.34 157.91 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 109.922 -0.399 . . . . 71.32 109.922 -176.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.555 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 44.6 mt-10 -110.01 105.44 14.58 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.773 0.829 . . . . 65.13 109.147 -167.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 58.7 t -122.11 101.98 10.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 115.198 -0.91 . . . . 75.2 109.335 -172.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.588 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -79.21 118.35 21.07 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 109.361 -0.607 . . . . 41.53 109.361 172.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 34.1 m -85.23 152.09 57.75 Favored Pre-proline 0 N--CA 1.482 1.164 0 C-N-CA 123.124 0.57 . . . . 33.45 110.363 -176.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . 0.474 ' HG3' ' HB2' ' A' ' 173' ' ' TYR . 36.2 Cg_endo -62.82 163.37 22.13 Favored 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 122.227 1.951 . . . . 65.41 112.362 176.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -85.37 32.96 0.47 Allowed 'Trans proline' 0 C--N 1.375 1.951 0 C-N-CA 122.899 2.4 . . . . 72.54 112.729 175.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . 0.42 ' HA ' ' HD2' ' A' ' 226' ' ' ARG . 13.2 tpt180 -149.41 4.32 0.6 Allowed 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 116.095 -0.502 . . . . 75.42 110.731 175.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.506 HG23 HG11 ' A' ' 253' ' ' VAL . 0.6 OUTLIER -59.94 154.35 19.05 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.896 -0.779 . . . . 74.43 108.896 -169.855 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -131.7 161.39 32.9 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.291 0.636 . . . . 72.44 110.384 -168.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -62.33 109.37 1.32 Allowed 'General case' 0 C--O 1.241 0.62 0 N-CA-C 107.922 -1.14 . . . . 45.55 107.922 167.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 113.85 2.76 23.74 Favored Glycine 0 C--N 1.337 0.589 0 CA-C-N 115.309 -0.859 . . . . 61.33 112.428 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.14 127.08 31.58 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.046 -0.724 . . . . 72.01 109.046 -175.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -99.73 98.19 9.04 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 123.466 0.706 . . . . 73.43 109.353 -171.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.466 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 20.3 mt -82.63 98.62 9.11 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 106.928 -1.508 . . . . 75.42 106.928 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 7.1 ppt_? -83.06 114.0 20.99 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-O 121.349 0.595 . . . . 74.15 111.374 -179.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.483 ' O ' ' HB2' ' A' ' 248' ' ' ASP . 8.0 mp -104.11 126.67 51.41 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 106.52 -1.659 . . . . 74.51 106.52 174.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -102.92 119.05 38.16 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.476 0.71 . . . . 72.34 111.35 -174.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 79.0 31.42 43.33 Favored Glycine 0 C--N 1.354 1.564 0 O-C-N 123.969 0.793 . . . . 51.43 112.309 -175.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -127.98 20.33 6.45 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.389 0.676 . . . . 71.32 111.053 -178.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -98.01 -131.27 7.08 Favored Glycine 0 C--N 1.349 1.267 0 CA-C-O 119.576 -0.569 . . . . 53.22 112.407 -177.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -71.16 155.18 93.45 Favored Pre-proline 0 CA--C 1.55 0.98 0 CA-C-N 117.453 0.627 . . . . 74.34 112.453 -178.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.653 ' HD3' HD21 ' A' ' 215' ' ' LEU . 88.8 Cg_endo -72.99 171.67 17.05 Favored 'Trans proline' 0 C--N 1.387 2.603 0 C-N-CA 123.502 2.801 . . . . 75.51 112.67 -174.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -66.41 -38.72 93.79 Favored Glycine 0 CA--C 1.545 1.958 0 CA-C-O 118.382 -1.232 . . . . 75.43 113.575 -179.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . 0.447 ' HD2' ' HB2' ' A' ' 241' ' ' PRO . 53.5 Cg_exo -46.3 -44.47 20.11 Favored 'Trans proline' 0 C--N 1.385 2.464 0 C-N-CA 123.047 2.498 . . . . 73.21 114.041 163.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -78.73 -23.81 45.22 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.675 0.79 . . . . 72.14 110.765 177.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 105.27 114.49 3.96 Favored Glycine 0 C--N 1.341 0.861 0 N-CA-C 108.458 -1.857 . . . . 44.31 108.458 -165.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.61 124.0 23.74 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.163 0.585 . . . . 72.33 109.53 -172.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -137.8 -156.69 7.28 Favored Glycine 0 N--CA 1.477 1.432 0 CA-C-O 119.886 -0.397 . . . . 24.21 112.305 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . 0.483 ' HB2' ' O ' ' A' ' 235' ' ' LEU . 6.5 p30 -123.0 167.54 13.47 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.178 0.591 . . . . 64.32 111.706 -175.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 11.7 tp -134.67 134.41 41.09 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.634 0.774 . . . . 62.11 109.265 -170.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 4.2 m-30 -118.94 148.94 42.41 Favored 'General case' 0 C--O 1.25 1.114 0 N-CA-C 108.708 -0.849 . . . . 74.35 108.708 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.466 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 88.4 mt -120.72 124.42 45.12 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.446 -0.576 . . . . 61.4 109.446 -177.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -91.51 100.82 13.51 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 107.197 -1.408 . . . . 74.45 107.197 -177.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.506 HG11 HG23 ' A' ' 227' ' ' THR . 55.7 t -63.15 123.58 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-O 121.488 0.661 . . . . 62.54 110.7 -178.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -114.66 123.5 49.46 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 107.606 -1.257 . . . . 70.51 107.606 177.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 47.0 mm -88.21 111.57 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 O-C-N 123.981 0.801 . . . . 74.22 110.181 -175.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.6 t . . . . . 0 C--O 1.255 1.376 0 C-N-CA 124.143 0.977 . . . . 42.04 110.196 -173.526 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 64.0 mtt . . . . . 0 N--CA 1.48 1.027 0 CA-C-O 120.725 0.298 . . . . 72.42 110.211 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -155.62 85.7 1.05 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.734 1.214 . . . . 74.23 108.829 179.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -53.53 -49.17 68.18 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.687 1.195 . . . . 73.01 112.915 -168.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -97.37 32.92 6.22 Favored Glycine 0 C--N 1.346 1.102 0 CA-C-N 116.207 -0.451 . . . . 54.12 112.852 -176.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -153.48 172.93 16.38 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 123.805 0.842 . . . . 65.11 110.477 177.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 45.7 t -115.33 152.71 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.559 1.143 . . . . 73.34 110.61 178.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 50.6 mtm -98.8 -177.69 3.73 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 125.226 1.41 . . . . 71.51 110.212 -169.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 7.7 p -99.05 87.79 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.065 0 CA-C-O 122.989 1.376 . . . . 53.14 107.49 162.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.1 -4.97 8.97 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 125.495 1.518 . . . . 63.14 109.979 -176.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 69.9 m -36.36 -66.15 0.23 Allowed 'General case' 0 C--N 1.35 0.612 0 C-N-CA 126.906 2.082 . . . . 74.1 114.559 -167.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . 0.409 ' HB2' ' HG3' ' A' ' 224' ' ' PRO . 77.2 t80 -63.22 -49.28 74.79 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 110.1 -0.333 . . . . 73.52 110.1 -177.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 68.21 97.61 0.04 OUTLIER Glycine 0 C--N 1.348 1.249 0 CA-C-N 115.149 -0.932 . . . . 35.42 111.453 -174.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -76.17 -83.1 0.07 Allowed 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 123.068 0.547 . . . . 63.44 111.767 -171.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 58.7 m -121.39 121.32 37.35 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 113.079 0.77 . . . . 62.2 113.079 -172.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -95.95 17.95 14.32 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 124.812 1.245 . . . . 74.42 110.071 165.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -58.19 174.31 0.29 Allowed 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.697 1.199 . . . . 72.23 111.597 169.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -42.59 -27.03 0.14 Allowed 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 126.007 1.723 . . . . 63.4 115.224 -172.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -60.76 -53.87 41.72 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 123.604 0.621 . . . . 72.22 114.483 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 76.7 p -153.43 157.5 40.02 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 122.903 0.481 . . . . 75.13 110.819 -177.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 115.78 -146.18 18.8 Favored Glycine 0 C--N 1.343 0.957 0 N-CA-C 111.274 -0.73 . . . . 70.32 111.274 -178.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 72.32 26.61 71.61 Favored Glycine 0 C--N 1.347 1.151 0 N-CA-C 113.777 0.271 . . . . 71.01 113.777 176.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 24.5 m -144.32 101.81 3.75 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.473 0.709 . . . . 71.22 109.234 179.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.541 ' HA2' ' HE3' ' A' ' 236' ' ' LYS . . . -117.07 159.64 13.9 Favored Glycine 0 C--N 1.337 0.591 0 N-CA-C 111.389 -0.684 . . . . 40.44 111.389 176.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -69.43 -66.09 2.36 Favored Glycine 0 C--N 1.346 1.139 0 N-CA-C 111.298 -0.721 . . . . 21.21 111.298 176.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 88.4 p 56.31 28.0 12.73 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 125.873 1.669 . . . . 75.14 112.628 177.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -114.49 148.24 18.83 Favored Glycine 0 C--N 1.345 1.057 0 CA-C-O 119.456 -0.636 . . . . 54.1 111.532 178.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -58.86 -65.91 3.16 Favored Glycine 0 C--N 1.35 1.33 0 C-N-CA 123.266 0.46 . . . . 54.04 113.159 -174.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 78.3 p -95.03 34.04 1.43 Allowed 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.406 0.682 . . . . 75.54 110.427 176.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.431 ' HG2' ' HA3' ' A' ' 245' ' ' GLY . 70.9 mt-30 -117.9 -45.23 2.68 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.496 0.718 . . . . 61.41 109.675 177.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -77.0 165.09 25.11 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-N 115.051 -0.977 . . . . 55.14 109.625 177.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 35.2 tp -151.47 139.14 19.71 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.933 -0.576 . . . . 71.25 109.841 178.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -116.55 140.21 49.64 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.411 1.084 . . . . 74.33 109.555 174.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -149.59 160.87 43.13 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 123.908 0.883 . . . . 54.34 108.781 168.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 34.7 p -83.91 154.4 23.43 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 121.757 0.789 . . . . 75.33 111.458 163.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.662 HD13 ' HB2' ' A' ' 212' ' ' ALA . 37.4 tp -121.11 132.05 54.63 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 113.768 -1.56 . . . . 62.34 107.152 162.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -93.18 111.36 22.97 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 108.248 -1.019 . . . . 63.41 108.248 -178.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.578 HG22 HG21 ' A' ' 210' ' ' VAL . 56.4 t -120.36 131.73 24.34 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 123.87 0.868 . . . . 72.32 108.892 -178.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -66.49 148.19 83.45 Favored 'Trans proline' 0 C--N 1.369 1.631 0 C-N-CA 121.957 1.771 . . . . 64.32 111.253 168.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.433 ' HB3' ' HD3' ' A' ' 202' ' ' PRO . . . -53.77 -46.78 98.27 Favored Pre-proline 0 CA--C 1.56 1.336 0 CA-C-O 118.609 -0.71 . . . . 41.11 111.523 174.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.433 ' HD3' ' HB3' ' A' ' 201' ' ' ALA . 73.0 Cg_exo -51.37 -39.62 63.14 Favored 'Trans proline' 0 C--N 1.396 3.061 0 C-N-CA 122.744 2.296 . . . . 73.24 114.08 172.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -84.99 -24.73 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 N-CA-C 109.525 -0.546 . . . . 73.44 109.525 -174.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.433 ' HA ' HG22 ' A' ' 227' ' ' THR . . . -74.21 -37.95 63.73 Favored 'General case' 0 C--O 1.247 0.955 0 CA-C-O 121.548 0.69 . . . . 73.42 111.552 179.052 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 14.1 t -88.14 -38.49 11.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 113.798 -1.547 . . . . 70.43 112.008 -177.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 90.3 t -97.15 -41.73 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 122.931 0.493 . . . . 53.41 110.37 -174.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 120.85 145.97 7.42 Favored Glycine 0 C--N 1.35 1.311 0 N-CA-C 110.803 -0.919 . . . . 73.14 110.803 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 166.96 154.66 8.55 Favored Glycine 0 C--O 1.247 0.959 0 CA-C-N 117.202 0.501 . . . . 52.45 112.715 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.626 ' HD3' ' HB3' ' A' ' 220' ' ' GLU . 38.8 ttmt -85.65 129.84 34.72 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.627 0.771 . . . . 70.32 110.09 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.578 HG21 HG22 ' A' ' 199' ' ' VAL . 14.0 m -131.05 151.46 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 123.917 0.887 . . . . 72.31 109.753 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -95.02 141.51 28.59 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 109.034 -0.728 . . . . 62.21 109.034 -172.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.662 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -132.37 120.96 22.74 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.841 0.856 . . . . 63.32 108.831 -176.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 34.6 tpp -77.79 110.16 12.42 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 108.625 -0.88 . . . . 73.03 108.625 173.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 61.0 p -116.92 -179.55 3.72 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.827 0.851 . . . . 73.11 110.068 -177.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.541 HD21 ' HD3' ' A' ' 241' ' ' PRO . 65.7 tp -46.03 -52.05 12.57 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.544 1.138 . . . . 64.33 112.159 175.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -72.97 -26.81 61.5 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.533 1.133 . . . . 62.41 111.738 -174.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 139.19 -166.61 25.42 Favored Glycine 0 C--N 1.343 0.941 0 CA-C-O 119.437 -0.646 . . . . 63.51 111.981 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.28 129.73 23.56 Favored 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 122.026 1.817 . . . . 73.24 111.021 175.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 24.7 m -130.37 160.84 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 123.363 0.665 . . . . 45.54 110.227 -177.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.626 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 45.2 mt-10 -112.81 111.42 22.18 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.393 0.677 . . . . 72.1 109.684 -173.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 62.7 t -121.63 103.18 13.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 124.887 1.275 . . . . 71.41 109.43 -173.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.618 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -78.95 118.12 20.67 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 110.004 -0.369 . . . . 42.44 110.004 175.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 33.7 m -86.18 150.08 51.39 Favored Pre-proline 0 N--CA 1.485 1.298 0 C-N-CA 122.936 0.494 . . . . 72.21 110.516 -177.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . 0.467 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 24.1 Cg_endo -62.66 163.1 22.46 Favored 'Trans proline' 0 C--N 1.384 2.411 0 C-N-CA 122.431 2.088 . . . . 73.15 112.912 178.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -83.85 35.58 0.56 Allowed 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 123.225 2.617 . . . . 55.51 112.945 177.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -150.6 -4.93 0.32 Allowed 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.06 0.544 . . . . 73.13 111.549 176.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.583 HG23 HG11 ' A' ' 253' ' ' VAL . 0.6 OUTLIER -60.59 151.14 29.61 Favored 'General case' 0 CA--C 1.57 1.735 0 N-CA-C 109.266 -0.642 . . . . 74.4 109.266 -165.529 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . 0.438 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 20.6 pt20 -134.2 162.43 32.16 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.025 0.53 . . . . 74.15 110.368 -170.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -56.53 111.33 0.97 Allowed 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 109.824 -0.436 . . . . 74.13 109.824 175.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 114.82 -0.29 23.01 Favored Glycine 0 C--N 1.337 0.615 0 CA-C-N 115.564 -0.744 . . . . 65.32 112.094 178.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.438 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -72.45 122.72 21.73 Favored 'General case' 0 C--N 1.354 0.782 0 N-CA-C 108.661 -0.866 . . . . 73.0 108.661 -173.808 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 10.8 mmmm -98.35 97.57 8.92 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 109.307 -0.627 . . . . 70.03 109.307 -168.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . . . . . . . . . 22.2 mt -80.5 97.06 6.97 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.14 -1.43 . . . . 74.42 107.14 -177.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.07 117.26 23.31 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.772 -0.649 . . . . 74.42 111.328 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 7.5 mp -97.69 127.55 43.73 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 105.807 -1.923 . . . . 70.35 105.807 171.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.541 ' HE3' ' HA2' ' A' ' 185' ' ' GLY . 15.3 tptt -101.23 115.45 30.53 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.525 0.33 . . . . 61.41 110.478 -167.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 77.84 32.49 45.11 Favored Glycine 0 C--N 1.349 1.281 0 O-C-N 123.922 0.764 . . . . 62.44 112.144 -175.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -125.98 23.41 7.19 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.796 0.838 . . . . 73.04 111.611 -174.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -93.8 -129.44 5.37 Favored Glycine 0 C--N 1.342 0.891 0 N-CA-C 110.916 -0.874 . . . . 3.41 110.916 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 6.9 m-30 -70.89 151.19 95.15 Favored Pre-proline 0 CA--C 1.551 1.011 0 CA-C-N 117.72 0.76 . . . . 64.03 111.678 177.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.541 ' HD3' HD21 ' A' ' 215' ' ' LEU . 60.3 Cg_endo -66.27 172.69 8.5 Favored 'Trans proline' 0 C--N 1.385 2.469 0 C-N-CA 123.561 2.841 . . . . 52.04 112.157 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.422 ' N ' ' HD2' ' A' ' 243' ' ' PRO . . . -66.35 -42.18 94.12 Favored Glycine 0 CA--C 1.545 1.964 0 CA-C-O 118.311 -1.272 . . . . 64.35 114.067 -174.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . 0.422 ' HD2' ' N ' ' A' ' 242' ' ' GLY . 9.3 Cg_endo -53.76 -36.44 82.2 Favored 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 122.74 2.293 . . . . 74.45 113.441 169.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -78.98 -24.07 44.03 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.318 0.647 . . . . 44.01 110.692 174.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . 0.431 ' HA3' ' HG2' ' A' ' 191' ' ' GLN . . . 109.33 116.05 3.84 Favored Glycine 0 C--N 1.344 1.018 0 N-CA-C 109.599 -1.4 . . . . 73.22 109.599 -170.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -72.36 124.48 25.21 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 117.355 0.577 . . . . 71.31 110.402 -178.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -140.07 -157.46 7.25 Favored Glycine 0 N--CA 1.466 0.639 0 N-CA-C 111.044 -0.823 . . . . 70.51 111.044 174.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 8.4 p30 -119.86 167.56 11.99 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 117.515 0.657 . . . . 71.42 110.708 -177.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 9.8 tp -133.53 133.92 42.76 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 108.923 -0.769 . . . . 61.05 108.923 -172.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -115.46 146.05 42.01 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 109.105 -0.702 . . . . 74.5 109.105 -177.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 81.2 mt -125.79 113.09 16.82 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 107.896 -1.15 . . . . 74.34 107.896 178.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -89.6 113.36 24.79 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.846 -0.798 . . . . 74.23 108.846 -177.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.583 HG11 HG23 ' A' ' 227' ' ' THR . 55.8 t -59.36 124.28 13.3 Favored 'Isoleucine or valine' 0 C--N 1.344 0.365 0 O-C-N 124.089 0.868 . . . . 71.24 109.479 178.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 8.4 mmt180 -122.9 122.79 39.47 Favored 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 107.376 -1.342 . . . . 64.01 107.376 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 48.9 mm -84.17 120.67 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 O-C-N 124.216 0.948 . . . . 63.2 110.603 -170.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.4 t . . . . . 0 CA--C 1.558 1.267 0 CA-C-O 118.038 -0.982 . . . . 51.2 109.691 -169.794 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 70.8 mtm . . . . . 0 N--CA 1.482 1.17 0 N-CA-C 109.715 -0.476 . . . . 72.35 109.715 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.415 ' HB2' ' HB3' ' A' ' 167' ' ' ALA . 16.0 ptpt -160.68 114.31 2.07 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.761 0.824 . . . . 74.42 110.426 -178.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -85.78 -44.25 12.65 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.37 1.068 . . . . 71.22 110.391 -177.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -97.27 16.89 60.03 Favored Glycine 0 C--N 1.348 1.208 0 CA-C-N 115.635 -0.711 . . . . 71.33 113.204 -176.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.415 ' HB3' ' HB2' ' A' ' 164' ' ' LYS . . . -141.0 171.88 13.45 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 123.88 0.872 . . . . 44.53 109.365 176.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.46 HG11 HG22 ' A' ' 221' ' ' VAL . 52.9 t -111.65 149.28 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-O 121.806 0.812 . . . . 74.11 111.25 -173.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 43.2 mtm -100.48 -175.49 2.93 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 126.362 1.865 . . . . 73.05 109.433 -166.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 9.1 p -99.28 87.97 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.147 0 CA-C-O 123.022 1.391 . . . . 65.43 107.856 163.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.51 -6.46 8.13 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 113.851 -1.522 . . . . 64.43 110.637 -175.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.54 ' HA ' ' HB3' ' A' ' 233' ' ' LEU . 68.5 m -44.36 -65.25 0.54 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.272 1.829 . . . . 75.35 113.586 -172.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . 0.42 ' HB2' ' HB3' ' A' ' 224' ' ' PRO . 42.6 t80 -75.0 -35.62 61.99 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.776 0.83 . . . . 73.0 109.588 -177.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 92.85 4.98 64.8 Favored Glycine 0 C--N 1.35 1.361 0 CA-C-N 115.113 -0.949 . . . . 44.45 112.835 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 12.9 m120 68.98 -1.09 2.18 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 124.907 1.283 . . . . 65.41 112.787 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 28.2 p -70.22 112.05 6.28 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.538 -0.912 . . . . 62.22 108.538 177.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -57.29 -24.86 57.67 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.289 1.036 . . . . 74.45 112.443 -171.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -68.08 141.79 56.02 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.594 0.758 . . . . 72.43 109.768 171.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -67.67 -36.87 81.51 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 123.783 0.833 . . . . 72.0 110.773 -171.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -86.04 142.54 19.13 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-N 114.426 -1.261 . . . . 54.3 111.938 175.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 39.0 p -162.72 131.87 4.2 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.04 0.936 . . . . 64.31 109.051 175.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -84.06 -94.35 0.67 Allowed Glycine 0 C--N 1.347 1.19 0 N-CA-C 112.711 -0.156 . . . . 72.41 112.711 -178.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 86.61 66.86 1.36 Allowed Glycine 0 C--N 1.343 0.952 0 C-N-CA 122.69 0.186 . . . . 74.13 112.675 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 80.2 p -84.61 177.57 8.02 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.375 0.67 . . . . 72.24 109.526 173.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -159.93 -125.15 0.77 Allowed Glycine 0 C--N 1.347 1.152 0 CA-C-O 119.328 -0.706 . . . . 61.15 113.371 -173.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -69.63 -72.88 0.8 Allowed Glycine 0 C--N 1.354 1.531 0 O-C-N 124.009 0.476 . . . . 73.55 113.721 -170.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.637 ' H ' ' HB2' ' A' ' 192' ' ' ASP . 14.8 m 73.76 -66.06 0.32 Allowed 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 125.84 1.656 . . . . 74.45 112.97 176.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -57.49 -40.11 91.77 Favored Glycine 0 C--N 1.351 1.412 0 N-CA-C 115.501 0.961 . . . . 71.51 115.501 -169.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -82.97 9.19 60.86 Favored Glycine 0 C--N 1.346 1.112 0 CA-C-O 118.867 -0.963 . . . . 71.13 114.396 -175.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 89.0 p 54.0 35.28 21.65 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 124.543 1.137 . . . . 74.12 112.005 -176.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -105.8 -22.83 12.85 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 125.219 1.408 . . . . 74.43 109.931 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.637 ' HB2' ' H ' ' A' ' 187' ' ' SER . 61.1 t0 -75.37 153.9 37.51 Favored 'General case' 0 C--O 1.244 0.791 0 CA-C-N 114.489 -1.232 . . . . 72.42 107.923 174.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 46.7 tp -147.54 141.42 25.82 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 122.802 0.441 . . . . 71.23 110.123 -170.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -116.69 139.44 50.55 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.322 0.649 . . . . 75.2 109.849 172.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -141.17 156.84 45.88 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 108.078 -1.082 . . . . 54.43 108.078 167.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 35.3 p -86.51 152.63 22.48 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-O 121.95 0.881 . . . . 64.55 111.656 168.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.674 HD13 ' HB2' ' A' ' 212' ' ' ALA . 42.4 tp -121.62 131.08 53.91 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 113.264 -1.789 . . . . 75.21 107.3 167.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -94.43 111.77 23.53 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 122.023 0.916 . . . . 53.43 108.982 -177.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.6 HG22 HG21 ' A' ' 210' ' ' VAL . 53.4 t -120.09 132.32 24.13 Favored Pre-proline 0 CA--C 1.546 0.789 0 CA-C-N 114.707 -1.133 . . . . 65.13 109.964 -176.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -68.96 147.28 67.65 Favored 'Trans proline' 0 C--N 1.372 1.807 0 C-N-CA 122.326 2.018 . . . . 52.33 111.269 167.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.418 ' HB3' ' HD3' ' A' ' 202' ' ' PRO . . . -53.2 -46.67 97.71 Favored Pre-proline 0 CA--C 1.569 1.686 0 C-N-CA 123.447 0.699 . . . . 75.2 111.945 174.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.418 ' HD3' ' HB3' ' A' ' 201' ' ' ALA . 78.2 Cg_exo -51.13 -39.97 60.49 Favored 'Trans proline' 0 C--N 1.396 3.033 0 C-N-CA 122.638 2.225 . . . . 61.53 113.817 172.092 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.7 mp -84.68 -23.13 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 N-CA-C 109.327 -0.62 . . . . 73.12 109.327 -174.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -73.32 -39.28 65.4 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 123.143 0.577 . . . . 53.31 111.897 178.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 39.7 t -88.93 -34.32 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 CA-C-N 114.787 -1.097 . . . . 75.34 113.201 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 54.5 t -97.96 -42.17 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 O-C-N 121.514 -0.741 . . . . 75.32 110.636 -175.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 123.52 152.36 8.45 Favored Glycine 0 C--N 1.341 0.836 0 N-CA-C 111.05 -0.82 . . . . 34.44 111.05 -176.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.45 149.21 5.71 Favored Glycine 0 C--O 1.242 0.647 0 N-CA-C 111.476 -0.65 . . . . 74.32 111.476 176.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.64 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 36.0 ttmt -85.62 130.0 34.68 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 109.444 -0.576 . . . . 73.12 109.444 174.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.6 HG21 HG22 ' A' ' 199' ' ' VAL . 8.7 m -130.64 151.4 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.46 1.104 . . . . 72.3 108.693 -178.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 47.7 ttt180 -94.68 140.38 29.96 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.188 -0.914 . . . . 75.54 109.558 -167.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.674 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -132.23 115.35 15.56 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.028 0.931 . . . . 73.43 109.097 -171.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 32.5 tpp -78.78 110.9 14.38 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 108.167 -1.049 . . . . 75.24 108.167 175.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 69.6 p -115.28 -176.25 2.87 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.56 0.744 . . . . 73.43 110.456 -176.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.598 HD21 ' HD3' ' A' ' 241' ' ' PRO . 66.3 tp -47.57 -51.68 20.22 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.624 1.169 . . . . 45.31 111.998 177.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -72.17 -27.95 62.91 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 114.507 -1.224 . . . . 70.13 111.078 -174.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 136.64 -165.91 24.93 Favored Glycine 0 C--N 1.34 0.79 0 N-CA-C 111.464 -0.654 . . . . 44.4 111.464 -175.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -65.9 132.62 30.9 Favored 'Trans proline' 0 C--N 1.368 1.59 0 C-N-CA 122.565 2.176 . . . . 73.33 112.024 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 31.5 m -132.6 160.82 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.432 1.093 . . . . 72.5 109.333 177.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.403 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 47.9 mt-10 -113.16 115.73 28.71 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 122.959 0.504 . . . . 63.22 110.035 -176.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.46 HG22 HG11 ' A' ' 168' ' ' VAL . 59.0 t -121.77 105.73 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.16 1.384 . . . . 73.25 110.705 -168.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.64 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -73.82 118.52 16.88 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.889 0.476 . . . . 71.55 110.946 176.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 27.1 m -88.66 150.59 46.4 Favored Pre-proline 0 N--CA 1.483 1.184 0 C-N-CA 122.566 0.346 . . . . 73.3 110.776 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . 0.491 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 33.1 Cg_endo -64.97 165.57 21.1 Favored 'Trans proline' 0 C--N 1.373 1.829 0 C-N-CA 122.625 2.217 . . . . 73.1 113.653 176.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -83.68 29.1 0.55 Allowed 'Trans proline' 0 C--N 1.374 1.874 0 C-N-CA 123.167 2.578 . . . . 74.13 113.664 172.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 35.4 mmt180 -143.97 -1.44 0.97 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.099 0.56 . . . . 73.41 111.505 177.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.544 HG23 HG11 ' A' ' 253' ' ' VAL . 0.6 OUTLIER -61.17 152.12 29.5 Favored 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 108.919 -0.771 . . . . 53.51 108.919 -166.27 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . 0.512 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 4.5 pt20 -135.31 163.03 30.91 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.314 0.645 . . . . 65.31 110.407 -174.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -61.1 110.76 1.46 Allowed 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 109.288 -0.634 . . . . 73.31 109.288 175.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.74 -0.25 21.57 Favored Glycine 0 CA--C 1.525 0.683 0 CA-C-N 115.369 -0.832 . . . . 75.44 112.308 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.512 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -68.26 125.45 26.45 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.737 0.815 . . . . 71.11 109.605 -174.189 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 49.2 mmtm -99.4 98.23 9.18 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.232 0.613 . . . . 74.4 109.504 -172.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.54 ' HB3' ' HA ' ' A' ' 172' ' ' SER . 22.5 mt -82.25 99.96 9.61 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 107.048 -1.464 . . . . 72.33 107.048 178.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -79.77 125.89 30.26 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 121.169 0.509 . . . . 75.25 110.99 -177.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 7.7 mp -111.13 127.91 55.72 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 105.999 -1.852 . . . . 74.35 105.999 172.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 41.4 tptt -101.75 117.89 35.81 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 118.054 0.388 . . . . 63.04 110.84 -173.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 79.22 30.69 45.08 Favored Glycine 0 C--N 1.347 1.159 0 O-C-N 123.481 0.488 . . . . 74.13 111.98 -178.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -127.43 20.51 6.72 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.007 0.923 . . . . 62.11 110.424 -176.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -96.92 -130.5 6.6 Favored Glycine 0 C--N 1.347 1.155 0 N-CA-C 111.19 -0.764 . . . . 45.34 111.19 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . 0.47 ' O ' ' HA ' ' A' ' 246' ' ' ARG . 4.8 m-30 -71.16 155.53 93.0 Favored Pre-proline 0 N--CA 1.478 0.931 0 N-CA-C 112.479 0.548 . . . . 62.41 112.479 -178.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.598 ' HD3' HD21 ' A' ' 215' ' ' LEU . 73.2 Cg_endo -69.35 171.81 13.35 Favored 'Trans proline' 0 C--N 1.388 2.633 0 C-N-CA 123.297 2.665 . . . . 74.25 112.396 -174.067 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.436 ' N ' ' HD2' ' A' ' 243' ' ' PRO . . . -66.81 -38.05 92.73 Favored Glycine 0 CA--C 1.544 1.851 0 CA-C-O 118.204 -1.331 . . . . 75.43 114.424 -176.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 242' ' ' GLY . 10.2 Cg_endo -52.27 -42.1 62.18 Favored 'Trans proline' 0 C--N 1.383 2.391 0 CA-C-N 120.696 2.248 . . . . 60.45 113.237 166.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -77.32 -23.04 51.06 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.546 0.738 . . . . 51.54 110.256 174.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 104.37 115.46 4.08 Favored Glycine 0 C--N 1.342 0.888 0 N-CA-C 109.33 -1.508 . . . . 74.33 109.33 -169.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 240' ' ' PHE . 38.4 ttp180 -69.04 124.08 22.79 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 117.663 0.731 . . . . 73.44 110.681 -178.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -133.93 -157.05 8.12 Favored Glycine 0 C--N 1.337 0.615 0 CA-C-N 115.193 -0.912 . . . . 72.01 111.003 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . 0.4 ' O ' ' HA ' ' A' ' 192' ' ' ASP . 0.2 OUTLIER -121.04 160.62 23.22 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.412 0.685 . . . . 73.12 110.764 -171.259 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 11.6 tp -135.32 133.79 39.18 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.729 0.811 . . . . 70.23 108.994 -172.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 3.5 m-30 -114.7 150.38 35.33 Favored 'General case' 0 C--O 1.245 0.867 0 N-CA-C 108.527 -0.916 . . . . 72.02 108.527 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 64.6 mt -121.13 113.4 19.96 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.548 -1.278 . . . . 64.45 107.548 178.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -88.61 112.16 22.74 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 107.556 -1.276 . . . . 72.12 107.556 -179.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.544 HG11 HG23 ' A' ' 227' ' ' THR . 55.7 t -62.28 128.69 24.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 115.085 -0.961 . . . . 63.22 110.509 177.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 42.5 mtp180 -115.08 125.27 53.32 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 106.805 -1.554 . . . . 64.13 106.805 171.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 48.3 mm -87.3 127.03 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 N-CA-C 109.576 -0.527 . . . . 73.35 109.576 -176.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.7 t . . . . . 0 CA--C 1.56 1.355 0 N-CA-C 108.275 -1.009 . . . . 64.3 108.275 -174.078 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . 0.438 ' SD ' ' N ' ' A' ' 163' ' ' MET . 1.1 mpt? . . . . . 0 N--CA 1.483 1.219 0 CA-C-O 120.703 0.287 . . . . 72.15 110.434 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 14.9 ttmm -71.24 110.85 6.14 Favored 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 109.044 -0.724 . . . . 73.25 109.044 -177.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -69.07 -66.61 0.56 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.143 0.977 . . . . 71.44 112.488 -167.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -101.77 26.74 23.32 Favored Glycine 0 C--N 1.344 0.974 0 CA-C-N 116.32 -0.4 . . . . 63.54 113.623 -178.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -154.0 173.17 16.35 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.993 0.917 . . . . 42.14 109.45 176.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 55.5 t -109.54 149.59 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 CA-C-O 121.822 0.82 . . . . 51.13 112.22 -169.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 39.4 mtm -100.97 -176.18 3.09 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.526 1.931 . . . . 62.51 110.17 -165.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 9.4 p -96.88 88.13 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 CA-C-O 122.939 1.352 . . . . 73.43 108.238 163.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.71 -4.8 8.14 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 114.418 -1.265 . . . . 75.31 110.64 -176.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.514 ' HA ' ' HB3' ' A' ' 233' ' ' LEU . 69.9 m -41.29 -66.12 0.37 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.493 1.917 . . . . 61.43 114.508 -169.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -67.18 -51.15 57.11 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.031 0.443 . . . . 74.41 110.829 -173.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 64.98 101.83 0.01 OUTLIER Glycine 0 C--N 1.341 0.846 0 CA-C-N 115.032 -0.986 . . . . 64.04 111.211 -169.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -61.51 90.79 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.399 0.68 . . . . 70.42 110.517 -176.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 50.2 m -84.14 117.72 23.66 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 114.853 -1.067 . . . . 61.25 111.418 -172.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -77.36 -5.41 49.54 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 114.58 -1.191 . . . . 73.42 110.487 166.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -79.56 160.54 26.41 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.088 0.955 . . . . 60.05 109.682 169.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -73.42 -18.2 61.17 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.211 0.604 . . . . 61.32 111.546 176.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -124.81 128.26 6.64 Favored Glycine 0 C--N 1.334 0.472 0 N-CA-C 111.399 -0.68 . . . . 64.11 111.399 175.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 16.4 t -94.11 120.44 34.37 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.693 0.797 . . . . 72.12 109.052 175.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -148.75 -101.19 0.24 Allowed Glycine 0 N--CA 1.467 0.747 0 N-CA-C 110.568 -1.013 . . . . 33.3 110.568 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 130.84 86.31 0.39 Allowed Glycine 0 C--N 1.346 1.094 0 N-CA-C 114.25 0.46 . . . . 61.21 114.25 170.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 54.5 p -86.36 156.66 20.11 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.876 0.87 . . . . 70.43 110.635 171.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -152.86 -138.43 2.71 Favored Glycine 0 C--N 1.34 0.796 0 N-CA-C 111.592 -0.603 . . . . 43.01 111.592 175.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -75.0 69.44 1.89 Allowed Glycine 0 C--N 1.344 0.978 0 C-N-CA 123.09 0.376 . . . . 41.05 112.818 176.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 23.1 t -80.64 110.72 16.4 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.604 -0.887 . . . . 73.22 108.604 178.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -153.17 -137.49 2.52 Favored Glycine 0 C--N 1.346 1.108 0 CA-C-O 120.171 -0.238 . . . . 72.31 113.182 -171.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -81.74 -59.32 2.36 Favored Glycine 0 C--N 1.347 1.179 0 C-N-CA 122.839 0.257 . . . . 51.54 113.518 -173.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 46.8 m -142.78 42.36 1.58 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.571 0.748 . . . . 53.42 109.802 -178.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.421 ' HA ' ' O ' ' A' ' 245' ' ' GLY . 23.1 mt-30 -108.94 -56.42 2.28 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-O 121.83 0.824 . . . . 63.14 109.085 175.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 29.3 p-10 -74.27 160.97 30.39 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 114.016 -1.447 . . . . 73.51 110.8 -177.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 48.5 tp -150.63 135.05 17.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.159 -0.928 . . . . 62.42 108.628 173.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -116.27 138.84 50.96 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.663 -0.866 . . . . 73.32 108.663 176.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -149.15 158.58 44.29 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.399 0.679 . . . . 44.41 109.406 171.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 37.0 p -81.33 154.37 26.54 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.924 0.869 . . . . 53.34 111.842 165.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.695 HD13 ' HB2' ' A' ' 212' ' ' ALA . 34.9 tp -125.74 133.48 52.07 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 113.52 -1.673 . . . . 74.23 106.924 170.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -94.68 111.7 23.47 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.79 -0.818 . . . . 74.11 108.79 -175.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.611 HG22 HG21 ' A' ' 210' ' ' VAL . 46.4 t -123.18 129.78 24.81 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 124.328 1.051 . . . . 65.54 109.813 -177.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -67.52 149.03 79.78 Favored 'Trans proline' 0 C--N 1.365 1.429 0 C-N-CA 122.586 2.191 . . . . 63.11 112.079 169.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.426 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.3 -46.96 97.67 Favored Pre-proline 0 CA--C 1.562 1.432 0 CA-C-O 118.353 -0.832 . . . . 54.01 112.446 173.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.459 ' O ' ' HB ' ' A' ' 206' ' ' VAL . 24.2 Cg_endo -60.43 -31.77 93.0 Favored 'Trans proline' 0 C--N 1.395 3.017 0 C-N-CA 121.719 1.613 . . . . 43.2 112.461 177.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.7 mp -86.2 -22.96 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 N-CA-C 109.475 -0.565 . . . . 71.33 109.475 -178.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.407 ' HA ' HG22 ' A' ' 227' ' ' THR . . . -73.31 -37.96 65.99 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 122.989 0.516 . . . . 61.1 111.098 176.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 19.5 t -89.2 -33.18 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.977 1.311 . . . . 74.51 113.011 -178.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.459 ' HB ' ' O ' ' A' ' 202' ' ' PRO . 51.2 t -100.49 -43.18 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 O-C-N 121.611 -0.68 . . . . 61.34 110.726 -176.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 121.22 152.18 8.73 Favored Glycine 0 N--CA 1.466 0.699 0 N-CA-C 110.811 -0.916 . . . . 74.35 110.811 -176.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.71 152.98 7.25 Favored Glycine 0 C--O 1.243 0.658 0 N-CA-C 111.671 -0.572 . . . . 71.11 111.671 177.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.572 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 30.2 tttt -85.62 130.41 34.58 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.747 -0.834 . . . . 73.33 108.747 176.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.611 HG21 HG22 ' A' ' 199' ' ' VAL . 13.1 m -129.1 151.83 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 N-CA-C 108.632 -0.877 . . . . 75.41 108.632 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . 0.409 ' HD2' ' N ' ' A' ' 212' ' ' ALA . 6.2 tmm_? -94.09 142.14 27.73 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 109.322 -0.622 . . . . 74.04 109.322 -169.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.695 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -132.73 119.24 20.08 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.083 0.953 . . . . 65.31 108.612 -177.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 37.4 tpp -79.68 107.66 12.63 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 107.756 -1.201 . . . . 74.15 107.756 173.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 63.9 p -117.03 -174.8 2.66 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.24 0.616 . . . . 51.34 110.77 -172.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.519 HD21 ' HD3' ' A' ' 241' ' ' PRO . 64.9 tp -48.73 -51.94 26.19 Favored 'General case' 0 C--N 1.358 0.963 0 C-N-CA 123.896 0.879 . . . . 72.11 111.872 175.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -72.46 -28.31 62.84 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.234 -0.894 . . . . 74.34 110.701 -173.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 138.4 -166.58 25.23 Favored Glycine 0 C--N 1.341 0.829 0 CA-C-O 119.648 -0.529 . . . . 44.22 112.186 -174.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -64.92 129.56 23.56 Favored 'Trans proline' 0 C--N 1.369 1.609 0 C-N-CA 122.454 2.103 . . . . 73.4 111.286 176.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.437 HG22 ' O ' ' A' ' 212' ' ' ALA . 21.0 m -133.28 160.66 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 123.445 0.698 . . . . 60.54 110.558 -176.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -113.12 115.43 28.28 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.893 0.877 . . . . 65.53 109.746 -176.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 58.5 t -121.96 103.55 13.62 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.887 0 C-N-CA 124.866 1.266 . . . . 74.21 110.103 -170.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.572 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -77.88 118.22 19.99 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.605 0.362 . . . . 63.52 110.673 177.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 34.0 m -89.01 152.33 48.17 Favored Pre-proline 0 N--CA 1.48 1.064 0 C-N-CA 123.27 0.628 . . . . 73.43 111.225 -177.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . 0.584 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 32.0 Cg_endo -63.73 164.08 22.55 Favored 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 122.593 2.195 . . . . 61.04 113.094 175.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -86.74 28.73 0.53 Allowed 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 123.137 2.558 . . . . 63.21 113.393 177.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 60.1 mmt-85 -145.64 1.21 0.9 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.335 0.654 . . . . 74.2 111.705 176.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.637 HG23 HG11 ' A' ' 253' ' ' VAL . 0.7 OUTLIER -61.26 154.97 22.19 Favored 'General case' 0 CA--C 1.57 1.747 0 O-C-N 123.383 0.427 . . . . 70.32 110.116 -168.986 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . 0.465 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 13.8 pt20 -140.7 162.62 34.98 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.318 0.647 . . . . 74.01 110.63 -174.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -59.27 111.56 1.4 Allowed 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 121.14 0.495 . . . . 62.44 110.527 -178.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.44 0.56 21.94 Favored Glycine 0 CA--C 1.519 0.324 0 CA-C-N 114.882 -1.053 . . . . 74.24 111.823 179.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -69.12 125.12 25.69 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 109.051 -0.722 . . . . 74.21 109.051 -175.065 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -98.55 98.44 9.62 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.146 0.578 . . . . 72.54 109.7 -169.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.514 ' HB3' ' HA ' ' A' ' 172' ' ' SER . 21.5 mt -81.87 100.31 9.54 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.253 -1.388 . . . . 72.14 107.253 -179.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.61 126.11 30.84 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.245 0.545 . . . . 64.41 111.205 -178.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.546 ' HB3' ' HB2' ' A' ' 238' ' ' LYS . 7.3 mp -110.07 124.93 52.38 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 105.948 -1.871 . . . . 75.14 105.948 173.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.32 115.34 30.36 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.079 0.552 . . . . 73.02 111.652 -172.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 76.99 31.82 51.7 Favored Glycine 0 C--N 1.351 1.375 0 CA-C-N 115.05 -0.977 . . . . 73.23 111.92 -175.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.546 ' HB2' ' HB3' ' A' ' 235' ' ' LEU . 30.5 mmmt -128.91 19.96 5.99 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.833 0.853 . . . . 74.21 111.204 -176.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -96.93 -134.56 8.21 Favored Glycine 0 C--N 1.343 0.943 0 N-CA-C 111.633 -0.587 . . . . 74.3 111.633 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 4.6 m-30 -70.09 151.78 95.95 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 122.676 0.39 . . . . 63.24 111.754 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.519 ' HD3' HD21 ' A' ' 215' ' ' LEU . 60.8 Cg_endo -66.97 172.14 10.19 Favored 'Trans proline' 0 C--N 1.381 2.262 0 C-N-CA 123.532 2.821 . . . . 64.21 112.373 -177.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -66.36 -38.68 93.82 Favored Glycine 0 CA--C 1.539 1.56 0 CA-C-O 118.158 -1.356 . . . . 71.42 114.012 -177.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . 0.463 ' HD2' ' HB2' ' A' ' 241' ' ' PRO . 73.8 Cg_exo -45.73 -45.99 15.87 Favored 'Trans proline' 0 C--N 1.385 2.475 0 C-N-CA 122.771 2.314 . . . . 74.25 114.033 165.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -80.34 -24.45 39.86 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.535 0.734 . . . . 72.21 111.05 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 191' ' ' GLN . . . 113.34 112.29 3.07 Favored Glycine 0 C--N 1.337 0.63 0 N-CA-C 109.617 -1.393 . . . . 73.2 109.617 -169.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.93 123.09 17.63 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.7 0.8 . . . . 73.0 110.457 -179.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -147.67 -155.63 6.68 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-N 116.236 -0.438 . . . . 43.4 113.319 -175.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -119.91 164.17 16.46 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.745 0.818 . . . . 45.12 110.197 -170.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 10.3 tp -134.02 133.53 41.36 Favored 'General case' 0 C--O 1.214 -0.815 0 N-CA-C 107.634 -1.247 . . . . 63.2 107.634 -178.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -122.11 146.18 47.45 Favored 'General case' 0 C--O 1.246 0.908 0 N-CA-C 108.389 -0.967 . . . . 63.1 108.389 -177.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 88.1 mt -124.82 115.91 21.42 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.807 0.843 . . . . 41.43 108.857 -176.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -89.09 110.16 20.92 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.815 -1.18 . . . . 64.53 107.815 -176.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.637 HG11 HG23 ' A' ' 227' ' ' THR . 45.4 t -60.04 128.54 21.21 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.365 0 O-C-N 123.872 0.733 . . . . 54.02 109.73 -179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.84 123.35 45.69 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 105.981 -1.859 . . . . 63.52 105.981 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 48.8 mm -86.38 117.95 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 109.006 -0.739 . . . . 74.22 109.006 -177.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.2 t . . . . . 0 CA--C 1.557 1.245 0 N-CA-C 107.687 -1.227 . . . . 73.34 107.687 -174.0 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 26.9 ttt . . . . . 0 N--CA 1.482 1.161 0 N-CA-C 110.227 -0.286 . . . . 75.1 110.227 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.627 ' HG2' ' HB3' ' A' ' 167' ' ' ALA . 36.2 ttpt -75.84 95.6 3.53 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 107.819 -1.178 . . . . 64.2 107.819 173.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -77.77 -45.71 23.8 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.676 1.19 . . . . 73.11 113.616 -162.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -98.34 20.02 52.13 Favored Glycine 0 N--CA 1.474 1.232 0 C-N-CA 122.761 0.22 . . . . 70.25 112.759 -175.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.627 ' HB3' ' HG2' ' A' ' 164' ' ' LYS . . . -148.06 172.06 14.85 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.722 0.809 . . . . 74.53 109.538 -179.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.435 HG11 HG22 ' A' ' 221' ' ' VAL . 53.6 t -111.43 150.58 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 CA-C-O 121.906 0.86 . . . . 54.44 112.139 -166.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 40.6 mtm -99.69 -175.68 3.05 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 126.051 1.74 . . . . 63.32 109.263 -169.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 10.3 p -97.28 88.12 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.184 0 CA-C-O 122.858 1.313 . . . . 74.41 108.275 164.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.27 -5.16 8.34 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 113.771 -1.559 . . . . 73.42 109.945 -178.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.426 ' HA ' ' HB3' ' A' ' 233' ' ' LEU . 67.0 m -39.22 -64.93 0.42 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 127.029 2.132 . . . . 62.04 114.578 -169.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . 0.419 ' HB2' ' HB3' ' A' ' 224' ' ' PRO . 72.6 t80 -62.68 -35.31 79.26 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.462 0.705 . . . . 73.43 110.901 -176.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 85.62 47.59 5.05 Favored Glycine 0 C--N 1.339 0.717 0 N-CA-C 108.727 -1.749 . . . . 74.21 108.727 -164.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -62.26 81.82 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.245 1.418 . . . . 71.45 111.892 -173.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 45.4 m -104.12 122.39 45.22 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.484 1.114 . . . . 70.21 109.447 -178.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -60.62 -33.6 73.0 Favored 'General case' 0 CA--C 1.55 0.966 0 O-C-N 123.831 0.707 . . . . 64.23 110.833 178.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 16.7 mp0 -97.31 171.34 8.48 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.427 1.091 . . . . 74.02 110.049 174.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -64.71 -35.41 80.97 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.831 0.852 . . . . 74.31 111.133 175.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -72.7 86.13 0.54 Allowed Glycine 0 C--N 1.34 0.8 0 CA-C-N 114.565 -1.198 . . . . 73.31 112.681 -176.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . 0.45 ' HB3' ' NH2' ' A' ' 234' ' ' ARG . 27.1 m -83.8 -26.06 29.9 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.204 1.002 . . . . 54.21 110.669 175.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 86.78 -162.3 34.14 Favored Glycine 0 C--N 1.354 1.541 0 O-C-N 123.781 0.676 . . . . 72.44 112.696 -178.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -174.48 21.25 0.06 OUTLIER Glycine 0 N--CA 1.468 0.77 0 N-CA-C 111.823 -0.511 . . . . 62.13 111.823 175.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 31.5 m -82.05 116.75 21.79 Favored 'General case' 0 C--O 1.243 0.741 0 C-N-CA 123.533 0.733 . . . . 71.2 110.736 -176.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 177.03 58.74 0.06 OUTLIER Glycine 0 C--N 1.345 1.045 0 CA-C-N 115.979 -0.555 . . . . 75.23 111.823 177.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 82.19 -65.45 4.07 Favored Glycine 0 CA--C 1.531 1.051 0 N-CA-C 112.141 -0.384 . . . . 75.31 112.141 178.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 42.4 m 61.06 33.72 19.48 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.35 1.06 . . . . 62.43 111.93 173.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 117.82 43.22 0.58 Allowed Glycine 0 C--N 1.347 1.178 0 CA-C-N 115.222 -0.899 . . . . 64.11 111.486 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -113.96 0.45 24.24 Favored Glycine 0 C--N 1.351 1.383 0 CA-C-O 119.671 -0.516 . . . . 72.12 112.804 -178.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 23.1 t 62.03 17.51 9.13 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 124.556 1.142 . . . . 42.21 111.426 -174.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -106.03 -33.79 7.78 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.756 1.623 . . . . 74.04 107.482 176.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.444 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 17.9 p-10 -74.3 160.7 30.74 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 113.08 -1.873 . . . . 72.13 110.411 170.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.456 HD23 HD13 ' A' ' 249' ' ' LEU . 57.6 tp -149.22 143.74 26.11 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.779 -0.646 . . . . 72.35 109.749 -174.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -116.25 139.13 50.69 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.911 0.885 . . . . 70.05 110.169 174.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -148.59 157.39 43.43 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.257 1.023 . . . . 33.12 108.979 173.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 24.9 p -83.75 153.43 24.14 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 122.091 0.948 . . . . 72.52 112.663 168.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.669 HD13 ' HB2' ' A' ' 212' ' ' ALA . 31.6 tp -126.29 133.67 51.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 112.909 -1.951 . . . . 64.05 106.971 167.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -94.3 114.03 26.04 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.206 -1.035 . . . . 75.21 108.206 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.621 HG22 HG21 ' A' ' 210' ' ' VAL . 48.9 t -121.56 132.0 24.32 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 124.186 0.994 . . . . 62.43 109.688 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -69.24 144.21 56.0 Favored 'Trans proline' 0 C--N 1.37 1.703 0 C-N-CA 122.289 1.993 . . . . 74.43 111.014 166.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.435 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -54.48 -42.21 93.31 Favored Pre-proline 0 CA--C 1.565 1.54 0 CA-C-O 118.059 -0.972 . . . . 73.34 112.544 173.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 11.5 Cg_endo -55.22 -36.63 93.79 Favored 'Trans proline' 0 C--N 1.404 3.465 0 C-N-CA 121.885 1.723 . . . . 74.55 112.83 172.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -85.46 -23.89 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 N-CA-C 109.14 -0.689 . . . . 71.41 109.14 -177.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.461 ' HA ' HG22 ' A' ' 227' ' ' THR . . . -73.83 -37.33 64.88 Favored 'General case' 0 C--O 1.247 0.934 0 CA-C-O 121.44 0.638 . . . . 75.21 111.299 179.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 25.2 t -88.71 -38.0 10.93 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-N 113.72 -1.582 . . . . 63.41 112.435 -177.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 76.1 t -97.51 -42.59 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 O-C-N 122.13 -0.356 . . . . 73.11 110.341 -176.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 121.1 148.95 8.06 Favored Glycine 0 C--N 1.341 0.855 0 N-CA-C 110.612 -0.995 . . . . 63.34 110.612 -176.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 165.73 155.39 8.66 Favored Glycine 0 C--O 1.246 0.876 0 N-CA-C 111.856 -0.497 . . . . 63.34 111.856 178.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.648 ' HD3' ' HB3' ' A' ' 220' ' ' GLU . 3.5 ttmp? -84.94 131.22 34.52 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.373 0.669 . . . . 75.43 109.701 178.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.621 HG21 HG22 ' A' ' 199' ' ' VAL . 9.5 m -130.04 151.76 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.444 1.098 . . . . 75.14 108.642 177.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? -95.5 140.84 29.78 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 108.976 -0.75 . . . . 74.31 108.976 -172.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.669 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -131.25 119.8 22.32 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.719 -0.845 . . . . 74.14 108.719 -177.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 37.3 tpp -79.35 107.35 12.05 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 107.592 -1.262 . . . . 74.53 107.592 172.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . 0.42 HG22 HD21 ' A' ' 251' ' ' LEU . 71.5 p -112.43 -173.55 2.27 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.836 0.854 . . . . 62.32 110.878 -174.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 61.7 tp -44.98 -52.63 8.59 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.314 1.046 . . . . 64.53 112.063 167.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -71.81 -26.53 62.44 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 114.263 -1.335 . . . . 62.2 111.46 -169.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 131.09 -165.77 22.95 Favored Glycine 0 C--N 1.34 0.777 0 N-CA-C 110.661 -0.976 . . . . 52.5 110.661 -171.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -65.78 131.02 26.17 Favored 'Trans proline' 0 C--N 1.37 1.67 0 C-N-CA 121.89 1.727 . . . . 64.42 110.715 175.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 212' ' ' ALA . 26.6 m -133.36 162.82 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 123.754 0.821 . . . . 62.41 110.495 -178.283 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.648 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 38.3 mt-10 -112.02 116.07 29.96 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.395 1.078 . . . . 72.23 109.307 -175.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.435 HG22 HG11 ' A' ' 168' ' ' VAL . 44.5 t -124.32 103.28 12.31 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 C-N-CA 124.233 1.013 . . . . 75.33 109.635 -173.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.534 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -78.1 118.4 20.32 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.552 -0.536 . . . . 74.1 109.552 173.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 34.7 m -89.03 151.43 46.95 Favored Pre-proline 0 N--CA 1.483 1.182 0 C-N-CA 123.031 0.532 . . . . 52.43 110.54 -178.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . 0.468 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 41.4 Cg_endo -65.22 165.83 20.88 Favored 'Trans proline' 0 C--N 1.38 2.189 0 C-N-CA 122.939 2.426 . . . . 54.44 113.412 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -80.27 31.97 0.5 Allowed 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 123.163 2.575 . . . . 54.4 113.1 172.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -150.17 -2.32 0.39 Allowed 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 112.275 0.472 . . . . 74.4 112.275 178.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.569 HG23 HG11 ' A' ' 253' ' ' VAL . 0.6 OUTLIER -59.95 150.48 28.75 Favored 'General case' 0 CA--C 1.566 1.596 0 N-CA-C 108.901 -0.778 . . . . 74.34 108.901 -168.423 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . 0.441 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 4.5 pt20 -133.36 162.2 32.47 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.039 0.535 . . . . 74.21 109.876 -171.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . 0.589 ' HB1' HH21 ' A' ' 254' ' ' ARG . . . -59.18 111.52 1.37 Allowed 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 109.318 -0.623 . . . . 71.01 109.318 174.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 114.89 1.16 22.71 Favored Glycine 0 C--N 1.338 0.641 0 CA-C-N 115.696 -0.684 . . . . 71.04 112.013 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.441 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -69.66 123.76 22.21 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 108.967 -0.753 . . . . 72.54 108.967 -174.098 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.439 ' HB3' ' HD1' ' A' ' 250' ' ' TYR . 30.7 mmmt -100.15 97.21 8.05 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 108.767 -0.827 . . . . 73.34 108.767 -172.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 250' ' ' TYR . 20.3 mt -81.51 99.07 8.58 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 106.406 -1.701 . . . . 64.22 106.406 -176.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . 0.696 ' HD3' ' HE2' ' A' ' 236' ' ' LYS . 0.5 OUTLIER -83.02 126.16 32.24 Favored 'General case' 0 CA--C 1.561 1.401 0 C-N-CA 123.854 0.862 . . . . 71.43 112.262 179.803 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.442 ' HB3' ' HB2' ' A' ' 238' ' ' LYS . 7.6 mp -113.72 124.44 52.3 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.964 1.306 . . . . 72.14 108.697 -176.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.696 ' HE2' ' HD3' ' A' ' 234' ' ' ARG . 5.2 mptp? -94.31 115.11 27.29 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 118.537 0.608 . . . . 73.41 110.942 -169.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 77.48 20.48 74.48 Favored Glycine 0 C--N 1.349 1.283 0 O-C-N 124.236 0.96 . . . . 72.44 112.305 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.442 ' HB2' ' HB3' ' A' ' 235' ' ' LEU . 1.0 OUTLIER -117.45 19.46 14.0 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.814 0.846 . . . . 62.12 110.037 -178.575 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -95.85 -139.98 10.72 Favored Glycine 0 C--N 1.35 1.338 0 N-CA-C 110.951 -0.86 . . . . 53.21 110.951 176.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . 0.435 ' O ' ' HA ' ' A' ' 246' ' ' ARG . 6.1 m-30 -61.11 146.94 87.32 Favored Pre-proline 0 N--CA 1.477 0.878 0 N-CA-C 112.645 0.609 . . . . 72.4 112.645 -175.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -59.71 171.08 2.96 Favored 'Trans proline' 0 C--N 1.385 2.497 0 C-N-CA 123.486 2.791 . . . . 75.24 112.524 -178.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.42 ' N ' ' HD2' ' A' ' 243' ' ' PRO . . . -67.64 -41.34 89.74 Favored Glycine 0 CA--C 1.552 2.392 0 CA-C-O 118.284 -1.287 . . . . 73.11 114.237 -174.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' A' ' 242' ' ' GLY . 10.8 Cg_endo -55.57 -36.5 94.63 Favored 'Trans proline' 0 C--N 1.392 2.843 0 C-N-CA 122.749 2.299 . . . . 70.54 112.914 168.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -77.47 -24.67 50.17 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.24 0.616 . . . . 65.51 110.688 174.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 106.68 115.59 4.03 Favored Glycine 0 C--N 1.341 0.821 0 N-CA-C 109.34 -1.504 . . . . 42.42 109.34 -172.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.435 ' HA ' ' O ' ' A' ' 240' ' ' PHE . 29.0 ttm180 -72.87 123.9 24.32 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 117.603 0.702 . . . . 71.3 111.274 -177.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -139.65 -152.74 5.92 Favored Glycine 0 C--N 1.341 0.83 0 CA-C-N 114.808 -1.087 . . . . 73.0 112.304 -177.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . 0.444 ' O ' ' HA ' ' A' ' 192' ' ' ASP . 11.0 t70 -114.69 163.01 16.06 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.403 1.081 . . . . 71.12 108.705 -168.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.456 HD13 HD23 ' A' ' 193' ' ' LEU . 18.8 tp -134.84 132.77 39.01 Favored 'General case' 0 C--O 1.214 -0.804 0 N-CA-C 109.209 -0.663 . . . . 71.25 109.209 -177.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.471 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 0.4 OUTLIER -112.04 145.27 39.99 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-O 121.688 0.756 . . . . 73.21 109.691 178.856 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.42 HD21 HG22 ' A' ' 214' ' ' THR . 72.5 mt -125.65 113.85 17.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 113.909 -1.496 . . . . 74.51 107.602 174.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -91.54 109.55 20.86 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 107.774 -1.195 . . . . 52.15 107.774 -173.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.569 HG11 HG23 ' A' ' 227' ' ' THR . 52.1 t -61.53 122.77 12.94 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 O-C-N 124.301 1.0 . . . . 72.31 109.988 -179.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . 0.589 HH21 ' HB1' ' A' ' 229' ' ' ALA . 0.3 OUTLIER -115.2 122.89 47.41 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 106.872 -1.529 . . . . 74.45 106.872 176.878 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 44.9 mm -87.62 114.97 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 O-C-N 123.918 0.761 . . . . 63.33 110.108 -174.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 CA--C 1.56 1.362 0 C-N-CA 124.09 0.956 . . . . 75.35 109.516 -172.057 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . 0.571 ' HA ' ' SD ' ' A' ' 169' ' ' MET . 44.6 ttm . . . . . 0 N--CA 1.482 1.175 0 N-CA-C 109.363 -0.606 . . . . 62.2 109.363 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -104.21 126.25 51.17 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 108.767 -0.827 . . . . 74.42 108.767 171.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -78.29 -52.85 8.02 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.783 0.833 . . . . 65.13 111.552 -173.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -97.26 13.01 65.03 Favored Glycine 0 C--N 1.346 1.089 0 CA-C-N 116.208 -0.451 . . . . 54.33 113.033 -177.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -146.27 169.24 19.21 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.851 0.86 . . . . 50.3 109.47 176.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.422 HG11 HG22 ' A' ' 221' ' ' VAL . 54.4 t -110.93 151.13 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 123.669 0.788 . . . . 72.24 110.119 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.571 ' SD ' ' HA ' ' A' ' 163' ' ' MET . 42.9 mtm -99.17 -176.91 3.45 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 125.552 1.541 . . . . 73.14 109.515 -167.029 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 12.6 p -100.53 86.32 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 CA-C-O 123.428 1.585 . . . . 73.31 107.453 165.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . 0.485 ' HG3' ' HA ' ' A' ' 235' ' ' LEU . 0.0 OUTLIER -124.07 -3.86 8.03 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 113.394 -1.73 . . . . 54.32 110.263 -173.554 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.559 ' HB3' HD22 ' A' ' 233' ' ' LEU . 66.7 m -44.74 -69.84 0.12 Allowed 'General case' 0 C--N 1.351 0.65 0 C-N-CA 125.856 1.662 . . . . 74.41 113.542 -166.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . 0.516 ' HB2' ' HG3' ' A' ' 224' ' ' PRO . 50.8 t80 -69.47 -47.68 63.19 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 108.215 -1.031 . . . . 74.42 108.215 -179.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 47.89 44.47 24.79 Favored Glycine 0 C--N 1.361 1.959 0 O-C-N 125.007 1.442 . . . . 54.41 114.702 165.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -89.65 168.3 12.24 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.634 0.73 . . . . 74.11 111.12 -177.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 18.7 m -87.93 126.19 34.92 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 106.216 -1.772 . . . . 74.14 106.216 163.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -49.96 -23.87 2.25 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 124.271 1.028 . . . . 62.23 111.33 -178.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -60.02 176.84 0.28 Allowed 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 126.257 1.823 . . . . 73.12 111.709 169.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -43.62 -46.97 7.49 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 114.794 1.405 . . . . 73.34 114.794 -175.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -132.88 -164.26 10.83 Favored Glycine 0 N--CA 1.47 0.917 0 CA-C-N 115.843 -0.617 . . . . 41.22 112.256 -176.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 23.7 t -138.55 153.26 48.71 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.422 0.689 . . . . 70.21 109.884 176.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -132.77 102.37 0.48 Allowed Glycine 0 C--N 1.34 0.77 0 N-CA-C 109.981 -1.247 . . . . 63.34 109.981 178.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -155.04 59.34 0.38 Allowed Glycine 0 C--N 1.346 1.112 0 N-CA-C 111.748 -0.541 . . . . 63.44 111.748 -176.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 24.1 t -81.92 176.33 9.66 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.668 0.787 . . . . 74.42 110.221 177.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -69.25 163.81 50.83 Favored Glycine 0 C--N 1.346 1.131 0 N-CA-C 115.733 1.053 . . . . 72.44 115.733 -168.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -76.43 -29.26 58.38 Favored Glycine 0 C--N 1.349 1.269 0 CA-C-N 114.982 -0.609 . . . . 53.53 112.847 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 44.3 t -165.41 -58.03 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.033 0.533 . . . . 64.13 110.502 177.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 100.03 -9.25 59.72 Favored Glycine 0 C--N 1.35 1.355 0 CA-C-O 119.652 -0.527 . . . . 74.23 113.943 -178.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -65.29 -68.8 1.53 Allowed Glycine 0 C--N 1.349 1.303 0 CA-C-N 116.821 0.31 . . . . 62.24 112.396 179.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 44.4 m -145.94 30.22 1.07 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.994 0.918 . . . . 72.41 109.432 179.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.435 ' HG2' ' HA3' ' A' ' 245' ' ' GLY . 75.0 mt-30 -116.69 -50.19 2.62 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.734 0.813 . . . . 62.51 110.752 -173.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -85.35 158.8 20.17 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 114.908 -1.042 . . . . 72.41 110.081 -174.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 53.6 tp -150.31 142.48 24.1 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.04 0.536 . . . . 62.23 110.042 -176.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -114.1 142.07 46.68 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.677 0.791 . . . . 74.32 109.286 173.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -148.62 162.4 39.77 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 123.936 0.894 . . . . 73.21 108.916 173.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 34.6 p -85.95 154.6 21.36 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 122.015 0.912 . . . . 65.15 111.984 166.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.678 HD13 ' HB2' ' A' ' 212' ' ' ALA . 29.2 tp -124.55 133.63 53.24 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 113.404 -1.725 . . . . 73.41 107.172 160.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -93.33 114.03 26.37 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 108.205 -1.035 . . . . 74.42 108.205 178.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.611 HG22 HG21 ' A' ' 210' ' ' VAL . 46.1 t -121.56 131.15 24.51 Favored Pre-proline 0 CA--C 1.546 0.803 0 CA-C-N 115.049 -0.978 . . . . 74.52 109.018 -178.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -68.59 148.27 72.07 Favored 'Trans proline' 0 C--N 1.364 1.391 0 C-N-CA 122.522 2.148 . . . . 61.43 111.379 169.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.411 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.28 -45.75 98.24 Favored Pre-proline 0 CA--C 1.558 1.262 0 CA-C-O 118.597 -0.716 . . . . 53.54 112.887 174.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.432 ' O ' ' HB ' ' A' ' 206' ' ' VAL . 30.1 Cg_endo -61.16 -30.15 88.22 Favored 'Trans proline' 0 C--N 1.395 2.998 0 C-N-CA 121.685 1.59 . . . . 74.43 112.193 178.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -86.47 -25.37 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 N-CA-C 109.482 -0.562 . . . . 74.42 109.482 -177.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -73.4 -37.67 65.87 Favored 'General case' 0 C--O 1.247 0.936 0 C-N-CA 122.89 0.476 . . . . 74.04 111.18 178.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 25.6 t -88.36 -38.0 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 C-N-CA 124.884 1.274 . . . . 73.41 112.869 -178.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.432 ' HB ' ' O ' ' A' ' 202' ' ' PRO . 54.5 t -97.26 -41.47 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 O-C-N 121.841 -0.537 . . . . 74.24 110.545 -175.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 121.61 148.15 7.79 Favored Glycine 0 C--N 1.341 0.847 0 N-CA-C 110.789 -0.925 . . . . 73.41 110.789 -177.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 166.51 151.41 6.8 Favored Glycine 0 C--O 1.245 0.792 0 N-CA-C 112.098 -0.401 . . . . 44.4 112.098 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.664 ' HD3' ' HB3' ' A' ' 220' ' ' GLU . 37.5 ttmt -85.06 132.39 34.33 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.781 0.832 . . . . 71.15 109.615 175.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.611 HG21 HG22 ' A' ' 199' ' ' VAL . 11.2 m -136.11 152.18 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.365 1.066 . . . . 75.54 109.407 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 8.8 tmm_? -94.59 142.83 26.99 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.581 0.752 . . . . 70.1 110.711 -170.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.678 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -131.17 123.12 27.83 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.912 0.885 . . . . 63.2 109.366 -176.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 33.8 tpp -78.6 109.05 12.45 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 108.52 -0.918 . . . . 32.12 108.52 175.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 51.6 p -113.73 -178.35 3.36 Favored 'General case' 0 C--O 1.244 0.8 0 C-N-CA 123.242 0.617 . . . . 72.43 111.132 -174.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.531 HD21 ' HD3' ' A' ' 241' ' ' PRO . 65.5 tp -45.83 -51.66 12.55 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 124.278 0.986 . . . . 73.35 111.33 170.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -73.56 -29.4 62.4 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 114.05 -1.432 . . . . 74.54 111.442 -174.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 136.68 -167.18 24.64 Favored Glycine 0 C--N 1.348 1.211 0 CA-C-O 119.558 -0.579 . . . . 61.42 112.407 -177.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.91 129.47 24.71 Favored 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 122.329 2.019 . . . . 43.25 111.046 176.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.408 HG22 ' O ' ' A' ' 212' ' ' ALA . 28.1 m -132.8 161.55 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 123.573 0.749 . . . . 74.45 110.138 -176.297 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.664 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 51.8 mt-10 -111.54 115.56 29.38 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.711 0.804 . . . . 75.22 109.416 -173.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.422 HG22 HG11 ' A' ' 168' ' ' VAL . 59.8 t -126.63 104.66 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 124.451 1.1 . . . . 72.33 110.102 -169.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.574 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -76.89 117.99 19.04 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 110.066 -0.346 . . . . 54.12 110.066 176.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 34.0 m -88.07 152.36 50.55 Favored Pre-proline 0 N--CA 1.48 1.034 0 C-N-CA 123.002 0.521 . . . . 70.32 110.765 -178.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . 0.548 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 34.6 Cg_endo -62.55 163.69 20.39 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.242 1.961 . . . . 64.31 112.231 174.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -86.76 32.94 0.44 Allowed 'Trans proline' 0 C--N 1.371 1.75 0 C-N-CA 123.249 2.633 . . . . 75.52 112.074 176.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 5.2 tpt180 -148.99 -0.71 0.5 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 122.764 0.426 . . . . 74.34 111.324 178.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.585 HG23 HG11 ' A' ' 253' ' ' VAL . 0.6 OUTLIER -61.12 153.01 26.84 Favored 'General case' 0 CA--C 1.563 1.476 0 N-CA-C 109.519 -0.549 . . . . 41.33 109.519 -167.242 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . 0.464 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 19.5 pt20 -132.77 161.56 33.75 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.182 0.593 . . . . 70.23 110.41 -170.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . 0.461 ' HB1' ' NH2' ' A' ' 254' ' ' ARG . . . -61.27 110.84 1.52 Allowed 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 109.509 -0.552 . . . . 71.25 109.509 174.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 113.92 0.46 24.21 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 111.28 -0.728 . . . . 64.11 111.28 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.464 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -68.84 126.93 31.31 Favored 'General case' 0 C--N 1.362 1.152 0 N-CA-C 109.187 -0.671 . . . . 74.25 109.187 -173.513 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -97.71 97.7 9.24 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 108.947 -0.76 . . . . 64.44 108.947 -169.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.559 HD22 ' HB3' ' A' ' 172' ' ' SER . 25.8 mt -81.11 99.56 8.57 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.696 -1.224 . . . . 61.22 107.696 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.44 113.32 17.49 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.733 -0.667 . . . . 71.33 110.363 -178.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.555 ' HB3' ' HB2' ' A' ' 238' ' ' LYS . 7.5 mp -99.55 124.73 45.01 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 105.943 -1.873 . . . . 62.02 105.943 169.268 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -102.68 118.05 36.0 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.563 0.745 . . . . 64.31 109.777 -176.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 78.42 31.2 46.96 Favored Glycine 0 C--N 1.349 1.264 0 O-C-N 124.103 0.877 . . . . 53.23 112.735 -177.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.555 ' HB2' ' HB3' ' A' ' 235' ' ' LEU . 29.9 mmmt -129.94 21.25 5.4 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.028 0.931 . . . . 74.32 111.042 -179.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -96.81 -131.1 6.8 Favored Glycine 0 C--N 1.346 1.089 0 N-CA-C 111.468 -0.653 . . . . 75.35 111.468 -179.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 7.1 m-30 -70.8 151.77 95.19 Favored Pre-proline 0 CA--C 1.553 1.093 0 C-N-CA 123.458 0.703 . . . . 73.24 112.321 -178.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.531 ' HD3' HD21 ' A' ' 215' ' ' LEU . 58.8 Cg_endo -66.3 171.36 10.51 Favored 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 124.142 3.228 . . . . 73.11 112.977 179.08 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -66.35 -40.5 94.6 Favored Glycine 0 CA--C 1.543 1.84 0 CA-C-O 118.233 -1.315 . . . . 74.01 115.604 -175.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -53.9 -36.86 84.77 Favored 'Trans proline' 0 C--N 1.379 2.18 0 CA-C-N 120.827 2.313 . . . . 64.24 113.029 168.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -79.56 -26.61 41.34 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 122.987 0.515 . . . . 42.04 110.398 174.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . 0.435 ' HA3' ' HG2' ' A' ' 191' ' ' GLN . . . 110.65 115.67 3.63 Favored Glycine 0 C--N 1.345 1.083 0 N-CA-C 109.413 -1.475 . . . . 60.3 109.413 -170.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 11.1 mmm-85 -67.91 121.98 17.2 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.02 0.528 . . . . 61.13 110.292 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -143.73 -156.15 6.69 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-N 115.823 -0.626 . . . . 72.14 112.131 -177.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -120.64 165.53 14.92 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 123.675 0.79 . . . . 61.22 110.749 -172.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 16.1 tp -135.46 134.49 39.64 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 107.828 -1.175 . . . . 73.35 107.828 -173.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 8.9 m-30 -114.39 148.48 37.62 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 109.144 -0.687 . . . . 72.31 109.144 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.448 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 69.9 mt -122.93 113.94 19.78 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.24 -1.393 . . . . 74.22 107.24 178.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -89.65 111.68 22.71 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 106.986 -1.487 . . . . 72.31 106.986 -176.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.585 HG11 HG23 ' A' ' 227' ' ' THR . 54.7 t -62.21 125.82 19.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 O-C-N 123.977 0.798 . . . . 73.05 110.278 -178.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . 0.461 ' NH2' ' HB1' ' A' ' 229' ' ' ALA . 3.8 mmp_? -117.0 122.53 44.49 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.036 -1.468 . . . . 74.22 107.036 176.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 48.7 mm -88.37 115.42 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 O-C-N 123.799 0.687 . . . . 62.41 110.273 -172.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.0 t . . . . . 0 CA--C 1.562 1.413 0 C-N-CA 124.389 1.076 . . . . 54.24 109.23 -169.377 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 66.4 mtt . . . . . 0 N--CA 1.483 1.187 0 N-CA-C 109.51 -0.552 . . . . 73.43 109.51 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -103.54 140.81 37.02 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.999 0.919 . . . . 74.3 110.474 179.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -100.41 -42.03 6.78 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.247 1.019 . . . . 75.43 110.922 -170.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -100.42 24.6 31.46 Favored Glycine 0 C--N 1.345 1.034 0 CA-C-N 115.639 -0.709 . . . . 70.25 113.391 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -140.78 166.97 23.31 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.031 0.932 . . . . 34.3 109.056 178.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.526 HG11 HG22 ' A' ' 221' ' ' VAL . 60.7 t -110.94 149.93 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-O 121.62 0.724 . . . . 75.52 112.301 -162.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 42.6 mtm -99.51 -176.05 3.17 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.618 1.967 . . . . 64.2 108.813 -171.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 9.9 p -101.57 86.58 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.179 0 CA-C-O 123.067 1.413 . . . . 72.22 108.642 166.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.7 -4.76 9.2 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 113.933 -1.485 . . . . 75.1 110.232 -174.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 68.9 m -39.92 -67.31 0.24 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.778 2.031 . . . . 42.24 114.661 -164.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -66.53 -42.82 86.67 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 122.482 0.313 . . . . 73.31 110.537 -169.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 56.45 69.38 1.29 Allowed Glycine 0 C--N 1.344 1.023 0 N-CA-C 111.489 -0.644 . . . . 74.25 111.489 -176.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -72.87 20.03 0.08 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.085 0.954 . . . . 74.41 113.282 -174.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . 0.451 ' O ' ' HA ' ' A' ' 181' ' ' SER . 14.8 m -101.02 95.71 6.76 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.954 0.901 . . . . 64.12 109.188 170.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 13.2 mp0 -84.44 -28.57 26.75 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.776 0.798 . . . . 74.5 109.162 172.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -65.5 177.76 1.11 Allowed 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 114.046 -1.434 . . . . 74.01 110.091 167.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -10.51 -55.79 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.302 0 C-N-CA 127.949 2.5 . . . . 75.33 116.397 -174.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -81.18 55.25 4.81 Favored Glycine 0 N--CA 1.473 1.152 0 O-C-N 123.789 0.681 . . . . 31.24 112.649 178.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 176' ' ' SER . 34.8 t -79.36 -11.43 59.93 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.269 1.028 . . . . 65.25 112.992 -168.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 87.49 44.97 5.39 Favored Glycine 0 C--N 1.346 1.092 0 N-CA-C 111.737 -0.545 . . . . 65.12 111.737 -176.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -69.96 176.39 33.36 Favored Glycine 0 C--N 1.351 1.407 0 O-C-N 124.145 0.556 . . . . 65.15 113.257 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 51.4 p -69.16 101.75 1.52 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.827 0.851 . . . . 74.44 111.841 -173.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -92.91 -44.18 3.94 Favored Glycine 0 C--N 1.349 1.279 0 N-CA-C 111.54 -0.624 . . . . 64.33 111.54 173.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' ' 191' ' ' GLN . . . -70.16 -20.45 76.52 Favored Glycine 0 C--N 1.355 1.602 0 CA-C-N 115.457 -0.371 . . . . 32.51 112.471 176.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 18.3 m 60.26 22.57 11.98 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.683 1.193 . . . . 62.2 112.416 172.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 82.48 -78.2 2.01 Favored Glycine 0 C--N 1.352 1.456 0 CA-C-O 119.569 -0.573 . . . . 71.23 114.281 176.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -20.54 -72.1 0.01 OUTLIER Glycine 0 N--CA 1.486 1.99 0 C-N-CA 126.395 1.95 . . . . 24.53 117.854 -162.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 49.7 m -148.55 21.52 1.04 Allowed 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.38 0.672 . . . . 63.45 110.857 -177.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.406 ' HB3' ' HA3' ' A' ' 247' ' ' GLY . 15.9 mt-30 -118.76 -42.22 2.74 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.095 0.558 . . . . 65.22 110.724 -177.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -76.04 154.93 35.31 Favored 'General case' 0 N--CA 1.481 1.125 0 CA-C-N 115.342 -0.845 . . . . 72.24 109.547 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 56.9 tp -148.23 140.39 24.14 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.028 0.531 . . . . 74.24 110.34 175.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -114.55 138.76 50.24 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.089 0.955 . . . . 73.02 110.097 173.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -147.8 156.59 42.89 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.792 -0.818 . . . . 74.51 108.792 167.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 30.0 p -81.85 151.46 27.32 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 122.113 0.959 . . . . 75.03 112.14 168.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.634 HD13 ' HB2' ' A' ' 212' ' ' ALA . 27.2 tp -120.74 132.38 55.02 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 112.977 -1.92 . . . . 71.33 107.155 164.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -94.93 114.53 26.38 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 107.973 -1.121 . . . . 64.32 107.973 178.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.59 HG22 HG21 ' A' ' 210' ' ' VAL . 46.4 t -113.52 130.23 23.91 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 114.866 -1.061 . . . . 52.22 108.649 178.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -66.01 146.22 81.78 Favored 'Trans proline' 0 C--N 1.373 1.83 0 C-N-CA 122.287 1.992 . . . . 74.14 110.924 169.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.421 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.64 -46.21 98.36 Favored Pre-proline 0 CA--C 1.568 1.672 0 CA-C-O 118.334 -0.841 . . . . 45.22 112.304 175.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.421 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 26.0 Cg_endo -60.82 -31.48 91.77 Favored 'Trans proline' 0 C--N 1.403 3.446 0 C-N-CA 121.697 1.598 . . . . 62.43 112.549 176.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -86.44 -23.69 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 N-CA-C 109.153 -0.684 . . . . 74.31 109.153 -177.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -74.17 -38.53 63.65 Favored 'General case' 0 C--O 1.247 0.931 0 C-N-CA 122.938 0.495 . . . . 73.24 110.933 179.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 22.1 t -88.64 -36.45 9.05 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 CA-C-N 113.532 -1.667 . . . . 73.2 112.504 -177.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 55.5 t -98.61 -42.81 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 O-C-N 122.163 -0.335 . . . . 74.31 110.782 -177.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 122.26 152.14 8.57 Favored Glycine 0 N--CA 1.466 0.651 0 N-CA-C 110.919 -0.873 . . . . 72.1 110.919 -176.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.72 155.68 8.57 Favored Glycine 0 C--O 1.241 0.538 0 N-CA-C 111.444 -0.662 . . . . 63.3 111.444 178.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.571 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 35.4 ttmt -84.45 129.67 34.84 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 109.128 -0.693 . . . . 53.04 109.128 177.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.59 HG21 HG22 ' A' ' 199' ' ' VAL . 15.9 m -132.08 147.84 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.425 0.69 . . . . 65.01 109.594 179.062 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 14.4 ttp-105 -96.84 139.98 32.08 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.901 -1.045 . . . . 73.01 110.258 -167.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.634 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -132.24 120.59 22.39 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.001 0.92 . . . . 60.32 108.87 -174.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 33.5 tpp -78.04 110.02 12.62 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 108.826 -0.805 . . . . 74.44 108.826 174.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 56.4 p -112.33 -176.11 2.84 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 123.865 0.866 . . . . 72.3 109.971 -176.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.584 HD21 ' HD3' ' A' ' 241' ' ' PRO . 65.1 tp -47.9 -52.1 20.66 Favored 'General case' 0 C--N 1.354 0.782 0 C-N-CA 124.003 0.921 . . . . 74.22 111.55 173.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -72.84 -26.95 61.66 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 114.661 -1.154 . . . . 73.31 111.811 -171.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 137.85 -165.56 25.32 Favored Glycine 0 C--N 1.34 0.78 0 N-CA-C 111.299 -0.72 . . . . 23.13 111.299 -173.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.36 131.69 23.9 Favored 'Trans proline' 0 C--N 1.37 1.699 0 C-N-CA 122.081 1.854 . . . . 71.4 110.741 178.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 19.3 m -126.56 157.31 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 108.778 -0.823 . . . . 73.54 108.778 177.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.529 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 43.1 mt-10 -114.56 114.45 25.76 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 123.105 0.562 . . . . 60.32 109.511 -178.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.526 HG22 HG11 ' A' ' 168' ' ' VAL . 89.2 t -120.26 104.79 16.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 C-N-CA 125.474 1.51 . . . . 53.14 109.16 -169.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.571 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -76.11 117.63 18.01 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 122.836 0.454 . . . . 74.4 110.167 177.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 35.3 m -90.35 152.63 45.81 Favored Pre-proline 0 N--CA 1.478 0.927 0 C-N-CA 123.43 0.692 . . . . 64.24 111.289 -175.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . 0.539 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 45.2 Cg_endo -63.4 166.74 14.42 Favored 'Trans proline' 0 C--N 1.376 2.001 0 C-N-CA 123.507 2.805 . . . . 71.23 113.425 176.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -84.51 32.13 0.5 Allowed 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 122.83 2.353 . . . . 64.32 112.503 173.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 -150.51 -1.19 0.39 Allowed 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 112.561 0.578 . . . . 75.14 112.561 -179.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.539 ' HB ' ' HG2' ' A' ' 224' ' ' PRO . 0.6 OUTLIER -60.05 153.13 22.34 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 109.762 -0.458 . . . . 72.13 109.762 -167.101 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . 0.462 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 4.1 pt20 -133.08 161.51 34.21 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.55 0.74 . . . . 64.21 110.028 -174.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -63.46 110.66 2.02 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 109.024 -0.732 . . . . 64.13 109.024 174.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 114.72 3.74 21.87 Favored Glycine 0 C--O 1.241 0.545 0 CA-C-N 115.031 -0.986 . . . . 72.41 112.148 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.462 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -68.46 127.93 34.78 Favored 'General case' 0 CA--C 1.553 1.094 0 N-CA-C 109.288 -0.634 . . . . 74.43 109.288 -179.806 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -97.24 96.99 8.79 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.113 0.565 . . . . 74.02 109.776 -173.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.493 ' HB2' ' HB2' ' A' ' 251' ' ' LEU . 19.3 mt -81.83 99.21 8.88 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 106.558 -1.645 . . . . 61.51 106.558 179.092 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 5.0 ppt_? -82.56 116.2 21.87 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.832 -0.622 . . . . 72.44 111.396 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 7.3 mp -105.1 126.99 52.68 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 106.56 -1.645 . . . . 72.4 106.56 173.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 15.9 tptm -101.61 117.1 34.21 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 122.612 0.365 . . . . 72.31 110.668 -171.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 78.89 24.18 62.56 Favored Glycine 0 C--N 1.342 0.863 0 O-C-N 124.004 0.815 . . . . 64.34 112.907 -177.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 1.9 mmmp? -117.21 21.24 13.28 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 122.836 0.454 . . . . 72.22 111.144 -177.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -96.95 -129.95 6.4 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-O 119.406 -0.663 . . . . 64.54 112.095 -178.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 6.0 m-30 -71.04 152.76 94.82 Favored Pre-proline 0 CA--C 1.557 1.229 0 C-N-CA 123.264 0.626 . . . . 75.52 112.427 -177.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.584 ' HD3' HD21 ' A' ' 215' ' ' LEU . 74.3 Cg_endo -69.29 172.83 11.48 Favored 'Trans proline' 0 C--N 1.392 2.825 0 C-N-CA 123.837 3.025 . . . . 73.13 112.72 -179.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.4 ' N ' ' HD2' ' A' ' 243' ' ' PRO . . . -67.52 -39.73 91.04 Favored Glycine 0 CA--C 1.542 1.753 0 CA-C-O 118.058 -1.412 . . . . 61.14 114.671 -174.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . 0.4 ' HD2' ' N ' ' A' ' 242' ' ' GLY . 8.7 Cg_endo -52.28 -41.14 67.99 Favored 'Trans proline' 0 C--N 1.386 2.547 0 CA-C-N 121.071 2.435 . . . . 72.03 112.72 167.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -76.72 -25.21 53.28 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.16 0.584 . . . . 73.32 110.679 176.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 109.02 115.73 3.84 Favored Glycine 0 C--N 1.342 0.869 0 N-CA-C 109.354 -1.498 . . . . 73.22 109.354 -168.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -70.1 122.4 19.34 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 108.732 -0.84 . . . . 74.05 108.732 -178.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.406 ' HA3' ' HB3' ' A' ' 191' ' ' GLN . . . -142.82 -156.16 6.68 Favored Glycine 0 N--CA 1.465 0.596 0 N-CA-C 111.445 -0.662 . . . . 55.14 111.445 177.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 12.2 p30 -120.13 168.48 11.16 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-O 121.753 0.787 . . . . 71.54 111.357 -171.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 14.7 tp -135.5 133.46 38.49 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 107.84 -1.171 . . . . 74.43 107.84 -171.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -118.53 148.49 42.58 Favored 'General case' 0 C--O 1.253 1.28 0 N-CA-C 108.63 -0.878 . . . . 74.22 108.63 -178.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.493 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 91.6 mt -121.25 119.62 32.8 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.514 0.725 . . . . 71.2 109.162 -178.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -89.25 104.6 17.13 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 107.287 -1.375 . . . . 64.1 107.287 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.484 HG11 HG23 ' A' ' 227' ' ' THR . 55.4 t -62.89 128.43 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 121.271 0.558 . . . . 52.33 110.294 178.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 21.5 mtm105 -117.16 126.08 52.24 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.135 -1.432 . . . . 73.24 107.135 172.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 40.9 mm -88.5 127.28 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 109.751 -0.463 . . . . 64.05 109.751 -178.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.7 t . . . . . 0 CA--C 1.559 1.318 0 N-CA-C 107.775 -1.195 . . . . 72.53 107.775 -177.856 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 42.7 ttm . . . . . 0 N--CA 1.479 0.986 0 N-CA-C 109.72 -0.474 . . . . 54.35 109.72 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -138.24 73.18 1.43 Allowed 'General case' 0 N--CA 1.482 1.161 0 CA-C-O 122.233 1.015 . . . . 70.44 110.651 175.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -92.71 -12.08 32.35 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 115.341 -0.845 . . . . 75.21 110.87 176.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -96.26 7.73 66.74 Favored Glycine 0 C--N 1.35 1.329 0 CA-C-N 115.88 -0.6 . . . . 44.54 112.108 176.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -141.12 171.59 13.85 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.327 1.451 . . . . 75.24 107.328 172.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.475 HG11 HG22 ' A' ' 221' ' ' VAL . 55.9 t -108.65 152.52 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 123.498 0.719 . . . . 42.2 110.075 -176.027 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 46.5 mtm -99.28 -178.78 4.02 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.099 1.36 . . . . 73.1 109.212 -169.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 10.0 p -97.71 85.73 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 CA-C-O 123.429 1.585 . . . . 71.32 107.318 164.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.65 -4.7 9.23 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 113.608 -1.633 . . . . 70.21 109.846 -174.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.537 ' HA ' ' HB3' ' A' ' 233' ' ' LEU . 67.5 m -43.1 -64.11 0.69 Allowed 'General case' 0 C--O 1.241 0.608 0 C-N-CA 126.681 1.992 . . . . 64.32 113.425 -176.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . 0.419 ' HB2' ' HB3' ' A' ' 224' ' ' PRO . 45.5 t80 -72.16 -35.54 69.07 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.535 0.734 . . . . 63.03 109.355 -178.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 94.86 -2.55 66.67 Favored Glycine 0 C--N 1.346 1.131 0 CA-C-N 114.529 -1.214 . . . . 64.33 112.634 -176.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 66.5 t30 67.32 5.93 4.54 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 125.039 1.336 . . . . 62.31 111.968 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 21.8 p -84.35 113.85 21.45 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.821 -0.807 . . . . 64.42 108.821 175.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -56.7 -17.02 7.46 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.382 1.073 . . . . 72.4 112.385 -174.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -56.06 158.35 3.99 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.514 1.126 . . . . 74.31 111.937 172.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -60.98 -23.16 65.15 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.695 0.798 . . . . 64.45 112.532 -175.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -160.32 -179.98 35.46 Favored Glycine 0 C--O 1.241 0.573 0 O-C-N 123.582 0.551 . . . . 52.43 112.38 177.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 27.3 t -161.28 140.44 10.15 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.658 0.783 . . . . 51.52 109.432 178.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -154.82 129.48 2.58 Favored Glycine 0 C--N 1.337 0.596 0 N-CA-C 111.075 -0.81 . . . . 45.12 111.075 179.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -145.45 123.41 1.89 Allowed Glycine 0 C--N 1.337 0.633 0 N-CA-C 111.248 -0.741 . . . . 75.11 111.248 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 43.7 p -80.1 151.78 29.65 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.815 0.846 . . . . 73.12 110.797 -178.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -135.03 -65.75 0.07 OUTLIER Glycine 0 C--N 1.347 1.176 0 N-CA-C 111.976 -0.45 . . . . 71.43 111.976 179.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -73.14 86.13 0.58 Allowed Glycine 0 C--N 1.343 0.971 0 N-CA-C 112.346 -0.302 . . . . 72.13 112.346 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 33.8 m -76.59 74.3 3.3 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.313 1.045 . . . . 62.2 111.747 -172.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 54.88 33.5 56.5 Favored Glycine 0 C--N 1.352 1.448 0 CA-C-N 115.708 -0.678 . . . . 74.53 113.037 -177.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -107.45 11.56 39.43 Favored Glycine 0 C--N 1.343 0.932 0 CA-C-O 119.295 -0.725 . . . . 61.2 113.305 -172.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 20.7 m 65.25 30.83 11.09 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.174 0.99 . . . . 73.12 110.241 -173.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.579 ' HB3' ' HA3' ' A' ' 247' ' ' GLY . 91.4 mt-30 -110.38 -41.87 4.27 Favored 'General case' 0 C--O 1.247 0.932 0 C-N-CA 124.647 1.179 . . . . 71.22 110.721 -173.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -73.53 153.8 40.13 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 114.407 -1.269 . . . . 70.2 108.978 -177.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 60.5 tp -148.89 138.91 22.18 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 123.841 0.856 . . . . 72.54 108.994 174.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -111.56 142.14 44.23 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.861 0.864 . . . . 71.53 108.74 171.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -147.67 156.37 42.71 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 108.734 -0.839 . . . . 72.23 108.734 167.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 33.0 p -84.69 153.01 23.36 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-O 122.368 1.08 . . . . 65.53 112.127 168.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.593 HD13 ' HB2' ' A' ' 212' ' ' ALA . 20.5 tp -125.52 132.86 52.53 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 112.507 -2.133 . . . . 73.23 106.361 167.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -95.26 112.24 23.98 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.875 0.845 . . . . 75.42 108.772 -179.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.649 HG22 HG21 ' A' ' 210' ' ' VAL . 41.1 t -117.18 132.13 23.65 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 124.589 1.156 . . . . 63.23 108.882 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -68.79 147.55 69.33 Favored 'Trans proline' 0 C--N 1.369 1.647 0 C-N-CA 122.108 1.872 . . . . 74.41 111.159 167.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -54.43 -45.69 99.28 Favored Pre-proline 0 N--CA 1.487 1.38 0 CA-C-O 118.3 -0.857 . . . . 55.41 111.784 174.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -50.85 -40.43 57.48 Favored 'Trans proline' 0 C--N 1.405 3.536 0 C-N-CA 122.172 1.915 . . . . 54.03 113.169 172.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -84.64 -23.25 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 109.398 -0.593 . . . . 75.12 109.398 -175.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.498 ' HA ' HG22 ' A' ' 227' ' ' THR . . . -74.2 -39.57 63.07 Favored 'General case' 0 C--O 1.246 0.902 0 C-N-CA 123.06 0.544 . . . . 61.12 111.515 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 25.1 t -88.73 -36.92 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-N 114.558 -1.201 . . . . 75.2 112.598 -178.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 73.4 t -98.72 -41.02 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 O-C-N 122.136 -0.352 . . . . 73.3 110.807 -176.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 123.13 150.38 8.04 Favored Glycine 0 N--CA 1.475 1.236 0 CA-C-N 118.248 0.476 . . . . 55.33 112.068 177.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.91 153.6 7.57 Favored Glycine 0 C--N 1.343 0.946 0 N-CA-C 112.356 -0.297 . . . . 42.22 112.356 177.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 37.1 ttmt -84.63 131.95 34.54 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 122.945 0.498 . . . . 71.31 110.026 175.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.649 HG21 HG22 ' A' ' 199' ' ' VAL . 12.6 m -135.44 150.56 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.78 1.232 . . . . 72.32 108.639 -177.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -95.81 142.52 27.98 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.032 0.533 . . . . 74.32 110.563 -169.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.593 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -130.74 123.62 29.63 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.728 0.811 . . . . 53.3 109.301 -176.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 35.7 tpp -78.78 111.01 14.48 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 115.621 -0.718 . . . . 73.41 109.502 174.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 46.0 p -119.59 -177.05 3.29 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.955 0.902 . . . . 75.3 110.998 -174.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.571 HD21 ' HD3' ' A' ' 241' ' ' PRO . 59.6 tp -49.4 -51.16 36.93 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.465 1.106 . . . . 51.33 111.114 167.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -71.84 -25.75 62.1 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 113.444 -1.707 . . . . 74.43 111.002 -171.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 135.14 -166.6 24.37 Favored Glycine 0 C--N 1.342 0.897 0 N-CA-C 111.136 -0.786 . . . . 72.04 111.136 178.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -66.79 128.79 19.57 Favored 'Trans proline' 0 C--N 1.364 1.357 0 C-N-CA 121.44 1.427 . . . . 63.51 109.852 171.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.4 HG22 ' O ' ' A' ' 212' ' ' ALA . 27.3 m -130.19 160.2 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.159 0.584 . . . . 73.54 110.143 -176.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.557 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 44.2 mt-10 -111.72 115.8 29.68 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.868 0.867 . . . . 65.52 109.016 -174.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.475 HG22 HG11 ' A' ' 168' ' ' VAL . 60.2 t -125.34 104.14 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 124.633 1.173 . . . . 61.24 110.414 -168.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.562 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -74.59 117.26 16.21 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 109.846 -0.427 . . . . 63.04 109.846 175.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 32.9 m -90.93 151.74 43.69 Favored Pre-proline 0 N--CA 1.482 1.168 0 C-N-CA 122.803 0.441 . . . . 71.11 109.96 179.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . 0.528 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 39.3 Cg_endo -65.17 166.03 20.19 Favored 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 122.535 2.157 . . . . 45.21 113.284 178.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -79.2 35.5 0.56 Allowed 'Trans proline' 0 C--N 1.37 1.673 0 C-N-CA 122.803 2.336 . . . . 62.43 112.626 167.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 19.3 tpt180 -147.88 -10.65 0.39 Allowed 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.339 0.496 . . . . 71.01 112.339 -178.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.554 HG23 HG11 ' A' ' 253' ' ' VAL . 0.6 OUTLIER -61.16 150.15 35.18 Favored 'General case' 0 CA--C 1.565 1.547 0 N-CA-C 109.226 -0.657 . . . . 73.04 109.226 -164.66 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . 0.503 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 10.7 pt20 -132.52 162.5 31.07 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 122.991 0.517 . . . . 60.31 109.917 -174.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . 0.659 ' HB1' HH21 ' A' ' 254' ' ' ARG . . . -56.91 111.47 1.04 Allowed 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 109.601 -0.518 . . . . 54.5 109.601 174.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.14 -0.83 22.59 Favored Glycine 0 C--N 1.336 0.553 0 CA-C-N 115.268 -0.878 . . . . 60.54 112.418 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.503 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -70.37 124.65 24.7 Favored 'General case' 0 C--N 1.358 0.939 0 N-CA-C 109.262 -0.644 . . . . 72.44 109.262 -171.129 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -98.87 96.62 7.98 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 109.599 -0.519 . . . . 74.34 109.599 -168.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.537 ' HB3' ' HA ' ' A' ' 172' ' ' SER . 19.7 mt -81.88 99.52 9.09 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 106.822 -1.547 . . . . 64.42 106.822 -175.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . 0.46 ' HD2' ' O ' ' A' ' 234' ' ' ARG . 5.1 ppt_? -79.84 121.52 25.5 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 123.645 0.591 . . . . 73.13 110.899 -176.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 8.1 mp -108.55 125.74 52.16 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 105.861 -1.903 . . . . 54.22 105.861 172.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 17.5 tptt -101.87 116.3 32.4 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 118.138 0.426 . . . . 73.44 109.929 -171.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 79.35 21.71 66.6 Favored Glycine 0 C--N 1.349 1.278 0 O-C-N 123.763 0.664 . . . . 40.01 113.834 -178.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -117.54 20.81 13.37 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.736 0.814 . . . . 71.44 109.884 -178.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -98.94 -132.61 7.75 Favored Glycine 0 C--N 1.349 1.303 0 CA-C-O 119.097 -0.835 . . . . 72.44 111.82 -178.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -70.29 152.1 95.67 Favored Pre-proline 0 N--CA 1.481 1.079 0 N-CA-C 112.943 0.72 . . . . 70.53 112.943 -172.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.571 ' HD3' HD21 ' A' ' 215' ' ' LEU . 61.0 Cg_endo -67.2 170.56 13.01 Favored 'Trans proline' 0 C--N 1.392 2.859 0 C-N-CA 122.928 2.419 . . . . 74.02 112.526 -178.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.432 ' N ' ' HD2' ' A' ' 243' ' ' PRO . . . -67.71 -38.58 89.95 Favored Glycine 0 CA--C 1.544 1.874 0 CA-C-O 117.973 -1.459 . . . . 75.23 114.357 -175.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 242' ' ' GLY . 10.1 Cg_endo -54.02 -36.28 83.87 Favored 'Trans proline' 0 C--N 1.388 2.644 0 CA-C-N 120.998 2.399 . . . . 55.54 113.438 167.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -81.33 -25.06 36.71 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-O 121.136 0.493 . . . . 63.51 110.125 174.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 112.22 114.8 3.37 Favored Glycine 0 C--N 1.341 0.82 0 N-CA-C 109.66 -1.376 . . . . 74.5 109.66 -168.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -72.38 122.64 21.53 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 117.825 0.812 . . . . 72.52 109.639 -177.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.579 ' HA3' ' HB3' ' A' ' 191' ' ' GLN . . . -148.34 -154.61 6.35 Favored Glycine 0 CA--C 1.503 -0.713 0 CA-C-N 116.003 -0.544 . . . . 45.14 112.315 -176.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 38.5 p-10 -121.46 163.54 18.61 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.507 0.723 . . . . 74.31 111.125 -167.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 9.5 tp -134.71 134.5 41.12 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.365 -0.976 . . . . 72.22 108.365 -171.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -115.81 148.46 39.87 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.471 -0.937 . . . . 71.42 108.471 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . . . . . . . . . 67.7 mt -123.17 115.15 21.3 Favored 'General case' 0 C--O 1.22 -0.474 0 N-CA-C 108.29 -1.004 . . . . 53.25 108.29 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -89.38 113.54 24.87 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.618 -0.882 . . . . 73.03 108.618 -177.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.554 HG11 HG23 ' A' ' 227' ' ' THR . 50.3 t -60.75 124.79 15.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 O-C-N 124.019 0.824 . . . . 71.45 110.335 176.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . 0.659 HH21 ' HB1' ' A' ' 229' ' ' ALA . 0.5 OUTLIER -120.08 122.31 40.79 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 107.356 -1.35 . . . . 71.12 107.356 176.195 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.433 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 49.1 mm -83.8 122.36 37.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 O-C-N 123.984 0.803 . . . . 54.14 109.835 -173.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.2 t . . . . . 0 CA--C 1.565 1.549 0 C-N-CA 124.23 1.012 . . . . 64.45 108.822 -172.622 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . 0.615 ' HA ' ' SD ' ' A' ' 169' ' ' MET . 26.8 ptt? . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 109.948 -0.389 . . . . 73.23 109.948 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.436 ' HB2' ' HG2' ' A' ' 169' ' ' MET . 11.6 ttmm -118.27 128.41 54.65 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 107.388 -1.338 . . . . 73.4 107.388 179.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -83.93 -64.61 1.13 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.365 0.666 . . . . 70.11 112.255 -162.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -97.56 12.74 64.62 Favored Glycine 0 N--CA 1.472 1.077 0 CA-C-N 116.354 -0.384 . . . . 71.22 112.167 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -142.45 174.24 10.81 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.454 1.102 . . . . 70.42 109.35 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 52.4 t -110.67 150.99 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 123.442 0.697 . . . . 72.22 110.992 -176.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . 0.615 ' SD ' ' HA ' ' A' ' 163' ' ' MET . 53.4 mtm -99.4 -176.68 3.36 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 125.915 1.686 . . . . 75.45 110.894 -164.121 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 8.5 p -101.88 86.17 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.073 0 N-CA-C 107.195 -1.409 . . . . 72.41 107.195 160.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . 0.402 ' SD ' ' HB2' ' A' ' 169' ' ' MET . 0.0 OUTLIER -124.17 -4.25 7.95 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 114.148 -1.387 . . . . 75.01 110.76 -173.365 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.477 ' HA ' ' HB3' ' A' ' 233' ' ' LEU . 67.2 m -44.1 -65.82 0.46 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.995 1.718 . . . . 65.34 114.046 -168.23 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -70.85 -46.89 61.88 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 108.601 -0.889 . . . . 62.01 108.601 -176.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 68.28 28.95 73.07 Favored Glycine 0 C--N 1.354 1.54 0 CA-C-N 114.536 -1.211 . . . . 55.03 114.489 171.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . 0.633 HD21 ' HB2' ' A' ' 178' ' ' GLU . 59.7 t30 -161.0 158.31 27.75 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.031 0.443 . . . . 75.24 110.151 -177.074 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 16.1 p -87.96 115.76 25.66 Favored 'General case' 0 CA--C 1.555 1.163 0 N-CA-C 108.563 -0.903 . . . . 73.15 108.563 169.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -4.95 20.63 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.076 1 N-CA-C 122.062 4.097 . . . . 73.33 122.062 -159.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.633 ' HB2' HD21 ' A' ' 175' ' ' ASN . 43.4 mm-40 -86.9 157.5 19.5 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 119.872 1.214 . . . . 63.14 110.512 179.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -78.96 -62.43 1.7 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.235 1.014 . . . . 73.31 111.275 -173.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -66.82 91.81 0.19 Allowed Glycine 0 CA--C 1.529 0.943 0 O-C-N 124.366 1.041 . . . . 62.11 113.066 -175.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 29.7 p -155.84 142.73 18.94 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.593 0.757 . . . . 42.31 110.193 -177.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -134.54 -75.27 0.09 OUTLIER Glycine 0 C--N 1.343 0.972 0 CA-C-N 116.163 -0.471 . . . . 64.11 112.114 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 89.95 14.87 58.69 Favored Glycine 0 N--CA 1.473 1.137 0 O-C-N 123.824 0.367 . . . . 51.22 113.005 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 34.3 m -88.89 113.53 24.53 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.827 0.851 . . . . 52.41 109.78 178.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -170.36 165.1 38.4 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-O 120.008 -0.329 . . . . 70.23 112.883 -175.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 69.94 42.19 69.8 Favored Glycine 0 C--N 1.35 1.324 0 N-CA-C 111.907 -0.477 . . . . 44.31 111.907 -176.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 38.1 t -65.77 150.99 47.63 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.233 1.013 . . . . 70.23 113.267 -169.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -139.09 146.59 18.31 Favored Glycine 0 C--N 1.34 0.779 0 CA-C-N 115.031 -0.986 . . . . 74.44 110.903 173.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -62.73 -33.39 86.67 Favored Glycine 0 C--N 1.349 1.267 0 O-C-N 123.947 0.44 . . . . 72.14 113.734 -173.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 57.9 m -146.6 37.02 0.98 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.426 1.09 . . . . 70.12 109.233 174.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -105.47 -39.29 6.17 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 108.908 -0.775 . . . . 72.33 108.908 174.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -76.57 168.57 19.84 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-N 114.638 -1.165 . . . . 75.15 109.958 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 39.1 tp -152.44 142.97 22.72 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.269 -0.423 . . . . 74.41 110.104 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -116.13 138.14 51.51 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.797 0.839 . . . . 72.53 109.107 171.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -148.77 160.14 43.48 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.628 0.771 . . . . 73.51 109.42 174.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 37.9 p -84.42 154.54 22.74 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 122.276 1.036 . . . . 72.13 112.195 167.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.766 HD13 ' HB2' ' A' ' 212' ' ' ALA . 30.8 tp -120.47 134.4 55.28 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 112.844 -1.98 . . . . 53.43 106.789 165.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -97.52 111.72 23.87 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 109.107 -0.701 . . . . 74.34 109.107 179.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.65 HG22 HG21 ' A' ' 210' ' ' VAL . 28.1 t -123.01 130.98 24.39 Favored Pre-proline 0 N--CA 1.479 0.979 0 C-N-CA 124.549 1.139 . . . . 75.44 109.579 -177.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -69.95 144.93 54.55 Favored 'Trans proline' 0 C--N 1.366 1.489 0 C-N-CA 122.22 1.947 . . . . 43.11 111.232 165.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -53.13 -44.63 97.61 Favored Pre-proline 0 N--CA 1.487 1.413 0 CA-C-O 118.348 -0.834 . . . . 74.11 111.953 174.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -47.55 -41.49 29.87 Favored 'Trans proline' 0 C--N 1.401 3.317 0 C-N-CA 122.556 2.171 . . . . 73.53 113.416 171.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 1.8 mp -85.91 -23.29 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 109.716 -0.476 . . . . 70.11 109.716 -175.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.417 ' HA ' HG22 ' A' ' 227' ' ' THR . . . -72.45 -37.76 68.45 Favored 'General case' 0 C--O 1.249 1.051 0 CA-C-O 121.05 0.452 . . . . 63.21 111.535 178.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 20.3 t -89.73 -36.05 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.987 0 C-N-CA 125.444 1.497 . . . . 34.03 113.168 -178.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 54.4 t -97.12 -43.14 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 O-C-N 121.998 -0.438 . . . . 72.24 110.268 -176.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 120.95 151.51 8.62 Favored Glycine 0 C--N 1.339 0.744 0 N-CA-C 110.89 -0.884 . . . . 70.35 110.89 -176.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 164.6 155.89 8.65 Favored Glycine 0 C--O 1.246 0.886 0 N-CA-C 112.048 -0.421 . . . . 64.34 112.048 177.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.594 ' HD3' ' HB3' ' A' ' 220' ' ' GLU . 38.5 ttmt -84.54 131.6 34.62 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.319 0.648 . . . . 74.51 109.519 174.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.65 HG21 HG22 ' A' ' 199' ' ' VAL . 6.7 m -134.42 154.4 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.4 1.08 . . . . 61.44 110.581 -175.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 2.5 tmm_? -93.32 139.92 30.13 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.569 1.147 . . . . 64.33 109.751 -171.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.766 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -132.42 122.6 25.23 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.145 0.978 . . . . 73.01 108.734 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 31.3 tpp -77.68 110.2 12.32 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.679 -0.86 . . . . 61.33 108.679 173.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 62.2 p -121.25 -179.28 4.0 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.998 0.919 . . . . 73.22 110.221 -176.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.503 HD21 ' HD3' ' A' ' 241' ' ' PRO . 61.2 tp -45.09 -52.9 8.59 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.686 1.195 . . . . 75.22 112.485 176.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -72.39 -27.48 62.39 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 114.218 -1.355 . . . . 73.24 111.385 -173.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 138.02 -165.11 25.47 Favored Glycine 0 C--N 1.345 1.055 0 N-CA-C 111.561 -0.616 . . . . 54.21 111.561 -176.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -67.01 129.25 20.27 Favored 'Trans proline' 0 C--N 1.369 1.62 0 C-N-CA 122.147 1.898 . . . . 61.31 111.011 175.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 30.2 m -129.72 160.23 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 123.528 0.731 . . . . 73.41 110.659 -175.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.594 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 44.4 mt-10 -113.01 114.53 27.02 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.835 0.854 . . . . 72.22 109.655 -168.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 61.9 t -127.34 103.43 10.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 124.87 1.268 . . . . 74.03 109.39 -166.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.511 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -77.82 116.79 18.61 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.892 -0.41 . . . . 73.4 109.892 175.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 29.8 m -89.35 152.04 47.12 Favored Pre-proline 0 N--CA 1.492 1.626 0 C-N-CA 123.222 0.609 . . . . 63.21 111.116 -176.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . 0.57 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 29.7 Cg_endo -62.21 162.47 23.16 Favored 'Trans proline' 0 C--N 1.382 2.307 0 C-N-CA 122.197 1.931 . . . . 73.24 112.517 175.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -85.4 30.97 0.49 Allowed 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 123.115 2.543 . . . . 73.52 112.519 176.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -149.06 3.17 0.6 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 122.747 0.419 . . . . 75.11 111.447 176.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.57 ' HB ' ' HG2' ' A' ' 224' ' ' PRO . 0.7 OUTLIER -61.85 155.64 22.74 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 109.829 -0.434 . . . . 64.25 109.829 -171.776 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -136.55 162.41 33.19 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.078 0.551 . . . . 74.3 110.097 -176.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . 0.567 ' HB1' HH21 ' A' ' 254' ' ' ARG . . . -56.15 112.25 1.17 Allowed 'General case' 0 CA--C 1.538 0.505 0 O-C-N 123.471 0.482 . . . . 44.22 109.915 174.017 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.29 -1.07 22.37 Favored Glycine 0 C--O 1.239 0.418 0 CA-C-N 114.968 -1.014 . . . . 71.14 111.982 176.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.62 129.72 40.75 Favored 'General case' 0 C--N 1.361 1.108 0 N-CA-C 109.179 -0.674 . . . . 70.04 109.179 -174.071 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm -98.67 97.69 8.92 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.977 0.911 . . . . 74.42 110.065 -170.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.477 ' HB3' ' HA ' ' A' ' 172' ' ' SER . 17.3 mt -88.09 101.04 13.41 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 107.65 -1.241 . . . . 71.41 107.65 -178.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.48 125.53 29.69 Favored 'General case' 0 CA--C 1.551 1.009 0 CA-C-O 121.164 0.507 . . . . 71.53 110.213 178.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.4 ' HB3' ' HB2' ' A' ' 238' ' ' LYS . 6.9 mp -106.04 126.77 52.6 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 105.879 -1.897 . . . . 53.14 105.879 171.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 8.1 tptp -101.32 115.75 31.23 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 109.994 -0.373 . . . . 72.12 109.994 -168.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 77.5 29.25 56.03 Favored Glycine 0 C--N 1.354 1.574 0 O-C-N 123.676 0.61 . . . . 70.14 112.676 -178.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.4 ' HB2' ' HB3' ' A' ' 235' ' ' LEU . 30.8 mmmt -124.53 23.85 8.04 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.807 0.843 . . . . 73.54 110.715 -177.098 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -94.41 -132.04 6.47 Favored Glycine 0 C--N 1.353 1.523 0 N-CA-C 111.167 -0.773 . . . . 74.14 111.167 178.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 6.2 m-30 -69.48 154.36 94.93 Favored Pre-proline 0 N--CA 1.481 1.08 0 CA-C-N 117.47 0.635 . . . . 62.52 112.043 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.503 ' HD3' HD21 ' A' ' 215' ' ' LEU . 72.8 Cg_endo -70.13 171.26 15.2 Favored 'Trans proline' 0 C--N 1.387 2.565 0 C-N-CA 122.826 2.351 . . . . 75.21 111.909 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -67.68 -38.96 90.43 Favored Glycine 0 CA--C 1.542 1.774 0 CA-C-O 118.479 -1.178 . . . . 75.23 114.078 -178.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . 0.424 ' HD2' ' HB2' ' A' ' 241' ' ' PRO . 87.8 Cg_exo -48.72 -35.19 29.56 Favored 'Trans proline' 0 C--N 1.383 2.36 0 C-N-CA 123.054 2.503 . . . . 70.43 114.09 165.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -88.3 -24.62 23.13 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.457 0.703 . . . . 51.31 110.998 174.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 105.76 115.23 4.03 Favored Glycine 0 C--N 1.345 1.06 0 N-CA-C 109.192 -1.563 . . . . 73.42 109.192 -169.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 35.3 mtt180 -73.1 134.07 44.38 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 122.988 0.515 . . . . 62.15 112.145 -178.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -145.75 -155.91 6.67 Favored Glycine 0 C--O 1.242 0.606 0 CA-C-N 114.654 -1.157 . . . . 53.53 110.304 174.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 12.6 p30 -118.01 168.03 10.91 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 122.949 0.5 . . . . 50.41 110.083 -175.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 9.7 tp -134.42 133.3 40.37 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 107.862 -1.162 . . . . 74.41 107.862 -172.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 10.0 m-30 -114.26 149.46 35.86 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.761 -0.829 . . . . 64.04 108.761 -177.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.403 ' HB2' ' HB2' ' A' ' 233' ' ' LEU . 92.1 mt -123.76 121.94 36.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.546 -0.752 . . . . 74.34 109.038 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -88.76 112.55 23.31 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 107.289 -1.375 . . . . 71.11 107.289 174.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.497 HG11 HG23 ' A' ' 227' ' ' THR . 54.1 t -60.8 123.47 13.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 108.868 -0.789 . . . . 62.12 108.868 173.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . 0.567 HH21 ' HB1' ' A' ' 229' ' ' ALA . 0.4 OUTLIER -114.65 123.29 48.92 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 106.71 -1.589 . . . . 73.04 106.71 176.411 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 38.1 mm -86.78 119.99 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 O-C-N 123.783 0.677 . . . . 74.32 109.721 -176.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.3 t . . . . . 0 CA--C 1.562 1.413 0 C-N-CA 125.292 1.437 . . . . 63.01 107.669 -170.533 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . 0.446 ' N ' ' SD ' ' A' ' 163' ' ' MET . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.372 0 N-CA-C 109.268 -0.641 . . . . 50.33 109.268 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -147.94 132.21 17.47 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.799 0.84 . . . . 64.53 110.201 176.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -89.2 -38.66 14.1 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.677 0.791 . . . . 51.43 111.972 -169.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -95.31 21.96 41.35 Favored Glycine 0 N--CA 1.476 1.359 0 N-CA-C 112.553 -0.219 . . . . 60.25 112.553 -174.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -153.63 173.24 16.03 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 124.579 1.151 . . . . 51.21 109.195 175.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.423 HG11 HG22 ' A' ' 221' ' ' VAL . 55.4 t -110.64 152.75 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 123.798 0.839 . . . . 72.52 110.39 -177.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' MET . . . . . . . . . . . . . 48.8 mtm -98.29 -176.2 3.33 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.88 1.672 . . . . 64.22 110.074 -168.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 8.7 p -101.71 88.47 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.026 0 CA-C-O 123.125 1.441 . . . . 72.23 108.079 161.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . 0.417 ' HG3' ' HA ' ' A' ' 235' ' ' LEU . 0.0 OUTLIER -123.81 -6.03 7.99 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 113.717 -1.583 . . . . 73.2 110.021 -177.129 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.459 ' HA ' ' HB3' ' A' ' 233' ' ' LEU . 68.5 m -37.64 -64.63 0.37 Allowed 'General case' 0 C--N 1.351 0.643 0 C-N-CA 126.97 2.108 . . . . 44.23 114.379 -168.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . 0.43 ' HB2' ' HB3' ' A' ' 224' ' ' PRO . 53.3 t80 -63.51 -53.37 53.02 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 123.661 0.6 . . . . 74.23 109.639 -174.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 64.15 -15.45 0.13 Allowed Glycine 0 CA--C 1.542 1.747 0 N-CA-C 115.937 1.135 . . . . 74.42 115.937 176.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 -78.58 107.76 11.49 Favored 'General case' 0 C--N 1.349 0.566 0 C-N-CA 124.151 0.98 . . . . 72.31 108.725 -175.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 33.0 m -67.29 123.19 19.65 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 117.69 -1.148 . . . . 75.41 107.913 169.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -11.24 -46.72 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.806 0 C-N-CA 128.576 2.75 . . . . 65.34 116.884 -164.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -58.18 168.37 1.06 Allowed 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 124.647 1.179 . . . . 61.02 111.868 176.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -78.48 -6.16 54.61 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.164 0.585 . . . . 72.01 112.403 -179.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -76.65 -115.36 0.14 Allowed Glycine 0 CA--C 1.534 1.278 0 CA-C-O 119.899 -0.389 . . . . 60.15 113.691 -176.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 38.5 m 63.06 -83.14 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.904 1.281 . . . . 74.33 113.058 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 73.45 -88.65 0.61 Allowed Glycine 0 C--N 1.352 1.452 0 N-CA-C 111.64 -0.584 . . . . 23.14 111.64 -173.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 72.86 75.73 0.69 Allowed Glycine 0 C--N 1.351 1.414 0 C-N-CA 123.025 0.345 . . . . 72.51 113.275 173.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 34.5 p -138.45 123.1 18.62 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.501 0.72 . . . . 53.11 109.627 178.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -83.54 -77.83 1.1 Allowed Glycine 0 C--N 1.341 0.814 0 N-CA-C 110.757 -0.937 . . . . 41.03 110.757 177.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 86.32 -89.13 1.61 Allowed Glycine 0 C--N 1.342 0.892 0 CA-C-O 119.855 -0.414 . . . . 61.34 112.738 176.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 32.9 t 68.84 176.8 0.27 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 125.444 1.497 . . . . 53.21 111.236 -171.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -123.04 37.74 2.7 Favored Glycine 0 C--N 1.348 1.243 0 O-C-N 122.038 -0.414 . . . . 51.41 112.481 -177.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -120.5 11.97 10.34 Favored Glycine 0 N--CA 1.471 1.002 0 CA-C-O 119.18 -0.789 . . . . 53.2 113.852 -175.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 19.5 m 63.4 43.72 5.88 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 124.055 0.942 . . . . 62.52 110.652 -177.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -107.2 -37.5 6.25 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.817 1.247 . . . . 65.31 110.636 -172.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 35.1 p-10 -75.54 172.83 11.88 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-N 115.7 -0.682 . . . . 65.3 110.578 178.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.414 HD13 ' CE1' ' A' ' 240' ' ' PHE . 33.9 tp -152.96 140.7 20.0 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.878 -0.601 . . . . 73.42 110.545 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -112.36 137.95 49.78 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.508 -0.769 . . . . 72.42 108.927 169.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.417 ' O ' ' HA ' ' A' ' 251' ' ' LEU . . . -148.13 158.01 43.83 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 107.919 -1.141 . . . . 73.32 107.919 170.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 25.1 p -89.87 154.11 20.13 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 122.188 0.994 . . . . 65.2 112.511 169.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.68 HD13 ' HB2' ' A' ' 212' ' ' ALA . 22.2 tp -124.28 132.84 53.59 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 112.997 -1.911 . . . . 61.31 107.352 164.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -94.72 113.7 25.51 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 108.372 -0.973 . . . . 73.53 108.372 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.637 HG22 HG21 ' A' ' 210' ' ' VAL . 24.8 t -118.0 130.9 24.43 Favored Pre-proline 0 CA--C 1.542 0.636 0 CA-C-N 114.95 -1.023 . . . . 74.04 108.578 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.494 ' HG2' ' HB ' ' A' ' 203' ' ' ILE . 59.3 Cg_endo -73.76 149.76 43.5 Favored 'Trans proline' 0 C--N 1.366 1.475 0 C-N-CA 121.47 1.447 . . . . 73.23 110.833 168.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -53.45 -44.71 98.14 Favored Pre-proline 0 N--CA 1.483 1.202 0 CA-C-O 118.193 -0.908 . . . . 50.14 112.186 177.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.453 ' HD2' ' HB2' ' A' ' 200' ' ' PRO . 86.0 Cg_exo -50.56 -41.22 53.67 Favored 'Trans proline' 0 C--N 1.399 3.223 0 C-N-CA 122.46 2.107 . . . . 71.52 113.525 173.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.494 ' HB ' ' HG2' ' A' ' 200' ' ' PRO . 1.8 mp -86.42 -23.07 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 N-CA-C 109.718 -0.475 . . . . 74.31 109.718 -176.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -72.57 -36.71 68.25 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 122.934 0.494 . . . . 73.11 111.044 177.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 25.4 t -89.56 -36.37 8.57 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 125.663 1.585 . . . . 72.23 112.873 -178.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 50.2 t -98.23 -42.58 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 O-C-N 121.663 -0.648 . . . . 64.0 110.91 -176.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 120.82 153.95 9.19 Favored Glycine 0 C--N 1.341 0.855 0 N-CA-C 110.704 -0.958 . . . . 42.5 110.704 -176.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 161.03 154.94 7.61 Favored Glycine 0 C--O 1.245 0.786 0 N-CA-C 111.57 -0.612 . . . . 41.13 111.57 177.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 222' ' ' ALA . 39.3 ttmt -86.54 128.95 35.02 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.905 0.352 . . . . 63.31 110.655 176.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.637 HG21 HG22 ' A' ' 199' ' ' VAL . 13.5 m -130.74 144.51 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.958 1.303 . . . . 74.34 108.533 -179.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 24.2 ttt180 -97.08 141.62 30.0 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.059 0.943 . . . . 73.14 110.437 -167.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.68 ' HB2' HD13 ' A' ' 197' ' ' LEU . . . -133.18 124.75 28.02 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.429 1.491 . . . . 72.03 110.187 -168.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 33.6 tpp -77.48 114.95 16.83 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 109.024 -0.732 . . . . 73.13 109.024 174.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 63.0 p -124.16 -176.3 3.46 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.193 0.997 . . . . 61.24 110.292 -177.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.537 HD21 ' HD3' ' A' ' 241' ' ' PRO . 66.9 tp -47.24 -51.58 18.38 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.623 1.169 . . . . 72.24 112.657 176.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -72.01 -27.22 62.58 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 114.75 -1.114 . . . . 74.21 111.085 -172.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 137.14 -165.2 25.22 Favored Glycine 0 C--O 1.244 0.774 0 N-CA-C 110.702 -0.959 . . . . 53.42 110.702 -173.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.79 131.54 24.44 Favored 'Trans proline' 0 CA--C 1.549 1.226 0 C-N-CA 121.979 1.786 . . . . 73.33 111.187 175.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 25.7 m -129.65 157.25 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 124.087 0.955 . . . . 74.45 108.742 -179.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.538 ' HB3' ' HD3' ' A' ' 209' ' ' LYS . 47.0 mt-10 -115.24 117.23 29.91 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-O 121.145 0.498 . . . . 71.12 111.358 -176.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.423 HG22 HG11 ' A' ' 168' ' ' VAL . 100.0 t -121.86 107.15 19.31 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 125.65 1.58 . . . . 61.43 110.893 -165.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.603 ' HA ' ' HA ' ' A' ' 209' ' ' LYS . . . -75.19 118.19 17.84 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.583 0.353 . . . . 71.42 111.122 176.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 26.8 m -89.6 154.4 48.32 Favored Pre-proline 0 N--CA 1.489 1.48 0 C-N-CA 123.71 0.804 . . . . 71.43 111.693 -176.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . 0.566 ' HG2' ' HB ' ' A' ' 227' ' ' THR . 34.2 Cg_endo -63.02 164.04 20.63 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 122.658 2.239 . . . . 74.12 113.057 174.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -87.08 32.13 0.44 Allowed 'Trans proline' 0 C--N 1.37 1.66 0 C-N-CA 122.779 2.319 . . . . 74.22 113.19 174.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -147.97 1.46 0.66 Allowed 'General case' 0 N--CA 1.485 1.29 0 CA-C-O 118.903 -0.57 . . . . 65.02 112.333 175.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.566 ' HB ' ' HG2' ' A' ' 224' ' ' PRO . 0.7 OUTLIER -60.57 154.64 20.57 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 123.466 0.479 . . . . 44.43 110.406 -168.144 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . 0.48 ' O ' ' HB2' ' A' ' 231' ' ' ARG . 4.9 pt20 -134.38 161.19 35.68 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.27 0.628 . . . . 71.03 110.698 -174.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -60.29 112.15 1.82 Allowed 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.906 -0.405 . . . . 63.31 109.906 176.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 115.41 0.75 21.96 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-N 115.083 -0.962 . . . . 63.02 112.122 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.48 ' HB2' ' O ' ' A' ' 228' ' ' GLN . 0.0 OUTLIER -72.81 126.05 28.99 Favored 'General case' 0 C--N 1.359 0.98 0 N-CA-C 108.835 -0.802 . . . . 63.11 108.835 -174.735 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -97.17 98.15 9.78 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 108.255 -1.016 . . . . 71.35 108.255 -173.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.459 ' HB3' ' HA ' ' A' ' 172' ' ' SER . 30.9 mt -77.96 99.94 6.24 Favored 'General case' 0 C--N 1.343 0.297 0 N-CA-C 106.803 -1.555 . . . . 52.42 106.803 -179.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . 0.521 ' HB2' ' HE2' ' A' ' 236' ' ' LYS . 0.0 OUTLIER -81.4 111.42 17.74 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 114.282 -1.326 . . . . 64.42 111.642 -173.952 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.527 ' O ' ' HB2' ' A' ' 248' ' ' ASP . 7.3 mp -100.28 127.85 46.48 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 106.193 -1.78 . . . . 22.12 106.193 173.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.521 ' HE2' ' HB2' ' A' ' 234' ' ' ARG . 5.3 mptp? -101.48 119.49 38.85 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.46 0.704 . . . . 73.31 110.868 -175.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 78.19 23.58 65.62 Favored Glycine 0 C--N 1.354 1.546 0 O-C-N 123.89 0.744 . . . . 41.43 112.662 -179.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.496 ' HB2' ' HB3' ' A' ' 235' ' ' LEU . 26.8 mmmt -119.06 21.28 12.42 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.297 1.039 . . . . 60.53 111.052 -175.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -94.12 -128.6 5.19 Favored Glycine 0 C--N 1.345 1.043 0 N-CA-C 110.243 -1.143 . . . . 74.11 110.243 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . 0.436 ' O ' ' HA ' ' A' ' 246' ' ' ARG . 7.3 m-30 -70.98 152.41 94.95 Favored Pre-proline 0 CA--C 1.551 0.985 0 CA-C-N 117.479 0.64 . . . . 70.04 111.668 178.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.537 ' HD3' HD21 ' A' ' 215' ' ' LEU . 48.2 Cg_endo -64.92 171.8 8.15 Favored 'Trans proline' 0 C--N 1.387 2.6 0 C-N-CA 123.182 2.588 . . . . 74.33 112.166 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -66.19 -41.87 94.62 Favored Glycine 0 CA--C 1.541 1.706 0 CA-C-O 118.489 -1.173 . . . . 55.45 113.445 -177.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . 0.449 ' HD2' ' HB2' ' A' ' 241' ' ' PRO . 81.4 Cg_exo -54.67 -39.9 86.84 Favored 'Trans proline' 0 C--N 1.388 2.632 0 C-N-CA 122.556 2.171 . . . . 61.4 114.095 168.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -76.68 -22.43 54.0 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.479 0.712 . . . . 71.23 110.646 177.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 106.93 111.78 3.61 Favored Glycine 0 C--N 1.343 0.953 0 N-CA-C 108.679 -1.768 . . . . 62.51 108.679 -172.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.436 ' HA ' ' O ' ' A' ' 240' ' ' PHE . 54.1 ttp180 -73.4 124.66 26.21 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 117.086 0.443 . . . . 62.14 110.76 -174.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -135.84 -158.8 8.3 Favored Glycine 0 CA--C 1.505 -0.552 0 N-CA-C 110.488 -1.045 . . . . 43.2 110.488 174.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . 0.527 ' HB2' ' O ' ' A' ' 235' ' ' LEU . 34.2 p-10 -123.14 161.96 23.42 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.137 0.575 . . . . 72.22 110.125 -174.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . . 8.4 tp -132.0 134.89 46.09 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 108.375 -0.972 . . . . 43.52 108.375 -168.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -115.67 148.96 39.1 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 108.53 -0.915 . . . . 74.33 108.53 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.417 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 75.0 mt -122.38 112.49 18.15 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 108.594 -0.891 . . . . 71.11 108.594 179.045 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -89.76 112.28 23.53 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.285 -1.006 . . . . 70.21 108.285 -173.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.505 HG11 HG23 ' A' ' 227' ' ' THR . 53.8 t -61.6 125.9 18.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 114.969 -1.014 . . . . 72.52 110.222 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 41.8 mtp180 -115.54 122.51 45.9 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 106.571 -1.64 . . . . 74.32 106.571 171.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.459 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 46.8 mm -83.76 123.57 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 122.665 0.386 . . . . 62.13 110.123 -175.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.2 t . . . . . 0 CA--C 1.561 1.4 0 C-N-CA 124.273 1.029 . . . . 75.43 109.056 -172.275 . . . . . . . . 0 0 . 1 stop_ save_